data_2m0z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m0z _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 103.462 -2.792 . . . . 73.04 103.462 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.59 153.61 44.91 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.715 -1.587 . . . . 74.41 106.715 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -108.76 141.59 40.54 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.175 -1.787 . . . . 73.15 106.175 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.4 t -128.53 130.61 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 N-CA-C 104.819 -2.289 . . . . 71.45 104.819 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -105.71 113.21 26.64 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 104.931 -2.248 . . . . 72.13 104.931 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 120.98 41.54 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.231 -1.766 . . . . 72.31 106.231 -169.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.72 142.59 28.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.232 -1.766 . . . . 64.51 106.232 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm . . . . . 0 CA--C 1.499 -1.015 0 N-CA-C 107.026 -1.472 . . . . 73.25 107.026 -178.503 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 N-CA-C 110.27 -1.132 . . . . 65.04 110.27 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mt -129.24 158.86 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.433 -2.432 . . . . 74.12 104.433 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -149.99 165.42 32.72 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.147 -3.279 . . . . 43.43 102.147 168.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.71 168.19 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 105.936 -1.875 . . . . 74.01 105.936 -170.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -146.45 166.59 25.95 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 103.029 -2.952 . . . . 73.43 103.029 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.5 -173.3 14.66 Favored Glycine 0 CA--C 1.472 -2.624 0 N-CA-C 107.548 -2.221 . . . . 73.42 107.548 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.78 -127.81 6.08 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 108.838 -1.705 . . . . 44.12 108.838 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -73.18 19.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 126.222 1.809 . . . . 71.22 112.419 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.262 9.5 m120 87.31 65.52 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.672 0 N-CA-C 106.34 -1.726 . . . . 62.43 106.34 -168.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 30' ' ' SER . 3.4 m -80.96 -165.78 0.98 Allowed 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 104.003 -2.592 . . . . 73.2 104.003 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.58 ' H ' HG23 ' A' ' 29' ' ' THR . 3.4 p -42.96 -40.73 3.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 53.04 112.032 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.51 138.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.583 -0.895 . . . . 74.44 108.583 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.24 -42.39 68.92 Favored 'General case' 0 C--N 1.364 1.206 0 N-CA-C 109.787 -0.449 . . . . 75.31 109.787 -171.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -73.9 -5.64 42.34 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.843 -0.799 . . . . 71.23 108.843 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.22 3.25 11.5 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.304 -0.718 . . . . 74.41 111.304 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.53 150.19 42.09 Favored Glycine 0 CA--C 1.475 -2.448 0 N-CA-C 109.625 -1.39 . . . . 54.34 109.625 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.81 87.96 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 105.49 -2.041 . . . . 74.32 105.49 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -88.75 144.19 26.41 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.585 -1.635 . . . . 74.21 106.585 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.21 133.82 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.535 -1.654 . . . . 70.21 106.535 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -104.1 -43.66 5.2 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 106.712 -1.588 . . . . 64.53 106.712 -167.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.18 150.8 36.55 Favored 'General case' 0 CA--C 1.458 -2.569 0 N-CA-C 105.441 -2.059 . . . . 70.21 105.441 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -137.26 132.14 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.622 -2.362 . . . . 72.55 104.622 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.3 mt -70.6 137.88 85.91 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 105.546 -2.02 . . . . 75.15 105.546 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.56 123.53 13.96 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.165 1.91 . . . . 75.24 108.744 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 55.74 32.6 19.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.497 1.119 . . . . 71.54 112.053 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.92 -177.95 46.08 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 105.36 -3.096 . . . . 64.41 105.36 168.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.51 98.75 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.279 1.04 . . . . 63.2 109.6 -168.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.05 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 109.233 -0.654 . . . . 64.12 109.233 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -69.24 -38.74 78.62 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 109.648 -0.501 . . . . 73.44 109.648 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -65.38 -37.49 87.16 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.958 -1.126 . . . . 74.41 107.958 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.42 -32.56 66.43 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.532 -1.285 . . . . 72.34 107.532 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.79 64.99 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.726 -0.95 . . . . 73.53 110.726 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -83.33 -41.03 18.71 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.459 -0.941 . . . . 73.24 108.459 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.8 mt -104.78 136.69 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.902 -1.888 . . . . 62.13 105.902 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -138.33 -178.52 5.32 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 104.843 -2.28 . . . . 74.31 104.843 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.42 146.9 54.04 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.678 -0.86 . . . . 73.02 108.678 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.21 -3.73 86.57 Favored Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 109.704 -1.359 . . . . 52.23 109.704 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -80.51 155.45 27.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.461 -2.052 . . . . 75.32 105.461 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -119.68 127.35 52.8 Favored 'General case' 0 CA--C 1.478 -1.807 0 C-N-CA 119.411 -0.916 . . . . 71.32 109.099 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.07 148.13 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.09 -2.189 . . . . 72.41 105.09 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.65 -45.05 2.52 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 106.929 -1.508 . . . . 75.45 106.929 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.81 34.86 Favored 'General case' 0 CA--C 1.482 -1.667 0 C-N-CA 119.226 -0.99 . . . . 75.33 109.288 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.11 110.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 104.097 -2.557 . . . . 70.53 104.097 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.303 0.8 OUTLIER 46.48 38.3 5.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.541 1.137 . . . . 63.11 112.292 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.28 65.87 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.799 -1.32 . . . . 73.53 109.799 171.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.08 119.91 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.693 0 N-CA-C 104.971 -2.233 . . . . 74.04 104.971 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m -67.59 111.0 3.93 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.358 -1.349 . . . . 72.44 107.358 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.31 -14.91 51.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.926 -0.768 . . . . 72.03 108.926 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.98 146.58 46.46 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 109.332 -0.618 . . . . 65.55 109.332 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 -39.23 3.01 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 109.555 -1.418 . . . . 74.43 109.555 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 166.13 22.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.354 -0.98 . . . . 73.55 108.354 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.8 p -89.73 174.55 7.66 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.009 -1.108 . . . . 75.53 108.009 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -64.98 -38.73 91.93 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.987 -0.745 . . . . 64.1 108.987 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -59.59 -45.13 92.79 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 120.016 -0.674 . . . . 64.01 111.008 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -62.65 -39.99 95.63 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 119.746 1.157 . . . . 72.43 108.302 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.1 -42.97 86.8 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.8 -0.445 . . . . 74.14 109.8 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -69.25 -54.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 107.2 -1.407 . . . . 75.53 107.2 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -57.39 -26.46 61.11 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.222 -0.659 . . . . 71.31 109.222 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -65.81 -56.13 13.53 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.52 -55.1 35.8 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.153 -1.054 . . . . 74.5 108.153 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -45.63 -34.89 3.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.251 1.02 . . . . 73.32 111.975 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -96.6 -3.05 43.61 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.435 -0.79 . . . . 72.33 109.69 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -84.35 170.17 13.89 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.736 -1.227 . . . . 73.43 108.627 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.74 -149.32 24.59 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 122.508 1.06 . . . . 62.44 110.616 -171.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -77.82 -53.15 7.82 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.831 -1.174 . . . . 73.54 107.831 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.12 127.89 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.798 0 N-CA-C 103.576 -2.75 . . . . 71.43 103.576 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -133.16 143.13 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 103.796 -2.668 . . . . 74.34 103.796 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -97.28 116.0 28.67 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.542 -2.392 . . . . 73.04 104.542 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -114.52 138.0 51.16 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 105.7 -1.963 . . . . 75.24 105.7 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -113.82 127.85 56.17 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.548 -2.019 . . . . 64.33 105.548 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.81 155.97 49.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.26 -1.756 . . . . 74.52 106.26 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 CA--C 1.488 -1.419 0 N-CA-C 105.596 -2.002 . . . . 72.11 105.596 -178.714 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 104.719 -2.326 . . . . 71.51 104.719 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -145.88 157.11 43.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 105.893 -1.891 . . . . 75.14 105.893 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.25 143.62 32.41 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.848 -1.908 . . . . 73.32 105.848 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.06 128.12 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 104.167 -2.531 . . . . 73.01 104.167 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.26 114.62 26.39 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 105.552 -2.018 . . . . 73.43 105.552 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.61 120.84 41.69 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 105.994 -1.854 . . . . 74.45 105.994 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.85 134.71 37.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.163 -1.421 . . . . 71.25 107.163 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 106.356 -1.72 . . . . 75.0 106.356 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.496 -1.095 0 CA-C-O 119.749 -0.473 . . . . 70.22 112.459 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.2 mt -123.05 153.02 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.394 -2.447 . . . . 75.54 104.394 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.5 m -151.81 163.37 39.33 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 102.769 -3.048 . . . . 71.53 102.769 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.74 168.32 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.401 -2.444 . . . . 73.14 104.401 -166.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -149.65 167.4 26.51 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 103.962 -2.607 . . . . 71.34 103.962 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.65 -171.89 13.99 Favored Glycine 0 CA--C 1.473 -2.56 0 N-CA-C 107.0 -2.44 . . . . 65.02 107.0 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.48 -124.23 5.83 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 108.687 -1.765 . . . . 74.13 108.687 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 m -73.27 20.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.694 0 C-N-CA 125.883 1.673 . . . . 72.1 113.142 -167.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.1 t30 89.93 66.04 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 123.146 1.45 . . . . 72.33 107.39 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 30' ' ' SER . 2.0 m -82.71 -167.2 1.54 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.465 -2.42 . . . . 73.1 104.465 170.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.526 ' H ' HG23 ' A' ' 29' ' ' THR . 16.3 m -58.17 -25.21 61.23 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 121.5 -0.75 . . . . 64.33 111.535 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 m -78.79 131.45 34.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 107.505 -1.295 . . . . 75.02 107.505 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 34' ' ' GLY . 39.5 ttp-105 -60.11 -53.69 54.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.921 0.488 . . . . 72.25 110.675 -171.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -76.87 4.77 9.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.829 -0.544 . . . . 74.1 109.88 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 32' ' ' ARG . . . 59.62 13.46 24.17 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.249 -0.74 . . . . 75.52 111.249 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.31 148.02 50.46 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 108.385 -1.886 . . . . 52.52 108.385 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.13 97.11 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.542 -1.651 . . . . 75.41 106.542 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -95.76 143.93 26.58 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 107.043 -1.465 . . . . 74.25 107.043 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.6 t -72.02 130.61 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 N-CA-C 105.064 -2.198 . . . . 45.41 105.064 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -103.09 -39.97 6.66 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 107.316 -1.365 . . . . 73.23 107.316 -166.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.38 158.48 40.12 Favored 'General case' 0 CA--C 1.465 -2.29 0 N-CA-C 106.011 -1.848 . . . . 73.32 106.011 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.46 140.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 104.221 -2.511 . . . . 75.02 104.221 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.421 HG12 ' CA ' ' A' ' 20' ' ' GLY . 24.3 mm -70.67 143.99 90.51 Favored Pre-proline 0 C--N 1.355 0.805 0 N-CA-C 105.741 -1.948 . . . . 75.13 105.741 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.2 112.18 0.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.429 2.086 . . . . 70.34 108.948 165.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 74.91 22.04 1.93 Allowed 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.354 1.034 . . . . 63.13 110.483 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.74 175.68 30.17 Favored Glycine 0 C--N 1.375 2.732 0 N-CA-C 108.275 -1.93 . . . . 74.3 108.275 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.69 98.74 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.036 -0.727 . . . . 60.45 109.036 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.27 76.61 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.582 -0.525 . . . . 74.01 109.582 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.66 -35.13 79.43 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.134 -0.691 . . . . 63.04 109.134 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 m -66.02 -37.43 85.88 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.135 -1.061 . . . . 72.32 108.135 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.48 -41.24 89.27 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.397 -0.964 . . . . 71.23 108.397 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 90.71 -22.83 26.04 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.104 -1.198 . . . . 74.24 110.104 173.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -78.48 -38.72 40.27 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.693 -1.225 . . . . 72.32 107.693 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mt -104.84 129.37 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.258 -1.386 . . . . 72.53 107.258 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.46 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 76.8 m80 -140.19 -175.71 4.34 Favored 'General case' 0 CA--C 1.467 -2.25 0 N-CA-C 104.039 -2.578 . . . . 74.55 104.039 172.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 146.38 53.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.339 -1.356 . . . . 73.33 107.339 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.69 -25.23 28.22 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 107.827 -2.109 . . . . 64.22 107.827 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.27 154.68 32.71 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.223 -1.769 . . . . 72.44 106.223 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -134.39 141.0 46.7 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 107.487 -1.301 . . . . 74.34 107.487 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.33 150.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.401 -1.704 . . . . 74.21 106.401 -172.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.59 -46.41 2.86 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 106.953 -1.499 . . . . 73.34 106.953 169.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.16 161.89 30.1 Favored 'General case' 0 CA--C 1.484 -1.577 0 C-N-CA 118.915 -1.114 . . . . 72.43 110.19 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.37 107.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 104.206 -2.516 . . . . 74.11 104.206 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 t30 48.83 37.98 11.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.496 1.119 . . . . 73.33 111.021 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.64 10.17 70.64 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.345 -1.102 . . . . 63.44 110.345 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.59 117.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.948 0 N-CA-C 103.933 -2.617 . . . . 73.45 103.933 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 m -71.66 111.48 6.99 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.561 -1.274 . . . . 73.13 107.561 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.26 -3.26 58.89 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.674 -0.861 . . . . 73.24 108.674 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -63.94 144.03 57.39 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 106.963 -1.495 . . . . 72.31 106.963 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -34.83 3.09 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.022 -0.831 . . . . 62.33 111.022 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.68 162.11 24.41 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 118.356 1.078 . . . . 64.22 108.281 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -82.94 170.21 15.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.94 -0.763 . . . . 74.11 108.94 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -62.81 -44.1 97.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.702 -0.851 . . . . 75.33 108.702 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -62.35 -43.31 99.13 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 118.574 -0.727 . . . . 74.44 111.129 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -35.31 80.16 Favored 'General case' 0 C--N 1.383 2.028 0 CA-C-N 120.166 1.348 . . . . 73.42 109.005 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.89 74.23 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.913 -0.773 . . . . 61.05 108.913 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -73.88 -54.65 14.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 107.527 -1.286 . . . . 75.12 107.527 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 14.4 m -55.33 -29.27 57.97 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 122.705 1.24 . . . . 75.2 108.365 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -68.51 -54.36 17.31 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.504 -1.372 . . . . 72.0 107.647 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.6 mt -54.7 -56.18 21.9 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.707 -0.849 . . . . 71.24 108.707 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -46.15 -47.09 17.62 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.185 0.439 . . . . 73.12 112.185 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -82.93 3.35 30.31 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.357 -0.84 . . . . 75.15 111.077 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.2 p -82.17 173.71 11.87 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.583 1.083 . . . . 74.32 108.375 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.93 -163.12 26.91 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 109.6 -1.4 . . . . 74.4 109.6 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.75 -32.98 27.56 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.101 -1.074 . . . . 75.13 108.101 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.2 t -115.95 127.19 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.605 -2.739 . . . . 61.35 103.605 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.46 151.32 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 104.609 -2.367 . . . . 75.51 104.609 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -102.08 123.68 46.37 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 104.271 -2.492 . . . . 64.13 104.271 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.1 mt -114.99 138.69 50.55 Favored 'General case' 0 CA--C 1.467 -2.242 0 N-CA-C 104.301 -2.481 . . . . 72.51 104.301 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -112.63 125.37 54.21 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.647 -1.983 . . . . 74.2 105.647 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.75 153.68 49.83 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.164 -1.791 . . . . 65.24 106.164 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.475 -1.932 0 N-CA-C 105.024 -2.214 . . . . 73.41 105.024 -178.421 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 103.692 -2.707 . . . . 53.52 103.692 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -138.58 146.51 41.91 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.233 -1.766 . . . . 75.12 106.233 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.18 138.84 40.07 Favored 'General case' 0 N--CA 1.396 -3.128 0 N-CA-C 104.483 -2.414 . . . . 62.42 104.483 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.02 130.99 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.772 0 N-CA-C 105.498 -2.038 . . . . 73.11 105.498 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -100.78 119.86 39.26 Favored 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 104.707 -2.331 . . . . 72.22 104.707 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 121.08 44.04 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 105.979 -1.86 . . . . 74.45 105.979 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.32 134.29 41.54 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.653 -1.24 . . . . 74.31 107.653 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 107.018 -1.475 . . . . 74.42 107.018 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.51 0 N-CA-C 108.636 -1.786 . . . . 73.01 108.636 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.84 158.65 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 106.184 -1.784 . . . . 73.34 106.184 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.2 m -153.31 163.62 39.59 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 102.517 -3.142 . . . . 74.42 102.517 164.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.39 167.33 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 107.036 -1.468 . . . . 62.25 107.036 -161.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -143.71 165.99 26.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 104.562 -2.384 . . . . 71.2 104.562 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.22 -163.06 12.21 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 107.939 -2.065 . . . . 53.32 107.939 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.32 -127.5 6.08 Favored Glycine 0 C--N 1.36 1.877 0 N-CA-C 110.379 -1.088 . . . . 24.23 110.379 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 m -59.85 18.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.195 0 C-N-CA 128.282 2.633 . . . . 71.43 115.29 -167.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 86.44 64.34 0.01 OUTLIER 'General case' 0 CA--C 1.468 -2.196 0 N-CA-C 105.754 -1.943 . . . . 73.23 105.754 -165.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.586 HG23 ' H ' ' A' ' 30' ' ' SER . 2.3 m -88.43 -166.29 1.55 Allowed 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 111.686 -2.506 . . . . 72.25 104.546 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.586 ' H ' HG23 ' A' ' 29' ' ' THR . 11.8 m -58.35 -20.49 43.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.39 0.676 . . . . 33.53 111.226 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.629 -1.248 . . . . 74.34 107.629 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -70.32 -34.24 72.46 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-O 121.508 0.67 . . . . 74.44 109.756 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.44 -15.65 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.202 -1.036 . . . . 72.3 108.202 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.24 8.72 25.89 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 110.391 -1.083 . . . . 75.41 110.391 -176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.97 159.46 53.9 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 107.976 -2.05 . . . . 52.42 107.976 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.0 mm -90.64 95.16 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.464 -2.05 . . . . 52.42 105.464 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.05 146.74 26.5 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.507 -1.294 . . . . 74.32 107.507 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.39 129.0 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.426 -1.694 . . . . 70.23 106.426 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -106.41 -43.79 4.68 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 107.88 -1.155 . . . . 73.5 107.88 -171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.8 144.59 39.42 Favored 'General case' 0 CA--C 1.46 -2.502 0 N-CA-C 105.732 -1.951 . . . . 74.3 105.732 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.7 120.01 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 104.17 -2.53 . . . . 74.03 104.17 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.3 mt -72.88 135.06 80.79 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.122 -1.807 . . . . 64.22 106.122 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.2 121.6 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.803 2.335 . . . . 74.01 109.647 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 65.65 23.2 11.66 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.482 1.114 . . . . 74.31 110.461 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 175.34 49.18 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 106.698 -2.561 . . . . 51.34 106.698 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.1 82.92 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.613 -0.884 . . . . 74.41 108.613 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.48 76.85 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.222 -0.659 . . . . 75.24 109.222 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.32 -35.07 73.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.816 0.341 . . . . 75.42 110.112 -173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -68.33 -37.13 80.24 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.176 -1.046 . . . . 72.21 108.176 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.12 -47.0 72.45 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 107.124 -1.436 . . . . 65.43 107.124 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.09 -21.6 19.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 111.386 -0.686 . . . . 53.44 111.386 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -72.82 -35.13 67.24 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.559 1.18 . . . . 75.51 107.984 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.2 mt -94.55 135.98 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 105.964 -1.865 . . . . 74.12 105.964 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -144.31 176.06 9.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.262 -1.755 . . . . 73.32 106.262 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.95 137.1 56.28 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.799 -1.556 . . . . 74.23 106.799 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.99 -18.2 26.49 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 107.336 -2.306 . . . . 54.42 107.336 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.28 155.45 27.29 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 108.109 -1.071 . . . . 70.03 108.109 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.415 HH12 ' CD ' ' A' ' 91' ' ' GLU . 19.1 ttm180 -120.15 135.33 55.0 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 104.785 -2.302 . . . . 73.55 104.785 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.0 143.95 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 104.555 -2.387 . . . . 71.32 104.555 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -46.9 2.53 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.14 -1.43 . . . . 71.53 107.14 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.37 165.34 22.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 CA-C-O 122.394 1.093 . . . . 74.41 109.625 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -142.13 113.0 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 N-CA-C 103.486 -2.783 . . . . 74.22 103.486 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 53.52 31.27 12.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.072 0.549 . . . . 73.11 110.473 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.49 79.61 Favored Glycine 0 C--N 1.357 1.728 0 N-CA-C 110.209 -1.156 . . . . 62.21 110.209 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.98 124.92 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 104.707 -2.331 . . . . 74.24 104.707 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.0 m -64.35 104.33 0.75 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.436 -1.32 . . . . 63.41 107.436 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -21.3 21.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.486 -1.302 . . . . 74.33 107.486 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.41 146.26 48.93 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.005 . . . . 73.45 108.288 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.27 -35.39 3.58 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 109.872 -1.291 . . . . 51.31 109.872 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.78 161.65 28.0 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.102 -1.073 . . . . 73.52 108.102 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.0 p -77.83 168.46 19.89 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.685 0.755 . . . . 75.15 109.301 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -63.16 -42.27 99.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.986 -1.116 . . . . 71.42 107.986 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -56.02 -50.63 70.35 Favored 'General case' 0 C--N 1.367 1.338 0 N-CA-C 109.919 -0.4 . . . . 75.33 109.919 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -64.53 -37.12 86.45 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.307 -0.627 . . . . 75.54 109.307 -171.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.62 77.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.099 -0.704 . . . . 74.25 109.099 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.3 t -73.69 -52.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.529 -1.285 . . . . 73.32 107.529 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 46.6 m -53.04 -28.14 23.03 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-O 121.901 0.858 . . . . 70.21 109.009 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.25 -56.37 10.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.21 -1.404 . . . . 75.13 107.21 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.6 mt -56.75 -56.61 19.32 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.712 -0.847 . . . . 75.04 108.712 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -47.62 -27.14 1.73 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.048 1.129 . . . . 72.01 114.048 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.85 4.79 43.08 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 119.666 1.121 . . . . 74.43 109.047 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.2 p -84.86 170.28 13.29 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 121.055 -1.028 . . . . 73.12 108.4 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.6 -151.14 26.56 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.711 -1.755 . . . . 65.14 108.711 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -80.79 -43.17 20.52 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 107.994 -1.113 . . . . 74.25 107.994 -171.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.58 123.62 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 104.741 -2.318 . . . . 72.3 104.741 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -127.99 147.53 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.758 0 N-CA-C 105.373 -2.084 . . . . 53.41 105.373 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -99.88 115.66 30.13 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.152 -2.166 . . . . 75.31 105.152 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.82 134.27 52.66 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 104.62 -2.363 . . . . 71.04 104.62 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.57 124.37 52.2 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 105.129 -2.174 . . . . 75.12 105.129 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -133.18 159.34 40.46 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 106.843 -1.54 . . . . 75.21 106.843 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' CD ' HH12 ' A' ' 58' ' ' ARG . 42.9 tt0 . . . . . 0 CA--C 1.478 -1.81 0 N-CA-C 103.112 -2.922 . . . . 74.34 103.112 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 103.91 -2.626 . . . . 74.41 103.91 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.13 150.51 45.74 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.656 -1.239 . . . . 74.2 107.656 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -102.69 136.7 42.04 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 104.875 -2.269 . . . . 71.13 104.875 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -125.56 134.26 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 105.63 -1.989 . . . . 74.01 105.63 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -106.68 109.88 21.92 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.575 -2.009 . . . . 75.45 105.575 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.99 121.6 42.88 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.841 -1.911 . . . . 74.32 105.841 -171.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.34 130.0 35.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.068 -1.456 . . . . 71.1 107.068 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 106.99 -1.485 . . . . 72.51 106.99 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.527 ' HA3' ' H ' ' A' ' 47' ' ' ALA . . . . . . . . 0 C--O 1.203 -1.789 0 N-CA-C 111.437 -0.665 . . . . 65.13 111.437 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mm -110.13 157.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 106.404 -1.702 . . . . 74.21 106.404 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.8 m -146.49 155.93 42.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 101.571 -3.492 . . . . 74.33 101.571 163.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.31 160.57 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 C-N-CA 119.309 -0.956 . . . . 74.32 109.833 -166.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 t -145.22 166.29 25.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 103.032 -2.951 . . . . 64.5 103.032 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.74 123.72 4.0 Favored Glycine 0 C--O 1.193 -2.408 0 N-CA-C 108.407 -1.877 . . . . 51.45 108.407 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.18 -115.37 0.44 Allowed Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.096 -1.602 . . . . 75.51 109.096 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.79 20.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 126.17 1.788 . . . . 70.31 115.031 -163.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.3 t30 88.3 64.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 123.702 1.715 . . . . 73.21 106.476 -164.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -90.0 -165.28 1.31 Allowed 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 102.587 -3.116 . . . . 73.33 102.587 165.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -40.49 -33.35 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.412 1.085 . . . . 72.22 112.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.68 132.99 36.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 O-C-N 121.15 -0.969 . . . . 75.21 108.579 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -64.12 -58.03 7.83 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.565 -1.198 . . . . 65.24 111.899 -168.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -79.94 5.06 14.92 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.49 -0.756 . . . . 75.11 109.071 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.85 33.26 83.54 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 108.504 -1.839 . . . . 75.3 108.504 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.4 124.77 34.17 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 107.525 -2.23 . . . . 63.15 107.525 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mm -81.39 90.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.675 -2.342 . . . . 73.03 104.675 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -85.57 146.16 27.02 Favored 'General case' 0 CA--C 1.467 -2.212 0 N-CA-C 107.887 -1.153 . . . . 65.11 107.887 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.12 125.98 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.749 -1.945 . . . . 71.23 105.749 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -91.55 -38.38 12.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 106.672 -1.603 . . . . 75.33 106.672 -168.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.59 155.5 38.56 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 105.825 -1.917 . . . . 75.02 105.825 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.97 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 102.06 -3.311 . . . . 74.51 102.06 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.95 130.35 93.93 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 106.554 -1.647 . . . . 71.35 106.554 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.26 123.93 14.49 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.809 2.339 . . . . 71.24 109.477 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 68.67 10.09 7.69 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 124.781 1.3 . . . . 73.01 110.756 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.57 -175.18 37.17 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.973 -1.651 . . . . 55.12 108.973 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.85 74.34 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.054 -0.721 . . . . 73.11 109.054 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.527 ' H ' ' HA3' ' A' ' 20' ' ' GLY . . . -68.99 -46.03 69.08 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 108.908 -0.775 . . . . 75.04 108.908 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.22 -36.0 80.62 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 108.741 -0.837 . . . . 73.11 108.741 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.7 t -64.18 -40.13 95.45 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 108.203 -1.036 . . . . 54.42 108.203 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -73.86 -48.25 32.44 Favored 'General case' 0 C--N 1.351 0.63 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.34 -17.44 13.47 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.771 -0.532 . . . . 63.22 111.771 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . 33.9 ttm105 -72.98 -33.76 66.02 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.852 -1.166 . . . . 73.21 107.852 -173.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.16 135.61 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.069 -1.826 . . . . 72.32 106.069 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 52' ' ' ARG . 25.6 m80 -118.59 162.87 17.68 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 106.995 -1.483 . . . . 73.55 106.995 -175.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -65.78 136.42 56.19 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 106.981 -1.488 . . . . 71.41 106.981 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.75 -10.0 72.88 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.78 -1.728 . . . . 70.13 108.78 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -66.51 143.41 57.09 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 105.884 -1.895 . . . . 70.15 105.884 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.7 tmm_? -103.15 119.82 39.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.376 -1.342 . . . . 75.51 107.376 -169.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 t -89.18 141.62 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 105.766 -1.939 . . . . 74.51 105.766 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -47.0 2.51 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 71.14 107.32 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.32 167.63 18.92 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.373 1.082 . . . . 74.25 109.493 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -141.07 108.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 103.533 -2.766 . . . . 74.24 103.533 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 49.91 39.64 18.99 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.089 0.956 . . . . 73.12 110.598 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.55 20.1 78.74 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 109.936 -1.266 . . . . 62.34 109.936 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.63 119.35 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 N-CA-C 104.124 -2.547 . . . . 73.44 104.124 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -70.24 105.9 3.13 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.234 -0.654 . . . . 54.01 109.234 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.88 -7.07 53.23 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.027 -1.471 . . . . 72.35 107.027 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.97 143.67 57.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.109 -1.441 . . . . 72.41 107.109 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.83 2.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.983 -0.847 . . . . 75.5 110.983 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.89 172.66 4.19 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 118.218 1.009 . . . . 60.3 109.766 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -82.65 156.47 23.84 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.603 -1.258 . . . . 75.53 107.603 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -66.28 -37.65 85.94 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.89 -1.152 . . . . 72.34 107.89 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HZ2' ' HB2' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -60.34 -39.45 87.16 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 120.639 -0.424 . . . . 72.21 110.188 175.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.71 -36.45 83.9 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-N 119.389 0.995 . . . . 73.23 109.018 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.14 75.83 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.078 -0.712 . . . . 72.11 109.078 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 -53.45 25.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 N-CA-C 107.278 -1.379 . . . . 74.32 107.278 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.0 m -52.49 -29.19 23.7 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 108.294 -1.002 . . . . 74.22 108.294 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.1 m -69.19 -56.23 8.25 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 108.015 -1.105 . . . . 70.51 108.015 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -53.52 -56.17 19.31 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.844 -0.799 . . . . 71.2 108.844 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -46.58 -43.3 17.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.551 -0.749 . . . . 74.5 111.475 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -77.37 -14.55 59.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.509 0.323 . . . . 73.32 110.711 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -76.13 163.26 27.27 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 120.668 -1.27 . . . . 75.43 108.927 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.84 -146.68 6.46 Favored Glycine 0 CA--C 1.491 -1.447 0 N-CA-C 109.245 -1.542 . . . . 72.24 109.245 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -85.39 -42.64 14.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 107.793 -1.188 . . . . 75.32 107.793 -172.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.6 t -108.08 128.31 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 104.277 -2.49 . . . . 73.33 104.277 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.07 139.15 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 105.825 -1.917 . . . . 74.23 105.825 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -97.24 115.87 28.41 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 104.699 -2.334 . . . . 73.12 104.699 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 18.1 mt -112.84 137.22 51.51 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 104.84 -2.281 . . . . 75.31 104.84 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 tp -114.62 124.17 51.17 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.943 -2.243 . . . . 72.34 104.943 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.5 158.18 41.58 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 107.436 -1.32 . . . . 75.13 107.436 -173.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 58' ' ' ARG . 42.2 tt0 . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 103.876 -2.639 . . . . 71.13 103.876 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 104.139 -2.541 . . . . 75.41 104.139 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -152.34 159.77 43.41 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.346 -2.094 . . . . 72.33 105.346 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.12 145.79 28.85 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 105.256 -2.128 . . . . 73.1 105.256 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.72 122.74 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 103.448 -2.797 . . . . 71.02 103.448 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -99.6 109.48 21.98 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.283 -2.488 . . . . 75.45 104.283 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 105.44 -2.059 . . . . 74.1 105.44 -171.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.18 134.18 34.13 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.064 -1.828 . . . . 60.45 106.064 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 108.313 -0.995 . . . . 73.32 108.313 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.025 0 N-CA-C 106.981 -2.447 . . . . 62.25 106.981 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 mt -131.05 160.04 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 104.959 -2.237 . . . . 74.3 104.959 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.14 162.86 37.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.562 -3.125 . . . . 71.12 102.562 163.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.97 167.85 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 N-CA-C 105.801 -1.925 . . . . 71.33 105.801 -165.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -147.41 166.5 26.99 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 102.721 -3.066 . . . . 74.1 102.721 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.92 178.57 15.4 Favored Glycine 0 CA--C 1.459 -3.46 0 N-CA-C 105.715 -2.954 . . . . 51.33 105.715 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.75 -130.52 6.99 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 108.823 -1.711 . . . . 54.13 108.823 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.39 19.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 126.721 2.008 . . . . 74.32 114.212 -165.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.5 t30 88.37 65.6 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.051 -1.463 . . . . 74.44 107.051 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 t -94.71 -166.24 1.44 Allowed 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 104.094 -2.558 . . . . 73.24 104.094 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 m -47.41 -40.7 18.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.732 1.213 . . . . 60.23 112.59 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 m -76.16 133.78 30.4 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 N-CA-C 108.871 -0.788 . . . . 74.53 108.871 -173.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -57.77 -55.15 38.54 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.19 0.996 . . . . 75.13 112.492 -169.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -76.22 6.61 5.21 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.297 -0.877 . . . . 75.53 110.111 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 57.53 6.44 2.38 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 121.516 -0.74 . . . . 55.44 111.967 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.68 160.65 53.81 Favored Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 107.364 -2.294 . . . . 74.44 107.364 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mm -83.92 108.62 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 106.14 -1.8 . . . . 75.51 106.14 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' A' ' 58' ' ' ARG . 42.9 m-85 -103.75 144.08 31.94 Favored 'General case' 0 CA--C 1.48 -1.74 0 N-CA-C 106.84 -1.541 . . . . 74.11 106.84 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.94 132.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.031 -1.841 . . . . 75.03 106.031 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -114.72 -37.48 4.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.228 -1.027 . . . . 75.24 108.228 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.57 146.43 34.59 Favored 'General case' 0 CA--C 1.463 -2.366 0 N-CA-C 106.716 -1.587 . . . . 63.24 106.716 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.03 119.35 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 104.979 -2.23 . . . . 73.54 104.979 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.3 mt -72.46 140.09 81.75 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 106.575 -1.639 . . . . 71.24 106.575 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.6 119.9 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.731 2.287 . . . . 63.42 109.785 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 68.75 25.29 6.38 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 125.12 1.512 . . . . 74.34 110.372 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.02 173.44 52.62 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 107.653 -2.179 . . . . 72.22 107.653 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.38 99.29 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.796 -0.816 . . . . 74.24 108.796 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.19 77.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.311 -0.626 . . . . 74.45 109.311 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.5 -42.17 95.81 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.027 -0.731 . . . . 61.54 109.027 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -67.82 -36.69 80.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.614 -0.513 . . . . 61.54 109.614 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.86 -36.91 75.89 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.637 -1.246 . . . . 71.33 107.637 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -18.95 23.94 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.039 -0.824 . . . . 62.24 111.039 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -74.62 -39.75 61.94 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.426 -0.953 . . . . 74.44 108.426 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -95.74 120.62 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 105.829 -1.915 . . . . 73.3 105.829 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.21 169.85 10.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.657 -1.979 . . . . 72.15 105.657 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -66.52 137.86 57.09 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.501 -1.666 . . . . 75.32 106.501 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.05 -26.16 23.99 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 108.328 -1.909 . . . . 75.13 108.328 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.55 166.5 21.68 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.69 -1.226 . . . . 71.03 107.69 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.408 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -130.29 139.39 50.74 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 107.489 -1.3 . . . . 71.12 107.489 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.48 143.97 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 104.086 -2.561 . . . . 72.02 104.086 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.37 -46.92 3.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.563 -1.273 . . . . 74.33 107.563 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.91 166.09 21.69 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.377 1.085 . . . . 70.34 109.827 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.46 104.35 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 103.783 -2.673 . . . . 62.11 103.783 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 46.91 43.28 13.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.091 0.956 . . . . 64.52 110.849 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.81 76.6 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.217 -1.153 . . . . 64.15 110.217 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.34 117.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 104.467 -2.42 . . . . 74.25 104.467 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -75.33 107.48 7.47 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.786 -1.191 . . . . 73.55 107.786 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.35 -6.29 56.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.513 -0.767 . . . . 73.23 110.034 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -61.47 142.75 56.81 Favored 'General case' 0 C--N 1.361 1.073 0 O-C-N 120.875 -1.141 . . . . 74.54 108.834 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.94 -25.06 6.19 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.385 -1.086 . . . . 54.25 110.385 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 164.0 26.5 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.203 1.001 . . . . 62.42 108.892 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 p -81.54 163.62 22.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.625 -0.88 . . . . 72.11 108.625 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -61.49 -44.94 96.19 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.445 -0.798 . . . . 73.21 108.936 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -30.73 70.66 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 120.302 -0.559 . . . . 72.34 109.918 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -65.55 -36.2 83.09 Favored 'General case' 0 C--N 1.373 1.622 0 N-CA-C 108.521 -0.918 . . . . 73.23 108.521 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.39 -34.19 73.56 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.553 -0.906 . . . . 60.21 108.553 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.67 -53.63 19.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.156 -1.424 . . . . 75.34 107.156 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.3 m -53.26 -29.05 30.71 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.199 -1.038 . . . . 54.11 108.199 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.5 m -69.91 -55.83 8.65 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.531 -1.285 . . . . 72.45 107.531 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -55.78 -55.49 31.74 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.062 -0.718 . . . . 74.11 109.062 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -45.97 -37.91 7.07 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.653 0.612 . . . . 73.34 112.653 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -90.23 8.28 33.95 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.29 0.95 . . . . 65.44 110.283 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -74.32 163.54 27.68 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-N 119.587 1.085 . . . . 63.14 109.51 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.74 -158.79 19.87 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 109.067 -1.613 . . . . 52.32 109.067 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -81.99 -38.45 25.08 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.886 -0.783 . . . . 74.31 108.886 -169.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.8 t -113.34 130.06 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 103.553 -2.758 . . . . 73.5 103.553 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -122.27 142.12 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 104.827 -2.286 . . . . 75.5 104.827 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -100.71 119.22 38.28 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 104.333 -2.469 . . . . 73.31 104.333 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.46 134.62 54.56 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 103.726 -2.694 . . . . 72.42 103.726 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.57 126.94 53.49 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 105.764 -1.939 . . . . 73.12 105.764 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -134.37 155.33 50.46 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.211 -1.774 . . . . 75.24 106.211 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 . . . . . 0 CA--C 1.477 -1.863 0 N-CA-C 102.685 -3.079 . . . . 55.35 102.685 176.053 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 104.704 -2.332 . . . . 75.03 104.704 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -138.53 149.04 44.94 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.599 -1.63 . . . . 74.22 106.599 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.401 ' HG2' HD11 ' A' ' 89' ' ' LEU . 89.4 mt-10 -103.22 139.72 38.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.574 -1.639 . . . . 65.44 106.574 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.04 135.28 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 106.939 -1.504 . . . . 71.41 106.939 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -105.9 112.8 26.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 104.533 -2.395 . . . . 65.24 104.533 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.18 125.12 50.69 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.586 -1.635 . . . . 74.32 106.586 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.22 133.84 37.32 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.931 -1.507 . . . . 73.34 106.931 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HZ1' ' CG2' ' A' ' 86' ' ' VAL . 11.0 mptt . . . . . 0 CA--C 1.483 -1.599 0 N-CA-C 105.993 -1.854 . . . . 71.33 105.993 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.478 -2.247 0 N-CA-C 109.498 -1.441 . . . . 54.11 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.51 145.7 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 103.537 -2.764 . . . . 75.02 103.537 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.48 162.99 34.38 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 103.07 -2.937 . . . . 74.52 103.07 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.09 168.0 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 N-CA-C 104.829 -2.286 . . . . 74.22 104.829 -167.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.6 t -145.79 166.03 27.11 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.319 -2.474 . . . . 71.12 104.319 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 87.83 131.74 3.64 Favored Glycine 0 C--O 1.2 -2.01 0 N-CA-C 108.594 -1.802 . . . . 42.13 108.594 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.2 -99.07 0.14 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 107.526 -2.229 . . . . 64.51 107.526 167.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.31 20.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.386 1.874 . . . . 65.11 114.94 -170.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 88.71 66.41 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.926 0 CA-C-O 123.337 1.542 . . . . 75.11 106.991 -168.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.679 HG23 ' H ' ' A' ' 30' ' ' SER . 4.3 m -84.38 -166.57 1.48 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.478 -2.416 . . . . 71.52 104.478 173.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.679 ' H ' HG23 ' A' ' 29' ' ' THR . 10.5 m -53.16 -28.11 24.57 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.339 0.656 . . . . 60.11 110.9 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 m -82.57 122.25 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.787 -1.56 . . . . 72.25 106.787 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -83.59 -16.76 44.1 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.683 -0.858 . . . . 75.41 108.683 -170.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.482 ' C ' ' H ' ' A' ' 35' ' ' GLY . 43.3 t60 -70.77 -12.19 61.4 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.739 -1.208 . . . . 74.52 107.739 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.37 -5.36 1.54 Allowed Glycine 0 C--N 1.365 2.147 0 C-N-CA 124.155 0.883 . . . . 71.13 111.505 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 33' ' ' HIS . . . -70.28 151.19 49.59 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 107.931 -2.067 . . . . 71.15 107.931 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 25' ' ' GLY . 10.7 mm -82.17 126.08 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.449 -2.426 . . . . 74.12 104.449 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -111.91 145.6 39.26 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 106.89 -1.522 . . . . 71.52 106.89 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -74.52 129.36 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.386 -2.079 . . . . 73.13 105.386 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -116.45 -35.28 4.32 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.741 -1.207 . . . . 70.32 107.741 -170.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.04 136.28 45.87 Favored 'General case' 0 CA--C 1.452 -2.798 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 -167.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -139.39 129.76 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 103.765 -2.68 . . . . 73.11 103.765 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.433 HG12 ' CA ' ' A' ' 20' ' ' GLY . 6.5 mm -70.94 147.46 94.0 Favored Pre-proline 0 CA--C 1.505 -0.751 0 N-CA-C 105.082 -2.192 . . . . 75.41 105.082 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 114.35 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.876 1.717 . . . . 72.43 107.801 164.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 68.95 26.49 5.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 124.542 1.151 . . . . 72.02 111.044 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.15 177.12 43.14 Favored Glycine 0 C--N 1.368 2.34 0 N-CA-C 106.474 -2.65 . . . . 51.03 106.474 167.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.04 95.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 122.124 -0.633 . . . . 72.42 109.342 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.25 -49.2 78.07 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.413 -0.588 . . . . 73.24 109.413 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.46 -36.8 81.88 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -65.18 -44.02 89.79 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.458 -0.942 . . . . 71.01 108.458 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -70.36 -33.0 70.92 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.235 -1.395 . . . . 74.31 107.235 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.27 -16.12 45.76 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 110.481 -1.048 . . . . 55.21 110.481 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -79.42 -34.68 41.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.695 -0.854 . . . . 74.04 108.695 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.4 mt -105.25 141.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.852 -1.907 . . . . 75.32 105.852 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -143.56 178.33 7.86 Favored 'General case' 0 CA--C 1.466 -2.252 0 N-CA-C 104.526 -2.398 . . . . 74.4 104.526 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.91 146.96 53.85 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.007 -1.479 . . . . 74.21 107.007 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.14 -16.49 53.62 Favored Glycine 0 CA--C 1.498 -0.997 0 N-CA-C 107.335 -2.306 . . . . 65.51 107.335 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.29 146.57 31.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.998 -1.852 . . . . 73.23 105.998 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.481 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.8 tmm_? -108.83 123.82 49.65 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 105.377 -2.083 . . . . 74.43 105.377 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.29 141.2 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 105.545 -2.021 . . . . 72.33 105.545 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -49.01 2.31 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.89 -1.152 . . . . 72.11 107.89 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.98 166.83 19.27 Favored 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 118.873 -1.131 . . . . 74.5 109.92 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.71 100.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 103.395 -2.817 . . . . 73.32 103.395 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 t30 48.16 41.99 16.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.731 1.212 . . . . 62.24 110.954 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 13.04 77.02 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.053 -1.219 . . . . 75.23 110.053 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.14 116.85 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.759 0 N-CA-C 103.647 -2.723 . . . . 74.24 103.647 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 m -72.45 112.22 8.32 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.137 -1.06 . . . . 53.53 108.137 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.79 9.63 26.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.905 -1.517 . . . . 72.51 106.905 172.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.79 140.01 49.25 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.436 -1.69 . . . . 75.12 106.436 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 -23.23 4.58 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.291 -1.124 . . . . 62.21 110.291 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.93 164.72 16.93 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.895 0.855 . . . . 70.31 109.53 -175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 p -82.36 155.16 24.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.958 -1.497 . . . . 75.15 106.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -62.72 -37.63 87.28 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -55.84 -43.05 76.66 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 110.097 -0.334 . . . . 65.4 110.097 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -66.23 -39.97 89.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.277 -1.009 . . . . 63.23 108.277 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.97 -39.73 72.22 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 110.056 -0.35 . . . . 72.31 110.056 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.04 -56.25 9.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 107.754 -1.202 . . . . 65.41 107.754 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 72.0 m -63.59 -25.97 68.48 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.788 -0.819 . . . . 74.12 108.788 -166.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.7 m -60.7 -52.81 63.55 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 107.669 -1.234 . . . . 71.44 107.669 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.1 mt -55.27 -55.23 33.82 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.657 0.742 . . . . 74.12 109.519 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -48.16 -36.41 13.48 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.035 -0.415 . . . . 74.32 112.082 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -89.93 -9.75 47.67 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.67 -0.644 . . . . 72.52 110.095 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -81.31 179.54 7.81 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.754 -1.202 . . . . 71.2 107.754 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.88 -166.73 31.43 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.843 -1.303 . . . . 71.2 109.843 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.63 -35.95 38.62 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.808 -1.553 . . . . 74.11 106.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -116.29 127.74 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 N-CA-C 103.036 -2.95 . . . . 75.14 103.036 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.476 ' CG2' ' HZ1' ' A' ' 14' ' ' LYS . 12.0 t -138.76 151.58 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.87 0 N-CA-C 104.606 -2.368 . . . . 64.34 104.606 -174.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.85 123.88 40.68 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 104.305 -2.48 . . . . 72.04 104.305 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.4 mt -118.84 140.77 49.42 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 105.428 -2.064 . . . . 72.52 105.428 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.401 HD11 ' HG2' ' A' ' 9' ' ' GLU . 17.8 tp -114.22 124.14 51.3 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 105.053 -2.203 . . . . 75.02 105.053 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.11 157.19 44.85 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.691 -1.226 . . . . 74.11 107.691 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.481 ' CD ' HH21 ' A' ' 58' ' ' ARG . 36.2 tt0 . . . . . 0 N--CA 1.4 -2.972 0 N-CA-C 103.154 -2.906 . . . . 75.43 103.154 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 103.82 -2.659 . . . . 61.04 103.82 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.21 146.57 52.11 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 105.209 -2.145 . . . . 73.11 105.209 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -102.44 135.4 44.12 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.024 -2.213 . . . . 72.21 105.024 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.27 129.94 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 105.851 -1.907 . . . . 74.44 105.851 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -101.05 112.5 24.97 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 103.72 -2.696 . . . . 54.4 103.72 168.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -102.87 124.71 48.89 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.486 -2.042 . . . . 72.2 105.486 -173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.8 120.31 29.0 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.504 -1.665 . . . . 52.23 106.504 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? . . . . . 0 CA--C 1.492 -1.274 0 N-CA-C 107.034 -1.469 . . . . 73.13 107.034 176.177 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.976 0 N-CA-C 110.691 -0.964 . . . . 75.13 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.63 154.28 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.026 -2.583 . . . . 71.21 104.026 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.5 t -154.14 165.87 34.86 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.461 -2.422 . . . . 74.34 104.461 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.21 167.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 105.688 -1.967 . . . . 74.22 105.688 -168.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -146.11 166.53 25.87 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 104.584 -2.376 . . . . 75.42 104.584 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 84.93 134.37 3.02 Favored Glycine 0 C--O 1.196 -2.241 0 N-CA-C 108.853 -1.699 . . . . 44.1 108.853 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.97 -97.41 0.12 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 108.717 -1.753 . . . . 40.34 108.717 167.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.98 21.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 127.183 2.193 . . . . 74.41 116.017 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 87.37 66.29 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.733 -1.58 . . . . 64.31 106.733 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.631 HG21 ' H ' ' A' ' 30' ' ' SER . 4.1 m -88.38 -166.97 1.73 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.184 -2.524 . . . . 74.24 104.184 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.631 ' H ' HG21 ' A' ' 29' ' ' THR . 15.6 m -58.43 -21.01 49.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.553 -0.717 . . . . 54.21 110.625 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.58 126.27 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.765 -1.568 . . . . 64.13 106.765 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.7 mtm-85 -51.92 -57.6 8.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 115.204 -0.907 . . . . 72.4 112.363 -168.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -82.87 7.15 16.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.938 -0.764 . . . . 71.52 108.938 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.13 25.1 69.32 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 108.592 -1.803 . . . . 33.31 108.592 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.43 139.84 38.14 Favored Glycine 0 CA--C 1.479 -2.201 0 N-CA-C 107.394 -2.282 . . . . 52.4 107.394 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 25' ' ' GLY . 10.6 mm -84.29 120.35 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 104.645 -2.354 . . . . 74.2 104.645 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.55 146.65 41.54 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 106.306 -1.739 . . . . 74.4 106.306 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.26 135.02 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 73.34 107.084 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -49.12 3.22 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.518 -1.29 . . . . 74.34 107.518 -167.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 144.42 34.0 Favored 'General case' 0 CA--C 1.461 -2.469 0 N-CA-C 104.859 -2.274 . . . . 73.54 104.859 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.83 132.57 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 104.265 -2.494 . . . . 72.32 104.265 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.53 133.46 80.19 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 106.037 -1.838 . . . . 74.31 106.037 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.48 113.66 1.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.52 2.146 . . . . 72.41 108.141 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.36 21.9 5.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 124.621 1.201 . . . . 72.21 111.327 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.67 -166.74 27.96 Favored Glycine 0 C--N 1.367 2.271 0 N-CA-C 106.206 -2.758 . . . . 71.54 106.206 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 117.999 0.899 . . . . 75.22 110.427 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.58 -45.75 74.65 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 109.916 -0.402 . . . . 75.14 109.916 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -71.88 -39.06 69.88 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.481 -0.563 . . . . 72.35 109.481 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 t -65.9 -46.12 79.48 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.777 -1.194 . . . . 73.31 107.777 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.52 -32.33 71.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 106.92 -1.511 . . . . 60.22 106.92 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.73 -10.4 51.65 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.524 -0.762 . . . . 71.43 111.281 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -69.78 -38.25 76.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.945 -0.738 . . . . 72.33 110.025 -172.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.69 140.31 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 105.945 -1.872 . . . . 72.53 105.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -131.36 176.19 8.5 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.99 -1.485 . . . . 75.1 106.99 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.84 144.04 56.52 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.334 -0.987 . . . . 73.42 108.334 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.86 -4.17 74.93 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 109.678 -1.369 . . . . 72.12 109.678 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -86.25 156.35 20.32 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.823 -1.177 . . . . 71.54 107.823 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 118.56 37.04 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.992 -1.484 . . . . 74.33 106.992 -170.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.6 t -103.43 141.71 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 104.998 -2.223 . . . . 73.41 104.998 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.38 -45.66 2.62 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.589 -1.263 . . . . 75.01 107.589 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.34 158.21 39.76 Favored 'General case' 0 CA--C 1.477 -1.834 0 C-N-CA 118.695 -1.202 . . . . 75.44 109.345 -175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.79 106.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 104.775 -2.305 . . . . 74.44 104.775 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 45.19 43.9 8.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.255 1.422 . . . . 75.04 111.262 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.56 84.92 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.068 -1.213 . . . . 64.2 110.068 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.37 117.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.396 0 N-CA-C 103.151 -2.907 . . . . 75.41 103.151 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.7 m -75.69 114.33 14.15 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.775 -1.565 . . . . 74.3 106.775 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.29 28.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.594 -1.262 . . . . 74.52 107.594 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -75.55 122.5 23.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.12 -1.437 . . . . 64.01 107.12 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -9.68 52.81 Favored Glycine 0 C--N 1.328 0.1 0 N-CA-C 110.918 -0.873 . . . . 43.43 110.918 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 161.29 29.69 Favored 'General case' 0 C--N 1.364 1.232 0 CA-C-N 118.806 1.303 . . . . 74.21 107.598 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.6 p -82.31 167.14 18.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.406 -0.961 . . . . 72.45 108.406 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -66.52 -41.87 88.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.147 -0.686 . . . . 73.12 109.147 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -38.06 89.68 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.697 -0.668 . . . . 74.14 110.3 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -65.58 -35.8 81.9 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.143 1.338 . . . . 75.24 109.182 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.1 69.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.408 -0.59 . . . . 75.14 109.408 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.9 -53.75 19.13 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.265 -1.383 . . . . 71.53 107.265 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 63.8 m -54.7 -29.26 52.61 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 122.38 1.086 . . . . 75.32 108.374 -173.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.8 m -64.98 -53.32 47.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.149 -1.426 . . . . 73.23 107.149 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.42 -55.12 35.41 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.041 -0.725 . . . . 60.34 109.041 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -46.48 -41.07 13.45 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 116.629 -0.26 . . . . 73.3 111.273 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.52 -3.76 58.2 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.697 -0.627 . . . . 72.15 110.947 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 p -81.61 169.76 16.66 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 120.254 1.388 . . . . 73.53 108.598 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.02 -168.75 30.06 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.682 -1.367 . . . . 73.42 109.682 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -79.01 -25.07 43.3 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.485 -0.932 . . . . 70.34 108.485 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.13 130.35 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 103.625 -2.731 . . . . 73.24 103.625 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.94 139.59 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.791 -1.929 . . . . 70.24 105.791 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -95.67 116.57 29.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 104.402 -2.444 . . . . 73.12 104.402 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.7 mt -118.79 139.82 50.96 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 106.138 -1.801 . . . . 73.33 106.138 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 127.87 55.72 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.461 -2.051 . . . . 72.32 105.461 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.86 156.72 47.57 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.689 -1.226 . . . . 73.43 107.689 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 CA--C 1.438 -3.336 0 N-CA-C 104.995 -2.224 . . . . 71.21 104.995 175.056 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.498 -1.029 0 N-CA-C 104.291 -2.485 . . . . 72.52 104.291 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -144.81 152.07 39.76 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.044 -2.206 . . . . 72.43 105.044 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.04 148.13 28.1 Favored 'General case' 0 N--CA 1.402 -2.829 0 N-CA-C 104.758 -2.312 . . . . 60.2 104.758 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.82 131.15 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 N-CA-C 103.712 -2.699 . . . . 75.34 103.712 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -103.85 111.91 24.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 104.327 -2.472 . . . . 75.11 104.327 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.68 125.24 50.05 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.908 -1.516 . . . . 74.54 106.908 -164.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.1 124.8 37.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 105.694 -1.965 . . . . 65.42 105.694 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 107.639 -1.245 . . . . 64.54 107.639 -176.138 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.375 0 N-CA-C 110.543 -1.023 . . . . 62.13 110.543 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.5 mt -128.43 163.12 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 102.263 -3.236 . . . . 75.52 102.263 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.2 t -153.15 159.09 42.67 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 102.821 -3.029 . . . . 74.31 102.821 174.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.86 167.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.941 -1.874 . . . . 73.42 105.941 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -153.78 167.71 28.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 103.499 -2.778 . . . . 72.43 103.499 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.16 -172.32 15.57 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 106.071 -2.812 . . . . 75.31 106.071 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.22 -124.63 5.38 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.962 -1.655 . . . . 64.43 108.962 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.08 18.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 126.292 1.837 . . . . 64.14 114.368 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 86.92 65.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.971 1.367 . . . . 71.31 107.342 -172.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.3 t -89.1 -165.12 1.26 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.076 -2.194 . . . . 71.11 105.076 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 m -49.63 -26.68 3.82 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.169 0.988 . . . . 61.1 112.208 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -86.71 118.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 N-CA-C 105.361 -2.088 . . . . 71.31 105.361 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.22 -14.35 60.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.787 -0.642 . . . . 74.41 111.053 -165.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -85.87 -5.99 59.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.346 -0.983 . . . . 75.34 108.346 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 10.59 27.49 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.894 -0.883 . . . . 74.4 110.894 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.56 158.29 53.5 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 107.986 -2.046 . . . . 61.34 107.986 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.47 129.0 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.602 -1.999 . . . . 72.44 105.602 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -125.38 144.97 50.26 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.281 -2.118 . . . . 75.41 105.281 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.72 134.16 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.09 -1.448 . . . . 74.2 107.09 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -103.93 -44.4 5.04 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.032 -1.099 . . . . 75.4 108.032 -171.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.68 153.97 40.0 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 105.964 -1.865 . . . . 70.15 105.964 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.42 130.0 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.309 -2.108 . . . . 70.12 105.309 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.1 mt -74.45 137.19 74.61 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.144 -1.799 . . . . 72.3 106.144 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.55 125.6 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.494 2.129 . . . . 75.22 108.685 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 33.9 mt-30 68.4 18.24 9.07 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 124.063 0.852 . . . . 74.31 109.817 -175.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.37 -177.68 52.01 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 106.153 -2.779 . . . . 60.31 106.153 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.563 -0.375 . . . . 73.33 110.82 -168.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.89 94.8 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.065 -0.716 . . . . 75.42 109.065 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 44' ' ' GLN . 50.8 tp10 -59.49 -46.47 88.71 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.26 -0.644 . . . . 73.24 109.26 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 m -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.34 -0.615 . . . . 61.12 109.34 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.96 -45.49 74.05 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.204 -1.036 . . . . 74.34 108.204 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -32.8 5.52 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.312 -1.115 . . . . 72.31 110.312 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -75.17 -36.98 61.45 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 117.614 0.707 . . . . 73.25 109.132 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.04 138.24 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 104.761 -2.311 . . . . 73.33 104.761 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -136.6 179.11 6.56 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.124 -1.806 . . . . 75.15 106.124 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.08 139.85 58.76 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.7 -0.852 . . . . 74.41 108.7 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -3.34 87.22 Favored Glycine 0 CA--C 1.497 -1.082 0 N-CA-C 110.459 -1.056 . . . . 52.41 110.459 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.44 154.42 39.98 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-N 119.342 1.571 . . . . 74.33 107.219 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.71 118.29 36.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.555 -1.276 . . . . 75.44 107.555 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.57 145.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.843 -2.281 . . . . 75.21 104.843 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 -48.33 2.43 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.441 -1.318 . . . . 74.55 107.441 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.15 167.19 18.76 Favored 'General case' 0 CA--C 1.469 -2.148 0 C-N-CA 118.914 -1.114 . . . . 75.21 109.718 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.52 102.54 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 103.702 -2.703 . . . . 74.45 103.702 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.97 41.19 28.1 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.783 0.833 . . . . 73.25 111.03 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.04 15.06 73.38 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 109.935 -1.266 . . . . 73.35 109.935 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.44 116.31 52.23 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 104.353 -2.462 . . . . 74.45 104.353 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -76.4 7.39 4.43 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.546 0.738 . . . . 60.34 111.796 -171.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt 34.25 38.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.967 1.307 . . . . 61.45 111.775 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.9 129.72 36.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 O-C-N 121.148 -0.97 . . . . 65.21 109.534 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 0.98 83.03 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 109.102 -1.599 . . . . 72.53 109.102 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 152.26 45.99 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.951 -1.129 . . . . 75.42 107.951 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 159.74 26.89 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.673 -1.232 . . . . 74.2 107.673 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -62.29 -41.59 98.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.16 -1.052 . . . . 70.14 108.16 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -58.15 -41.76 84.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.793 -0.64 . . . . 73.24 109.865 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -66.25 -34.52 78.2 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 108.673 -0.862 . . . . 71.5 108.673 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.79 74.49 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.826 -0.805 . . . . 64.23 108.826 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.69 -52.6 22.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 107.26 -1.385 . . . . 74.55 107.26 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.6 m -52.96 -28.37 23.38 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.105 0.955 . . . . 62.13 108.45 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -65.75 -55.91 14.76 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.269 -1.382 . . . . 74.5 107.269 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.6 mt -53.78 -55.03 30.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 108.934 -0.765 . . . . 73.54 108.934 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -46.25 -42.13 13.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.231 -0.44 . . . . 75.44 111.615 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -86.68 -5.59 59.09 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 121.72 -0.612 . . . . 72.3 110.87 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -85.06 170.51 12.89 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.755 -1.216 . . . . 74.53 108.404 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 -161.56 22.04 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.394 -1.482 . . . . 75.11 109.394 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.406 ' HG3' HG21 ' A' ' 85' ' ' VAL . 4.0 pt20 -77.99 -28.89 49.39 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.122 -1.066 . . . . 75.13 108.122 -173.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG21 ' HG3' ' A' ' 84' ' ' GLN . 57.7 t -114.87 134.47 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.105 -2.554 . . . . 63.02 104.105 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.66 143.29 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.678 -2.341 . . . . 71.43 104.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -96.89 117.13 30.44 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.975 -2.232 . . . . 72.45 104.975 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.03 137.82 51.99 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 105.215 -2.143 . . . . 73.34 105.215 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.79 127.66 56.1 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 105.313 -2.106 . . . . 75.13 105.313 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.57 154.35 48.92 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.761 -1.57 . . . . 72.23 106.761 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 . . . . . 0 CA--C 1.476 -1.87 0 N-CA-C 105.089 -2.189 . . . . 60.52 105.089 179.173 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 105.963 -1.866 . . . . 72.13 105.963 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -133.78 149.84 51.44 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.19 -1.782 . . . . 73.23 106.19 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -102.26 138.1 39.65 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.99 -1.855 . . . . 72.13 105.99 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.9 t -129.11 127.58 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 104.939 -2.245 . . . . 72.41 104.939 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -103.34 109.45 21.07 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.676 -1.972 . . . . 73.25 105.676 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.99 122.95 45.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 N-CA-C 106.459 -1.682 . . . . 70.11 106.459 -164.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.37 138.18 32.64 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.343 -1.355 . . . . 74.41 107.343 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 106.359 -1.719 . . . . 74.33 106.359 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.482 0 N-CA-C 110.944 -0.862 . . . . 71.45 110.944 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mm -111.7 160.94 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.214 -2.513 . . . . 74.41 104.214 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -154.01 159.23 41.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 102.624 -3.102 . . . . 73.1 102.624 165.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.59 166.83 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 105.918 -1.882 . . . . 72.24 105.918 -168.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -147.87 165.86 29.35 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.199 -2.889 . . . . 74.24 103.199 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.72 -171.79 15.23 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 107.378 -2.289 . . . . 74.35 107.378 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.87 -128.81 6.81 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.205 -1.558 . . . . 71.33 109.205 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.48 19.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 127.24 2.216 . . . . 74.41 114.396 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 85.52 64.03 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.919 -1.512 . . . . 75.11 106.919 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -93.28 -166.15 1.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 104.357 -2.46 . . . . 61.42 104.357 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -38.42 -38.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.628 1.571 . . . . 71.34 113.305 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.69 131.97 33.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.235 0 N-CA-C 107.683 -1.229 . . . . 74.53 107.683 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -59.93 -50.7 72.74 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.636 -0.711 . . . . 75.14 111.446 -168.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.36 -3.64 31.55 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.8 -0.562 . . . . 75.12 109.692 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.54 14.25 41.59 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 110.345 -1.102 . . . . 74.21 110.345 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.42 154.5 50.47 Favored Glycine 0 CA--C 1.478 -2.231 0 N-CA-C 107.643 -2.183 . . . . 73.44 107.643 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.86 108.62 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.639 -1.615 . . . . 74.34 106.639 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 58' ' ' ARG . 36.1 m-85 -98.28 143.19 29.04 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 106.225 -1.769 . . . . 72.32 106.225 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.28 126.99 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 105.717 -1.957 . . . . 74.34 105.717 169.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -99.69 -49.54 4.35 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 107.363 -1.347 . . . . 75.51 107.363 -168.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.87 149.13 38.12 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 106.042 -1.836 . . . . 61.41 106.042 -171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.76 121.95 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 104.221 -2.511 . . . . 71.32 104.221 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.2 mt -75.58 138.27 70.63 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 105.215 -2.142 . . . . 73.3 105.215 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.47 129.48 34.94 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.133 1.889 . . . . 73.05 109.347 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 64.18 22.2 12.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 124.975 1.422 . . . . 63.4 111.329 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.69 175.95 43.38 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 107.202 -2.359 . . . . 74.44 107.202 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.54 73.48 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.255 -0.646 . . . . 74.24 109.255 -172.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.09 -49.71 59.53 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.231 -0.655 . . . . 60.04 109.231 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.24 -37.03 82.86 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 109.503 -0.554 . . . . 75.25 109.503 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.3 m -65.49 -37.97 88.39 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.47 -0.937 . . . . 74.4 108.47 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.74 -37.12 79.2 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.248 -1.019 . . . . 55.04 108.248 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.58 -21.71 8.64 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.898 -0.881 . . . . 31.33 110.898 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.9 mtt85 -75.44 -41.09 56.71 Favored 'General case' 0 CA--C 1.495 -1.165 0 O-C-N 121.524 -0.986 . . . . 72.55 108.61 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.36 128.02 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 106.15 -1.796 . . . . 71.34 106.15 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -131.34 177.4 7.51 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.645 -1.983 . . . . 72.22 105.645 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -67.06 145.27 55.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.615 -1.995 . . . . 73.22 105.615 171.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.05 58.04 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 107.377 -2.289 . . . . 45.01 107.377 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -84.8 158.47 20.67 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 105.301 -2.111 . . . . 54.42 105.301 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.424 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -137.23 150.64 48.0 Favored 'General case' 0 CA--C 1.47 -2.115 0 N-CA-C 107.054 -1.461 . . . . 74.44 107.054 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 t -104.86 145.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 104.786 -2.301 . . . . 65.32 104.786 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -48.23 3.02 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.329 -1.73 . . . . 71.22 106.329 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.18 161.49 31.0 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.429 1.109 . . . . 62.3 110.151 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -142.75 111.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 104.217 -2.512 . . . . 74.52 104.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 50.53 39.8 21.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.755 0.822 . . . . 72.51 110.466 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.37 7.18 79.96 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 109.978 -1.249 . . . . 53.52 109.978 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.424 ' C ' ' H ' ' A' ' 67' ' ' LEU . 43.5 t -108.32 116.56 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.686 -2.338 . . . . 74.24 104.686 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -79.92 14.82 1.64 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.417 0.287 . . . . 63.42 111.348 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 65' ' ' VAL . 4.5 mm? 38.09 38.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.06 1.344 . . . . 74.15 111.329 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -76.09 125.25 28.79 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.762 -1.212 . . . . 64.11 108.499 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.72 -7.49 65.5 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 109.706 -1.358 . . . . 71.54 109.706 172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.41 41.81 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.874 -1.158 . . . . 75.54 107.874 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -83.85 165.94 18.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.153 -1.054 . . . . 51.32 108.153 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.9 -36.6 84.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.302 -0.863 . . . . 74.51 109.118 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.2 -48.37 73.95 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 109.652 -0.499 . . . . 74.53 109.652 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -68.83 -30.21 68.71 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.598 -0.689 . . . . 73.32 109.334 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.11 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.336 -0.987 . . . . 70.2 108.336 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.16 -51.05 42.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 107.285 -1.376 . . . . 73.45 107.285 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.2 m -52.66 -28.36 21.22 Favored 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 108.554 -0.906 . . . . 73.24 108.554 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.2 m -72.67 -57.27 4.25 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.711 -1.218 . . . . 63.25 107.711 -171.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.81 -56.9 16.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.708 -0.849 . . . . 75.21 108.708 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -47.26 -38.75 12.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.89 0.7 . . . . 74.42 112.89 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -88.54 -2.01 58.36 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.324 -0.86 . . . . 63.5 110.241 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -77.73 176.67 8.8 Favored 'General case' 0 C--O 1.243 0.723 0 O-C-N 120.61 -1.306 . . . . 74.32 108.181 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.18 -163.62 26.03 Favored Glycine 0 CA--C 1.491 -1.425 0 N-CA-C 108.741 -1.744 . . . . 24.43 108.741 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.44 -33.93 42.07 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.945 -1.502 . . . . 62.13 106.945 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 t -113.57 130.54 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.096 0 N-CA-C 104.037 -2.579 . . . . 70.24 104.037 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 t -129.35 149.58 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 105.944 -1.873 . . . . 73.11 105.944 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -97.42 111.77 23.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.163 -2.162 . . . . 74.0 105.163 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -112.34 137.74 50.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.321 -2.103 . . . . 75.42 105.321 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 tp -115.92 124.18 49.95 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.807 -2.294 . . . . 73.54 104.807 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.8 155.41 46.01 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 106.934 -1.506 . . . . 71.44 106.934 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.416 -2.131 0 N-CA-C 103.248 -2.871 . . . . 72.41 103.248 179.49 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 105.384 -2.08 . . . . 75.0 105.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -142.95 149.69 38.72 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.255 -1.757 . . . . 73.43 106.255 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.15 140.86 36.78 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.553 -2.017 . . . . 72.04 105.553 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.38 133.12 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 105.914 -1.884 . . . . 75.54 105.914 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.67 116.97 33.91 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.475 -2.046 . . . . 72.02 105.475 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.17 121.21 42.19 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.874 -1.898 . . . . 62.23 105.874 -173.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 134.42 38.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.827 -1.175 . . . . 71.41 107.827 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp . . . . . 0 C--O 1.21 -1.01 0 N-CA-C 107.268 -1.382 . . . . 73.24 107.268 175.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.128 0 CA-C-O 120.021 -0.322 . . . . 72.24 112.988 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.9 mt -132.06 152.49 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.463 -2.791 . . . . 72.0 103.463 170.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.1 m -148.51 164.25 34.77 Favored 'General case' 0 CA--C 1.469 -2.164 0 N-CA-C 103.636 -2.727 . . . . 75.44 103.636 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -145.12 168.69 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 105.196 -2.15 . . . . 71.33 105.196 -168.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -142.79 166.0 25.84 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 102.108 -3.293 . . . . 74.12 102.108 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.71 -174.36 16.0 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 107.09 -2.404 . . . . 63.13 107.09 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.38 -128.27 5.91 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.115 -1.594 . . . . 64.52 109.115 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 m -66.92 19.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.638 1.975 . . . . 74.25 113.962 -168.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.256 85.5 m-20 87.04 66.35 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.956 0 CA-C-O 123.198 1.475 . . . . 75.44 107.479 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -80.82 -166.62 1.15 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.088 -2.56 . . . . 72.42 104.088 170.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -57.57 -19.42 25.44 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 121.536 -0.727 . . . . 70.33 112.178 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.6 m -85.84 135.23 25.42 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 N-CA-C 107.569 -1.271 . . . . 72.32 107.569 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -57.36 -55.47 34.42 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.624 0.77 . . . . 75.32 112.048 -166.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -85.63 12.07 9.52 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 121.166 -0.959 . . . . 63.2 109.308 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.44 22.94 59.68 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 110.217 -1.153 . . . . 70.52 110.217 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.8 145.88 50.03 Favored Glycine 0 C--N 1.36 1.902 0 N-CA-C 108.931 -1.668 . . . . 53.41 108.931 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mm -83.97 94.77 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.982 -1.858 . . . . 64.55 105.982 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -91.48 143.73 26.3 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 106.998 -1.482 . . . . 72.21 106.998 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.8 131.47 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.351 -1.722 . . . . 71.44 106.351 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -102.61 -47.52 4.41 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.785 -1.561 . . . . 73.33 106.785 -166.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.45 151.22 36.06 Favored 'General case' 0 CA--C 1.465 -2.322 0 N-CA-C 105.473 -2.047 . . . . 71.42 105.473 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.26 130.21 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 104.065 -2.569 . . . . 74.31 104.065 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.46 146.21 96.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 105.141 -2.17 . . . . 74.52 105.141 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.05 118.36 5.07 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.087 1.858 . . . . 62.21 108.217 167.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.54 29.49 19.06 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.16 0.913 . . . . 74.05 111.654 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.64 -174.31 35.76 Favored Glycine 0 C--N 1.379 2.956 0 N-CA-C 106.724 -2.551 . . . . 62.53 106.724 167.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.19 74.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 122.004 -0.703 . . . . 75.24 110.378 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.5 91.24 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.819 -0.438 . . . . 70.51 109.819 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.2 -38.87 91.84 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.104 -0.702 . . . . 73.43 109.104 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 t -65.14 -42.47 93.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.438 -0.949 . . . . 53.43 108.438 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.93 -39.87 94.18 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 107.499 -1.297 . . . . 71.25 107.499 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 82.49 -14.94 32.48 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 110.631 -0.988 . . . . 44.04 110.631 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -81.5 -38.8 25.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.55 -0.971 . . . . 71.33 108.554 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.6 mt -101.98 133.08 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.016 -1.846 . . . . 63.41 106.016 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 93.3 m-70 -126.54 179.19 5.45 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.573 -1.64 . . . . 75.23 106.573 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.02 144.25 55.21 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 105.455 -2.054 . . . . 73.11 105.455 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.24 -23.86 32.99 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.207 -1.957 . . . . 70.21 108.207 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.19 152.18 46.2 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 107.52 -1.289 . . . . 74.21 107.52 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.71 131.92 47.97 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 106.938 -1.505 . . . . 72.2 106.938 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.06 150.54 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 105.246 -2.131 . . . . 74.51 105.246 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.49 -46.63 2.86 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.54 -1.281 . . . . 74.24 107.54 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.47 159.58 35.84 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 118.974 -1.091 . . . . 61.53 109.235 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.99 107.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.748 -2.315 . . . . 74.44 104.748 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.2 t30 51.2 36.91 17.02 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.365 1.066 . . . . 74.15 111.417 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.52 68.65 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.648 -1.381 . . . . 73.14 109.648 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.12 120.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 105.024 -2.213 . . . . 71.43 105.024 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -68.24 106.75 2.55 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.516 -1.661 . . . . 71.44 106.516 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -21.38 56.76 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.168 -0.679 . . . . 72.33 109.168 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -57.85 145.0 36.76 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.073 -0.714 . . . . 72.22 109.073 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.57 -38.5 3.11 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 108.976 -1.65 . . . . 52.0 108.976 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.44 158.37 29.63 Favored 'General case' 0 C--N 1.363 1.162 0 CA-C-N 117.783 0.791 . . . . 74.53 109.596 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -84.73 166.11 17.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.394 -1.336 . . . . 73.32 107.394 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -65.04 -41.04 95.59 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.05 -0.722 . . . . 75.5 109.05 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -54.88 -46.18 74.71 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 109.932 -0.395 . . . . 64.22 109.932 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -69.7 -35.81 75.4 Favored 'General case' 0 C--N 1.366 1.302 0 N-CA-C 108.864 -0.791 . . . . 75.11 108.864 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.41 -41.94 77.18 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.383 -0.599 . . . . 74.5 109.383 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 23' ' ' VAL . 48.0 t -68.89 -54.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 N-CA-C 107.861 -1.162 . . . . 73.32 107.861 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.92 -27.57 44.22 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 108.587 -0.894 . . . . 61.13 108.587 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -66.48 -53.46 34.99 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.325 -1.361 . . . . 61.32 107.325 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.93 -56.92 15.47 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.677 -0.86 . . . . 73.3 108.677 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -48.27 -26.13 1.85 Allowed 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 113.382 0.882 . . . . 75.01 113.382 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -92.36 -10.63 37.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.09 0.859 . . . . 75.35 109.379 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -78.55 175.5 10.29 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 120.97 -1.081 . . . . 73.01 108.795 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.72 -163.38 26.91 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.406 -1.478 . . . . 63.52 109.406 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -78.5 -35.82 45.88 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.968 -1.493 . . . . 74.24 106.968 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.07 128.54 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.825 0 N-CA-C 102.692 -3.077 . . . . 72.34 102.692 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.73 140.1 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.905 0 N-CA-C 105.101 -2.185 . . . . 74.13 105.101 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -92.42 111.24 22.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 104.783 -2.302 . . . . 73.0 104.783 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.2 mt -114.77 140.33 48.99 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 106.163 -1.792 . . . . 75.01 106.163 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 tp -111.86 127.14 55.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.888 -1.893 . . . . 75.34 105.888 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mp -133.48 155.56 49.33 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.472 -1.677 . . . . 75.1 106.472 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 104.872 -2.27 . . . . 74.12 104.872 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 104.925 -2.25 . . . . 70.11 104.925 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.01 160.32 43.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.464 -1.68 . . . . 65.43 106.464 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -102.48 139.36 38.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.824 -1.917 . . . . 75.32 105.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.37 134.16 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 N-CA-C 105.841 -1.911 . . . . 75.54 105.841 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.68 124.01 48.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.008 -2.219 . . . . 72.45 105.008 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.84 120.94 43.02 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 104.894 -2.262 . . . . 73.02 104.894 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.32 29.72 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 107.923 -1.14 . . . . 74.33 107.923 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp . . . . . 0 N--CA 1.433 -1.281 0 N-CA-C 106.88 -1.526 . . . . 75.25 106.88 175.01 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.104 0 N-CA-C 108.458 -1.857 . . . . 63.22 108.458 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 mt -127.99 153.43 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 104.131 -2.544 . . . . 73.34 104.131 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.4 m -144.97 160.38 41.43 Favored 'General case' 0 CA--C 1.479 -1.75 0 N-CA-C 102.918 -2.993 . . . . 55.44 102.918 169.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.56 167.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 106.736 -1.579 . . . . 72.21 106.736 -162.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -149.57 166.62 28.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 103.619 -2.734 . . . . 71.44 103.619 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.83 -177.39 17.1 Favored Glycine 0 CA--C 1.486 -1.733 0 N-CA-C 107.417 -2.273 . . . . 60.32 107.417 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.53 -133.65 6.94 Favored Glycine 0 C--N 1.364 2.086 0 N-CA-C 110.014 -1.234 . . . . 54.43 110.014 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.04 19.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.823 2.449 . . . . 75.15 114.812 -167.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.0 t30 86.23 65.24 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.667 -1.605 . . . . 73.24 106.667 -169.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.1 t -96.34 -164.82 1.19 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.571 -2.751 . . . . 64.04 103.571 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -27.88 -49.46 0.06 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.027 1.731 . . . . 54.45 113.12 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.3 129.95 38.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.132 -1.062 . . . . 75.53 108.132 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.18 -27.11 59.52 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 107.655 -1.239 . . . . 74.03 107.655 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 35' ' ' GLY . 46.3 t60 -63.34 -17.75 62.91 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 108.466 -0.939 . . . . 75.32 108.466 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.15 -5.65 2.64 Favored Glycine 0 C--N 1.372 2.539 0 N-CA-C 111.34 -0.704 . . . . 72.25 111.34 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 33' ' ' HIS . . . -68.46 153.51 52.94 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 108.978 -1.649 . . . . 42.34 108.978 -172.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -83.13 97.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 105.918 -1.882 . . . . 63.03 105.918 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.32 146.09 25.48 Favored 'General case' 0 CA--C 1.477 -1.865 0 N-CA-C 107.46 -1.311 . . . . 73.02 107.46 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.52 130.83 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.851 -1.907 . . . . 73.13 105.851 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -108.09 -36.82 6.22 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.146 -1.427 . . . . 70.43 107.146 -167.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.23 151.48 33.08 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 106.897 -1.519 . . . . 73.11 106.897 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.46 128.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 104.743 -2.317 . . . . 72.11 104.743 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 mt -69.27 136.01 88.97 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 107.471 -1.307 . . . . 74.54 107.471 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.12 111.16 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.757 2.305 . . . . 74.14 108.725 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 74.7 21.3 2.19 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 124.552 1.157 . . . . 74.35 110.602 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.61 179.26 40.94 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 107.049 -2.42 . . . . 61.41 107.049 165.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.8 98.84 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.871 -0.788 . . . . 74.04 108.871 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -47.64 73.61 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.195 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.56 -37.95 89.27 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 109.232 -0.655 . . . . 64.51 109.232 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -64.28 -37.43 87.46 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 107.999 -1.111 . . . . 70.01 107.999 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.26 -46.38 70.59 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 107.648 -1.241 . . . . 72.11 107.648 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.5 -13.27 47.63 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.394 -0.682 . . . . 63.11 111.394 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -73.91 -41.71 61.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.636 1.218 . . . . 72.33 108.39 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.78 135.48 33.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 106.982 -1.488 . . . . 75.51 106.982 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.52 -178.56 5.17 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 105.582 -2.007 . . . . 64.02 105.582 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 141.24 57.74 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.873 -1.899 . . . . 73.14 105.873 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.26 -13.29 48.27 Favored Glycine 0 CA--C 1.477 -2.296 0 N-CA-C 107.91 -2.076 . . . . 71.25 107.91 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -82.87 150.25 26.64 Favored 'General case' 0 CA--C 1.485 -1.538 0 N-CA-C 106.184 -1.784 . . . . 74.23 106.184 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.542 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.7 tmm_? -115.91 123.08 47.2 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 106.265 -1.754 . . . . 73.41 106.265 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -94.12 140.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.248 -2.13 . . . . 72.15 105.248 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 -43.95 3.06 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 106.96 -1.496 . . . . 72.23 106.96 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.51 165.37 22.83 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 122.536 1.16 . . . . 75.22 110.029 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.56 102.37 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 103.376 -2.824 . . . . 74.13 103.376 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 t30 51.89 42.28 30.03 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.373 1.069 . . . . 73.3 110.275 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.98 14.31 79.66 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.27 -1.132 . . . . 74.1 110.27 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.16 117.25 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 103.835 -2.654 . . . . 73.5 103.835 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -70.4 115.93 10.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.189 -1.041 . . . . 72.23 108.189 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.6 13.97 7.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.827 -1.175 . . . . 73.35 107.827 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.72 137.7 54.31 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.704 -1.221 . . . . 61.4 107.704 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.26 -16.93 14.6 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.012 -1.235 . . . . 55.02 110.012 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.54 154.44 41.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.095 -1.076 . . . . 75.21 108.095 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.75 163.13 19.33 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.589 -1.263 . . . . 74.43 107.589 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -63.07 -38.87 92.92 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 116.167 -0.47 . . . . 72.51 110.951 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.32 -35.21 79.62 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 120.384 -0.526 . . . . 63.34 109.929 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.15 -31.07 69.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 121.145 -0.972 . . . . 64.34 108.99 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.19 79.88 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.975 -1.12 . . . . 75.41 107.975 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.22 -55.02 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.625 -1.25 . . . . 73.21 107.625 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.3 m -56.2 -27.73 55.74 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 108.829 -0.804 . . . . 62.41 108.829 -171.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -61.79 -55.86 25.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 106.975 -1.491 . . . . 61.11 106.975 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.57 -55.68 30.79 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 109.027 -0.731 . . . . 74.14 109.027 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -46.77 -34.02 4.88 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.625 -0.672 . . . . 74.31 112.52 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -98.56 4.2 48.11 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.255 -0.903 . . . . 74.11 110.413 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 p -80.76 173.63 12.42 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.645 -1.284 . . . . 72.13 108.685 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.2 -136.08 7.22 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.297 -0.721 . . . . 64.11 111.297 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -82.99 -49.09 9.94 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.32 -0.993 . . . . 72.44 108.32 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.0 132.98 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 N-CA-C 104.11 -2.552 . . . . 74.45 104.11 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -116.83 134.23 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 105.056 -2.202 . . . . 61.45 105.056 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.92 120.2 35.78 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.546 -2.02 . . . . 72.32 105.546 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.67 137.23 52.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.074 -1.825 . . . . 73.14 106.074 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.88 125.69 53.9 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.454 -2.424 . . . . 73.34 104.454 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.25 155.44 46.28 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 108.449 -0.945 . . . . 75.32 108.449 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.542 ' CD ' HH21 ' A' ' 58' ' ' ARG . 35.6 tt0 . . . . . 0 N--CA 1.414 -2.262 0 N-CA-C 102.404 -3.184 . . . . 60.32 102.404 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 103.878 -2.638 . . . . 74.41 103.878 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.68 143.77 51.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.843 -1.91 . . . . 74.54 105.843 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.5 130.76 50.94 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.883 -1.895 . . . . 63.23 105.883 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.98 129.8 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.13 0 N-CA-C 105.024 -2.213 . . . . 75.43 105.024 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -103.44 110.75 22.88 Favored 'General case' 0 CA--C 1.471 -2.059 0 N-CA-C 105.745 -1.946 . . . . 72.04 105.745 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.683 -1.599 . . . . 70.3 106.683 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.36 147.84 25.85 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.964 -1.495 . . . . 74.55 106.964 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 105.596 -2.002 . . . . 75.21 105.596 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.438 -1.199 0 N-CA-C 111.205 -0.758 . . . . 61.23 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.2 161.38 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 103.839 -2.652 . . . . 72.14 103.839 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.68 162.72 41.01 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.396 -2.816 . . . . 75.33 103.396 163.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.43 167.86 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 105.389 -2.078 . . . . 74.54 105.389 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -146.77 166.33 26.97 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.958 -2.608 . . . . 74.5 103.958 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 83.92 138.6 3.74 Favored Glycine 0 C--O 1.191 -2.543 0 N-CA-C 111.472 -0.651 . . . . 73.15 111.472 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.31 -89.08 0.07 OUTLIER Glycine 0 C--N 1.362 2.002 0 N-CA-C 109.228 -1.549 . . . . 54.32 109.228 167.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.21 20.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 117.279 2.326 . . . . 64.3 117.279 -165.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 88.32 65.08 0.01 OUTLIER 'General case' 0 CA--C 1.466 -2.27 0 N-CA-C 105.332 -2.099 . . . . 74.41 105.332 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 t -85.7 -166.66 1.59 Allowed 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 110.972 -2.831 . . . . 73.4 106.115 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 m -60.93 -31.0 70.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.473 1.109 . . . . 73.52 110.552 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 m -87.33 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 107.849 -1.167 . . . . 72.41 107.849 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -67.11 -37.31 83.67 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.398 0.679 . . . . 70.32 110.111 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -69.47 -9.02 51.91 Favored 'General case' 0 C--O 1.211 -0.938 0 O-C-N 121.393 -0.817 . . . . 64.32 109.742 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.82 13.77 57.17 Favored Glycine 0 C--N 1.37 2.438 0 N-CA-C 108.589 -1.804 . . . . 72.45 108.589 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 144.99 47.57 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 109.609 -1.396 . . . . 64.51 109.609 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 25' ' ' GLY . 1.7 mm -85.83 104.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 102.454 -3.165 . . . . 71.04 102.454 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -101.29 147.51 26.21 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 107.501 -1.296 . . . . 73.0 107.501 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.25 132.62 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 106.77 -1.567 . . . . 74.22 106.77 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -109.07 -48.11 3.32 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.501 -0.926 . . . . 62.4 108.501 -167.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.61 146.04 34.13 Favored 'General case' 0 CA--C 1.463 -2.388 0 N-CA-C 105.806 -1.924 . . . . 55.32 105.806 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.9 t -130.59 130.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 103.981 -2.6 . . . . 74.24 103.981 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG12 ' CA ' ' A' ' 20' ' ' GLY . 34.0 mm -67.59 141.13 95.05 Favored Pre-proline 0 C--N 1.353 0.718 0 N-CA-C 106.093 -1.817 . . . . 75.35 106.093 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.52 109.12 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.153 1.902 . . . . 73.44 107.896 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 70.15 30.28 3.53 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.446 1.091 . . . . 73.41 110.929 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.45 -179.0 33.83 Favored Glycine 0 C--N 1.369 2.385 0 N-CA-C 107.279 -2.328 . . . . 65.21 107.279 162.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.89 -35.34 80.33 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 122.102 -0.646 . . . . 52.23 109.48 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.85 82.32 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.273 -0.64 . . . . 71.1 109.273 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.58 -34.71 77.59 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.617 -0.512 . . . . 73.23 109.617 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -70.05 -42.32 73.03 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.74 -0.837 . . . . 62.12 108.74 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -67.71 -37.07 81.76 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.691 -1.226 . . . . 74.44 107.691 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.64 -14.28 47.95 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 111.32 -0.712 . . . . 63.14 111.32 170.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -80.88 -35.06 33.12 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.741 -0.858 . . . . 73.0 108.968 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.2 mt -95.24 133.04 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.136 -1.801 . . . . 70.21 106.136 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -135.41 175.27 9.74 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.275 -1.75 . . . . 73.34 106.275 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -65.85 132.58 49.02 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.407 -0.96 . . . . 75.44 108.407 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.81 -12.07 62.6 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.078 -1.609 . . . . 52.53 109.078 170.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -65.87 150.92 47.81 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 106.767 -1.568 . . . . 64.33 106.767 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.9 tmm_? -109.32 127.48 54.34 Favored 'General case' 0 C--O 1.197 -1.672 0 N-CA-C 106.265 -1.754 . . . . 71.54 106.265 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.48 138.66 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 106.17 -1.789 . . . . 74.34 106.17 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -52.21 2.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.553 -1.277 . . . . 72.35 107.553 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.3 165.52 23.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-O 122.157 0.98 . . . . 65.1 110.354 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.28 108.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 104.228 -2.508 . . . . 73.43 104.228 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.7 t30 54.94 38.18 30.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.333 0.653 . . . . 74.54 109.851 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.63 79.3 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 109.528 -1.429 . . . . 63.21 109.528 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.87 119.82 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 104.776 -2.305 . . . . 75.21 104.776 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.2 m -71.91 113.23 8.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.167 -1.049 . . . . 61.52 108.167 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.03 -28.8 62.56 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 107.589 -1.263 . . . . 74.33 107.589 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -52.3 145.04 11.66 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 122.806 0.442 . . . . 73.43 110.53 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.49 -36.45 3.58 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 110.062 -1.215 . . . . 54.31 110.062 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.52 173.82 5.58 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.191 0.996 . . . . 74.02 110.006 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 p -81.01 160.56 24.54 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 107.966 -1.124 . . . . 71.2 107.966 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -64.29 -38.6 91.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.7 -0.852 . . . . 75.41 108.7 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -60.88 -41.86 96.79 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 120.449 -0.5 . . . . 73.24 109.661 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -63.64 -38.88 92.79 Favored 'General case' 0 C--N 1.369 1.421 0 N-CA-C 108.523 -0.917 . . . . 74.53 108.523 -172.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.91 70.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 109.958 -0.386 . . . . 74.34 109.958 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -74.17 -53.87 16.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.528 -1.286 . . . . 65.01 107.528 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.09 -28.31 38.36 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.263 -1.014 . . . . 52.43 108.263 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -67.7 -53.75 25.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.986 -1.116 . . . . 74.31 107.986 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -58.0 -56.83 16.95 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.158 -0.682 . . . . 62.41 109.158 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -51.63 -16.29 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.49 0.922 . . . . 74.43 113.49 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -99.53 -2.86 34.75 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.994 -1.066 . . . . 74.02 108.555 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -78.57 166.54 22.43 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.374 -0.829 . . . . 75.24 109.435 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.4 -140.9 6.08 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 109.364 -1.494 . . . . 51.01 109.364 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -84.03 -48.74 9.6 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.125 -1.065 . . . . 71.15 108.125 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.81 135.63 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.968 -2.605 . . . . 73.41 103.968 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -123.51 142.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 104.7 -2.333 . . . . 73.43 104.7 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -96.25 115.63 27.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.354 -2.462 . . . . 70.23 104.354 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.1 mt -117.4 143.35 46.08 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 106.073 -1.825 . . . . 75.34 106.073 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.51 131.29 56.74 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 103.982 -2.599 . . . . 74.31 103.982 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.99 155.32 48.2 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.987 -1.857 . . . . 74.23 105.987 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 58' ' ' ARG . 39.0 tt0 . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 105.019 -2.215 . . . . 75.3 105.019 -176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.494 -1.194 0 N-CA-C 104.499 -2.408 . . . . 74.33 104.499 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -129.43 141.14 51.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.064 -1.828 . . . . 65.21 106.064 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -102.58 134.32 46.13 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 105.926 -1.879 . . . . 73.51 105.926 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -130.44 130.65 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.116 0 N-CA-C 105.461 -2.051 . . . . 74.51 105.461 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 9.0 pt-20 -106.25 125.92 51.59 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.666 -2.346 . . . . 72.24 104.666 169.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.32 122.73 47.98 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.544 -1.651 . . . . 73.14 106.544 -167.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.88 137.17 35.33 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.476 -1.305 . . . . 74.55 107.476 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 106.652 -1.61 . . . . 74.12 106.652 173.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.457 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 111.524 -0.631 . . . . 72.33 111.524 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.45 156.17 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.79 -3.041 . . . . 74.34 102.79 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.2 m -145.57 160.88 40.99 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 102.575 -3.12 . . . . 71.41 102.575 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.63 165.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 105.738 -1.949 . . . . 74.15 105.738 -167.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -144.41 166.16 25.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 103.045 -2.946 . . . . 75.31 103.045 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.08 -178.43 17.53 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 107.694 -2.162 . . . . 73.21 107.694 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.45 -133.19 7.4 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.172 -1.571 . . . . 70.23 109.172 172.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.21 19.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.87 2.068 . . . . 74.54 113.588 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 87.82 65.58 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.429 -1.323 . . . . 65.53 107.429 -169.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.8 t -89.37 -165.81 1.44 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.304 -2.48 . . . . 63.42 104.304 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -46.14 -31.06 2.18 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.788 0.835 . . . . 71.34 112.89 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 m -84.96 133.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -56.65 -57.06 14.03 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 115.945 -0.57 . . . . 74.41 111.064 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -74.75 -0.39 18.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.491 -0.559 . . . . 73.32 109.491 -169.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.73 14.32 43.31 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 110.148 -1.181 . . . . 64.15 110.148 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.35 154.38 52.91 Favored Glycine 0 CA--C 1.473 -2.552 0 N-CA-C 107.581 -2.208 . . . . 52.11 107.581 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 86.68 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 105.672 -1.973 . . . . 75.22 105.672 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -84.56 142.18 30.17 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 106.992 -1.484 . . . . 75.24 106.992 -174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.84 128.5 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.262 -1.755 . . . . 70.13 106.262 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -102.51 -42.21 6.03 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.91 -1.144 . . . . 73.55 107.91 -166.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.38 153.2 34.28 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 106.53 -1.656 . . . . 75.21 106.53 -173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.92 131.72 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 104.116 -2.55 . . . . 74.21 104.116 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.457 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.9 mm -75.43 143.04 75.45 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 104.288 -2.486 . . . . 71.24 104.288 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.75 115.01 2.24 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 107.714 -1.687 . . . . 64.14 107.714 166.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 77.16 18.28 1.47 Allowed 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 124.857 1.348 . . . . 73.31 111.01 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.11 172.68 40.41 Favored Glycine 0 C--N 1.367 2.282 0 N-CA-C 106.447 -2.661 . . . . 45.41 106.447 164.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.4 80.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.811 -0.817 . . . . 61.43 109.165 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.58 91.98 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.078 -0.712 . . . . 75.42 109.078 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -69.58 -36.32 76.16 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.76 -0.829 . . . . 71.0 108.76 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.6 m -70.27 -35.37 73.7 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.392 -0.966 . . . . 73.33 108.392 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.439 -1.319 . . . . 75.13 107.439 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.6 49.92 Favored Glycine 0 C--O 1.214 -1.151 0 N-CA-C 110.771 -0.932 . . . . 75.34 110.771 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -73.09 -39.1 66.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.419 -1.048 . . . . 65.12 109.144 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.45 131.76 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 107.225 -1.398 . . . . 61.23 107.225 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -141.49 -179.67 6.29 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.646 -1.983 . . . . 73.35 105.646 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -66.61 143.81 56.79 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.162 -1.792 . . . . 74.01 106.162 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.51 50.52 Favored Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 108.085 -2.006 . . . . 64.42 108.085 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.83 161.06 17.74 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.309 -2.108 . . . . 61.53 105.309 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -132.34 146.68 52.15 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.8 -1.556 . . . . 74.42 106.8 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.1 145.3 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.579 -2.378 . . . . 73.25 104.579 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 -47.43 2.63 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.735 -1.58 . . . . 74.12 106.735 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.54 166.8 19.81 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.52 1.152 . . . . 74.32 109.779 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -137.71 103.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 103.743 -2.688 . . . . 75.34 103.743 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.5 t30 56.44 36.96 28.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.315 0.579 . . . . 64.52 110.314 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.21 10.43 84.78 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 109.389 -1.484 . . . . 54.22 109.389 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.82 119.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 N-CA-C 104.311 -2.478 . . . . 72.41 104.311 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -69.69 106.41 3.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.665 -1.235 . . . . 54.34 107.665 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -18.07 36.92 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.109 -1.071 . . . . 73.14 108.109 -175.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.64 146.13 46.59 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.811 -0.811 . . . . 72.14 108.811 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.16 -35.03 4.26 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.452 -1.459 . . . . 74.44 109.452 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.66 156.28 39.68 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.286 -1.005 . . . . 62.0 108.286 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.5 p -75.67 166.14 24.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.827 -0.805 . . . . 73.33 108.827 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -65.8 -40.14 91.6 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.237 -1.023 . . . . 75.32 108.237 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -54.38 -48.16 71.86 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 110.256 -0.275 . . . . 71.41 110.256 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -34.6 78.13 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 108.95 -0.759 . . . . 75.4 108.95 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.92 85.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.23 -0.655 . . . . 71.04 109.23 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.46 -54.79 16.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.641 -1.244 . . . . 74.33 107.641 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.4 m -56.2 -26.84 52.41 Favored 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 108.101 -1.074 . . . . 75.54 108.101 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -64.87 -54.63 27.97 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 107.018 -1.475 . . . . 73.42 107.018 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.4 -55.5 30.94 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.525 -0.917 . . . . 75.34 108.525 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.8 mtp85 -45.83 -47.14 15.87 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.041 0.386 . . . . 75.31 112.041 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -87.89 1.09 54.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.121 0.873 . . . . 74.54 111.19 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.0 p -79.93 174.32 11.71 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.941 1.246 . . . . 74.42 108.374 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.8 -156.83 30.84 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 109.739 -1.344 . . . . 71.3 109.739 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.65 -44.48 27.97 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.72 -1.215 . . . . 72.23 107.72 -172.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.8 127.69 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.75 0 N-CA-C 103.879 -2.637 . . . . 73.13 103.879 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.54 143.63 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.888 0 N-CA-C 104.942 -2.244 . . . . 74.02 104.942 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.426 ' HE1' ' OE1' ' A' ' 11' ' ' GLU . 68.6 m-70 -99.44 117.99 35.07 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 105.138 -2.171 . . . . 63.55 105.138 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.9 mt -114.88 139.32 49.88 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 105.055 -2.202 . . . . 72.01 105.055 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.85 123.94 49.41 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 104.336 -2.468 . . . . 62.41 104.336 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.46 159.3 38.47 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.194 -1.41 . . . . 75.21 107.194 -171.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 104.042 -2.577 . . . . 74.03 104.042 175.819 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 105.224 -2.139 . . . . 72.01 105.224 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.75 159.5 36.88 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.385 -2.079 . . . . 74.1 105.385 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -102.81 148.24 25.87 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.244 -2.132 . . . . 75.33 105.244 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.25 131.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 N-CA-C 104.321 -2.474 . . . . 71.25 104.321 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.03 133.43 54.2 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.382 -1.71 . . . . 75.12 106.382 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.66 128.89 51.2 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.657 -1.979 . . . . 73.43 105.657 -173.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.24 141.87 28.09 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.189 -1.041 . . . . 72.4 108.189 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 107.022 -1.473 . . . . 75.03 107.022 171.825 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.82 0 N-CA-C 110.438 -1.065 . . . . 71.32 110.438 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mt -124.17 152.65 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 103.687 -2.709 . . . . 71.24 103.687 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.6 m -150.54 161.85 41.77 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 103.372 -2.825 . . . . 74.23 103.372 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.96 167.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 105.094 -2.188 . . . . 71.24 105.094 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -143.62 166.15 25.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 102.919 -2.993 . . . . 74.02 102.919 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.04 -173.37 16.18 Favored Glycine 0 CA--C 1.473 -2.562 0 N-CA-C 107.584 -2.206 . . . . 51.23 107.584 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 -123.69 5.53 Favored Glycine 0 CA--C 1.485 -1.789 0 N-CA-C 108.427 -1.869 . . . . 60.54 108.427 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.75 20.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 126.003 1.721 . . . . 73.3 113.659 -169.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 87.32 66.21 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.657 1.218 . . . . 75.35 107.876 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -84.27 -166.51 1.46 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.591 -2.744 . . . . 73.11 103.591 171.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -53.56 -22.04 7.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.762 0.652 . . . . 73.43 112.762 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.85 128.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 107.295 -1.372 . . . . 75.54 107.295 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -61.62 -46.16 91.0 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 122.952 0.501 . . . . 75.33 109.904 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -73.64 -5.33 39.76 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.766 -0.828 . . . . 73.03 108.766 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.02 10.25 19.04 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 110.998 -0.841 . . . . 73.32 110.998 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.9 151.74 51.14 Favored Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 108.477 -1.849 . . . . 43.23 108.477 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.69 89.66 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 N-CA-C 105.737 -1.949 . . . . 74.53 105.737 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -87.42 144.26 26.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.774 -1.565 . . . . 73.11 106.774 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.62 132.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.112 -1.81 . . . . 71.13 106.112 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.06 -45.08 4.62 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.382 -1.34 . . . . 73.43 107.382 -166.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 155.45 38.72 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 106.502 -1.666 . . . . 72.51 106.502 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.29 139.16 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 105.529 -2.026 . . . . 74.04 105.529 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mt -72.95 144.55 85.43 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.337 -1.357 . . . . 73.23 107.337 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.57 108.49 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.639 2.226 . . . . 60.2 108.879 168.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 75.15 27.63 1.1 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.745 1.218 . . . . 73.42 110.318 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.04 173.62 55.09 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 106.556 -2.618 . . . . 65.55 106.556 162.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.35 79.15 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.323 0.649 . . . . 62.02 110.298 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.17 -49.52 64.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.618 -0.512 . . . . 74.24 109.618 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.2 -42.0 99.25 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.615 -0.513 . . . . 63.33 109.615 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.5 m -59.96 -42.14 93.45 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-O 121.355 0.598 . . . . 72.21 109.624 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -77.71 -35.48 52.05 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.813 -1.18 . . . . 73.1 107.813 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 81.23 -4.63 70.85 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 111.306 -0.718 . . . . 73.14 111.306 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.17 -44.3 63.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.658 -0.907 . . . . 74.53 109.131 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 mt -109.98 136.54 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 105.826 -1.916 . . . . 73.41 105.826 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.418 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 53.5 m80 -122.96 170.03 10.55 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.98 -1.859 . . . . 75.43 105.98 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 146.49 53.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.338 -1.356 . . . . 75.3 107.338 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.72 -8.2 78.71 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 109.804 -1.318 . . . . 50.21 109.804 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -86.0 163.38 18.0 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.104 -1.813 . . . . 71.13 106.104 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -115.39 129.88 56.72 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.7 0.762 . . . . 73.41 109.148 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.94 148.82 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 104.942 -2.244 . . . . 73.34 104.942 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -44.43 2.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.742 -1.207 . . . . 73.03 107.742 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.23 164.35 24.73 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.017 -1.073 . . . . 73.41 109.905 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.5 t -140.76 107.51 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.917 -2.253 . . . . 75.15 104.917 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.8 t30 45.71 43.48 9.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.417 1.487 . . . . 72.23 111.073 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.97 76.87 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 109.614 -1.395 . . . . 72.43 109.614 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.87 117.53 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 103.815 -2.661 . . . . 75.54 103.815 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.0 m -69.62 110.44 4.84 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.501 -1.296 . . . . 70.34 107.501 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.61 -6.48 57.49 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.9 -1.148 . . . . 71.24 107.9 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.96 143.64 57.27 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.556 -1.276 . . . . 72.14 107.556 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.36 -39.12 3.13 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.116 -1.193 . . . . 34.44 110.116 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 163.98 24.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 108.951 -0.759 . . . . 62.14 108.951 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -84.58 168.65 15.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.799 0.809 . . . . 72.42 109.36 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -62.03 -40.46 95.79 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 115.404 -0.816 . . . . 71.1 109.27 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -60.78 -40.58 93.11 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.892 -0.505 . . . . 74.11 110.54 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.21 -39.2 93.95 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.5 1.045 . . . . 71.25 109.378 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.89 79.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.427 -0.583 . . . . 73.14 109.427 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -71.24 -54.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 107.423 -1.325 . . . . 74.11 107.423 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.7 t -53.35 -28.94 31.51 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.55 1.167 . . . . 73.01 108.521 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 m -70.59 -56.36 6.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.507 -1.294 . . . . 75.14 107.507 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -57.15 -54.72 43.61 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 107.937 -1.134 . . . . 73.13 107.937 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -44.49 -43.99 8.28 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.542 1.137 . . . . 75.31 111.9 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.15 9.02 43.91 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.713 1.142 . . . . 75.2 111.201 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.4 p -80.72 174.45 11.6 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.861 -1.149 . . . . 72.14 107.925 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.28 -148.53 16.38 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.599 -1.4 . . . . 73.4 109.599 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -80.6 -47.81 13.6 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 108.173 -1.047 . . . . 74.14 108.173 -169.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.12 132.69 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 N-CA-C 103.817 -2.66 . . . . 74.34 103.817 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.55 151.0 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 104.479 -2.415 . . . . 71.14 104.479 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -103.36 124.26 48.36 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 104.933 -2.247 . . . . 73.32 104.933 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.02 137.79 49.55 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.191 -2.522 . . . . 75.42 104.191 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -106.97 126.27 52.1 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 105.815 -1.92 . . . . 72.34 105.815 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 152.52 51.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.423 -2.065 . . . . 73.43 105.423 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.462 -2.429 0 N-CA-C 102.608 -3.108 . . . . 72.2 102.608 176.218 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 104.827 -2.286 . . . . 74.53 104.827 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.6 152.29 41.21 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.944 -1.873 . . . . 73.15 105.944 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.439 ' HG2' HD11 ' A' ' 89' ' ' LEU . 46.9 mt-10 -105.31 143.53 33.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.669 -1.974 . . . . 72.44 105.669 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.95 130.74 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.0 0 N-CA-C 104.952 -2.24 . . . . 74.54 104.952 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.49 113.14 26.24 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 103.866 -2.642 . . . . 73.34 103.866 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -103.58 122.21 44.5 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.885 -1.894 . . . . 75.22 105.885 -169.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.75 150.3 39.34 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.036 -1.839 . . . . 71.45 106.036 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 tptm . . . . . 0 CA--C 1.456 -2.659 0 N-CA-C 103.119 -2.919 . . . . 74.3 103.119 165.761 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.322 0 N-CA-C 107.49 -2.244 . . . . 44.42 107.49 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 22.2 mt -138.54 156.93 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 102.744 -3.058 . . . . 70.01 102.744 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.5 m -153.11 168.64 25.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.527 -2.768 . . . . 73.42 103.527 169.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -140.6 167.99 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 106.497 -1.668 . . . . 74.21 106.497 -167.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 t -143.58 167.0 23.27 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 103.68 -2.711 . . . . 73.4 103.68 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 88.31 134.45 4.73 Favored Glycine 0 C--O 1.201 -1.969 0 N-CA-C 108.83 -1.708 . . . . 73.01 108.83 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.3 -98.89 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 108.986 -1.646 . . . . 43.11 108.986 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.04 20.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 126.617 1.967 . . . . 74.3 115.833 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.9 t30 87.2 65.19 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.181 -1.414 . . . . 75.22 107.181 -172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 t -92.29 -166.09 1.48 Allowed 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.705 -2.331 . . . . 75.35 104.705 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -52.29 -21.8 3.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.5 1.12 . . . . 73.15 112.391 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.52 130.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 107.61 -1.256 . . . . 73.15 107.61 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -68.73 -36.31 78.25 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 116.017 -0.538 . . . . 75.34 111.532 -168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -79.06 -4.36 49.81 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.966 -1.084 . . . . 75.54 108.909 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.68 62.98 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 108.355 -1.898 . . . . 74.02 108.355 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.41 134.78 39.05 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 109.095 -1.602 . . . . 70.32 109.095 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 25' ' ' GLY . 2.3 mm -78.08 103.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 103.516 -2.772 . . . . 74.55 103.516 173.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.39 147.83 24.3 Favored 'General case' 0 CA--C 1.468 -2.205 0 N-CA-C 106.58 -1.637 . . . . 71.33 106.58 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.66 133.98 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 106.657 -1.608 . . . . 73.42 106.657 168.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.03 -49.34 2.98 Favored 'General case' 0 CA--C 1.472 -2.038 0 N-CA-C 107.195 -1.409 . . . . 73.1 107.195 -169.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.09 130.81 41.73 Favored 'General case' 0 CA--C 1.456 -2.637 0 N-CA-C 105.868 -1.901 . . . . 74.25 105.868 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' A' ' 47' ' ' ALA . 95.3 t -120.37 117.43 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 103.576 -2.75 . . . . 62.12 103.576 172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.59 136.23 96.68 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 106.712 -1.588 . . . . 72.04 106.712 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.67 111.4 1.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.495 2.13 . . . . 75.32 107.665 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 75.73 20.68 1.78 Allowed 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.259 0.974 . . . . 73.42 110.541 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.52 -176.88 45.74 Favored Glycine 0 C--N 1.358 1.796 0 N-CA-C 107.024 -2.43 . . . . 71.12 107.024 168.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.72 -19.84 61.99 Favored 'General case' 0 C--O 1.219 -0.53 0 O-C-N 122.359 -0.495 . . . . 75.3 110.744 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HB1' HG11 ' A' ' 41' ' ' VAL . . . -81.09 -49.19 11.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.163 -1.421 . . . . 71.13 107.163 -174.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.99 -38.16 87.56 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.169 -0.678 . . . . 74.44 109.169 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -70.65 -39.38 73.65 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.569 -0.9 . . . . 71.12 108.569 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.4 -39.05 88.78 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.384 -1.339 . . . . 73.31 107.384 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.6 -19.36 37.18 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 110.322 -1.111 . . . . 64.41 110.322 171.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.18 -39.68 40.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.81 -1.182 . . . . 71.01 107.81 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.85 132.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.722 -1.584 . . . . 72.24 106.722 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -142.67 -176.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 104.715 -2.328 . . . . 73.31 104.715 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -66.58 141.71 57.74 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.295 -1.743 . . . . 72.53 106.295 172.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.84 -30.13 8.34 Favored Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 107.486 -2.246 . . . . 34.53 107.486 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -72.78 150.73 42.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.428 -0.953 . . . . 70.12 108.428 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -123.56 128.77 50.2 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.157 -1.794 . . . . 72.41 106.157 -173.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.84 144.27 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 106.249 -1.76 . . . . 71.11 106.249 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.28 -44.08 2.6 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.559 -1.274 . . . . 73.52 107.559 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.89 159.49 36.47 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.944 -1.102 . . . . 74.33 109.378 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.16 116.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 104.942 -2.244 . . . . 73.3 104.942 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.3 t30 55.09 30.98 15.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.595 0.758 . . . . 73.33 109.886 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 16.43 77.21 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 109.324 -1.51 . . . . 72.52 109.324 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -106.72 124.01 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.814 0 N-CA-C 104.682 -2.34 . . . . 65.22 104.682 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -68.81 112.69 5.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.415 -1.328 . . . . 71.11 107.415 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.22 -1.0 57.58 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.571 -1.27 . . . . 73.21 107.571 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.74 143.13 58.09 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.608 -1.256 . . . . 63.12 107.608 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.85 3.81 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.451 -1.06 . . . . 63.12 110.451 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.44 13.37 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.761 0.78 . . . . 64.31 109.323 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -81.39 162.99 23.15 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.515 -1.291 . . . . 75.41 107.515 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -65.23 -36.75 85.13 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.532 -1.285 . . . . 75.43 107.532 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.03 -51.64 56.1 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 109.983 -0.377 . . . . 74.44 109.983 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -66.92 -37.68 84.78 Favored 'General case' 0 C--N 1.369 1.455 0 N-CA-C 109.286 -0.635 . . . . 70.24 109.286 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.75 -43.97 77.17 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 118.033 0.379 . . . . 54.34 110.175 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.66 -50.77 36.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.267 -1.383 . . . . 74.01 107.267 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.5 t -53.92 -28.65 38.21 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-O 122.127 0.965 . . . . 50.44 108.671 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.87 -55.15 13.98 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 107.184 -1.413 . . . . 73.33 107.184 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.65 -55.79 29.58 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.074 0.94 . . . . 74.33 108.613 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -46.6 -25.56 0.73 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.23 -0.896 . . . . 71.03 113.177 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -116.57 10.62 14.52 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.639 -1.288 . . . . 75.24 110.07 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.3 p -84.92 173.42 10.59 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.63 -155.19 22.55 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 109.767 -1.333 . . . . 62.12 109.767 -172.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -80.77 -31.89 35.65 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 108.439 -0.949 . . . . 62.13 108.439 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.33 133.52 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 103.908 -2.626 . . . . 73.43 103.908 175.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.57 141.98 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 105.461 -2.051 . . . . 64.34 105.461 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -95.61 115.82 27.98 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.321 -2.474 . . . . 74.25 104.321 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.4 mt -116.57 140.37 49.46 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 106.36 -1.719 . . . . 74.15 106.36 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 9' ' ' GLU . 26.1 tp -114.52 126.08 54.53 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 105.107 -2.182 . . . . 74.34 105.107 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.81 156.15 46.53 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.267 -1.383 . . . . 70.03 107.267 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.418 -2.057 0 N-CA-C 103.676 -2.713 . . . . 61.43 103.676 175.381 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 103.86 -2.645 . . . . 74.53 103.86 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.99 160.24 42.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 105.594 -2.002 . . . . 74.41 105.594 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.7 146.22 28.54 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.138 -1.801 . . . . 65.4 106.138 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.7 t -127.81 127.34 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.226 0 N-CA-C 103.453 -2.795 . . . . 70.53 103.453 167.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.49 114.09 28.1 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.31 -2.478 . . . . 72.42 104.31 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 124.31 48.51 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.809 -1.923 . . . . 75.24 105.809 -169.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.69 147.22 25.07 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.102 -1.444 . . . . 73.0 107.102 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 106.276 -1.749 . . . . 73.44 106.276 176.245 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.475 1.261 0 CA-C-O 120.392 -0.115 . . . . 61.14 113.056 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -135.67 165.19 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 102.921 -2.992 . . . . 73.33 102.921 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.6 m -152.17 165.53 34.54 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 102.625 -3.102 . . . . 74.3 102.625 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.83 169.37 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 105.957 -1.868 . . . . 74.12 105.957 -167.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -148.88 167.32 26.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 103.002 -2.962 . . . . 73.25 103.002 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.6 -168.93 13.15 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 106.652 -2.579 . . . . 72.43 106.652 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 -116.04 3.2 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 107.879 -2.088 . . . . 51.12 107.879 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.18 19.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.89 1.276 . . . . 72.11 113.742 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.27 82.1 m-20 88.68 68.17 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 123.179 1.466 . . . . 75.31 108.442 -170.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.621 HG23 ' H ' ' A' ' 30' ' ' SER . 6.3 m -81.99 -166.99 1.37 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 103.423 -2.806 . . . . 73.21 103.423 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.621 ' H ' HG23 ' A' ' 29' ' ' THR . 11.8 m -53.74 -20.16 5.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 53.41 112.573 -174.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -89.97 128.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.625 -1.25 . . . . 70.32 107.625 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.29 -45.71 90.14 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 115.629 -0.714 . . . . 75.54 110.834 -170.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.04 1.79 14.55 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.731 -0.606 . . . . 72.13 109.747 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.17 22.26 68.85 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 109.984 -1.247 . . . . 50.54 109.984 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.57 150.82 50.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.137 -1.985 . . . . 71.51 108.137 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mm -93.09 105.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.026 -2.583 . . . . 73.14 104.026 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -97.74 142.28 29.72 Favored 'General case' 0 CA--C 1.465 -2.296 0 N-CA-C 106.699 -1.593 . . . . 75.0 106.699 -174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.45 135.45 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 106.97 -1.492 . . . . 72.33 106.97 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -45.25 4.04 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.549 -1.649 . . . . 74.33 106.549 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.15 156.08 44.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.633 -1.988 . . . . 70.14 105.633 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.55 136.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 103.67 -2.715 . . . . 74.25 103.67 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.431 HG12 ' CA ' ' A' ' 20' ' ' GLY . 21.5 mm -69.1 143.92 94.76 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.179 -1.785 . . . . 72.13 106.179 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.33 114.93 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.295 1.997 . . . . 74.14 107.766 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 60.46 35.87 20.27 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.715 0.806 . . . . 71.44 111.122 -172.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 178.42 48.6 Favored Glycine 0 C--N 1.366 2.196 0 N-CA-C 106.614 -2.594 . . . . 74.14 106.614 163.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.21 93.88 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 109.383 -0.599 . . . . 71.04 109.383 -172.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.59 75.75 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.596 -0.52 . . . . 71.44 109.596 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.79 -39.86 87.93 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.303 -0.629 . . . . 75.53 109.303 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.0 m -64.97 -36.12 83.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.26 -0.644 . . . . 73.21 109.26 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.59 -32.52 68.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 108.246 -1.02 . . . . 71.15 108.246 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -20.01 29.48 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.546 -1.022 . . . . 61.3 110.546 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -72.64 -44.9 61.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.111 -1.07 . . . . 74.34 108.111 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mt -98.15 149.77 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.878 -1.897 . . . . 71.3 105.878 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -151.49 170.38 19.76 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.082 -2.192 . . . . 75.55 105.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -67.29 142.57 56.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.627 -1.62 . . . . 71.3 106.627 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.3 -3.36 84.02 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 119.84 -1.171 . . . . 74.4 110.181 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -80.16 150.34 30.21 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 106.939 -1.504 . . . . 61.53 106.939 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.88 118.48 36.93 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.073 -1.455 . . . . 72.34 107.073 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 t -103.61 148.52 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 105.457 -2.053 . . . . 74.51 105.457 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.38 -48.01 2.9 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.773 -1.195 . . . . 73.23 107.773 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.08 162.37 28.94 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.576 -0.85 . . . . 70.41 109.184 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.18 111.82 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.349 -2.093 . . . . 73.3 105.349 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 49.45 36.84 10.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.13 1.372 . . . . 75.13 111.363 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.48 4.87 76.19 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 109.671 -1.371 . . . . 71.32 109.671 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.93 120.53 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 104.572 -2.381 . . . . 74.03 104.572 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -72.72 108.57 5.78 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 106.861 -1.533 . . . . 74.54 106.861 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.98 -2.01 42.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.565 -0.743 . . . . 75.13 109.798 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.29 143.8 57.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.865 -1.161 . . . . 73.34 107.865 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.2 -31.32 4.12 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.74 -1.344 . . . . 64.34 109.74 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.46 162.16 29.84 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 118.495 1.148 . . . . 72.04 108.383 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.1 p -85.38 169.52 13.61 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.856 0.836 . . . . 64.35 109.06 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -64.26 -44.91 90.31 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.854 -1.165 . . . . 74.41 107.854 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.11 -41.35 96.54 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 119.265 -0.397 . . . . 65.43 110.095 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -37.45 87.08 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 119.281 0.946 . . . . 61.1 108.84 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.78 -38.23 69.62 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.539 0.609 . . . . 73.33 109.973 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.11 -55.06 14.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 107.641 -1.244 . . . . 73.22 107.641 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.36 -26.75 68.62 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.758 -0.83 . . . . 72.4 108.758 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.6 m -60.16 -54.0 51.09 Favored 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 107.088 -1.449 . . . . 73.21 107.088 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -56.11 -56.05 25.61 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 121.701 0.762 . . . . 74.11 109.123 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -48.72 -30.2 5.3 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 121.647 -0.658 . . . . 74.24 112.676 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -93.2 -7.34 45.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.349 -0.844 . . . . 75.43 109.939 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 p -79.41 170.28 16.83 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.856 -1.165 . . . . 64.21 107.856 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.16 -136.57 3.74 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 110.142 -1.183 . . . . 62.24 110.142 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.3 -45.88 8.76 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.82 -1.178 . . . . 73.12 107.82 -172.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.94 128.31 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 104.079 -2.563 . . . . 75.32 104.079 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -123.94 138.43 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.212 -2.514 . . . . 72.24 104.212 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.54 117.92 31.95 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 104.694 -2.336 . . . . 72.32 104.694 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.9 mt -116.74 137.84 51.91 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.864 -1.902 . . . . 75.41 105.864 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.74 130.31 56.11 Favored 'General case' 0 CA--C 1.463 -2.4 0 N-CA-C 104.589 -2.374 . . . . 73.11 104.589 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.68 153.84 49.58 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 105.848 -1.908 . . . . 72.34 105.848 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 . . . . . 0 CA--C 1.476 -1.865 0 N-CA-C 103.786 -2.672 . . . . 63.11 103.786 179.146 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 104.035 -2.58 . . . . 72.23 104.035 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -128.01 142.12 51.32 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 105.78 -1.933 . . . . 72.4 105.78 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -103.05 132.13 49.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 104.711 -2.329 . . . . 71.43 104.711 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.25 135.93 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 106.318 -1.734 . . . . 75.54 106.318 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.04 118.13 36.13 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.234 -2.506 . . . . 70.12 104.234 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.91 121.09 41.81 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 104.962 -2.236 . . . . 74.42 104.962 -175.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.1 133.36 37.66 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.253 -1.388 . . . . 63.11 107.253 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm . . . . . 0 CA--C 1.495 -1.138 0 C-N-CA 124.648 1.179 . . . . 74.01 108.072 179.349 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.451 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.478 -2.259 0 N-CA-C 110.982 -0.847 . . . . 52.33 110.982 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.7 mt -131.68 148.43 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 101.042 -3.688 . . . . 74.22 101.042 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -146.68 164.02 34.04 Favored 'General case' 0 CA--C 1.46 -2.488 0 N-CA-C 102.568 -3.123 . . . . 74.13 102.568 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.48 167.92 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 106.498 -1.667 . . . . 74.22 106.498 -161.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -144.72 165.89 26.78 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.233 -2.506 . . . . 75.2 104.233 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 79.39 140.5 2.06 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 110.871 -0.891 . . . . 64.34 110.871 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.62 -87.42 0.07 OUTLIER Glycine 0 C--N 1.351 1.41 0 N-CA-C 109.782 -1.327 . . . . 74.3 109.782 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.56 20.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 128.934 2.893 . . . . 75.23 117.057 -172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 86.91 66.13 0.01 OUTLIER 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 105.564 -2.013 . . . . 71.41 105.564 -170.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -84.39 -166.88 1.57 Allowed 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 111.807 -2.451 . . . . 72.33 105.785 -175.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -59.43 -26.57 65.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 123.803 0.841 . . . . 73.34 110.952 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.566 ' H ' HG22 ' A' ' 29' ' ' THR . 27.3 m -87.46 139.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.749 -1.574 . . . . 74.52 106.749 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -51.95 -58.16 7.32 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.882 0.873 . . . . 73.45 111.711 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.93 8.49 6.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.941 -0.474 . . . . 63.41 111.062 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.25 29.33 74.2 Favored Glycine 0 C--N 1.36 1.864 0 N-CA-C 108.537 -1.825 . . . . 71.11 108.537 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.14 127.53 27.29 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.037 -1.625 . . . . 72.31 109.037 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 25' ' ' GLY . 1.2 mm -79.03 104.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.361 -2.829 . . . . 72.22 103.361 172.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -98.43 146.5 25.67 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 107.69 -1.226 . . . . 74.53 107.69 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 130.72 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.983 -1.858 . . . . 71.15 105.983 171.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -104.92 -47.14 4.1 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.005 -1.48 . . . . 72.3 107.005 -168.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.06 147.89 39.32 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 105.841 -1.911 . . . . 74.22 105.841 -169.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.93 128.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 103.552 -2.758 . . . . 75.11 103.552 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.4 mm -64.61 144.87 98.76 Favored Pre-proline 0 N--CA 1.477 0.875 0 N-CA-C 105.959 -1.867 . . . . 74.41 105.959 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 111.99 1.05 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 N-CA-C 107.319 -1.839 . . . . 73.14 107.319 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 70.55 29.58 3.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 124.58 1.175 . . . . 72.41 110.654 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.03 172.38 40.67 Favored Glycine 0 C--N 1.363 2.08 0 N-CA-C 107.946 -2.062 . . . . 74.23 107.946 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.73 76.2 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 108.689 -0.856 . . . . 41.21 108.689 -175.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.8 80.18 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 109.443 -0.577 . . . . 45.04 109.443 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -62.3 -40.66 97.02 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 109.017 -0.735 . . . . 75.11 109.017 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -66.08 -41.71 90.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.15 -1.056 . . . . 55.21 108.15 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.01 -40.59 91.24 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.616 -1.253 . . . . 74.4 107.616 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.81 -10.45 59.97 Favored Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 110.859 -0.896 . . . . 74.22 110.859 172.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -81.45 -40.13 23.8 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.158 -1.052 . . . . 73.44 108.158 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.1 mt -93.75 140.78 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.848 -1.538 . . . . 73.32 106.848 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.32 174.9 10.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.057 -1.831 . . . . 71.45 106.057 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.41 143.47 57.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 106.15 -1.796 . . . . 75.05 106.15 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.12 52.27 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.785 -2.126 . . . . 74.52 107.785 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.36 147.33 40.14 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.592 -1.633 . . . . 52.31 106.592 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.53 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.6 tmm_? -109.73 118.85 37.63 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.045 -2.206 . . . . 74.35 105.045 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.24 131.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.252 -2.129 . . . . 74.24 105.252 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 -50.77 3.24 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.868 -1.53 . . . . 73.32 106.868 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.59 166.44 20.64 Favored 'General case' 0 CA--C 1.47 -2.099 0 CA-C-O 122.313 1.054 . . . . 73.33 109.272 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.09 109.5 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 103.684 -2.709 . . . . 74.5 103.684 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.73 40.02 11.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.596 1.158 . . . . 75.43 111.556 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.28 6.81 70.63 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 110.426 -1.07 . . . . 43.3 110.426 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.55 117.75 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.816 0 N-CA-C 104.284 -2.487 . . . . 75.21 104.284 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -69.16 110.98 4.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.646 -1.242 . . . . 73.21 107.646 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.27 -7.96 58.75 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.807 -0.812 . . . . 62.42 108.807 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.97 144.31 56.95 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.288 -1.004 . . . . 55.33 108.288 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 -30.86 3.93 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.784 -0.926 . . . . 62.1 110.784 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.63 164.97 15.69 Favored 'General case' 0 C--N 1.365 1.244 0 CA-C-N 118.396 1.098 . . . . 75.22 109.16 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 p -83.38 164.39 20.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.745 -1.206 . . . . 73.42 107.745 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.58 -37.95 86.01 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.569 -0.9 . . . . 75.15 108.569 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -58.58 -42.02 87.1 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 119.661 -0.816 . . . . 73.04 110.211 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.93 -40.12 91.14 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 108.625 -0.88 . . . . 74.51 108.625 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.26 -43.29 78.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.691 -0.485 . . . . 72.33 109.691 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.58 -50.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 107.281 -1.378 . . . . 72.04 107.281 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.2 t -53.41 -28.63 30.77 Favored 'General case' 0 N--CA 1.514 2.74 0 CA-C-O 122.446 1.117 . . . . 73.42 108.649 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.7 m -71.73 -46.71 57.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.64 -53.06 57.42 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.006 -1.109 . . . . 64.13 108.006 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -44.45 -46.35 9.57 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 74.42 111.607 174.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -95.0 61.12 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -111.16 156.53 21.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.95 -1.13 . . . . 71.35 107.95 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.12 -125.43 3.58 Favored Glycine 0 CA--C 1.492 -1.348 0 N-CA-C 108.573 -1.811 . . . . 62.31 108.573 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -89.32 -52.12 5.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.868 -1.16 . . . . 75.32 107.868 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.04 136.63 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 105.243 -2.132 . . . . 72.44 105.243 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -114.82 130.55 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 105.21 -2.144 . . . . 73.02 105.21 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -95.11 116.86 29.27 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.788 -2.301 . . . . 71.41 104.788 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 mt -122.1 144.56 48.85 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.552 -1.647 . . . . 71.53 106.552 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -116.73 131.53 56.93 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 103.777 -2.675 . . . . 72.22 103.777 172.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mp -133.32 155.71 48.94 Favored 'General case' 0 CA--C 1.469 -2.153 0 N-CA-C 106.493 -1.669 . . . . 74.11 106.493 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.53 ' CD ' HH21 ' A' ' 58' ' ' ARG . 31.8 tt0 . . . . . 0 N--CA 1.416 -2.168 0 N-CA-C 104.894 -2.261 . . . . 75.41 104.894 -175.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.434 -1.254 0 N-CA-C 103.643 -2.725 . . . . 75.23 103.643 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.16 150.76 44.62 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.327 -1.731 . . . . 74.43 106.327 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -102.71 140.95 36.32 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.497 -2.038 . . . . 72.52 105.497 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.1 t -124.9 125.99 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 103.878 -2.638 . . . . 72.24 103.878 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -102.76 125.06 49.36 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.414 -2.069 . . . . 50.34 105.414 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 121.66 42.66 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.638 -1.616 . . . . 74.05 106.638 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.55 139.49 34.19 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.274 -1.75 . . . . 63.11 106.274 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.816 0 N-CA-C 106.304 -1.739 . . . . 72.14 106.304 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.14 0 CA-C-O 119.734 -0.481 . . . . 74.24 112.753 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.21 150.52 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 104.056 -2.572 . . . . 71.21 104.056 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.2 m -151.88 167.21 29.04 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 102.673 -3.084 . . . . 64.52 102.673 167.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.08 168.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 106.111 -1.811 . . . . 73.02 106.111 -167.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -139.54 166.12 25.42 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 102.711 -3.07 . . . . 73.13 102.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 87.66 131.19 3.41 Favored Glycine 0 C--O 1.199 -2.054 0 N-CA-C 109.637 -1.385 . . . . 74.11 109.637 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.27 -92.18 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 107.874 -2.09 . . . . 63.22 107.874 165.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.36 19.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.376 1.471 . . . . 72.33 114.169 -171.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 88.5 65.79 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.942 -1.503 . . . . 73.13 106.942 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.59 HG23 ' H ' ' A' ' 30' ' ' SER . 2.4 m -88.09 -166.45 1.59 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.877 -2.638 . . . . 74.11 103.877 172.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.59 ' H ' HG23 ' A' ' 29' ' ' THR . 5.0 m -44.86 -33.22 1.86 Allowed 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.661 1.184 . . . . 62.21 112.063 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 m -85.36 129.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.055 -1.091 . . . . 74.43 108.055 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -66.45 -34.16 77.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.041 -0.981 . . . . 74.31 112.789 -166.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -75.57 -2.25 28.27 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.962 -1.086 . . . . 73.1 109.338 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.97 20.2 59.83 Favored Glycine 0 C--N 1.36 1.906 0 N-CA-C 108.281 -1.927 . . . . 54.1 108.281 -167.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.38 153.06 48.92 Favored Glycine 0 CA--C 1.476 -2.358 0 N-CA-C 107.964 -2.054 . . . . 44.23 107.964 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 25' ' ' GLY . 2.8 mm -90.72 119.87 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 103.89 -2.633 . . . . 73.54 103.89 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.69 145.88 43.15 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 106.667 -1.605 . . . . 71.41 106.667 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.67 131.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.175 -1.416 . . . . 71.42 107.175 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.0 -47.02 3.79 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 106.665 -1.605 . . . . 74.42 106.665 -168.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.84 138.51 42.59 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 105.594 -2.002 . . . . 71.13 105.594 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.02 126.31 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 105.081 -2.192 . . . . 72.4 105.081 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -69.9 137.24 87.51 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.685 -1.598 . . . . 74.55 106.685 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.87 117.67 4.46 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.367 2.045 . . . . 62.3 108.31 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 62.03 25.37 15.21 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.863 0.865 . . . . 63.13 111.879 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.77 54.86 Favored Glycine 0 C--N 1.364 2.092 0 N-CA-C 105.689 -2.964 . . . . 63.12 105.689 165.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.13 48.79 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 117.325 0.562 . . . . 65.33 111.782 -171.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.95 67.03 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.199 -0.667 . . . . 73.32 109.199 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.04 -34.4 77.62 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.875 -0.417 . . . . 74.33 109.875 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.5 m -64.1 -31.96 73.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.743 -0.836 . . . . 72.41 108.743 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.85 -42.31 73.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.646 -1.242 . . . . 73.34 107.646 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.03 -20.6 35.43 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.122 -1.191 . . . . 63.22 110.122 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -78.27 -41.2 34.76 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.031 -1.099 . . . . 75.34 108.031 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.9 mt -95.94 134.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.578 -1.638 . . . . 72.44 106.578 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.18 179.91 7.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.952 -1.87 . . . . 74.23 105.952 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -66.82 138.56 57.43 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 106.781 -1.562 . . . . 73.53 106.781 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.6 -14.18 50.3 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 108.528 -1.829 . . . . 71.4 108.528 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.64 151.02 44.06 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.737 -0.838 . . . . 73.35 108.737 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -113.18 126.9 55.94 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.287 -2.116 . . . . 75.13 105.287 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 t -104.77 142.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 104.554 -2.388 . . . . 72.3 104.554 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.81 -48.22 2.76 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.342 -1.355 . . . . 75.34 107.342 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.95 164.14 24.89 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 122.327 1.06 . . . . 72.44 109.785 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.14 109.1 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 N-CA-C 104.302 -2.481 . . . . 72.35 104.302 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 48.0 42.16 16.18 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.829 0.852 . . . . 71.31 110.598 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.4 10.08 82.59 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.691 -0.964 . . . . 70.31 110.691 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.31 118.02 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 104.712 -2.329 . . . . 75.03 104.712 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -71.42 113.07 8.08 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.307 -1.368 . . . . 72.21 107.307 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.2 mt -70.68 -23.15 62.43 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.222 -0.899 . . . . 74.42 109.608 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -55.49 144.94 24.24 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.532 0.682 . . . . 74.4 110.664 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.85 -33.31 5.28 Favored Glycine 0 CA--C 1.496 -1.15 0 N-CA-C 109.369 -1.492 . . . . 70.43 109.369 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.59 162.55 28.69 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.033 -0.729 . . . . 55.44 109.033 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -80.48 167.32 20.29 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.832 -1.174 . . . . 70.02 107.832 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -64.69 -39.05 93.0 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 106.543 -1.651 . . . . 71.1 106.543 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -51.9 -51.03 59.69 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 123.618 0.767 . . . . 73.43 110.047 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -66.65 -39.73 88.37 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 109.165 -0.679 . . . . 55.1 109.165 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.06 70.59 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.42 0.555 . . . . 64.52 109.778 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.03 -54.64 17.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 N-CA-C 106.873 -1.528 . . . . 73.34 106.873 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 11.1 t -54.77 -28.65 50.31 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 122.268 1.032 . . . . 74.01 108.763 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.4 m -66.57 -53.76 31.05 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.331 -1.359 . . . . 63.44 107.331 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.35 -55.51 27.83 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 108.589 -0.893 . . . . 74.31 108.589 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -46.67 -32.82 3.78 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.882 0.697 . . . . 73.31 112.882 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.64 2.17 51.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.49 -0.756 . . . . 72.41 110.252 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.5 p -73.98 168.47 19.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 119.5 1.045 . . . . 75.34 109.44 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.1 -166.39 28.5 Favored Glycine 0 C--N 1.371 2.499 0 N-CA-C 108.783 -1.727 . . . . 64.43 108.783 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.29 -32.18 26.51 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.792 -0.818 . . . . 70.02 108.792 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.3 t -112.37 130.46 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 103.573 -2.751 . . . . 73.53 103.573 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.88 150.19 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.116 -2.179 . . . . 75.14 105.116 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -110.3 121.62 45.72 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 104.968 -2.234 . . . . 73.12 104.968 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.8 mt -116.4 141.33 48.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 N-CA-C 104.711 -2.329 . . . . 74.4 104.711 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 tp -114.73 127.84 55.97 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 105.672 -1.973 . . . . 74.33 105.672 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.11 155.8 50.11 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.337 -1.727 . . . . 73.0 106.337 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 CA--C 1.483 -1.599 0 N-CA-C 105.085 -2.191 . . . . 73.22 105.085 -178.07 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.494 -1.18 0 N-CA-C 105.003 -2.221 . . . . 74.25 105.003 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -137.6 153.6 49.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.572 -2.01 . . . . 74.51 105.572 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.76 141.46 35.52 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.758 -1.571 . . . . 74.45 106.758 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.5 126.06 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 103.894 -2.632 . . . . 75.21 103.894 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -96.76 125.53 41.28 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.553 -2.388 . . . . 73.33 104.553 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 121.04 44.34 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.611 -1.626 . . . . 75.14 106.611 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.71 102.78 13.26 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 104.268 -2.493 . . . . 75.12 104.268 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp . . . . . 0 N--CA 1.424 -1.765 0 CA-C-N 114.456 -1.247 . . . . 75.4 107.89 -164.027 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.471 0 N-CA-C 109.702 -1.359 . . . . 53.53 109.702 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.8 mt -131.32 144.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 103.02 -2.956 . . . . 74.13 103.02 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.1 m -147.81 163.69 35.95 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 103.484 -2.784 . . . . 74.4 103.484 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.03 169.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 105.727 -1.953 . . . . 75.14 105.727 -160.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -145.53 167.23 23.51 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.65 -2.722 . . . . 62.52 103.65 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.86 -172.98 14.67 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.061 -2.415 . . . . 51.24 107.061 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.06 -123.17 5.24 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 109.185 -1.566 . . . . 71.01 109.185 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 m -72.47 19.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 126.114 1.765 . . . . 72.5 112.908 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 87.58 64.47 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.12 -1.807 . . . . 72.13 106.12 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 30' ' ' SER . 3.3 m -84.8 -165.7 1.27 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 103.827 -2.657 . . . . 73.23 103.827 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.617 ' H ' HG23 ' A' ' 29' ' ' THR . 3.6 m -37.45 -40.37 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.616 1.566 . . . . 74.14 112.911 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.57 135.34 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.159 -1.052 . . . . 71.54 108.159 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.7 mtm105 -72.47 -35.33 68.21 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.57 -0.9 . . . . 73.43 108.57 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.88 -17.25 63.0 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 109.118 -0.697 . . . . 63.21 109.118 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 -3.19 3.78 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.189 -0.364 . . . . 73.45 112.189 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.32 170.61 47.72 Favored Glycine 0 CA--C 1.483 -1.956 0 N-CA-C 107.229 -2.348 . . . . 71.01 107.229 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.39 132.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.436 -2.061 . . . . 72.23 105.436 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -124.97 140.71 52.67 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 104.989 -2.226 . . . . 74.12 104.989 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -68.51 132.67 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.953 -1.499 . . . . 75.32 106.953 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -106.21 -46.23 4.11 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.295 -1.372 . . . . 54.42 107.295 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.26 144.17 38.28 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 105.608 -1.997 . . . . 71.43 105.608 -173.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.9 129.55 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 104.581 -2.378 . . . . 74.33 104.581 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 mt -74.36 138.91 74.84 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.125 -1.805 . . . . 72.4 106.125 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.8 110.76 0.88 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.614 2.21 . . . . 71.24 108.166 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 70.67 25.5 4.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.378 1.049 . . . . 71.42 111.318 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.44 -173.67 33.94 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 106.34 -2.704 . . . . 54.52 106.34 162.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.27 78.46 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 121.942 -0.74 . . . . 52.45 110.091 -171.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.4 80.53 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 110.155 -0.313 . . . . 75.24 110.155 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.13 -34.42 73.05 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.345 -0.613 . . . . 71.0 109.345 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -67.98 -39.69 83.26 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.481 -1.303 . . . . 73.03 107.481 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.76 -32.76 73.57 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 107.931 -1.137 . . . . 55.12 107.931 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.48 -25.99 4.78 Favored Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 110.951 -0.86 . . . . 72.33 110.951 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -69.63 -40.1 76.74 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.536 -0.912 . . . . 74.51 108.536 -173.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 mt -98.38 138.46 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 105.924 -1.88 . . . . 73.34 105.924 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -134.76 174.43 10.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.143 -1.428 . . . . 72.13 107.143 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -66.53 138.98 57.89 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.695 -1.965 . . . . 73.23 105.695 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.7 -4.8 61.72 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 109.191 -1.563 . . . . 63.05 109.191 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.43 152.96 37.9 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.383 -1.34 . . . . 73.42 107.383 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -112.79 123.83 51.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.15 -2.167 . . . . 74.02 105.15 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.73 139.97 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 104.741 -2.318 . . . . 70.14 104.741 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' H ' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -107.08 -55.35 2.34 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.019 -1.474 . . . . 75.2 107.019 176.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.459 ' H ' ' HG ' ' A' ' 60' ' ' LEU . . . -130.57 165.18 23.3 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 122.153 0.977 . . . . 73.33 109.531 -168.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.62 109.84 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 105.085 -2.191 . . . . 73.4 105.085 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 51.72 41.37 29.0 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.615 1.166 . . . . 72.34 111.812 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.44 7.01 73.07 Favored Glycine 0 CA--C 1.498 -1.006 0 N-CA-C 109.396 -1.482 . . . . 34.4 109.396 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 67' ' ' LEU . 26.8 t -112.12 117.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 105.134 -2.172 . . . . 73.05 105.134 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -80.8 15.39 1.78 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.332 -0.395 . . . . 74.21 110.424 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 65' ' ' VAL . 87.5 mt 38.79 45.11 0.89 Allowed 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.236 1.414 . . . . 74.31 110.937 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.2 125.14 28.62 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.514 -0.921 . . . . 60.04 108.514 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.96 -4.52 81.61 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.822 -1.711 . . . . 74.1 108.822 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.71 137.4 56.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 108.299 -1.0 . . . . 54.34 108.299 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.7 p -76.13 174.04 10.56 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.752 -1.573 . . . . 75.55 106.752 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -61.18 -39.83 91.62 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 107.816 -1.179 . . . . 74.31 107.816 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.01 -50.68 66.08 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.878 0.471 . . . . 70.42 110.713 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -66.62 -29.25 69.25 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.241 0.928 . . . . 63.3 109.437 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.53 -38.5 84.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.562 -0.903 . . . . 70.32 108.562 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.5 t -72.82 -49.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.009 -1.478 . . . . 73.45 107.009 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.1 m -52.49 -29.28 24.15 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 108.488 -0.93 . . . . 72.34 108.488 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -65.81 -55.87 14.88 Favored 'General case' 0 C--O 1.199 -1.597 0 N-CA-C 107.486 -1.301 . . . . 65.43 107.486 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.03 -56.14 24.34 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.943 -0.762 . . . . 74.33 108.943 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -49.85 -28.01 5.9 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.482 0.549 . . . . 63.23 112.482 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -92.87 -13.15 29.39 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.774 -0.579 . . . . 54.23 109.708 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.3 p -80.56 173.71 12.33 Favored 'General case' 0 C--O 1.245 0.839 0 O-C-N 120.795 -1.191 . . . . 74.22 108.909 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.79 -155.33 11.8 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.645 -1.382 . . . . 55.13 109.645 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -80.11 -43.77 21.14 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 107.443 -1.318 . . . . 72.31 107.443 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.75 131.27 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.892 0 N-CA-C 103.502 -2.777 . . . . 72.21 103.502 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.54 140.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 105.379 -2.082 . . . . 71.13 105.379 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -97.18 118.11 32.88 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 104.834 -2.284 . . . . 74.43 104.834 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 34.5 mt -121.19 142.39 49.94 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 105.661 -1.978 . . . . 73.31 105.661 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.06 133.25 56.23 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 104.723 -2.325 . . . . 74.21 104.723 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.43 152.74 51.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.314 -1.736 . . . . 62.25 106.314 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 . . . . . 0 CA--C 1.48 -1.741 0 N-CA-C 105.627 -1.99 . . . . 73.22 105.627 -173.912 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' CB ' ' A' ' 91' ' ' GLU . 1.7 mp . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 103.847 -2.649 . . . . 74.12 103.847 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -138.85 153.13 48.3 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 106.75 -1.574 . . . . 72.52 106.75 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -103.06 136.95 41.92 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 105.515 -2.032 . . . . 74.41 105.515 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.36 130.71 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.123 0 N-CA-C 104.217 -2.512 . . . . 71.15 104.217 173.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -107.22 114.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.048 -2.575 . . . . 73.35 104.048 170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.31 122.66 44.68 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 105.051 -2.203 . . . . 74.51 105.051 -168.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 146.67 25.97 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.025 -1.842 . . . . 73.52 106.025 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.5 -0.963 0 N-CA-C 106.714 -1.588 . . . . 75.1 106.714 177.822 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.464 0.553 0 CA-C-O 119.535 -0.592 . . . . 63.31 114.171 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -136.72 154.39 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 104.095 -2.557 . . . . 72.51 104.095 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -149.76 165.81 31.33 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 103.249 -2.871 . . . . 53.23 103.249 168.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.51 168.39 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 106.735 -1.58 . . . . 72.21 106.735 -164.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -148.3 167.21 25.76 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 102.625 -3.102 . . . . 73.31 102.625 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.34 -171.77 14.42 Favored Glycine 0 CA--C 1.474 -2.499 0 N-CA-C 107.568 -2.213 . . . . 33.35 107.568 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.89 -120.87 4.41 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 110.098 -1.201 . . . . 71.23 110.098 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.99 19.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 126.204 1.801 . . . . 74.3 113.96 -165.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 88.05 66.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 123.251 1.501 . . . . 74.32 107.915 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -86.78 -165.4 1.27 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 103.107 -2.923 . . . . 74.33 103.107 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -44.73 -28.91 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.902 0.881 . . . . 75.12 112.626 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -88.18 124.07 41.05 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 107.476 -1.305 . . . . 75.44 107.476 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -72.66 -23.61 60.92 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 116.088 -0.505 . . . . 72.24 109.883 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.68 -17.02 64.0 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.197 -1.038 . . . . 73.32 108.197 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.08 7.86 26.42 Favored Glycine 0 C--N 1.356 1.673 0 N-CA-C 110.479 -1.048 . . . . 74.22 110.479 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 162.03 49.56 Favored Glycine 0 CA--C 1.48 -2.155 0 N-CA-C 108.238 -1.945 . . . . 53.22 108.238 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.2 mm -90.45 133.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 104.221 -2.511 . . . . 72.42 104.221 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.79 145.29 49.82 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.154 -2.165 . . . . 73.1 105.154 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.12 134.33 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.675 -1.232 . . . . 74.34 107.675 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -106.38 -49.39 3.35 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.465 -1.68 . . . . 75.51 106.465 -169.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.08 140.85 34.26 Favored 'General case' 0 CA--C 1.463 -2.393 0 N-CA-C 105.948 -1.871 . . . . 74.22 105.948 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.51 131.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 103.593 -2.743 . . . . 73.22 103.593 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.417 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.1 mm -64.66 142.16 98.44 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 105.568 -2.012 . . . . 73.0 105.568 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.11 111.33 0.96 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.121 -1.915 . . . . 74.13 107.121 165.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 75.32 26.0 1.22 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.826 1.329 . . . . 73.22 110.957 -174.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.62 172.62 48.24 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 107.397 -2.281 . . . . 71.14 107.397 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.88 71.01 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 122.091 -0.653 . . . . 74.24 109.36 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.01 74.97 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.513 -0.921 . . . . 74.0 108.513 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.53 -36.41 82.62 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 109.129 -0.693 . . . . 71.3 109.129 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -65.67 -39.69 91.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.715 -0.846 . . . . 73.43 108.715 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.64 -40.72 72.92 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.17 -1.048 . . . . 75.14 108.17 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.459 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 95.5 -13.75 66.07 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.42 -1.072 . . . . 72.23 110.42 172.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -84.99 -41.35 15.92 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.618 -0.931 . . . . 73.13 109.808 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 mt -97.09 127.95 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 106.275 -1.75 . . . . 74.15 106.275 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 44.5 m-70 -122.69 174.59 7.01 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.46 -1.682 . . . . 73.21 106.46 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -66.7 137.83 56.97 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.357 -1.72 . . . . 74.14 106.357 166.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 -17.25 57.34 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 108.923 -1.671 . . . . 63.41 108.923 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.22 147.21 53.86 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 109.044 -0.724 . . . . 75.12 109.044 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -105.66 125.88 51.5 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 106.286 -1.746 . . . . 72.5 106.286 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.99 144.07 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 104.811 -2.292 . . . . 74.32 104.811 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -45.13 2.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.314 -1.365 . . . . 71.21 107.314 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.85 160.46 33.45 Favored 'General case' 0 CA--C 1.48 -1.733 0 C-N-CA 118.838 -1.145 . . . . 72.4 109.268 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.6 109.39 6.39 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 N-CA-C 105.315 -2.106 . . . . 70.54 105.315 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 47.79 40.51 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.922 1.689 . . . . 73.41 111.911 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.24 4.58 83.74 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 109.483 -1.447 . . . . 75.25 109.483 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.04 122.76 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 104.826 -2.287 . . . . 71.11 104.826 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.9 m -70.63 111.18 5.92 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.23 -1.026 . . . . 74.35 108.23 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.72 9.39 37.24 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 106.842 -1.54 . . . . 73.43 106.842 171.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -65.69 133.67 51.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.983 -1.488 . . . . 74.23 106.983 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.26 -18.65 5.18 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-O 119.629 -0.54 . . . . 72.21 111.78 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 171.71 1.87 Allowed 'General case' 0 C--N 1.37 1.459 0 CA-C-N 118.397 1.099 . . . . 74.33 110.228 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -83.85 159.86 21.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.485 -1.302 . . . . 73.31 107.485 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.33 -42.51 98.97 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.43 -0.952 . . . . 75.21 108.43 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.7 -43.13 94.22 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 110.024 -0.361 . . . . 74.14 110.024 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -61.71 -36.28 80.49 Favored 'General case' 0 C--N 1.383 2.035 0 O-C-N 121.368 -0.833 . . . . 54.2 109.164 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.97 79.53 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.958 -0.756 . . . . 52.24 108.958 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.9 t -73.89 -50.56 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.219 -1.4 . . . . 75.35 107.219 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.0 m -53.01 -29.94 32.41 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-O 122.07 0.938 . . . . 74.43 108.617 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -67.32 -53.82 26.16 Favored 'General case' 0 C--O 1.209 -1.074 0 O-C-N 120.933 -1.104 . . . . 72.41 108.033 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.84 -55.48 31.94 Favored 'General case' 0 C--O 1.211 -0.97 0 N-CA-C 109.149 -0.686 . . . . 74.42 109.149 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -48.28 -28.22 2.96 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.57 0.582 . . . . 73.23 112.57 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.77 -14.66 27.58 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.638 -0.664 . . . . 62.25 110.078 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 p -81.86 171.13 14.85 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.725 -1.234 . . . . 71.34 109.659 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.95 -154.2 12.91 Favored Glycine 0 C--N 1.36 1.881 0 N-CA-C 110.037 -1.225 . . . . 72.25 110.037 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -80.48 -35.8 34.3 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 107.857 -1.164 . . . . 70.12 107.857 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.84 126.87 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 104.554 -2.387 . . . . 61.45 104.554 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 139.36 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 N-CA-C 103.486 -2.783 . . . . 61.24 103.486 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -96.7 118.98 34.33 Favored 'General case' 0 CA--C 1.474 -1.96 0 N-CA-C 104.649 -2.352 . . . . 74.23 104.649 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -115.97 136.82 52.68 Favored 'General case' 0 CA--C 1.468 -2.173 0 N-CA-C 105.18 -2.156 . . . . 70.25 105.18 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.21 125.51 54.41 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.051 -2.203 . . . . 72.43 105.051 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.12 161.33 36.03 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 105.634 -1.988 . . . . 63.13 105.634 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.446 ' CB ' HD12 ' A' ' 7' ' ' ILE . 16.4 pt-20 . . . . . 0 CA--C 1.468 -2.191 0 N-CA-C 108.0 -1.111 . . . . 65.22 108.0 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.028 0 N-CA-C 107.519 -2.233 . . . . 52.14 107.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.71 151.9 81.66 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.071 1.847 . . . . 65.44 108.461 174.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -79.39 159.76 71.7 Favored Pre-proline 0 C--N 1.351 0.637 0 N-CA-C 108.303 -0.999 . . . . 74.44 108.303 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.66 128.7 18.48 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.063 1.842 . . . . 74.44 108.181 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 93.99 13.97 53.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 107.927 -2.069 . . . . 75.1 107.927 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.453 ' H ' ' HB2' ' A' ' 92' ' ' LYS . 18.5 t0 -89.77 134.57 34.11 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 105.594 -2.002 . . . . 73.11 105.594 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.84 130.91 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.397 0 N-CA-C 103.462 -2.792 . . . . 73.04 103.462 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.59 153.61 44.91 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.715 -1.587 . . . . 74.41 106.715 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -108.76 141.59 40.54 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.175 -1.787 . . . . 73.15 106.175 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.4 t -128.53 130.61 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 N-CA-C 104.819 -2.289 . . . . 71.45 104.819 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -105.71 113.21 26.64 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 104.931 -2.248 . . . . 72.13 104.931 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 120.98 41.54 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.231 -1.766 . . . . 72.31 106.231 -169.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.72 142.59 28.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.232 -1.766 . . . . 64.51 106.232 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -101.94 33.77 2.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.026 -1.472 . . . . 73.25 107.026 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.29 -51.45 15.2 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.262 -1.385 . . . . 73.51 107.262 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.7 -58.17 9.59 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 109.456 -0.572 . . . . 73.11 109.456 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -154.54 175.4 13.67 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.262 -1.755 . . . . 73.03 106.262 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.2 t -44.88 156.65 0.08 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.011 1.724 . . . . 72.25 110.39 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mt -54.88 -57.81 10.13 Favored 'General case' 0 C--N 1.374 1.674 0 N-CA-C 108.6 -0.889 . . . . 75.33 108.6 -170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.45 48.53 85.54 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 110.27 -1.132 . . . . 65.04 110.27 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mt -129.24 158.86 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.433 -2.432 . . . . 74.12 104.433 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -149.99 165.42 32.72 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.147 -3.279 . . . . 43.43 102.147 168.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.71 168.19 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 105.936 -1.875 . . . . 74.01 105.936 -170.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -146.45 166.59 25.95 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 103.029 -2.952 . . . . 73.43 103.029 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.5 -173.3 14.66 Favored Glycine 0 CA--C 1.472 -2.624 0 N-CA-C 107.548 -2.221 . . . . 73.42 107.548 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.78 -127.81 6.08 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 108.838 -1.705 . . . . 44.12 108.838 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -73.18 19.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 126.222 1.809 . . . . 71.22 112.419 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.262 9.5 m120 87.31 65.52 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.672 0 N-CA-C 106.34 -1.726 . . . . 62.43 106.34 -168.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 30' ' ' SER . 3.4 m -80.96 -165.78 0.98 Allowed 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 104.003 -2.592 . . . . 73.2 104.003 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.58 ' H ' HG23 ' A' ' 29' ' ' THR . 3.4 p -42.96 -40.73 3.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 53.04 112.032 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.51 138.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.583 -0.895 . . . . 74.44 108.583 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.24 -42.39 68.92 Favored 'General case' 0 C--N 1.364 1.206 0 N-CA-C 109.787 -0.449 . . . . 75.31 109.787 -171.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -73.9 -5.64 42.34 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.843 -0.799 . . . . 71.23 108.843 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.22 3.25 11.5 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.304 -0.718 . . . . 74.41 111.304 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.53 150.19 42.09 Favored Glycine 0 CA--C 1.475 -2.448 0 N-CA-C 109.625 -1.39 . . . . 54.34 109.625 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.81 87.96 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 105.49 -2.041 . . . . 74.32 105.49 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -88.75 144.19 26.41 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.585 -1.635 . . . . 74.21 106.585 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.21 133.82 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.535 -1.654 . . . . 70.21 106.535 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -104.1 -43.66 5.2 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 106.712 -1.588 . . . . 64.53 106.712 -167.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.18 150.8 36.55 Favored 'General case' 0 CA--C 1.458 -2.569 0 N-CA-C 105.441 -2.059 . . . . 70.21 105.441 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -137.26 132.14 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.622 -2.362 . . . . 72.55 104.622 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.3 mt -70.6 137.88 85.91 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 105.546 -2.02 . . . . 75.15 105.546 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.56 123.53 13.96 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.165 1.91 . . . . 75.24 108.744 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 55.74 32.6 19.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.497 1.119 . . . . 71.54 112.053 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.92 -177.95 46.08 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 105.36 -3.096 . . . . 64.41 105.36 168.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.51 98.75 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.279 1.04 . . . . 63.2 109.6 -168.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.05 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 109.233 -0.654 . . . . 64.12 109.233 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -69.24 -38.74 78.62 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 109.648 -0.501 . . . . 73.44 109.648 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -65.38 -37.49 87.16 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.958 -1.126 . . . . 74.41 107.958 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.42 -32.56 66.43 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.532 -1.285 . . . . 72.34 107.532 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.79 64.99 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.726 -0.95 . . . . 73.53 110.726 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -83.33 -41.03 18.71 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.459 -0.941 . . . . 73.24 108.459 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.8 mt -104.78 136.69 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.902 -1.888 . . . . 62.13 105.902 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -138.33 -178.52 5.32 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 104.843 -2.28 . . . . 74.31 104.843 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.42 146.9 54.04 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.678 -0.86 . . . . 73.02 108.678 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.21 -3.73 86.57 Favored Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 109.704 -1.359 . . . . 52.23 109.704 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -80.51 155.45 27.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.461 -2.052 . . . . 75.32 105.461 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -119.68 127.35 52.8 Favored 'General case' 0 CA--C 1.478 -1.807 0 C-N-CA 119.411 -0.916 . . . . 71.32 109.099 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.07 148.13 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.09 -2.189 . . . . 72.41 105.09 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.65 -45.05 2.52 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 106.929 -1.508 . . . . 75.45 106.929 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.81 34.86 Favored 'General case' 0 CA--C 1.482 -1.667 0 C-N-CA 119.226 -0.99 . . . . 75.33 109.288 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.11 110.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 104.097 -2.557 . . . . 70.53 104.097 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.303 0.8 OUTLIER 46.48 38.3 5.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.541 1.137 . . . . 63.11 112.292 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.28 65.87 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.799 -1.32 . . . . 73.53 109.799 171.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.08 119.91 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.693 0 N-CA-C 104.971 -2.233 . . . . 74.04 104.971 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m -67.59 111.0 3.93 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.358 -1.349 . . . . 72.44 107.358 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.31 -14.91 51.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.926 -0.768 . . . . 72.03 108.926 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.98 146.58 46.46 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 109.332 -0.618 . . . . 65.55 109.332 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 -39.23 3.01 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 109.555 -1.418 . . . . 74.43 109.555 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 166.13 22.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.354 -0.98 . . . . 73.55 108.354 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.8 p -89.73 174.55 7.66 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.009 -1.108 . . . . 75.53 108.009 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -64.98 -38.73 91.93 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.987 -0.745 . . . . 64.1 108.987 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -59.59 -45.13 92.79 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 120.016 -0.674 . . . . 64.01 111.008 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -62.65 -39.99 95.63 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 119.746 1.157 . . . . 72.43 108.302 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.1 -42.97 86.8 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.8 -0.445 . . . . 74.14 109.8 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -69.25 -54.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 107.2 -1.407 . . . . 75.53 107.2 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -57.39 -26.46 61.11 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.222 -0.659 . . . . 71.31 109.222 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -65.81 -56.13 13.53 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.52 -55.1 35.8 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.153 -1.054 . . . . 74.5 108.153 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -45.63 -34.89 3.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.251 1.02 . . . . 73.32 111.975 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -96.6 -3.05 43.61 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.435 -0.79 . . . . 72.33 109.69 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -84.35 170.17 13.89 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.736 -1.227 . . . . 73.43 108.627 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.74 -149.32 24.59 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 122.508 1.06 . . . . 62.44 110.616 -171.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -77.82 -53.15 7.82 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.831 -1.174 . . . . 73.54 107.831 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.12 127.89 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.798 0 N-CA-C 103.576 -2.75 . . . . 71.43 103.576 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -133.16 143.13 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 103.796 -2.668 . . . . 74.34 103.796 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -97.28 116.0 28.67 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.542 -2.392 . . . . 73.04 104.542 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -114.52 138.0 51.16 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 105.7 -1.963 . . . . 75.24 105.7 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -113.82 127.85 56.17 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.548 -2.019 . . . . 64.33 105.548 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.81 155.97 49.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.26 -1.756 . . . . 74.52 106.26 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -129.28 137.64 51.16 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 105.596 -2.002 . . . . 72.11 105.596 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.548 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 72.3 mmtt -66.45 150.33 49.09 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.372 1.082 . . . . 62.32 110.844 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.72 45.35 0.39 Allowed Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 104.893 -3.283 . . . . 71.4 104.893 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.75 168.8 8.9 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 107.147 -1.427 . . . . 73.3 107.147 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 m -68.88 162.87 61.08 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.711 -1.218 . . . . 40.02 107.711 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.36 171.7 7.58 Favored 'Trans proline' 0 C--O 1.257 1.435 0 C-N-CA 122.492 2.128 . . . . 61.2 109.276 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.414 -2.254 0 N-CA-C 105.035 -2.209 . . . . 75.41 105.035 -173.392 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.722 0 N-CA-C 108.426 -1.87 . . . . 74.33 108.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.46 116.11 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.855 2.37 . . . . 74.33 109.116 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 99.3 mttt -88.65 165.92 25.34 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 105.324 -2.102 . . . . 75.1 105.324 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 16.8 Cg_endo -57.46 116.33 3.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.547 2.165 . . . . 73.22 110.705 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 12.28 51.64 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 108.237 -1.945 . . . . 64.41 108.237 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.44 136.76 36.51 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.691 -1.966 . . . . 74.43 105.691 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.22 137.07 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 104.719 -2.326 . . . . 71.51 104.719 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -145.88 157.11 43.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 105.893 -1.891 . . . . 75.14 105.893 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.25 143.62 32.41 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.848 -1.908 . . . . 73.32 105.848 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.06 128.12 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 104.167 -2.531 . . . . 73.01 104.167 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.26 114.62 26.39 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 105.552 -2.018 . . . . 73.43 105.552 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.61 120.84 41.69 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 105.994 -1.854 . . . . 74.45 105.994 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.85 134.71 37.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.163 -1.421 . . . . 71.25 107.163 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.99 35.36 0.85 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.356 -1.72 . . . . 75.0 106.356 174.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -58.24 -38.38 76.75 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 108.557 -0.905 . . . . 71.22 108.557 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 34.8 t70 -74.28 175.08 7.94 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 107.482 -1.303 . . . . 73.14 107.482 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.431 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 70.6 m-80 -80.6 -48.06 13.24 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 106.834 -1.543 . . . . 73.22 106.834 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.9 p -77.01 117.73 18.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.045 -0.724 . . . . 53.03 109.045 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.0 mt -72.88 -57.99 3.66 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 104.654 -2.35 . . . . 75.32 104.654 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 52.5 50.65 47.18 Favored Glycine 0 C--N 1.353 1.521 0 CA-C-N 113.373 -1.74 . . . . 70.22 112.459 169.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.2 mt -123.05 153.02 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.394 -2.447 . . . . 75.54 104.394 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.5 m -151.81 163.37 39.33 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 102.769 -3.048 . . . . 71.53 102.769 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.74 168.32 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.401 -2.444 . . . . 73.14 104.401 -166.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -149.65 167.4 26.51 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 103.962 -2.607 . . . . 71.34 103.962 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.65 -171.89 13.99 Favored Glycine 0 CA--C 1.473 -2.56 0 N-CA-C 107.0 -2.44 . . . . 65.02 107.0 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.48 -124.23 5.83 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 108.687 -1.765 . . . . 74.13 108.687 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 m -73.27 20.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.694 0 C-N-CA 125.883 1.673 . . . . 72.1 113.142 -167.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.1 t30 89.93 66.04 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 123.146 1.45 . . . . 72.33 107.39 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 30' ' ' SER . 2.0 m -82.71 -167.2 1.54 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.465 -2.42 . . . . 73.1 104.465 170.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.526 ' H ' HG23 ' A' ' 29' ' ' THR . 16.3 m -58.17 -25.21 61.23 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 121.5 -0.75 . . . . 64.33 111.535 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 m -78.79 131.45 34.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 107.505 -1.295 . . . . 75.02 107.505 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 34' ' ' GLY . 39.5 ttp-105 -60.11 -53.69 54.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.921 0.488 . . . . 72.25 110.675 -171.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -76.87 4.77 9.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.829 -0.544 . . . . 74.1 109.88 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 32' ' ' ARG . . . 59.62 13.46 24.17 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.249 -0.74 . . . . 75.52 111.249 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.31 148.02 50.46 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 108.385 -1.886 . . . . 52.52 108.385 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.13 97.11 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.542 -1.651 . . . . 75.41 106.542 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -95.76 143.93 26.58 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 107.043 -1.465 . . . . 74.25 107.043 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.6 t -72.02 130.61 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 N-CA-C 105.064 -2.198 . . . . 45.41 105.064 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -103.09 -39.97 6.66 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 107.316 -1.365 . . . . 73.23 107.316 -166.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.38 158.48 40.12 Favored 'General case' 0 CA--C 1.465 -2.29 0 N-CA-C 106.011 -1.848 . . . . 73.32 106.011 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.46 140.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 104.221 -2.511 . . . . 75.02 104.221 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.421 HG12 ' CA ' ' A' ' 20' ' ' GLY . 24.3 mm -70.67 143.99 90.51 Favored Pre-proline 0 C--N 1.355 0.805 0 N-CA-C 105.741 -1.948 . . . . 75.13 105.741 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.2 112.18 0.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.429 2.086 . . . . 70.34 108.948 165.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 74.91 22.04 1.93 Allowed 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.354 1.034 . . . . 63.13 110.483 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.74 175.68 30.17 Favored Glycine 0 C--N 1.375 2.732 0 N-CA-C 108.275 -1.93 . . . . 74.3 108.275 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.69 98.74 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.036 -0.727 . . . . 60.45 109.036 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.27 76.61 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.582 -0.525 . . . . 74.01 109.582 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.66 -35.13 79.43 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.134 -0.691 . . . . 63.04 109.134 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 m -66.02 -37.43 85.88 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.135 -1.061 . . . . 72.32 108.135 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.48 -41.24 89.27 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.397 -0.964 . . . . 71.23 108.397 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 90.71 -22.83 26.04 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.104 -1.198 . . . . 74.24 110.104 173.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -78.48 -38.72 40.27 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.693 -1.225 . . . . 72.32 107.693 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mt -104.84 129.37 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.258 -1.386 . . . . 72.53 107.258 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.46 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 76.8 m80 -140.19 -175.71 4.34 Favored 'General case' 0 CA--C 1.467 -2.25 0 N-CA-C 104.039 -2.578 . . . . 74.55 104.039 172.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 146.38 53.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.339 -1.356 . . . . 73.33 107.339 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.69 -25.23 28.22 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 107.827 -2.109 . . . . 64.22 107.827 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 94' ' ' GLN . 6.7 m-20 -77.27 154.68 32.71 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.223 -1.769 . . . . 72.44 106.223 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -134.39 141.0 46.7 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 107.487 -1.301 . . . . 74.34 107.487 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.33 150.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.401 -1.704 . . . . 74.21 106.401 -172.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.59 -46.41 2.86 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 106.953 -1.499 . . . . 73.34 106.953 169.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.16 161.89 30.1 Favored 'General case' 0 CA--C 1.484 -1.577 0 C-N-CA 118.915 -1.114 . . . . 72.43 110.19 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.37 107.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 104.206 -2.516 . . . . 74.11 104.206 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 t30 48.83 37.98 11.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.496 1.119 . . . . 73.33 111.021 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.64 10.17 70.64 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.345 -1.102 . . . . 63.44 110.345 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.59 117.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.948 0 N-CA-C 103.933 -2.617 . . . . 73.45 103.933 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 m -71.66 111.48 6.99 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.561 -1.274 . . . . 73.13 107.561 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.26 -3.26 58.89 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.674 -0.861 . . . . 73.24 108.674 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -63.94 144.03 57.39 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 106.963 -1.495 . . . . 72.31 106.963 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -34.83 3.09 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.022 -0.831 . . . . 62.33 111.022 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.68 162.11 24.41 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 118.356 1.078 . . . . 64.22 108.281 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -82.94 170.21 15.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.94 -0.763 . . . . 74.11 108.94 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -62.81 -44.1 97.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.702 -0.851 . . . . 75.33 108.702 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -62.35 -43.31 99.13 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 118.574 -0.727 . . . . 74.44 111.129 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -35.31 80.16 Favored 'General case' 0 C--N 1.383 2.028 0 CA-C-N 120.166 1.348 . . . . 73.42 109.005 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.89 74.23 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.913 -0.773 . . . . 61.05 108.913 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -73.88 -54.65 14.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 107.527 -1.286 . . . . 75.12 107.527 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 14.4 m -55.33 -29.27 57.97 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 122.705 1.24 . . . . 75.2 108.365 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -68.51 -54.36 17.31 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.504 -1.372 . . . . 72.0 107.647 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.6 mt -54.7 -56.18 21.9 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.707 -0.849 . . . . 71.24 108.707 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -46.15 -47.09 17.62 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.185 0.439 . . . . 73.12 112.185 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -82.93 3.35 30.31 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.357 -0.84 . . . . 75.15 111.077 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.2 p -82.17 173.71 11.87 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.583 1.083 . . . . 74.32 108.375 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.93 -163.12 26.91 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 109.6 -1.4 . . . . 74.4 109.6 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.75 -32.98 27.56 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.101 -1.074 . . . . 75.13 108.101 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.2 t -115.95 127.19 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.605 -2.739 . . . . 61.35 103.605 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.46 151.32 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 104.609 -2.367 . . . . 75.51 104.609 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -102.08 123.68 46.37 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 104.271 -2.492 . . . . 64.13 104.271 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.1 mt -114.99 138.69 50.55 Favored 'General case' 0 CA--C 1.467 -2.242 0 N-CA-C 104.301 -2.481 . . . . 72.51 104.301 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -112.63 125.37 54.21 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.647 -1.983 . . . . 74.2 105.647 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.75 153.68 49.83 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.164 -1.791 . . . . 65.24 106.164 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -123.76 133.29 53.87 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 105.024 -2.214 . . . . 73.41 105.024 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -67.19 142.65 56.92 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.575 0.702 . . . . 75.52 109.463 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.12 56.56 0.04 OUTLIER Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 104.295 -3.522 . . . . 73.4 104.295 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG3' ' HA ' ' A' ' 57' ' ' ASP . 29.2 mp0 -91.37 134.66 34.42 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.157 -1.794 . . . . 73.32 106.157 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.0 m -99.65 148.06 34.22 Favored Pre-proline 0 N--CA 1.437 -1.124 0 N-CA-C 104.231 -2.507 . . . . 73.41 104.231 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.79 90.59 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.184 1.923 . . . . 74.23 107.584 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.415 -2.198 0 N-CA-C 105.929 -1.878 . . . . 74.33 105.929 -177.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.454 ' H1A' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.861 0 N-CA-C 108.377 -1.889 . . . . 72.44 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.07 101.81 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.861 2.374 . . . . 52.2 108.402 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -80.68 161.04 65.45 Favored Pre-proline 0 C--O 1.22 -0.478 0 N-CA-C 105.891 -1.892 . . . . 75.15 105.891 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.85 115.61 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 74.23 109.837 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.95 58.52 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 108.369 -1.893 . . . . 72.01 108.369 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -94.61 141.69 28.31 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 105.179 -2.156 . . . . 72.54 105.179 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.54 129.39 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 103.692 -2.707 . . . . 53.52 103.692 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -138.58 146.51 41.91 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.233 -1.766 . . . . 75.12 106.233 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.18 138.84 40.07 Favored 'General case' 0 N--CA 1.396 -3.128 0 N-CA-C 104.483 -2.414 . . . . 62.42 104.483 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.02 130.99 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.772 0 N-CA-C 105.498 -2.038 . . . . 73.11 105.498 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -100.78 119.86 39.26 Favored 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 104.707 -2.331 . . . . 72.22 104.707 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 121.08 44.04 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 105.979 -1.86 . . . . 74.45 105.979 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.32 134.29 41.54 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.653 -1.24 . . . . 74.31 107.653 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.37 34.64 1.41 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.018 -1.475 . . . . 74.42 107.018 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -58.94 -25.43 63.49 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.404 -0.591 . . . . 70.22 109.404 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -86.98 -131.26 0.06 Allowed 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.492 -1.67 . . . . 74.13 106.492 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -126.98 -51.23 1.44 Allowed 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.631 -0.877 . . . . 73.12 108.631 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.5 p -84.56 139.87 31.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.612 -1.255 . . . . 74.41 107.612 -170.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.03 -58.96 2.94 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.863 -2.273 . . . . 74.55 104.863 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.64 24.13 19.06 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 108.636 -1.786 . . . . 73.01 108.636 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.84 158.65 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 106.184 -1.784 . . . . 73.34 106.184 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.2 m -153.31 163.62 39.59 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 102.517 -3.142 . . . . 74.42 102.517 164.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.39 167.33 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 107.036 -1.468 . . . . 62.25 107.036 -161.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -143.71 165.99 26.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 104.562 -2.384 . . . . 71.2 104.562 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.22 -163.06 12.21 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 107.939 -2.065 . . . . 53.32 107.939 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.32 -127.5 6.08 Favored Glycine 0 C--N 1.36 1.877 0 N-CA-C 110.379 -1.088 . . . . 24.23 110.379 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 m -59.85 18.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.195 0 C-N-CA 128.282 2.633 . . . . 71.43 115.29 -167.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 86.44 64.34 0.01 OUTLIER 'General case' 0 CA--C 1.468 -2.196 0 N-CA-C 105.754 -1.943 . . . . 73.23 105.754 -165.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.586 HG23 ' H ' ' A' ' 30' ' ' SER . 2.3 m -88.43 -166.29 1.55 Allowed 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 111.686 -2.506 . . . . 72.25 104.546 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.586 ' H ' HG23 ' A' ' 29' ' ' THR . 11.8 m -58.35 -20.49 43.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.39 0.676 . . . . 33.53 111.226 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.629 -1.248 . . . . 74.34 107.629 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -70.32 -34.24 72.46 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-O 121.508 0.67 . . . . 74.44 109.756 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.44 -15.65 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.202 -1.036 . . . . 72.3 108.202 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.24 8.72 25.89 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 110.391 -1.083 . . . . 75.41 110.391 -176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.97 159.46 53.9 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 107.976 -2.05 . . . . 52.42 107.976 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.0 mm -90.64 95.16 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.464 -2.05 . . . . 52.42 105.464 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.05 146.74 26.5 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.507 -1.294 . . . . 74.32 107.507 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.39 129.0 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.426 -1.694 . . . . 70.23 106.426 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -106.41 -43.79 4.68 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 107.88 -1.155 . . . . 73.5 107.88 -171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.8 144.59 39.42 Favored 'General case' 0 CA--C 1.46 -2.502 0 N-CA-C 105.732 -1.951 . . . . 74.3 105.732 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.7 120.01 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 104.17 -2.53 . . . . 74.03 104.17 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.3 mt -72.88 135.06 80.79 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.122 -1.807 . . . . 64.22 106.122 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.2 121.6 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.803 2.335 . . . . 74.01 109.647 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 65.65 23.2 11.66 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.482 1.114 . . . . 74.31 110.461 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 175.34 49.18 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 106.698 -2.561 . . . . 51.34 106.698 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.1 82.92 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.613 -0.884 . . . . 74.41 108.613 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.48 76.85 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.222 -0.659 . . . . 75.24 109.222 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.32 -35.07 73.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.816 0.341 . . . . 75.42 110.112 -173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -68.33 -37.13 80.24 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.176 -1.046 . . . . 72.21 108.176 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.12 -47.0 72.45 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 107.124 -1.436 . . . . 65.43 107.124 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.09 -21.6 19.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 111.386 -0.686 . . . . 53.44 111.386 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -72.82 -35.13 67.24 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.559 1.18 . . . . 75.51 107.984 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.2 mt -94.55 135.98 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 105.964 -1.865 . . . . 74.12 105.964 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -144.31 176.06 9.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.262 -1.755 . . . . 73.32 106.262 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.95 137.1 56.28 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.799 -1.556 . . . . 74.23 106.799 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.99 -18.2 26.49 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 107.336 -2.306 . . . . 54.42 107.336 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.28 155.45 27.29 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 108.109 -1.071 . . . . 70.03 108.109 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.415 HH12 ' CD ' ' A' ' 91' ' ' GLU . 19.1 ttm180 -120.15 135.33 55.0 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 104.785 -2.302 . . . . 73.55 104.785 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.0 143.95 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 104.555 -2.387 . . . . 71.32 104.555 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -46.9 2.53 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.14 -1.43 . . . . 71.53 107.14 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.37 165.34 22.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 CA-C-O 122.394 1.093 . . . . 74.41 109.625 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -142.13 113.0 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 N-CA-C 103.486 -2.783 . . . . 74.22 103.486 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 53.52 31.27 12.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.072 0.549 . . . . 73.11 110.473 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.49 79.61 Favored Glycine 0 C--N 1.357 1.728 0 N-CA-C 110.209 -1.156 . . . . 62.21 110.209 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.98 124.92 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 104.707 -2.331 . . . . 74.24 104.707 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.0 m -64.35 104.33 0.75 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.436 -1.32 . . . . 63.41 107.436 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -21.3 21.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.486 -1.302 . . . . 74.33 107.486 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.41 146.26 48.93 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.005 . . . . 73.45 108.288 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.27 -35.39 3.58 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 109.872 -1.291 . . . . 51.31 109.872 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.78 161.65 28.0 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.102 -1.073 . . . . 73.52 108.102 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.0 p -77.83 168.46 19.89 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.685 0.755 . . . . 75.15 109.301 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -63.16 -42.27 99.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.986 -1.116 . . . . 71.42 107.986 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -56.02 -50.63 70.35 Favored 'General case' 0 C--N 1.367 1.338 0 N-CA-C 109.919 -0.4 . . . . 75.33 109.919 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -64.53 -37.12 86.45 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.307 -0.627 . . . . 75.54 109.307 -171.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.62 77.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.099 -0.704 . . . . 74.25 109.099 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.3 t -73.69 -52.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.529 -1.285 . . . . 73.32 107.529 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 46.6 m -53.04 -28.14 23.03 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-O 121.901 0.858 . . . . 70.21 109.009 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.25 -56.37 10.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.21 -1.404 . . . . 75.13 107.21 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.6 mt -56.75 -56.61 19.32 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.712 -0.847 . . . . 75.04 108.712 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -47.62 -27.14 1.73 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.048 1.129 . . . . 72.01 114.048 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.85 4.79 43.08 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 119.666 1.121 . . . . 74.43 109.047 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.2 p -84.86 170.28 13.29 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 121.055 -1.028 . . . . 73.12 108.4 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.6 -151.14 26.56 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.711 -1.755 . . . . 65.14 108.711 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -80.79 -43.17 20.52 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 107.994 -1.113 . . . . 74.25 107.994 -171.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.58 123.62 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 104.741 -2.318 . . . . 72.3 104.741 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -127.99 147.53 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.758 0 N-CA-C 105.373 -2.084 . . . . 53.41 105.373 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -99.88 115.66 30.13 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.152 -2.166 . . . . 75.31 105.152 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.82 134.27 52.66 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 104.62 -2.363 . . . . 71.04 104.62 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.57 124.37 52.2 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 105.129 -2.174 . . . . 75.12 105.129 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -133.18 159.34 40.46 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 106.843 -1.54 . . . . 75.21 106.843 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' CD ' HH12 ' A' ' 58' ' ' ARG . 42.9 tt0 -123.8 135.09 53.58 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.112 -2.922 . . . . 74.34 103.112 172.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -66.4 150.97 48.1 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.986 0.898 . . . . 64.14 109.569 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -114.18 -168.29 16.26 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 105.26 -3.136 . . . . 65.52 105.26 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.2 155.99 37.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.128 -1.064 . . . . 72.05 108.128 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.1 m -79.87 165.12 49.42 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 104.888 -2.264 . . . . 72.52 104.888 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -56.95 106.93 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.405 2.07 . . . . 74.21 109.135 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.416 -2.147 0 N-CA-C 104.705 -2.331 . . . . 62.25 104.705 -175.689 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.959 0 N-CA-C 108.794 -1.722 . . . . 64.33 108.794 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.94 124.93 12.41 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.753 2.302 . . . . 72.2 108.158 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.05 156.71 71.9 Favored Pre-proline 0 CA--C 1.506 -0.715 0 N-CA-C 106.177 -1.786 . . . . 73.13 106.177 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.82 141.49 59.4 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 N-CA-C 107.671 -1.703 . . . . 73.14 107.671 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.28 75.79 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 108.262 -1.935 . . . . 53.33 108.262 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 92' ' ' LYS . 22.4 t0 -89.58 136.48 33.01 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 104.545 -2.391 . . . . 74.5 104.545 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.55 131.14 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 103.91 -2.626 . . . . 74.41 103.91 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.13 150.51 45.74 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.656 -1.239 . . . . 74.2 107.656 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -102.69 136.7 42.04 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 104.875 -2.269 . . . . 71.13 104.875 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -125.56 134.26 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 105.63 -1.989 . . . . 74.01 105.63 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -106.68 109.88 21.92 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.575 -2.009 . . . . 75.45 105.575 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.99 121.6 42.88 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.841 -1.911 . . . . 74.32 105.841 -171.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -88.34 130.0 35.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.068 -1.456 . . . . 71.1 107.068 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 32.51 0.64 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.99 -1.485 . . . . 72.51 106.99 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 13' ' ' ALA . 14.4 p-10 -71.5 -14.68 62.19 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.758 -0.83 . . . . 75.11 108.758 -172.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 29.5 t70 -81.28 -154.43 0.11 Allowed 'General case' 0 C--N 1.351 0.671 0 N-CA-C 105.526 -2.027 . . . . 72.13 105.526 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.561 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 35.7 m120 -118.0 -39.97 3.03 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 104.576 -2.379 . . . . 74.14 104.576 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.0 m -76.19 150.07 37.17 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.455 -1.313 . . . . 55.13 107.455 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -71.85 -19.04 62.02 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.089 -1.078 . . . . 75.03 108.089 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.527 ' HA3' ' H ' ' A' ' 47' ' ' ALA . . . 77.49 -34.5 1.57 Allowed Glycine 0 C--O 1.203 -1.789 0 CA-C-N 115.363 -0.835 . . . . 65.13 111.437 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mm -110.13 157.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 106.404 -1.702 . . . . 74.21 106.404 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.8 m -146.49 155.93 42.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 101.571 -3.492 . . . . 74.33 101.571 163.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.31 160.57 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 C-N-CA 119.309 -0.956 . . . . 74.32 109.833 -166.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 t -145.22 166.29 25.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 103.032 -2.951 . . . . 64.5 103.032 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.74 123.72 4.0 Favored Glycine 0 C--O 1.193 -2.408 0 N-CA-C 108.407 -1.877 . . . . 51.45 108.407 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.18 -115.37 0.44 Allowed Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.096 -1.602 . . . . 75.51 109.096 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.79 20.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 126.17 1.788 . . . . 70.31 115.031 -163.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.3 t30 88.3 64.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 123.702 1.715 . . . . 73.21 106.476 -164.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -90.0 -165.28 1.31 Allowed 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 102.587 -3.116 . . . . 73.33 102.587 165.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -40.49 -33.35 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.412 1.085 . . . . 72.22 112.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.68 132.99 36.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 O-C-N 121.15 -0.969 . . . . 75.21 108.579 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -64.12 -58.03 7.83 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.565 -1.198 . . . . 65.24 111.899 -168.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -79.94 5.06 14.92 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.49 -0.756 . . . . 75.11 109.071 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.85 33.26 83.54 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 108.504 -1.839 . . . . 75.3 108.504 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.4 124.77 34.17 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 107.525 -2.23 . . . . 63.15 107.525 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mm -81.39 90.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.675 -2.342 . . . . 73.03 104.675 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -85.57 146.16 27.02 Favored 'General case' 0 CA--C 1.467 -2.212 0 N-CA-C 107.887 -1.153 . . . . 65.11 107.887 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.12 125.98 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.749 -1.945 . . . . 71.23 105.749 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -91.55 -38.38 12.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 106.672 -1.603 . . . . 75.33 106.672 -168.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.59 155.5 38.56 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 105.825 -1.917 . . . . 75.02 105.825 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.97 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 102.06 -3.311 . . . . 74.51 102.06 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.95 130.35 93.93 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 106.554 -1.647 . . . . 71.35 106.554 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.26 123.93 14.49 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.809 2.339 . . . . 71.24 109.477 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 68.67 10.09 7.69 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 124.781 1.3 . . . . 73.01 110.756 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.57 -175.18 37.17 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.973 -1.651 . . . . 55.12 108.973 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.85 74.34 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.054 -0.721 . . . . 73.11 109.054 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.527 ' H ' ' HA3' ' A' ' 20' ' ' GLY . . . -68.99 -46.03 69.08 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 108.908 -0.775 . . . . 75.04 108.908 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.22 -36.0 80.62 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 108.741 -0.837 . . . . 73.11 108.741 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.7 t -64.18 -40.13 95.45 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 108.203 -1.036 . . . . 54.42 108.203 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -73.86 -48.25 32.44 Favored 'General case' 0 C--N 1.351 0.63 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.34 -17.44 13.47 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.771 -0.532 . . . . 63.22 111.771 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . 33.9 ttm105 -72.98 -33.76 66.02 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.852 -1.166 . . . . 73.21 107.852 -173.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.16 135.61 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.069 -1.826 . . . . 72.32 106.069 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 52' ' ' ARG . 25.6 m80 -118.59 162.87 17.68 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 106.995 -1.483 . . . . 73.55 106.995 -175.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HZ2' ' C ' ' A' ' 97' ' ' THR . 66.6 tttt -65.78 136.42 56.19 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 106.981 -1.488 . . . . 71.41 106.981 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.75 -10.0 72.88 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.78 -1.728 . . . . 70.13 108.78 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -66.51 143.41 57.09 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 105.884 -1.895 . . . . 70.15 105.884 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.7 tmm_? -103.15 119.82 39.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.376 -1.342 . . . . 75.51 107.376 -169.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 t -89.18 141.62 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 105.766 -1.939 . . . . 74.51 105.766 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -47.0 2.51 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 71.14 107.32 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.32 167.63 18.92 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.373 1.082 . . . . 74.25 109.493 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -141.07 108.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 103.533 -2.766 . . . . 74.24 103.533 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 49.91 39.64 18.99 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.089 0.956 . . . . 73.12 110.598 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.55 20.1 78.74 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 109.936 -1.266 . . . . 62.34 109.936 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.63 119.35 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 N-CA-C 104.124 -2.547 . . . . 73.44 104.124 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -70.24 105.9 3.13 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.234 -0.654 . . . . 54.01 109.234 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.88 -7.07 53.23 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.027 -1.471 . . . . 72.35 107.027 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.97 143.67 57.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.109 -1.441 . . . . 72.41 107.109 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.83 2.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.983 -0.847 . . . . 75.5 110.983 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.89 172.66 4.19 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 118.218 1.009 . . . . 60.3 109.766 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -82.65 156.47 23.84 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.603 -1.258 . . . . 75.53 107.603 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -66.28 -37.65 85.94 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.89 -1.152 . . . . 72.34 107.89 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HZ2' ' HB2' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -60.34 -39.45 87.16 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 120.639 -0.424 . . . . 72.21 110.188 175.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.71 -36.45 83.9 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-N 119.389 0.995 . . . . 73.23 109.018 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.14 75.83 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.078 -0.712 . . . . 72.11 109.078 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 -53.45 25.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 N-CA-C 107.278 -1.379 . . . . 74.32 107.278 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.0 m -52.49 -29.19 23.7 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 108.294 -1.002 . . . . 74.22 108.294 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.1 m -69.19 -56.23 8.25 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 108.015 -1.105 . . . . 70.51 108.015 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -53.52 -56.17 19.31 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.844 -0.799 . . . . 71.2 108.844 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -46.58 -43.3 17.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.551 -0.749 . . . . 74.5 111.475 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -77.37 -14.55 59.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.509 0.323 . . . . 73.32 110.711 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -76.13 163.26 27.27 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 120.668 -1.27 . . . . 75.43 108.927 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.84 -146.68 6.46 Favored Glycine 0 CA--C 1.491 -1.447 0 N-CA-C 109.245 -1.542 . . . . 72.24 109.245 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -85.39 -42.64 14.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 107.793 -1.188 . . . . 75.32 107.793 -172.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.6 t -108.08 128.31 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 104.277 -2.49 . . . . 73.33 104.277 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.07 139.15 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 105.825 -1.917 . . . . 74.23 105.825 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -97.24 115.87 28.41 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 104.699 -2.334 . . . . 73.12 104.699 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 18.1 mt -112.84 137.22 51.51 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 104.84 -2.281 . . . . 75.31 104.84 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 tp -114.62 124.17 51.17 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.943 -2.243 . . . . 72.34 104.943 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.5 158.18 41.58 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 107.436 -1.32 . . . . 75.13 107.436 -173.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 58' ' ' ARG . 42.2 tt0 -120.28 128.1 53.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 103.876 -2.639 . . . . 71.13 103.876 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HB2' ' H ' ' A' ' 6' ' ' ASP . 25.5 mmtp -62.84 153.07 34.3 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-O 122.244 1.021 . . . . 75.42 110.498 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.06 58.57 0.03 OUTLIER Glycine 0 CA--C 1.451 -3.933 0 N-CA-C 104.075 -3.61 . . . . 74.24 104.075 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -79.25 130.42 35.45 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 105.401 -2.074 . . . . 73.33 105.401 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.9 p -104.14 149.94 37.8 Favored Pre-proline 0 N--CA 1.416 -2.162 0 N-CA-C 106.392 -1.707 . . . . 74.15 106.392 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.4 76.2 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.548 2.166 . . . . 74.44 107.796 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.409 ' C ' ' HZ2' ' A' ' 55' ' ' LYS . 15.8 m . . . . . 0 C--O 1.25 1.096 0 N-CA-C 106.071 -1.826 . . . . 71.21 106.071 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.609 0 N-CA-C 108.689 -1.764 . . . . 74.31 108.689 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.84 137.99 66.14 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.982 2.454 . . . . 71.13 108.935 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -81.61 165.5 43.6 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 106.245 -1.761 . . . . 74.22 106.245 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.76 112.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.742 2.295 . . . . 75.15 108.78 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.66 12.9 29.27 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.685 -1.366 . . . . 70.21 109.685 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.46 137.92 32.27 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 105.618 -1.993 . . . . 71.53 105.618 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.3 140.01 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 104.139 -2.541 . . . . 75.41 104.139 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -152.34 159.77 43.41 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.346 -2.094 . . . . 72.33 105.346 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.12 145.79 28.85 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 105.256 -2.128 . . . . 73.1 105.256 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.72 122.74 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 103.448 -2.797 . . . . 71.02 103.448 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -99.6 109.48 21.98 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.283 -2.488 . . . . 75.45 104.283 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 105.44 -2.059 . . . . 74.1 105.44 -171.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -89.18 134.18 34.13 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.064 -1.828 . . . . 60.45 106.064 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.67 33.71 0.32 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.313 -0.995 . . . . 73.32 108.313 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 13' ' ' ALA . 16.1 t-20 -53.77 -33.4 55.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 123.45 0.7 . . . . 62.21 109.247 -171.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.6 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.676 0 N-CA-C 107.15 -1.426 . . . . 53.44 107.15 171.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.4 t30 165.49 -32.71 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 103.935 -2.617 . . . . 72.22 103.935 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 m -94.61 149.21 21.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 105.372 -2.084 . . . . 75.41 105.372 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.07 -57.28 4.14 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 104.301 -2.481 . . . . 71.4 104.301 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.14 34.42 9.76 Favored Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.981 -2.447 . . . . 62.25 106.981 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 mt -131.05 160.04 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 104.959 -2.237 . . . . 74.3 104.959 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.14 162.86 37.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.562 -3.125 . . . . 71.12 102.562 163.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.97 167.85 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 N-CA-C 105.801 -1.925 . . . . 71.33 105.801 -165.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -147.41 166.5 26.99 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 102.721 -3.066 . . . . 74.1 102.721 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.92 178.57 15.4 Favored Glycine 0 CA--C 1.459 -3.46 0 N-CA-C 105.715 -2.954 . . . . 51.33 105.715 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.75 -130.52 6.99 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 108.823 -1.711 . . . . 54.13 108.823 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.39 19.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 126.721 2.008 . . . . 74.32 114.212 -165.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.5 t30 88.37 65.6 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.051 -1.463 . . . . 74.44 107.051 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 t -94.71 -166.24 1.44 Allowed 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 104.094 -2.558 . . . . 73.24 104.094 173.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 m -47.41 -40.7 18.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.732 1.213 . . . . 60.23 112.59 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 m -76.16 133.78 30.4 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 N-CA-C 108.871 -0.788 . . . . 74.53 108.871 -173.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -57.77 -55.15 38.54 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.19 0.996 . . . . 75.13 112.492 -169.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -76.22 6.61 5.21 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.297 -0.877 . . . . 75.53 110.111 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 57.53 6.44 2.38 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 121.516 -0.74 . . . . 55.44 111.967 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.68 160.65 53.81 Favored Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 107.364 -2.294 . . . . 74.44 107.364 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mm -83.92 108.62 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 106.14 -1.8 . . . . 75.51 106.14 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' A' ' 58' ' ' ARG . 42.9 m-85 -103.75 144.08 31.94 Favored 'General case' 0 CA--C 1.48 -1.74 0 N-CA-C 106.84 -1.541 . . . . 74.11 106.84 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.94 132.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.031 -1.841 . . . . 75.03 106.031 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -114.72 -37.48 4.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.228 -1.027 . . . . 75.24 108.228 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.57 146.43 34.59 Favored 'General case' 0 CA--C 1.463 -2.366 0 N-CA-C 106.716 -1.587 . . . . 63.24 106.716 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.03 119.35 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 104.979 -2.23 . . . . 73.54 104.979 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.3 mt -72.46 140.09 81.75 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 106.575 -1.639 . . . . 71.24 106.575 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.6 119.9 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.731 2.287 . . . . 63.42 109.785 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 68.75 25.29 6.38 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 125.12 1.512 . . . . 74.34 110.372 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.02 173.44 52.62 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 107.653 -2.179 . . . . 72.22 107.653 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.38 99.29 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.796 -0.816 . . . . 74.24 108.796 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.19 77.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.311 -0.626 . . . . 74.45 109.311 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.5 -42.17 95.81 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.027 -0.731 . . . . 61.54 109.027 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -67.82 -36.69 80.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.614 -0.513 . . . . 61.54 109.614 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.86 -36.91 75.89 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.637 -1.246 . . . . 71.33 107.637 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -18.95 23.94 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.039 -0.824 . . . . 62.24 111.039 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -74.62 -39.75 61.94 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.426 -0.953 . . . . 74.44 108.426 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -95.74 120.62 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 105.829 -1.915 . . . . 73.3 105.829 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.21 169.85 10.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.657 -1.979 . . . . 72.15 105.657 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -66.52 137.86 57.09 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.501 -1.666 . . . . 75.32 106.501 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.05 -26.16 23.99 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 108.328 -1.909 . . . . 75.13 108.328 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.55 166.5 21.68 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.69 -1.226 . . . . 71.03 107.69 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.408 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -130.29 139.39 50.74 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 107.489 -1.3 . . . . 71.12 107.489 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.48 143.97 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 104.086 -2.561 . . . . 72.02 104.086 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.37 -46.92 3.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.563 -1.273 . . . . 74.33 107.563 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.91 166.09 21.69 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.377 1.085 . . . . 70.34 109.827 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.46 104.35 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 103.783 -2.673 . . . . 62.11 103.783 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 46.91 43.28 13.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.091 0.956 . . . . 64.52 110.849 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.81 76.6 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.217 -1.153 . . . . 64.15 110.217 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.34 117.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 104.467 -2.42 . . . . 74.25 104.467 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -75.33 107.48 7.47 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.786 -1.191 . . . . 73.55 107.786 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.35 -6.29 56.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.513 -0.767 . . . . 73.23 110.034 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -61.47 142.75 56.81 Favored 'General case' 0 C--N 1.361 1.073 0 O-C-N 120.875 -1.141 . . . . 74.54 108.834 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.94 -25.06 6.19 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.385 -1.086 . . . . 54.25 110.385 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 164.0 26.5 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.203 1.001 . . . . 62.42 108.892 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 p -81.54 163.62 22.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.625 -0.88 . . . . 72.11 108.625 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -61.49 -44.94 96.19 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.445 -0.798 . . . . 73.21 108.936 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -30.73 70.66 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 120.302 -0.559 . . . . 72.34 109.918 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -65.55 -36.2 83.09 Favored 'General case' 0 C--N 1.373 1.622 0 N-CA-C 108.521 -0.918 . . . . 73.23 108.521 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.39 -34.19 73.56 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.553 -0.906 . . . . 60.21 108.553 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.67 -53.63 19.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.156 -1.424 . . . . 75.34 107.156 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.3 m -53.26 -29.05 30.71 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.199 -1.038 . . . . 54.11 108.199 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.5 m -69.91 -55.83 8.65 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.531 -1.285 . . . . 72.45 107.531 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -55.78 -55.49 31.74 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.062 -0.718 . . . . 74.11 109.062 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -45.97 -37.91 7.07 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.653 0.612 . . . . 73.34 112.653 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -90.23 8.28 33.95 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.29 0.95 . . . . 65.44 110.283 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -74.32 163.54 27.68 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-N 119.587 1.085 . . . . 63.14 109.51 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.74 -158.79 19.87 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 109.067 -1.613 . . . . 52.32 109.067 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -81.99 -38.45 25.08 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.886 -0.783 . . . . 74.31 108.886 -169.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.8 t -113.34 130.06 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 103.553 -2.758 . . . . 73.5 103.553 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -122.27 142.12 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 104.827 -2.286 . . . . 75.5 104.827 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -100.71 119.22 38.28 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 104.333 -2.469 . . . . 73.31 104.333 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.46 134.62 54.56 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 103.726 -2.694 . . . . 72.42 103.726 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.57 126.94 53.49 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 105.764 -1.939 . . . . 73.12 105.764 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -134.37 155.33 50.46 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.211 -1.774 . . . . 75.24 106.211 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -118.21 135.65 54.12 Favored 'General case' 0 CA--C 1.477 -1.863 0 N-CA-C 102.685 -3.079 . . . . 55.35 102.685 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.48 141.76 50.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.665 -0.865 . . . . 74.22 108.665 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.21 67.01 0.05 OUTLIER Glycine 0 CA--C 1.472 -2.628 0 N-CA-C 107.44 -2.264 . . . . 64.32 107.44 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -75.17 130.21 38.8 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 105.478 -2.045 . . . . 73.35 105.478 171.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m -87.23 151.9 52.0 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 105.688 -1.967 . . . . 62.23 105.688 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.42 65.6 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.658 2.239 . . . . 74.12 108.199 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.421 -1.899 0 N-CA-C 105.309 -2.108 . . . . 62.31 105.309 -178.382 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 108.406 -1.877 . . . . 72.34 108.406 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.59 169.57 17.05 Favored 'Trans proline' 0 CA--C 1.512 -0.593 0 C-N-CA 123.082 2.521 . . . . 65.15 108.283 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -97.57 152.64 38.28 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 105.841 -1.911 . . . . 73.41 105.841 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 132.63 31.82 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.606 2.204 . . . . 74.31 109.915 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.0 64.25 Favored Glycine 0 CA--C 1.497 -1.042 0 N-CA-C 109.518 -1.433 . . . . 70.4 109.518 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.52 139.6 30.55 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 105.765 -1.939 . . . . 74.34 105.765 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.41 130.69 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 104.704 -2.332 . . . . 75.03 104.704 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -138.53 149.04 44.94 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.599 -1.63 . . . . 74.22 106.599 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' HG2' HD11 ' A' ' 89' ' ' LEU . 89.4 mt-10 -103.22 139.72 38.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.574 -1.639 . . . . 65.44 106.574 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.04 135.28 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 106.939 -1.504 . . . . 71.41 106.939 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -105.9 112.8 26.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 104.533 -2.395 . . . . 65.24 104.533 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.18 125.12 50.69 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.586 -1.635 . . . . 74.32 106.586 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.22 133.84 37.32 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.931 -1.507 . . . . 73.34 106.931 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HZ1' ' CG2' ' A' ' 86' ' ' VAL . 11.0 mptt -103.91 34.89 2.84 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 105.993 -1.854 . . . . 71.33 105.993 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.97 83.97 3.5 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.86 -1.904 . . . . 72.34 105.86 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -175.19 -171.25 0.49 Allowed 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 100.527 -3.879 . . . . 73.32 100.527 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -91.2 -47.23 7.63 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 106.715 -1.587 . . . . 72.51 106.715 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -93.15 139.62 30.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.84 -1.541 . . . . 64.11 106.84 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.98 -57.66 3.88 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 104.022 -2.584 . . . . 71.3 104.022 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 81.07 39.22 13.31 Favored Glycine 0 CA--C 1.478 -2.247 0 CA-C-N 113.731 -1.577 . . . . 54.11 109.498 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.51 145.7 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 103.537 -2.764 . . . . 75.02 103.537 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.48 162.99 34.38 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 103.07 -2.937 . . . . 74.52 103.07 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.09 168.0 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 N-CA-C 104.829 -2.286 . . . . 74.22 104.829 -167.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.6 t -145.79 166.03 27.11 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.319 -2.474 . . . . 71.12 104.319 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 87.83 131.74 3.64 Favored Glycine 0 C--O 1.2 -2.01 0 N-CA-C 108.594 -1.802 . . . . 42.13 108.594 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.2 -99.07 0.14 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 107.526 -2.229 . . . . 64.51 107.526 167.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.31 20.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.386 1.874 . . . . 65.11 114.94 -170.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 88.71 66.41 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.926 0 CA-C-O 123.337 1.542 . . . . 75.11 106.991 -168.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.679 HG23 ' H ' ' A' ' 30' ' ' SER . 4.3 m -84.38 -166.57 1.48 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.478 -2.416 . . . . 71.52 104.478 173.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.679 ' H ' HG23 ' A' ' 29' ' ' THR . 10.5 m -53.16 -28.11 24.57 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.339 0.656 . . . . 60.11 110.9 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 m -82.57 122.25 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.787 -1.56 . . . . 72.25 106.787 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -83.59 -16.76 44.1 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.683 -0.858 . . . . 75.41 108.683 -170.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.482 ' C ' ' H ' ' A' ' 35' ' ' GLY . 43.3 t60 -70.77 -12.19 61.4 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.739 -1.208 . . . . 74.52 107.739 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.37 -5.36 1.54 Allowed Glycine 0 C--N 1.365 2.147 0 C-N-CA 124.155 0.883 . . . . 71.13 111.505 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 33' ' ' HIS . . . -70.28 151.19 49.59 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 107.931 -2.067 . . . . 71.15 107.931 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 25' ' ' GLY . 10.7 mm -82.17 126.08 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.449 -2.426 . . . . 74.12 104.449 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -111.91 145.6 39.26 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 106.89 -1.522 . . . . 71.52 106.89 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -74.52 129.36 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.386 -2.079 . . . . 73.13 105.386 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -116.45 -35.28 4.32 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.741 -1.207 . . . . 70.32 107.741 -170.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.04 136.28 45.87 Favored 'General case' 0 CA--C 1.452 -2.798 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 -167.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -139.39 129.76 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 103.765 -2.68 . . . . 73.11 103.765 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.433 HG12 ' CA ' ' A' ' 20' ' ' GLY . 6.5 mm -70.94 147.46 94.0 Favored Pre-proline 0 CA--C 1.505 -0.751 0 N-CA-C 105.082 -2.192 . . . . 75.41 105.082 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 114.35 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.876 1.717 . . . . 72.43 107.801 164.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 68.95 26.49 5.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 124.542 1.151 . . . . 72.02 111.044 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.15 177.12 43.14 Favored Glycine 0 C--N 1.368 2.34 0 N-CA-C 106.474 -2.65 . . . . 51.03 106.474 167.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.04 95.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 122.124 -0.633 . . . . 72.42 109.342 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.25 -49.2 78.07 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.413 -0.588 . . . . 73.24 109.413 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.46 -36.8 81.88 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -65.18 -44.02 89.79 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.458 -0.942 . . . . 71.01 108.458 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -70.36 -33.0 70.92 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.235 -1.395 . . . . 74.31 107.235 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.27 -16.12 45.76 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 110.481 -1.048 . . . . 55.21 110.481 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -79.42 -34.68 41.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.695 -0.854 . . . . 74.04 108.695 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.4 mt -105.25 141.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.852 -1.907 . . . . 75.32 105.852 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -143.56 178.33 7.86 Favored 'General case' 0 CA--C 1.466 -2.252 0 N-CA-C 104.526 -2.398 . . . . 74.4 104.526 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.91 146.96 53.85 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.007 -1.479 . . . . 74.21 107.007 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.14 -16.49 53.62 Favored Glycine 0 CA--C 1.498 -0.997 0 N-CA-C 107.335 -2.306 . . . . 65.51 107.335 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.29 146.57 31.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.998 -1.852 . . . . 73.23 105.998 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.481 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.8 tmm_? -108.83 123.82 49.65 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 105.377 -2.083 . . . . 74.43 105.377 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.29 141.2 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 105.545 -2.021 . . . . 72.33 105.545 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -49.01 2.31 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.89 -1.152 . . . . 72.11 107.89 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.98 166.83 19.27 Favored 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 118.873 -1.131 . . . . 74.5 109.92 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.71 100.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 103.395 -2.817 . . . . 73.32 103.395 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 t30 48.16 41.99 16.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.731 1.212 . . . . 62.24 110.954 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 13.04 77.02 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.053 -1.219 . . . . 75.23 110.053 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.14 116.85 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.759 0 N-CA-C 103.647 -2.723 . . . . 74.24 103.647 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 m -72.45 112.22 8.32 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.137 -1.06 . . . . 53.53 108.137 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.79 9.63 26.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.905 -1.517 . . . . 72.51 106.905 172.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.79 140.01 49.25 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.436 -1.69 . . . . 75.12 106.436 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 -23.23 4.58 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.291 -1.124 . . . . 62.21 110.291 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.93 164.72 16.93 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.895 0.855 . . . . 70.31 109.53 -175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 p -82.36 155.16 24.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.958 -1.497 . . . . 75.15 106.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -62.72 -37.63 87.28 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -55.84 -43.05 76.66 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 110.097 -0.334 . . . . 65.4 110.097 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -66.23 -39.97 89.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.277 -1.009 . . . . 63.23 108.277 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.97 -39.73 72.22 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 110.056 -0.35 . . . . 72.31 110.056 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.04 -56.25 9.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 107.754 -1.202 . . . . 65.41 107.754 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 72.0 m -63.59 -25.97 68.48 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.788 -0.819 . . . . 74.12 108.788 -166.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.7 m -60.7 -52.81 63.55 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 107.669 -1.234 . . . . 71.44 107.669 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.1 mt -55.27 -55.23 33.82 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.657 0.742 . . . . 74.12 109.519 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -48.16 -36.41 13.48 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.035 -0.415 . . . . 74.32 112.082 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -89.93 -9.75 47.67 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.67 -0.644 . . . . 72.52 110.095 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -81.31 179.54 7.81 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.754 -1.202 . . . . 71.2 107.754 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.88 -166.73 31.43 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.843 -1.303 . . . . 71.2 109.843 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.63 -35.95 38.62 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.808 -1.553 . . . . 74.11 106.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -116.29 127.74 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 N-CA-C 103.036 -2.95 . . . . 75.14 103.036 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.476 ' CG2' ' HZ1' ' A' ' 14' ' ' LYS . 12.0 t -138.76 151.58 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.87 0 N-CA-C 104.606 -2.368 . . . . 64.34 104.606 -174.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.85 123.88 40.68 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 104.305 -2.48 . . . . 72.04 104.305 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.4 mt -118.84 140.77 49.42 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 105.428 -2.064 . . . . 72.52 105.428 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.401 HD11 ' HG2' ' A' ' 9' ' ' GLU . 17.8 tp -114.22 124.14 51.3 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 105.053 -2.203 . . . . 75.02 105.053 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.11 157.19 44.85 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.691 -1.226 . . . . 74.11 107.691 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.481 ' CD ' HH21 ' A' ' 58' ' ' ARG . 36.2 tt0 -123.95 131.58 53.59 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 103.154 -2.906 . . . . 75.43 103.154 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.636 ' HE3' ' H ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -61.3 150.18 35.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.792 -0.818 . . . . 74.43 108.792 179.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.636 ' H ' ' HE3' ' A' ' 92' ' ' LYS . . . -137.65 -149.64 5.58 Favored Glycine 0 CA--C 1.467 -2.929 0 N-CA-C 103.322 -3.911 . . . . 74.23 103.322 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -142.66 173.19 11.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.288 -2.486 . . . . 74.04 104.288 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.7 m -84.39 114.19 53.35 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 105.489 -2.041 . . . . 74.05 105.489 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.19 120.47 7.44 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 122.592 2.195 . . . . 55.31 109.0 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.401 -2.909 0 N-CA-C 102.137 -3.283 . . . . 70.41 102.137 175.629 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.41 ' H20' ' H15' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.772 0 N-CA-C 108.272 -1.931 . . . . 72.44 108.272 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.8 157.17 60.35 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.073 2.515 . . . . 72.51 109.172 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -78.79 159.88 72.99 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 107.031 -1.47 . . . . 63.22 107.031 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.07 132.01 30.57 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 106.959 -1.977 . . . . 71.42 106.959 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.57 56.79 Favored Glycine 0 CA--C 1.497 -1.056 0 N-CA-C 109.395 -1.482 . . . . 34.52 109.395 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.86 143.74 57.61 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 118.686 1.243 . . . . 72.14 108.414 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.93 131.4 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.82 -2.659 . . . . 61.04 103.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.21 146.57 52.11 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 105.209 -2.145 . . . . 73.11 105.209 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -102.44 135.4 44.12 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.024 -2.213 . . . . 72.21 105.024 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.27 129.94 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 105.851 -1.907 . . . . 74.44 105.851 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -101.05 112.5 24.97 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 103.72 -2.696 . . . . 54.4 103.72 168.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -102.87 124.71 48.89 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.486 -2.042 . . . . 72.2 105.486 -173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -87.8 120.31 29.0 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.504 -1.665 . . . . 52.23 106.504 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.52 33.74 1.1 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.034 -1.469 . . . . 73.13 107.034 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 13' ' ' ALA . 73.9 m-80 6.05 -91.95 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 128.584 2.753 . . . . 75.12 112.134 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -158.74 -178.48 7.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.746 -2.316 . . . . 52.53 104.746 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 74.14 -120.24 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.281 1.032 . . . . 74.41 108.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.1 m -91.68 132.53 36.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.557 -1.275 . . . . 70.23 107.557 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 mt -73.46 -58.87 3.01 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 105.869 -1.901 . . . . 73.3 105.869 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.73 41.98 55.12 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 110.691 -0.964 . . . . 75.13 110.691 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.63 154.28 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.026 -2.583 . . . . 71.21 104.026 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.5 t -154.14 165.87 34.86 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.461 -2.422 . . . . 74.34 104.461 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.21 167.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 105.688 -1.967 . . . . 74.22 105.688 -168.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -146.11 166.53 25.87 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 104.584 -2.376 . . . . 75.42 104.584 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 84.93 134.37 3.02 Favored Glycine 0 C--O 1.196 -2.241 0 N-CA-C 108.853 -1.699 . . . . 44.1 108.853 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.97 -97.41 0.12 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 108.717 -1.753 . . . . 40.34 108.717 167.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.98 21.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 127.183 2.193 . . . . 74.41 116.017 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 87.37 66.29 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.733 -1.58 . . . . 64.31 106.733 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.631 HG21 ' H ' ' A' ' 30' ' ' SER . 4.1 m -88.38 -166.97 1.73 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.184 -2.524 . . . . 74.24 104.184 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.631 ' H ' HG21 ' A' ' 29' ' ' THR . 15.6 m -58.43 -21.01 49.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.553 -0.717 . . . . 54.21 110.625 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.58 126.27 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.765 -1.568 . . . . 64.13 106.765 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.7 mtm-85 -51.92 -57.6 8.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 115.204 -0.907 . . . . 72.4 112.363 -168.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -82.87 7.15 16.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.938 -0.764 . . . . 71.52 108.938 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.13 25.1 69.32 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 108.592 -1.803 . . . . 33.31 108.592 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.43 139.84 38.14 Favored Glycine 0 CA--C 1.479 -2.201 0 N-CA-C 107.394 -2.282 . . . . 52.4 107.394 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 25' ' ' GLY . 10.6 mm -84.29 120.35 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 104.645 -2.354 . . . . 74.2 104.645 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.55 146.65 41.54 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 106.306 -1.739 . . . . 74.4 106.306 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.26 135.02 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 73.34 107.084 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -49.12 3.22 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.518 -1.29 . . . . 74.34 107.518 -167.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 144.42 34.0 Favored 'General case' 0 CA--C 1.461 -2.469 0 N-CA-C 104.859 -2.274 . . . . 73.54 104.859 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.83 132.57 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 104.265 -2.494 . . . . 72.32 104.265 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.53 133.46 80.19 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 106.037 -1.838 . . . . 74.31 106.037 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.48 113.66 1.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.52 2.146 . . . . 72.41 108.141 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.36 21.9 5.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 124.621 1.201 . . . . 72.21 111.327 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.67 -166.74 27.96 Favored Glycine 0 C--N 1.367 2.271 0 N-CA-C 106.206 -2.758 . . . . 71.54 106.206 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 117.999 0.899 . . . . 75.22 110.427 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.58 -45.75 74.65 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 109.916 -0.402 . . . . 75.14 109.916 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -71.88 -39.06 69.88 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.481 -0.563 . . . . 72.35 109.481 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 t -65.9 -46.12 79.48 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.777 -1.194 . . . . 73.31 107.777 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.52 -32.33 71.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 106.92 -1.511 . . . . 60.22 106.92 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.73 -10.4 51.65 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.524 -0.762 . . . . 71.43 111.281 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -69.78 -38.25 76.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.945 -0.738 . . . . 72.33 110.025 -172.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.69 140.31 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 105.945 -1.872 . . . . 72.53 105.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -131.36 176.19 8.5 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.99 -1.485 . . . . 75.1 106.99 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.84 144.04 56.52 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.334 -0.987 . . . . 73.42 108.334 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.86 -4.17 74.93 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 109.678 -1.369 . . . . 72.12 109.678 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -86.25 156.35 20.32 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.823 -1.177 . . . . 71.54 107.823 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 118.56 37.04 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.992 -1.484 . . . . 74.33 106.992 -170.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.6 t -103.43 141.71 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 104.998 -2.223 . . . . 73.41 104.998 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.38 -45.66 2.62 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.589 -1.263 . . . . 75.01 107.589 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.34 158.21 39.76 Favored 'General case' 0 CA--C 1.477 -1.834 0 C-N-CA 118.695 -1.202 . . . . 75.44 109.345 -175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.79 106.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 104.775 -2.305 . . . . 74.44 104.775 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 45.19 43.9 8.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.255 1.422 . . . . 75.04 111.262 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.56 84.92 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.068 -1.213 . . . . 64.2 110.068 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.37 117.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.396 0 N-CA-C 103.151 -2.907 . . . . 75.41 103.151 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.7 m -75.69 114.33 14.15 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.775 -1.565 . . . . 74.3 106.775 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.29 28.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.594 -1.262 . . . . 74.52 107.594 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -75.55 122.5 23.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.12 -1.437 . . . . 64.01 107.12 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -9.68 52.81 Favored Glycine 0 C--N 1.328 0.1 0 N-CA-C 110.918 -0.873 . . . . 43.43 110.918 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 161.29 29.69 Favored 'General case' 0 C--N 1.364 1.232 0 CA-C-N 118.806 1.303 . . . . 74.21 107.598 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.6 p -82.31 167.14 18.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.406 -0.961 . . . . 72.45 108.406 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -66.52 -41.87 88.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.147 -0.686 . . . . 73.12 109.147 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -38.06 89.68 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.697 -0.668 . . . . 74.14 110.3 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -65.58 -35.8 81.9 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.143 1.338 . . . . 75.24 109.182 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.1 69.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.408 -0.59 . . . . 75.14 109.408 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.9 -53.75 19.13 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.265 -1.383 . . . . 71.53 107.265 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 63.8 m -54.7 -29.26 52.61 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 122.38 1.086 . . . . 75.32 108.374 -173.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.8 m -64.98 -53.32 47.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.149 -1.426 . . . . 73.23 107.149 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.42 -55.12 35.41 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.041 -0.725 . . . . 60.34 109.041 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -46.48 -41.07 13.45 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 116.629 -0.26 . . . . 73.3 111.273 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.52 -3.76 58.2 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.697 -0.627 . . . . 72.15 110.947 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 p -81.61 169.76 16.66 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 120.254 1.388 . . . . 73.53 108.598 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.02 -168.75 30.06 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.682 -1.367 . . . . 73.42 109.682 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -79.01 -25.07 43.3 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.485 -0.932 . . . . 70.34 108.485 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.13 130.35 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 103.625 -2.731 . . . . 73.24 103.625 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.94 139.59 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.791 -1.929 . . . . 70.24 105.791 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -95.67 116.57 29.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 104.402 -2.444 . . . . 73.12 104.402 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.7 mt -118.79 139.82 50.96 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 106.138 -1.801 . . . . 73.33 106.138 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 127.87 55.72 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.461 -2.051 . . . . 72.32 105.461 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.86 156.72 47.57 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.689 -1.226 . . . . 73.43 107.689 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -117.3 133.51 55.9 Favored 'General case' 0 CA--C 1.438 -3.336 0 N-CA-C 104.995 -2.224 . . . . 71.21 104.995 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -62.71 150.61 40.69 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 74.34 110.289 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.54 50.44 0.21 Allowed Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 105.601 -2.999 . . . . 74.21 105.601 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.79 153.15 29.37 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.59 -1.263 . . . . 70.05 107.59 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.2 m -83.39 163.89 47.92 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.352 -2.092 . . . . 42.52 105.352 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.35 163.72 25.59 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.272 1.982 . . . . 73.11 108.944 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.428 -1.525 0 N-CA-C 106.548 -1.649 . . . . 73.2 106.548 -176.504 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.655 0 N-CA-C 108.524 -1.831 . . . . 75.12 108.524 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.28 154.57 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.061 2.508 . . . . 61.25 108.889 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.658 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -94.22 161.96 27.89 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 105.063 -2.199 . . . . 74.34 105.063 -178.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 3' ' ' LYS . 18.9 Cg_endo -57.81 115.23 2.37 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.655 2.237 . . . . 74.42 110.761 -176.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.45 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 98.65 12.39 44.28 Favored Glycine 0 CA--C 1.497 -1.052 0 N-CA-C 109.07 -1.612 . . . . 64.12 109.07 175.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -92.46 136.12 33.48 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 104.881 -2.266 . . . . 71.22 104.881 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.99 132.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 104.291 -2.485 . . . . 72.52 104.291 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -144.81 152.07 39.76 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.044 -2.206 . . . . 72.43 105.044 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.04 148.13 28.1 Favored 'General case' 0 N--CA 1.402 -2.829 0 N-CA-C 104.758 -2.312 . . . . 60.2 104.758 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.82 131.15 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 N-CA-C 103.712 -2.699 . . . . 75.34 103.712 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -103.85 111.91 24.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 104.327 -2.472 . . . . 75.11 104.327 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.68 125.24 50.05 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.908 -1.516 . . . . 74.54 106.908 -164.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -93.1 124.8 37.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 105.694 -1.965 . . . . 65.42 105.694 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm -91.98 31.96 1.19 Allowed 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.639 -1.245 . . . . 64.54 107.639 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.449 ' H ' ' C ' ' A' ' 13' ' ' ALA . 77.1 m-20 18.19 51.19 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 128.261 2.624 . . . . 74.24 111.196 -168.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t0 11.31 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.056 2.142 . . . . 64.22 113.054 -164.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -145.69 -116.54 0.08 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 105.062 -2.199 . . . . 73.31 105.062 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -80.81 131.22 35.38 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.025 -1.472 . . . . 54.51 107.025 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -58.65 3.16 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.45 -2.426 . . . . 75.12 104.45 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.25 39.78 96.25 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-N 113.412 -1.722 . . . . 62.13 110.543 167.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.5 mt -128.43 163.12 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 102.263 -3.236 . . . . 75.52 102.263 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.2 t -153.15 159.09 42.67 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 102.821 -3.029 . . . . 74.31 102.821 174.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.86 167.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.941 -1.874 . . . . 73.42 105.941 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -153.78 167.71 28.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 103.499 -2.778 . . . . 72.43 103.499 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.16 -172.32 15.57 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 106.071 -2.812 . . . . 75.31 106.071 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.22 -124.63 5.38 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.962 -1.655 . . . . 64.43 108.962 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.08 18.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 126.292 1.837 . . . . 64.14 114.368 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 86.92 65.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.971 1.367 . . . . 71.31 107.342 -172.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.3 t -89.1 -165.12 1.26 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.076 -2.194 . . . . 71.11 105.076 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 m -49.63 -26.68 3.82 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.169 0.988 . . . . 61.1 112.208 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -86.71 118.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 N-CA-C 105.361 -2.088 . . . . 71.31 105.361 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.22 -14.35 60.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.787 -0.642 . . . . 74.41 111.053 -165.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -85.87 -5.99 59.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.346 -0.983 . . . . 75.34 108.346 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 10.59 27.49 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.894 -0.883 . . . . 74.4 110.894 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.56 158.29 53.5 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 107.986 -2.046 . . . . 61.34 107.986 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.47 129.0 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.602 -1.999 . . . . 72.44 105.602 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -125.38 144.97 50.26 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.281 -2.118 . . . . 75.41 105.281 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.72 134.16 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.09 -1.448 . . . . 74.2 107.09 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -103.93 -44.4 5.04 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.032 -1.099 . . . . 75.4 108.032 -171.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.68 153.97 40.0 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 105.964 -1.865 . . . . 70.15 105.964 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.42 130.0 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.309 -2.108 . . . . 70.12 105.309 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.1 mt -74.45 137.19 74.61 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.144 -1.799 . . . . 72.3 106.144 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.55 125.6 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.494 2.129 . . . . 75.22 108.685 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 33.9 mt-30 68.4 18.24 9.07 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 124.063 0.852 . . . . 74.31 109.817 -175.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.37 -177.68 52.01 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 106.153 -2.779 . . . . 60.31 106.153 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.563 -0.375 . . . . 73.33 110.82 -168.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.89 94.8 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.065 -0.716 . . . . 75.42 109.065 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 44' ' ' GLN . 50.8 tp10 -59.49 -46.47 88.71 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.26 -0.644 . . . . 73.24 109.26 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 m -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.34 -0.615 . . . . 61.12 109.34 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.96 -45.49 74.05 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.204 -1.036 . . . . 74.34 108.204 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -32.8 5.52 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.312 -1.115 . . . . 72.31 110.312 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -75.17 -36.98 61.45 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 117.614 0.707 . . . . 73.25 109.132 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.04 138.24 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 104.761 -2.311 . . . . 73.33 104.761 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.489 ' HE1' ' OE1' ' A' ' 94' ' ' GLN . 28.1 p80 -136.6 179.11 6.56 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.124 -1.806 . . . . 75.15 106.124 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.08 139.85 58.76 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.7 -0.852 . . . . 74.41 108.7 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -3.34 87.22 Favored Glycine 0 CA--C 1.497 -1.082 0 N-CA-C 110.459 -1.056 . . . . 52.41 110.459 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.44 154.42 39.98 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-N 119.342 1.571 . . . . 74.33 107.219 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.71 118.29 36.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.555 -1.276 . . . . 75.44 107.555 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.57 145.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.843 -2.281 . . . . 75.21 104.843 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 -48.33 2.43 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.441 -1.318 . . . . 74.55 107.441 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.15 167.19 18.76 Favored 'General case' 0 CA--C 1.469 -2.148 0 C-N-CA 118.914 -1.114 . . . . 75.21 109.718 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.52 102.54 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 103.702 -2.703 . . . . 74.45 103.702 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.97 41.19 28.1 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.783 0.833 . . . . 73.25 111.03 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.04 15.06 73.38 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 109.935 -1.266 . . . . 73.35 109.935 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.44 116.31 52.23 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 104.353 -2.462 . . . . 74.45 104.353 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -76.4 7.39 4.43 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.546 0.738 . . . . 60.34 111.796 -171.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt 34.25 38.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.967 1.307 . . . . 61.45 111.775 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.9 129.72 36.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 O-C-N 121.148 -0.97 . . . . 65.21 109.534 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 0.98 83.03 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 109.102 -1.599 . . . . 72.53 109.102 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 152.26 45.99 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.951 -1.129 . . . . 75.42 107.951 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 159.74 26.89 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.673 -1.232 . . . . 74.2 107.673 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -62.29 -41.59 98.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.16 -1.052 . . . . 70.14 108.16 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -58.15 -41.76 84.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.793 -0.64 . . . . 73.24 109.865 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -66.25 -34.52 78.2 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 108.673 -0.862 . . . . 71.5 108.673 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.79 74.49 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.826 -0.805 . . . . 64.23 108.826 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.69 -52.6 22.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 107.26 -1.385 . . . . 74.55 107.26 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.6 m -52.96 -28.37 23.38 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.105 0.955 . . . . 62.13 108.45 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -65.75 -55.91 14.76 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.269 -1.382 . . . . 74.5 107.269 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.6 mt -53.78 -55.03 30.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 108.934 -0.765 . . . . 73.54 108.934 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -46.25 -42.13 13.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.231 -0.44 . . . . 75.44 111.615 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -86.68 -5.59 59.09 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 121.72 -0.612 . . . . 72.3 110.87 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -85.06 170.51 12.89 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.755 -1.216 . . . . 74.53 108.404 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 -161.56 22.04 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.394 -1.482 . . . . 75.11 109.394 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.406 ' HG3' HG21 ' A' ' 85' ' ' VAL . 4.0 pt20 -77.99 -28.89 49.39 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.122 -1.066 . . . . 75.13 108.122 -173.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG21 ' HG3' ' A' ' 84' ' ' GLN . 57.7 t -114.87 134.47 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.105 -2.554 . . . . 63.02 104.105 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.66 143.29 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.678 -2.341 . . . . 71.43 104.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -96.89 117.13 30.44 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.975 -2.232 . . . . 72.45 104.975 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.03 137.82 51.99 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 105.215 -2.143 . . . . 73.34 105.215 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.79 127.66 56.1 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 105.313 -2.106 . . . . 75.13 105.313 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.57 154.35 48.92 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.761 -1.57 . . . . 72.23 106.761 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.1 135.73 46.64 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.089 -2.189 . . . . 60.52 105.089 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 71.1 mmtt -75.76 153.29 37.09 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.454 1.121 . . . . 74.33 111.002 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.14 48.46 0.12 Allowed Glycine 0 CA--C 1.468 -2.88 0 N-CA-C 105.034 -3.226 . . . . 35.45 105.034 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.489 ' OE1' ' HE1' ' A' ' 54' ' ' HIS . 3.0 pp0? -110.21 166.85 10.63 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.084 -1.45 . . . . 73.32 107.084 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.9 m -113.84 142.01 27.09 Favored Pre-proline 0 N--CA 1.427 -1.593 0 N-CA-C 104.385 -2.45 . . . . 74.21 104.385 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.25 115.38 3.29 Favored 'Trans proline' 0 CA--C 1.504 -0.997 0 C-N-CA 122.45 2.1 . . . . 74.1 107.15 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.417 -2.084 0 N-CA-C 104.866 -2.272 . . . . 73.44 104.866 -173.75 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.155 0 N-CA-C 109.513 -1.435 . . . . 63.12 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.82 156.5 65.75 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.046 2.498 . . . . 61.35 109.292 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -68.79 169.26 11.55 Favored Pre-proline 0 C--N 1.353 0.722 0 N-CA-C 106.69 -1.596 . . . . 75.55 106.69 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.68 128.01 20.09 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 107.489 -1.773 . . . . 72.43 107.489 163.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.22 70.57 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 110.005 -1.238 . . . . 61.41 110.005 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -104.88 147.77 27.39 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.997 -1.853 . . . . 72.4 105.997 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -99.2 132.08 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 105.963 -1.866 . . . . 72.13 105.963 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -133.78 149.84 51.44 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.19 -1.782 . . . . 73.23 106.19 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -102.26 138.1 39.65 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.99 -1.855 . . . . 72.13 105.99 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.9 t -129.11 127.58 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 104.939 -2.245 . . . . 72.41 104.939 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -103.34 109.45 21.07 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.676 -1.972 . . . . 73.25 105.676 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.99 122.95 45.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 N-CA-C 106.459 -1.682 . . . . 70.11 106.459 -164.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.37 138.18 32.64 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.343 -1.355 . . . . 74.41 107.343 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.49 33.61 0.64 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.359 -1.719 . . . . 74.33 106.359 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.72 74.58 4.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.919 -1.882 . . . . 63.21 105.919 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 33.0 t70 -176.72 -130.62 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 100.853 -3.758 . . . . 75.54 100.853 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 59.8 m-80 -150.45 -45.81 0.12 Allowed 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.448 -2.056 . . . . 75.24 105.448 173.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -74.87 122.51 23.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.021 -1.474 . . . . 64.41 107.021 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.4 mt -73.2 -57.08 4.27 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 104.476 -2.416 . . . . 74.41 104.476 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.88 37.28 94.09 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.063 -1.88 . . . . 71.45 110.944 174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mm -111.7 160.94 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.214 -2.513 . . . . 74.41 104.214 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -154.01 159.23 41.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 102.624 -3.102 . . . . 73.1 102.624 165.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.59 166.83 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 105.918 -1.882 . . . . 72.24 105.918 -168.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -147.87 165.86 29.35 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.199 -2.889 . . . . 74.24 103.199 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.72 -171.79 15.23 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 107.378 -2.289 . . . . 74.35 107.378 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.87 -128.81 6.81 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.205 -1.558 . . . . 71.33 109.205 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.48 19.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 127.24 2.216 . . . . 74.41 114.396 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 85.52 64.03 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.919 -1.512 . . . . 75.11 106.919 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -93.28 -166.15 1.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 104.357 -2.46 . . . . 61.42 104.357 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -38.42 -38.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.628 1.571 . . . . 71.34 113.305 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.69 131.97 33.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.235 0 N-CA-C 107.683 -1.229 . . . . 74.53 107.683 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -59.93 -50.7 72.74 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.636 -0.711 . . . . 75.14 111.446 -168.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.36 -3.64 31.55 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.8 -0.562 . . . . 75.12 109.692 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.54 14.25 41.59 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 110.345 -1.102 . . . . 74.21 110.345 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.42 154.5 50.47 Favored Glycine 0 CA--C 1.478 -2.231 0 N-CA-C 107.643 -2.183 . . . . 73.44 107.643 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.86 108.62 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.639 -1.615 . . . . 74.34 106.639 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 58' ' ' ARG . 36.1 m-85 -98.28 143.19 29.04 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 106.225 -1.769 . . . . 72.32 106.225 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.28 126.99 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 105.717 -1.957 . . . . 74.34 105.717 169.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -99.69 -49.54 4.35 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 107.363 -1.347 . . . . 75.51 107.363 -168.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.87 149.13 38.12 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 106.042 -1.836 . . . . 61.41 106.042 -171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.76 121.95 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 104.221 -2.511 . . . . 71.32 104.221 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.2 mt -75.58 138.27 70.63 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 105.215 -2.142 . . . . 73.3 105.215 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.47 129.48 34.94 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.133 1.889 . . . . 73.05 109.347 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 64.18 22.2 12.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 124.975 1.422 . . . . 63.4 111.329 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.69 175.95 43.38 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 107.202 -2.359 . . . . 74.44 107.202 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.54 73.48 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.255 -0.646 . . . . 74.24 109.255 -172.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.09 -49.71 59.53 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.231 -0.655 . . . . 60.04 109.231 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.24 -37.03 82.86 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 109.503 -0.554 . . . . 75.25 109.503 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.3 m -65.49 -37.97 88.39 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.47 -0.937 . . . . 74.4 108.47 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.74 -37.12 79.2 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.248 -1.019 . . . . 55.04 108.248 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.58 -21.71 8.64 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.898 -0.881 . . . . 31.33 110.898 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.9 mtt85 -75.44 -41.09 56.71 Favored 'General case' 0 CA--C 1.495 -1.165 0 O-C-N 121.524 -0.986 . . . . 72.55 108.61 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.36 128.02 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 106.15 -1.796 . . . . 71.34 106.15 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -131.34 177.4 7.51 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.645 -1.983 . . . . 72.22 105.645 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -67.06 145.27 55.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.615 -1.995 . . . . 73.22 105.615 171.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.05 58.04 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 107.377 -2.289 . . . . 45.01 107.377 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -84.8 158.47 20.67 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 105.301 -2.111 . . . . 54.42 105.301 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.424 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -137.23 150.64 48.0 Favored 'General case' 0 CA--C 1.47 -2.115 0 N-CA-C 107.054 -1.461 . . . . 74.44 107.054 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 t -104.86 145.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 104.786 -2.301 . . . . 65.32 104.786 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -48.23 3.02 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.329 -1.73 . . . . 71.22 106.329 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.18 161.49 31.0 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.429 1.109 . . . . 62.3 110.151 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -142.75 111.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 104.217 -2.512 . . . . 74.52 104.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 50.53 39.8 21.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.755 0.822 . . . . 72.51 110.466 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.37 7.18 79.96 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 109.978 -1.249 . . . . 53.52 109.978 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.424 ' C ' ' H ' ' A' ' 67' ' ' LEU . 43.5 t -108.32 116.56 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.686 -2.338 . . . . 74.24 104.686 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -79.92 14.82 1.64 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.417 0.287 . . . . 63.42 111.348 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 65' ' ' VAL . 4.5 mm? 38.09 38.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.06 1.344 . . . . 74.15 111.329 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -76.09 125.25 28.79 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.762 -1.212 . . . . 64.11 108.499 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.72 -7.49 65.5 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 109.706 -1.358 . . . . 71.54 109.706 172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.41 41.81 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.874 -1.158 . . . . 75.54 107.874 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -83.85 165.94 18.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.153 -1.054 . . . . 51.32 108.153 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.9 -36.6 84.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.302 -0.863 . . . . 74.51 109.118 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.2 -48.37 73.95 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 109.652 -0.499 . . . . 74.53 109.652 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -68.83 -30.21 68.71 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.598 -0.689 . . . . 73.32 109.334 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.11 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.336 -0.987 . . . . 70.2 108.336 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.16 -51.05 42.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 107.285 -1.376 . . . . 73.45 107.285 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.2 m -52.66 -28.36 21.22 Favored 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 108.554 -0.906 . . . . 73.24 108.554 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.2 m -72.67 -57.27 4.25 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.711 -1.218 . . . . 63.25 107.711 -171.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.81 -56.9 16.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.708 -0.849 . . . . 75.21 108.708 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -47.26 -38.75 12.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.89 0.7 . . . . 74.42 112.89 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -88.54 -2.01 58.36 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.324 -0.86 . . . . 63.5 110.241 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -77.73 176.67 8.8 Favored 'General case' 0 C--O 1.243 0.723 0 O-C-N 120.61 -1.306 . . . . 74.32 108.181 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.18 -163.62 26.03 Favored Glycine 0 CA--C 1.491 -1.425 0 N-CA-C 108.741 -1.744 . . . . 24.43 108.741 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.44 -33.93 42.07 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.945 -1.502 . . . . 62.13 106.945 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 t -113.57 130.54 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.096 0 N-CA-C 104.037 -2.579 . . . . 70.24 104.037 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 t -129.35 149.58 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 105.944 -1.873 . . . . 73.11 105.944 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -97.42 111.77 23.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.163 -2.162 . . . . 74.0 105.163 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -112.34 137.74 50.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.321 -2.103 . . . . 75.42 105.321 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 tp -115.92 124.18 49.95 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.807 -2.294 . . . . 73.54 104.807 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.8 155.41 46.01 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 106.934 -1.506 . . . . 71.44 106.934 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -129.79 137.95 50.78 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 103.248 -2.871 . . . . 72.41 103.248 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -68.44 148.65 50.33 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.24 1.019 . . . . 74.11 109.743 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.93 174.01 38.62 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.696 -2.962 . . . . 73.23 105.696 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -86.03 166.38 15.91 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.295 -2.113 . . . . 61.22 105.295 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.0 m -77.65 137.42 62.93 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.396 -1.705 . . . . 64.12 106.396 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.35 155.43 64.02 Favored 'Trans proline' 0 CA--C 1.496 -1.387 0 C-N-CA 122.566 2.177 . . . . 75.02 108.156 -169.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 104.264 -2.495 . . . . 73.41 104.264 176.108 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.409 ' H13' ' C8 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 109.372 -1.491 . . . . 75.44 109.372 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.73 156.49 63.27 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.054 2.502 . . . . 71.12 109.285 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -76.86 162.22 71.01 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 107.99 -1.115 . . . . 65.45 107.99 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.98 120.81 8.29 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.465 2.11 . . . . 75.42 109.183 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.87 13.24 59.5 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 108.873 -1.691 . . . . 73.01 108.873 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -101.38 146.06 28.1 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.216 -2.142 . . . . 50.44 105.216 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.66 139.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 105.384 -2.08 . . . . 75.0 105.384 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -142.95 149.69 38.72 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.255 -1.757 . . . . 73.43 106.255 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.15 140.86 36.78 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.553 -2.017 . . . . 72.04 105.553 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.3 t -126.38 133.12 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 105.914 -1.884 . . . . 75.54 105.914 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.67 116.97 33.91 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.475 -2.046 . . . . 72.02 105.475 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.17 121.21 42.19 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.874 -1.898 . . . . 62.23 105.874 -173.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 134.42 38.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.827 -1.175 . . . . 71.41 107.827 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -86.96 33.76 0.67 Allowed 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.268 -1.382 . . . . 73.24 107.268 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -44.56 -36.86 3.21 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 124.797 1.239 . . . . 71.11 112.043 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.58 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 30.0 t70 -73.15 -153.21 0.03 OUTLIER 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.335 -1.357 . . . . 75.33 107.335 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.58 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 59.8 t30 -112.64 -32.13 6.54 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 105.128 -2.175 . . . . 73.22 105.128 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.0 m -76.54 118.64 19.4 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.996 -1.483 . . . . 74.25 106.996 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.36 -56.96 4.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.657 -2.349 . . . . 75.3 104.657 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 50.88 58.31 9.59 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 113.902 -1.499 . . . . 72.24 112.988 167.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.9 mt -132.06 152.49 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.463 -2.791 . . . . 72.0 103.463 170.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.1 m -148.51 164.25 34.77 Favored 'General case' 0 CA--C 1.469 -2.164 0 N-CA-C 103.636 -2.727 . . . . 75.44 103.636 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -145.12 168.69 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 105.196 -2.15 . . . . 71.33 105.196 -168.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -142.79 166.0 25.84 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 102.108 -3.293 . . . . 74.12 102.108 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.71 -174.36 16.0 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 107.09 -2.404 . . . . 63.13 107.09 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.38 -128.27 5.91 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.115 -1.594 . . . . 64.52 109.115 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 m -66.92 19.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.638 1.975 . . . . 74.25 113.962 -168.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.256 85.5 m-20 87.04 66.35 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.956 0 CA-C-O 123.198 1.475 . . . . 75.44 107.479 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -80.82 -166.62 1.15 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.088 -2.56 . . . . 72.42 104.088 170.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -57.57 -19.42 25.44 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 121.536 -0.727 . . . . 70.33 112.178 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.6 m -85.84 135.23 25.42 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 N-CA-C 107.569 -1.271 . . . . 72.32 107.569 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -57.36 -55.47 34.42 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.624 0.77 . . . . 75.32 112.048 -166.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -85.63 12.07 9.52 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 121.166 -0.959 . . . . 63.2 109.308 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.44 22.94 59.68 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 110.217 -1.153 . . . . 70.52 110.217 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.8 145.88 50.03 Favored Glycine 0 C--N 1.36 1.902 0 N-CA-C 108.931 -1.668 . . . . 53.41 108.931 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mm -83.97 94.77 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.982 -1.858 . . . . 64.55 105.982 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -91.48 143.73 26.3 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 106.998 -1.482 . . . . 72.21 106.998 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.8 131.47 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.351 -1.722 . . . . 71.44 106.351 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -102.61 -47.52 4.41 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.785 -1.561 . . . . 73.33 106.785 -166.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.45 151.22 36.06 Favored 'General case' 0 CA--C 1.465 -2.322 0 N-CA-C 105.473 -2.047 . . . . 71.42 105.473 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.26 130.21 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 104.065 -2.569 . . . . 74.31 104.065 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.46 146.21 96.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 105.141 -2.17 . . . . 74.52 105.141 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.05 118.36 5.07 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.087 1.858 . . . . 62.21 108.217 167.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.54 29.49 19.06 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.16 0.913 . . . . 74.05 111.654 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.64 -174.31 35.76 Favored Glycine 0 C--N 1.379 2.956 0 N-CA-C 106.724 -2.551 . . . . 62.53 106.724 167.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.19 74.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 122.004 -0.703 . . . . 75.24 110.378 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.5 91.24 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.819 -0.438 . . . . 70.51 109.819 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.2 -38.87 91.84 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.104 -0.702 . . . . 73.43 109.104 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 t -65.14 -42.47 93.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.438 -0.949 . . . . 53.43 108.438 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.93 -39.87 94.18 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 107.499 -1.297 . . . . 71.25 107.499 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 82.49 -14.94 32.48 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 110.631 -0.988 . . . . 44.04 110.631 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -81.5 -38.8 25.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.55 -0.971 . . . . 71.33 108.554 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.6 mt -101.98 133.08 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.016 -1.846 . . . . 63.41 106.016 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 93.3 m-70 -126.54 179.19 5.45 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.573 -1.64 . . . . 75.23 106.573 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.02 144.25 55.21 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 105.455 -2.054 . . . . 73.11 105.455 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.24 -23.86 32.99 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.207 -1.957 . . . . 70.21 108.207 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.19 152.18 46.2 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 107.52 -1.289 . . . . 74.21 107.52 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.71 131.92 47.97 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 106.938 -1.505 . . . . 72.2 106.938 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.06 150.54 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 105.246 -2.131 . . . . 74.51 105.246 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.49 -46.63 2.86 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.54 -1.281 . . . . 74.24 107.54 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.47 159.58 35.84 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 118.974 -1.091 . . . . 61.53 109.235 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.99 107.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.748 -2.315 . . . . 74.44 104.748 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.2 t30 51.2 36.91 17.02 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.365 1.066 . . . . 74.15 111.417 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.52 68.65 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.648 -1.381 . . . . 73.14 109.648 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.12 120.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 105.024 -2.213 . . . . 71.43 105.024 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -68.24 106.75 2.55 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.516 -1.661 . . . . 71.44 106.516 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -21.38 56.76 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.168 -0.679 . . . . 72.33 109.168 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -57.85 145.0 36.76 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.073 -0.714 . . . . 72.22 109.073 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.57 -38.5 3.11 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 108.976 -1.65 . . . . 52.0 108.976 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.44 158.37 29.63 Favored 'General case' 0 C--N 1.363 1.162 0 CA-C-N 117.783 0.791 . . . . 74.53 109.596 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -84.73 166.11 17.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.394 -1.336 . . . . 73.32 107.394 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -65.04 -41.04 95.59 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.05 -0.722 . . . . 75.5 109.05 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -54.88 -46.18 74.71 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 109.932 -0.395 . . . . 64.22 109.932 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -69.7 -35.81 75.4 Favored 'General case' 0 C--N 1.366 1.302 0 N-CA-C 108.864 -0.791 . . . . 75.11 108.864 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.41 -41.94 77.18 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.383 -0.599 . . . . 74.5 109.383 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 23' ' ' VAL . 48.0 t -68.89 -54.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 N-CA-C 107.861 -1.162 . . . . 73.32 107.861 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.92 -27.57 44.22 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 108.587 -0.894 . . . . 61.13 108.587 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -66.48 -53.46 34.99 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.325 -1.361 . . . . 61.32 107.325 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.93 -56.92 15.47 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.677 -0.86 . . . . 73.3 108.677 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -48.27 -26.13 1.85 Allowed 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 113.382 0.882 . . . . 75.01 113.382 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -92.36 -10.63 37.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.09 0.859 . . . . 75.35 109.379 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -78.55 175.5 10.29 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 120.97 -1.081 . . . . 73.01 108.795 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.72 -163.38 26.91 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.406 -1.478 . . . . 63.52 109.406 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -78.5 -35.82 45.88 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.968 -1.493 . . . . 74.24 106.968 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.07 128.54 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.825 0 N-CA-C 102.692 -3.077 . . . . 72.34 102.692 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.73 140.1 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.905 0 N-CA-C 105.101 -2.185 . . . . 74.13 105.101 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -92.42 111.24 22.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 104.783 -2.302 . . . . 73.0 104.783 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 80.2 mt -114.77 140.33 48.99 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 106.163 -1.792 . . . . 75.01 106.163 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 tp -111.86 127.14 55.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.888 -1.893 . . . . 75.34 105.888 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mp -133.48 155.56 49.33 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.472 -1.677 . . . . 75.1 106.472 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -127.55 138.66 52.96 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 104.872 -2.27 . . . . 74.12 104.872 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -65.68 150.62 48.19 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.033 0.92 . . . . 74.44 109.61 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.3 42.88 0.57 Allowed Glycine 0 CA--C 1.48 -2.105 0 N-CA-C 104.908 -3.277 . . . . 54.21 104.908 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.85 167.73 10.34 Favored 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 106.678 -1.601 . . . . 75.14 106.678 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 m -74.69 159.85 82.29 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.072 -1.085 . . . . 64.53 108.072 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -177.12 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.196 2.598 . . . . 75.23 109.445 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.358 0.953 0 N-CA-C 103.961 -2.607 . . . . 72.12 103.961 -170.907 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.657 0 N-CA-C 108.294 -1.922 . . . . 74.22 108.294 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.42 150.86 87.5 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 123.18 2.587 . . . . 70.12 109.314 -173.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -83.14 159.41 62.48 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 105.747 -1.946 . . . . 74.3 105.747 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.49 124.17 13.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.103 1.868 . . . . 74.1 108.759 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.7 64.48 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.71 -1.356 . . . . 60.54 109.71 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.61 145.12 27.17 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 105.489 -2.041 . . . . 70.52 105.489 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.65 140.3 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.925 -2.25 . . . . 70.11 104.925 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.01 160.32 43.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.464 -1.68 . . . . 65.43 106.464 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -102.48 139.36 38.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.824 -1.917 . . . . 75.32 105.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.37 134.16 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 N-CA-C 105.841 -1.911 . . . . 75.54 105.841 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.68 124.01 48.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.008 -2.219 . . . . 72.45 105.008 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.84 120.94 43.02 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 104.894 -2.262 . . . . 73.02 104.894 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.32 29.72 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 107.923 -1.14 . . . . 74.33 107.923 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -92.06 31.49 1.26 Allowed 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.88 -1.526 . . . . 75.25 106.88 175.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.54 -26.45 62.65 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.017 -1.846 . . . . 73.43 106.017 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.47 -83.1 0.1 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.359 -1.349 . . . . 74.32 107.359 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -156.21 -168.65 2.8 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.765 -2.309 . . . . 73.24 104.765 -168.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -47.67 152.99 0.63 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.132 -0.692 . . . . 63.44 109.132 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.65 -56.69 18.3 Favored 'General case' 0 C--N 1.374 1.642 0 N-CA-C 108.381 -0.97 . . . . 74.31 108.381 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.67 47.63 7.16 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.458 -1.857 . . . . 63.22 108.458 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 mt -127.99 153.43 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 104.131 -2.544 . . . . 73.34 104.131 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.4 m -144.97 160.38 41.43 Favored 'General case' 0 CA--C 1.479 -1.75 0 N-CA-C 102.918 -2.993 . . . . 55.44 102.918 169.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.56 167.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 106.736 -1.579 . . . . 72.21 106.736 -162.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -149.57 166.62 28.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 103.619 -2.734 . . . . 71.44 103.619 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.83 -177.39 17.1 Favored Glycine 0 CA--C 1.486 -1.733 0 N-CA-C 107.417 -2.273 . . . . 60.32 107.417 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.53 -133.65 6.94 Favored Glycine 0 C--N 1.364 2.086 0 N-CA-C 110.014 -1.234 . . . . 54.43 110.014 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.04 19.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.823 2.449 . . . . 75.15 114.812 -167.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.0 t30 86.23 65.24 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.667 -1.605 . . . . 73.24 106.667 -169.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.1 t -96.34 -164.82 1.19 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.571 -2.751 . . . . 64.04 103.571 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -27.88 -49.46 0.06 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.027 1.731 . . . . 54.45 113.12 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.3 129.95 38.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.132 -1.062 . . . . 75.53 108.132 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.18 -27.11 59.52 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 107.655 -1.239 . . . . 74.03 107.655 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 35' ' ' GLY . 46.3 t60 -63.34 -17.75 62.91 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 108.466 -0.939 . . . . 75.32 108.466 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.15 -5.65 2.64 Favored Glycine 0 C--N 1.372 2.539 0 N-CA-C 111.34 -0.704 . . . . 72.25 111.34 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 33' ' ' HIS . . . -68.46 153.51 52.94 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 108.978 -1.649 . . . . 42.34 108.978 -172.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -83.13 97.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 105.918 -1.882 . . . . 63.03 105.918 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.32 146.09 25.48 Favored 'General case' 0 CA--C 1.477 -1.865 0 N-CA-C 107.46 -1.311 . . . . 73.02 107.46 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.52 130.83 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.851 -1.907 . . . . 73.13 105.851 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -108.09 -36.82 6.22 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.146 -1.427 . . . . 70.43 107.146 -167.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.23 151.48 33.08 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 106.897 -1.519 . . . . 73.11 106.897 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.46 128.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 104.743 -2.317 . . . . 72.11 104.743 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 mt -69.27 136.01 88.97 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 107.471 -1.307 . . . . 74.54 107.471 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.12 111.16 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.757 2.305 . . . . 74.14 108.725 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 74.7 21.3 2.19 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 124.552 1.157 . . . . 74.35 110.602 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.61 179.26 40.94 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 107.049 -2.42 . . . . 61.41 107.049 165.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.8 98.84 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.871 -0.788 . . . . 74.04 108.871 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -47.64 73.61 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.195 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.56 -37.95 89.27 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 109.232 -0.655 . . . . 64.51 109.232 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -64.28 -37.43 87.46 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 107.999 -1.111 . . . . 70.01 107.999 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.26 -46.38 70.59 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 107.648 -1.241 . . . . 72.11 107.648 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.5 -13.27 47.63 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.394 -0.682 . . . . 63.11 111.394 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -73.91 -41.71 61.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.636 1.218 . . . . 72.33 108.39 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.78 135.48 33.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 106.982 -1.488 . . . . 75.51 106.982 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.52 -178.56 5.17 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 105.582 -2.007 . . . . 64.02 105.582 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 141.24 57.74 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.873 -1.899 . . . . 73.14 105.873 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.26 -13.29 48.27 Favored Glycine 0 CA--C 1.477 -2.296 0 N-CA-C 107.91 -2.076 . . . . 71.25 107.91 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -82.87 150.25 26.64 Favored 'General case' 0 CA--C 1.485 -1.538 0 N-CA-C 106.184 -1.784 . . . . 74.23 106.184 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.542 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.7 tmm_? -115.91 123.08 47.2 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 106.265 -1.754 . . . . 73.41 106.265 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -94.12 140.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.248 -2.13 . . . . 72.15 105.248 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 -43.95 3.06 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 106.96 -1.496 . . . . 72.23 106.96 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.51 165.37 22.83 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 122.536 1.16 . . . . 75.22 110.029 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.56 102.37 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 103.376 -2.824 . . . . 74.13 103.376 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 t30 51.89 42.28 30.03 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.373 1.069 . . . . 73.3 110.275 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.98 14.31 79.66 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.27 -1.132 . . . . 74.1 110.27 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.16 117.25 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 103.835 -2.654 . . . . 73.5 103.835 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -70.4 115.93 10.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.189 -1.041 . . . . 72.23 108.189 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.6 13.97 7.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.827 -1.175 . . . . 73.35 107.827 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.72 137.7 54.31 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.704 -1.221 . . . . 61.4 107.704 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.26 -16.93 14.6 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.012 -1.235 . . . . 55.02 110.012 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.54 154.44 41.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.095 -1.076 . . . . 75.21 108.095 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.75 163.13 19.33 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.589 -1.263 . . . . 74.43 107.589 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -63.07 -38.87 92.92 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 116.167 -0.47 . . . . 72.51 110.951 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.32 -35.21 79.62 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 120.384 -0.526 . . . . 63.34 109.929 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.15 -31.07 69.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 121.145 -0.972 . . . . 64.34 108.99 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.19 79.88 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.975 -1.12 . . . . 75.41 107.975 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.22 -55.02 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.625 -1.25 . . . . 73.21 107.625 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.3 m -56.2 -27.73 55.74 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 108.829 -0.804 . . . . 62.41 108.829 -171.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -61.79 -55.86 25.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 106.975 -1.491 . . . . 61.11 106.975 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.57 -55.68 30.79 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 109.027 -0.731 . . . . 74.14 109.027 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -46.77 -34.02 4.88 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.625 -0.672 . . . . 74.31 112.52 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -98.56 4.2 48.11 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.255 -0.903 . . . . 74.11 110.413 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 p -80.76 173.63 12.42 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.645 -1.284 . . . . 72.13 108.685 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.2 -136.08 7.22 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.297 -0.721 . . . . 64.11 111.297 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -82.99 -49.09 9.94 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.32 -0.993 . . . . 72.44 108.32 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.0 132.98 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 N-CA-C 104.11 -2.552 . . . . 74.45 104.11 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -116.83 134.23 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 105.056 -2.202 . . . . 61.45 105.056 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.92 120.2 35.78 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.546 -2.02 . . . . 72.32 105.546 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.67 137.23 52.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.074 -1.825 . . . . 73.14 106.074 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.88 125.69 53.9 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.454 -2.424 . . . . 73.34 104.454 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.25 155.44 46.28 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 108.449 -0.945 . . . . 75.32 108.449 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.542 ' CD ' HH21 ' A' ' 58' ' ' ARG . 35.6 tt0 -115.35 126.95 55.06 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 102.404 -3.184 . . . . 60.32 102.404 174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -56.75 139.17 51.64 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.175 -1.046 . . . . 70.42 108.175 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.95 152.52 44.09 Favored Glycine 0 CA--C 1.476 -2.357 0 N-CA-C 106.602 -2.599 . . . . 61.23 106.602 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -105.29 -171.9 2.0 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 104.773 -2.306 . . . . 71.5 104.773 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 p -82.45 153.22 68.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 105.501 -2.037 . . . . 74.4 105.501 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.13 152.9 62.56 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 107.792 -1.657 . . . . 73.14 107.792 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 101.503 -3.517 . . . . 75.34 101.503 172.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.407 ' H15' H20A ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.736 0 N-CA-C 108.564 -1.814 . . . . 65.04 108.564 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.38 155.35 67.45 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.812 2.341 . . . . 73.52 107.972 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -89.09 161.73 39.81 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 105.161 -2.163 . . . . 75.3 105.161 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.58 132.92 48.48 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.686 1.591 . . . . 75.53 108.858 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.32 -19.44 42.76 Favored Glycine 0 CA--C 1.482 -2.007 0 N-CA-C 108.87 -1.692 . . . . 62.43 108.87 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.01 136.13 53.38 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.046 -1.094 . . . . 64.31 108.046 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.27 131.88 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 103.878 -2.638 . . . . 74.41 103.878 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.68 143.77 51.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.843 -1.91 . . . . 74.54 105.843 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.5 130.76 50.94 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.883 -1.895 . . . . 63.23 105.883 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.98 129.8 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.13 0 N-CA-C 105.024 -2.213 . . . . 75.43 105.024 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -103.44 110.75 22.88 Favored 'General case' 0 CA--C 1.471 -2.059 0 N-CA-C 105.745 -1.946 . . . . 72.04 105.745 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.683 -1.599 . . . . 70.3 106.683 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.36 147.84 25.85 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.964 -1.495 . . . . 74.55 106.964 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.43 31.05 1.58 Allowed 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.596 -2.002 . . . . 75.21 105.596 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.76 -51.08 7.05 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.496 -1.298 . . . . 72.14 107.496 -167.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.53 -56.37 22.85 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.738 -0.838 . . . . 75.12 108.738 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -154.14 164.85 37.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.642 -2.725 . . . . 74.43 103.642 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.1 m -46.23 150.79 0.57 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.726 0.81 . . . . 63.43 110.296 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -58.14 -57.33 13.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.505 -0.77 . . . . 73.23 111.78 -164.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 61.38 52.77 49.3 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.205 -0.758 . . . . 61.23 111.205 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.2 161.38 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 103.839 -2.652 . . . . 72.14 103.839 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.68 162.72 41.01 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.396 -2.816 . . . . 75.33 103.396 163.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.43 167.86 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 105.389 -2.078 . . . . 74.54 105.389 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -146.77 166.33 26.97 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.958 -2.608 . . . . 74.5 103.958 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 83.92 138.6 3.74 Favored Glycine 0 C--O 1.191 -2.543 0 N-CA-C 111.472 -0.651 . . . . 73.15 111.472 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.31 -89.08 0.07 OUTLIER Glycine 0 C--N 1.362 2.002 0 N-CA-C 109.228 -1.549 . . . . 54.32 109.228 167.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.21 20.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 117.279 2.326 . . . . 64.3 117.279 -165.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 88.32 65.08 0.01 OUTLIER 'General case' 0 CA--C 1.466 -2.27 0 N-CA-C 105.332 -2.099 . . . . 74.41 105.332 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 t -85.7 -166.66 1.59 Allowed 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 110.972 -2.831 . . . . 73.4 106.115 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 m -60.93 -31.0 70.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.473 1.109 . . . . 73.52 110.552 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 m -87.33 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 107.849 -1.167 . . . . 72.41 107.849 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -67.11 -37.31 83.67 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.398 0.679 . . . . 70.32 110.111 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -69.47 -9.02 51.91 Favored 'General case' 0 C--O 1.211 -0.938 0 O-C-N 121.393 -0.817 . . . . 64.32 109.742 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.82 13.77 57.17 Favored Glycine 0 C--N 1.37 2.438 0 N-CA-C 108.589 -1.804 . . . . 72.45 108.589 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 144.99 47.57 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 109.609 -1.396 . . . . 64.51 109.609 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 25' ' ' GLY . 1.7 mm -85.83 104.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 102.454 -3.165 . . . . 71.04 102.454 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -101.29 147.51 26.21 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 107.501 -1.296 . . . . 73.0 107.501 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.25 132.62 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 106.77 -1.567 . . . . 74.22 106.77 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -109.07 -48.11 3.32 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.501 -0.926 . . . . 62.4 108.501 -167.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.61 146.04 34.13 Favored 'General case' 0 CA--C 1.463 -2.388 0 N-CA-C 105.806 -1.924 . . . . 55.32 105.806 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.9 t -130.59 130.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 103.981 -2.6 . . . . 74.24 103.981 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG12 ' CA ' ' A' ' 20' ' ' GLY . 34.0 mm -67.59 141.13 95.05 Favored Pre-proline 0 C--N 1.353 0.718 0 N-CA-C 106.093 -1.817 . . . . 75.35 106.093 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.52 109.12 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.153 1.902 . . . . 73.44 107.896 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 70.15 30.28 3.53 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.446 1.091 . . . . 73.41 110.929 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.45 -179.0 33.83 Favored Glycine 0 C--N 1.369 2.385 0 N-CA-C 107.279 -2.328 . . . . 65.21 107.279 162.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.89 -35.34 80.33 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 122.102 -0.646 . . . . 52.23 109.48 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.85 82.32 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.273 -0.64 . . . . 71.1 109.273 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.58 -34.71 77.59 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.617 -0.512 . . . . 73.23 109.617 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -70.05 -42.32 73.03 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.74 -0.837 . . . . 62.12 108.74 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -67.71 -37.07 81.76 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.691 -1.226 . . . . 74.44 107.691 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.64 -14.28 47.95 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 111.32 -0.712 . . . . 63.14 111.32 170.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -80.88 -35.06 33.12 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.741 -0.858 . . . . 73.0 108.968 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.2 mt -95.24 133.04 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.136 -1.801 . . . . 70.21 106.136 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -135.41 175.27 9.74 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.275 -1.75 . . . . 73.34 106.275 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -65.85 132.58 49.02 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.407 -0.96 . . . . 75.44 108.407 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.81 -12.07 62.6 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.078 -1.609 . . . . 52.53 109.078 170.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -65.87 150.92 47.81 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 106.767 -1.568 . . . . 64.33 106.767 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.9 tmm_? -109.32 127.48 54.34 Favored 'General case' 0 C--O 1.197 -1.672 0 N-CA-C 106.265 -1.754 . . . . 71.54 106.265 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.48 138.66 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 106.17 -1.789 . . . . 74.34 106.17 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -52.21 2.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.553 -1.277 . . . . 72.35 107.553 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.3 165.52 23.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-O 122.157 0.98 . . . . 65.1 110.354 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.28 108.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 104.228 -2.508 . . . . 73.43 104.228 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.7 t30 54.94 38.18 30.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.333 0.653 . . . . 74.54 109.851 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.63 79.3 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 109.528 -1.429 . . . . 63.21 109.528 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.87 119.82 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 104.776 -2.305 . . . . 75.21 104.776 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.2 m -71.91 113.23 8.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.167 -1.049 . . . . 61.52 108.167 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.03 -28.8 62.56 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 107.589 -1.263 . . . . 74.33 107.589 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -52.3 145.04 11.66 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 122.806 0.442 . . . . 73.43 110.53 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.49 -36.45 3.58 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 110.062 -1.215 . . . . 54.31 110.062 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.52 173.82 5.58 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.191 0.996 . . . . 74.02 110.006 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 p -81.01 160.56 24.54 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 107.966 -1.124 . . . . 71.2 107.966 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -64.29 -38.6 91.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.7 -0.852 . . . . 75.41 108.7 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -60.88 -41.86 96.79 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 120.449 -0.5 . . . . 73.24 109.661 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -63.64 -38.88 92.79 Favored 'General case' 0 C--N 1.369 1.421 0 N-CA-C 108.523 -0.917 . . . . 74.53 108.523 -172.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.91 70.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 109.958 -0.386 . . . . 74.34 109.958 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -74.17 -53.87 16.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.528 -1.286 . . . . 65.01 107.528 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.09 -28.31 38.36 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.263 -1.014 . . . . 52.43 108.263 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -67.7 -53.75 25.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.986 -1.116 . . . . 74.31 107.986 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -58.0 -56.83 16.95 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.158 -0.682 . . . . 62.41 109.158 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -51.63 -16.29 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.49 0.922 . . . . 74.43 113.49 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -99.53 -2.86 34.75 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.994 -1.066 . . . . 74.02 108.555 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -78.57 166.54 22.43 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.374 -0.829 . . . . 75.24 109.435 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.4 -140.9 6.08 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 109.364 -1.494 . . . . 51.01 109.364 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -84.03 -48.74 9.6 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.125 -1.065 . . . . 71.15 108.125 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.81 135.63 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.968 -2.605 . . . . 73.41 103.968 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -123.51 142.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 104.7 -2.333 . . . . 73.43 104.7 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -96.25 115.63 27.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.354 -2.462 . . . . 70.23 104.354 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.1 mt -117.4 143.35 46.08 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 106.073 -1.825 . . . . 75.34 106.073 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.51 131.29 56.74 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 103.982 -2.599 . . . . 74.31 103.982 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.99 155.32 48.2 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.987 -1.857 . . . . 74.23 105.987 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 58' ' ' ARG . 39.0 tt0 -121.36 132.76 54.95 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 105.019 -2.215 . . . . 75.3 105.019 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -69.86 152.35 44.63 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 122.63 1.205 . . . . 53.13 111.798 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.17 53.42 0.06 OUTLIER Glycine 0 CA--C 1.459 -3.412 0 N-CA-C 103.93 -3.668 . . . . 65.22 103.93 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -82.97 145.28 29.44 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 107.385 -1.339 . . . . 72.13 107.385 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 m -62.61 159.62 41.49 Favored Pre-proline 0 N--CA 1.436 -1.163 0 C-N-CA 123.211 0.604 . . . . 62.01 109.592 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.06 167.85 20.64 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.611 2.207 . . . . 75.42 107.738 171.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.41 -2.432 0 N-CA-C 103.173 -2.899 . . . . 74.2 103.173 177.14 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.134 0 N-CA-C 107.915 -2.074 . . . . 72.55 107.915 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.68 137.26 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.536 2.158 . . . . 72.45 108.277 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -86.02 160.98 51.15 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 105.551 -2.018 . . . . 73.31 105.551 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.43 138.17 69.38 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.866 1.71 . . . . 75.13 109.388 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.88 12.94 73.29 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.038 -1.625 . . . . 73.24 109.038 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -98.01 145.55 26.4 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.822 -2.288 . . . . 61.22 104.822 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.72 129.04 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.499 -2.408 . . . . 74.33 104.499 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -129.43 141.14 51.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.064 -1.828 . . . . 65.21 106.064 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -102.58 134.32 46.13 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 105.926 -1.879 . . . . 73.51 105.926 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -130.44 130.65 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.116 0 N-CA-C 105.461 -2.051 . . . . 74.51 105.461 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 9.0 pt-20 -106.25 125.92 51.59 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.666 -2.346 . . . . 72.24 104.666 169.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.32 122.73 47.98 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.544 -1.651 . . . . 73.14 106.544 -167.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.88 137.17 35.33 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.476 -1.305 . . . . 74.55 107.476 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.2 35.07 0.86 Allowed 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.652 -1.61 . . . . 74.12 106.652 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -60.35 -44.65 95.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.9 -1.519 . . . . 74.33 106.9 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -81.83 146.13 30.04 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 105.118 -2.179 . . . . 73.5 105.118 169.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.12 -35.69 59.16 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.934 -0.395 . . . . 65.44 109.934 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.2 m -72.38 121.0 18.77 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.204 -1.036 . . . . 71.3 108.204 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -72.86 -57.58 3.97 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 104.913 -2.254 . . . . 75.44 104.913 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 53.77 47.8 63.78 Favored Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 113.408 -1.723 . . . . 72.33 111.524 172.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.45 156.17 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.79 -3.041 . . . . 74.34 102.79 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.2 m -145.57 160.88 40.99 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 102.575 -3.12 . . . . 71.41 102.575 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.63 165.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 105.738 -1.949 . . . . 74.15 105.738 -167.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -144.41 166.16 25.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 103.045 -2.946 . . . . 75.31 103.045 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.08 -178.43 17.53 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 107.694 -2.162 . . . . 73.21 107.694 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.45 -133.19 7.4 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.172 -1.571 . . . . 70.23 109.172 172.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.21 19.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.87 2.068 . . . . 74.54 113.588 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 87.82 65.58 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.429 -1.323 . . . . 65.53 107.429 -169.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.8 t -89.37 -165.81 1.44 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.304 -2.48 . . . . 63.42 104.304 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -46.14 -31.06 2.18 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.788 0.835 . . . . 71.34 112.89 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 m -84.96 133.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -56.65 -57.06 14.03 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 115.945 -0.57 . . . . 74.41 111.064 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -74.75 -0.39 18.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.491 -0.559 . . . . 73.32 109.491 -169.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.73 14.32 43.31 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 110.148 -1.181 . . . . 64.15 110.148 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.35 154.38 52.91 Favored Glycine 0 CA--C 1.473 -2.552 0 N-CA-C 107.581 -2.208 . . . . 52.11 107.581 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 86.68 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 105.672 -1.973 . . . . 75.22 105.672 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -84.56 142.18 30.17 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 106.992 -1.484 . . . . 75.24 106.992 -174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.84 128.5 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.262 -1.755 . . . . 70.13 106.262 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -102.51 -42.21 6.03 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.91 -1.144 . . . . 73.55 107.91 -166.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.38 153.2 34.28 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 106.53 -1.656 . . . . 75.21 106.53 -173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.92 131.72 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 104.116 -2.55 . . . . 74.21 104.116 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.457 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.9 mm -75.43 143.04 75.45 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 104.288 -2.486 . . . . 71.24 104.288 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.75 115.01 2.24 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 107.714 -1.687 . . . . 64.14 107.714 166.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 77.16 18.28 1.47 Allowed 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 124.857 1.348 . . . . 73.31 111.01 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.11 172.68 40.41 Favored Glycine 0 C--N 1.367 2.282 0 N-CA-C 106.447 -2.661 . . . . 45.41 106.447 164.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.4 80.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.811 -0.817 . . . . 61.43 109.165 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.58 91.98 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.078 -0.712 . . . . 75.42 109.078 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -69.58 -36.32 76.16 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.76 -0.829 . . . . 71.0 108.76 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.6 m -70.27 -35.37 73.7 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.392 -0.966 . . . . 73.33 108.392 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.439 -1.319 . . . . 75.13 107.439 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.6 49.92 Favored Glycine 0 C--O 1.214 -1.151 0 N-CA-C 110.771 -0.932 . . . . 75.34 110.771 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -73.09 -39.1 66.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.419 -1.048 . . . . 65.12 109.144 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.45 131.76 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 107.225 -1.398 . . . . 61.23 107.225 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -141.49 -179.67 6.29 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.646 -1.983 . . . . 73.35 105.646 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -66.61 143.81 56.79 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.162 -1.792 . . . . 74.01 106.162 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.51 50.52 Favored Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 108.085 -2.006 . . . . 64.42 108.085 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.83 161.06 17.74 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.309 -2.108 . . . . 61.53 105.309 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.6 ptt-85 -132.34 146.68 52.15 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.8 -1.556 . . . . 74.42 106.8 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.1 145.3 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.579 -2.378 . . . . 73.25 104.579 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 -47.43 2.63 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.735 -1.58 . . . . 74.12 106.735 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.54 166.8 19.81 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.52 1.152 . . . . 74.32 109.779 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -137.71 103.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 103.743 -2.688 . . . . 75.34 103.743 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.5 t30 56.44 36.96 28.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.315 0.579 . . . . 64.52 110.314 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.21 10.43 84.78 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 109.389 -1.484 . . . . 54.22 109.389 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.82 119.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 N-CA-C 104.311 -2.478 . . . . 72.41 104.311 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -69.69 106.41 3.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.665 -1.235 . . . . 54.34 107.665 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -18.07 36.92 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.109 -1.071 . . . . 73.14 108.109 -175.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.64 146.13 46.59 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.811 -0.811 . . . . 72.14 108.811 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.16 -35.03 4.26 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.452 -1.459 . . . . 74.44 109.452 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.66 156.28 39.68 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.286 -1.005 . . . . 62.0 108.286 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.5 p -75.67 166.14 24.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.827 -0.805 . . . . 73.33 108.827 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -65.8 -40.14 91.6 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.237 -1.023 . . . . 75.32 108.237 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -54.38 -48.16 71.86 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 110.256 -0.275 . . . . 71.41 110.256 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -34.6 78.13 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 108.95 -0.759 . . . . 75.4 108.95 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.92 85.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.23 -0.655 . . . . 71.04 109.23 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.46 -54.79 16.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.641 -1.244 . . . . 74.33 107.641 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.4 m -56.2 -26.84 52.41 Favored 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 108.101 -1.074 . . . . 75.54 108.101 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -64.87 -54.63 27.97 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 107.018 -1.475 . . . . 73.42 107.018 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.4 -55.5 30.94 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.525 -0.917 . . . . 75.34 108.525 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.8 mtp85 -45.83 -47.14 15.87 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.041 0.386 . . . . 75.31 112.041 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -87.89 1.09 54.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.121 0.873 . . . . 74.54 111.19 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.0 p -79.93 174.32 11.71 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.941 1.246 . . . . 74.42 108.374 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.8 -156.83 30.84 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 109.739 -1.344 . . . . 71.3 109.739 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.65 -44.48 27.97 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.72 -1.215 . . . . 72.23 107.72 -172.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.8 127.69 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.75 0 N-CA-C 103.879 -2.637 . . . . 73.13 103.879 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.54 143.63 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.888 0 N-CA-C 104.942 -2.244 . . . . 74.02 104.942 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.426 ' HE1' ' OE1' ' A' ' 11' ' ' GLU . 68.6 m-70 -99.44 117.99 35.07 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 105.138 -2.171 . . . . 63.55 105.138 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.9 mt -114.88 139.32 49.88 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 105.055 -2.202 . . . . 72.01 105.055 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.85 123.94 49.41 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 104.336 -2.468 . . . . 62.41 104.336 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.46 159.3 38.47 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.194 -1.41 . . . . 75.21 107.194 -171.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -123.34 134.83 53.99 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 104.042 -2.577 . . . . 74.03 104.042 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 142.62 51.25 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.446 -0.946 . . . . 75.4 108.446 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.25 178.34 34.28 Favored Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.851 -3.3 . . . . 61.21 104.851 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -67.49 146.89 53.52 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.895 -1.52 . . . . 72.41 106.895 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 m -55.53 140.72 65.38 Favored Pre-proline 0 C--N 1.347 0.461 0 CA-C-O 121.447 0.641 . . . . 63.15 109.929 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 128.21 19.05 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.89 2.394 . . . . 73.03 109.321 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.414 -2.241 0 N-CA-C 104.466 -2.42 . . . . 73.25 104.466 175.691 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.033 0 N-CA-C 107.424 -2.271 . . . . 63.32 107.424 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.29 110.91 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.929 2.419 . . . . 65.25 109.445 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' HZ3' ' CG ' ' A' ' 6' ' ' ASP . 9.2 mtmp? -77.96 165.01 53.83 Favored Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 105.38 -2.081 . . . . 75.35 105.38 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.52 116.82 3.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.009 1.806 . . . . 72.42 108.809 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 98.61 12.93 42.66 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 109.529 -1.428 . . . . 32.44 109.529 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.457 ' CG ' ' HZ3' ' A' ' 3' ' ' LYS . 74.6 m-20 -97.95 143.12 28.87 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.251 -1.759 . . . . 72.02 106.251 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.61 141.24 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 105.224 -2.139 . . . . 72.01 105.224 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.75 159.5 36.88 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.385 -2.079 . . . . 74.1 105.385 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -102.81 148.24 25.87 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.244 -2.132 . . . . 75.33 105.244 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.25 131.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 N-CA-C 104.321 -2.474 . . . . 71.25 104.321 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.03 133.43 54.2 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.382 -1.71 . . . . 75.12 106.382 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.66 128.89 51.2 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.657 -1.979 . . . . 73.43 105.657 -173.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.24 141.87 28.09 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.189 -1.041 . . . . 72.4 108.189 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -84.64 33.6 0.52 Allowed 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.022 -1.473 . . . . 75.03 107.022 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -62.13 -41.43 98.24 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 106.95 -1.5 . . . . 70.54 106.95 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.86 160.65 30.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.427 -1.323 . . . . 73.14 107.427 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -74.33 -52.58 11.81 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.16 -1.422 . . . . 74.34 107.16 -172.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.8 m -85.71 136.23 33.43 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.303 -1.369 . . . . 75.31 107.303 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.45 -58.53 3.31 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.471 -2.418 . . . . 73.22 104.471 167.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.55 48.94 83.71 Favored Glycine 0 CA--C 1.485 -1.82 0 CA-C-N 114.342 -1.299 . . . . 71.32 110.438 171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mt -124.17 152.65 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 103.687 -2.709 . . . . 71.24 103.687 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.6 m -150.54 161.85 41.77 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 103.372 -2.825 . . . . 74.23 103.372 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.96 167.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 105.094 -2.188 . . . . 71.24 105.094 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -143.62 166.15 25.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 102.919 -2.993 . . . . 74.02 102.919 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.04 -173.37 16.18 Favored Glycine 0 CA--C 1.473 -2.562 0 N-CA-C 107.584 -2.206 . . . . 51.23 107.584 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 -123.69 5.53 Favored Glycine 0 CA--C 1.485 -1.789 0 N-CA-C 108.427 -1.869 . . . . 60.54 108.427 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.75 20.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 126.003 1.721 . . . . 73.3 113.659 -169.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 87.32 66.21 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.657 1.218 . . . . 75.35 107.876 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -84.27 -166.51 1.46 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.591 -2.744 . . . . 73.11 103.591 171.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -53.56 -22.04 7.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.762 0.652 . . . . 73.43 112.762 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.85 128.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 107.295 -1.372 . . . . 75.54 107.295 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -61.62 -46.16 91.0 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 122.952 0.501 . . . . 75.33 109.904 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -73.64 -5.33 39.76 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.766 -0.828 . . . . 73.03 108.766 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.02 10.25 19.04 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 110.998 -0.841 . . . . 73.32 110.998 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.9 151.74 51.14 Favored Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 108.477 -1.849 . . . . 43.23 108.477 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.69 89.66 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 N-CA-C 105.737 -1.949 . . . . 74.53 105.737 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -87.42 144.26 26.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.774 -1.565 . . . . 73.11 106.774 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.62 132.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.112 -1.81 . . . . 71.13 106.112 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.06 -45.08 4.62 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.382 -1.34 . . . . 73.43 107.382 -166.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 155.45 38.72 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 106.502 -1.666 . . . . 72.51 106.502 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.29 139.16 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 105.529 -2.026 . . . . 74.04 105.529 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mt -72.95 144.55 85.43 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.337 -1.357 . . . . 73.23 107.337 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.57 108.49 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.639 2.226 . . . . 60.2 108.879 168.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 75.15 27.63 1.1 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.745 1.218 . . . . 73.42 110.318 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.04 173.62 55.09 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 106.556 -2.618 . . . . 65.55 106.556 162.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.35 79.15 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.323 0.649 . . . . 62.02 110.298 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.17 -49.52 64.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.618 -0.512 . . . . 74.24 109.618 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.2 -42.0 99.25 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.615 -0.513 . . . . 63.33 109.615 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.5 m -59.96 -42.14 93.45 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-O 121.355 0.598 . . . . 72.21 109.624 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -77.71 -35.48 52.05 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.813 -1.18 . . . . 73.1 107.813 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 81.23 -4.63 70.85 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 111.306 -0.718 . . . . 73.14 111.306 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.17 -44.3 63.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.658 -0.907 . . . . 74.53 109.131 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 mt -109.98 136.54 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 105.826 -1.916 . . . . 73.41 105.826 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.418 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 53.5 m80 -122.96 170.03 10.55 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.98 -1.859 . . . . 75.43 105.98 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 146.49 53.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.338 -1.356 . . . . 75.3 107.338 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.72 -8.2 78.71 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 109.804 -1.318 . . . . 50.21 109.804 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -86.0 163.38 18.0 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.104 -1.813 . . . . 71.13 106.104 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -115.39 129.88 56.72 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.7 0.762 . . . . 73.41 109.148 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.94 148.82 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 104.942 -2.244 . . . . 73.34 104.942 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -44.43 2.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.742 -1.207 . . . . 73.03 107.742 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.23 164.35 24.73 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.017 -1.073 . . . . 73.41 109.905 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.5 t -140.76 107.51 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.917 -2.253 . . . . 75.15 104.917 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.8 t30 45.71 43.48 9.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.417 1.487 . . . . 72.23 111.073 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.97 76.87 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 109.614 -1.395 . . . . 72.43 109.614 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.87 117.53 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 103.815 -2.661 . . . . 75.54 103.815 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.0 m -69.62 110.44 4.84 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.501 -1.296 . . . . 70.34 107.501 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.61 -6.48 57.49 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.9 -1.148 . . . . 71.24 107.9 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.96 143.64 57.27 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.556 -1.276 . . . . 72.14 107.556 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.36 -39.12 3.13 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.116 -1.193 . . . . 34.44 110.116 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 163.98 24.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 108.951 -0.759 . . . . 62.14 108.951 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -84.58 168.65 15.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.799 0.809 . . . . 72.42 109.36 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -62.03 -40.46 95.79 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 115.404 -0.816 . . . . 71.1 109.27 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -60.78 -40.58 93.11 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.892 -0.505 . . . . 74.11 110.54 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.21 -39.2 93.95 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.5 1.045 . . . . 71.25 109.378 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.89 79.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.427 -0.583 . . . . 73.14 109.427 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -71.24 -54.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 107.423 -1.325 . . . . 74.11 107.423 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.7 t -53.35 -28.94 31.51 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.55 1.167 . . . . 73.01 108.521 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 m -70.59 -56.36 6.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.507 -1.294 . . . . 75.14 107.507 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -57.15 -54.72 43.61 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 107.937 -1.134 . . . . 73.13 107.937 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -44.49 -43.99 8.28 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.542 1.137 . . . . 75.31 111.9 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.15 9.02 43.91 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.713 1.142 . . . . 75.2 111.201 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.4 p -80.72 174.45 11.6 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.861 -1.149 . . . . 72.14 107.925 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.28 -148.53 16.38 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.599 -1.4 . . . . 73.4 109.599 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -80.6 -47.81 13.6 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 108.173 -1.047 . . . . 74.14 108.173 -169.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.12 132.69 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 N-CA-C 103.817 -2.66 . . . . 74.34 103.817 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.55 151.0 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 104.479 -2.415 . . . . 71.14 104.479 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -103.36 124.26 48.36 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 104.933 -2.247 . . . . 73.32 104.933 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.02 137.79 49.55 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.191 -2.522 . . . . 75.42 104.191 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -106.97 126.27 52.1 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 105.815 -1.92 . . . . 72.34 105.815 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 152.52 51.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.423 -2.065 . . . . 73.43 105.423 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -123.71 140.86 52.57 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 102.608 -3.108 . . . . 72.2 102.608 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 24.7 mmtp -61.73 139.63 58.3 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.809 0.814 . . . . 72.22 109.527 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.04 49.75 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 106.138 -2.785 . . . . 71.32 106.138 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -73.6 143.08 46.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 105.007 -2.22 . . . . 75.1 105.007 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -66.71 145.42 98.93 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 107.079 -1.452 . . . . 73.43 107.079 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.63 168.01 19.45 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.342 2.028 . . . . 72.55 107.025 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.415 -2.176 0 N-CA-C 105.862 -1.903 . . . . 73.32 105.862 -174.798 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.652 0 N-CA-C 108.019 -2.032 . . . . 73.2 108.019 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 113.73 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.977 2.451 . . . . 45.2 109.055 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -81.14 165.65 43.55 Favored Pre-proline 0 N--CA 1.441 -0.877 0 N-CA-C 106.21 -1.774 . . . . 70.03 106.21 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.36 124.62 16.58 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.152 1.902 . . . . 64.33 108.253 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.42 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 89.95 12.14 62.45 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.435 -1.066 . . . . 61.2 110.435 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.22 141.56 28.46 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.682 -2.34 . . . . 74.42 104.682 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.07 136.02 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 104.827 -2.286 . . . . 74.53 104.827 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.6 152.29 41.21 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.944 -1.873 . . . . 73.15 105.944 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.439 ' HG2' HD11 ' A' ' 89' ' ' LEU . 46.9 mt-10 -105.31 143.53 33.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.669 -1.974 . . . . 72.44 105.669 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.95 130.74 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.0 0 N-CA-C 104.952 -2.24 . . . . 74.54 104.952 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.49 113.14 26.24 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 103.866 -2.642 . . . . 73.34 103.866 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -103.58 122.21 44.5 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.885 -1.894 . . . . 75.22 105.885 -169.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.75 150.3 39.34 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.036 -1.839 . . . . 71.45 106.036 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -120.89 -72.71 0.68 Allowed 'General case' 0 CA--C 1.456 -2.659 0 N-CA-C 103.119 -2.919 . . . . 74.3 103.119 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 46.9 t30 170.73 -171.57 0.03 OUTLIER 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 97.719 -4.919 . . . . 73.22 97.719 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -79.55 99.93 7.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.287 -1.745 . . . . 55.41 106.287 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -167.31 -110.57 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.826 -2.286 . . . . 63.53 104.826 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.8 m -135.99 152.81 51.32 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 104.274 -2.491 . . . . 62.24 104.274 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.9 mt -73.09 -43.63 61.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.62 -0.881 . . . . 75.31 108.62 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.0 41.62 8.01 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 107.49 -2.244 . . . . 44.42 107.49 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 22.2 mt -138.54 156.93 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 102.744 -3.058 . . . . 70.01 102.744 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.5 m -153.11 168.64 25.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.527 -2.768 . . . . 73.42 103.527 169.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -140.6 167.99 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 106.497 -1.668 . . . . 74.21 106.497 -167.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 t -143.58 167.0 23.27 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 103.68 -2.711 . . . . 73.4 103.68 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 88.31 134.45 4.73 Favored Glycine 0 C--O 1.201 -1.969 0 N-CA-C 108.83 -1.708 . . . . 73.01 108.83 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.3 -98.89 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 108.986 -1.646 . . . . 43.11 108.986 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.04 20.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 126.617 1.967 . . . . 74.3 115.833 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.9 t30 87.2 65.19 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.181 -1.414 . . . . 75.22 107.181 -172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 t -92.29 -166.09 1.48 Allowed 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.705 -2.331 . . . . 75.35 104.705 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -52.29 -21.8 3.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.5 1.12 . . . . 73.15 112.391 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.52 130.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 107.61 -1.256 . . . . 73.15 107.61 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -68.73 -36.31 78.25 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 116.017 -0.538 . . . . 75.34 111.532 -168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -79.06 -4.36 49.81 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.966 -1.084 . . . . 75.54 108.909 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.68 62.98 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 108.355 -1.898 . . . . 74.02 108.355 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.41 134.78 39.05 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 109.095 -1.602 . . . . 70.32 109.095 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 25' ' ' GLY . 2.3 mm -78.08 103.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 103.516 -2.772 . . . . 74.55 103.516 173.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.39 147.83 24.3 Favored 'General case' 0 CA--C 1.468 -2.205 0 N-CA-C 106.58 -1.637 . . . . 71.33 106.58 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.66 133.98 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 106.657 -1.608 . . . . 73.42 106.657 168.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.03 -49.34 2.98 Favored 'General case' 0 CA--C 1.472 -2.038 0 N-CA-C 107.195 -1.409 . . . . 73.1 107.195 -169.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.09 130.81 41.73 Favored 'General case' 0 CA--C 1.456 -2.637 0 N-CA-C 105.868 -1.901 . . . . 74.25 105.868 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG11 ' HB1' ' A' ' 47' ' ' ALA . 95.3 t -120.37 117.43 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 103.576 -2.75 . . . . 62.12 103.576 172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.59 136.23 96.68 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 106.712 -1.588 . . . . 72.04 106.712 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.67 111.4 1.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.495 2.13 . . . . 75.32 107.665 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 75.73 20.68 1.78 Allowed 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.259 0.974 . . . . 73.42 110.541 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.52 -176.88 45.74 Favored Glycine 0 C--N 1.358 1.796 0 N-CA-C 107.024 -2.43 . . . . 71.12 107.024 168.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.72 -19.84 61.99 Favored 'General case' 0 C--O 1.219 -0.53 0 O-C-N 122.359 -0.495 . . . . 75.3 110.744 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HB1' HG11 ' A' ' 41' ' ' VAL . . . -81.09 -49.19 11.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.163 -1.421 . . . . 71.13 107.163 -174.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.99 -38.16 87.56 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.169 -0.678 . . . . 74.44 109.169 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -70.65 -39.38 73.65 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.569 -0.9 . . . . 71.12 108.569 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.4 -39.05 88.78 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.384 -1.339 . . . . 73.31 107.384 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.6 -19.36 37.18 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 110.322 -1.111 . . . . 64.41 110.322 171.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.18 -39.68 40.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.81 -1.182 . . . . 71.01 107.81 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.85 132.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.722 -1.584 . . . . 72.24 106.722 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -142.67 -176.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 104.715 -2.328 . . . . 73.31 104.715 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -66.58 141.71 57.74 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.295 -1.743 . . . . 72.53 106.295 172.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.84 -30.13 8.34 Favored Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 107.486 -2.246 . . . . 34.53 107.486 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -72.78 150.73 42.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.428 -0.953 . . . . 70.12 108.428 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -123.56 128.77 50.2 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.157 -1.794 . . . . 72.41 106.157 -173.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.84 144.27 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 106.249 -1.76 . . . . 71.11 106.249 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.28 -44.08 2.6 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.559 -1.274 . . . . 73.52 107.559 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.89 159.49 36.47 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.944 -1.102 . . . . 74.33 109.378 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.16 116.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 104.942 -2.244 . . . . 73.3 104.942 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.3 t30 55.09 30.98 15.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.595 0.758 . . . . 73.33 109.886 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 16.43 77.21 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 109.324 -1.51 . . . . 72.52 109.324 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -106.72 124.01 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.814 0 N-CA-C 104.682 -2.34 . . . . 65.22 104.682 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -68.81 112.69 5.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.415 -1.328 . . . . 71.11 107.415 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.22 -1.0 57.58 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.571 -1.27 . . . . 73.21 107.571 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.74 143.13 58.09 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.608 -1.256 . . . . 63.12 107.608 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.85 3.81 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.451 -1.06 . . . . 63.12 110.451 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.44 13.37 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.761 0.78 . . . . 64.31 109.323 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -81.39 162.99 23.15 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.515 -1.291 . . . . 75.41 107.515 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -65.23 -36.75 85.13 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.532 -1.285 . . . . 75.43 107.532 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.03 -51.64 56.1 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 109.983 -0.377 . . . . 74.44 109.983 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -66.92 -37.68 84.78 Favored 'General case' 0 C--N 1.369 1.455 0 N-CA-C 109.286 -0.635 . . . . 70.24 109.286 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.75 -43.97 77.17 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 118.033 0.379 . . . . 54.34 110.175 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.66 -50.77 36.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.267 -1.383 . . . . 74.01 107.267 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.5 t -53.92 -28.65 38.21 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-O 122.127 0.965 . . . . 50.44 108.671 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.87 -55.15 13.98 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 107.184 -1.413 . . . . 73.33 107.184 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.65 -55.79 29.58 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.074 0.94 . . . . 74.33 108.613 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -46.6 -25.56 0.73 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.23 -0.896 . . . . 71.03 113.177 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -116.57 10.62 14.52 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.639 -1.288 . . . . 75.24 110.07 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.3 p -84.92 173.42 10.59 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.63 -155.19 22.55 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 109.767 -1.333 . . . . 62.12 109.767 -172.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -80.77 -31.89 35.65 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 108.439 -0.949 . . . . 62.13 108.439 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.33 133.52 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 103.908 -2.626 . . . . 73.43 103.908 175.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.57 141.98 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 105.461 -2.051 . . . . 64.34 105.461 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -95.61 115.82 27.98 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.321 -2.474 . . . . 74.25 104.321 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.4 mt -116.57 140.37 49.46 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 106.36 -1.719 . . . . 74.15 106.36 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 9' ' ' GLU . 26.1 tp -114.52 126.08 54.53 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 105.107 -2.182 . . . . 74.34 105.107 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.81 156.15 46.53 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.267 -1.383 . . . . 70.03 107.267 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.39 136.36 52.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 103.676 -2.713 . . . . 61.43 103.676 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 69.9 mmtt -61.84 149.74 39.32 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.981 0.896 . . . . 71.34 109.643 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.96 -166.79 21.49 Favored Glycine 0 CA--C 1.472 -2.648 0 N-CA-C 104.086 -3.606 . . . . 71.25 104.086 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.84 117.68 7.29 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.582 -1.266 . . . . 75.01 107.582 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.4 m -115.82 147.94 40.16 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 103.637 -2.727 . . . . 62.31 103.637 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.0 -25.39 44.42 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.662 1.575 . . . . 64.4 109.0 173.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 C--O 1.257 1.487 0 N-CA-C 104.752 -2.314 . . . . 73.11 104.752 177.509 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.242 0 N-CA-C 108.899 -1.68 . . . . 51.43 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.28 146.57 76.06 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.324 2.016 . . . . 74.51 107.596 170.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.57 162.66 67.66 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.318 -1.734 . . . . 62.23 106.318 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.82 120.43 8.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.221 1.947 . . . . 75.54 109.089 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.91 12.74 57.49 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 108.636 -1.785 . . . . 31.32 108.636 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -96.0 140.21 31.07 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 105.142 -2.17 . . . . 74.34 105.142 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.18 139.93 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.205 0 N-CA-C 103.86 -2.645 . . . . 74.53 103.86 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.99 160.24 42.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 105.594 -2.002 . . . . 74.41 105.594 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.7 146.22 28.54 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.138 -1.801 . . . . 65.4 106.138 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.7 t -127.81 127.34 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.226 0 N-CA-C 103.453 -2.795 . . . . 70.53 103.453 167.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.49 114.09 28.1 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.31 -2.478 . . . . 72.42 104.31 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 124.31 48.51 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.809 -1.923 . . . . 75.24 105.809 -169.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.69 147.22 25.07 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.102 -1.444 . . . . 73.0 107.102 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -95.12 31.59 1.87 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.276 -1.749 . . . . 73.44 106.276 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -77.48 -50.08 13.42 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.017 -1.475 . . . . 63.33 107.017 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.09 -64.18 1.04 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.834 -0.802 . . . . 70.31 108.834 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -148.77 167.48 25.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.215 -2.142 . . . . 74.4 105.215 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -53.17 173.18 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.131 0.972 . . . . 74.51 110.737 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -58.36 -58.75 7.14 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.106 -0.952 . . . . 71.04 109.816 -164.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.431 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 52.42 51.21 44.11 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 122.462 -0.149 . . . . 61.14 113.056 173.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -135.67 165.19 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 102.921 -2.992 . . . . 73.33 102.921 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.6 m -152.17 165.53 34.54 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 102.625 -3.102 . . . . 74.3 102.625 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.83 169.37 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 105.957 -1.868 . . . . 74.12 105.957 -167.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -148.88 167.32 26.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 103.002 -2.962 . . . . 73.25 103.002 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.6 -168.93 13.15 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 106.652 -2.579 . . . . 72.43 106.652 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 -116.04 3.2 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 107.879 -2.088 . . . . 51.12 107.879 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.18 19.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.89 1.276 . . . . 72.11 113.742 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.27 82.1 m-20 88.68 68.17 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 123.179 1.466 . . . . 75.31 108.442 -170.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.621 HG23 ' H ' ' A' ' 30' ' ' SER . 6.3 m -81.99 -166.99 1.37 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 103.423 -2.806 . . . . 73.21 103.423 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.621 ' H ' HG23 ' A' ' 29' ' ' THR . 11.8 m -53.74 -20.16 5.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 53.41 112.573 -174.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -89.97 128.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.625 -1.25 . . . . 70.32 107.625 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.29 -45.71 90.14 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 115.629 -0.714 . . . . 75.54 110.834 -170.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.04 1.79 14.55 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.731 -0.606 . . . . 72.13 109.747 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.17 22.26 68.85 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 109.984 -1.247 . . . . 50.54 109.984 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.57 150.82 50.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.137 -1.985 . . . . 71.51 108.137 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mm -93.09 105.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.026 -2.583 . . . . 73.14 104.026 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -97.74 142.28 29.72 Favored 'General case' 0 CA--C 1.465 -2.296 0 N-CA-C 106.699 -1.593 . . . . 75.0 106.699 -174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.45 135.45 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 106.97 -1.492 . . . . 72.33 106.97 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -45.25 4.04 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.549 -1.649 . . . . 74.33 106.549 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.15 156.08 44.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.633 -1.988 . . . . 70.14 105.633 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.55 136.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 103.67 -2.715 . . . . 74.25 103.67 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.431 HG12 ' CA ' ' A' ' 20' ' ' GLY . 21.5 mm -69.1 143.92 94.76 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.179 -1.785 . . . . 72.13 106.179 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.33 114.93 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.295 1.997 . . . . 74.14 107.766 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 60.46 35.87 20.27 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.715 0.806 . . . . 71.44 111.122 -172.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 178.42 48.6 Favored Glycine 0 C--N 1.366 2.196 0 N-CA-C 106.614 -2.594 . . . . 74.14 106.614 163.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.21 93.88 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 109.383 -0.599 . . . . 71.04 109.383 -172.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.59 75.75 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.596 -0.52 . . . . 71.44 109.596 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.79 -39.86 87.93 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.303 -0.629 . . . . 75.53 109.303 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.0 m -64.97 -36.12 83.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.26 -0.644 . . . . 73.21 109.26 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.59 -32.52 68.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 108.246 -1.02 . . . . 71.15 108.246 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -20.01 29.48 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.546 -1.022 . . . . 61.3 110.546 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -72.64 -44.9 61.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.111 -1.07 . . . . 74.34 108.111 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mt -98.15 149.77 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.878 -1.897 . . . . 71.3 105.878 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -151.49 170.38 19.76 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.082 -2.192 . . . . 75.55 105.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -67.29 142.57 56.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.627 -1.62 . . . . 71.3 106.627 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.3 -3.36 84.02 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 119.84 -1.171 . . . . 74.4 110.181 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -80.16 150.34 30.21 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 106.939 -1.504 . . . . 61.53 106.939 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.88 118.48 36.93 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.073 -1.455 . . . . 72.34 107.073 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 t -103.61 148.52 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 105.457 -2.053 . . . . 74.51 105.457 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.38 -48.01 2.9 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.773 -1.195 . . . . 73.23 107.773 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.08 162.37 28.94 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.576 -0.85 . . . . 70.41 109.184 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.18 111.82 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.349 -2.093 . . . . 73.3 105.349 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 49.45 36.84 10.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.13 1.372 . . . . 75.13 111.363 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.48 4.87 76.19 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 109.671 -1.371 . . . . 71.32 109.671 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.93 120.53 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 104.572 -2.381 . . . . 74.03 104.572 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -72.72 108.57 5.78 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 106.861 -1.533 . . . . 74.54 106.861 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.98 -2.01 42.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.565 -0.743 . . . . 75.13 109.798 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.29 143.8 57.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.865 -1.161 . . . . 73.34 107.865 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.2 -31.32 4.12 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.74 -1.344 . . . . 64.34 109.74 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.46 162.16 29.84 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 118.495 1.148 . . . . 72.04 108.383 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.1 p -85.38 169.52 13.61 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.856 0.836 . . . . 64.35 109.06 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -64.26 -44.91 90.31 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.854 -1.165 . . . . 74.41 107.854 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.11 -41.35 96.54 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 119.265 -0.397 . . . . 65.43 110.095 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -37.45 87.08 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 119.281 0.946 . . . . 61.1 108.84 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.78 -38.23 69.62 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.539 0.609 . . . . 73.33 109.973 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.11 -55.06 14.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 107.641 -1.244 . . . . 73.22 107.641 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.36 -26.75 68.62 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.758 -0.83 . . . . 72.4 108.758 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.6 m -60.16 -54.0 51.09 Favored 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 107.088 -1.449 . . . . 73.21 107.088 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -56.11 -56.05 25.61 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 121.701 0.762 . . . . 74.11 109.123 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -48.72 -30.2 5.3 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 121.647 -0.658 . . . . 74.24 112.676 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -93.2 -7.34 45.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.349 -0.844 . . . . 75.43 109.939 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 p -79.41 170.28 16.83 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.856 -1.165 . . . . 64.21 107.856 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.16 -136.57 3.74 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 110.142 -1.183 . . . . 62.24 110.142 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.3 -45.88 8.76 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.82 -1.178 . . . . 73.12 107.82 -172.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.94 128.31 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 104.079 -2.563 . . . . 75.32 104.079 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -123.94 138.43 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.212 -2.514 . . . . 72.24 104.212 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.54 117.92 31.95 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 104.694 -2.336 . . . . 72.32 104.694 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.9 mt -116.74 137.84 51.91 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.864 -1.902 . . . . 75.41 105.864 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.74 130.31 56.11 Favored 'General case' 0 CA--C 1.463 -2.4 0 N-CA-C 104.589 -2.374 . . . . 73.11 104.589 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.68 153.84 49.58 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 105.848 -1.908 . . . . 72.34 105.848 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -117.3 133.33 56.11 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 103.786 -2.672 . . . . 63.11 103.786 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 135.81 56.6 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.704 -0.85 . . . . 74.45 108.704 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.49 51.74 0.02 OUTLIER Glycine 0 CA--C 1.47 -2.724 0 N-CA-C 105.334 -3.106 . . . . 54.15 105.334 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.93 151.63 23.6 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.916 -1.512 . . . . 74.21 106.916 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.3 p -84.9 168.51 20.43 Favored Pre-proline 0 N--CA 1.417 -2.084 0 N-CA-C 104.055 -2.572 . . . . 51.23 104.055 166.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.43 161.3 28.05 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.769 1.646 . . . . 75.32 108.661 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 105.895 -1.891 . . . . 75.21 105.895 -177.688 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.682 0 N-CA-C 108.428 -1.869 . . . . 74.13 108.428 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.68 118.04 5.31 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.869 2.38 . . . . 72.42 108.267 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -80.93 164.28 51.56 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 105.805 -1.924 . . . . 74.13 105.805 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.18 118.09 4.91 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.156 1.904 . . . . 54.44 108.783 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 110.46 -24.44 17.79 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 109.32 -1.512 . . . . 74.2 109.32 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.57 143.66 57.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 117.669 0.735 . . . . 74.23 109.24 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.52 134.79 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.035 -2.58 . . . . 72.23 104.035 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -128.01 142.12 51.32 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 105.78 -1.933 . . . . 72.4 105.78 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -103.05 132.13 49.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 104.711 -2.329 . . . . 71.43 104.711 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.25 135.93 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 106.318 -1.734 . . . . 75.54 106.318 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.04 118.13 36.13 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.234 -2.506 . . . . 70.12 104.234 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.91 121.09 41.81 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 104.962 -2.236 . . . . 74.42 104.962 -175.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.1 133.36 37.66 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.253 -1.388 . . . . 63.11 107.253 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -87.72 34.33 0.71 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.648 1.179 . . . . 74.01 108.072 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.06 -25.89 68.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.219 -1.771 . . . . 73.15 106.219 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -93.86 140.66 29.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 104.049 -2.575 . . . . 53.53 104.049 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.6 -25.9 41.38 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.616 -0.513 . . . . 74.5 109.616 -166.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -87.94 122.05 31.09 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.308 -1.738 . . . . 73.11 106.308 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.79 -57.37 5.18 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 104.446 -2.428 . . . . 74.44 104.446 172.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 72.3 48.78 23.28 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 110.982 -0.847 . . . . 52.33 110.982 162.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.7 mt -131.68 148.43 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 101.042 -3.688 . . . . 74.22 101.042 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -146.68 164.02 34.04 Favored 'General case' 0 CA--C 1.46 -2.488 0 N-CA-C 102.568 -3.123 . . . . 74.13 102.568 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.48 167.92 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 106.498 -1.667 . . . . 74.22 106.498 -161.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -144.72 165.89 26.78 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.233 -2.506 . . . . 75.2 104.233 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 79.39 140.5 2.06 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 110.871 -0.891 . . . . 64.34 110.871 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.62 -87.42 0.07 OUTLIER Glycine 0 C--N 1.351 1.41 0 N-CA-C 109.782 -1.327 . . . . 74.3 109.782 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.56 20.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 128.934 2.893 . . . . 75.23 117.057 -172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 86.91 66.13 0.01 OUTLIER 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 105.564 -2.013 . . . . 71.41 105.564 -170.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -84.39 -166.88 1.57 Allowed 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 111.807 -2.451 . . . . 72.33 105.785 -175.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -59.43 -26.57 65.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 123.803 0.841 . . . . 73.34 110.952 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.566 ' H ' HG22 ' A' ' 29' ' ' THR . 27.3 m -87.46 139.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.749 -1.574 . . . . 74.52 106.749 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -51.95 -58.16 7.32 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.882 0.873 . . . . 73.45 111.711 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.93 8.49 6.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.941 -0.474 . . . . 63.41 111.062 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.25 29.33 74.2 Favored Glycine 0 C--N 1.36 1.864 0 N-CA-C 108.537 -1.825 . . . . 71.11 108.537 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.14 127.53 27.29 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.037 -1.625 . . . . 72.31 109.037 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 25' ' ' GLY . 1.2 mm -79.03 104.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.361 -2.829 . . . . 72.22 103.361 172.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -98.43 146.5 25.67 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 107.69 -1.226 . . . . 74.53 107.69 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 130.72 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.983 -1.858 . . . . 71.15 105.983 171.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -104.92 -47.14 4.1 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.005 -1.48 . . . . 72.3 107.005 -168.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.06 147.89 39.32 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 105.841 -1.911 . . . . 74.22 105.841 -169.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.93 128.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 103.552 -2.758 . . . . 75.11 103.552 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.4 mm -64.61 144.87 98.76 Favored Pre-proline 0 N--CA 1.477 0.875 0 N-CA-C 105.959 -1.867 . . . . 74.41 105.959 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 111.99 1.05 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 N-CA-C 107.319 -1.839 . . . . 73.14 107.319 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 70.55 29.58 3.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 124.58 1.175 . . . . 72.41 110.654 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.03 172.38 40.67 Favored Glycine 0 C--N 1.363 2.08 0 N-CA-C 107.946 -2.062 . . . . 74.23 107.946 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.73 76.2 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 108.689 -0.856 . . . . 41.21 108.689 -175.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.8 80.18 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 109.443 -0.577 . . . . 45.04 109.443 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -62.3 -40.66 97.02 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 109.017 -0.735 . . . . 75.11 109.017 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -66.08 -41.71 90.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.15 -1.056 . . . . 55.21 108.15 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.01 -40.59 91.24 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.616 -1.253 . . . . 74.4 107.616 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.81 -10.45 59.97 Favored Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 110.859 -0.896 . . . . 74.22 110.859 172.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -81.45 -40.13 23.8 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.158 -1.052 . . . . 73.44 108.158 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.1 mt -93.75 140.78 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.848 -1.538 . . . . 73.32 106.848 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.32 174.9 10.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.057 -1.831 . . . . 71.45 106.057 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.41 143.47 57.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 106.15 -1.796 . . . . 75.05 106.15 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.12 52.27 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.785 -2.126 . . . . 74.52 107.785 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.36 147.33 40.14 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.592 -1.633 . . . . 52.31 106.592 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.53 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.6 tmm_? -109.73 118.85 37.63 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.045 -2.206 . . . . 74.35 105.045 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.24 131.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.252 -2.129 . . . . 74.24 105.252 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 -50.77 3.24 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.868 -1.53 . . . . 73.32 106.868 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.59 166.44 20.64 Favored 'General case' 0 CA--C 1.47 -2.099 0 CA-C-O 122.313 1.054 . . . . 73.33 109.272 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.09 109.5 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 103.684 -2.709 . . . . 74.5 103.684 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.73 40.02 11.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.596 1.158 . . . . 75.43 111.556 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.28 6.81 70.63 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 110.426 -1.07 . . . . 43.3 110.426 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.55 117.75 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.816 0 N-CA-C 104.284 -2.487 . . . . 75.21 104.284 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -69.16 110.98 4.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.646 -1.242 . . . . 73.21 107.646 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.27 -7.96 58.75 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.807 -0.812 . . . . 62.42 108.807 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.97 144.31 56.95 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.288 -1.004 . . . . 55.33 108.288 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 -30.86 3.93 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.784 -0.926 . . . . 62.1 110.784 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.63 164.97 15.69 Favored 'General case' 0 C--N 1.365 1.244 0 CA-C-N 118.396 1.098 . . . . 75.22 109.16 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 p -83.38 164.39 20.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.745 -1.206 . . . . 73.42 107.745 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.58 -37.95 86.01 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.569 -0.9 . . . . 75.15 108.569 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -58.58 -42.02 87.1 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 119.661 -0.816 . . . . 73.04 110.211 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.93 -40.12 91.14 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 108.625 -0.88 . . . . 74.51 108.625 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.26 -43.29 78.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.691 -0.485 . . . . 72.33 109.691 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.58 -50.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 107.281 -1.378 . . . . 72.04 107.281 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.2 t -53.41 -28.63 30.77 Favored 'General case' 0 N--CA 1.514 2.74 0 CA-C-O 122.446 1.117 . . . . 73.42 108.649 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.7 m -71.73 -46.71 57.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.64 -53.06 57.42 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.006 -1.109 . . . . 64.13 108.006 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -44.45 -46.35 9.57 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 74.42 111.607 174.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -95.0 61.12 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -111.16 156.53 21.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.95 -1.13 . . . . 71.35 107.95 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.12 -125.43 3.58 Favored Glycine 0 CA--C 1.492 -1.348 0 N-CA-C 108.573 -1.811 . . . . 62.31 108.573 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -89.32 -52.12 5.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.868 -1.16 . . . . 75.32 107.868 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.04 136.63 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 105.243 -2.132 . . . . 72.44 105.243 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -114.82 130.55 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 105.21 -2.144 . . . . 73.02 105.21 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -95.11 116.86 29.27 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.788 -2.301 . . . . 71.41 104.788 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 mt -122.1 144.56 48.85 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.552 -1.647 . . . . 71.53 106.552 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -116.73 131.53 56.93 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 103.777 -2.675 . . . . 72.22 103.777 172.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mp -133.32 155.71 48.94 Favored 'General case' 0 CA--C 1.469 -2.153 0 N-CA-C 106.493 -1.669 . . . . 74.11 106.493 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.53 ' CD ' HH21 ' A' ' 58' ' ' ARG . 31.8 tt0 -123.93 133.82 53.65 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.894 -2.261 . . . . 75.41 104.894 -175.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -69.08 150.7 47.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.081 0.943 . . . . 74.24 109.517 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.25 23.69 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.363 0 N-CA-C 108.877 -1.689 . . . . 64.54 108.877 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -77.88 -178.86 5.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.451 -1.315 . . . . 75.54 107.451 176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -83.59 119.65 74.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 103.577 -2.749 . . . . 74.02 103.577 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.72 76.68 2.37 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.659 2.239 . . . . 72.14 109.783 -167.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.415 -2.204 0 N-CA-C 104.477 -2.416 . . . . 74.31 104.477 172.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.276 0 N-CA-C 108.466 -1.853 . . . . 72.23 108.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.18 158.66 14.34 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.605 2.87 . . . . 75.31 109.687 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -82.46 161.6 58.79 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 106.332 -1.729 . . . . 72.01 106.332 -173.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.62 120.29 8.11 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.33 2.02 . . . . 74.15 109.881 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.503 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 105.32 -21.06 36.16 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 108.624 -1.79 . . . . 62.54 108.624 177.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.92 140.58 58.3 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.907 -0.775 . . . . 64.23 108.907 -176.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.83 134.92 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 103.643 -2.725 . . . . 75.23 103.643 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.16 150.76 44.62 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.327 -1.731 . . . . 74.43 106.327 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -102.71 140.95 36.32 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.497 -2.038 . . . . 72.52 105.497 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.1 t -124.9 125.99 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 103.878 -2.638 . . . . 72.24 103.878 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -102.76 125.06 49.36 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.414 -2.069 . . . . 50.34 105.414 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 121.66 42.66 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.638 -1.616 . . . . 74.05 106.638 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.55 139.49 34.19 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.274 -1.75 . . . . 63.11 106.274 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.08 33.44 3.81 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.304 -1.739 . . . . 72.14 106.304 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -81.77 55.46 2.72 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.445 -1.687 . . . . 71.35 106.445 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 22.8 t70 -139.13 -133.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 102.073 -3.306 . . . . 74.43 102.073 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 72.1 m-20 -135.18 -55.68 0.81 Allowed 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 103.981 -2.6 . . . . 75.23 103.981 171.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -73.24 110.75 7.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.086 -1.079 . . . . 73.21 108.086 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -72.7 -56.87 4.64 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.597 -2.742 . . . . 65.25 103.597 171.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.47 49.3 80.0 Favored Glycine 0 CA--C 1.48 -2.14 0 CA-C-N 112.425 -2.17 . . . . 74.24 112.753 165.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.21 150.52 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 104.056 -2.572 . . . . 71.21 104.056 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.2 m -151.88 167.21 29.04 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 102.673 -3.084 . . . . 64.52 102.673 167.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.08 168.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 106.111 -1.811 . . . . 73.02 106.111 -167.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -139.54 166.12 25.42 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 102.711 -3.07 . . . . 73.13 102.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 36' ' ' ILE . . . 87.66 131.19 3.41 Favored Glycine 0 C--O 1.199 -2.054 0 N-CA-C 109.637 -1.385 . . . . 74.11 109.637 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.27 -92.18 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 107.874 -2.09 . . . . 63.22 107.874 165.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.36 19.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.376 1.471 . . . . 72.33 114.169 -171.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 88.5 65.79 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.942 -1.503 . . . . 73.13 106.942 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.59 HG23 ' H ' ' A' ' 30' ' ' SER . 2.4 m -88.09 -166.45 1.59 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.877 -2.638 . . . . 74.11 103.877 172.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.59 ' H ' HG23 ' A' ' 29' ' ' THR . 5.0 m -44.86 -33.22 1.86 Allowed 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.661 1.184 . . . . 62.21 112.063 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 m -85.36 129.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.055 -1.091 . . . . 74.43 108.055 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -66.45 -34.16 77.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.041 -0.981 . . . . 74.31 112.789 -166.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -75.57 -2.25 28.27 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.962 -1.086 . . . . 73.1 109.338 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.97 20.2 59.83 Favored Glycine 0 C--N 1.36 1.906 0 N-CA-C 108.281 -1.927 . . . . 54.1 108.281 -167.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.38 153.06 48.92 Favored Glycine 0 CA--C 1.476 -2.358 0 N-CA-C 107.964 -2.054 . . . . 44.23 107.964 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 25' ' ' GLY . 2.8 mm -90.72 119.87 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 103.89 -2.633 . . . . 73.54 103.89 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.69 145.88 43.15 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 106.667 -1.605 . . . . 71.41 106.667 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.67 131.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.175 -1.416 . . . . 71.42 107.175 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.0 -47.02 3.79 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 106.665 -1.605 . . . . 74.42 106.665 -168.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.84 138.51 42.59 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 105.594 -2.002 . . . . 71.13 105.594 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.02 126.31 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 105.081 -2.192 . . . . 72.4 105.081 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -69.9 137.24 87.51 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.685 -1.598 . . . . 74.55 106.685 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.87 117.67 4.46 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.367 2.045 . . . . 62.3 108.31 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 62.03 25.37 15.21 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.863 0.865 . . . . 63.13 111.879 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.77 54.86 Favored Glycine 0 C--N 1.364 2.092 0 N-CA-C 105.689 -2.964 . . . . 63.12 105.689 165.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.13 48.79 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 117.325 0.562 . . . . 65.33 111.782 -171.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.95 67.03 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.199 -0.667 . . . . 73.32 109.199 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.04 -34.4 77.62 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.875 -0.417 . . . . 74.33 109.875 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.5 m -64.1 -31.96 73.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.743 -0.836 . . . . 72.41 108.743 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.85 -42.31 73.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.646 -1.242 . . . . 73.34 107.646 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.03 -20.6 35.43 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.122 -1.191 . . . . 63.22 110.122 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -78.27 -41.2 34.76 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.031 -1.099 . . . . 75.34 108.031 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.9 mt -95.94 134.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.578 -1.638 . . . . 72.44 106.578 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.18 179.91 7.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.952 -1.87 . . . . 74.23 105.952 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -66.82 138.56 57.43 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 106.781 -1.562 . . . . 73.53 106.781 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.6 -14.18 50.3 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 108.528 -1.829 . . . . 71.4 108.528 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.64 151.02 44.06 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.737 -0.838 . . . . 73.35 108.737 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -113.18 126.9 55.94 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.287 -2.116 . . . . 75.13 105.287 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 t -104.77 142.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 104.554 -2.388 . . . . 72.3 104.554 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.81 -48.22 2.76 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.342 -1.355 . . . . 75.34 107.342 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.95 164.14 24.89 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 122.327 1.06 . . . . 72.44 109.785 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.14 109.1 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 N-CA-C 104.302 -2.481 . . . . 72.35 104.302 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 48.0 42.16 16.18 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.829 0.852 . . . . 71.31 110.598 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.4 10.08 82.59 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.691 -0.964 . . . . 70.31 110.691 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.31 118.02 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 104.712 -2.329 . . . . 75.03 104.712 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -71.42 113.07 8.08 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.307 -1.368 . . . . 72.21 107.307 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.2 mt -70.68 -23.15 62.43 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.222 -0.899 . . . . 74.42 109.608 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -55.49 144.94 24.24 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.532 0.682 . . . . 74.4 110.664 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.85 -33.31 5.28 Favored Glycine 0 CA--C 1.496 -1.15 0 N-CA-C 109.369 -1.492 . . . . 70.43 109.369 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.59 162.55 28.69 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.033 -0.729 . . . . 55.44 109.033 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -80.48 167.32 20.29 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.832 -1.174 . . . . 70.02 107.832 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -64.69 -39.05 93.0 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 106.543 -1.651 . . . . 71.1 106.543 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -51.9 -51.03 59.69 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 123.618 0.767 . . . . 73.43 110.047 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -66.65 -39.73 88.37 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 109.165 -0.679 . . . . 55.1 109.165 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.06 70.59 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.42 0.555 . . . . 64.52 109.778 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.03 -54.64 17.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 N-CA-C 106.873 -1.528 . . . . 73.34 106.873 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 11.1 t -54.77 -28.65 50.31 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 122.268 1.032 . . . . 74.01 108.763 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.4 m -66.57 -53.76 31.05 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.331 -1.359 . . . . 63.44 107.331 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.35 -55.51 27.83 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 108.589 -0.893 . . . . 74.31 108.589 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -46.67 -32.82 3.78 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.882 0.697 . . . . 73.31 112.882 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.64 2.17 51.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.49 -0.756 . . . . 72.41 110.252 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.5 p -73.98 168.47 19.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 119.5 1.045 . . . . 75.34 109.44 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.1 -166.39 28.5 Favored Glycine 0 C--N 1.371 2.499 0 N-CA-C 108.783 -1.727 . . . . 64.43 108.783 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.29 -32.18 26.51 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.792 -0.818 . . . . 70.02 108.792 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.3 t -112.37 130.46 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 103.573 -2.751 . . . . 73.53 103.573 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.88 150.19 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.116 -2.179 . . . . 75.14 105.116 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -110.3 121.62 45.72 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 104.968 -2.234 . . . . 73.12 104.968 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.8 mt -116.4 141.33 48.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 N-CA-C 104.711 -2.329 . . . . 74.4 104.711 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 tp -114.73 127.84 55.97 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 105.672 -1.973 . . . . 74.33 105.672 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.11 155.8 50.11 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.337 -1.727 . . . . 73.0 106.337 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -124.45 136.53 54.11 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 105.085 -2.191 . . . . 73.22 105.085 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 74.2 mmtt -69.1 144.69 53.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 122.236 1.017 . . . . 74.45 109.579 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.94 49.94 0.08 OUTLIER Glycine 0 CA--C 1.469 -2.823 0 N-CA-C 103.975 -3.65 . . . . 72.33 103.975 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.451 HE22 ' HA ' ' A' ' 92' ' ' LYS . 11.7 mp0 -76.0 136.13 39.98 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 105.488 -2.041 . . . . 72.02 105.488 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.2 m -81.12 161.09 64.08 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 105.979 -1.86 . . . . 75.03 105.979 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.4 162.2 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.234 1.956 . . . . 73.31 108.957 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 106.225 -1.768 . . . . 74.02 106.225 -179.726 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.624 0 N-CA-C 107.842 -2.103 . . . . 75.35 107.842 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.5 146.84 81.14 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.65 2.233 . . . . 72.02 108.606 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -106.88 159.99 27.93 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 105.037 -2.209 . . . . 74.01 105.037 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.21 138.14 70.28 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.217 1.944 . . . . 64.23 108.806 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.71 -21.35 16.56 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 108.322 -1.911 . . . . 43.35 108.322 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.36 132.99 43.67 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.6 -0.889 . . . . 74.34 108.6 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.03 137.8 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 N-CA-C 105.003 -2.221 . . . . 74.25 105.003 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -137.6 153.6 49.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.572 -2.01 . . . . 74.51 105.572 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.76 141.46 35.52 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.758 -1.571 . . . . 74.45 106.758 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.5 126.06 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 103.894 -2.632 . . . . 75.21 103.894 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -96.76 125.53 41.28 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.553 -2.388 . . . . 73.33 104.553 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 121.04 44.34 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.611 -1.626 . . . . 75.14 106.611 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.71 102.78 13.26 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 104.268 -2.493 . . . . 75.12 104.268 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -119.61 36.49 4.48 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.456 -1.247 . . . . 75.4 107.89 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -56.74 162.93 2.08 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 109.087 -0.709 . . . . 74.42 109.087 -170.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.5 124.98 22.37 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.238 -1.023 . . . . 70.2 108.238 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -176.56 -148.64 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 99.379 -4.304 . . . . 71.11 99.379 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.0 m -80.28 112.65 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.594 -2.373 . . . . 51.51 104.594 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.66 -57.91 3.95 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 105.137 -2.172 . . . . 72.22 105.137 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 41.55 40.61 Favored Glycine 0 CA--C 1.474 -2.471 0 N-CA-C 109.702 -1.359 . . . . 53.53 109.702 161.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.8 mt -131.32 144.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 103.02 -2.956 . . . . 74.13 103.02 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.1 m -147.81 163.69 35.95 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 103.484 -2.784 . . . . 74.4 103.484 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.03 169.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 105.727 -1.953 . . . . 75.14 105.727 -160.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -145.53 167.23 23.51 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.65 -2.722 . . . . 62.52 103.65 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.86 -172.98 14.67 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.061 -2.415 . . . . 51.24 107.061 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.06 -123.17 5.24 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 109.185 -1.566 . . . . 71.01 109.185 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 m -72.47 19.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 126.114 1.765 . . . . 72.5 112.908 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 87.58 64.47 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.12 -1.807 . . . . 72.13 106.12 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 30' ' ' SER . 3.3 m -84.8 -165.7 1.27 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 103.827 -2.657 . . . . 73.23 103.827 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.617 ' H ' HG23 ' A' ' 29' ' ' THR . 3.6 m -37.45 -40.37 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.616 1.566 . . . . 74.14 112.911 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.57 135.34 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.159 -1.052 . . . . 71.54 108.159 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.7 mtm105 -72.47 -35.33 68.21 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.57 -0.9 . . . . 73.43 108.57 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.88 -17.25 63.0 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 109.118 -0.697 . . . . 63.21 109.118 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 -3.19 3.78 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.189 -0.364 . . . . 73.45 112.189 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.32 170.61 47.72 Favored Glycine 0 CA--C 1.483 -1.956 0 N-CA-C 107.229 -2.348 . . . . 71.01 107.229 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.39 132.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.436 -2.061 . . . . 72.23 105.436 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -124.97 140.71 52.67 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 104.989 -2.226 . . . . 74.12 104.989 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -68.51 132.67 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.953 -1.499 . . . . 75.32 106.953 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -106.21 -46.23 4.11 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.295 -1.372 . . . . 54.42 107.295 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.26 144.17 38.28 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 105.608 -1.997 . . . . 71.43 105.608 -173.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.9 129.55 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 104.581 -2.378 . . . . 74.33 104.581 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 mt -74.36 138.91 74.84 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.125 -1.805 . . . . 72.4 106.125 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.8 110.76 0.88 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.614 2.21 . . . . 71.24 108.166 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 70.67 25.5 4.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.378 1.049 . . . . 71.42 111.318 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.44 -173.67 33.94 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 106.34 -2.704 . . . . 54.52 106.34 162.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.27 78.46 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 121.942 -0.74 . . . . 52.45 110.091 -171.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.4 80.53 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 110.155 -0.313 . . . . 75.24 110.155 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.13 -34.42 73.05 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.345 -0.613 . . . . 71.0 109.345 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -67.98 -39.69 83.26 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.481 -1.303 . . . . 73.03 107.481 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.76 -32.76 73.57 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 107.931 -1.137 . . . . 55.12 107.931 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.48 -25.99 4.78 Favored Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 110.951 -0.86 . . . . 72.33 110.951 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -69.63 -40.1 76.74 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.536 -0.912 . . . . 74.51 108.536 -173.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 mt -98.38 138.46 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 105.924 -1.88 . . . . 73.34 105.924 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -134.76 174.43 10.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.143 -1.428 . . . . 72.13 107.143 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -66.53 138.98 57.89 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.695 -1.965 . . . . 73.23 105.695 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.7 -4.8 61.72 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 109.191 -1.563 . . . . 63.05 109.191 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.43 152.96 37.9 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.383 -1.34 . . . . 73.42 107.383 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -112.79 123.83 51.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.15 -2.167 . . . . 74.02 105.15 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.73 139.97 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 104.741 -2.318 . . . . 70.14 104.741 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' H ' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -107.08 -55.35 2.34 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.019 -1.474 . . . . 75.2 107.019 176.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.459 ' H ' ' HG ' ' A' ' 60' ' ' LEU . . . -130.57 165.18 23.3 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 122.153 0.977 . . . . 73.33 109.531 -168.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.62 109.84 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 105.085 -2.191 . . . . 73.4 105.085 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 51.72 41.37 29.0 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.615 1.166 . . . . 72.34 111.812 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.44 7.01 73.07 Favored Glycine 0 CA--C 1.498 -1.006 0 N-CA-C 109.396 -1.482 . . . . 34.4 109.396 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 67' ' ' LEU . 26.8 t -112.12 117.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 105.134 -2.172 . . . . 73.05 105.134 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -80.8 15.39 1.78 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.332 -0.395 . . . . 74.21 110.424 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 65' ' ' VAL . 87.5 mt 38.79 45.11 0.89 Allowed 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.236 1.414 . . . . 74.31 110.937 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.2 125.14 28.62 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.514 -0.921 . . . . 60.04 108.514 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.96 -4.52 81.61 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.822 -1.711 . . . . 74.1 108.822 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.71 137.4 56.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 108.299 -1.0 . . . . 54.34 108.299 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.7 p -76.13 174.04 10.56 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.752 -1.573 . . . . 75.55 106.752 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -61.18 -39.83 91.62 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 107.816 -1.179 . . . . 74.31 107.816 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.01 -50.68 66.08 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.878 0.471 . . . . 70.42 110.713 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -66.62 -29.25 69.25 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.241 0.928 . . . . 63.3 109.437 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.53 -38.5 84.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.562 -0.903 . . . . 70.32 108.562 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.5 t -72.82 -49.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.009 -1.478 . . . . 73.45 107.009 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.1 m -52.49 -29.28 24.15 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 108.488 -0.93 . . . . 72.34 108.488 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -65.81 -55.87 14.88 Favored 'General case' 0 C--O 1.199 -1.597 0 N-CA-C 107.486 -1.301 . . . . 65.43 107.486 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.03 -56.14 24.34 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.943 -0.762 . . . . 74.33 108.943 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -49.85 -28.01 5.9 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.482 0.549 . . . . 63.23 112.482 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -92.87 -13.15 29.39 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.774 -0.579 . . . . 54.23 109.708 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.3 p -80.56 173.71 12.33 Favored 'General case' 0 C--O 1.245 0.839 0 O-C-N 120.795 -1.191 . . . . 74.22 108.909 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.79 -155.33 11.8 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.645 -1.382 . . . . 55.13 109.645 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -80.11 -43.77 21.14 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 107.443 -1.318 . . . . 72.31 107.443 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.75 131.27 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.892 0 N-CA-C 103.502 -2.777 . . . . 72.21 103.502 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.54 140.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 105.379 -2.082 . . . . 71.13 105.379 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -97.18 118.11 32.88 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 104.834 -2.284 . . . . 74.43 104.834 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 34.5 mt -121.19 142.39 49.94 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 105.661 -1.978 . . . . 73.31 105.661 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.06 133.25 56.23 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 104.723 -2.325 . . . . 74.21 104.723 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.43 152.74 51.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.314 -1.736 . . . . 62.25 106.314 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -115.2 129.52 56.67 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.627 -1.99 . . . . 73.22 105.627 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -62.4 138.05 58.38 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.32 -0.622 . . . . 73.51 109.32 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.13 51.39 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.188 0 N-CA-C 104.139 -3.585 . . . . 75.11 104.139 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -90.11 155.05 19.32 Favored 'General case' 0 CA--C 1.478 -1.823 0 N-CA-C 107.036 -1.468 . . . . 63.54 107.036 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.1 m -83.88 166.1 35.73 Favored Pre-proline 0 N--CA 1.428 -1.533 0 N-CA-C 105.124 -2.176 . . . . 75.24 105.124 169.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.7 167.91 11.0 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.276 1.984 . . . . 73.11 110.062 172.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 105.43 -2.063 . . . . 74.41 105.43 -174.515 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.447 ' H1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.367 0 N-CA-C 108.291 -1.924 . . . . 71.12 108.291 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.17 143.92 73.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.033 2.489 . . . . 74.4 109.217 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.19 163.19 46.42 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 106.707 -1.59 . . . . 74.33 106.707 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.81 137.93 60.88 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.067 1.845 . . . . 71.42 107.712 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.55 61.08 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 108.97 -1.652 . . . . 70.23 108.97 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.01 126.57 28.99 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.804 -1.184 . . . . 64.43 107.804 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.446 HD12 ' CB ' ' A' ' 91' ' ' GLU . 1.7 mp -93.59 134.96 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.847 -2.649 . . . . 74.12 103.847 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -138.85 153.13 48.3 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 106.75 -1.574 . . . . 72.52 106.75 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -103.06 136.95 41.92 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 105.515 -2.032 . . . . 74.41 105.515 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.36 130.71 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.123 0 N-CA-C 104.217 -2.512 . . . . 71.15 104.217 173.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -107.22 114.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.048 -2.575 . . . . 73.35 104.048 170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.31 122.66 44.68 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 105.051 -2.203 . . . . 74.51 105.051 -168.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 146.67 25.97 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.025 -1.842 . . . . 73.52 106.025 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.32 33.57 3.07 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.714 -1.588 . . . . 75.1 106.714 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -69.23 -46.48 67.26 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.524 -1.658 . . . . 73.31 106.524 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.36 -71.85 0.11 Allowed 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.913 -0.773 . . . . 73.15 108.913 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -148.82 -177.79 5.99 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.6 -1.259 . . . . 65.51 107.6 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 m -45.44 176.34 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.979 1.712 . . . . 75.5 113.947 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 mt -59.37 -57.88 11.07 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-N 114.819 -1.082 . . . . 73.55 110.751 -166.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 43.39 48.92 6.94 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.835 1.684 . . . . 63.31 114.171 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -136.72 154.39 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 104.095 -2.557 . . . . 72.51 104.095 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -149.76 165.81 31.33 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 103.249 -2.871 . . . . 53.23 103.249 168.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.51 168.39 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 106.735 -1.58 . . . . 72.21 106.735 -164.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -148.3 167.21 25.76 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 102.625 -3.102 . . . . 73.31 102.625 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.34 -171.77 14.42 Favored Glycine 0 CA--C 1.474 -2.499 0 N-CA-C 107.568 -2.213 . . . . 33.35 107.568 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.89 -120.87 4.41 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 110.098 -1.201 . . . . 71.23 110.098 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.99 19.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 126.204 1.801 . . . . 74.3 113.96 -165.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 88.05 66.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 123.251 1.501 . . . . 74.32 107.915 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -86.78 -165.4 1.27 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 103.107 -2.923 . . . . 74.33 103.107 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -44.73 -28.91 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.902 0.881 . . . . 75.12 112.626 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -88.18 124.07 41.05 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 107.476 -1.305 . . . . 75.44 107.476 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -72.66 -23.61 60.92 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 116.088 -0.505 . . . . 72.24 109.883 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.68 -17.02 64.0 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.197 -1.038 . . . . 73.32 108.197 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.08 7.86 26.42 Favored Glycine 0 C--N 1.356 1.673 0 N-CA-C 110.479 -1.048 . . . . 74.22 110.479 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 162.03 49.56 Favored Glycine 0 CA--C 1.48 -2.155 0 N-CA-C 108.238 -1.945 . . . . 53.22 108.238 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.2 mm -90.45 133.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 104.221 -2.511 . . . . 72.42 104.221 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.79 145.29 49.82 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.154 -2.165 . . . . 73.1 105.154 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.12 134.33 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.675 -1.232 . . . . 74.34 107.675 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -106.38 -49.39 3.35 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.465 -1.68 . . . . 75.51 106.465 -169.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.08 140.85 34.26 Favored 'General case' 0 CA--C 1.463 -2.393 0 N-CA-C 105.948 -1.871 . . . . 74.22 105.948 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.51 131.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 103.593 -2.743 . . . . 73.22 103.593 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.417 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.1 mm -64.66 142.16 98.44 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 105.568 -2.012 . . . . 73.0 105.568 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.11 111.33 0.96 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.121 -1.915 . . . . 74.13 107.121 165.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 75.32 26.0 1.22 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.826 1.329 . . . . 73.22 110.957 -174.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.62 172.62 48.24 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 107.397 -2.281 . . . . 71.14 107.397 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.88 71.01 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 122.091 -0.653 . . . . 74.24 109.36 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.01 74.97 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.513 -0.921 . . . . 74.0 108.513 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.53 -36.41 82.62 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 109.129 -0.693 . . . . 71.3 109.129 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -65.67 -39.69 91.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.715 -0.846 . . . . 73.43 108.715 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.64 -40.72 72.92 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.17 -1.048 . . . . 75.14 108.17 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.459 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 95.5 -13.75 66.07 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.42 -1.072 . . . . 72.23 110.42 172.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -84.99 -41.35 15.92 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.618 -0.931 . . . . 73.13 109.808 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 mt -97.09 127.95 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 106.275 -1.75 . . . . 74.15 106.275 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 44.5 m-70 -122.69 174.59 7.01 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.46 -1.682 . . . . 73.21 106.46 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -66.7 137.83 56.97 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.357 -1.72 . . . . 74.14 106.357 166.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 -17.25 57.34 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 108.923 -1.671 . . . . 63.41 108.923 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 94' ' ' GLN . 1.0 OUTLIER -65.22 147.21 53.86 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 109.044 -0.724 . . . . 75.12 109.044 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -105.66 125.88 51.5 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 106.286 -1.746 . . . . 72.5 106.286 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.99 144.07 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 104.811 -2.292 . . . . 74.32 104.811 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -45.13 2.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.314 -1.365 . . . . 71.21 107.314 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.85 160.46 33.45 Favored 'General case' 0 CA--C 1.48 -1.733 0 C-N-CA 118.838 -1.145 . . . . 72.4 109.268 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.6 109.39 6.39 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 N-CA-C 105.315 -2.106 . . . . 70.54 105.315 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 47.79 40.51 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.922 1.689 . . . . 73.41 111.911 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.24 4.58 83.74 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 109.483 -1.447 . . . . 75.25 109.483 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.04 122.76 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 104.826 -2.287 . . . . 71.11 104.826 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.9 m -70.63 111.18 5.92 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.23 -1.026 . . . . 74.35 108.23 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.72 9.39 37.24 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 106.842 -1.54 . . . . 73.43 106.842 171.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -65.69 133.67 51.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.983 -1.488 . . . . 74.23 106.983 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.26 -18.65 5.18 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-O 119.629 -0.54 . . . . 72.21 111.78 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 171.71 1.87 Allowed 'General case' 0 C--N 1.37 1.459 0 CA-C-N 118.397 1.099 . . . . 74.33 110.228 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -83.85 159.86 21.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.485 -1.302 . . . . 73.31 107.485 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.33 -42.51 98.97 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.43 -0.952 . . . . 75.21 108.43 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.7 -43.13 94.22 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 110.024 -0.361 . . . . 74.14 110.024 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -61.71 -36.28 80.49 Favored 'General case' 0 C--N 1.383 2.035 0 O-C-N 121.368 -0.833 . . . . 54.2 109.164 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.97 79.53 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.958 -0.756 . . . . 52.24 108.958 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.9 t -73.89 -50.56 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.219 -1.4 . . . . 75.35 107.219 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.0 m -53.01 -29.94 32.41 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-O 122.07 0.938 . . . . 74.43 108.617 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -67.32 -53.82 26.16 Favored 'General case' 0 C--O 1.209 -1.074 0 O-C-N 120.933 -1.104 . . . . 72.41 108.033 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.84 -55.48 31.94 Favored 'General case' 0 C--O 1.211 -0.97 0 N-CA-C 109.149 -0.686 . . . . 74.42 109.149 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -48.28 -28.22 2.96 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.57 0.582 . . . . 73.23 112.57 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.77 -14.66 27.58 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.638 -0.664 . . . . 62.25 110.078 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 p -81.86 171.13 14.85 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.725 -1.234 . . . . 71.34 109.659 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.95 -154.2 12.91 Favored Glycine 0 C--N 1.36 1.881 0 N-CA-C 110.037 -1.225 . . . . 72.25 110.037 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -80.48 -35.8 34.3 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 107.857 -1.164 . . . . 70.12 107.857 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.84 126.87 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 104.554 -2.387 . . . . 61.45 104.554 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 139.36 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 N-CA-C 103.486 -2.783 . . . . 61.24 103.486 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -96.7 118.98 34.33 Favored 'General case' 0 CA--C 1.474 -1.96 0 N-CA-C 104.649 -2.352 . . . . 74.23 104.649 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -115.97 136.82 52.68 Favored 'General case' 0 CA--C 1.468 -2.173 0 N-CA-C 105.18 -2.156 . . . . 70.25 105.18 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.21 125.51 54.41 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.051 -2.203 . . . . 72.43 105.051 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.12 161.33 36.03 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 105.634 -1.988 . . . . 63.13 105.634 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.446 ' CB ' HD12 ' A' ' 7' ' ' ILE . 16.4 pt-20 -138.48 158.41 44.32 Favored 'General case' 0 CA--C 1.468 -2.191 0 N-CA-C 108.0 -1.111 . . . . 65.22 108.0 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -70.55 144.58 51.23 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.258 -1.337 . . . . 74.44 110.931 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.27 34.85 0.52 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 105.03 -3.228 . . . . 70.32 105.03 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -91.03 151.77 20.92 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 106.855 -1.535 . . . . 63.12 106.855 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -83.29 168.03 25.15 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 106.513 -1.662 . . . . 75.11 106.513 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.29 169.34 12.51 Favored 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 122.34 2.027 . . . . 64.3 108.965 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 C--O 1.258 1.537 0 N-CA-C 108.438 -0.949 . . . . 73.32 108.438 -177.058 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 103.462 -2.792 . . . . 42.11 103.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.59 153.61 44.91 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.715 -1.587 . . . . 74.41 106.715 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -108.76 141.59 40.54 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.175 -1.787 . . . . 73.15 106.175 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.4 t -128.53 130.61 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 N-CA-C 104.819 -2.289 . . . . 61.52 104.819 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -105.71 113.21 26.64 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 104.931 -2.248 . . . . 72.13 104.931 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 120.98 41.54 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.231 -1.766 . . . . 64.22 106.231 -169.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.72 142.59 28.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.232 -1.766 . . . . 61.11 106.232 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm . . . . . 0 CA--C 1.499 -1.015 0 N-CA-C 107.026 -1.472 . . . . 65.43 107.026 -178.503 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 N-CA-C 110.27 -1.132 . . . . 40.22 110.27 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mt -129.24 158.86 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.433 -2.432 . . . . 53.52 104.433 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -149.99 165.42 32.72 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.147 -3.279 . . . . 43.43 102.147 168.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.71 168.19 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 105.936 -1.875 . . . . 74.01 105.936 -170.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -146.45 166.59 25.95 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 103.029 -2.952 . . . . 73.43 103.029 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.5 -173.3 14.66 Favored Glycine 0 CA--C 1.472 -2.624 0 N-CA-C 107.548 -2.221 . . . . 73.42 107.548 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.78 -127.81 6.08 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 108.838 -1.705 . . . . 31.42 108.838 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -73.18 19.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 126.222 1.809 . . . . 71.22 112.419 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.262 9.5 m120 87.31 65.52 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.672 0 N-CA-C 106.34 -1.726 . . . . 62.43 106.34 -168.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 30' ' ' SER . 3.4 m -80.96 -165.78 0.98 Allowed 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 104.003 -2.592 . . . . 73.2 104.003 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.661 ' H ' HG22 ' A' ' 29' ' ' THR . 3.4 p -42.96 -40.73 3.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 53.04 112.032 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.51 138.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.583 -0.895 . . . . 74.44 108.583 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.24 -42.39 68.92 Favored 'General case' 0 C--N 1.364 1.206 0 N-CA-C 109.787 -0.449 . . . . 63.5 109.787 -171.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -73.9 -5.64 42.34 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.843 -0.799 . . . . 71.23 108.843 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.22 3.25 11.5 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.304 -0.718 . . . . 74.41 111.304 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.53 150.19 42.09 Favored Glycine 0 CA--C 1.475 -2.448 0 N-CA-C 109.625 -1.39 . . . . 40.41 109.625 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.81 87.96 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 105.49 -2.041 . . . . 74.32 105.49 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -88.75 144.19 26.41 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.585 -1.635 . . . . 73.51 106.585 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.21 133.82 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.535 -1.654 . . . . 70.21 106.535 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -104.1 -43.66 5.2 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 106.712 -1.588 . . . . 64.53 106.712 -167.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.18 150.8 36.55 Favored 'General case' 0 CA--C 1.458 -2.569 0 N-CA-C 105.441 -2.059 . . . . 54.41 105.441 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -137.26 132.14 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.622 -2.362 . . . . 72.55 104.622 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.419 HG23 ' HD2' ' A' ' 43' ' ' PRO . 27.3 mt -70.6 137.88 85.91 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 105.546 -2.02 . . . . 74.33 105.546 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 42' ' ' ILE . 19.6 Cg_endo -57.56 123.53 13.96 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.165 1.91 . . . . 71.43 108.744 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 55.74 32.6 19.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.497 1.119 . . . . 71.54 112.053 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.92 -177.95 46.08 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 105.36 -3.096 . . . . 64.41 105.36 168.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.51 98.75 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.279 1.04 . . . . 63.2 109.6 -168.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.05 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 109.233 -0.654 . . . . 64.12 109.233 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -69.24 -38.74 78.62 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 109.648 -0.501 . . . . 73.44 109.648 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -65.38 -37.49 87.16 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.958 -1.126 . . . . 74.41 107.958 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.42 -32.56 66.43 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.532 -1.285 . . . . 72.34 107.532 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.79 64.99 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.726 -0.95 . . . . 61.34 110.726 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -83.33 -41.03 18.71 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.459 -0.941 . . . . 73.24 108.459 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.8 mt -104.78 136.69 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.902 -1.888 . . . . 62.13 105.902 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -138.33 -178.52 5.32 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 104.843 -2.28 . . . . 74.31 104.843 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.42 146.9 54.04 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.678 -0.86 . . . . 70.43 108.678 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.21 -3.73 86.57 Favored Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 109.704 -1.359 . . . . 52.23 109.704 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -80.51 155.45 27.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.461 -2.052 . . . . 75.32 105.461 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -119.68 127.35 52.8 Favored 'General case' 0 CA--C 1.478 -1.807 0 C-N-CA 119.411 -0.916 . . . . 62.33 109.099 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.07 148.13 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.09 -2.189 . . . . 64.12 105.09 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.65 -45.05 2.52 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 106.929 -1.508 . . . . 72.14 106.929 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.81 34.86 Favored 'General case' 0 CA--C 1.482 -1.667 0 C-N-CA 119.226 -0.99 . . . . 75.33 109.288 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.11 110.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 104.097 -2.557 . . . . 70.53 104.097 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.303 0.8 OUTLIER 46.48 38.3 5.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.541 1.137 . . . . 62.34 112.292 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.28 65.87 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.799 -1.32 . . . . 73.53 109.799 171.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.08 119.91 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.693 0 N-CA-C 104.971 -2.233 . . . . 70.52 104.971 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m -67.59 111.0 3.93 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.358 -1.349 . . . . 70.2 107.358 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.31 -14.91 51.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.926 -0.768 . . . . 72.03 108.926 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.98 146.58 46.46 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 109.332 -0.618 . . . . 65.55 109.332 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 -39.23 3.01 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 109.555 -1.418 . . . . 74.43 109.555 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 166.13 22.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.354 -0.98 . . . . 73.55 108.354 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.8 p -89.73 174.55 7.66 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.009 -1.108 . . . . 53.13 108.009 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -64.98 -38.73 91.93 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.987 -0.745 . . . . 64.1 108.987 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -59.59 -45.13 92.79 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 120.016 -0.674 . . . . 64.01 111.008 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -62.65 -39.99 95.63 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 119.746 1.157 . . . . 72.32 108.302 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.1 -42.97 86.8 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.8 -0.445 . . . . 74.14 109.8 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -69.25 -54.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 107.2 -1.407 . . . . 72.22 107.2 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -57.39 -26.46 61.11 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.222 -0.659 . . . . 71.31 109.222 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -65.81 -56.13 13.53 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.52 -55.1 35.8 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.153 -1.054 . . . . 74.5 108.153 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -45.63 -34.89 3.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.251 1.02 . . . . 70.21 111.975 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -96.6 -3.05 43.61 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.435 -0.79 . . . . 72.33 109.69 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -84.35 170.17 13.89 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.736 -1.227 . . . . 73.43 108.627 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.74 -149.32 24.59 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 122.508 1.06 . . . . 41.21 110.616 -171.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -77.82 -53.15 7.82 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.831 -1.174 . . . . 73.54 107.831 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.12 127.89 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.798 0 N-CA-C 103.576 -2.75 . . . . 71.43 103.576 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -133.16 143.13 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 103.796 -2.668 . . . . 74.34 103.796 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -97.28 116.0 28.67 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.542 -2.392 . . . . 73.04 104.542 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -114.52 138.0 51.16 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 105.7 -1.963 . . . . 62.3 105.7 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -113.82 127.85 56.17 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.548 -2.019 . . . . 44.24 105.548 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.81 155.97 49.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.26 -1.756 . . . . 74.52 106.26 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 CA--C 1.488 -1.419 0 N-CA-C 105.596 -2.002 . . . . 72.11 105.596 -178.714 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 104.719 -2.326 . . . . 71.51 104.719 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -145.88 157.11 43.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 105.893 -1.891 . . . . 72.1 105.893 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.25 143.62 32.41 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.848 -1.908 . . . . 73.32 105.848 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.06 128.12 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 104.167 -2.531 . . . . 73.01 104.167 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.26 114.62 26.39 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 105.552 -2.018 . . . . 73.43 105.552 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -103.61 120.84 41.69 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 105.994 -1.854 . . . . 72.43 105.994 -174.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.85 134.71 37.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.163 -1.421 . . . . 71.01 107.163 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 106.356 -1.72 . . . . 75.0 106.356 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.571 ' HA3' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.496 -1.095 0 CA-C-O 119.749 -0.473 . . . . 64.34 112.459 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.2 mt -123.05 153.02 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.394 -2.447 . . . . 75.54 104.394 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.5 m -151.81 163.37 39.33 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 102.769 -3.048 . . . . 71.53 102.769 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.74 168.32 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.401 -2.444 . . . . 73.14 104.401 -166.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -149.65 167.4 26.51 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 103.962 -2.607 . . . . 62.41 103.962 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.65 -171.89 13.99 Favored Glycine 0 CA--C 1.473 -2.56 0 N-CA-C 107.0 -2.44 . . . . 65.02 107.0 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.48 -124.23 5.83 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 108.687 -1.765 . . . . 74.13 108.687 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 m -73.27 20.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.694 0 C-N-CA 125.883 1.673 . . . . 50.24 113.142 -167.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.1 t30 89.93 66.04 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 123.146 1.45 . . . . 72.33 107.39 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 30' ' ' SER . 2.0 m -82.71 -167.2 1.54 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.465 -2.42 . . . . 73.1 104.465 170.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.582 ' H ' HG22 ' A' ' 29' ' ' THR . 16.3 m -58.17 -25.21 61.23 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 121.5 -0.75 . . . . 64.33 111.535 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 m -78.79 131.45 34.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 107.505 -1.295 . . . . 72.52 107.505 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -60.11 -53.69 54.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.921 0.488 . . . . 72.25 110.675 -171.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -76.87 4.77 9.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.829 -0.544 . . . . 74.1 109.88 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.62 13.46 24.17 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.249 -0.74 . . . . 75.52 111.249 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.31 148.02 50.46 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 108.385 -1.886 . . . . 50.1 108.385 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.13 97.11 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.542 -1.651 . . . . 75.41 106.542 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -95.76 143.93 26.58 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 107.043 -1.465 . . . . 74.25 107.043 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.6 t -72.02 130.61 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 N-CA-C 105.064 -2.198 . . . . 45.41 105.064 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -103.09 -39.97 6.66 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 107.316 -1.365 . . . . 50.53 107.316 -166.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.38 158.48 40.12 Favored 'General case' 0 CA--C 1.465 -2.29 0 N-CA-C 106.011 -1.848 . . . . 73.32 106.011 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.46 140.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 104.221 -2.511 . . . . 75.02 104.221 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.571 HG12 ' HA3' ' A' ' 20' ' ' GLY . 24.3 mm -70.67 143.99 90.51 Favored Pre-proline 0 C--N 1.355 0.805 0 N-CA-C 105.741 -1.948 . . . . 74.25 105.741 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.2 112.18 0.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.429 2.086 . . . . 70.34 108.948 165.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 74.91 22.04 1.93 Allowed 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.354 1.034 . . . . 60.24 110.483 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.74 175.68 30.17 Favored Glycine 0 C--N 1.375 2.732 0 N-CA-C 108.275 -1.93 . . . . 74.3 108.275 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.69 98.74 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.036 -0.727 . . . . 60.45 109.036 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.27 76.61 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.582 -0.525 . . . . 74.01 109.582 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.66 -35.13 79.43 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.134 -0.691 . . . . 63.04 109.134 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 m -66.02 -37.43 85.88 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.135 -1.061 . . . . 72.32 108.135 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.48 -41.24 89.27 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.397 -0.964 . . . . 71.23 108.397 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.71 -22.83 26.04 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.104 -1.198 . . . . 74.24 110.104 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -78.48 -38.72 40.27 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.693 -1.225 . . . . 72.32 107.693 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mt -104.84 129.37 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.258 -1.386 . . . . 72.53 107.258 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -140.19 -175.71 4.34 Favored 'General case' 0 CA--C 1.467 -2.25 0 N-CA-C 104.039 -2.578 . . . . 72.14 104.039 172.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 146.38 53.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.339 -1.356 . . . . 73.33 107.339 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.69 -25.23 28.22 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 107.827 -2.109 . . . . 52.54 107.827 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.27 154.68 32.71 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.223 -1.769 . . . . 72.44 106.223 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -134.39 141.0 46.7 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 107.487 -1.301 . . . . 64.25 107.487 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.33 150.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.401 -1.704 . . . . 74.21 106.401 -172.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.59 -46.41 2.86 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 106.953 -1.499 . . . . 73.34 106.953 169.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.16 161.89 30.1 Favored 'General case' 0 CA--C 1.484 -1.577 0 C-N-CA 118.915 -1.114 . . . . 64.55 110.19 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.37 107.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 104.206 -2.516 . . . . 74.11 104.206 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 t30 48.83 37.98 11.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.496 1.119 . . . . 73.33 111.021 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.64 10.17 70.64 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.345 -1.102 . . . . 63.44 110.345 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.59 117.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.948 0 N-CA-C 103.933 -2.617 . . . . 73.12 103.933 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 m -71.66 111.48 6.99 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.561 -1.274 . . . . 73.13 107.561 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.26 -3.26 58.89 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.674 -0.861 . . . . 65.22 108.674 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -63.94 144.03 57.39 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 106.963 -1.495 . . . . 72.31 106.963 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -34.83 3.09 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.022 -0.831 . . . . 62.33 111.022 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.68 162.11 24.41 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 118.356 1.078 . . . . 64.22 108.281 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -82.94 170.21 15.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.94 -0.763 . . . . 54.35 108.94 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -62.81 -44.1 97.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.702 -0.851 . . . . 73.24 108.702 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -62.35 -43.31 99.13 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 118.574 -0.727 . . . . 63.14 111.129 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -35.31 80.16 Favored 'General case' 0 C--N 1.383 2.028 0 CA-C-N 120.166 1.348 . . . . 70.33 109.005 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.89 74.23 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.913 -0.773 . . . . 61.05 108.913 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -73.88 -54.65 14.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 107.527 -1.286 . . . . 75.12 107.527 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 14.4 m -55.33 -29.27 57.97 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 122.705 1.24 . . . . 51.0 108.365 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -68.51 -54.36 17.31 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.504 -1.372 . . . . 72.0 107.647 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.6 mt -54.7 -56.18 21.9 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.707 -0.849 . . . . 71.24 108.707 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -46.15 -47.09 17.62 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.185 0.439 . . . . 73.12 112.185 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -82.93 3.35 30.31 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.357 -0.84 . . . . 60.31 111.077 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.2 p -82.17 173.71 11.87 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.583 1.083 . . . . 73.41 108.375 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.93 -163.12 26.91 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 109.6 -1.4 . . . . 74.4 109.6 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.75 -32.98 27.56 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.101 -1.074 . . . . 62.33 108.101 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.2 t -115.95 127.19 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.605 -2.739 . . . . 61.31 103.605 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.46 151.32 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 104.609 -2.367 . . . . 75.51 104.609 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -102.08 123.68 46.37 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 104.271 -2.492 . . . . 61.1 104.271 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 12' ' ' LEU . 62.1 mt -114.99 138.69 50.55 Favored 'General case' 0 CA--C 1.467 -2.242 0 N-CA-C 104.301 -2.481 . . . . 72.51 104.301 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -112.63 125.37 54.21 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.647 -1.983 . . . . 74.2 105.647 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.75 153.68 49.83 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.164 -1.791 . . . . 65.13 106.164 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.475 -1.932 0 N-CA-C 105.024 -2.214 . . . . 73.41 105.024 -178.421 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 103.692 -2.707 . . . . 53.52 103.692 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -138.58 146.51 41.91 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.233 -1.766 . . . . 71.25 106.233 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.18 138.84 40.07 Favored 'General case' 0 N--CA 1.396 -3.128 0 N-CA-C 104.483 -2.414 . . . . 62.42 104.483 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.02 130.99 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.772 0 N-CA-C 105.498 -2.038 . . . . 72.5 105.498 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -100.78 119.86 39.26 Favored 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 104.707 -2.331 . . . . 72.22 104.707 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 121.08 44.04 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 105.979 -1.86 . . . . 74.45 105.979 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.32 134.29 41.54 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.653 -1.24 . . . . 23.44 107.653 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 107.018 -1.475 . . . . 63.23 107.018 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.418 -2.51 0 N-CA-C 108.636 -1.786 . . . . 73.01 108.636 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.84 158.65 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 106.184 -1.784 . . . . 70.2 106.184 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.2 m -153.31 163.62 39.59 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 102.517 -3.142 . . . . 74.42 102.517 164.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.39 167.33 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 107.036 -1.468 . . . . 62.12 107.036 -161.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -143.71 165.99 26.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 104.562 -2.384 . . . . 71.2 104.562 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.22 -163.06 12.21 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 107.939 -2.065 . . . . 53.21 107.939 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.32 -127.5 6.08 Favored Glycine 0 C--N 1.36 1.877 0 N-CA-C 110.379 -1.088 . . . . 24.23 110.379 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 m -59.85 18.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.195 0 C-N-CA 128.282 2.633 . . . . 63.31 115.29 -167.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 86.44 64.34 0.01 OUTLIER 'General case' 0 CA--C 1.468 -2.196 0 N-CA-C 105.754 -1.943 . . . . 72.33 105.754 -165.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 30' ' ' SER . 2.3 m -88.43 -166.29 1.55 Allowed 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 111.686 -2.506 . . . . 64.4 104.546 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.668 ' H ' HG22 ' A' ' 29' ' ' THR . 11.8 m -58.35 -20.49 43.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.39 0.676 . . . . 21.23 111.226 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.629 -1.248 . . . . 51.41 107.629 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -70.32 -34.24 72.46 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-O 121.508 0.67 . . . . 72.34 109.756 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.44 -15.65 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.202 -1.036 . . . . 72.3 108.202 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.24 8.72 25.89 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 110.391 -1.083 . . . . 75.41 110.391 -176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.97 159.46 53.9 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 107.976 -2.05 . . . . 52.42 107.976 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.0 mm -90.64 95.16 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.464 -2.05 . . . . 33.51 105.464 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.05 146.74 26.5 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.507 -1.294 . . . . 74.32 107.507 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.39 129.0 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.426 -1.694 . . . . 70.23 106.426 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -106.41 -43.79 4.68 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 107.88 -1.155 . . . . 73.5 107.88 -171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.8 144.59 39.42 Favored 'General case' 0 CA--C 1.46 -2.502 0 N-CA-C 105.732 -1.951 . . . . 74.3 105.732 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.7 120.01 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 104.17 -2.53 . . . . 74.03 104.17 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.498 HD12 ' HA2' ' A' ' 20' ' ' GLY . 18.3 mt -72.88 135.06 80.79 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.122 -1.807 . . . . 64.22 106.122 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 42' ' ' ILE . 19.0 Cg_endo -58.2 121.6 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.803 2.335 . . . . 74.01 109.647 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 65.65 23.2 11.66 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.482 1.114 . . . . 74.31 110.461 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 175.34 49.18 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 106.698 -2.561 . . . . 50.04 106.698 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.1 82.92 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.613 -0.884 . . . . 74.41 108.613 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.48 76.85 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.222 -0.659 . . . . 71.55 109.222 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.32 -35.07 73.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.816 0.341 . . . . 74.04 110.112 -173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -68.33 -37.13 80.24 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.176 -1.046 . . . . 72.21 108.176 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.12 -47.0 72.45 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 107.124 -1.436 . . . . 65.43 107.124 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.09 -21.6 19.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 111.386 -0.686 . . . . 53.44 111.386 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -72.82 -35.13 67.24 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.559 1.18 . . . . 71.43 107.984 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.2 mt -94.55 135.98 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 105.964 -1.865 . . . . 45.54 105.964 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -144.31 176.06 9.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.262 -1.755 . . . . 54.13 106.262 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.95 137.1 56.28 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.799 -1.556 . . . . 72.12 106.799 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.99 -18.2 26.49 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 107.336 -2.306 . . . . 54.42 107.336 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.28 155.45 27.29 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 108.109 -1.071 . . . . 70.03 108.109 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -120.15 135.33 55.0 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 104.785 -2.302 . . . . 73.55 104.785 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.0 143.95 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 104.555 -2.387 . . . . 70.32 104.555 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -46.9 2.53 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.14 -1.43 . . . . 71.53 107.14 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.37 165.34 22.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 CA-C-O 122.394 1.093 . . . . 63.4 109.625 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -142.13 113.0 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 N-CA-C 103.486 -2.783 . . . . 72.43 103.486 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 53.52 31.27 12.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.072 0.549 . . . . 73.11 110.473 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.49 79.61 Favored Glycine 0 C--N 1.357 1.728 0 N-CA-C 110.209 -1.156 . . . . 62.21 110.209 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.98 124.92 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 104.707 -2.331 . . . . 72.32 104.707 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.0 m -64.35 104.33 0.75 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.436 -1.32 . . . . 62.44 107.436 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -21.3 21.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.486 -1.302 . . . . 74.33 107.486 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.41 146.26 48.93 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.005 . . . . 73.45 108.288 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.27 -35.39 3.58 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 109.872 -1.291 . . . . 51.31 109.872 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.78 161.65 28.0 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.102 -1.073 . . . . 73.52 108.102 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.0 p -77.83 168.46 19.89 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.685 0.755 . . . . 62.43 109.301 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -63.16 -42.27 99.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.986 -1.116 . . . . 63.05 107.986 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -56.02 -50.63 70.35 Favored 'General case' 0 C--N 1.367 1.338 0 N-CA-C 109.919 -0.4 . . . . 74.33 109.919 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -64.53 -37.12 86.45 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.307 -0.627 . . . . 64.4 109.307 -171.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.62 77.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.099 -0.704 . . . . 73.34 109.099 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.3 t -73.69 -52.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.529 -1.285 . . . . 73.32 107.529 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 46.6 m -53.04 -28.14 23.03 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-O 121.901 0.858 . . . . 70.21 109.009 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.25 -56.37 10.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.21 -1.404 . . . . 75.13 107.21 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.6 mt -56.75 -56.61 19.32 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.712 -0.847 . . . . 65.32 108.712 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -47.62 -27.14 1.73 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.048 1.129 . . . . 64.14 114.048 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.85 4.79 43.08 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 119.666 1.121 . . . . 74.43 109.047 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.2 p -84.86 170.28 13.29 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 121.055 -1.028 . . . . 73.12 108.4 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.6 -151.14 26.56 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.711 -1.755 . . . . 65.14 108.711 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -80.79 -43.17 20.52 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 107.994 -1.113 . . . . 64.32 107.994 -171.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.58 123.62 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 104.741 -2.318 . . . . 71.05 104.741 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -127.99 147.53 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.758 0 N-CA-C 105.373 -2.084 . . . . 53.35 105.373 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -99.88 115.66 30.13 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.152 -2.166 . . . . 62.21 105.152 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.82 134.27 52.66 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 104.62 -2.363 . . . . 60.32 104.62 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.57 124.37 52.2 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 105.129 -2.174 . . . . 75.12 105.129 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -133.18 159.34 40.46 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 106.843 -1.54 . . . . 75.21 106.843 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.478 -1.81 0 N-CA-C 103.112 -2.922 . . . . 74.34 103.112 172.751 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 103.91 -2.626 . . . . 72.24 103.91 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.13 150.51 45.74 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.656 -1.239 . . . . 74.2 107.656 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -102.69 136.7 42.04 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 104.875 -2.269 . . . . 71.13 104.875 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -125.56 134.26 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 105.63 -1.989 . . . . 74.01 105.63 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -106.68 109.88 21.92 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.575 -2.009 . . . . 75.45 105.575 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -102.99 121.6 42.88 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.841 -1.911 . . . . 74.32 105.841 -171.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.34 130.0 35.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.068 -1.456 . . . . 71.1 107.068 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 106.99 -1.485 . . . . 72.51 106.99 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.64 ' HA3' ' H ' ' A' ' 47' ' ' ALA . . . . . . . . 0 C--O 1.203 -1.789 0 N-CA-C 111.437 -0.665 . . . . 65.13 111.437 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mm -110.13 157.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 106.404 -1.702 . . . . 74.21 106.404 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.8 m -146.49 155.93 42.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 101.571 -3.492 . . . . 74.33 101.571 163.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.31 160.57 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 C-N-CA 119.309 -0.956 . . . . 74.32 109.833 -166.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 t -145.22 166.29 25.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 103.032 -2.951 . . . . 54.35 103.032 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.74 123.72 4.0 Favored Glycine 0 C--O 1.193 -2.408 0 N-CA-C 108.407 -1.877 . . . . 51.45 108.407 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.18 -115.37 0.44 Allowed Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.096 -1.602 . . . . 75.51 109.096 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.79 20.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 126.17 1.788 . . . . 51.24 115.031 -163.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.3 t30 88.3 64.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 123.702 1.715 . . . . 52.44 106.476 -164.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -90.0 -165.28 1.31 Allowed 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 102.587 -3.116 . . . . 73.33 102.587 165.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -40.49 -33.35 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.412 1.085 . . . . 72.22 112.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.68 132.99 36.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 O-C-N 121.15 -0.969 . . . . 75.21 108.579 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -64.12 -58.03 7.83 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.565 -1.198 . . . . 61.14 111.899 -168.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -79.94 5.06 14.92 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.49 -0.756 . . . . 75.11 109.071 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.85 33.26 83.54 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 108.504 -1.839 . . . . 75.3 108.504 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.4 124.77 34.17 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 107.525 -2.23 . . . . 63.15 107.525 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mm -81.39 90.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.675 -2.342 . . . . 73.03 104.675 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -85.57 146.16 27.02 Favored 'General case' 0 CA--C 1.467 -2.212 0 N-CA-C 107.887 -1.153 . . . . 65.11 107.887 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.12 125.98 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.749 -1.945 . . . . 71.23 105.749 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -91.55 -38.38 12.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 106.672 -1.603 . . . . 65.54 106.672 -168.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.59 155.5 38.56 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 105.825 -1.917 . . . . 75.02 105.825 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.97 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 102.06 -3.311 . . . . 74.51 102.06 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.95 130.35 93.93 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 106.554 -1.647 . . . . 65.43 106.554 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.26 123.93 14.49 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.809 2.339 . . . . 64.42 109.477 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 68.67 10.09 7.69 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 124.781 1.3 . . . . 72.25 110.756 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.57 -175.18 37.17 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.973 -1.651 . . . . 54.41 108.973 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.85 74.34 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.054 -0.721 . . . . 63.24 109.054 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.64 ' H ' ' HA3' ' A' ' 20' ' ' GLY . . . -68.99 -46.03 69.08 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 108.908 -0.775 . . . . 72.14 108.908 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.22 -36.0 80.62 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 108.741 -0.837 . . . . 73.11 108.741 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.7 t -64.18 -40.13 95.45 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 108.203 -1.036 . . . . 54.42 108.203 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -73.86 -48.25 32.44 Favored 'General case' 0 C--N 1.351 0.63 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.34 -17.44 13.47 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.771 -0.532 . . . . 63.22 111.771 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . 33.9 ttm105 -72.98 -33.76 66.02 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.852 -1.166 . . . . 72.23 107.852 -173.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.16 135.61 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.069 -1.826 . . . . 72.32 106.069 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 52' ' ' ARG . 25.6 m80 -118.59 162.87 17.68 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 106.995 -1.483 . . . . 73.55 106.995 -175.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -65.78 136.42 56.19 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 106.981 -1.488 . . . . 71.41 106.981 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.75 -10.0 72.88 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.78 -1.728 . . . . 70.13 108.78 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -66.51 143.41 57.09 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 105.884 -1.895 . . . . 70.15 105.884 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.7 tmm_? -103.15 119.82 39.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.376 -1.342 . . . . 75.51 107.376 -169.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 t -89.18 141.62 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 105.766 -1.939 . . . . 73.22 105.766 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -47.0 2.51 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 70.31 107.32 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.32 167.63 18.92 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.373 1.082 . . . . 64.31 109.493 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -141.07 108.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 103.533 -2.766 . . . . 70.5 103.533 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 49.91 39.64 18.99 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.089 0.956 . . . . 73.1 110.598 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.55 20.1 78.74 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 109.936 -1.266 . . . . 62.34 109.936 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.63 119.35 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 N-CA-C 104.124 -2.547 . . . . 64.33 104.124 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -70.24 105.9 3.13 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.234 -0.654 . . . . 54.01 109.234 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.88 -7.07 53.23 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.027 -1.471 . . . . 72.25 107.027 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.97 143.67 57.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.109 -1.441 . . . . 72.41 107.109 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.83 2.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.983 -0.847 . . . . 23.01 110.983 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.89 172.66 4.19 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 118.218 1.009 . . . . 60.3 109.766 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -82.65 156.47 23.84 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.603 -1.258 . . . . 75.53 107.603 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -66.28 -37.65 85.94 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.89 -1.152 . . . . 72.34 107.89 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -39.45 87.16 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 120.639 -0.424 . . . . 72.21 110.188 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.71 -36.45 83.9 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-N 119.389 0.995 . . . . 73.23 109.018 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.14 75.83 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.078 -0.712 . . . . 72.11 109.078 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 -53.45 25.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 N-CA-C 107.278 -1.379 . . . . 71.4 107.278 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.0 m -52.49 -29.19 23.7 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 108.294 -1.002 . . . . 74.22 108.294 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.1 m -69.19 -56.23 8.25 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 108.015 -1.105 . . . . 70.51 108.015 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -53.52 -56.17 19.31 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.844 -0.799 . . . . 54.45 108.844 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -46.58 -43.3 17.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.551 -0.749 . . . . 74.5 111.475 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -77.37 -14.55 59.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.509 0.323 . . . . 62.22 110.711 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -76.13 163.26 27.27 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 120.668 -1.27 . . . . 74.42 108.927 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.84 -146.68 6.46 Favored Glycine 0 CA--C 1.491 -1.447 0 N-CA-C 109.245 -1.542 . . . . 72.24 109.245 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -85.39 -42.64 14.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 107.793 -1.188 . . . . 75.32 107.793 -172.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.6 t -108.08 128.31 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 104.277 -2.49 . . . . 55.5 104.277 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.07 139.15 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 105.825 -1.917 . . . . 74.23 105.825 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -97.24 115.87 28.41 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 104.699 -2.334 . . . . 73.12 104.699 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 12' ' ' LEU . 18.1 mt -112.84 137.22 51.51 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 104.84 -2.281 . . . . 75.31 104.84 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 tp -114.62 124.17 51.17 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.943 -2.243 . . . . 62.53 104.943 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.5 158.18 41.58 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 107.436 -1.32 . . . . 73.33 107.436 -173.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 58' ' ' ARG . 42.2 tt0 . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 103.876 -2.639 . . . . 71.13 103.876 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 104.139 -2.541 . . . . 75.32 104.139 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -152.34 159.77 43.41 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.346 -2.094 . . . . 72.33 105.346 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.12 145.79 28.85 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 105.256 -2.128 . . . . 73.1 105.256 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.72 122.74 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 103.448 -2.797 . . . . 44.22 103.448 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -99.6 109.48 21.98 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.283 -2.488 . . . . 63.22 104.283 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 105.44 -2.059 . . . . 74.1 105.44 -171.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.18 134.18 34.13 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.064 -1.828 . . . . 60.45 106.064 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 108.313 -0.995 . . . . 73.32 108.313 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.482 -2.025 0 N-CA-C 106.981 -2.447 . . . . 52.33 106.981 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 mt -131.05 160.04 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 104.959 -2.237 . . . . 71.44 104.959 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.14 162.86 37.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.562 -3.125 . . . . 71.12 102.562 163.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.97 167.85 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 N-CA-C 105.801 -1.925 . . . . 71.12 105.801 -165.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -147.41 166.5 26.99 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 102.721 -3.066 . . . . 63.33 102.721 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.496 ' H ' HG21 ' A' ' 29' ' ' THR . . . 127.92 178.57 15.4 Favored Glycine 0 CA--C 1.459 -3.46 0 N-CA-C 105.715 -2.954 . . . . 51.33 105.715 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.75 -130.52 6.99 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 108.823 -1.711 . . . . 54.13 108.823 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.39 19.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 126.721 2.008 . . . . 64.05 114.212 -165.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.5 t30 88.37 65.6 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.051 -1.463 . . . . 54.24 107.051 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.496 HG21 ' H ' ' A' ' 25' ' ' GLY . 15.3 t -94.71 -166.24 1.44 Allowed 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 104.094 -2.558 . . . . 73.24 104.094 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 m -47.41 -40.7 18.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.732 1.213 . . . . 60.23 112.59 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 m -76.16 133.78 30.4 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 N-CA-C 108.871 -0.788 . . . . 64.12 108.871 -173.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -57.77 -55.15 38.54 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.19 0.996 . . . . 75.13 112.492 -169.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -76.22 6.61 5.21 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.297 -0.877 . . . . 60.14 110.111 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 57.53 6.44 2.38 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 121.516 -0.74 . . . . 55.44 111.967 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.68 160.65 53.81 Favored Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 107.364 -2.294 . . . . 74.44 107.364 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mm -83.92 108.62 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 106.14 -1.8 . . . . 75.51 106.14 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 42.9 m-85 -103.75 144.08 31.94 Favored 'General case' 0 CA--C 1.48 -1.74 0 N-CA-C 106.84 -1.541 . . . . 74.11 106.84 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.94 132.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.031 -1.841 . . . . 54.44 106.031 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -114.72 -37.48 4.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.228 -1.027 . . . . 74.24 108.228 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.57 146.43 34.59 Favored 'General case' 0 CA--C 1.463 -2.366 0 N-CA-C 106.716 -1.587 . . . . 60.2 106.716 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.03 119.35 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 104.979 -2.23 . . . . 73.54 104.979 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 20' ' ' GLY . 23.3 mt -72.46 140.09 81.75 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 106.575 -1.639 . . . . 71.24 106.575 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 42' ' ' ILE . 18.7 Cg_endo -57.6 119.9 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.731 2.287 . . . . 63.42 109.785 177.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 68.75 25.29 6.38 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 125.12 1.512 . . . . 74.34 110.372 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.02 173.44 52.62 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 107.653 -2.179 . . . . 72.22 107.653 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.38 99.29 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.796 -0.816 . . . . 74.24 108.796 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.19 77.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.311 -0.626 . . . . 62.14 109.311 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.5 -42.17 95.81 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.027 -0.731 . . . . 61.54 109.027 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -67.82 -36.69 80.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.614 -0.513 . . . . 61.54 109.614 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.86 -36.91 75.89 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.637 -1.246 . . . . 35.31 107.637 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -18.95 23.94 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.039 -0.824 . . . . 62.24 111.039 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -74.62 -39.75 61.94 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.426 -0.953 . . . . 74.44 108.426 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -95.74 120.62 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 105.829 -1.915 . . . . 63.53 105.829 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.21 169.85 10.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.657 -1.979 . . . . 72.15 105.657 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -66.52 137.86 57.09 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.501 -1.666 . . . . 75.32 106.501 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.05 -26.16 23.99 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 108.328 -1.909 . . . . 75.13 108.328 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.55 166.5 21.68 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.69 -1.226 . . . . 71.03 107.69 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -130.29 139.39 50.74 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 107.489 -1.3 . . . . 71.12 107.489 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.48 143.97 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 104.086 -2.561 . . . . 54.5 104.086 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.37 -46.92 3.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.563 -1.273 . . . . 74.33 107.563 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.91 166.09 21.69 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.377 1.085 . . . . 70.34 109.827 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.46 104.35 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 103.783 -2.673 . . . . 61.25 103.783 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 46.91 43.28 13.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.091 0.956 . . . . 52.25 110.849 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.81 76.6 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.217 -1.153 . . . . 64.15 110.217 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.34 117.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 104.467 -2.42 . . . . 72.22 104.467 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -75.33 107.48 7.47 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.786 -1.191 . . . . 64.12 107.786 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.35 -6.29 56.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.513 -0.767 . . . . 71.2 110.034 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -61.47 142.75 56.81 Favored 'General case' 0 C--N 1.361 1.073 0 O-C-N 120.875 -1.141 . . . . 74.54 108.834 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.94 -25.06 6.19 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.385 -1.086 . . . . 54.25 110.385 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 164.0 26.5 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.203 1.001 . . . . 62.42 108.892 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 p -81.54 163.62 22.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.625 -0.88 . . . . 72.11 108.625 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -61.49 -44.94 96.19 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.445 -0.798 . . . . 72.05 108.936 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -30.73 70.66 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 120.302 -0.559 . . . . 72.34 109.918 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -65.55 -36.2 83.09 Favored 'General case' 0 C--N 1.373 1.622 0 N-CA-C 108.521 -0.918 . . . . 73.23 108.521 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.39 -34.19 73.56 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.553 -0.906 . . . . 50.13 108.553 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.67 -53.63 19.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.156 -1.424 . . . . 75.34 107.156 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.3 m -53.26 -29.05 30.71 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.199 -1.038 . . . . 54.11 108.199 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.5 m -69.91 -55.83 8.65 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.531 -1.285 . . . . 72.45 107.531 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -55.78 -55.49 31.74 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.062 -0.718 . . . . 73.14 109.062 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -45.97 -37.91 7.07 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.653 0.612 . . . . 73.25 112.653 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -90.23 8.28 33.95 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.29 0.95 . . . . 65.44 110.283 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -74.32 163.54 27.68 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-N 119.587 1.085 . . . . 63.14 109.51 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.74 -158.79 19.87 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 109.067 -1.613 . . . . 52.32 109.067 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.449 ' H ' ' CD ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -81.99 -38.45 25.08 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.886 -0.783 . . . . 62.32 108.886 -169.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.8 t -113.34 130.06 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 103.553 -2.758 . . . . 70.43 103.553 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -122.27 142.12 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 104.827 -2.286 . . . . 73.12 104.827 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -100.71 119.22 38.28 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 104.333 -2.469 . . . . 73.31 104.333 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.46 134.62 54.56 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 103.726 -2.694 . . . . 72.42 103.726 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.57 126.94 53.49 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 105.764 -1.939 . . . . 71.04 105.764 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -134.37 155.33 50.46 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.211 -1.774 . . . . 70.31 106.211 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 . . . . . 0 CA--C 1.477 -1.863 0 N-CA-C 102.685 -3.079 . . . . 53.25 102.685 176.053 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 104.704 -2.332 . . . . 75.03 104.704 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -138.53 149.04 44.94 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.599 -1.63 . . . . 74.22 106.599 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HG2' HD13 ' A' ' 89' ' ' LEU . 89.4 mt-10 -103.22 139.72 38.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.574 -1.639 . . . . 65.44 106.574 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.04 135.28 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 106.939 -1.504 . . . . 71.41 106.939 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -105.9 112.8 26.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 104.533 -2.395 . . . . 65.24 104.533 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.18 125.12 50.69 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.586 -1.635 . . . . 74.32 106.586 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.22 133.84 37.32 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.931 -1.507 . . . . 73.34 106.931 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mptt . . . . . 0 CA--C 1.483 -1.599 0 N-CA-C 105.993 -1.854 . . . . 60.43 105.993 -177.278 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.528 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.478 -2.247 0 N-CA-C 109.498 -1.441 . . . . 52.41 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.51 145.7 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 103.537 -2.764 . . . . 75.02 103.537 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.48 162.99 34.38 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 103.07 -2.937 . . . . 63.35 103.07 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.09 168.0 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 N-CA-C 104.829 -2.286 . . . . 71.41 104.829 -167.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.6 t -145.79 166.03 27.11 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.319 -2.474 . . . . 71.12 104.319 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.83 131.74 3.64 Favored Glycine 0 C--O 1.2 -2.01 0 N-CA-C 108.594 -1.802 . . . . 42.13 108.594 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.2 -99.07 0.14 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 107.526 -2.229 . . . . 64.51 107.526 167.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.31 20.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.386 1.874 . . . . 63.42 114.94 -170.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 88.71 66.41 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.926 0 CA-C-O 123.337 1.542 . . . . 75.11 106.991 -168.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.78 HG22 ' H ' ' A' ' 30' ' ' SER . 4.3 m -84.38 -166.57 1.48 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.478 -2.416 . . . . 71.52 104.478 173.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.78 ' H ' HG22 ' A' ' 29' ' ' THR . 10.5 m -53.16 -28.11 24.57 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.339 0.656 . . . . 60.11 110.9 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 m -82.57 122.25 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.787 -1.56 . . . . 63.13 106.787 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -83.59 -16.76 44.1 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.683 -0.858 . . . . 63.05 108.683 -170.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 35' ' ' GLY . 11.6 t-160 -70.77 -12.19 61.4 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.739 -1.208 . . . . 70.2 107.739 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.37 -5.36 1.54 Allowed Glycine 0 C--N 1.365 2.147 0 C-N-CA 124.155 0.883 . . . . 71.13 111.505 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 33' ' ' HIS . . . -70.28 151.19 49.59 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 107.931 -2.067 . . . . 71.15 107.931 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.408 HG21 ' HB1' ' A' ' 75' ' ' ALA . 10.7 mm -82.17 126.08 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.449 -2.426 . . . . 74.12 104.449 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -111.91 145.6 39.26 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 106.89 -1.522 . . . . 71.52 106.89 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -74.52 129.36 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.386 -2.079 . . . . 71.04 105.386 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -116.45 -35.28 4.32 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.741 -1.207 . . . . 70.32 107.741 -170.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.04 136.28 45.87 Favored 'General case' 0 CA--C 1.452 -2.798 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 -167.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -139.39 129.76 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 103.765 -2.68 . . . . 73.11 103.765 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.528 HG12 ' CA ' ' A' ' 20' ' ' GLY . 6.5 mm -70.94 147.46 94.0 Favored Pre-proline 0 CA--C 1.505 -0.751 0 N-CA-C 105.082 -2.192 . . . . 75.41 105.082 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 114.35 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.876 1.717 . . . . 63.1 107.801 164.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 68.95 26.49 5.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 124.542 1.151 . . . . 60.34 111.044 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.15 177.12 43.14 Favored Glycine 0 C--N 1.368 2.34 0 N-CA-C 106.474 -2.65 . . . . 51.03 106.474 167.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.04 95.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 122.124 -0.633 . . . . 72.42 109.342 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.25 -49.2 78.07 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.413 -0.588 . . . . 73.24 109.413 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.46 -36.8 81.88 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -65.18 -44.02 89.79 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.458 -0.942 . . . . 61.43 108.458 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -70.36 -33.0 70.92 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.235 -1.395 . . . . 74.31 107.235 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.27 -16.12 45.76 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 110.481 -1.048 . . . . 55.21 110.481 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -79.42 -34.68 41.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.695 -0.854 . . . . 74.04 108.695 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.4 mt -105.25 141.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.852 -1.907 . . . . 71.03 105.852 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -143.56 178.33 7.86 Favored 'General case' 0 CA--C 1.466 -2.252 0 N-CA-C 104.526 -2.398 . . . . 74.4 104.526 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.91 146.96 53.85 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.007 -1.479 . . . . 73.11 107.007 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.14 -16.49 53.62 Favored Glycine 0 CA--C 1.498 -0.997 0 N-CA-C 107.335 -2.306 . . . . 65.51 107.335 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.29 146.57 31.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.998 -1.852 . . . . 70.32 105.998 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.8 tmm_? -108.83 123.82 49.65 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 105.377 -2.083 . . . . 74.24 105.377 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.29 141.2 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 105.545 -2.021 . . . . 63.32 105.545 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -49.01 2.31 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.89 -1.152 . . . . 71.22 107.89 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.98 166.83 19.27 Favored 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 118.873 -1.131 . . . . 74.5 109.92 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.71 100.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 103.395 -2.817 . . . . 73.32 103.395 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 t30 48.16 41.99 16.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.731 1.212 . . . . 51.51 110.954 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 13.04 77.02 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.053 -1.219 . . . . 75.23 110.053 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.14 116.85 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.759 0 N-CA-C 103.647 -2.723 . . . . 74.24 103.647 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 m -72.45 112.22 8.32 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.137 -1.06 . . . . 53.35 108.137 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.79 9.63 26.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.905 -1.517 . . . . 70.15 106.905 172.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.79 140.01 49.25 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.436 -1.69 . . . . 72.23 106.436 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 -23.23 4.58 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.291 -1.124 . . . . 62.21 110.291 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.93 164.72 16.93 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.895 0.855 . . . . 53.34 109.53 -175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 p -82.36 155.16 24.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.958 -1.497 . . . . 55.33 106.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -62.72 -37.63 87.28 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -55.84 -43.05 76.66 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 110.097 -0.334 . . . . 65.4 110.097 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -66.23 -39.97 89.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.277 -1.009 . . . . 60.41 108.277 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB1' HG21 ' A' ' 36' ' ' ILE . . . -55.97 -39.73 72.22 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 110.056 -0.35 . . . . 42.41 110.056 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.04 -56.25 9.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 107.754 -1.202 . . . . 52.22 107.754 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 72.0 m -63.59 -25.97 68.48 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.788 -0.819 . . . . 74.12 108.788 -166.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.7 m -60.7 -52.81 63.55 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 107.669 -1.234 . . . . 71.44 107.669 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.1 mt -55.27 -55.23 33.82 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.657 0.742 . . . . 62.44 109.519 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -48.16 -36.41 13.48 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.035 -0.415 . . . . 74.32 112.082 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -89.93 -9.75 47.67 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.67 -0.644 . . . . 72.52 110.095 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -81.31 179.54 7.81 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.754 -1.202 . . . . 71.2 107.754 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.88 -166.73 31.43 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.843 -1.303 . . . . 71.2 109.843 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.63 -35.95 38.62 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.808 -1.553 . . . . 74.11 106.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -116.29 127.74 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 N-CA-C 103.036 -2.95 . . . . 75.14 103.036 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.76 151.58 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.87 0 N-CA-C 104.606 -2.368 . . . . 62.35 104.606 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.85 123.88 40.68 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 104.305 -2.48 . . . . 71.03 104.305 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.4 mt -118.84 140.77 49.42 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 105.428 -2.064 . . . . 54.04 105.428 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.406 HD13 ' HG2' ' A' ' 9' ' ' GLU . 17.8 tp -114.22 124.14 51.3 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 105.053 -2.203 . . . . 75.02 105.053 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.11 157.19 44.85 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.691 -1.226 . . . . 74.03 107.691 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 58' ' ' ARG . 36.2 tt0 . . . . . 0 N--CA 1.4 -2.972 0 N-CA-C 103.154 -2.906 . . . . 62.45 103.154 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 103.82 -2.659 . . . . 61.04 103.82 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.21 146.57 52.11 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 105.209 -2.145 . . . . 73.11 105.209 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -102.44 135.4 44.12 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.024 -2.213 . . . . 63.15 105.024 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.27 129.94 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 105.851 -1.907 . . . . 71.31 105.851 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -101.05 112.5 24.97 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 103.72 -2.696 . . . . 54.4 103.72 168.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HB2' HD12 ' A' ' 88' ' ' LEU . 1.3 tm? -102.87 124.71 48.89 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.486 -2.042 . . . . 61.41 105.486 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.8 120.31 29.0 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.504 -1.665 . . . . 52.11 106.504 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? . . . . . 0 CA--C 1.492 -1.274 0 N-CA-C 107.034 -1.469 . . . . 73.13 107.034 176.177 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.976 0 N-CA-C 110.691 -0.964 . . . . 75.13 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.63 154.28 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.026 -2.583 . . . . 64.34 104.026 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.5 t -154.14 165.87 34.86 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.461 -2.422 . . . . 74.34 104.461 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.21 167.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 105.688 -1.967 . . . . 72.41 105.688 -168.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -146.11 166.53 25.87 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 104.584 -2.376 . . . . 74.33 104.584 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.93 134.37 3.02 Favored Glycine 0 C--O 1.196 -2.241 0 N-CA-C 108.853 -1.699 . . . . 43.14 108.853 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.97 -97.41 0.12 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 108.717 -1.753 . . . . 40.34 108.717 167.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.98 21.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 127.183 2.193 . . . . 74.41 116.017 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 87.37 66.29 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.733 -1.58 . . . . 64.31 106.733 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 30' ' ' SER . 4.1 m -88.38 -166.97 1.73 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.184 -2.524 . . . . 74.24 104.184 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.715 ' H ' HG22 ' A' ' 29' ' ' THR . 15.6 m -58.43 -21.01 49.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.553 -0.717 . . . . 54.21 110.625 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.58 126.27 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.765 -1.568 . . . . 64.13 106.765 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.7 mtm-85 -51.92 -57.6 8.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 115.204 -0.907 . . . . 72.4 112.363 -168.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -82.87 7.15 16.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.938 -0.764 . . . . 71.52 108.938 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.13 25.1 69.32 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 108.592 -1.803 . . . . 33.31 108.592 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.43 139.84 38.14 Favored Glycine 0 CA--C 1.479 -2.201 0 N-CA-C 107.394 -2.282 . . . . 52.4 107.394 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.29 120.35 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 104.645 -2.354 . . . . 74.2 104.645 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.55 146.65 41.54 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 106.306 -1.739 . . . . 74.4 106.306 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.26 135.02 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 73.11 107.084 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -49.12 3.22 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.518 -1.29 . . . . 72.43 107.518 -167.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 144.42 34.0 Favored 'General case' 0 CA--C 1.461 -2.469 0 N-CA-C 104.859 -2.274 . . . . 73.54 104.859 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.83 132.57 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 104.265 -2.494 . . . . 72.32 104.265 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.53 133.46 80.19 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 106.037 -1.838 . . . . 71.01 106.037 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.48 113.66 1.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.52 2.146 . . . . 64.22 108.141 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.36 21.9 5.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 124.621 1.201 . . . . 72.21 111.327 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.67 -166.74 27.96 Favored Glycine 0 C--N 1.367 2.271 0 N-CA-C 106.206 -2.758 . . . . 71.54 106.206 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 117.999 0.899 . . . . 72.44 110.427 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.58 -45.75 74.65 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 109.916 -0.402 . . . . 75.14 109.916 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -71.88 -39.06 69.88 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.481 -0.563 . . . . 72.35 109.481 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 t -65.9 -46.12 79.48 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.777 -1.194 . . . . 71.15 107.777 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.52 -32.33 71.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 106.92 -1.511 . . . . 60.22 106.92 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.73 -10.4 51.65 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.524 -0.762 . . . . 71.43 111.281 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -69.78 -38.25 76.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.945 -0.738 . . . . 61.41 110.025 -172.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.69 140.31 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 105.945 -1.872 . . . . 72.53 105.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -131.36 176.19 8.5 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.99 -1.485 . . . . 75.1 106.99 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.84 144.04 56.52 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.334 -0.987 . . . . 64.25 108.334 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.86 -4.17 74.93 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 109.678 -1.369 . . . . 72.12 109.678 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -86.25 156.35 20.32 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.823 -1.177 . . . . 71.54 107.823 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 118.56 37.04 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.992 -1.484 . . . . 73.25 106.992 -170.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.6 t -103.43 141.71 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 104.998 -2.223 . . . . 64.11 104.998 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.38 -45.66 2.62 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.589 -1.263 . . . . 71.04 107.589 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.34 158.21 39.76 Favored 'General case' 0 CA--C 1.477 -1.834 0 C-N-CA 118.695 -1.202 . . . . 75.44 109.345 -175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.79 106.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 104.775 -2.305 . . . . 74.44 104.775 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 45.19 43.9 8.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.255 1.422 . . . . 54.52 111.262 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.56 84.92 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.068 -1.213 . . . . 64.2 110.068 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.37 117.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.396 0 N-CA-C 103.151 -2.907 . . . . 75.11 103.151 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.7 m -75.69 114.33 14.15 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.775 -1.565 . . . . 74.3 106.775 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.29 28.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.594 -1.262 . . . . 74.52 107.594 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -75.55 122.5 23.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.12 -1.437 . . . . 50.52 107.12 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -9.68 52.81 Favored Glycine 0 C--N 1.328 0.1 0 N-CA-C 110.918 -0.873 . . . . 43.43 110.918 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 161.29 29.69 Favored 'General case' 0 C--N 1.364 1.232 0 CA-C-N 118.806 1.303 . . . . 73.43 107.598 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.6 p -82.31 167.14 18.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.406 -0.961 . . . . 72.45 108.406 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -66.52 -41.87 88.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.147 -0.686 . . . . 64.34 109.147 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -38.06 89.68 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.697 -0.668 . . . . 73.31 110.3 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -65.58 -35.8 81.9 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.143 1.338 . . . . 75.24 109.182 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.1 69.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.408 -0.59 . . . . 75.14 109.408 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.9 -53.75 19.13 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.265 -1.383 . . . . 70.45 107.265 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 63.8 m -54.7 -29.26 52.61 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 122.38 1.086 . . . . 75.32 108.374 -173.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.8 m -64.98 -53.32 47.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.149 -1.426 . . . . 73.23 107.149 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.42 -55.12 35.41 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.041 -0.725 . . . . 60.32 109.041 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -46.48 -41.07 13.45 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 116.629 -0.26 . . . . 61.41 111.273 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.52 -3.76 58.2 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.697 -0.627 . . . . 63.43 110.947 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 p -81.61 169.76 16.66 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 120.254 1.388 . . . . 73.53 108.598 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.02 -168.75 30.06 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.682 -1.367 . . . . 72.25 109.682 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -79.01 -25.07 43.3 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.485 -0.932 . . . . 63.53 108.485 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.13 130.35 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 103.625 -2.731 . . . . 64.21 103.625 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.94 139.59 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.791 -1.929 . . . . 70.24 105.791 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -95.67 116.57 29.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 104.402 -2.444 . . . . 73.12 104.402 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 12' ' ' LEU . 41.7 mt -118.79 139.82 50.96 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 106.138 -1.801 . . . . 73.24 106.138 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 127.87 55.72 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.461 -2.051 . . . . 72.32 105.461 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.86 156.72 47.57 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.689 -1.226 . . . . 73.43 107.689 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 CA--C 1.438 -3.336 0 N-CA-C 104.995 -2.224 . . . . 71.21 104.995 175.056 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.498 -1.029 0 N-CA-C 104.291 -2.485 . . . . 72.52 104.291 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -144.81 152.07 39.76 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.044 -2.206 . . . . 72.43 105.044 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.04 148.13 28.1 Favored 'General case' 0 N--CA 1.402 -2.829 0 N-CA-C 104.758 -2.312 . . . . 60.2 104.758 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.82 131.15 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 N-CA-C 103.712 -2.699 . . . . 64.31 103.712 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -103.85 111.91 24.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 104.327 -2.472 . . . . 75.11 104.327 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.425 ' CD1' ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -103.68 125.24 50.05 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.908 -1.516 . . . . 74.54 106.908 -164.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.1 124.8 37.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 105.694 -1.965 . . . . 54.24 105.694 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 107.639 -1.245 . . . . 64.54 107.639 -176.138 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.492 -1.375 0 N-CA-C 110.543 -1.023 . . . . 62.13 110.543 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.5 mt -128.43 163.12 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 102.263 -3.236 . . . . 64.33 102.263 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.2 t -153.15 159.09 42.67 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 102.821 -3.029 . . . . 74.31 102.821 174.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.86 167.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.941 -1.874 . . . . 73.42 105.941 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -153.78 167.71 28.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 103.499 -2.778 . . . . 72.24 103.499 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.16 -172.32 15.57 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 106.071 -2.812 . . . . 75.31 106.071 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.22 -124.63 5.38 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.962 -1.655 . . . . 64.43 108.962 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.08 18.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 126.292 1.837 . . . . 62.43 114.368 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 86.92 65.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.971 1.367 . . . . 71.31 107.342 -172.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.3 t -89.1 -165.12 1.26 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.076 -2.194 . . . . 71.11 105.076 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 m -49.63 -26.68 3.82 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.169 0.988 . . . . 61.1 112.208 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -86.71 118.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 N-CA-C 105.361 -2.088 . . . . 71.31 105.361 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.22 -14.35 60.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.787 -0.642 . . . . 74.33 111.053 -165.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -85.87 -5.99 59.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.346 -0.983 . . . . 75.34 108.346 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 10.59 27.49 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.894 -0.883 . . . . 32.11 110.894 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.56 158.29 53.5 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 107.986 -2.046 . . . . 61.34 107.986 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.47 129.0 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.602 -1.999 . . . . 72.44 105.602 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -125.38 144.97 50.26 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.281 -2.118 . . . . 75.41 105.281 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.72 134.16 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.09 -1.448 . . . . 74.2 107.09 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -103.93 -44.4 5.04 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.032 -1.099 . . . . 75.4 108.032 -171.195 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.68 153.97 40.0 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 105.964 -1.865 . . . . 62.44 105.964 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.42 130.0 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.309 -2.108 . . . . 70.12 105.309 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.474 HD12 ' HA2' ' A' ' 20' ' ' GLY . 17.1 mt -74.45 137.19 74.61 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.144 -1.799 . . . . 50.44 106.144 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.55 125.6 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.494 2.129 . . . . 75.22 108.685 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.467 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 33.9 mt-30 68.4 18.24 9.07 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 124.063 0.852 . . . . 74.2 109.817 -175.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.37 -177.68 52.01 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 106.153 -2.779 . . . . 60.31 106.153 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 12' ' ' LEU . . . -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.563 -0.375 . . . . 73.33 110.82 -168.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.89 94.8 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.065 -0.716 . . . . 75.42 109.065 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 44' ' ' GLN . 50.8 tp10 -59.49 -46.47 88.71 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.26 -0.644 . . . . 73.24 109.26 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 m -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.34 -0.615 . . . . 51.11 109.34 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.96 -45.49 74.05 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.204 -1.036 . . . . 74.34 108.204 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -32.8 5.52 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.312 -1.115 . . . . 72.31 110.312 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -75.17 -36.98 61.45 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 117.614 0.707 . . . . 72.33 109.132 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.04 138.24 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 104.761 -2.311 . . . . 73.33 104.761 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -136.6 179.11 6.56 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.124 -1.806 . . . . 75.15 106.124 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.08 139.85 58.76 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.7 -0.852 . . . . 74.41 108.7 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -3.34 87.22 Favored Glycine 0 CA--C 1.497 -1.082 0 N-CA-C 110.459 -1.056 . . . . 52.41 110.459 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.44 154.42 39.98 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-N 119.342 1.571 . . . . 63.22 107.219 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.71 118.29 36.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.555 -1.276 . . . . 75.44 107.555 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.57 145.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.843 -2.281 . . . . 75.21 104.843 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 -48.33 2.43 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.441 -1.318 . . . . 74.55 107.441 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.15 167.19 18.76 Favored 'General case' 0 CA--C 1.469 -2.148 0 C-N-CA 118.914 -1.114 . . . . 75.21 109.718 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.52 102.54 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 103.702 -2.703 . . . . 74.04 103.702 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.97 41.19 28.1 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.783 0.833 . . . . 63.2 111.03 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.04 15.06 73.38 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 109.935 -1.266 . . . . 70.24 109.935 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.44 116.31 52.23 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 104.353 -2.462 . . . . 74.45 104.353 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -76.4 7.39 4.43 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.546 0.738 . . . . 60.34 111.796 -171.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt 34.25 38.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.967 1.307 . . . . 51.13 111.775 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.9 129.72 36.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 O-C-N 121.148 -0.97 . . . . 65.21 109.534 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 0.98 83.03 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 109.102 -1.599 . . . . 64.24 109.102 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 152.26 45.99 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.951 -1.129 . . . . 74.41 107.951 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 159.74 26.89 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.673 -1.232 . . . . 63.41 107.673 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -62.29 -41.59 98.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.16 -1.052 . . . . 70.14 108.16 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -58.15 -41.76 84.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.793 -0.64 . . . . 73.24 109.865 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -66.25 -34.52 78.2 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 108.673 -0.862 . . . . 63.1 108.673 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.79 74.49 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.826 -0.805 . . . . 52.14 108.826 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.69 -52.6 22.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 107.26 -1.385 . . . . 64.24 107.26 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.6 m -52.96 -28.37 23.38 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.105 0.955 . . . . 62.13 108.45 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -65.75 -55.91 14.76 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.269 -1.382 . . . . 74.24 107.269 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.6 mt -53.78 -55.03 30.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 108.934 -0.765 . . . . 73.54 108.934 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -46.25 -42.13 13.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.231 -0.44 . . . . 75.44 111.615 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -86.68 -5.59 59.09 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 121.72 -0.612 . . . . 72.3 110.87 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -85.06 170.51 12.89 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.755 -1.216 . . . . 74.53 108.404 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 -161.56 22.04 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.394 -1.482 . . . . 75.11 109.394 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.99 -28.89 49.39 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.122 -1.066 . . . . 75.13 108.122 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.87 134.47 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.105 -2.554 . . . . 52.11 104.105 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.66 143.29 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.678 -2.341 . . . . 71.43 104.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -96.89 117.13 30.44 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.975 -2.232 . . . . 52.52 104.975 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.03 137.82 51.99 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 105.215 -2.143 . . . . 73.34 105.215 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.79 127.66 56.1 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 105.313 -2.106 . . . . 72.34 105.313 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.57 154.35 48.92 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.761 -1.57 . . . . 62.23 106.761 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 . . . . . 0 CA--C 1.476 -1.87 0 N-CA-C 105.089 -2.189 . . . . 60.01 105.089 179.173 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 105.963 -1.866 . . . . 72.13 105.963 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -133.78 149.84 51.44 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.19 -1.782 . . . . 73.23 106.19 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -102.26 138.1 39.65 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.99 -1.855 . . . . 72.13 105.99 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.9 t -129.11 127.58 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 104.939 -2.245 . . . . 62.14 104.939 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -103.34 109.45 21.07 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.676 -1.972 . . . . 73.25 105.676 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.99 122.95 45.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 N-CA-C 106.459 -1.682 . . . . 70.11 106.459 -164.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.37 138.18 32.64 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.343 -1.355 . . . . 74.41 107.343 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 106.359 -1.719 . . . . 74.33 106.359 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.609 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.434 -1.482 0 N-CA-C 110.944 -0.862 . . . . 71.45 110.944 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mm -111.7 160.94 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.214 -2.513 . . . . 74.04 104.214 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -154.01 159.23 41.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 102.624 -3.102 . . . . 73.1 102.624 165.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.59 166.83 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 105.918 -1.882 . . . . 54.12 105.918 -168.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -147.87 165.86 29.35 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.199 -2.889 . . . . 74.24 103.199 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.72 -171.79 15.23 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 107.378 -2.289 . . . . 74.35 107.378 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.87 -128.81 6.81 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.205 -1.558 . . . . 54.32 109.205 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.48 19.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 127.24 2.216 . . . . 34.42 114.396 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 85.52 64.03 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.919 -1.512 . . . . 73.33 106.919 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -93.28 -166.15 1.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 104.357 -2.46 . . . . 61.23 104.357 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -38.42 -38.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.628 1.571 . . . . 71.34 113.305 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.69 131.97 33.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.235 0 N-CA-C 107.683 -1.229 . . . . 74.53 107.683 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -59.93 -50.7 72.74 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.636 -0.711 . . . . 75.14 111.446 -168.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.36 -3.64 31.55 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.8 -0.562 . . . . 75.12 109.692 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.54 14.25 41.59 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 110.345 -1.102 . . . . 74.21 110.345 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.42 154.5 50.47 Favored Glycine 0 CA--C 1.478 -2.231 0 N-CA-C 107.643 -2.183 . . . . 73.44 107.643 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.86 108.62 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.639 -1.615 . . . . 74.34 106.639 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 58' ' ' ARG . 36.1 m-85 -98.28 143.19 29.04 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 106.225 -1.769 . . . . 71.42 106.225 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.28 126.99 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 105.717 -1.957 . . . . 74.34 105.717 169.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -99.69 -49.54 4.35 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 107.363 -1.347 . . . . 75.51 107.363 -168.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.87 149.13 38.12 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 106.042 -1.836 . . . . 54.24 106.042 -171.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.76 121.95 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 104.221 -2.511 . . . . 71.15 104.221 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.609 HD12 ' HA2' ' A' ' 20' ' ' GLY . 25.2 mt -75.58 138.27 70.63 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 105.215 -2.142 . . . . 73.3 105.215 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 42' ' ' ILE . 17.7 Cg_endo -56.47 129.48 34.94 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.133 1.889 . . . . 73.05 109.347 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 64.18 22.2 12.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 124.975 1.422 . . . . 63.4 111.329 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.69 175.95 43.38 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 107.202 -2.359 . . . . 74.44 107.202 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.54 73.48 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.255 -0.646 . . . . 61.41 109.255 -172.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.09 -49.71 59.53 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.231 -0.655 . . . . 54.54 109.231 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.24 -37.03 82.86 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 109.503 -0.554 . . . . 64.11 109.503 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.3 m -65.49 -37.97 88.39 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.47 -0.937 . . . . 73.52 108.47 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.74 -37.12 79.2 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.248 -1.019 . . . . 55.04 108.248 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.58 -21.71 8.64 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.898 -0.881 . . . . 31.33 110.898 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.9 mtt85 -75.44 -41.09 56.71 Favored 'General case' 0 CA--C 1.495 -1.165 0 O-C-N 121.524 -0.986 . . . . 72.55 108.61 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.36 128.02 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 106.15 -1.796 . . . . 63.33 106.15 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -131.34 177.4 7.51 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.645 -1.983 . . . . 72.22 105.645 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -67.06 145.27 55.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.615 -1.995 . . . . 73.22 105.615 171.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.05 58.04 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 107.377 -2.289 . . . . 45.01 107.377 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -84.8 158.47 20.67 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 105.301 -2.111 . . . . 54.42 105.301 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.46 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -137.23 150.64 48.0 Favored 'General case' 0 CA--C 1.47 -2.115 0 N-CA-C 107.054 -1.461 . . . . 74.44 107.054 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 t -104.86 145.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 104.786 -2.301 . . . . 53.24 104.786 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -48.23 3.02 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.329 -1.73 . . . . 71.22 106.329 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.18 161.49 31.0 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.429 1.109 . . . . 61.25 110.151 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -142.75 111.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 104.217 -2.512 . . . . 74.52 104.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 50.53 39.8 21.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.755 0.822 . . . . 72.51 110.466 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.37 7.18 79.96 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 109.978 -1.249 . . . . 53.52 109.978 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 67' ' ' LEU . 43.5 t -108.32 116.56 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.686 -2.338 . . . . 73.03 104.686 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -79.92 14.82 1.64 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.417 0.287 . . . . 63.42 111.348 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.502 ' H ' HG12 ' A' ' 65' ' ' VAL . 4.5 mm? 38.09 38.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.06 1.344 . . . . 74.15 111.329 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -76.09 125.25 28.79 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.762 -1.212 . . . . 64.11 108.499 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.72 -7.49 65.5 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 109.706 -1.358 . . . . 71.54 109.706 172.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.41 41.81 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.874 -1.158 . . . . 64.23 107.874 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -83.85 165.94 18.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.153 -1.054 . . . . 34.02 108.153 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.9 -36.6 84.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.302 -0.863 . . . . 71.51 109.118 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.2 -48.37 73.95 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 109.652 -0.499 . . . . 64.44 109.652 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -68.83 -30.21 68.71 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.598 -0.689 . . . . 70.15 109.334 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.11 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.336 -0.987 . . . . 70.2 108.336 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.16 -51.05 42.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 107.285 -1.376 . . . . 73.45 107.285 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.2 m -52.66 -28.36 21.22 Favored 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 108.554 -0.906 . . . . 73.24 108.554 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.2 m -72.67 -57.27 4.25 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.711 -1.218 . . . . 55.34 107.711 -171.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.81 -56.9 16.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.708 -0.849 . . . . 75.21 108.708 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -47.26 -38.75 12.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.89 0.7 . . . . 63.14 112.89 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -88.54 -2.01 58.36 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.324 -0.86 . . . . 63.5 110.241 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -77.73 176.67 8.8 Favored 'General case' 0 C--O 1.243 0.723 0 O-C-N 120.61 -1.306 . . . . 74.32 108.181 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.18 -163.62 26.03 Favored Glycine 0 CA--C 1.491 -1.425 0 N-CA-C 108.741 -1.744 . . . . 24.43 108.741 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.44 -33.93 42.07 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.945 -1.502 . . . . 62.13 106.945 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 t -113.57 130.54 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.096 0 N-CA-C 104.037 -2.579 . . . . 70.24 104.037 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 t -129.35 149.58 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 105.944 -1.873 . . . . 60.01 105.944 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -97.42 111.77 23.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.163 -2.162 . . . . 74.0 105.163 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -112.34 137.74 50.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.321 -2.103 . . . . 75.42 105.321 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 tp -115.92 124.18 49.95 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.807 -2.294 . . . . 62.51 104.807 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.8 155.41 46.01 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 106.934 -1.506 . . . . 61.42 106.934 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.416 -2.131 0 N-CA-C 103.248 -2.871 . . . . 72.41 103.248 179.49 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 105.384 -2.08 . . . . 75.0 105.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -142.95 149.69 38.72 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.255 -1.757 . . . . 73.43 106.255 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.15 140.86 36.78 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.553 -2.017 . . . . 72.04 105.553 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 52' ' ' ARG . 91.3 t -126.38 133.12 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 105.914 -1.884 . . . . 63.45 105.914 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.67 116.97 33.91 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.475 -2.046 . . . . 61.4 105.475 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -103.17 121.21 42.19 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.874 -1.898 . . . . 53.55 105.874 -173.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 134.42 38.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.827 -1.175 . . . . 65.04 107.827 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp . . . . . 0 C--O 1.21 -1.01 0 N-CA-C 107.268 -1.382 . . . . 73.24 107.268 175.829 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.493 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.496 -1.128 0 CA-C-O 120.021 -0.322 . . . . 72.24 112.988 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.9 mt -132.06 152.49 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.463 -2.791 . . . . 72.0 103.463 170.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.1 m -148.51 164.25 34.77 Favored 'General case' 0 CA--C 1.469 -2.164 0 N-CA-C 103.636 -2.727 . . . . 75.44 103.636 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -145.12 168.69 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 105.196 -2.15 . . . . 42.21 105.196 -168.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -142.79 166.0 25.84 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 102.108 -3.293 . . . . 64.21 102.108 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.71 -174.36 16.0 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 107.09 -2.404 . . . . 63.13 107.09 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.38 -128.27 5.91 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.115 -1.594 . . . . 64.52 109.115 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 m -66.92 19.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.638 1.975 . . . . 74.25 113.962 -168.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.256 85.5 m-20 87.04 66.35 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.956 0 CA-C-O 123.198 1.475 . . . . 62.24 107.479 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -80.82 -166.62 1.15 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.088 -2.56 . . . . 71.22 104.088 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -57.57 -19.42 25.44 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 121.536 -0.727 . . . . 64.31 112.178 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.471 ' H ' HG23 ' A' ' 29' ' ' THR . 27.6 m -85.84 135.23 25.42 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 N-CA-C 107.569 -1.271 . . . . 72.32 107.569 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -57.36 -55.47 34.42 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.624 0.77 . . . . 75.32 112.048 -166.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -85.63 12.07 9.52 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 121.166 -0.959 . . . . 63.2 109.308 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.44 22.94 59.68 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 110.217 -1.153 . . . . 64.13 110.217 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.8 145.88 50.03 Favored Glycine 0 C--N 1.36 1.902 0 N-CA-C 108.931 -1.668 . . . . 53.35 108.931 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mm -83.97 94.77 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.982 -1.858 . . . . 64.55 105.982 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -91.48 143.73 26.3 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 106.998 -1.482 . . . . 64.41 106.998 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.8 131.47 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.351 -1.722 . . . . 62.32 106.351 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -102.61 -47.52 4.41 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.785 -1.561 . . . . 63.32 106.785 -166.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.45 151.22 36.06 Favored 'General case' 0 CA--C 1.465 -2.322 0 N-CA-C 105.473 -2.047 . . . . 52.1 105.473 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.26 130.21 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 104.065 -2.569 . . . . 74.31 104.065 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.493 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.8 mm -69.46 146.21 96.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 105.141 -2.17 . . . . 74.52 105.141 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 42' ' ' ILE . 13.0 Cg_endo -55.05 118.36 5.07 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.087 1.858 . . . . 42.43 108.217 167.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.54 29.49 19.06 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.16 0.913 . . . . 73.33 111.654 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.64 -174.31 35.76 Favored Glycine 0 C--N 1.379 2.956 0 N-CA-C 106.724 -2.551 . . . . 62.53 106.724 167.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.19 74.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 122.004 -0.703 . . . . 75.24 110.378 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.5 91.24 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.819 -0.438 . . . . 53.2 109.819 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.2 -38.87 91.84 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.104 -0.702 . . . . 73.43 109.104 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 t -65.14 -42.47 93.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.438 -0.949 . . . . 53.43 108.438 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.93 -39.87 94.18 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 107.499 -1.297 . . . . 70.11 107.499 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.49 -14.94 32.48 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 110.631 -0.988 . . . . 44.04 110.631 173.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.467 ' HD2' HG13 ' A' ' 10' ' ' VAL . 39.7 ttm105 -81.5 -38.8 25.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.55 -0.971 . . . . 64.51 108.554 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.6 mt -101.98 133.08 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.016 -1.846 . . . . 63.41 106.016 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -126.54 179.19 5.45 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.573 -1.64 . . . . 75.23 106.573 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.02 144.25 55.21 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 105.455 -2.054 . . . . 70.24 105.455 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.24 -23.86 32.99 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.207 -1.957 . . . . 70.21 108.207 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.19 152.18 46.2 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 107.52 -1.289 . . . . 74.21 107.52 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.71 131.92 47.97 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 106.938 -1.505 . . . . 34.53 106.938 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.06 150.54 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 105.246 -2.131 . . . . 73.23 105.246 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.49 -46.63 2.86 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.54 -1.281 . . . . 72.11 107.54 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.47 159.58 35.84 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 118.974 -1.091 . . . . 61.22 109.235 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.99 107.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.748 -2.315 . . . . 71.22 104.748 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.2 t30 51.2 36.91 17.02 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.365 1.066 . . . . 71.42 111.417 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.52 68.65 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.648 -1.381 . . . . 73.14 109.648 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.12 120.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 105.024 -2.213 . . . . 61.32 105.024 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -68.24 106.75 2.55 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.516 -1.661 . . . . 71.44 106.516 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -21.38 56.76 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.168 -0.679 . . . . 72.33 109.168 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -57.85 145.0 36.76 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.073 -0.714 . . . . 64.12 109.073 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.57 -38.5 3.11 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 108.976 -1.65 . . . . 52.0 108.976 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.44 158.37 29.63 Favored 'General case' 0 C--N 1.363 1.162 0 CA-C-N 117.783 0.791 . . . . 74.53 109.596 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -84.73 166.11 17.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.394 -1.336 . . . . 73.32 107.394 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -65.04 -41.04 95.59 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.05 -0.722 . . . . 75.5 109.05 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -54.88 -46.18 74.71 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 109.932 -0.395 . . . . 64.22 109.932 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -69.7 -35.81 75.4 Favored 'General case' 0 C--N 1.366 1.302 0 N-CA-C 108.864 -0.791 . . . . 75.11 108.864 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.41 -41.94 77.18 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.383 -0.599 . . . . 53.34 109.383 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 23' ' ' VAL . 48.0 t -68.89 -54.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 N-CA-C 107.861 -1.162 . . . . 73.32 107.861 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.92 -27.57 44.22 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 108.587 -0.894 . . . . 61.13 108.587 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -66.48 -53.46 34.99 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.325 -1.361 . . . . 61.32 107.325 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.93 -56.92 15.47 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.677 -0.86 . . . . 72.2 108.677 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -48.27 -26.13 1.85 Allowed 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 113.382 0.882 . . . . 54.04 113.382 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -92.36 -10.63 37.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.09 0.859 . . . . 75.35 109.379 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -78.55 175.5 10.29 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 120.97 -1.081 . . . . 72.13 108.795 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.72 -163.38 26.91 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.406 -1.478 . . . . 63.52 109.406 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -78.5 -35.82 45.88 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.968 -1.493 . . . . 74.24 106.968 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.07 128.54 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.825 0 N-CA-C 102.692 -3.077 . . . . 72.34 102.692 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.73 140.1 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.905 0 N-CA-C 105.101 -2.185 . . . . 74.13 105.101 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -92.42 111.24 22.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 104.783 -2.302 . . . . 42.13 104.783 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 12' ' ' LEU . 80.2 mt -114.77 140.33 48.99 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 106.163 -1.792 . . . . 75.01 106.163 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 tp -111.86 127.14 55.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.888 -1.893 . . . . 75.34 105.888 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mp -133.48 155.56 49.33 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.472 -1.677 . . . . 65.32 106.472 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 104.872 -2.27 . . . . 74.12 104.872 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 104.925 -2.25 . . . . 70.11 104.925 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.01 160.32 43.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.464 -1.68 . . . . 55.13 106.464 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -102.48 139.36 38.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.824 -1.917 . . . . 71.44 105.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.37 134.16 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 N-CA-C 105.841 -1.911 . . . . 62.4 105.841 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.68 124.01 48.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.008 -2.219 . . . . 72.45 105.008 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.84 120.94 43.02 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 104.894 -2.262 . . . . 65.24 104.894 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.32 29.72 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 107.923 -1.14 . . . . 74.33 107.923 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp . . . . . 0 N--CA 1.433 -1.281 0 N-CA-C 106.88 -1.526 . . . . 75.25 106.88 175.01 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.104 0 N-CA-C 108.458 -1.857 . . . . 63.22 108.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 mt -127.99 153.43 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 104.131 -2.544 . . . . 64.12 104.131 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.4 m -144.97 160.38 41.43 Favored 'General case' 0 CA--C 1.479 -1.75 0 N-CA-C 102.918 -2.993 . . . . 55.44 102.918 169.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.56 167.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 106.736 -1.579 . . . . 72.21 106.736 -162.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -149.57 166.62 28.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 103.619 -2.734 . . . . 71.3 103.619 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.83 -177.39 17.1 Favored Glycine 0 CA--C 1.486 -1.733 0 N-CA-C 107.417 -2.273 . . . . 60.32 107.417 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.53 -133.65 6.94 Favored Glycine 0 C--N 1.364 2.086 0 N-CA-C 110.014 -1.234 . . . . 54.43 110.014 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.04 19.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.823 2.449 . . . . 64.41 114.812 -167.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.0 t30 86.23 65.24 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.667 -1.605 . . . . 73.24 106.667 -169.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.1 t -96.34 -164.82 1.19 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.571 -2.751 . . . . 64.04 103.571 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -27.88 -49.46 0.06 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.027 1.731 . . . . 52.2 113.12 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.3 129.95 38.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.132 -1.062 . . . . 75.53 108.132 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.18 -27.11 59.52 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 107.655 -1.239 . . . . 74.03 107.655 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -63.34 -17.75 62.91 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 108.466 -0.939 . . . . 73.31 108.466 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.15 -5.65 2.64 Favored Glycine 0 C--N 1.372 2.539 0 N-CA-C 111.34 -0.704 . . . . 60.45 111.34 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.46 153.51 52.94 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 108.978 -1.649 . . . . 42.34 108.978 -172.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -83.13 97.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 105.918 -1.882 . . . . 63.03 105.918 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.32 146.09 25.48 Favored 'General case' 0 CA--C 1.477 -1.865 0 N-CA-C 107.46 -1.311 . . . . 73.02 107.46 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.52 130.83 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.851 -1.907 . . . . 65.55 105.851 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -108.09 -36.82 6.22 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.146 -1.427 . . . . 70.35 107.146 -167.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.23 151.48 33.08 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 106.897 -1.519 . . . . 73.11 106.897 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.46 128.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 104.743 -2.317 . . . . 71.24 104.743 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 mt -69.27 136.01 88.97 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 107.471 -1.307 . . . . 54.53 107.471 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.12 111.16 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.757 2.305 . . . . 71.15 108.725 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 74.7 21.3 2.19 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 124.552 1.157 . . . . 74.35 110.602 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.61 179.26 40.94 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 107.049 -2.42 . . . . 61.41 107.049 165.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.8 98.84 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.871 -0.788 . . . . 74.04 108.871 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -47.64 73.61 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.195 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.56 -37.95 89.27 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 109.232 -0.655 . . . . 64.51 109.232 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -64.28 -37.43 87.46 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 107.999 -1.111 . . . . 70.01 107.999 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.26 -46.38 70.59 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 107.648 -1.241 . . . . 72.11 107.648 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.5 -13.27 47.63 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.394 -0.682 . . . . 63.11 111.394 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -73.91 -41.71 61.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.636 1.218 . . . . 72.33 108.39 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.78 135.48 33.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 106.982 -1.488 . . . . 75.51 106.982 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.52 -178.56 5.17 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 105.582 -2.007 . . . . 64.02 105.582 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 141.24 57.74 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.873 -1.899 . . . . 73.14 105.873 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.26 -13.29 48.27 Favored Glycine 0 CA--C 1.477 -2.296 0 N-CA-C 107.91 -2.076 . . . . 71.25 107.91 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -82.87 150.25 26.64 Favored 'General case' 0 CA--C 1.485 -1.538 0 N-CA-C 106.184 -1.784 . . . . 74.23 106.184 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.545 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.7 tmm_? -115.91 123.08 47.2 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 106.265 -1.754 . . . . 72.03 106.265 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -94.12 140.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.248 -2.13 . . . . 72.15 105.248 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 -43.95 3.06 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 106.96 -1.496 . . . . 72.23 106.96 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.51 165.37 22.83 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 122.536 1.16 . . . . 74.02 110.029 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.56 102.37 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 103.376 -2.824 . . . . 64.54 103.376 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 t30 51.89 42.28 30.03 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.373 1.069 . . . . 71.5 110.275 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.98 14.31 79.66 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.27 -1.132 . . . . 74.1 110.27 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.16 117.25 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 103.835 -2.654 . . . . 72.0 103.835 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -70.4 115.93 10.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.189 -1.041 . . . . 53.34 108.189 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.6 13.97 7.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.827 -1.175 . . . . 73.35 107.827 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.72 137.7 54.31 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.704 -1.221 . . . . 61.4 107.704 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.26 -16.93 14.6 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.012 -1.235 . . . . 55.02 110.012 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.54 154.44 41.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.095 -1.076 . . . . 74.41 108.095 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.75 163.13 19.33 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.589 -1.263 . . . . 74.43 107.589 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -63.07 -38.87 92.92 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 116.167 -0.47 . . . . 72.51 110.951 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.32 -35.21 79.62 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 120.384 -0.526 . . . . 51.11 109.929 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.15 -31.07 69.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 121.145 -0.972 . . . . 61.4 108.99 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.19 79.88 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.975 -1.12 . . . . 75.41 107.975 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.22 -55.02 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.625 -1.25 . . . . 64.22 107.625 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.3 m -56.2 -27.73 55.74 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 108.829 -0.804 . . . . 62.41 108.829 -171.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -61.79 -55.86 25.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 106.975 -1.491 . . . . 61.11 106.975 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.57 -55.68 30.79 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 109.027 -0.731 . . . . 74.14 109.027 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -46.77 -34.02 4.88 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.625 -0.672 . . . . 71.24 112.52 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -98.56 4.2 48.11 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.255 -0.903 . . . . 74.11 110.413 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 p -80.76 173.63 12.42 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.645 -1.284 . . . . 72.13 108.685 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.2 -136.08 7.22 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.297 -0.721 . . . . 64.11 111.297 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -82.99 -49.09 9.94 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.32 -0.993 . . . . 72.44 108.32 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.0 132.98 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 N-CA-C 104.11 -2.552 . . . . 72.14 104.11 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -116.83 134.23 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 105.056 -2.202 . . . . 61.45 105.056 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.92 120.2 35.78 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.546 -2.02 . . . . 72.32 105.546 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.67 137.23 52.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.074 -1.825 . . . . 73.14 106.074 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.88 125.69 53.9 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.454 -2.424 . . . . 65.31 104.454 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.25 155.44 46.28 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 108.449 -0.945 . . . . 74.2 108.449 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.545 ' CD ' HH21 ' A' ' 58' ' ' ARG . 35.6 tt0 . . . . . 0 N--CA 1.414 -2.262 0 N-CA-C 102.404 -3.184 . . . . 44.43 102.404 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 103.878 -2.638 . . . . 72.43 103.878 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.68 143.77 51.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.843 -1.91 . . . . 74.54 105.843 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.5 130.76 50.94 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.883 -1.895 . . . . 63.23 105.883 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.98 129.8 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.13 0 N-CA-C 105.024 -2.213 . . . . 73.23 105.024 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -103.44 110.75 22.88 Favored 'General case' 0 CA--C 1.471 -2.059 0 N-CA-C 105.745 -1.946 . . . . 72.04 105.745 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.683 -1.599 . . . . 64.12 106.683 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.36 147.84 25.85 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.964 -1.495 . . . . 74.55 106.964 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 105.596 -2.002 . . . . 73.22 105.596 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.585 ' HA3' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.438 -1.199 0 N-CA-C 111.205 -0.758 . . . . 61.23 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.2 161.38 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 103.839 -2.652 . . . . 72.14 103.839 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.68 162.72 41.01 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.396 -2.816 . . . . 64.0 103.396 163.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.43 167.86 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 105.389 -2.078 . . . . 74.54 105.389 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -146.77 166.33 26.97 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.958 -2.608 . . . . 61.03 103.958 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 83.92 138.6 3.74 Favored Glycine 0 C--O 1.191 -2.543 0 N-CA-C 111.472 -0.651 . . . . 63.32 111.472 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.31 -89.08 0.07 OUTLIER Glycine 0 C--N 1.362 2.002 0 N-CA-C 109.228 -1.549 . . . . 54.32 109.228 167.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.21 20.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 117.279 2.326 . . . . 64.3 117.279 -165.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 88.32 65.08 0.01 OUTLIER 'General case' 0 CA--C 1.466 -2.27 0 N-CA-C 105.332 -2.099 . . . . 74.32 105.332 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.482 ' H ' HG22 ' A' ' 29' ' ' THR . 5.1 t -85.7 -166.66 1.59 Allowed 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 110.972 -2.831 . . . . 73.4 106.115 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 m -60.93 -31.0 70.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.473 1.109 . . . . 72.43 110.552 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 29' ' ' THR . 4.7 m -87.33 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 107.849 -1.167 . . . . 72.41 107.849 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -67.11 -37.31 83.67 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.398 0.679 . . . . 63.14 110.111 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -69.47 -9.02 51.91 Favored 'General case' 0 C--O 1.211 -0.938 0 O-C-N 121.393 -0.817 . . . . 64.32 109.742 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.82 13.77 57.17 Favored Glycine 0 C--N 1.37 2.438 0 N-CA-C 108.589 -1.804 . . . . 72.45 108.589 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 144.99 47.57 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 109.609 -1.396 . . . . 64.51 109.609 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 25' ' ' GLY . 1.7 mm -85.83 104.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 102.454 -3.165 . . . . 70.12 102.454 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -101.29 147.51 26.21 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 107.501 -1.296 . . . . 73.0 107.501 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.25 132.62 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 106.77 -1.567 . . . . 72.34 106.77 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -109.07 -48.11 3.32 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.501 -0.926 . . . . 53.31 108.501 -167.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.61 146.04 34.13 Favored 'General case' 0 CA--C 1.463 -2.388 0 N-CA-C 105.806 -1.924 . . . . 50.45 105.806 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.9 t -130.59 130.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 103.981 -2.6 . . . . 74.24 103.981 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.585 HG12 ' HA3' ' A' ' 20' ' ' GLY . 34.0 mm -67.59 141.13 95.05 Favored Pre-proline 0 C--N 1.353 0.718 0 N-CA-C 106.093 -1.817 . . . . 73.41 106.093 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.52 109.12 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.153 1.902 . . . . 64.34 107.896 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 70.15 30.28 3.53 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.446 1.091 . . . . 70.14 110.929 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.45 -179.0 33.83 Favored Glycine 0 C--N 1.369 2.385 0 N-CA-C 107.279 -2.328 . . . . 65.21 107.279 162.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.89 -35.34 80.33 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 122.102 -0.646 . . . . 52.23 109.48 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.85 82.32 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.273 -0.64 . . . . 64.54 109.273 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.58 -34.71 77.59 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.617 -0.512 . . . . 73.23 109.617 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -70.05 -42.32 73.03 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.74 -0.837 . . . . 62.12 108.74 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -67.71 -37.07 81.76 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.691 -1.226 . . . . 74.44 107.691 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.64 -14.28 47.95 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 111.32 -0.712 . . . . 63.14 111.32 170.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -80.88 -35.06 33.12 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.741 -0.858 . . . . 65.12 108.968 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.2 mt -95.24 133.04 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.136 -1.801 . . . . 70.21 106.136 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -135.41 175.27 9.74 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.275 -1.75 . . . . 52.42 106.275 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -65.85 132.58 49.02 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.407 -0.96 . . . . 75.44 108.407 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.81 -12.07 62.6 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.078 -1.609 . . . . 52.53 109.078 170.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -65.87 150.92 47.81 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 106.767 -1.568 . . . . 64.33 106.767 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.481 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.9 tmm_? -109.32 127.48 54.34 Favored 'General case' 0 C--O 1.197 -1.672 0 N-CA-C 106.265 -1.754 . . . . 71.54 106.265 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.48 138.66 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 106.17 -1.789 . . . . 65.14 106.17 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -52.21 2.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.553 -1.277 . . . . 72.35 107.553 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.3 165.52 23.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-O 122.157 0.98 . . . . 64.23 110.354 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.28 108.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 104.228 -2.508 . . . . 73.24 104.228 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.7 t30 54.94 38.18 30.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.333 0.653 . . . . 74.54 109.851 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.63 79.3 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 109.528 -1.429 . . . . 63.21 109.528 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.87 119.82 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 104.776 -2.305 . . . . 75.21 104.776 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.2 m -71.91 113.23 8.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.167 -1.049 . . . . 61.52 108.167 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.03 -28.8 62.56 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 107.589 -1.263 . . . . 73.42 107.589 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -52.3 145.04 11.66 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 122.806 0.442 . . . . 73.43 110.53 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.49 -36.45 3.58 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 110.062 -1.215 . . . . 54.31 110.062 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.52 173.82 5.58 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.191 0.996 . . . . 74.02 110.006 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 p -81.01 160.56 24.54 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 107.966 -1.124 . . . . 71.13 107.966 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -64.29 -38.6 91.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.7 -0.852 . . . . 75.2 108.7 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -60.88 -41.86 96.79 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 120.449 -0.5 . . . . 63.43 109.661 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -63.64 -38.88 92.79 Favored 'General case' 0 C--N 1.369 1.421 0 N-CA-C 108.523 -0.917 . . . . 73.52 108.523 -172.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.91 70.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 109.958 -0.386 . . . . 74.34 109.958 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -74.17 -53.87 16.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.528 -1.286 . . . . 65.01 107.528 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.09 -28.31 38.36 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.263 -1.014 . . . . 52.43 108.263 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -67.7 -53.75 25.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.986 -1.116 . . . . 74.31 107.986 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -58.0 -56.83 16.95 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.158 -0.682 . . . . 52.12 109.158 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -51.63 -16.29 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.49 0.922 . . . . 73.44 113.49 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -99.53 -2.86 34.75 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.994 -1.066 . . . . 74.02 108.555 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -78.57 166.54 22.43 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.374 -0.829 . . . . 75.24 109.435 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.4 -140.9 6.08 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 109.364 -1.494 . . . . 51.01 109.364 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -84.03 -48.74 9.6 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.125 -1.065 . . . . 71.15 108.125 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.81 135.63 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.968 -2.605 . . . . 63.42 103.968 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -123.51 142.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 104.7 -2.333 . . . . 64.23 104.7 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -96.25 115.63 27.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.354 -2.462 . . . . 63.3 104.354 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.1 mt -117.4 143.35 46.08 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 106.073 -1.825 . . . . 75.34 106.073 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.51 131.29 56.74 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 103.982 -2.599 . . . . 74.31 103.982 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.99 155.32 48.2 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.987 -1.857 . . . . 72.24 105.987 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.481 ' CD ' HH21 ' A' ' 58' ' ' ARG . 39.0 tt0 . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 105.019 -2.215 . . . . 75.13 105.019 -176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.494 -1.194 0 N-CA-C 104.499 -2.408 . . . . 74.33 104.499 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -129.43 141.14 51.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.064 -1.828 . . . . 63.15 106.064 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -102.58 134.32 46.13 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 105.926 -1.879 . . . . 73.51 105.926 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -130.44 130.65 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.116 0 N-CA-C 105.461 -2.051 . . . . 74.51 105.461 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -106.25 125.92 51.59 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.666 -2.346 . . . . 72.24 104.666 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.32 122.73 47.98 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.544 -1.651 . . . . 62.53 106.544 -167.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.88 137.17 35.33 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.476 -1.305 . . . . 62.12 107.476 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 106.652 -1.61 . . . . 72.14 106.652 173.957 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.55 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 111.524 -0.631 . . . . 72.33 111.524 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.45 156.17 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.79 -3.041 . . . . 65.44 102.79 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.2 m -145.57 160.88 40.99 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 102.575 -3.12 . . . . 71.41 102.575 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.63 165.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 105.738 -1.949 . . . . 74.15 105.738 -167.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -144.41 166.16 25.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 103.045 -2.946 . . . . 75.31 103.045 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.426 ' H ' HG21 ' A' ' 29' ' ' THR . . . 130.08 -178.43 17.53 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 107.694 -2.162 . . . . 72.2 107.694 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.45 -133.19 7.4 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.172 -1.571 . . . . 70.23 109.172 172.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.21 19.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.87 2.068 . . . . 74.54 113.588 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 87.82 65.58 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.429 -1.323 . . . . 52.1 107.429 -169.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 25' ' ' GLY . 14.8 t -89.37 -165.81 1.44 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.304 -2.48 . . . . 62.2 104.304 170.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -46.14 -31.06 2.18 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.788 0.835 . . . . 71.34 112.89 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 m -84.96 133.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -56.65 -57.06 14.03 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 115.945 -0.57 . . . . 74.41 111.064 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -74.75 -0.39 18.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.491 -0.559 . . . . 73.32 109.491 -169.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.73 14.32 43.31 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 110.148 -1.181 . . . . 64.15 110.148 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.35 154.38 52.91 Favored Glycine 0 CA--C 1.473 -2.552 0 N-CA-C 107.581 -2.208 . . . . 52.11 107.581 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 86.68 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 105.672 -1.973 . . . . 75.22 105.672 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 70.6 m-85 -84.56 142.18 30.17 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 106.992 -1.484 . . . . 75.24 106.992 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.84 128.5 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.262 -1.755 . . . . 63.02 106.262 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -102.51 -42.21 6.03 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.91 -1.144 . . . . 73.55 107.91 -166.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.38 153.2 34.28 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 106.53 -1.656 . . . . 73.03 106.53 -173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.92 131.72 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 104.116 -2.55 . . . . 52.21 104.116 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.55 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.9 mm -75.43 143.04 75.45 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 104.288 -2.486 . . . . 71.24 104.288 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.75 115.01 2.24 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 107.714 -1.687 . . . . 55.4 107.714 166.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 77.16 18.28 1.47 Allowed 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 124.857 1.348 . . . . 73.31 111.01 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.11 172.68 40.41 Favored Glycine 0 C--N 1.367 2.282 0 N-CA-C 106.447 -2.661 . . . . 42.42 106.447 164.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.4 80.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.811 -0.817 . . . . 61.43 109.165 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.58 91.98 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.078 -0.712 . . . . 71.25 109.078 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -69.58 -36.32 76.16 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.76 -0.829 . . . . 71.0 108.76 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.6 m -70.27 -35.37 73.7 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.392 -0.966 . . . . 73.33 108.392 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.439 -1.319 . . . . 75.13 107.439 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.6 49.92 Favored Glycine 0 C--O 1.214 -1.151 0 N-CA-C 110.771 -0.932 . . . . 75.34 110.771 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -73.09 -39.1 66.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.419 -1.048 . . . . 65.12 109.144 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.45 131.76 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 107.225 -1.398 . . . . 61.23 107.225 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -141.49 -179.67 6.29 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.646 -1.983 . . . . 71.34 105.646 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -66.61 143.81 56.79 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.162 -1.792 . . . . 71.53 106.162 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.51 50.52 Favored Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 108.085 -2.006 . . . . 61.32 108.085 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.83 161.06 17.74 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.309 -2.108 . . . . 61.53 105.309 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.6 ptt-85 -132.34 146.68 52.15 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.8 -1.556 . . . . 71.12 106.8 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.1 145.3 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.579 -2.378 . . . . 72.14 104.579 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 -47.43 2.63 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.735 -1.58 . . . . 74.12 106.735 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.54 166.8 19.81 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.52 1.152 . . . . 52.3 109.779 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -137.71 103.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 103.743 -2.688 . . . . 75.03 103.743 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.5 t30 56.44 36.96 28.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.315 0.579 . . . . 64.52 110.314 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.21 10.43 84.78 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 109.389 -1.484 . . . . 54.22 109.389 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.82 119.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 N-CA-C 104.311 -2.478 . . . . 43.12 104.311 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -69.69 106.41 3.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.665 -1.235 . . . . 51.31 107.665 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -18.07 36.92 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.109 -1.071 . . . . 73.14 108.109 -175.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.64 146.13 46.59 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.811 -0.811 . . . . 72.14 108.811 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.16 -35.03 4.26 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.452 -1.459 . . . . 74.44 109.452 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.66 156.28 39.68 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.286 -1.005 . . . . 62.0 108.286 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.5 p -75.67 166.14 24.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.827 -0.805 . . . . 73.33 108.827 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -65.8 -40.14 91.6 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.237 -1.023 . . . . 75.32 108.237 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -54.38 -48.16 71.86 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 110.256 -0.275 . . . . 71.41 110.256 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -34.6 78.13 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 108.95 -0.759 . . . . 75.4 108.95 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.92 85.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.23 -0.655 . . . . 71.04 109.23 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.46 -54.79 16.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.641 -1.244 . . . . 70.03 107.641 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.4 m -56.2 -26.84 52.41 Favored 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 108.101 -1.074 . . . . 75.54 108.101 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -64.87 -54.63 27.97 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 107.018 -1.475 . . . . 73.14 107.018 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.4 -55.5 30.94 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.525 -0.917 . . . . 74.22 108.525 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.8 mtp85 -45.83 -47.14 15.87 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.041 0.386 . . . . 74.22 112.041 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -87.89 1.09 54.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.121 0.873 . . . . 74.54 111.19 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.0 p -79.93 174.32 11.71 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.941 1.246 . . . . 50.32 108.374 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.8 -156.83 30.84 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 109.739 -1.344 . . . . 71.3 109.739 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.65 -44.48 27.97 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.72 -1.215 . . . . 72.23 107.72 -172.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.8 127.69 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.75 0 N-CA-C 103.879 -2.637 . . . . 72.21 103.879 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.54 143.63 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.888 0 N-CA-C 104.942 -2.244 . . . . 74.02 104.942 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -99.44 117.99 35.07 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 105.138 -2.171 . . . . 63.55 105.138 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.9 mt -114.88 139.32 49.88 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 105.055 -2.202 . . . . 55.31 105.055 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.85 123.94 49.41 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 104.336 -2.468 . . . . 54.12 104.336 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.46 159.3 38.47 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.194 -1.41 . . . . 63.34 107.194 -171.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 104.042 -2.577 . . . . 74.03 104.042 175.819 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 7' ' ' ILE . 3.2 mp . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 105.224 -2.139 . . . . 72.01 105.224 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.75 159.5 36.88 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.385 -2.079 . . . . 73.13 105.385 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -102.81 148.24 25.87 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.244 -2.132 . . . . 75.33 105.244 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.25 131.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 N-CA-C 104.321 -2.474 . . . . 71.25 104.321 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.03 133.43 54.2 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.382 -1.71 . . . . 75.12 106.382 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.66 128.89 51.2 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.657 -1.979 . . . . 73.43 105.657 -173.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.24 141.87 28.09 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.189 -1.041 . . . . 71.25 108.189 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 107.022 -1.473 . . . . 75.03 107.022 171.825 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.485 -1.82 0 N-CA-C 110.438 -1.065 . . . . 71.32 110.438 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mt -124.17 152.65 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 103.687 -2.709 . . . . 71.24 103.687 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.6 m -150.54 161.85 41.77 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 103.372 -2.825 . . . . 71.31 103.372 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.96 167.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 105.094 -2.188 . . . . 71.24 105.094 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -143.62 166.15 25.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 102.919 -2.993 . . . . 74.02 102.919 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.04 -173.37 16.18 Favored Glycine 0 CA--C 1.473 -2.562 0 N-CA-C 107.584 -2.206 . . . . 51.23 107.584 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 -123.69 5.53 Favored Glycine 0 CA--C 1.485 -1.789 0 N-CA-C 108.427 -1.869 . . . . 60.54 108.427 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.75 20.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 126.003 1.721 . . . . 72.2 113.659 -169.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 87.32 66.21 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.657 1.218 . . . . 61.25 107.876 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -84.27 -166.51 1.46 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.591 -2.744 . . . . 73.11 103.591 171.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -53.56 -22.04 7.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.762 0.652 . . . . 73.43 112.762 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.85 128.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 107.295 -1.372 . . . . 63.32 107.295 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -61.62 -46.16 91.0 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 122.952 0.501 . . . . 64.24 109.904 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -73.64 -5.33 39.76 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.766 -0.828 . . . . 73.03 108.766 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.02 10.25 19.04 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 110.998 -0.841 . . . . 73.32 110.998 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.9 151.74 51.14 Favored Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 108.477 -1.849 . . . . 43.23 108.477 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.69 89.66 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 N-CA-C 105.737 -1.949 . . . . 71.12 105.737 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -87.42 144.26 26.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.774 -1.565 . . . . 64.22 106.774 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.62 132.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.112 -1.81 . . . . 71.13 106.112 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.06 -45.08 4.62 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.382 -1.34 . . . . 73.43 107.382 -166.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 155.45 38.72 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 106.502 -1.666 . . . . 64.12 106.502 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.29 139.16 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 105.529 -2.026 . . . . 72.21 105.529 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HB ' ' HA3' ' A' ' 20' ' ' GLY . 6.0 mt -72.95 144.55 85.43 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.337 -1.357 . . . . 52.41 107.337 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.57 108.49 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.639 2.226 . . . . 55.33 108.879 168.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 75.15 27.63 1.1 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.745 1.218 . . . . 73.42 110.318 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.04 173.62 55.09 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 106.556 -2.618 . . . . 65.55 106.556 162.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.35 79.15 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.323 0.649 . . . . 62.02 110.298 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.17 -49.52 64.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.618 -0.512 . . . . 74.24 109.618 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.2 -42.0 99.25 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.615 -0.513 . . . . 55.42 109.615 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.5 m -59.96 -42.14 93.45 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-O 121.355 0.598 . . . . 72.21 109.624 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -77.71 -35.48 52.05 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.813 -1.18 . . . . 70.34 107.813 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.23 -4.63 70.85 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 111.306 -0.718 . . . . 73.14 111.306 173.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.17 -44.3 63.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.658 -0.907 . . . . 73.01 109.131 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 mt -109.98 136.54 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 105.826 -1.916 . . . . 72.13 105.826 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -122.96 170.03 10.55 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.98 -1.859 . . . . 75.43 105.98 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 146.49 53.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.338 -1.356 . . . . 75.3 107.338 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.72 -8.2 78.71 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 109.804 -1.318 . . . . 50.21 109.804 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -86.0 163.38 18.0 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.104 -1.813 . . . . 71.13 106.104 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -115.39 129.88 56.72 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.7 0.762 . . . . 65.32 109.148 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.94 148.82 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 104.942 -2.244 . . . . 73.34 104.942 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -44.43 2.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.742 -1.207 . . . . 70.12 107.742 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.23 164.35 24.73 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.017 -1.073 . . . . 73.25 109.905 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.5 t -140.76 107.51 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.917 -2.253 . . . . 75.15 104.917 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.8 t30 45.71 43.48 9.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.417 1.487 . . . . 72.23 111.073 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.97 76.87 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 109.614 -1.395 . . . . 72.43 109.614 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.87 117.53 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 103.815 -2.661 . . . . 75.54 103.815 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.0 m -69.62 110.44 4.84 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.501 -1.296 . . . . 70.34 107.501 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.61 -6.48 57.49 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.9 -1.148 . . . . 53.44 107.9 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.96 143.64 57.27 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.556 -1.276 . . . . 54.1 107.556 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.36 -39.12 3.13 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.116 -1.193 . . . . 34.44 110.116 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 163.98 24.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 108.951 -0.759 . . . . 50.32 108.951 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -84.58 168.65 15.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.799 0.809 . . . . 71.45 109.36 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -62.03 -40.46 95.79 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 115.404 -0.816 . . . . 71.1 109.27 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -60.78 -40.58 93.11 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.892 -0.505 . . . . 73.24 110.54 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.21 -39.2 93.95 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.5 1.045 . . . . 71.25 109.378 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.89 79.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.427 -0.583 . . . . 73.14 109.427 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -71.24 -54.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 107.423 -1.325 . . . . 74.11 107.423 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.7 t -53.35 -28.94 31.51 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.55 1.167 . . . . 73.01 108.521 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 m -70.59 -56.36 6.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.507 -1.294 . . . . 65.13 107.507 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -57.15 -54.72 43.61 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 107.937 -1.134 . . . . 52.45 107.937 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -44.49 -43.99 8.28 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.542 1.137 . . . . 73.22 111.9 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.15 9.02 43.91 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.713 1.142 . . . . 75.2 111.201 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.4 p -80.72 174.45 11.6 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.861 -1.149 . . . . 72.14 107.925 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.28 -148.53 16.38 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.599 -1.4 . . . . 63.43 109.599 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -80.6 -47.81 13.6 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 108.173 -1.047 . . . . 74.14 108.173 -169.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.12 132.69 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 N-CA-C 103.817 -2.66 . . . . 54.41 103.817 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.55 151.0 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 104.479 -2.415 . . . . 64.43 104.479 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -103.36 124.26 48.36 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 104.933 -2.247 . . . . 73.32 104.933 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.02 137.79 49.55 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.191 -2.522 . . . . 75.42 104.191 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -106.97 126.27 52.1 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 105.815 -1.92 . . . . 72.34 105.815 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 152.52 51.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.423 -2.065 . . . . 70.33 105.423 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.462 -2.429 0 N-CA-C 102.608 -3.108 . . . . 72.2 102.608 176.218 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 104.827 -2.286 . . . . 74.53 104.827 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.6 152.29 41.21 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.944 -1.873 . . . . 73.15 105.944 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 89' ' ' LEU . 46.9 mt-10 -105.31 143.53 33.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.669 -1.974 . . . . 72.44 105.669 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.95 130.74 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.0 0 N-CA-C 104.952 -2.24 . . . . 44.24 104.952 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.49 113.14 26.24 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 103.866 -2.642 . . . . 73.34 103.866 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 12' ' ' LEU . 1.1 tm? -103.58 122.21 44.5 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.885 -1.894 . . . . 75.22 105.885 -169.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.75 150.3 39.34 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.036 -1.839 . . . . 71.45 106.036 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 9.3 tptm . . . . . 0 CA--C 1.456 -2.659 0 N-CA-C 103.119 -2.919 . . . . 73.14 103.119 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.322 0 N-CA-C 107.49 -2.244 . . . . 34.22 107.49 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 47' ' ' ALA . 22.2 mt -138.54 156.93 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 102.744 -3.058 . . . . 70.01 102.744 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.5 m -153.11 168.64 25.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.527 -2.768 . . . . 73.42 103.527 169.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.437 HG21 ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -140.6 167.99 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 106.497 -1.668 . . . . 74.21 106.497 -167.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 t -143.58 167.0 23.27 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 103.68 -2.711 . . . . 64.03 103.68 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 88.31 134.45 4.73 Favored Glycine 0 C--O 1.201 -1.969 0 N-CA-C 108.83 -1.708 . . . . 63.14 108.83 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.3 -98.89 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 108.986 -1.646 . . . . 43.11 108.986 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.04 20.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 126.617 1.967 . . . . 64.33 115.833 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.9 t30 87.2 65.19 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.181 -1.414 . . . . 75.22 107.181 -172.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 t -92.29 -166.09 1.48 Allowed 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.705 -2.331 . . . . 75.35 104.705 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -52.29 -21.8 3.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.5 1.12 . . . . 73.15 112.391 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.52 130.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 107.61 -1.256 . . . . 65.22 107.61 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -68.73 -36.31 78.25 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 116.017 -0.538 . . . . 61.32 111.532 -168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -79.06 -4.36 49.81 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.966 -1.084 . . . . 75.54 108.909 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.68 62.98 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 108.355 -1.898 . . . . 74.02 108.355 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.41 134.78 39.05 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 109.095 -1.602 . . . . 65.42 109.095 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.3 mm -78.08 103.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 103.516 -2.772 . . . . 74.55 103.516 173.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.39 147.83 24.3 Favored 'General case' 0 CA--C 1.468 -2.205 0 N-CA-C 106.58 -1.637 . . . . 71.33 106.58 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.66 133.98 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 106.657 -1.608 . . . . 73.42 106.657 168.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.03 -49.34 2.98 Favored 'General case' 0 CA--C 1.472 -2.038 0 N-CA-C 107.195 -1.409 . . . . 62.43 107.195 -169.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.09 130.81 41.73 Favored 'General case' 0 CA--C 1.456 -2.637 0 N-CA-C 105.868 -1.901 . . . . 55.42 105.868 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 47' ' ' ALA . 95.3 t -120.37 117.43 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 103.576 -2.75 . . . . 61.43 103.576 172.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.59 136.23 96.68 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 106.712 -1.588 . . . . 72.04 106.712 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.67 111.4 1.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.495 2.13 . . . . 75.32 107.665 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 75.73 20.68 1.78 Allowed 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.259 0.974 . . . . 73.42 110.541 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.52 -176.88 45.74 Favored Glycine 0 C--N 1.358 1.796 0 N-CA-C 107.024 -2.43 . . . . 71.12 107.024 168.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . . . -71.72 -19.84 61.99 Favored 'General case' 0 C--O 1.219 -0.53 0 O-C-N 122.359 -0.495 . . . . 75.3 110.744 -171.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG13 ' A' ' 41' ' ' VAL . . . -81.09 -49.19 11.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.163 -1.421 . . . . 70.25 107.163 -174.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.99 -38.16 87.56 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.169 -0.678 . . . . 74.44 109.169 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -70.65 -39.38 73.65 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.569 -0.9 . . . . 71.12 108.569 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.4 -39.05 88.78 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.384 -1.339 . . . . 61.54 107.384 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.6 -19.36 37.18 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 110.322 -1.111 . . . . 64.41 110.322 171.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.18 -39.68 40.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.81 -1.182 . . . . 70.21 107.81 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.85 132.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.722 -1.584 . . . . 72.24 106.722 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -142.67 -176.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 104.715 -2.328 . . . . 71.34 104.715 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -66.58 141.71 57.74 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.295 -1.743 . . . . 72.53 106.295 172.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.84 -30.13 8.34 Favored Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 107.486 -2.246 . . . . 31.33 107.486 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -72.78 150.73 42.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.428 -0.953 . . . . 70.12 108.428 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -123.56 128.77 50.2 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.157 -1.794 . . . . 72.31 106.157 -173.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.84 144.27 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 106.249 -1.76 . . . . 71.11 106.249 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.28 -44.08 2.6 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.559 -1.274 . . . . 61.32 107.559 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.89 159.49 36.47 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.944 -1.102 . . . . 45.14 109.378 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.16 116.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 104.942 -2.244 . . . . 73.3 104.942 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.3 t30 55.09 30.98 15.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.595 0.758 . . . . 73.33 109.886 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 16.43 77.21 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 109.324 -1.51 . . . . 72.52 109.324 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -106.72 124.01 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.814 0 N-CA-C 104.682 -2.34 . . . . 65.22 104.682 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -68.81 112.69 5.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.415 -1.328 . . . . 71.11 107.415 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.22 -1.0 57.58 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.571 -1.27 . . . . 52.51 107.571 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.74 143.13 58.09 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.608 -1.256 . . . . 44.21 107.608 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.85 3.81 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.451 -1.06 . . . . 63.12 110.451 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.44 13.37 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.761 0.78 . . . . 40.44 109.323 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -81.39 162.99 23.15 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.515 -1.291 . . . . 62.54 107.515 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -65.23 -36.75 85.13 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.532 -1.285 . . . . 75.43 107.532 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.03 -51.64 56.1 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 109.983 -0.377 . . . . 73.43 109.983 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -66.92 -37.68 84.78 Favored 'General case' 0 C--N 1.369 1.455 0 N-CA-C 109.286 -0.635 . . . . 70.24 109.286 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -55.75 -43.97 77.17 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 118.033 0.379 . . . . 42.3 110.175 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.66 -50.77 36.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.267 -1.383 . . . . 73.43 107.267 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.5 t -53.92 -28.65 38.21 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-O 122.127 0.965 . . . . 50.44 108.671 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.87 -55.15 13.98 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 107.184 -1.413 . . . . 73.33 107.184 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.65 -55.79 29.58 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.074 0.94 . . . . 73.53 108.613 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -46.6 -25.56 0.73 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.23 -0.896 . . . . 61.43 113.177 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -116.57 10.62 14.52 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.639 -1.288 . . . . 75.24 110.07 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.3 p -84.92 173.42 10.59 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.63 -155.19 22.55 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 109.767 -1.333 . . . . 62.12 109.767 -172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -80.77 -31.89 35.65 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 108.439 -0.949 . . . . 62.13 108.439 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.33 133.52 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 103.908 -2.626 . . . . 72.33 103.908 175.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.57 141.98 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 105.461 -2.051 . . . . 64.34 105.461 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -95.61 115.82 27.98 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.321 -2.474 . . . . 72.41 104.321 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.4 mt -116.57 140.37 49.46 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 106.36 -1.719 . . . . 62.2 106.36 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 9' ' ' GLU . 26.1 tp -114.52 126.08 54.53 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 105.107 -2.182 . . . . 74.34 105.107 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.81 156.15 46.53 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.267 -1.383 . . . . 70.03 107.267 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.418 -2.057 0 N-CA-C 103.676 -2.713 . . . . 61.22 103.676 175.381 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 103.86 -2.645 . . . . 70.2 103.86 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.99 160.24 42.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 105.594 -2.002 . . . . 74.41 105.594 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.7 146.22 28.54 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.138 -1.801 . . . . 65.4 106.138 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.7 t -127.81 127.34 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.226 0 N-CA-C 103.453 -2.795 . . . . 60.22 103.453 167.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.49 114.09 28.1 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.31 -2.478 . . . . 54.33 104.31 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 124.31 48.51 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.809 -1.923 . . . . 74.04 105.809 -169.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.69 147.22 25.07 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.102 -1.444 . . . . 73.0 107.102 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 106.276 -1.749 . . . . 73.44 106.276 176.245 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.475 1.261 0 CA-C-O 120.392 -0.115 . . . . 61.14 113.056 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -135.67 165.19 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 102.921 -2.992 . . . . 55.52 102.921 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.6 m -152.17 165.53 34.54 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 102.625 -3.102 . . . . 61.33 102.625 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.83 169.37 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 105.957 -1.868 . . . . 70.44 105.957 -167.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -148.88 167.32 26.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 103.002 -2.962 . . . . 73.25 103.002 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.6 -168.93 13.15 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 106.652 -2.579 . . . . 72.43 106.652 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 -116.04 3.2 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 107.879 -2.088 . . . . 51.12 107.879 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.18 19.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.89 1.276 . . . . 72.11 113.742 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.27 82.1 m-20 88.68 68.17 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 123.179 1.466 . . . . 75.31 108.442 -170.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.723 HG22 ' H ' ' A' ' 30' ' ' SER . 6.3 m -81.99 -166.99 1.37 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 103.423 -2.806 . . . . 73.21 103.423 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.723 ' H ' HG22 ' A' ' 29' ' ' THR . 11.8 m -53.74 -20.16 5.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 53.41 112.573 -174.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -89.97 128.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.625 -1.25 . . . . 70.32 107.625 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.29 -45.71 90.14 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 115.629 -0.714 . . . . 75.54 110.834 -170.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.04 1.79 14.55 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.731 -0.606 . . . . 72.13 109.747 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.17 22.26 68.85 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 109.984 -1.247 . . . . 50.54 109.984 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.57 150.82 50.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.137 -1.985 . . . . 71.51 108.137 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.5 mm -93.09 105.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.026 -2.583 . . . . 73.14 104.026 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -97.74 142.28 29.72 Favored 'General case' 0 CA--C 1.465 -2.296 0 N-CA-C 106.699 -1.593 . . . . 65.05 106.699 -174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.45 135.45 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 106.97 -1.492 . . . . 71.24 106.97 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -45.25 4.04 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.549 -1.649 . . . . 62.21 106.549 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.15 156.08 44.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.633 -1.988 . . . . 54.13 105.633 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.55 136.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 103.67 -2.715 . . . . 73.3 103.67 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.527 HG12 ' CA ' ' A' ' 20' ' ' GLY . 21.5 mm -69.1 143.92 94.76 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.179 -1.785 . . . . 71.1 106.179 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.33 114.93 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.295 1.997 . . . . 65.24 107.766 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 60.46 35.87 20.27 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.715 0.806 . . . . 71.32 111.122 -172.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 178.42 48.6 Favored Glycine 0 C--N 1.366 2.196 0 N-CA-C 106.614 -2.594 . . . . 74.14 106.614 163.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.21 93.88 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 109.383 -0.599 . . . . 71.04 109.383 -172.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.59 75.75 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.596 -0.52 . . . . 71.44 109.596 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.79 -39.86 87.93 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.303 -0.629 . . . . 75.53 109.303 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.0 m -64.97 -36.12 83.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.26 -0.644 . . . . 71.11 109.26 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.59 -32.52 68.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 108.246 -1.02 . . . . 71.15 108.246 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -20.01 29.48 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.546 -1.022 . . . . 61.3 110.546 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -72.64 -44.9 61.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.111 -1.07 . . . . 74.34 108.111 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mt -98.15 149.77 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.878 -1.897 . . . . 51.22 105.878 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -151.49 170.38 19.76 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.082 -2.192 . . . . 75.55 105.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -67.29 142.57 56.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.627 -1.62 . . . . 64.1 106.627 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.3 -3.36 84.02 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 119.84 -1.171 . . . . 74.4 110.181 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -80.16 150.34 30.21 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 106.939 -1.504 . . . . 61.53 106.939 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.88 118.48 36.93 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.073 -1.455 . . . . 63.43 107.073 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 t -103.61 148.52 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 105.457 -2.053 . . . . 74.51 105.457 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.38 -48.01 2.9 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.773 -1.195 . . . . 73.23 107.773 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.08 162.37 28.94 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.576 -0.85 . . . . 42.1 109.184 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.18 111.82 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.349 -2.093 . . . . 73.3 105.349 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 49.45 36.84 10.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.13 1.372 . . . . 75.13 111.363 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.48 4.87 76.19 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 109.671 -1.371 . . . . 71.32 109.671 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.93 120.53 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 104.572 -2.381 . . . . 74.0 104.572 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -72.72 108.57 5.78 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 106.861 -1.533 . . . . 74.54 106.861 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.98 -2.01 42.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.565 -0.743 . . . . 63.44 109.798 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.29 143.8 57.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.865 -1.161 . . . . 73.34 107.865 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.2 -31.32 4.12 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.74 -1.344 . . . . 41.24 109.74 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.46 162.16 29.84 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 118.495 1.148 . . . . 51.12 108.383 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.1 p -85.38 169.52 13.61 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.856 0.836 . . . . 60.13 109.06 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -64.26 -44.91 90.31 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.854 -1.165 . . . . 74.41 107.854 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.11 -41.35 96.54 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 119.265 -0.397 . . . . 64.03 110.095 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -37.45 87.08 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 119.281 0.946 . . . . 54.44 108.84 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -55.78 -38.23 69.62 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.539 0.609 . . . . 73.33 109.973 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.11 -55.06 14.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 107.641 -1.244 . . . . 70.21 107.641 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.36 -26.75 68.62 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.758 -0.83 . . . . 72.4 108.758 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.6 m -60.16 -54.0 51.09 Favored 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 107.088 -1.449 . . . . 73.21 107.088 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -56.11 -56.05 25.61 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 121.701 0.762 . . . . 71.32 109.123 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -48.72 -30.2 5.3 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 121.647 -0.658 . . . . 74.24 112.676 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -93.2 -7.34 45.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.349 -0.844 . . . . 75.43 109.939 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 p -79.41 170.28 16.83 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.856 -1.165 . . . . 52.43 107.856 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.16 -136.57 3.74 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 110.142 -1.183 . . . . 62.24 110.142 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.3 -45.88 8.76 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.82 -1.178 . . . . 63.23 107.82 -172.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.94 128.31 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 104.079 -2.563 . . . . 73.23 104.079 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -123.94 138.43 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.212 -2.514 . . . . 51.23 104.212 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.54 117.92 31.95 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 104.694 -2.336 . . . . 72.32 104.694 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.9 mt -116.74 137.84 51.91 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.864 -1.902 . . . . 75.41 105.864 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.74 130.31 56.11 Favored 'General case' 0 CA--C 1.463 -2.4 0 N-CA-C 104.589 -2.374 . . . . 73.11 104.589 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.68 153.84 49.58 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 105.848 -1.908 . . . . 72.34 105.848 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 . . . . . 0 CA--C 1.476 -1.865 0 N-CA-C 103.786 -2.672 . . . . 61.32 103.786 179.146 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 104.035 -2.58 . . . . 72.23 104.035 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -128.01 142.12 51.32 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 105.78 -1.933 . . . . 72.4 105.78 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -103.05 132.13 49.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 104.711 -2.329 . . . . 71.43 104.711 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.25 135.93 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 106.318 -1.734 . . . . 75.51 106.318 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.04 118.13 36.13 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.234 -2.506 . . . . 63.31 104.234 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -102.91 121.09 41.81 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 104.962 -2.236 . . . . 62.2 104.962 -175.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.1 133.36 37.66 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.253 -1.388 . . . . 63.11 107.253 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm . . . . . 0 CA--C 1.495 -1.138 0 C-N-CA 124.648 1.179 . . . . 74.01 108.072 179.349 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.478 -2.259 0 N-CA-C 110.982 -0.847 . . . . 52.33 110.982 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.7 mt -131.68 148.43 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 101.042 -3.688 . . . . 74.22 101.042 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -146.68 164.02 34.04 Favored 'General case' 0 CA--C 1.46 -2.488 0 N-CA-C 102.568 -3.123 . . . . 74.13 102.568 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG21 ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -141.48 167.92 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 106.498 -1.667 . . . . 74.22 106.498 -161.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -144.72 165.89 26.78 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.233 -2.506 . . . . 75.2 104.233 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.457 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 79.39 140.5 2.06 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 110.871 -0.891 . . . . 60.41 110.871 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.62 -87.42 0.07 OUTLIER Glycine 0 C--N 1.351 1.41 0 N-CA-C 109.782 -1.327 . . . . 74.3 109.782 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.56 20.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 128.934 2.893 . . . . 55.45 117.057 -172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 86.91 66.13 0.01 OUTLIER 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 105.564 -2.013 . . . . 53.32 105.564 -170.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -84.39 -166.88 1.57 Allowed 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 111.807 -2.451 . . . . 72.33 105.785 -175.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -59.43 -26.57 65.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 123.803 0.841 . . . . 73.34 110.952 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' THR . 27.3 m -87.46 139.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.749 -1.574 . . . . 63.13 106.749 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -51.95 -58.16 7.32 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.882 0.873 . . . . 72.33 111.711 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.93 8.49 6.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.941 -0.474 . . . . 63.41 111.062 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.25 29.33 74.2 Favored Glycine 0 C--N 1.36 1.864 0 N-CA-C 108.537 -1.825 . . . . 71.11 108.537 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.14 127.53 27.29 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.037 -1.625 . . . . 72.31 109.037 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 25' ' ' GLY . 1.2 mm -79.03 104.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.361 -2.829 . . . . 71.53 103.361 172.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -98.43 146.5 25.67 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 107.69 -1.226 . . . . 74.2 107.69 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 130.72 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.983 -1.858 . . . . 54.11 105.983 171.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -104.92 -47.14 4.1 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.005 -1.48 . . . . 71.22 107.005 -168.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.06 147.89 39.32 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 105.841 -1.911 . . . . 74.22 105.841 -169.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.93 128.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 103.552 -2.758 . . . . 73.54 103.552 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.542 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.4 mm -64.61 144.87 98.76 Favored Pre-proline 0 N--CA 1.477 0.875 0 N-CA-C 105.959 -1.867 . . . . 74.41 105.959 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 111.99 1.05 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 N-CA-C 107.319 -1.839 . . . . 73.14 107.319 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 34.8 mt-30 70.55 29.58 3.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 124.58 1.175 . . . . 71.13 110.654 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.03 172.38 40.67 Favored Glycine 0 C--N 1.363 2.08 0 N-CA-C 107.946 -2.062 . . . . 74.23 107.946 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.73 76.2 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 108.689 -0.856 . . . . 41.21 108.689 -175.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.8 80.18 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 109.443 -0.577 . . . . 34.11 109.443 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 44' ' ' GLN . 36.7 tt0 -62.3 -40.66 97.02 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 109.017 -0.735 . . . . 75.11 109.017 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -66.08 -41.71 90.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.15 -1.056 . . . . 55.21 108.15 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.01 -40.59 91.24 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.616 -1.253 . . . . 74.4 107.616 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.81 -10.45 59.97 Favored Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 110.859 -0.896 . . . . 74.22 110.859 172.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -81.45 -40.13 23.8 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.158 -1.052 . . . . 73.44 108.158 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.1 mt -93.75 140.78 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.848 -1.538 . . . . 73.32 106.848 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.32 174.9 10.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.057 -1.831 . . . . 71.45 106.057 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.41 143.47 57.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 106.15 -1.796 . . . . 74.42 106.15 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.12 52.27 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.785 -2.126 . . . . 74.52 107.785 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.36 147.33 40.14 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.592 -1.633 . . . . 52.31 106.592 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.538 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.6 tmm_? -109.73 118.85 37.63 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.045 -2.206 . . . . 70.15 105.045 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.24 131.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.252 -2.129 . . . . 74.24 105.252 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 -50.77 3.24 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.868 -1.53 . . . . 73.32 106.868 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.59 166.44 20.64 Favored 'General case' 0 CA--C 1.47 -2.099 0 CA-C-O 122.313 1.054 . . . . 73.33 109.272 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.09 109.5 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 103.684 -2.709 . . . . 74.5 103.684 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.73 40.02 11.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.596 1.158 . . . . 75.43 111.556 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.28 6.81 70.63 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 110.426 -1.07 . . . . 43.3 110.426 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.55 117.75 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.816 0 N-CA-C 104.284 -2.487 . . . . 75.21 104.284 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -69.16 110.98 4.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.646 -1.242 . . . . 73.21 107.646 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.27 -7.96 58.75 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.807 -0.812 . . . . 62.42 108.807 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.97 144.31 56.95 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.288 -1.004 . . . . 55.33 108.288 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 -30.86 3.93 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.784 -0.926 . . . . 41.33 110.784 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.63 164.97 15.69 Favored 'General case' 0 C--N 1.365 1.244 0 CA-C-N 118.396 1.098 . . . . 65.42 109.16 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 p -83.38 164.39 20.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.745 -1.206 . . . . 73.42 107.745 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.58 -37.95 86.01 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.569 -0.9 . . . . 75.15 108.569 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -58.58 -42.02 87.1 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 119.661 -0.816 . . . . 61.54 110.211 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.93 -40.12 91.14 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 108.625 -0.88 . . . . 62.51 108.625 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 23' ' ' VAL . . . -56.26 -43.29 78.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.691 -0.485 . . . . 70.45 109.691 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.58 -50.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 107.281 -1.378 . . . . 62.23 107.281 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.2 t -53.41 -28.63 30.77 Favored 'General case' 0 N--CA 1.514 2.74 0 CA-C-O 122.446 1.117 . . . . 71.41 108.649 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.7 m -71.73 -46.71 57.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.64 -53.06 57.42 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.006 -1.109 . . . . 63.1 108.006 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -44.45 -46.35 9.57 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 74.42 111.607 174.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -95.0 61.12 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' HG22 ' A' ' 86' ' ' VAL . 12.0 p -111.16 156.53 21.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.95 -1.13 . . . . 54.15 107.95 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.12 -125.43 3.58 Favored Glycine 0 CA--C 1.492 -1.348 0 N-CA-C 108.573 -1.811 . . . . 35.11 108.573 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -89.32 -52.12 5.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.868 -1.16 . . . . 75.32 107.868 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.04 136.63 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 105.243 -2.132 . . . . 52.05 105.243 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 82' ' ' THR . 3.9 t -114.82 130.55 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 105.21 -2.144 . . . . 73.02 105.21 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -95.11 116.86 29.27 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.788 -2.301 . . . . 70.03 104.788 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 mt -122.1 144.56 48.85 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.552 -1.647 . . . . 62.13 106.552 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -116.73 131.53 56.93 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 103.777 -2.675 . . . . 72.22 103.777 172.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mp -133.32 155.71 48.94 Favored 'General case' 0 CA--C 1.469 -2.153 0 N-CA-C 106.493 -1.669 . . . . 73.1 106.493 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.538 ' CD ' HH21 ' A' ' 58' ' ' ARG . 31.8 tt0 . . . . . 0 N--CA 1.416 -2.168 0 N-CA-C 104.894 -2.261 . . . . 75.41 104.894 -175.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.434 -1.254 0 N-CA-C 103.643 -2.725 . . . . 75.23 103.643 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.16 150.76 44.62 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.327 -1.731 . . . . 74.43 106.327 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -102.71 140.95 36.32 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.497 -2.038 . . . . 72.52 105.497 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.1 t -124.9 125.99 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 103.878 -2.638 . . . . 72.24 103.878 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -102.76 125.06 49.36 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.414 -2.069 . . . . 50.34 105.414 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 121.66 42.66 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.638 -1.616 . . . . 74.05 106.638 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.55 139.49 34.19 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.274 -1.75 . . . . 51.13 106.274 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.816 0 N-CA-C 106.304 -1.739 . . . . 61.52 106.304 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.14 0 CA-C-O 119.734 -0.481 . . . . 74.24 112.753 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.21 150.52 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 104.056 -2.572 . . . . 43.54 104.056 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.2 m -151.88 167.21 29.04 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 102.673 -3.084 . . . . 63.32 102.673 167.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.08 168.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 106.111 -1.811 . . . . 51.02 106.111 -167.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -139.54 166.12 25.42 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 102.711 -3.07 . . . . 54.53 102.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 87.66 131.19 3.41 Favored Glycine 0 C--O 1.199 -2.054 0 N-CA-C 109.637 -1.385 . . . . 73.01 109.637 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.27 -92.18 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 107.874 -2.09 . . . . 52.31 107.874 165.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.36 19.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.376 1.471 . . . . 61.44 114.169 -171.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m120 88.5 65.79 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.942 -1.503 . . . . 70.11 106.942 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 30' ' ' SER . 2.4 m -88.09 -166.45 1.59 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.877 -2.638 . . . . 74.11 103.877 172.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.68 ' H ' HG22 ' A' ' 29' ' ' THR . 5.0 m -44.86 -33.22 1.86 Allowed 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.661 1.184 . . . . 53.43 112.063 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 31' ' ' VAL . 14.4 m -85.36 129.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.055 -1.091 . . . . 74.43 108.055 -176.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -66.45 -34.16 77.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.041 -0.981 . . . . 74.31 112.789 -166.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -75.57 -2.25 28.27 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.962 -1.086 . . . . 73.1 109.338 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.97 20.2 59.83 Favored Glycine 0 C--N 1.36 1.906 0 N-CA-C 108.281 -1.927 . . . . 54.1 108.281 -167.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.38 153.06 48.92 Favored Glycine 0 CA--C 1.476 -2.358 0 N-CA-C 107.964 -2.054 . . . . 41.04 107.964 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.8 mm -90.72 119.87 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 103.89 -2.633 . . . . 73.54 103.89 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.69 145.88 43.15 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 106.667 -1.605 . . . . 71.41 106.667 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.67 131.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.175 -1.416 . . . . 71.34 107.175 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.0 -47.02 3.79 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 106.665 -1.605 . . . . 71.14 106.665 -168.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.84 138.51 42.59 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 105.594 -2.002 . . . . 71.13 105.594 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.02 126.31 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 105.081 -2.192 . . . . 70.24 105.081 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -69.9 137.24 87.51 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.685 -1.598 . . . . 62.21 106.685 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.87 117.67 4.46 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.367 2.045 . . . . 62.3 108.31 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 62.03 25.37 15.21 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.863 0.865 . . . . 63.13 111.879 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.77 54.86 Favored Glycine 0 C--N 1.364 2.092 0 N-CA-C 105.689 -2.964 . . . . 63.12 105.689 165.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.13 48.79 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 117.325 0.562 . . . . 54.15 111.782 -171.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.95 67.03 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.199 -0.667 . . . . 62.22 109.199 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.04 -34.4 77.62 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.875 -0.417 . . . . 74.33 109.875 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.5 m -64.1 -31.96 73.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.743 -0.836 . . . . 72.24 108.743 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.85 -42.31 73.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.646 -1.242 . . . . 73.34 107.646 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.03 -20.6 35.43 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.122 -1.191 . . . . 63.22 110.122 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -78.27 -41.2 34.76 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.031 -1.099 . . . . 61.34 108.031 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.9 mt -95.94 134.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.578 -1.638 . . . . 64.13 106.578 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.18 179.91 7.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.952 -1.87 . . . . 74.23 105.952 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -66.82 138.56 57.43 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 106.781 -1.562 . . . . 60.2 106.781 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.6 -14.18 50.3 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 108.528 -1.829 . . . . 71.4 108.528 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.64 151.02 44.06 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.737 -0.838 . . . . 73.35 108.737 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -113.18 126.9 55.94 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.287 -2.116 . . . . 75.13 105.287 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 t -104.77 142.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 104.554 -2.388 . . . . 72.3 104.554 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.81 -48.22 2.76 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.342 -1.355 . . . . 75.33 107.342 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.95 164.14 24.89 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 122.327 1.06 . . . . 72.44 109.785 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.14 109.1 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 N-CA-C 104.302 -2.481 . . . . 72.35 104.302 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 48.0 42.16 16.18 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.829 0.852 . . . . 63.22 110.598 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.4 10.08 82.59 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.691 -0.964 . . . . 70.31 110.691 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.31 118.02 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 104.712 -2.329 . . . . 73.14 104.712 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -71.42 113.07 8.08 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.307 -1.368 . . . . 72.21 107.307 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.2 mt -70.68 -23.15 62.43 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.222 -0.899 . . . . 74.42 109.608 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -55.49 144.94 24.24 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.532 0.682 . . . . 74.4 110.664 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.85 -33.31 5.28 Favored Glycine 0 CA--C 1.496 -1.15 0 N-CA-C 109.369 -1.492 . . . . 70.43 109.369 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.59 162.55 28.69 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.033 -0.729 . . . . 55.44 109.033 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -80.48 167.32 20.29 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.832 -1.174 . . . . 61.44 107.832 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -64.69 -39.05 93.0 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 106.543 -1.651 . . . . 71.1 106.543 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -51.9 -51.03 59.69 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 123.618 0.767 . . . . 73.43 110.047 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -66.65 -39.73 88.37 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 109.165 -0.679 . . . . 53.15 109.165 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -54.94 -41.06 70.59 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.42 0.555 . . . . 64.52 109.778 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.03 -54.64 17.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 N-CA-C 106.873 -1.528 . . . . 71.5 106.873 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 11.1 t -54.77 -28.65 50.31 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 122.268 1.032 . . . . 74.01 108.763 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.4 m -66.57 -53.76 31.05 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.331 -1.359 . . . . 54.01 107.331 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.35 -55.51 27.83 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 108.589 -0.893 . . . . 74.31 108.589 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -46.67 -32.82 3.78 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.882 0.697 . . . . 72.53 112.882 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.64 2.17 51.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.49 -0.756 . . . . 72.41 110.252 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.5 p -73.98 168.47 19.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 119.5 1.045 . . . . 75.34 109.44 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.1 -166.39 28.5 Favored Glycine 0 C--N 1.371 2.499 0 N-CA-C 108.783 -1.727 . . . . 52.14 108.783 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.29 -32.18 26.51 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.792 -0.818 . . . . 52.33 108.792 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.3 t -112.37 130.46 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 103.573 -2.751 . . . . 64.33 103.573 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.88 150.19 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.116 -2.179 . . . . 75.14 105.116 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -110.3 121.62 45.72 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 104.968 -2.234 . . . . 65.25 104.968 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.8 mt -116.4 141.33 48.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 N-CA-C 104.711 -2.329 . . . . 71.32 104.711 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 tp -114.73 127.84 55.97 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 105.672 -1.973 . . . . 64.35 105.672 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.11 155.8 50.11 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.337 -1.727 . . . . 73.0 106.337 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 CA--C 1.483 -1.599 0 N-CA-C 105.085 -2.191 . . . . 62.54 105.085 -178.07 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.494 -1.18 0 N-CA-C 105.003 -2.221 . . . . 73.45 105.003 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -137.6 153.6 49.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.572 -2.01 . . . . 51.42 105.572 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.76 141.46 35.52 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.758 -1.571 . . . . 74.45 106.758 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.5 126.06 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 103.894 -2.632 . . . . 75.21 103.894 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -96.76 125.53 41.28 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.553 -2.388 . . . . 73.33 104.553 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 121.04 44.34 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.611 -1.626 . . . . 75.14 106.611 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.71 102.78 13.26 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 104.268 -2.493 . . . . 75.12 104.268 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp . . . . . 0 N--CA 1.424 -1.765 0 CA-C-N 114.456 -1.247 . . . . 75.14 107.89 -164.027 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.471 0 N-CA-C 109.702 -1.359 . . . . 53.53 109.702 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.8 mt -131.32 144.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 103.02 -2.956 . . . . 73.42 103.02 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.1 m -147.81 163.69 35.95 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 103.484 -2.784 . . . . 64.1 103.484 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.03 169.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 105.727 -1.953 . . . . 74.45 105.727 -160.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -145.53 167.23 23.51 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.65 -2.722 . . . . 51.41 103.65 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.86 -172.98 14.67 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.061 -2.415 . . . . 51.24 107.061 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.06 -123.17 5.24 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 109.185 -1.566 . . . . 71.01 109.185 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 m -72.47 19.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 126.114 1.765 . . . . 72.5 112.908 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 87.58 64.47 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.12 -1.807 . . . . 61.42 106.12 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 30' ' ' SER . 3.3 m -84.8 -165.7 1.27 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 103.827 -2.657 . . . . 63.13 103.827 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.695 ' H ' HG22 ' A' ' 29' ' ' THR . 3.6 m -37.45 -40.37 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.616 1.566 . . . . 74.14 112.911 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.57 135.34 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.159 -1.052 . . . . 71.54 108.159 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.7 mtm105 -72.47 -35.33 68.21 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.57 -0.9 . . . . 72.21 108.57 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.88 -17.25 63.0 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 109.118 -0.697 . . . . 52.22 109.118 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 -3.19 3.78 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.189 -0.364 . . . . 73.45 112.189 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.32 170.61 47.72 Favored Glycine 0 CA--C 1.483 -1.956 0 N-CA-C 107.229 -2.348 . . . . 71.01 107.229 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.39 132.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.436 -2.061 . . . . 63.31 105.436 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -124.97 140.71 52.67 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 104.989 -2.226 . . . . 73.32 104.989 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -68.51 132.67 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.953 -1.499 . . . . 71.33 106.953 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -106.21 -46.23 4.11 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.295 -1.372 . . . . 50.14 107.295 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.26 144.17 38.28 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 105.608 -1.997 . . . . 43.34 105.608 -173.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.9 129.55 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 104.581 -2.378 . . . . 74.33 104.581 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 mt -74.36 138.91 74.84 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.125 -1.805 . . . . 72.4 106.125 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.8 110.76 0.88 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.614 2.21 . . . . 25.54 108.166 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 70.67 25.5 4.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.378 1.049 . . . . 71.42 111.318 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.44 -173.67 33.94 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 106.34 -2.704 . . . . 54.52 106.34 162.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.27 78.46 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 121.942 -0.74 . . . . 52.45 110.091 -171.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.4 80.53 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 110.155 -0.313 . . . . 75.24 110.155 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.13 -34.42 73.05 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.345 -0.613 . . . . 60.4 109.345 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -67.98 -39.69 83.26 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.481 -1.303 . . . . 72.22 107.481 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.76 -32.76 73.57 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 107.931 -1.137 . . . . 55.12 107.931 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.48 -25.99 4.78 Favored Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 110.951 -0.86 . . . . 72.33 110.951 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -69.63 -40.1 76.74 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.536 -0.912 . . . . 74.51 108.536 -173.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 mt -98.38 138.46 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 105.924 -1.88 . . . . 73.34 105.924 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -134.76 174.43 10.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.143 -1.428 . . . . 61.11 107.143 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -66.53 138.98 57.89 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.695 -1.965 . . . . 73.23 105.695 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.7 -4.8 61.72 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 109.191 -1.563 . . . . 40.52 109.191 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.43 152.96 37.9 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.383 -1.34 . . . . 73.42 107.383 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -112.79 123.83 51.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.15 -2.167 . . . . 71.21 105.15 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.73 139.97 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 104.741 -2.318 . . . . 70.14 104.741 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.08 -55.35 2.34 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.019 -1.474 . . . . 75.2 107.019 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.57 165.18 23.3 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 122.153 0.977 . . . . 72.2 109.531 -168.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.62 109.84 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 105.085 -2.191 . . . . 70.21 105.085 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 51.72 41.37 29.0 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.615 1.166 . . . . 62.23 111.812 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.44 7.01 73.07 Favored Glycine 0 CA--C 1.498 -1.006 0 N-CA-C 109.396 -1.482 . . . . 33.22 109.396 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 67' ' ' LEU . 26.8 t -112.12 117.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 105.134 -2.172 . . . . 73.05 105.134 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -80.8 15.39 1.78 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.332 -0.395 . . . . 74.21 110.424 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.496 ' H ' HG12 ' A' ' 65' ' ' VAL . 87.5 mt 38.79 45.11 0.89 Allowed 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.236 1.414 . . . . 72.21 110.937 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.2 125.14 28.62 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.514 -0.921 . . . . 45.14 108.514 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.96 -4.52 81.61 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.822 -1.711 . . . . 74.1 108.822 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.71 137.4 56.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 108.299 -1.0 . . . . 54.34 108.299 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.7 p -76.13 174.04 10.56 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.752 -1.573 . . . . 75.55 106.752 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -61.18 -39.83 91.62 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 107.816 -1.179 . . . . 71.32 107.816 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.01 -50.68 66.08 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.878 0.471 . . . . 65.45 110.713 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -66.62 -29.25 69.25 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.241 0.928 . . . . 63.3 109.437 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.53 -38.5 84.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.562 -0.903 . . . . 62.24 108.562 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.5 t -72.82 -49.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.009 -1.478 . . . . 73.45 107.009 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.1 m -52.49 -29.28 24.15 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 108.488 -0.93 . . . . 72.34 108.488 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -65.81 -55.87 14.88 Favored 'General case' 0 C--O 1.199 -1.597 0 N-CA-C 107.486 -1.301 . . . . 65.43 107.486 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.03 -56.14 24.34 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.943 -0.762 . . . . 72.33 108.943 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -49.85 -28.01 5.9 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.482 0.549 . . . . 54.42 112.482 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -92.87 -13.15 29.39 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.774 -0.579 . . . . 54.23 109.708 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.3 p -80.56 173.71 12.33 Favored 'General case' 0 C--O 1.245 0.839 0 O-C-N 120.795 -1.191 . . . . 74.15 108.909 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.79 -155.33 11.8 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.645 -1.382 . . . . 55.13 109.645 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -80.11 -43.77 21.14 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 107.443 -1.318 . . . . 72.31 107.443 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.75 131.27 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.892 0 N-CA-C 103.502 -2.777 . . . . 71.54 103.502 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.54 140.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 105.379 -2.082 . . . . 70.15 105.379 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -97.18 118.11 32.88 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 104.834 -2.284 . . . . 74.43 104.834 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 34.5 mt -121.19 142.39 49.94 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 105.661 -1.978 . . . . 72.54 105.661 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.06 133.25 56.23 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 104.723 -2.325 . . . . 74.21 104.723 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.43 152.74 51.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.314 -1.736 . . . . 53.43 106.314 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 . . . . . 0 CA--C 1.48 -1.741 0 N-CA-C 105.627 -1.99 . . . . 71.02 105.627 -173.912 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 103.847 -2.649 . . . . 74.12 103.847 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -138.85 153.13 48.3 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 106.75 -1.574 . . . . 72.52 106.75 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -103.06 136.95 41.92 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 105.515 -2.032 . . . . 74.41 105.515 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.36 130.71 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.123 0 N-CA-C 104.217 -2.512 . . . . 71.15 104.217 173.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -107.22 114.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.048 -2.575 . . . . 73.35 104.048 170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.31 122.66 44.68 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 105.051 -2.203 . . . . 64.4 105.051 -168.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 146.67 25.97 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.025 -1.842 . . . . 42.25 106.025 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.5 -0.963 0 N-CA-C 106.714 -1.588 . . . . 75.1 106.714 177.822 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.492 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.464 0.553 0 CA-C-O 119.535 -0.592 . . . . 63.31 114.171 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -136.72 154.39 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 104.095 -2.557 . . . . 72.51 104.095 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -149.76 165.81 31.33 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 103.249 -2.871 . . . . 53.23 103.249 168.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.51 168.39 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 106.735 -1.58 . . . . 72.21 106.735 -164.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -148.3 167.21 25.76 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 102.625 -3.102 . . . . 73.31 102.625 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.34 -171.77 14.42 Favored Glycine 0 CA--C 1.474 -2.499 0 N-CA-C 107.568 -2.213 . . . . 33.35 107.568 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.89 -120.87 4.41 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 110.098 -1.201 . . . . 71.23 110.098 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.99 19.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 126.204 1.801 . . . . 74.3 113.96 -165.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 88.05 66.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 123.251 1.501 . . . . 74.32 107.915 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -86.78 -165.4 1.27 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 103.107 -2.923 . . . . 73.45 103.107 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -44.73 -28.91 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.902 0.881 . . . . 61.23 112.626 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -88.18 124.07 41.05 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 107.476 -1.305 . . . . 75.44 107.476 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -72.66 -23.61 60.92 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 116.088 -0.505 . . . . 55.21 109.883 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.68 -17.02 64.0 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.197 -1.038 . . . . 71.11 108.197 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.08 7.86 26.42 Favored Glycine 0 C--N 1.356 1.673 0 N-CA-C 110.479 -1.048 . . . . 74.22 110.479 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 162.03 49.56 Favored Glycine 0 CA--C 1.48 -2.155 0 N-CA-C 108.238 -1.945 . . . . 53.22 108.238 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.2 mm -90.45 133.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 104.221 -2.511 . . . . 72.42 104.221 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.79 145.29 49.82 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.154 -2.165 . . . . 73.1 105.154 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.12 134.33 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.675 -1.232 . . . . 74.32 107.675 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -106.38 -49.39 3.35 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.465 -1.68 . . . . 71.51 106.465 -169.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.08 140.85 34.26 Favored 'General case' 0 CA--C 1.463 -2.393 0 N-CA-C 105.948 -1.871 . . . . 34.11 105.948 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.51 131.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 103.593 -2.743 . . . . 73.22 103.593 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.492 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.1 mm -64.66 142.16 98.44 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 105.568 -2.012 . . . . 73.0 105.568 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.11 111.33 0.96 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.121 -1.915 . . . . 54.34 107.121 165.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 75.32 26.0 1.22 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.826 1.329 . . . . 73.22 110.957 -174.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.62 172.62 48.24 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 107.397 -2.281 . . . . 71.14 107.397 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.88 71.01 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 122.091 -0.653 . . . . 72.54 109.36 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.01 74.97 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.513 -0.921 . . . . 74.0 108.513 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.53 -36.41 82.62 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 109.129 -0.693 . . . . 71.3 109.129 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -65.67 -39.69 91.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.715 -0.846 . . . . 73.43 108.715 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.64 -40.72 72.92 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.17 -1.048 . . . . 75.14 108.17 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.5 -13.75 66.07 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.42 -1.072 . . . . 72.23 110.42 172.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -84.99 -41.35 15.92 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.618 -0.931 . . . . 70.31 109.808 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 mt -97.09 127.95 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 106.275 -1.75 . . . . 72.3 106.275 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -122.69 174.59 7.01 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.46 -1.682 . . . . 72.12 106.46 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -66.7 137.83 56.97 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.357 -1.72 . . . . 74.12 106.357 166.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 -17.25 57.34 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 108.923 -1.671 . . . . 63.41 108.923 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.22 147.21 53.86 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 109.044 -0.724 . . . . 75.12 109.044 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -105.66 125.88 51.5 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 106.286 -1.746 . . . . 72.5 106.286 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.99 144.07 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 104.811 -2.292 . . . . 61.0 104.811 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -45.13 2.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.314 -1.365 . . . . 54.02 107.314 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.85 160.46 33.45 Favored 'General case' 0 CA--C 1.48 -1.733 0 C-N-CA 118.838 -1.145 . . . . 72.4 109.268 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.6 109.39 6.39 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 N-CA-C 105.315 -2.106 . . . . 33.13 105.315 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 47.79 40.51 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.922 1.689 . . . . 73.41 111.911 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.24 4.58 83.74 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 109.483 -1.447 . . . . 75.25 109.483 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.04 122.76 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 104.826 -2.287 . . . . 62.23 104.826 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.9 m -70.63 111.18 5.92 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.23 -1.026 . . . . 74.35 108.23 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.72 9.39 37.24 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 106.842 -1.54 . . . . 64.24 106.842 171.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -65.69 133.67 51.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.983 -1.488 . . . . 74.23 106.983 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.26 -18.65 5.18 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-O 119.629 -0.54 . . . . 72.21 111.78 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 171.71 1.87 Allowed 'General case' 0 C--N 1.37 1.459 0 CA-C-N 118.397 1.099 . . . . 74.33 110.228 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -83.85 159.86 21.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.485 -1.302 . . . . 73.31 107.485 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.33 -42.51 98.97 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.43 -0.952 . . . . 75.21 108.43 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.7 -43.13 94.22 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 110.024 -0.361 . . . . 71.31 110.024 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -61.71 -36.28 80.49 Favored 'General case' 0 C--N 1.383 2.035 0 O-C-N 121.368 -0.833 . . . . 54.2 109.164 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.97 79.53 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.958 -0.756 . . . . 52.24 108.958 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.9 t -73.89 -50.56 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.219 -1.4 . . . . 75.35 107.219 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.0 m -53.01 -29.94 32.41 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-O 122.07 0.938 . . . . 74.43 108.617 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -67.32 -53.82 26.16 Favored 'General case' 0 C--O 1.209 -1.074 0 O-C-N 120.933 -1.104 . . . . 53.12 108.033 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.84 -55.48 31.94 Favored 'General case' 0 C--O 1.211 -0.97 0 N-CA-C 109.149 -0.686 . . . . 63.15 109.149 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -48.28 -28.22 2.96 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.57 0.582 . . . . 70.22 112.57 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.77 -14.66 27.58 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.638 -0.664 . . . . 62.25 110.078 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 p -81.86 171.13 14.85 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.725 -1.234 . . . . 60.14 109.659 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.95 -154.2 12.91 Favored Glycine 0 C--N 1.36 1.881 0 N-CA-C 110.037 -1.225 . . . . 72.25 110.037 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -80.48 -35.8 34.3 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 107.857 -1.164 . . . . 55.12 107.857 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.84 126.87 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 104.554 -2.387 . . . . 52.34 104.554 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 139.36 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 N-CA-C 103.486 -2.783 . . . . 61.24 103.486 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -96.7 118.98 34.33 Favored 'General case' 0 CA--C 1.474 -1.96 0 N-CA-C 104.649 -2.352 . . . . 74.23 104.649 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -115.97 136.82 52.68 Favored 'General case' 0 CA--C 1.468 -2.173 0 N-CA-C 105.18 -2.156 . . . . 64.24 105.18 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.21 125.51 54.41 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.051 -2.203 . . . . 72.43 105.051 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.12 161.33 36.03 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 105.634 -1.988 . . . . 63.13 105.634 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 . . . . . 0 CA--C 1.468 -2.191 0 N-CA-C 108.0 -1.111 . . . . 65.22 108.0 174.319 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.028 0 N-CA-C 107.519 -2.233 . . . . 51.14 107.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.403 ' HG2' ' HE3' ' A' ' 92' ' ' LYS . 36.5 Cg_endo -66.71 151.9 81.66 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.071 1.847 . . . . 65.44 108.461 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -79.39 159.76 71.7 Favored Pre-proline 0 C--N 1.351 0.637 0 N-CA-C 108.303 -0.999 . . . . 74.44 108.303 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.66 128.7 18.48 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.063 1.842 . . . . 74.44 108.181 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 93.99 13.97 53.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 107.927 -2.069 . . . . 75.1 107.927 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 92' ' ' LYS . 18.5 t0 -89.77 134.57 34.11 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 105.594 -2.002 . . . . 73.11 105.594 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.84 130.91 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.397 0 N-CA-C 103.462 -2.792 . . . . 42.11 103.462 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.59 153.61 44.91 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.715 -1.587 . . . . 74.41 106.715 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -108.76 141.59 40.54 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.175 -1.787 . . . . 73.15 106.175 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.4 t -128.53 130.61 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 N-CA-C 104.819 -2.289 . . . . 61.52 104.819 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -105.71 113.21 26.64 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 104.931 -2.248 . . . . 72.13 104.931 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 120.98 41.54 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.231 -1.766 . . . . 64.22 106.231 -169.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.72 142.59 28.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.232 -1.766 . . . . 61.11 106.232 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HE2' HD22 ' A' ' 19' ' ' LEU . 33.4 mmtm -101.94 33.77 2.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.026 -1.472 . . . . 65.43 107.026 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.29 -51.45 15.2 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.262 -1.385 . . . . 73.13 107.262 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.7 -58.17 9.59 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 109.456 -0.572 . . . . 73.11 109.456 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -154.54 175.4 13.67 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.262 -1.755 . . . . 63.05 106.262 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.2 t -44.88 156.65 0.08 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.011 1.724 . . . . 72.25 110.39 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.406 HD22 ' HE2' ' A' ' 14' ' ' LYS . 5.5 mt -54.88 -57.81 10.13 Favored 'General case' 0 C--N 1.374 1.674 0 N-CA-C 108.6 -0.889 . . . . 54.22 108.6 -170.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.45 48.53 85.54 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 110.27 -1.132 . . . . 40.22 110.27 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mt -129.24 158.86 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.433 -2.432 . . . . 53.52 104.433 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -149.99 165.42 32.72 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.147 -3.279 . . . . 43.43 102.147 168.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.71 168.19 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 105.936 -1.875 . . . . 74.01 105.936 -170.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -146.45 166.59 25.95 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 103.029 -2.952 . . . . 73.43 103.029 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.5 -173.3 14.66 Favored Glycine 0 CA--C 1.472 -2.624 0 N-CA-C 107.548 -2.221 . . . . 73.42 107.548 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.78 -127.81 6.08 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 108.838 -1.705 . . . . 31.42 108.838 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -73.18 19.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 126.222 1.809 . . . . 71.22 112.419 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.262 9.5 m120 87.31 65.52 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.672 0 N-CA-C 106.34 -1.726 . . . . 62.43 106.34 -168.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 30' ' ' SER . 3.4 m -80.96 -165.78 0.98 Allowed 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 104.003 -2.592 . . . . 73.2 104.003 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.661 ' H ' HG22 ' A' ' 29' ' ' THR . 3.4 p -42.96 -40.73 3.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 53.04 112.032 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.51 138.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.583 -0.895 . . . . 74.44 108.583 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.24 -42.39 68.92 Favored 'General case' 0 C--N 1.364 1.206 0 N-CA-C 109.787 -0.449 . . . . 63.5 109.787 -171.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -73.9 -5.64 42.34 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.843 -0.799 . . . . 71.23 108.843 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.22 3.25 11.5 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.304 -0.718 . . . . 74.41 111.304 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.53 150.19 42.09 Favored Glycine 0 CA--C 1.475 -2.448 0 N-CA-C 109.625 -1.39 . . . . 40.41 109.625 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.81 87.96 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 105.49 -2.041 . . . . 74.32 105.49 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -88.75 144.19 26.41 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.585 -1.635 . . . . 73.51 106.585 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.21 133.82 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.535 -1.654 . . . . 70.21 106.535 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -104.1 -43.66 5.2 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 106.712 -1.588 . . . . 64.53 106.712 -167.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.18 150.8 36.55 Favored 'General case' 0 CA--C 1.458 -2.569 0 N-CA-C 105.441 -2.059 . . . . 54.41 105.441 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -137.26 132.14 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.622 -2.362 . . . . 72.55 104.622 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.419 HG23 ' HD2' ' A' ' 43' ' ' PRO . 27.3 mt -70.6 137.88 85.91 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 105.546 -2.02 . . . . 74.33 105.546 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 42' ' ' ILE . 19.6 Cg_endo -57.56 123.53 13.96 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.165 1.91 . . . . 71.43 108.744 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 55.74 32.6 19.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.497 1.119 . . . . 71.54 112.053 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.92 -177.95 46.08 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 105.36 -3.096 . . . . 64.41 105.36 168.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.51 98.75 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.279 1.04 . . . . 63.2 109.6 -168.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.05 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 109.233 -0.654 . . . . 64.12 109.233 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -69.24 -38.74 78.62 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 109.648 -0.501 . . . . 73.44 109.648 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -65.38 -37.49 87.16 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.958 -1.126 . . . . 74.41 107.958 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.42 -32.56 66.43 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.532 -1.285 . . . . 72.34 107.532 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.79 64.99 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.726 -0.95 . . . . 61.34 110.726 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -83.33 -41.03 18.71 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.459 -0.941 . . . . 73.24 108.459 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.8 mt -104.78 136.69 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.902 -1.888 . . . . 62.13 105.902 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -138.33 -178.52 5.32 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 104.843 -2.28 . . . . 74.31 104.843 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.42 146.9 54.04 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.678 -0.86 . . . . 70.43 108.678 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.21 -3.73 86.57 Favored Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 109.704 -1.359 . . . . 52.23 109.704 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -80.51 155.45 27.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.461 -2.052 . . . . 75.32 105.461 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -119.68 127.35 52.8 Favored 'General case' 0 CA--C 1.478 -1.807 0 C-N-CA 119.411 -0.916 . . . . 62.33 109.099 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.07 148.13 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.09 -2.189 . . . . 64.12 105.09 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.65 -45.05 2.52 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 106.929 -1.508 . . . . 72.14 106.929 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.81 34.86 Favored 'General case' 0 CA--C 1.482 -1.667 0 C-N-CA 119.226 -0.99 . . . . 75.33 109.288 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.11 110.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 104.097 -2.557 . . . . 70.53 104.097 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.303 0.8 OUTLIER 46.48 38.3 5.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.541 1.137 . . . . 62.34 112.292 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.28 65.87 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.799 -1.32 . . . . 73.53 109.799 171.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.08 119.91 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.693 0 N-CA-C 104.971 -2.233 . . . . 70.52 104.971 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m -67.59 111.0 3.93 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.358 -1.349 . . . . 70.2 107.358 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.31 -14.91 51.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.926 -0.768 . . . . 72.03 108.926 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.98 146.58 46.46 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 109.332 -0.618 . . . . 65.55 109.332 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 -39.23 3.01 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 109.555 -1.418 . . . . 74.43 109.555 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 166.13 22.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.354 -0.98 . . . . 73.55 108.354 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.8 p -89.73 174.55 7.66 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.009 -1.108 . . . . 53.13 108.009 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -64.98 -38.73 91.93 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.987 -0.745 . . . . 64.1 108.987 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -59.59 -45.13 92.79 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 120.016 -0.674 . . . . 64.01 111.008 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -62.65 -39.99 95.63 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 119.746 1.157 . . . . 72.32 108.302 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.1 -42.97 86.8 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.8 -0.445 . . . . 74.14 109.8 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -69.25 -54.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 107.2 -1.407 . . . . 72.22 107.2 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -57.39 -26.46 61.11 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.222 -0.659 . . . . 71.31 109.222 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -65.81 -56.13 13.53 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.52 -55.1 35.8 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.153 -1.054 . . . . 74.5 108.153 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -45.63 -34.89 3.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.251 1.02 . . . . 70.21 111.975 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -96.6 -3.05 43.61 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.435 -0.79 . . . . 72.33 109.69 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -84.35 170.17 13.89 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.736 -1.227 . . . . 73.43 108.627 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.74 -149.32 24.59 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 122.508 1.06 . . . . 41.21 110.616 -171.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -77.82 -53.15 7.82 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.831 -1.174 . . . . 73.54 107.831 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.12 127.89 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.798 0 N-CA-C 103.576 -2.75 . . . . 71.43 103.576 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -133.16 143.13 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 103.796 -2.668 . . . . 74.34 103.796 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -97.28 116.0 28.67 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.542 -2.392 . . . . 73.04 104.542 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -114.52 138.0 51.16 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 105.7 -1.963 . . . . 62.3 105.7 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -113.82 127.85 56.17 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.548 -2.019 . . . . 44.24 105.548 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.81 155.97 49.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.26 -1.756 . . . . 74.52 106.26 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -129.28 137.64 51.16 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 105.596 -2.002 . . . . 72.11 105.596 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.57 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 72.3 mmtt -66.45 150.33 49.09 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.372 1.082 . . . . 53.23 110.844 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.72 45.35 0.39 Allowed Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 104.893 -3.283 . . . . 71.4 104.893 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -103.75 168.8 8.9 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 107.147 -1.427 . . . . 73.3 107.147 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 5.3 m -68.88 162.87 61.08 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.711 -1.218 . . . . 40.02 107.711 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 34.9 Cg_endo -64.36 171.7 7.58 Favored 'Trans proline' 0 C--O 1.257 1.435 0 C-N-CA 122.492 2.128 . . . . 53.04 109.276 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.414 -2.254 0 N-CA-C 105.035 -2.209 . . . . 75.41 105.035 -173.392 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.414 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.722 0 N-CA-C 108.426 -1.87 . . . . 74.33 108.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.46 116.11 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.855 2.37 . . . . 74.33 109.116 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 99.3 mttt -88.65 165.92 25.34 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 105.324 -2.102 . . . . 75.1 105.324 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 16.8 Cg_endo -57.46 116.33 3.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.547 2.165 . . . . 73.22 110.705 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 12.28 51.64 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 108.237 -1.945 . . . . 64.41 108.237 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.44 136.76 36.51 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.691 -1.966 . . . . 74.43 105.691 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.22 137.07 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 104.719 -2.326 . . . . 71.51 104.719 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -145.88 157.11 43.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 105.893 -1.891 . . . . 72.1 105.893 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.25 143.62 32.41 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.848 -1.908 . . . . 73.32 105.848 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.06 128.12 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 104.167 -2.531 . . . . 73.01 104.167 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.26 114.62 26.39 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 105.552 -2.018 . . . . 73.43 105.552 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -103.61 120.84 41.69 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 105.994 -1.854 . . . . 72.43 105.994 -174.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.85 134.71 37.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.163 -1.421 . . . . 71.01 107.163 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.99 35.36 0.85 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.356 -1.72 . . . . 75.0 106.356 174.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -58.24 -38.38 76.75 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 108.557 -0.905 . . . . 71.22 108.557 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.28 175.08 7.94 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 107.482 -1.303 . . . . 73.14 107.482 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -80.6 -48.06 13.24 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 106.834 -1.543 . . . . 73.22 106.834 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.9 p -77.01 117.73 18.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.045 -0.724 . . . . 42.3 109.045 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.0 mt -72.88 -57.99 3.66 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 104.654 -2.35 . . . . 74.53 104.654 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.571 ' HA3' HG12 ' A' ' 42' ' ' ILE . . . 52.5 50.65 47.18 Favored Glycine 0 C--N 1.353 1.521 0 CA-C-N 113.373 -1.74 . . . . 64.34 112.459 169.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.2 mt -123.05 153.02 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.394 -2.447 . . . . 75.54 104.394 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.5 m -151.81 163.37 39.33 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 102.769 -3.048 . . . . 71.53 102.769 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.74 168.32 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.401 -2.444 . . . . 73.14 104.401 -166.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -149.65 167.4 26.51 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 103.962 -2.607 . . . . 62.41 103.962 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.65 -171.89 13.99 Favored Glycine 0 CA--C 1.473 -2.56 0 N-CA-C 107.0 -2.44 . . . . 65.02 107.0 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.48 -124.23 5.83 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 108.687 -1.765 . . . . 74.13 108.687 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 m -73.27 20.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.694 0 C-N-CA 125.883 1.673 . . . . 50.24 113.142 -167.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.1 t30 89.93 66.04 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 123.146 1.45 . . . . 72.33 107.39 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 30' ' ' SER . 2.0 m -82.71 -167.2 1.54 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.465 -2.42 . . . . 73.1 104.465 170.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.582 ' H ' HG22 ' A' ' 29' ' ' THR . 16.3 m -58.17 -25.21 61.23 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 121.5 -0.75 . . . . 64.33 111.535 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 m -78.79 131.45 34.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 107.505 -1.295 . . . . 72.52 107.505 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -60.11 -53.69 54.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.921 0.488 . . . . 72.25 110.675 -171.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -76.87 4.77 9.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.829 -0.544 . . . . 74.1 109.88 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.62 13.46 24.17 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.249 -0.74 . . . . 75.52 111.249 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.31 148.02 50.46 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 108.385 -1.886 . . . . 50.1 108.385 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.13 97.11 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.542 -1.651 . . . . 75.41 106.542 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -95.76 143.93 26.58 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 107.043 -1.465 . . . . 74.25 107.043 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.6 t -72.02 130.61 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 N-CA-C 105.064 -2.198 . . . . 45.41 105.064 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -103.09 -39.97 6.66 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 107.316 -1.365 . . . . 50.53 107.316 -166.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.38 158.48 40.12 Favored 'General case' 0 CA--C 1.465 -2.29 0 N-CA-C 106.011 -1.848 . . . . 73.32 106.011 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.46 140.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 104.221 -2.511 . . . . 75.02 104.221 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.571 HG12 ' HA3' ' A' ' 20' ' ' GLY . 24.3 mm -70.67 143.99 90.51 Favored Pre-proline 0 C--N 1.355 0.805 0 N-CA-C 105.741 -1.948 . . . . 74.25 105.741 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.2 112.18 0.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.429 2.086 . . . . 70.34 108.948 165.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 74.91 22.04 1.93 Allowed 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.354 1.034 . . . . 60.24 110.483 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.74 175.68 30.17 Favored Glycine 0 C--N 1.375 2.732 0 N-CA-C 108.275 -1.93 . . . . 74.3 108.275 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.69 98.74 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.036 -0.727 . . . . 60.45 109.036 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.27 76.61 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.582 -0.525 . . . . 74.01 109.582 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.66 -35.13 79.43 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.134 -0.691 . . . . 63.04 109.134 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 m -66.02 -37.43 85.88 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.135 -1.061 . . . . 72.32 108.135 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.48 -41.24 89.27 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.397 -0.964 . . . . 71.23 108.397 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.71 -22.83 26.04 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.104 -1.198 . . . . 74.24 110.104 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -78.48 -38.72 40.27 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.693 -1.225 . . . . 72.32 107.693 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mt -104.84 129.37 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.258 -1.386 . . . . 72.53 107.258 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -140.19 -175.71 4.34 Favored 'General case' 0 CA--C 1.467 -2.25 0 N-CA-C 104.039 -2.578 . . . . 72.14 104.039 172.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 146.38 53.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.339 -1.356 . . . . 73.33 107.339 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.69 -25.23 28.22 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 107.827 -2.109 . . . . 52.54 107.827 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' HA ' ' HG3' ' A' ' 94' ' ' GLN . 6.7 m-20 -77.27 154.68 32.71 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.223 -1.769 . . . . 72.44 106.223 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -134.39 141.0 46.7 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 107.487 -1.301 . . . . 64.25 107.487 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.33 150.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.401 -1.704 . . . . 74.21 106.401 -172.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.59 -46.41 2.86 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 106.953 -1.499 . . . . 73.34 106.953 169.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.16 161.89 30.1 Favored 'General case' 0 CA--C 1.484 -1.577 0 C-N-CA 118.915 -1.114 . . . . 64.55 110.19 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.37 107.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 104.206 -2.516 . . . . 74.11 104.206 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 t30 48.83 37.98 11.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.496 1.119 . . . . 73.33 111.021 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.64 10.17 70.64 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.345 -1.102 . . . . 63.44 110.345 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.59 117.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.948 0 N-CA-C 103.933 -2.617 . . . . 73.12 103.933 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 m -71.66 111.48 6.99 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.561 -1.274 . . . . 73.13 107.561 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.26 -3.26 58.89 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.674 -0.861 . . . . 65.22 108.674 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -63.94 144.03 57.39 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 106.963 -1.495 . . . . 72.31 106.963 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -34.83 3.09 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.022 -0.831 . . . . 62.33 111.022 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.68 162.11 24.41 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 118.356 1.078 . . . . 64.22 108.281 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -82.94 170.21 15.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.94 -0.763 . . . . 54.35 108.94 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -62.81 -44.1 97.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.702 -0.851 . . . . 73.24 108.702 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -62.35 -43.31 99.13 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 118.574 -0.727 . . . . 63.14 111.129 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -35.31 80.16 Favored 'General case' 0 C--N 1.383 2.028 0 CA-C-N 120.166 1.348 . . . . 70.33 109.005 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.89 74.23 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.913 -0.773 . . . . 61.05 108.913 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -73.88 -54.65 14.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 107.527 -1.286 . . . . 75.12 107.527 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 14.4 m -55.33 -29.27 57.97 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 122.705 1.24 . . . . 51.0 108.365 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -68.51 -54.36 17.31 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.504 -1.372 . . . . 72.0 107.647 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.6 mt -54.7 -56.18 21.9 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.707 -0.849 . . . . 71.24 108.707 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -46.15 -47.09 17.62 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.185 0.439 . . . . 73.12 112.185 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -82.93 3.35 30.31 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.357 -0.84 . . . . 60.31 111.077 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.2 p -82.17 173.71 11.87 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.583 1.083 . . . . 73.41 108.375 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.93 -163.12 26.91 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 109.6 -1.4 . . . . 74.4 109.6 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.75 -32.98 27.56 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.101 -1.074 . . . . 62.33 108.101 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.2 t -115.95 127.19 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.605 -2.739 . . . . 61.31 103.605 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.46 151.32 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 104.609 -2.367 . . . . 75.51 104.609 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -102.08 123.68 46.37 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 104.271 -2.492 . . . . 61.1 104.271 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 12' ' ' LEU . 62.1 mt -114.99 138.69 50.55 Favored 'General case' 0 CA--C 1.467 -2.242 0 N-CA-C 104.301 -2.481 . . . . 72.51 104.301 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -112.63 125.37 54.21 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.647 -1.983 . . . . 74.2 105.647 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.75 153.68 49.83 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.164 -1.791 . . . . 65.13 106.164 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -123.76 133.29 53.87 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 105.024 -2.214 . . . . 73.41 105.024 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -67.19 142.65 56.92 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.575 0.702 . . . . 72.43 109.463 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.12 56.56 0.04 OUTLIER Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 104.295 -3.522 . . . . 73.4 104.295 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 57' ' ' ASP . 29.2 mp0 -91.37 134.66 34.42 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.157 -1.794 . . . . 73.32 106.157 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.0 m -99.65 148.06 34.22 Favored Pre-proline 0 N--CA 1.437 -1.124 0 N-CA-C 104.231 -2.507 . . . . 73.41 104.231 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.79 90.59 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.184 1.923 . . . . 74.23 107.584 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.415 -2.198 0 N-CA-C 105.929 -1.878 . . . . 74.33 105.929 -177.581 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.432 ' H5 ' ' C1 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.861 0 N-CA-C 108.377 -1.889 . . . . 72.44 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.07 101.81 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.861 2.374 . . . . 52.2 108.402 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 94.9 mttt -80.68 161.04 65.45 Favored Pre-proline 0 C--O 1.22 -0.478 0 N-CA-C 105.891 -1.892 . . . . 71.12 105.891 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 26.3 Cg_endo -61.85 115.61 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 74.23 109.837 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.95 58.52 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 108.369 -1.893 . . . . 62.35 108.369 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -94.61 141.69 28.31 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 105.179 -2.156 . . . . 61.21 105.179 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.54 129.39 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 103.692 -2.707 . . . . 53.52 103.692 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -138.58 146.51 41.91 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.233 -1.766 . . . . 71.25 106.233 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.18 138.84 40.07 Favored 'General case' 0 N--CA 1.396 -3.128 0 N-CA-C 104.483 -2.414 . . . . 62.42 104.483 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.02 130.99 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.772 0 N-CA-C 105.498 -2.038 . . . . 72.5 105.498 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -100.78 119.86 39.26 Favored 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 104.707 -2.331 . . . . 72.22 104.707 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 121.08 44.04 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 105.979 -1.86 . . . . 74.45 105.979 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.32 134.29 41.54 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.653 -1.24 . . . . 23.44 107.653 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.37 34.64 1.41 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.018 -1.475 . . . . 63.23 107.018 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -58.94 -25.43 63.49 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.404 -0.591 . . . . 70.22 109.404 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -86.98 -131.26 0.06 Allowed 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.492 -1.67 . . . . 74.13 106.492 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -126.98 -51.23 1.44 Allowed 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.631 -0.877 . . . . 73.12 108.631 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.5 p -84.56 139.87 31.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.612 -1.255 . . . . 74.41 107.612 -170.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 80' ' ' ARG . 16.1 mt -73.03 -58.96 2.94 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.863 -2.273 . . . . 55.34 104.863 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . 94.64 24.13 19.06 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 108.636 -1.786 . . . . 73.01 108.636 164.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.84 158.65 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 106.184 -1.784 . . . . 70.2 106.184 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.2 m -153.31 163.62 39.59 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 102.517 -3.142 . . . . 74.42 102.517 164.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.39 167.33 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 107.036 -1.468 . . . . 62.12 107.036 -161.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -143.71 165.99 26.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 104.562 -2.384 . . . . 71.2 104.562 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.22 -163.06 12.21 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 107.939 -2.065 . . . . 53.21 107.939 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.32 -127.5 6.08 Favored Glycine 0 C--N 1.36 1.877 0 N-CA-C 110.379 -1.088 . . . . 24.23 110.379 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 m -59.85 18.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.195 0 C-N-CA 128.282 2.633 . . . . 63.31 115.29 -167.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 86.44 64.34 0.01 OUTLIER 'General case' 0 CA--C 1.468 -2.196 0 N-CA-C 105.754 -1.943 . . . . 72.33 105.754 -165.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 30' ' ' SER . 2.3 m -88.43 -166.29 1.55 Allowed 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 111.686 -2.506 . . . . 64.4 104.546 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.668 ' H ' HG22 ' A' ' 29' ' ' THR . 11.8 m -58.35 -20.49 43.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.39 0.676 . . . . 21.23 111.226 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.629 -1.248 . . . . 51.41 107.629 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -70.32 -34.24 72.46 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-O 121.508 0.67 . . . . 72.34 109.756 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.44 -15.65 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.202 -1.036 . . . . 72.3 108.202 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.24 8.72 25.89 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 110.391 -1.083 . . . . 75.41 110.391 -176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.97 159.46 53.9 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 107.976 -2.05 . . . . 52.42 107.976 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.0 mm -90.64 95.16 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.464 -2.05 . . . . 33.51 105.464 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.05 146.74 26.5 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.507 -1.294 . . . . 74.32 107.507 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.39 129.0 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.426 -1.694 . . . . 70.23 106.426 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -106.41 -43.79 4.68 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 107.88 -1.155 . . . . 73.5 107.88 -171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.8 144.59 39.42 Favored 'General case' 0 CA--C 1.46 -2.502 0 N-CA-C 105.732 -1.951 . . . . 74.3 105.732 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.7 120.01 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 104.17 -2.53 . . . . 74.03 104.17 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.498 HD12 ' HA2' ' A' ' 20' ' ' GLY . 18.3 mt -72.88 135.06 80.79 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.122 -1.807 . . . . 64.22 106.122 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 42' ' ' ILE . 19.0 Cg_endo -58.2 121.6 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.803 2.335 . . . . 74.01 109.647 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 65.65 23.2 11.66 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.482 1.114 . . . . 74.31 110.461 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 175.34 49.18 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 106.698 -2.561 . . . . 50.04 106.698 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.1 82.92 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.613 -0.884 . . . . 74.41 108.613 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.48 76.85 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.222 -0.659 . . . . 71.55 109.222 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.32 -35.07 73.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.816 0.341 . . . . 74.04 110.112 -173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -68.33 -37.13 80.24 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.176 -1.046 . . . . 72.21 108.176 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.12 -47.0 72.45 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 107.124 -1.436 . . . . 65.43 107.124 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.09 -21.6 19.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 111.386 -0.686 . . . . 53.44 111.386 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -72.82 -35.13 67.24 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.559 1.18 . . . . 71.43 107.984 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.2 mt -94.55 135.98 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 105.964 -1.865 . . . . 45.54 105.964 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -144.31 176.06 9.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.262 -1.755 . . . . 54.13 106.262 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.95 137.1 56.28 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.799 -1.556 . . . . 72.12 106.799 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.99 -18.2 26.49 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 107.336 -2.306 . . . . 54.42 107.336 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.28 155.45 27.29 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 108.109 -1.071 . . . . 70.03 108.109 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -120.15 135.33 55.0 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 104.785 -2.302 . . . . 73.55 104.785 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.0 143.95 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 104.555 -2.387 . . . . 70.32 104.555 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -46.9 2.53 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.14 -1.43 . . . . 71.53 107.14 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.37 165.34 22.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 CA-C-O 122.394 1.093 . . . . 63.4 109.625 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -142.13 113.0 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 N-CA-C 103.486 -2.783 . . . . 72.43 103.486 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 53.52 31.27 12.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.072 0.549 . . . . 73.11 110.473 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.49 79.61 Favored Glycine 0 C--N 1.357 1.728 0 N-CA-C 110.209 -1.156 . . . . 62.21 110.209 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.98 124.92 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 104.707 -2.331 . . . . 72.32 104.707 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.0 m -64.35 104.33 0.75 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.436 -1.32 . . . . 62.44 107.436 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -21.3 21.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.486 -1.302 . . . . 74.33 107.486 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.41 146.26 48.93 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.005 . . . . 73.45 108.288 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.27 -35.39 3.58 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 109.872 -1.291 . . . . 51.31 109.872 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.78 161.65 28.0 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.102 -1.073 . . . . 73.52 108.102 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.0 p -77.83 168.46 19.89 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.685 0.755 . . . . 62.43 109.301 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -63.16 -42.27 99.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.986 -1.116 . . . . 63.05 107.986 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -56.02 -50.63 70.35 Favored 'General case' 0 C--N 1.367 1.338 0 N-CA-C 109.919 -0.4 . . . . 74.33 109.919 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -64.53 -37.12 86.45 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.307 -0.627 . . . . 64.4 109.307 -171.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.62 77.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.099 -0.704 . . . . 73.34 109.099 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.3 t -73.69 -52.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.529 -1.285 . . . . 73.32 107.529 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 46.6 m -53.04 -28.14 23.03 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-O 121.901 0.858 . . . . 70.21 109.009 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.25 -56.37 10.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.21 -1.404 . . . . 75.13 107.21 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.6 mt -56.75 -56.61 19.32 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.712 -0.847 . . . . 65.32 108.712 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.409 ' HA ' HD11 ' A' ' 19' ' ' LEU . 98.6 mtt180 -47.62 -27.14 1.73 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.048 1.129 . . . . 64.14 114.048 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.85 4.79 43.08 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 119.666 1.121 . . . . 74.43 109.047 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.2 p -84.86 170.28 13.29 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 121.055 -1.028 . . . . 73.12 108.4 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.6 -151.14 26.56 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.711 -1.755 . . . . 65.14 108.711 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -80.79 -43.17 20.52 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 107.994 -1.113 . . . . 64.32 107.994 -171.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.58 123.62 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 104.741 -2.318 . . . . 71.05 104.741 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -127.99 147.53 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.758 0 N-CA-C 105.373 -2.084 . . . . 53.35 105.373 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -99.88 115.66 30.13 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.152 -2.166 . . . . 62.21 105.152 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.82 134.27 52.66 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 104.62 -2.363 . . . . 60.32 104.62 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.57 124.37 52.2 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 105.129 -2.174 . . . . 75.12 105.129 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -133.18 159.34 40.46 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 106.843 -1.54 . . . . 75.21 106.843 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.8 135.09 53.58 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.112 -2.922 . . . . 74.34 103.112 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -66.4 150.97 48.1 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.986 0.898 . . . . 64.14 109.569 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -114.18 -168.29 16.26 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 105.26 -3.136 . . . . 65.52 105.26 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.2 155.99 37.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.128 -1.064 . . . . 70.21 108.128 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.489 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 52.1 m -79.87 165.12 49.42 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 104.888 -2.264 . . . . 72.52 104.888 169.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 16.2 Cg_endo -56.95 106.93 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.405 2.07 . . . . 74.21 109.135 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.416 -2.147 0 N-CA-C 104.705 -2.331 . . . . 62.25 104.705 -175.689 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.417 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.959 0 N-CA-C 108.794 -1.722 . . . . 64.33 108.794 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.94 124.93 12.41 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.753 2.302 . . . . 72.2 108.158 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.05 156.71 71.9 Favored Pre-proline 0 CA--C 1.506 -0.715 0 N-CA-C 106.177 -1.786 . . . . 64.42 106.177 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.82 141.49 59.4 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 N-CA-C 107.671 -1.703 . . . . 62.34 107.671 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.28 75.79 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 108.262 -1.935 . . . . 45.14 108.262 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 92' ' ' LYS . 22.4 t0 -89.58 136.48 33.01 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 104.545 -2.391 . . . . 74.5 104.545 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.55 131.14 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 103.91 -2.626 . . . . 72.24 103.91 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.13 150.51 45.74 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.656 -1.239 . . . . 74.2 107.656 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -102.69 136.7 42.04 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 104.875 -2.269 . . . . 71.13 104.875 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -125.56 134.26 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 105.63 -1.989 . . . . 74.01 105.63 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -106.68 109.88 21.92 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.575 -2.009 . . . . 75.45 105.575 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -102.99 121.6 42.88 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.841 -1.911 . . . . 74.32 105.841 -171.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.34 130.0 35.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.068 -1.456 . . . . 71.1 107.068 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 32.51 0.64 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.99 -1.485 . . . . 72.51 106.99 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -71.5 -14.68 62.19 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.758 -0.83 . . . . 75.11 108.758 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 29.5 t70 -81.28 -154.43 0.11 Allowed 'General case' 0 C--N 1.351 0.671 0 N-CA-C 105.526 -2.027 . . . . 62.34 105.526 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.529 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 35.7 m120 -118.0 -39.97 3.03 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 104.576 -2.379 . . . . 74.14 104.576 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.0 m -76.19 150.07 37.17 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.455 -1.313 . . . . 55.13 107.455 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -71.85 -19.04 62.02 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.089 -1.078 . . . . 64.31 108.089 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.64 ' HA3' ' H ' ' A' ' 47' ' ' ALA . . . 77.49 -34.5 1.57 Allowed Glycine 0 C--O 1.203 -1.789 0 CA-C-N 115.363 -0.835 . . . . 65.13 111.437 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mm -110.13 157.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 106.404 -1.702 . . . . 74.21 106.404 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.8 m -146.49 155.93 42.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 101.571 -3.492 . . . . 74.33 101.571 163.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.31 160.57 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 C-N-CA 119.309 -0.956 . . . . 74.32 109.833 -166.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 t -145.22 166.29 25.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 103.032 -2.951 . . . . 54.35 103.032 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.74 123.72 4.0 Favored Glycine 0 C--O 1.193 -2.408 0 N-CA-C 108.407 -1.877 . . . . 51.45 108.407 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.18 -115.37 0.44 Allowed Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.096 -1.602 . . . . 75.51 109.096 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.79 20.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 126.17 1.788 . . . . 51.24 115.031 -163.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.3 t30 88.3 64.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 123.702 1.715 . . . . 52.44 106.476 -164.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -90.0 -165.28 1.31 Allowed 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 102.587 -3.116 . . . . 73.33 102.587 165.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -40.49 -33.35 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.412 1.085 . . . . 72.22 112.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.68 132.99 36.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 O-C-N 121.15 -0.969 . . . . 75.21 108.579 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -64.12 -58.03 7.83 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.565 -1.198 . . . . 61.14 111.899 -168.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -79.94 5.06 14.92 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.49 -0.756 . . . . 75.11 109.071 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.85 33.26 83.54 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 108.504 -1.839 . . . . 75.3 108.504 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.4 124.77 34.17 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 107.525 -2.23 . . . . 63.15 107.525 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mm -81.39 90.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.675 -2.342 . . . . 73.03 104.675 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -85.57 146.16 27.02 Favored 'General case' 0 CA--C 1.467 -2.212 0 N-CA-C 107.887 -1.153 . . . . 65.11 107.887 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.12 125.98 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.749 -1.945 . . . . 71.23 105.749 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -91.55 -38.38 12.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 106.672 -1.603 . . . . 65.54 106.672 -168.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.59 155.5 38.56 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 105.825 -1.917 . . . . 75.02 105.825 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.97 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 102.06 -3.311 . . . . 74.51 102.06 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.95 130.35 93.93 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 106.554 -1.647 . . . . 65.43 106.554 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.26 123.93 14.49 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.809 2.339 . . . . 64.42 109.477 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 68.67 10.09 7.69 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 124.781 1.3 . . . . 72.25 110.756 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.57 -175.18 37.17 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.973 -1.651 . . . . 54.41 108.973 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.85 74.34 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.054 -0.721 . . . . 63.24 109.054 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.64 ' H ' ' HA3' ' A' ' 20' ' ' GLY . . . -68.99 -46.03 69.08 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 108.908 -0.775 . . . . 72.14 108.908 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.22 -36.0 80.62 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 108.741 -0.837 . . . . 73.11 108.741 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.7 t -64.18 -40.13 95.45 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 108.203 -1.036 . . . . 54.42 108.203 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -73.86 -48.25 32.44 Favored 'General case' 0 C--N 1.351 0.63 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.34 -17.44 13.47 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.771 -0.532 . . . . 63.22 111.771 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . 33.9 ttm105 -72.98 -33.76 66.02 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.852 -1.166 . . . . 72.23 107.852 -173.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.16 135.61 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.069 -1.826 . . . . 72.32 106.069 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 52' ' ' ARG . 25.6 m80 -118.59 162.87 17.68 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 106.995 -1.483 . . . . 73.55 106.995 -175.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -65.78 136.42 56.19 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 106.981 -1.488 . . . . 71.41 106.981 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.75 -10.0 72.88 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.78 -1.728 . . . . 70.13 108.78 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -66.51 143.41 57.09 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 105.884 -1.895 . . . . 70.15 105.884 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.7 tmm_? -103.15 119.82 39.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.376 -1.342 . . . . 75.51 107.376 -169.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 t -89.18 141.62 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 105.766 -1.939 . . . . 73.22 105.766 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -47.0 2.51 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 70.31 107.32 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.32 167.63 18.92 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.373 1.082 . . . . 64.31 109.493 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -141.07 108.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 103.533 -2.766 . . . . 70.5 103.533 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 49.91 39.64 18.99 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.089 0.956 . . . . 73.1 110.598 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.55 20.1 78.74 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 109.936 -1.266 . . . . 62.34 109.936 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.63 119.35 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 N-CA-C 104.124 -2.547 . . . . 64.33 104.124 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -70.24 105.9 3.13 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.234 -0.654 . . . . 54.01 109.234 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.88 -7.07 53.23 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.027 -1.471 . . . . 72.25 107.027 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.97 143.67 57.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.109 -1.441 . . . . 72.41 107.109 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.83 2.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.983 -0.847 . . . . 23.01 110.983 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.89 172.66 4.19 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 118.218 1.009 . . . . 60.3 109.766 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -82.65 156.47 23.84 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.603 -1.258 . . . . 75.53 107.603 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -66.28 -37.65 85.94 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.89 -1.152 . . . . 72.34 107.89 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -39.45 87.16 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 120.639 -0.424 . . . . 72.21 110.188 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.71 -36.45 83.9 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-N 119.389 0.995 . . . . 73.23 109.018 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.14 75.83 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.078 -0.712 . . . . 72.11 109.078 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 -53.45 25.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 N-CA-C 107.278 -1.379 . . . . 71.4 107.278 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.0 m -52.49 -29.19 23.7 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 108.294 -1.002 . . . . 74.22 108.294 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.1 m -69.19 -56.23 8.25 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 108.015 -1.105 . . . . 70.51 108.015 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -53.52 -56.17 19.31 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.844 -0.799 . . . . 54.45 108.844 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -46.58 -43.3 17.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.551 -0.749 . . . . 74.5 111.475 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -77.37 -14.55 59.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.509 0.323 . . . . 62.22 110.711 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -76.13 163.26 27.27 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 120.668 -1.27 . . . . 74.42 108.927 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.84 -146.68 6.46 Favored Glycine 0 CA--C 1.491 -1.447 0 N-CA-C 109.245 -1.542 . . . . 72.24 109.245 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -85.39 -42.64 14.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 107.793 -1.188 . . . . 75.32 107.793 -172.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.6 t -108.08 128.31 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 104.277 -2.49 . . . . 55.5 104.277 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.07 139.15 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 105.825 -1.917 . . . . 74.23 105.825 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -97.24 115.87 28.41 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 104.699 -2.334 . . . . 73.12 104.699 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 12' ' ' LEU . 18.1 mt -112.84 137.22 51.51 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 104.84 -2.281 . . . . 75.31 104.84 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 tp -114.62 124.17 51.17 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.943 -2.243 . . . . 62.53 104.943 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.5 158.18 41.58 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 107.436 -1.32 . . . . 73.33 107.436 -173.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 58' ' ' ARG . 42.2 tt0 -120.28 128.1 53.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 103.876 -2.639 . . . . 71.13 103.876 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 6' ' ' ASP . 25.5 mmtp -62.84 153.07 34.3 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-O 122.244 1.021 . . . . 72.1 110.498 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.06 58.57 0.03 OUTLIER Glycine 0 CA--C 1.451 -3.933 0 N-CA-C 104.075 -3.61 . . . . 74.24 104.075 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -79.25 130.42 35.45 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 105.401 -2.074 . . . . 72.42 105.401 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.9 p -104.14 149.94 37.8 Favored Pre-proline 0 N--CA 1.416 -2.162 0 N-CA-C 106.392 -1.707 . . . . 74.15 106.392 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.4 76.2 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.548 2.166 . . . . 74.44 107.796 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.25 1.096 0 N-CA-C 106.071 -1.826 . . . . 71.21 106.071 -178.825 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.609 0 N-CA-C 108.689 -1.764 . . . . 74.31 108.689 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.84 137.99 66.14 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.982 2.454 . . . . 65.24 108.935 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 6.1 mtpm? -81.61 165.5 43.6 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 106.245 -1.761 . . . . 74.22 106.245 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 18.5 Cg_endo -58.76 112.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.742 2.295 . . . . 75.15 108.78 172.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.66 12.9 29.27 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.685 -1.366 . . . . 70.21 109.685 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.46 137.92 32.27 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 105.618 -1.993 . . . . 71.53 105.618 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.3 140.01 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 104.139 -2.541 . . . . 75.32 104.139 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -152.34 159.77 43.41 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.346 -2.094 . . . . 72.33 105.346 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.12 145.79 28.85 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 105.256 -2.128 . . . . 73.1 105.256 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.72 122.74 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 103.448 -2.797 . . . . 44.22 103.448 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -99.6 109.48 21.98 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.283 -2.488 . . . . 63.22 104.283 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 105.44 -2.059 . . . . 74.1 105.44 -171.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.18 134.18 34.13 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.064 -1.828 . . . . 60.45 106.064 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.67 33.71 0.32 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.313 -0.995 . . . . 73.32 108.313 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -53.77 -33.4 55.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 123.45 0.7 . . . . 62.21 109.247 -171.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.6 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.676 0 N-CA-C 107.15 -1.426 . . . . 53.44 107.15 171.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.4 t30 165.49 -32.71 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 103.935 -2.617 . . . . 64.54 103.935 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 m -94.61 149.21 21.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 105.372 -2.084 . . . . 75.41 105.372 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.07 -57.28 4.14 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 104.301 -2.481 . . . . 71.4 104.301 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . 88.14 34.42 9.76 Favored Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.981 -2.447 . . . . 52.33 106.981 175.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 mt -131.05 160.04 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 104.959 -2.237 . . . . 71.44 104.959 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.14 162.86 37.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.562 -3.125 . . . . 71.12 102.562 163.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.97 167.85 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 N-CA-C 105.801 -1.925 . . . . 71.12 105.801 -165.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -147.41 166.5 26.99 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 102.721 -3.066 . . . . 63.33 102.721 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' H ' HG21 ' A' ' 29' ' ' THR . . . 127.92 178.57 15.4 Favored Glycine 0 CA--C 1.459 -3.46 0 N-CA-C 105.715 -2.954 . . . . 51.33 105.715 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.75 -130.52 6.99 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 108.823 -1.711 . . . . 54.13 108.823 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.39 19.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 126.721 2.008 . . . . 64.05 114.212 -165.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.5 t30 88.37 65.6 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.051 -1.463 . . . . 54.24 107.051 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.496 HG21 ' H ' ' A' ' 25' ' ' GLY . 15.3 t -94.71 -166.24 1.44 Allowed 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 104.094 -2.558 . . . . 73.24 104.094 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 m -47.41 -40.7 18.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.732 1.213 . . . . 60.23 112.59 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 m -76.16 133.78 30.4 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 N-CA-C 108.871 -0.788 . . . . 64.12 108.871 -173.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -57.77 -55.15 38.54 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.19 0.996 . . . . 75.13 112.492 -169.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -76.22 6.61 5.21 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.297 -0.877 . . . . 60.14 110.111 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 57.53 6.44 2.38 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 121.516 -0.74 . . . . 55.44 111.967 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.68 160.65 53.81 Favored Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 107.364 -2.294 . . . . 74.44 107.364 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mm -83.92 108.62 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 106.14 -1.8 . . . . 75.51 106.14 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 42.9 m-85 -103.75 144.08 31.94 Favored 'General case' 0 CA--C 1.48 -1.74 0 N-CA-C 106.84 -1.541 . . . . 74.11 106.84 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.94 132.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.031 -1.841 . . . . 54.44 106.031 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -114.72 -37.48 4.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.228 -1.027 . . . . 74.24 108.228 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.57 146.43 34.59 Favored 'General case' 0 CA--C 1.463 -2.366 0 N-CA-C 106.716 -1.587 . . . . 60.2 106.716 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.03 119.35 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 104.979 -2.23 . . . . 73.54 104.979 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 20' ' ' GLY . 23.3 mt -72.46 140.09 81.75 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 106.575 -1.639 . . . . 71.24 106.575 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 42' ' ' ILE . 18.7 Cg_endo -57.6 119.9 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.731 2.287 . . . . 63.42 109.785 177.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 68.75 25.29 6.38 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 125.12 1.512 . . . . 74.34 110.372 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.02 173.44 52.62 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 107.653 -2.179 . . . . 72.22 107.653 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.38 99.29 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.796 -0.816 . . . . 74.24 108.796 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.19 77.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.311 -0.626 . . . . 62.14 109.311 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.5 -42.17 95.81 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.027 -0.731 . . . . 61.54 109.027 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -67.82 -36.69 80.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.614 -0.513 . . . . 61.54 109.614 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.86 -36.91 75.89 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.637 -1.246 . . . . 35.31 107.637 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -18.95 23.94 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.039 -0.824 . . . . 62.24 111.039 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -74.62 -39.75 61.94 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.426 -0.953 . . . . 74.44 108.426 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -95.74 120.62 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 105.829 -1.915 . . . . 63.53 105.829 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.21 169.85 10.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.657 -1.979 . . . . 72.15 105.657 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -66.52 137.86 57.09 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.501 -1.666 . . . . 75.32 106.501 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.05 -26.16 23.99 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 108.328 -1.909 . . . . 75.13 108.328 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.55 166.5 21.68 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.69 -1.226 . . . . 71.03 107.69 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -130.29 139.39 50.74 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 107.489 -1.3 . . . . 71.12 107.489 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.48 143.97 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 104.086 -2.561 . . . . 54.5 104.086 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.37 -46.92 3.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.563 -1.273 . . . . 74.33 107.563 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.91 166.09 21.69 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.377 1.085 . . . . 70.34 109.827 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.46 104.35 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 103.783 -2.673 . . . . 61.25 103.783 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 46.91 43.28 13.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.091 0.956 . . . . 52.25 110.849 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.81 76.6 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.217 -1.153 . . . . 64.15 110.217 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.34 117.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 104.467 -2.42 . . . . 72.22 104.467 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -75.33 107.48 7.47 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.786 -1.191 . . . . 64.12 107.786 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.35 -6.29 56.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.513 -0.767 . . . . 71.2 110.034 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -61.47 142.75 56.81 Favored 'General case' 0 C--N 1.361 1.073 0 O-C-N 120.875 -1.141 . . . . 74.54 108.834 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.94 -25.06 6.19 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.385 -1.086 . . . . 54.25 110.385 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 164.0 26.5 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.203 1.001 . . . . 62.42 108.892 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 p -81.54 163.62 22.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.625 -0.88 . . . . 72.11 108.625 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -61.49 -44.94 96.19 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.445 -0.798 . . . . 72.05 108.936 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -30.73 70.66 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 120.302 -0.559 . . . . 72.34 109.918 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -65.55 -36.2 83.09 Favored 'General case' 0 C--N 1.373 1.622 0 N-CA-C 108.521 -0.918 . . . . 73.23 108.521 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.39 -34.19 73.56 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.553 -0.906 . . . . 50.13 108.553 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.67 -53.63 19.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.156 -1.424 . . . . 75.34 107.156 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.3 m -53.26 -29.05 30.71 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.199 -1.038 . . . . 54.11 108.199 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.5 m -69.91 -55.83 8.65 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.531 -1.285 . . . . 72.45 107.531 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -55.78 -55.49 31.74 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.062 -0.718 . . . . 73.14 109.062 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -45.97 -37.91 7.07 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.653 0.612 . . . . 73.25 112.653 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -90.23 8.28 33.95 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.29 0.95 . . . . 65.44 110.283 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -74.32 163.54 27.68 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-N 119.587 1.085 . . . . 63.14 109.51 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.74 -158.79 19.87 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 109.067 -1.613 . . . . 52.32 109.067 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.449 ' H ' ' CD ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -81.99 -38.45 25.08 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.886 -0.783 . . . . 62.32 108.886 -169.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.8 t -113.34 130.06 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 103.553 -2.758 . . . . 70.43 103.553 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -122.27 142.12 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 104.827 -2.286 . . . . 73.12 104.827 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -100.71 119.22 38.28 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 104.333 -2.469 . . . . 73.31 104.333 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.46 134.62 54.56 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 103.726 -2.694 . . . . 72.42 103.726 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.57 126.94 53.49 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 105.764 -1.939 . . . . 71.04 105.764 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -134.37 155.33 50.46 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.211 -1.774 . . . . 70.31 106.211 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -118.21 135.65 54.12 Favored 'General case' 0 CA--C 1.477 -1.863 0 N-CA-C 102.685 -3.079 . . . . 53.25 102.685 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.48 141.76 50.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.665 -0.865 . . . . 73.11 108.665 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.21 67.01 0.05 OUTLIER Glycine 0 CA--C 1.472 -2.628 0 N-CA-C 107.44 -2.264 . . . . 64.32 107.44 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -75.17 130.21 38.8 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 105.478 -2.045 . . . . 73.35 105.478 171.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m -87.23 151.9 52.0 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 105.688 -1.967 . . . . 62.23 105.688 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.42 65.6 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.658 2.239 . . . . 74.12 108.199 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.421 -1.899 0 N-CA-C 105.309 -2.108 . . . . 62.31 105.309 -178.382 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 108.406 -1.877 . . . . 72.34 108.406 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.59 169.57 17.05 Favored 'Trans proline' 0 CA--C 1.512 -0.593 0 C-N-CA 123.082 2.521 . . . . 64.54 108.283 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -97.57 152.64 38.28 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 105.841 -1.911 . . . . 65.12 105.841 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 132.63 31.82 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.606 2.204 . . . . 74.31 109.915 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.0 64.25 Favored Glycine 0 CA--C 1.497 -1.042 0 N-CA-C 109.518 -1.433 . . . . 64.33 109.518 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.52 139.6 30.55 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 105.765 -1.939 . . . . 74.34 105.765 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.41 130.69 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 104.704 -2.332 . . . . 75.03 104.704 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -138.53 149.04 44.94 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.599 -1.63 . . . . 74.22 106.599 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HG2' HD13 ' A' ' 89' ' ' LEU . 89.4 mt-10 -103.22 139.72 38.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.574 -1.639 . . . . 65.44 106.574 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.04 135.28 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 106.939 -1.504 . . . . 71.41 106.939 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -105.9 112.8 26.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 104.533 -2.395 . . . . 65.24 104.533 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.18 125.12 50.69 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.586 -1.635 . . . . 74.32 106.586 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.22 133.84 37.32 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.931 -1.507 . . . . 73.34 106.931 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -103.91 34.89 2.84 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 105.993 -1.854 . . . . 60.43 105.993 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.97 83.97 3.5 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.86 -1.904 . . . . 72.34 105.86 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -175.19 -171.25 0.49 Allowed 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 100.527 -3.879 . . . . 73.32 100.527 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -91.2 -47.23 7.63 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 106.715 -1.587 . . . . 72.51 106.715 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -93.15 139.62 30.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.84 -1.541 . . . . 64.11 106.84 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.98 -57.66 3.88 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 104.022 -2.584 . . . . 71.3 104.022 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 81.07 39.22 13.31 Favored Glycine 0 CA--C 1.478 -2.247 0 CA-C-N 113.731 -1.577 . . . . 52.41 109.498 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.51 145.7 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 103.537 -2.764 . . . . 75.02 103.537 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.48 162.99 34.38 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 103.07 -2.937 . . . . 63.35 103.07 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.09 168.0 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 N-CA-C 104.829 -2.286 . . . . 71.41 104.829 -167.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.6 t -145.79 166.03 27.11 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.319 -2.474 . . . . 71.12 104.319 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.83 131.74 3.64 Favored Glycine 0 C--O 1.2 -2.01 0 N-CA-C 108.594 -1.802 . . . . 42.13 108.594 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.2 -99.07 0.14 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 107.526 -2.229 . . . . 64.51 107.526 167.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.31 20.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.386 1.874 . . . . 63.42 114.94 -170.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 88.71 66.41 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.926 0 CA-C-O 123.337 1.542 . . . . 75.11 106.991 -168.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.78 HG22 ' H ' ' A' ' 30' ' ' SER . 4.3 m -84.38 -166.57 1.48 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.478 -2.416 . . . . 71.52 104.478 173.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.78 ' H ' HG22 ' A' ' 29' ' ' THR . 10.5 m -53.16 -28.11 24.57 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.339 0.656 . . . . 60.11 110.9 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 m -82.57 122.25 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.787 -1.56 . . . . 63.13 106.787 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -83.59 -16.76 44.1 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.683 -0.858 . . . . 63.05 108.683 -170.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 35' ' ' GLY . 11.6 t-160 -70.77 -12.19 61.4 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.739 -1.208 . . . . 70.2 107.739 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.37 -5.36 1.54 Allowed Glycine 0 C--N 1.365 2.147 0 C-N-CA 124.155 0.883 . . . . 71.13 111.505 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 33' ' ' HIS . . . -70.28 151.19 49.59 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 107.931 -2.067 . . . . 71.15 107.931 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.408 HG21 ' HB1' ' A' ' 75' ' ' ALA . 10.7 mm -82.17 126.08 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.449 -2.426 . . . . 74.12 104.449 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -111.91 145.6 39.26 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 106.89 -1.522 . . . . 71.52 106.89 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -74.52 129.36 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.386 -2.079 . . . . 71.04 105.386 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -116.45 -35.28 4.32 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.741 -1.207 . . . . 70.32 107.741 -170.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.04 136.28 45.87 Favored 'General case' 0 CA--C 1.452 -2.798 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 -167.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -139.39 129.76 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 103.765 -2.68 . . . . 73.11 103.765 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.528 HG12 ' CA ' ' A' ' 20' ' ' GLY . 6.5 mm -70.94 147.46 94.0 Favored Pre-proline 0 CA--C 1.505 -0.751 0 N-CA-C 105.082 -2.192 . . . . 75.41 105.082 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 114.35 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.876 1.717 . . . . 63.1 107.801 164.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 68.95 26.49 5.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 124.542 1.151 . . . . 60.34 111.044 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.15 177.12 43.14 Favored Glycine 0 C--N 1.368 2.34 0 N-CA-C 106.474 -2.65 . . . . 51.03 106.474 167.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.04 95.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 122.124 -0.633 . . . . 72.42 109.342 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.25 -49.2 78.07 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.413 -0.588 . . . . 73.24 109.413 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.46 -36.8 81.88 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -65.18 -44.02 89.79 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.458 -0.942 . . . . 61.43 108.458 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -70.36 -33.0 70.92 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.235 -1.395 . . . . 74.31 107.235 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.27 -16.12 45.76 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 110.481 -1.048 . . . . 55.21 110.481 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -79.42 -34.68 41.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.695 -0.854 . . . . 74.04 108.695 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.4 mt -105.25 141.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.852 -1.907 . . . . 71.03 105.852 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -143.56 178.33 7.86 Favored 'General case' 0 CA--C 1.466 -2.252 0 N-CA-C 104.526 -2.398 . . . . 74.4 104.526 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.91 146.96 53.85 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.007 -1.479 . . . . 73.11 107.007 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.14 -16.49 53.62 Favored Glycine 0 CA--C 1.498 -0.997 0 N-CA-C 107.335 -2.306 . . . . 65.51 107.335 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.29 146.57 31.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.998 -1.852 . . . . 70.32 105.998 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.8 tmm_? -108.83 123.82 49.65 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 105.377 -2.083 . . . . 74.24 105.377 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.29 141.2 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 105.545 -2.021 . . . . 63.32 105.545 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -49.01 2.31 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.89 -1.152 . . . . 71.22 107.89 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.98 166.83 19.27 Favored 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 118.873 -1.131 . . . . 74.5 109.92 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.71 100.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 103.395 -2.817 . . . . 73.32 103.395 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 t30 48.16 41.99 16.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.731 1.212 . . . . 51.51 110.954 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 13.04 77.02 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.053 -1.219 . . . . 75.23 110.053 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.14 116.85 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.759 0 N-CA-C 103.647 -2.723 . . . . 74.24 103.647 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 m -72.45 112.22 8.32 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.137 -1.06 . . . . 53.35 108.137 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.79 9.63 26.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.905 -1.517 . . . . 70.15 106.905 172.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.79 140.01 49.25 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.436 -1.69 . . . . 72.23 106.436 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 -23.23 4.58 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.291 -1.124 . . . . 62.21 110.291 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.93 164.72 16.93 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.895 0.855 . . . . 53.34 109.53 -175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 p -82.36 155.16 24.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.958 -1.497 . . . . 55.33 106.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -62.72 -37.63 87.28 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -55.84 -43.05 76.66 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 110.097 -0.334 . . . . 65.4 110.097 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -66.23 -39.97 89.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.277 -1.009 . . . . 60.41 108.277 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB1' HG21 ' A' ' 36' ' ' ILE . . . -55.97 -39.73 72.22 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 110.056 -0.35 . . . . 42.41 110.056 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.04 -56.25 9.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 107.754 -1.202 . . . . 52.22 107.754 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 72.0 m -63.59 -25.97 68.48 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.788 -0.819 . . . . 74.12 108.788 -166.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.7 m -60.7 -52.81 63.55 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 107.669 -1.234 . . . . 71.44 107.669 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.1 mt -55.27 -55.23 33.82 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.657 0.742 . . . . 62.44 109.519 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -48.16 -36.41 13.48 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.035 -0.415 . . . . 74.32 112.082 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -89.93 -9.75 47.67 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.67 -0.644 . . . . 72.52 110.095 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -81.31 179.54 7.81 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.754 -1.202 . . . . 71.2 107.754 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.88 -166.73 31.43 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.843 -1.303 . . . . 71.2 109.843 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.63 -35.95 38.62 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.808 -1.553 . . . . 74.11 106.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -116.29 127.74 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 N-CA-C 103.036 -2.95 . . . . 75.14 103.036 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.76 151.58 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.87 0 N-CA-C 104.606 -2.368 . . . . 62.35 104.606 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.85 123.88 40.68 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 104.305 -2.48 . . . . 71.03 104.305 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.4 mt -118.84 140.77 49.42 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 105.428 -2.064 . . . . 54.04 105.428 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.406 HD13 ' HG2' ' A' ' 9' ' ' GLU . 17.8 tp -114.22 124.14 51.3 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 105.053 -2.203 . . . . 75.02 105.053 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.11 157.19 44.85 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.691 -1.226 . . . . 74.03 107.691 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 58' ' ' ARG . 36.2 tt0 -123.95 131.58 53.59 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 103.154 -2.906 . . . . 62.45 103.154 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.653 ' HE3' ' H ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -61.3 150.18 35.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.792 -0.818 . . . . 73.44 108.792 179.086 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.653 ' H ' ' HE3' ' A' ' 92' ' ' LYS . . . -137.65 -149.64 5.58 Favored Glycine 0 CA--C 1.467 -2.929 0 N-CA-C 103.322 -3.911 . . . . 74.23 103.322 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -142.66 173.19 11.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.288 -2.486 . . . . 74.04 104.288 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.7 m -84.39 114.19 53.35 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 105.489 -2.041 . . . . 74.05 105.489 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.19 120.47 7.44 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 122.592 2.195 . . . . 55.31 109.0 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.401 -2.909 0 N-CA-C 102.137 -3.283 . . . . 70.41 102.137 175.629 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.466 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.772 0 N-CA-C 108.272 -1.931 . . . . 72.44 108.272 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.8 157.17 60.35 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.073 2.515 . . . . 72.51 109.172 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -78.79 159.88 72.99 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 107.031 -1.47 . . . . 51.22 107.031 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.07 132.01 30.57 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 106.959 -1.977 . . . . 71.42 106.959 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.57 56.79 Favored Glycine 0 CA--C 1.497 -1.056 0 N-CA-C 109.395 -1.482 . . . . 34.2 109.395 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.86 143.74 57.61 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 118.686 1.243 . . . . 35.43 108.414 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.93 131.4 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.82 -2.659 . . . . 61.04 103.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.21 146.57 52.11 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 105.209 -2.145 . . . . 73.11 105.209 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -102.44 135.4 44.12 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.024 -2.213 . . . . 63.15 105.024 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.27 129.94 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 105.851 -1.907 . . . . 71.31 105.851 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -101.05 112.5 24.97 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 103.72 -2.696 . . . . 54.4 103.72 168.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HB2' HD12 ' A' ' 88' ' ' LEU . 1.3 tm? -102.87 124.71 48.89 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.486 -2.042 . . . . 61.41 105.486 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -87.8 120.31 29.0 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.504 -1.665 . . . . 52.11 106.504 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.52 33.74 1.1 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.034 -1.469 . . . . 73.13 107.034 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 13' ' ' ALA . 73.9 m-80 6.05 -91.95 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 128.584 2.753 . . . . 74.33 112.134 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -158.74 -178.48 7.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.746 -2.316 . . . . 32.42 104.746 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 74.14 -120.24 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.281 1.032 . . . . 74.3 108.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.1 m -91.68 132.53 36.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.557 -1.275 . . . . 70.23 107.557 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 mt -73.46 -58.87 3.01 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 105.869 -1.901 . . . . 73.3 105.869 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.73 41.98 55.12 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 110.691 -0.964 . . . . 75.13 110.691 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.63 154.28 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.026 -2.583 . . . . 64.34 104.026 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.5 t -154.14 165.87 34.86 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.461 -2.422 . . . . 74.34 104.461 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.21 167.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 105.688 -1.967 . . . . 72.41 105.688 -168.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -146.11 166.53 25.87 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 104.584 -2.376 . . . . 74.33 104.584 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.93 134.37 3.02 Favored Glycine 0 C--O 1.196 -2.241 0 N-CA-C 108.853 -1.699 . . . . 43.14 108.853 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.97 -97.41 0.12 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 108.717 -1.753 . . . . 40.34 108.717 167.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.98 21.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 127.183 2.193 . . . . 74.41 116.017 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 87.37 66.29 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.733 -1.58 . . . . 64.31 106.733 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 30' ' ' SER . 4.1 m -88.38 -166.97 1.73 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.184 -2.524 . . . . 74.24 104.184 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.715 ' H ' HG22 ' A' ' 29' ' ' THR . 15.6 m -58.43 -21.01 49.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.553 -0.717 . . . . 54.21 110.625 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.58 126.27 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.765 -1.568 . . . . 64.13 106.765 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.7 mtm-85 -51.92 -57.6 8.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 115.204 -0.907 . . . . 72.4 112.363 -168.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -82.87 7.15 16.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.938 -0.764 . . . . 71.52 108.938 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.13 25.1 69.32 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 108.592 -1.803 . . . . 33.31 108.592 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.43 139.84 38.14 Favored Glycine 0 CA--C 1.479 -2.201 0 N-CA-C 107.394 -2.282 . . . . 52.4 107.394 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.29 120.35 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 104.645 -2.354 . . . . 74.2 104.645 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.55 146.65 41.54 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 106.306 -1.739 . . . . 74.4 106.306 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.26 135.02 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 73.11 107.084 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -49.12 3.22 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.518 -1.29 . . . . 72.43 107.518 -167.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 144.42 34.0 Favored 'General case' 0 CA--C 1.461 -2.469 0 N-CA-C 104.859 -2.274 . . . . 73.54 104.859 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.83 132.57 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 104.265 -2.494 . . . . 72.32 104.265 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.53 133.46 80.19 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 106.037 -1.838 . . . . 71.01 106.037 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.48 113.66 1.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.52 2.146 . . . . 64.22 108.141 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.36 21.9 5.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 124.621 1.201 . . . . 72.21 111.327 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.67 -166.74 27.96 Favored Glycine 0 C--N 1.367 2.271 0 N-CA-C 106.206 -2.758 . . . . 71.54 106.206 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 117.999 0.899 . . . . 72.44 110.427 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.58 -45.75 74.65 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 109.916 -0.402 . . . . 75.14 109.916 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -71.88 -39.06 69.88 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.481 -0.563 . . . . 72.35 109.481 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 t -65.9 -46.12 79.48 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.777 -1.194 . . . . 71.15 107.777 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.52 -32.33 71.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 106.92 -1.511 . . . . 60.22 106.92 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.73 -10.4 51.65 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.524 -0.762 . . . . 71.43 111.281 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -69.78 -38.25 76.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.945 -0.738 . . . . 61.41 110.025 -172.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.69 140.31 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 105.945 -1.872 . . . . 72.53 105.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -131.36 176.19 8.5 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.99 -1.485 . . . . 75.1 106.99 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.84 144.04 56.52 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.334 -0.987 . . . . 64.25 108.334 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.86 -4.17 74.93 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 109.678 -1.369 . . . . 72.12 109.678 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -86.25 156.35 20.32 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.823 -1.177 . . . . 71.54 107.823 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 118.56 37.04 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.992 -1.484 . . . . 73.25 106.992 -170.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.6 t -103.43 141.71 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 104.998 -2.223 . . . . 64.11 104.998 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.38 -45.66 2.62 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.589 -1.263 . . . . 71.04 107.589 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.34 158.21 39.76 Favored 'General case' 0 CA--C 1.477 -1.834 0 C-N-CA 118.695 -1.202 . . . . 75.44 109.345 -175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.79 106.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 104.775 -2.305 . . . . 74.44 104.775 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 45.19 43.9 8.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.255 1.422 . . . . 54.52 111.262 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.56 84.92 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.068 -1.213 . . . . 64.2 110.068 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.37 117.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.396 0 N-CA-C 103.151 -2.907 . . . . 75.11 103.151 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.7 m -75.69 114.33 14.15 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.775 -1.565 . . . . 74.3 106.775 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.29 28.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.594 -1.262 . . . . 74.52 107.594 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -75.55 122.5 23.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.12 -1.437 . . . . 50.52 107.12 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -9.68 52.81 Favored Glycine 0 C--N 1.328 0.1 0 N-CA-C 110.918 -0.873 . . . . 43.43 110.918 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 161.29 29.69 Favored 'General case' 0 C--N 1.364 1.232 0 CA-C-N 118.806 1.303 . . . . 73.43 107.598 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.6 p -82.31 167.14 18.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.406 -0.961 . . . . 72.45 108.406 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -66.52 -41.87 88.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.147 -0.686 . . . . 64.34 109.147 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -38.06 89.68 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.697 -0.668 . . . . 73.31 110.3 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -65.58 -35.8 81.9 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.143 1.338 . . . . 75.24 109.182 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.1 69.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.408 -0.59 . . . . 75.14 109.408 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.9 -53.75 19.13 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.265 -1.383 . . . . 70.45 107.265 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 63.8 m -54.7 -29.26 52.61 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 122.38 1.086 . . . . 75.32 108.374 -173.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.8 m -64.98 -53.32 47.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.149 -1.426 . . . . 73.23 107.149 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.42 -55.12 35.41 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.041 -0.725 . . . . 60.32 109.041 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -46.48 -41.07 13.45 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 116.629 -0.26 . . . . 61.41 111.273 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.52 -3.76 58.2 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.697 -0.627 . . . . 63.43 110.947 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 p -81.61 169.76 16.66 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 120.254 1.388 . . . . 73.53 108.598 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.02 -168.75 30.06 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.682 -1.367 . . . . 72.25 109.682 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -79.01 -25.07 43.3 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.485 -0.932 . . . . 63.53 108.485 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.13 130.35 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 103.625 -2.731 . . . . 64.21 103.625 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.94 139.59 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.791 -1.929 . . . . 70.24 105.791 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -95.67 116.57 29.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 104.402 -2.444 . . . . 73.12 104.402 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 12' ' ' LEU . 41.7 mt -118.79 139.82 50.96 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 106.138 -1.801 . . . . 73.24 106.138 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 127.87 55.72 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.461 -2.051 . . . . 72.32 105.461 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.86 156.72 47.57 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.689 -1.226 . . . . 73.43 107.689 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -117.3 133.51 55.9 Favored 'General case' 0 CA--C 1.438 -3.336 0 N-CA-C 104.995 -2.224 . . . . 71.21 104.995 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -62.71 150.61 40.69 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 65.33 110.289 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.54 50.44 0.21 Allowed Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 105.601 -2.999 . . . . 74.21 105.601 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.79 153.15 29.37 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.59 -1.263 . . . . 63.23 107.59 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 20.2 m -83.39 163.89 47.92 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.352 -2.092 . . . . 42.52 105.352 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 32.6 Cg_endo -64.35 163.72 25.59 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.272 1.982 . . . . 72.1 108.944 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.428 -1.525 0 N-CA-C 106.548 -1.649 . . . . 72.42 106.548 -176.504 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.415 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.655 0 N-CA-C 108.524 -1.831 . . . . 72.1 108.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.28 154.57 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.061 2.508 . . . . 61.25 108.889 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -94.22 161.96 27.89 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 105.063 -2.199 . . . . 74.34 105.063 -178.319 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 3' ' ' LYS . 18.9 Cg_endo -57.81 115.23 2.37 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.655 2.237 . . . . 74.42 110.761 -176.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.434 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 98.65 12.39 44.28 Favored Glycine 0 CA--C 1.497 -1.052 0 N-CA-C 109.07 -1.612 . . . . 64.12 109.07 175.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -92.46 136.12 33.48 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 104.881 -2.266 . . . . 71.22 104.881 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.99 132.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 104.291 -2.485 . . . . 72.52 104.291 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -144.81 152.07 39.76 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.044 -2.206 . . . . 72.43 105.044 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.04 148.13 28.1 Favored 'General case' 0 N--CA 1.402 -2.829 0 N-CA-C 104.758 -2.312 . . . . 60.2 104.758 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.82 131.15 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 N-CA-C 103.712 -2.699 . . . . 64.31 103.712 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -103.85 111.91 24.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 104.327 -2.472 . . . . 75.11 104.327 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.425 ' CD1' ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -103.68 125.24 50.05 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.908 -1.516 . . . . 74.54 106.908 -164.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.1 124.8 37.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 105.694 -1.965 . . . . 54.24 105.694 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' CE ' HD22 ' A' ' 19' ' ' LEU . 19.6 mtmm -91.98 31.96 1.19 Allowed 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.639 -1.245 . . . . 64.54 107.639 -176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 18.19 51.19 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 128.261 2.624 . . . . 74.24 111.196 -168.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t0 11.31 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.056 2.142 . . . . 64.22 113.054 -164.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -145.69 -116.54 0.08 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 105.062 -2.199 . . . . 73.31 105.062 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -80.81 131.22 35.38 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.025 -1.472 . . . . 42.31 107.025 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.421 HD22 ' CE ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -73.26 -58.65 3.16 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.45 -2.426 . . . . 74.43 104.45 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . 65.25 39.78 96.25 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-N 113.412 -1.722 . . . . 62.13 110.543 167.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.5 mt -128.43 163.12 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 102.263 -3.236 . . . . 64.33 102.263 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.2 t -153.15 159.09 42.67 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 102.821 -3.029 . . . . 74.31 102.821 174.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.86 167.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.941 -1.874 . . . . 73.42 105.941 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -153.78 167.71 28.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 103.499 -2.778 . . . . 72.24 103.499 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.16 -172.32 15.57 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 106.071 -2.812 . . . . 75.31 106.071 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.22 -124.63 5.38 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.962 -1.655 . . . . 64.43 108.962 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.08 18.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 126.292 1.837 . . . . 62.43 114.368 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 86.92 65.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.971 1.367 . . . . 71.31 107.342 -172.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.3 t -89.1 -165.12 1.26 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.076 -2.194 . . . . 71.11 105.076 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 m -49.63 -26.68 3.82 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.169 0.988 . . . . 61.1 112.208 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -86.71 118.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 N-CA-C 105.361 -2.088 . . . . 71.31 105.361 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.22 -14.35 60.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.787 -0.642 . . . . 74.33 111.053 -165.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -85.87 -5.99 59.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.346 -0.983 . . . . 75.34 108.346 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 10.59 27.49 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.894 -0.883 . . . . 32.11 110.894 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.56 158.29 53.5 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 107.986 -2.046 . . . . 61.34 107.986 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.47 129.0 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.602 -1.999 . . . . 72.44 105.602 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -125.38 144.97 50.26 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.281 -2.118 . . . . 75.41 105.281 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.72 134.16 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.09 -1.448 . . . . 74.2 107.09 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -103.93 -44.4 5.04 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.032 -1.099 . . . . 75.4 108.032 -171.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.68 153.97 40.0 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 105.964 -1.865 . . . . 62.44 105.964 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.42 130.0 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.309 -2.108 . . . . 70.12 105.309 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.474 HD12 ' HA2' ' A' ' 20' ' ' GLY . 17.1 mt -74.45 137.19 74.61 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.144 -1.799 . . . . 50.44 106.144 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.55 125.6 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.494 2.129 . . . . 75.22 108.685 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.467 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 33.9 mt-30 68.4 18.24 9.07 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 124.063 0.852 . . . . 74.2 109.817 -175.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.37 -177.68 52.01 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 106.153 -2.779 . . . . 60.31 106.153 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 12' ' ' LEU . . . -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.563 -0.375 . . . . 73.33 110.82 -168.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.89 94.8 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.065 -0.716 . . . . 75.42 109.065 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 44' ' ' GLN . 50.8 tp10 -59.49 -46.47 88.71 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.26 -0.644 . . . . 73.24 109.26 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 m -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.34 -0.615 . . . . 51.11 109.34 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.96 -45.49 74.05 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.204 -1.036 . . . . 74.34 108.204 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -32.8 5.52 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.312 -1.115 . . . . 72.31 110.312 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -75.17 -36.98 61.45 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 117.614 0.707 . . . . 72.33 109.132 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.04 138.24 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 104.761 -2.311 . . . . 73.33 104.761 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.499 ' HE1' ' OE1' ' A' ' 94' ' ' GLN . 28.1 p80 -136.6 179.11 6.56 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.124 -1.806 . . . . 75.15 106.124 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.08 139.85 58.76 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.7 -0.852 . . . . 74.41 108.7 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -3.34 87.22 Favored Glycine 0 CA--C 1.497 -1.082 0 N-CA-C 110.459 -1.056 . . . . 52.41 110.459 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.44 154.42 39.98 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-N 119.342 1.571 . . . . 63.22 107.219 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.71 118.29 36.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.555 -1.276 . . . . 75.44 107.555 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.57 145.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.843 -2.281 . . . . 75.21 104.843 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 -48.33 2.43 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.441 -1.318 . . . . 74.55 107.441 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.15 167.19 18.76 Favored 'General case' 0 CA--C 1.469 -2.148 0 C-N-CA 118.914 -1.114 . . . . 75.21 109.718 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.52 102.54 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 103.702 -2.703 . . . . 74.04 103.702 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.97 41.19 28.1 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.783 0.833 . . . . 63.2 111.03 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.04 15.06 73.38 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 109.935 -1.266 . . . . 70.24 109.935 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.44 116.31 52.23 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 104.353 -2.462 . . . . 74.45 104.353 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -76.4 7.39 4.43 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.546 0.738 . . . . 60.34 111.796 -171.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt 34.25 38.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.967 1.307 . . . . 51.13 111.775 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.9 129.72 36.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 O-C-N 121.148 -0.97 . . . . 65.21 109.534 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 0.98 83.03 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 109.102 -1.599 . . . . 64.24 109.102 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 152.26 45.99 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.951 -1.129 . . . . 74.41 107.951 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 159.74 26.89 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.673 -1.232 . . . . 63.41 107.673 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -62.29 -41.59 98.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.16 -1.052 . . . . 70.14 108.16 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -58.15 -41.76 84.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.793 -0.64 . . . . 73.24 109.865 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -66.25 -34.52 78.2 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 108.673 -0.862 . . . . 63.1 108.673 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.79 74.49 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.826 -0.805 . . . . 52.14 108.826 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.69 -52.6 22.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 107.26 -1.385 . . . . 64.24 107.26 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.6 m -52.96 -28.37 23.38 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.105 0.955 . . . . 62.13 108.45 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -65.75 -55.91 14.76 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.269 -1.382 . . . . 74.24 107.269 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.6 mt -53.78 -55.03 30.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 108.934 -0.765 . . . . 73.54 108.934 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -46.25 -42.13 13.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.231 -0.44 . . . . 75.44 111.615 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -86.68 -5.59 59.09 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 121.72 -0.612 . . . . 72.3 110.87 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -85.06 170.51 12.89 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.755 -1.216 . . . . 74.53 108.404 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 -161.56 22.04 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.394 -1.482 . . . . 75.11 109.394 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.99 -28.89 49.39 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.122 -1.066 . . . . 75.13 108.122 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.87 134.47 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.105 -2.554 . . . . 52.11 104.105 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.66 143.29 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.678 -2.341 . . . . 71.43 104.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -96.89 117.13 30.44 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.975 -2.232 . . . . 52.52 104.975 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.03 137.82 51.99 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 105.215 -2.143 . . . . 73.34 105.215 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.79 127.66 56.1 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 105.313 -2.106 . . . . 72.34 105.313 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.57 154.35 48.92 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.761 -1.57 . . . . 62.23 106.761 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.1 135.73 46.64 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.089 -2.189 . . . . 60.01 105.089 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.434 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 71.1 mmtt -75.76 153.29 37.09 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.454 1.121 . . . . 74.33 111.002 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.14 48.46 0.12 Allowed Glycine 0 CA--C 1.468 -2.88 0 N-CA-C 105.034 -3.226 . . . . 33.2 105.034 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' OE1' ' HE1' ' A' ' 54' ' ' HIS . 3.0 pp0? -110.21 166.85 10.63 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.084 -1.45 . . . . 73.32 107.084 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.9 m -113.84 142.01 27.09 Favored Pre-proline 0 N--CA 1.427 -1.593 0 N-CA-C 104.385 -2.45 . . . . 54.2 104.385 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.25 115.38 3.29 Favored 'Trans proline' 0 CA--C 1.504 -0.997 0 C-N-CA 122.45 2.1 . . . . 70.25 107.15 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.417 -2.084 0 N-CA-C 104.866 -2.272 . . . . 73.44 104.866 -173.75 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.445 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.155 0 N-CA-C 109.513 -1.435 . . . . 63.12 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.82 156.5 65.75 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.046 2.498 . . . . 61.35 109.292 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 68.6 mttt -68.79 169.26 11.55 Favored Pre-proline 0 C--N 1.353 0.722 0 N-CA-C 106.69 -1.596 . . . . 64.42 106.69 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 33.7 Cg_endo -64.68 128.01 20.09 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 107.489 -1.773 . . . . 72.43 107.489 163.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.22 70.57 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 110.005 -1.238 . . . . 61.41 110.005 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -104.88 147.77 27.39 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.997 -1.853 . . . . 72.4 105.997 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -99.2 132.08 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 105.963 -1.866 . . . . 72.13 105.963 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -133.78 149.84 51.44 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.19 -1.782 . . . . 73.23 106.19 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -102.26 138.1 39.65 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.99 -1.855 . . . . 72.13 105.99 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.9 t -129.11 127.58 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 104.939 -2.245 . . . . 62.14 104.939 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -103.34 109.45 21.07 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.676 -1.972 . . . . 73.25 105.676 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.99 122.95 45.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 N-CA-C 106.459 -1.682 . . . . 70.11 106.459 -164.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.37 138.18 32.64 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.343 -1.355 . . . . 74.41 107.343 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.49 33.61 0.64 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.359 -1.719 . . . . 74.33 106.359 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.72 74.58 4.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.919 -1.882 . . . . 63.21 105.919 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -176.72 -130.62 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 100.853 -3.758 . . . . 75.54 100.853 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -150.45 -45.81 0.12 Allowed 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.448 -2.056 . . . . 65.12 105.448 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -74.87 122.51 23.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.021 -1.474 . . . . 64.41 107.021 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.4 mt -73.2 -57.08 4.27 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 104.476 -2.416 . . . . 74.41 104.476 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.609 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . 61.88 37.28 94.09 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.063 -1.88 . . . . 71.45 110.944 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mm -111.7 160.94 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.214 -2.513 . . . . 74.04 104.214 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -154.01 159.23 41.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 102.624 -3.102 . . . . 73.1 102.624 165.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.59 166.83 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 105.918 -1.882 . . . . 54.12 105.918 -168.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -147.87 165.86 29.35 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.199 -2.889 . . . . 74.24 103.199 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.72 -171.79 15.23 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 107.378 -2.289 . . . . 74.35 107.378 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.87 -128.81 6.81 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.205 -1.558 . . . . 54.32 109.205 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.48 19.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 127.24 2.216 . . . . 34.42 114.396 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 85.52 64.03 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.919 -1.512 . . . . 73.33 106.919 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -93.28 -166.15 1.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 104.357 -2.46 . . . . 61.23 104.357 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -38.42 -38.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.628 1.571 . . . . 71.34 113.305 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.69 131.97 33.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.235 0 N-CA-C 107.683 -1.229 . . . . 74.53 107.683 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -59.93 -50.7 72.74 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.636 -0.711 . . . . 75.14 111.446 -168.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.36 -3.64 31.55 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.8 -0.562 . . . . 75.12 109.692 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.54 14.25 41.59 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 110.345 -1.102 . . . . 74.21 110.345 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.42 154.5 50.47 Favored Glycine 0 CA--C 1.478 -2.231 0 N-CA-C 107.643 -2.183 . . . . 73.44 107.643 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.86 108.62 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.639 -1.615 . . . . 74.34 106.639 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 58' ' ' ARG . 36.1 m-85 -98.28 143.19 29.04 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 106.225 -1.769 . . . . 71.42 106.225 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.28 126.99 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 105.717 -1.957 . . . . 74.34 105.717 169.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -99.69 -49.54 4.35 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 107.363 -1.347 . . . . 75.51 107.363 -168.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.87 149.13 38.12 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 106.042 -1.836 . . . . 54.24 106.042 -171.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.76 121.95 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 104.221 -2.511 . . . . 71.15 104.221 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.609 HD12 ' HA2' ' A' ' 20' ' ' GLY . 25.2 mt -75.58 138.27 70.63 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 105.215 -2.142 . . . . 73.3 105.215 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 42' ' ' ILE . 17.7 Cg_endo -56.47 129.48 34.94 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.133 1.889 . . . . 73.05 109.347 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 64.18 22.2 12.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 124.975 1.422 . . . . 63.4 111.329 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.69 175.95 43.38 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 107.202 -2.359 . . . . 74.44 107.202 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.54 73.48 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.255 -0.646 . . . . 61.41 109.255 -172.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.09 -49.71 59.53 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.231 -0.655 . . . . 54.54 109.231 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.24 -37.03 82.86 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 109.503 -0.554 . . . . 64.11 109.503 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.3 m -65.49 -37.97 88.39 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.47 -0.937 . . . . 73.52 108.47 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.74 -37.12 79.2 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.248 -1.019 . . . . 55.04 108.248 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.58 -21.71 8.64 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.898 -0.881 . . . . 31.33 110.898 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.9 mtt85 -75.44 -41.09 56.71 Favored 'General case' 0 CA--C 1.495 -1.165 0 O-C-N 121.524 -0.986 . . . . 72.55 108.61 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.36 128.02 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 106.15 -1.796 . . . . 63.33 106.15 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -131.34 177.4 7.51 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.645 -1.983 . . . . 72.22 105.645 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -67.06 145.27 55.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.615 -1.995 . . . . 73.22 105.615 171.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.05 58.04 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 107.377 -2.289 . . . . 45.01 107.377 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -84.8 158.47 20.67 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 105.301 -2.111 . . . . 54.42 105.301 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.46 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -137.23 150.64 48.0 Favored 'General case' 0 CA--C 1.47 -2.115 0 N-CA-C 107.054 -1.461 . . . . 74.44 107.054 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 t -104.86 145.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 104.786 -2.301 . . . . 53.24 104.786 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -48.23 3.02 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.329 -1.73 . . . . 71.22 106.329 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.18 161.49 31.0 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.429 1.109 . . . . 61.25 110.151 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -142.75 111.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 104.217 -2.512 . . . . 74.52 104.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 50.53 39.8 21.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.755 0.822 . . . . 72.51 110.466 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.37 7.18 79.96 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 109.978 -1.249 . . . . 53.52 109.978 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 67' ' ' LEU . 43.5 t -108.32 116.56 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.686 -2.338 . . . . 73.03 104.686 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -79.92 14.82 1.64 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.417 0.287 . . . . 63.42 111.348 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.502 ' H ' HG12 ' A' ' 65' ' ' VAL . 4.5 mm? 38.09 38.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.06 1.344 . . . . 74.15 111.329 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -76.09 125.25 28.79 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.762 -1.212 . . . . 64.11 108.499 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.72 -7.49 65.5 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 109.706 -1.358 . . . . 71.54 109.706 172.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.41 41.81 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.874 -1.158 . . . . 64.23 107.874 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -83.85 165.94 18.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.153 -1.054 . . . . 34.02 108.153 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -63.9 -36.6 84.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.302 -0.863 . . . . 71.51 109.118 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.2 -48.37 73.95 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 109.652 -0.499 . . . . 64.44 109.652 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -68.83 -30.21 68.71 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.598 -0.689 . . . . 70.15 109.334 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.11 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.336 -0.987 . . . . 70.2 108.336 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.16 -51.05 42.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 107.285 -1.376 . . . . 73.45 107.285 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.2 m -52.66 -28.36 21.22 Favored 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 108.554 -0.906 . . . . 73.24 108.554 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.2 m -72.67 -57.27 4.25 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.711 -1.218 . . . . 55.34 107.711 -171.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.81 -56.9 16.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.708 -0.849 . . . . 75.21 108.708 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -47.26 -38.75 12.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.89 0.7 . . . . 63.14 112.89 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -88.54 -2.01 58.36 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.324 -0.86 . . . . 63.5 110.241 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -77.73 176.67 8.8 Favored 'General case' 0 C--O 1.243 0.723 0 O-C-N 120.61 -1.306 . . . . 74.32 108.181 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.18 -163.62 26.03 Favored Glycine 0 CA--C 1.491 -1.425 0 N-CA-C 108.741 -1.744 . . . . 24.43 108.741 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.44 -33.93 42.07 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.945 -1.502 . . . . 62.13 106.945 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 t -113.57 130.54 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.096 0 N-CA-C 104.037 -2.579 . . . . 70.24 104.037 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 t -129.35 149.58 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 105.944 -1.873 . . . . 60.01 105.944 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -97.42 111.77 23.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.163 -2.162 . . . . 74.0 105.163 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -112.34 137.74 50.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.321 -2.103 . . . . 75.42 105.321 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 tp -115.92 124.18 49.95 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.807 -2.294 . . . . 62.51 104.807 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.8 155.41 46.01 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 106.934 -1.506 . . . . 61.42 106.934 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -129.79 137.95 50.78 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 103.248 -2.871 . . . . 72.41 103.248 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 68.5 mmtt -68.44 148.65 50.33 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.24 1.019 . . . . 74.11 109.743 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.93 174.01 38.62 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.696 -2.962 . . . . 73.23 105.696 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -86.03 166.38 15.91 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.295 -2.113 . . . . 61.22 105.295 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.0 m -77.65 137.42 62.93 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.396 -1.705 . . . . 64.12 106.396 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.35 155.43 64.02 Favored 'Trans proline' 0 CA--C 1.496 -1.387 0 C-N-CA 122.566 2.177 . . . . 75.02 108.156 -169.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 104.264 -2.495 . . . . 73.12 104.264 176.108 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.452 ' H13' ' C8 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 109.372 -1.491 . . . . 75.44 109.372 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.73 156.49 63.27 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.054 2.502 . . . . 71.12 109.285 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 48.2 mttp -76.86 162.22 71.01 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 107.99 -1.115 . . . . 53.21 107.99 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 29.8 Cg_endo -63.98 120.81 8.29 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.465 2.11 . . . . 63.12 109.183 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.87 13.24 59.5 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 108.873 -1.691 . . . . 32.15 108.873 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -101.38 146.06 28.1 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.216 -2.142 . . . . 50.31 105.216 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.66 139.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 105.384 -2.08 . . . . 75.0 105.384 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -142.95 149.69 38.72 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.255 -1.757 . . . . 73.43 106.255 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.15 140.86 36.78 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.553 -2.017 . . . . 72.04 105.553 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 52' ' ' ARG . 91.3 t -126.38 133.12 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 105.914 -1.884 . . . . 63.45 105.914 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.67 116.97 33.91 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.475 -2.046 . . . . 61.4 105.475 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -103.17 121.21 42.19 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.874 -1.898 . . . . 53.55 105.874 -173.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 134.42 38.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.827 -1.175 . . . . 65.04 107.827 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -86.96 33.76 0.67 Allowed 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.268 -1.382 . . . . 73.24 107.268 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -44.56 -36.86 3.21 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 124.797 1.239 . . . . 71.11 112.043 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 30.0 t70 -73.15 -153.21 0.03 OUTLIER 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.335 -1.357 . . . . 75.33 107.335 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.56 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 59.8 t30 -112.64 -32.13 6.54 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 105.128 -2.175 . . . . 73.22 105.128 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.0 m -76.54 118.64 19.4 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.996 -1.483 . . . . 74.25 106.996 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.36 -56.96 4.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.657 -2.349 . . . . 72.21 104.657 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.493 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 50.88 58.31 9.59 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 113.902 -1.499 . . . . 72.24 112.988 167.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.9 mt -132.06 152.49 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.463 -2.791 . . . . 72.0 103.463 170.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.1 m -148.51 164.25 34.77 Favored 'General case' 0 CA--C 1.469 -2.164 0 N-CA-C 103.636 -2.727 . . . . 75.44 103.636 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -145.12 168.69 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 105.196 -2.15 . . . . 42.21 105.196 -168.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -142.79 166.0 25.84 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 102.108 -3.293 . . . . 64.21 102.108 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.71 -174.36 16.0 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 107.09 -2.404 . . . . 63.13 107.09 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.38 -128.27 5.91 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.115 -1.594 . . . . 64.52 109.115 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 m -66.92 19.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.638 1.975 . . . . 74.25 113.962 -168.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.256 85.5 m-20 87.04 66.35 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.956 0 CA-C-O 123.198 1.475 . . . . 62.24 107.479 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -80.82 -166.62 1.15 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.088 -2.56 . . . . 71.22 104.088 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -57.57 -19.42 25.44 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 121.536 -0.727 . . . . 64.31 112.178 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.471 ' H ' HG23 ' A' ' 29' ' ' THR . 27.6 m -85.84 135.23 25.42 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 N-CA-C 107.569 -1.271 . . . . 72.32 107.569 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -57.36 -55.47 34.42 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.624 0.77 . . . . 75.32 112.048 -166.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -85.63 12.07 9.52 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 121.166 -0.959 . . . . 63.2 109.308 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.44 22.94 59.68 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 110.217 -1.153 . . . . 64.13 110.217 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.8 145.88 50.03 Favored Glycine 0 C--N 1.36 1.902 0 N-CA-C 108.931 -1.668 . . . . 53.35 108.931 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mm -83.97 94.77 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.982 -1.858 . . . . 64.55 105.982 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -91.48 143.73 26.3 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 106.998 -1.482 . . . . 64.41 106.998 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.8 131.47 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.351 -1.722 . . . . 62.32 106.351 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -102.61 -47.52 4.41 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.785 -1.561 . . . . 63.32 106.785 -166.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.45 151.22 36.06 Favored 'General case' 0 CA--C 1.465 -2.322 0 N-CA-C 105.473 -2.047 . . . . 52.1 105.473 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.26 130.21 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 104.065 -2.569 . . . . 74.31 104.065 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.493 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.8 mm -69.46 146.21 96.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 105.141 -2.17 . . . . 74.52 105.141 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 42' ' ' ILE . 13.0 Cg_endo -55.05 118.36 5.07 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.087 1.858 . . . . 42.43 108.217 167.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.54 29.49 19.06 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.16 0.913 . . . . 73.33 111.654 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.64 -174.31 35.76 Favored Glycine 0 C--N 1.379 2.956 0 N-CA-C 106.724 -2.551 . . . . 62.53 106.724 167.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.19 74.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 122.004 -0.703 . . . . 75.24 110.378 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.5 91.24 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.819 -0.438 . . . . 53.2 109.819 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.2 -38.87 91.84 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.104 -0.702 . . . . 73.43 109.104 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 t -65.14 -42.47 93.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.438 -0.949 . . . . 53.43 108.438 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.93 -39.87 94.18 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 107.499 -1.297 . . . . 70.11 107.499 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.49 -14.94 32.48 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 110.631 -0.988 . . . . 44.04 110.631 173.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.467 ' HD2' HG13 ' A' ' 10' ' ' VAL . 39.7 ttm105 -81.5 -38.8 25.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.55 -0.971 . . . . 64.51 108.554 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.6 mt -101.98 133.08 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.016 -1.846 . . . . 63.41 106.016 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -126.54 179.19 5.45 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.573 -1.64 . . . . 75.23 106.573 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.02 144.25 55.21 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 105.455 -2.054 . . . . 70.24 105.455 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.24 -23.86 32.99 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.207 -1.957 . . . . 70.21 108.207 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.19 152.18 46.2 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 107.52 -1.289 . . . . 74.21 107.52 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.71 131.92 47.97 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 106.938 -1.505 . . . . 34.53 106.938 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.06 150.54 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 105.246 -2.131 . . . . 73.23 105.246 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.49 -46.63 2.86 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.54 -1.281 . . . . 72.11 107.54 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.47 159.58 35.84 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 118.974 -1.091 . . . . 61.22 109.235 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.99 107.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.748 -2.315 . . . . 71.22 104.748 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.2 t30 51.2 36.91 17.02 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.365 1.066 . . . . 71.42 111.417 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.52 68.65 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.648 -1.381 . . . . 73.14 109.648 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.12 120.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 105.024 -2.213 . . . . 61.32 105.024 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -68.24 106.75 2.55 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.516 -1.661 . . . . 71.44 106.516 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -21.38 56.76 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.168 -0.679 . . . . 72.33 109.168 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -57.85 145.0 36.76 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.073 -0.714 . . . . 64.12 109.073 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.57 -38.5 3.11 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 108.976 -1.65 . . . . 52.0 108.976 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.44 158.37 29.63 Favored 'General case' 0 C--N 1.363 1.162 0 CA-C-N 117.783 0.791 . . . . 74.53 109.596 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -84.73 166.11 17.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.394 -1.336 . . . . 73.32 107.394 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -65.04 -41.04 95.59 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.05 -0.722 . . . . 75.5 109.05 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -54.88 -46.18 74.71 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 109.932 -0.395 . . . . 64.22 109.932 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -69.7 -35.81 75.4 Favored 'General case' 0 C--N 1.366 1.302 0 N-CA-C 108.864 -0.791 . . . . 75.11 108.864 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.41 -41.94 77.18 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.383 -0.599 . . . . 53.34 109.383 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 23' ' ' VAL . 48.0 t -68.89 -54.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 N-CA-C 107.861 -1.162 . . . . 73.32 107.861 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.92 -27.57 44.22 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 108.587 -0.894 . . . . 61.13 108.587 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -66.48 -53.46 34.99 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.325 -1.361 . . . . 61.32 107.325 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.93 -56.92 15.47 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.677 -0.86 . . . . 72.2 108.677 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -48.27 -26.13 1.85 Allowed 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 113.382 0.882 . . . . 54.04 113.382 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -92.36 -10.63 37.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.09 0.859 . . . . 75.35 109.379 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -78.55 175.5 10.29 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 120.97 -1.081 . . . . 72.13 108.795 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.72 -163.38 26.91 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.406 -1.478 . . . . 63.52 109.406 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -78.5 -35.82 45.88 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.968 -1.493 . . . . 74.24 106.968 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.07 128.54 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.825 0 N-CA-C 102.692 -3.077 . . . . 72.34 102.692 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.73 140.1 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.905 0 N-CA-C 105.101 -2.185 . . . . 74.13 105.101 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -92.42 111.24 22.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 104.783 -2.302 . . . . 42.13 104.783 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 12' ' ' LEU . 80.2 mt -114.77 140.33 48.99 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 106.163 -1.792 . . . . 75.01 106.163 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 tp -111.86 127.14 55.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.888 -1.893 . . . . 75.34 105.888 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mp -133.48 155.56 49.33 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.472 -1.677 . . . . 65.32 106.472 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -127.55 138.66 52.96 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 104.872 -2.27 . . . . 74.12 104.872 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -65.68 150.62 48.19 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.033 0.92 . . . . 74.44 109.61 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.3 42.88 0.57 Allowed Glycine 0 CA--C 1.48 -2.105 0 N-CA-C 104.908 -3.277 . . . . 54.21 104.908 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.85 167.73 10.34 Favored 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 106.678 -1.601 . . . . 72.31 106.678 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 m -74.69 159.85 82.29 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.072 -1.085 . . . . 64.53 108.072 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -177.12 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.196 2.598 . . . . 71.34 109.445 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.358 0.953 0 N-CA-C 103.961 -2.607 . . . . 63.11 103.961 -170.907 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.657 0 N-CA-C 108.294 -1.922 . . . . 74.22 108.294 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.42 150.86 87.5 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 123.18 2.587 . . . . 70.12 109.314 -173.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 52.2 mtmt -83.14 159.41 62.48 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 105.747 -1.946 . . . . 74.3 105.747 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 28.3 Cg_endo -62.49 124.17 13.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.103 1.868 . . . . 74.1 108.759 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.7 64.48 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.71 -1.356 . . . . 60.54 109.71 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.61 145.12 27.17 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 105.489 -2.041 . . . . 70.52 105.489 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.65 140.3 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.925 -2.25 . . . . 70.11 104.925 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.01 160.32 43.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.464 -1.68 . . . . 55.13 106.464 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -102.48 139.36 38.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.824 -1.917 . . . . 71.44 105.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.37 134.16 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 N-CA-C 105.841 -1.911 . . . . 62.4 105.841 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.68 124.01 48.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.008 -2.219 . . . . 72.45 105.008 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.84 120.94 43.02 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 104.894 -2.262 . . . . 65.24 104.894 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.32 29.72 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 107.923 -1.14 . . . . 74.33 107.923 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -92.06 31.49 1.26 Allowed 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.88 -1.526 . . . . 75.25 106.88 175.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.54 -26.45 62.65 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.017 -1.846 . . . . 73.43 106.017 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.47 -83.1 0.1 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.359 -1.349 . . . . 74.32 107.359 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -156.21 -168.65 2.8 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.765 -2.309 . . . . 73.24 104.765 -168.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -47.67 152.99 0.63 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.132 -0.692 . . . . 63.44 109.132 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.65 -56.69 18.3 Favored 'General case' 0 C--N 1.374 1.642 0 N-CA-C 108.381 -0.97 . . . . 74.31 108.381 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.67 47.63 7.16 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.458 -1.857 . . . . 63.22 108.458 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 mt -127.99 153.43 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 104.131 -2.544 . . . . 64.12 104.131 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.4 m -144.97 160.38 41.43 Favored 'General case' 0 CA--C 1.479 -1.75 0 N-CA-C 102.918 -2.993 . . . . 55.44 102.918 169.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.56 167.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 106.736 -1.579 . . . . 72.21 106.736 -162.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -149.57 166.62 28.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 103.619 -2.734 . . . . 71.3 103.619 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.83 -177.39 17.1 Favored Glycine 0 CA--C 1.486 -1.733 0 N-CA-C 107.417 -2.273 . . . . 60.32 107.417 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.53 -133.65 6.94 Favored Glycine 0 C--N 1.364 2.086 0 N-CA-C 110.014 -1.234 . . . . 54.43 110.014 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.04 19.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.823 2.449 . . . . 64.41 114.812 -167.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.0 t30 86.23 65.24 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.667 -1.605 . . . . 73.24 106.667 -169.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.1 t -96.34 -164.82 1.19 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.571 -2.751 . . . . 64.04 103.571 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -27.88 -49.46 0.06 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.027 1.731 . . . . 52.2 113.12 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.3 129.95 38.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.132 -1.062 . . . . 75.53 108.132 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.18 -27.11 59.52 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 107.655 -1.239 . . . . 74.03 107.655 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -63.34 -17.75 62.91 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 108.466 -0.939 . . . . 73.31 108.466 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.15 -5.65 2.64 Favored Glycine 0 C--N 1.372 2.539 0 N-CA-C 111.34 -0.704 . . . . 60.45 111.34 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.46 153.51 52.94 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 108.978 -1.649 . . . . 42.34 108.978 -172.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -83.13 97.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 105.918 -1.882 . . . . 63.03 105.918 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.32 146.09 25.48 Favored 'General case' 0 CA--C 1.477 -1.865 0 N-CA-C 107.46 -1.311 . . . . 73.02 107.46 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.52 130.83 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.851 -1.907 . . . . 65.55 105.851 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -108.09 -36.82 6.22 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.146 -1.427 . . . . 70.35 107.146 -167.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.23 151.48 33.08 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 106.897 -1.519 . . . . 73.11 106.897 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.46 128.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 104.743 -2.317 . . . . 71.24 104.743 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 mt -69.27 136.01 88.97 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 107.471 -1.307 . . . . 54.53 107.471 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.12 111.16 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.757 2.305 . . . . 71.15 108.725 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 74.7 21.3 2.19 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 124.552 1.157 . . . . 74.35 110.602 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.61 179.26 40.94 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 107.049 -2.42 . . . . 61.41 107.049 165.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.8 98.84 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.871 -0.788 . . . . 74.04 108.871 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -47.64 73.61 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.195 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.56 -37.95 89.27 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 109.232 -0.655 . . . . 64.51 109.232 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -64.28 -37.43 87.46 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 107.999 -1.111 . . . . 70.01 107.999 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.26 -46.38 70.59 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 107.648 -1.241 . . . . 72.11 107.648 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.5 -13.27 47.63 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.394 -0.682 . . . . 63.11 111.394 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -73.91 -41.71 61.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.636 1.218 . . . . 72.33 108.39 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.78 135.48 33.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 106.982 -1.488 . . . . 75.51 106.982 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.52 -178.56 5.17 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 105.582 -2.007 . . . . 64.02 105.582 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 141.24 57.74 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.873 -1.899 . . . . 73.14 105.873 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.26 -13.29 48.27 Favored Glycine 0 CA--C 1.477 -2.296 0 N-CA-C 107.91 -2.076 . . . . 71.25 107.91 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -82.87 150.25 26.64 Favored 'General case' 0 CA--C 1.485 -1.538 0 N-CA-C 106.184 -1.784 . . . . 74.23 106.184 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.545 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.7 tmm_? -115.91 123.08 47.2 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 106.265 -1.754 . . . . 72.03 106.265 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -94.12 140.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.248 -2.13 . . . . 72.15 105.248 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 -43.95 3.06 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 106.96 -1.496 . . . . 72.23 106.96 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.51 165.37 22.83 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 122.536 1.16 . . . . 74.02 110.029 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.56 102.37 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 103.376 -2.824 . . . . 64.54 103.376 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 t30 51.89 42.28 30.03 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.373 1.069 . . . . 71.5 110.275 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.98 14.31 79.66 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.27 -1.132 . . . . 74.1 110.27 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.16 117.25 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 103.835 -2.654 . . . . 72.0 103.835 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -70.4 115.93 10.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.189 -1.041 . . . . 53.34 108.189 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.6 13.97 7.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.827 -1.175 . . . . 73.35 107.827 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.72 137.7 54.31 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.704 -1.221 . . . . 61.4 107.704 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.26 -16.93 14.6 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.012 -1.235 . . . . 55.02 110.012 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.54 154.44 41.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.095 -1.076 . . . . 74.41 108.095 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.75 163.13 19.33 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.589 -1.263 . . . . 74.43 107.589 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -63.07 -38.87 92.92 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 116.167 -0.47 . . . . 72.51 110.951 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.32 -35.21 79.62 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 120.384 -0.526 . . . . 51.11 109.929 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.15 -31.07 69.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 121.145 -0.972 . . . . 61.4 108.99 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.19 79.88 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.975 -1.12 . . . . 75.41 107.975 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.22 -55.02 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.625 -1.25 . . . . 64.22 107.625 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.3 m -56.2 -27.73 55.74 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 108.829 -0.804 . . . . 62.41 108.829 -171.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -61.79 -55.86 25.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 106.975 -1.491 . . . . 61.11 106.975 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.57 -55.68 30.79 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 109.027 -0.731 . . . . 74.14 109.027 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -46.77 -34.02 4.88 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.625 -0.672 . . . . 71.24 112.52 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -98.56 4.2 48.11 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.255 -0.903 . . . . 74.11 110.413 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 p -80.76 173.63 12.42 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.645 -1.284 . . . . 72.13 108.685 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.2 -136.08 7.22 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.297 -0.721 . . . . 64.11 111.297 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -82.99 -49.09 9.94 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.32 -0.993 . . . . 72.44 108.32 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.0 132.98 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 N-CA-C 104.11 -2.552 . . . . 72.14 104.11 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -116.83 134.23 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 105.056 -2.202 . . . . 61.45 105.056 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.92 120.2 35.78 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.546 -2.02 . . . . 72.32 105.546 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.67 137.23 52.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.074 -1.825 . . . . 73.14 106.074 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.88 125.69 53.9 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.454 -2.424 . . . . 65.31 104.454 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.25 155.44 46.28 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 108.449 -0.945 . . . . 74.2 108.449 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.545 ' CD ' HH21 ' A' ' 58' ' ' ARG . 35.6 tt0 -115.35 126.95 55.06 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 102.404 -3.184 . . . . 44.43 102.404 174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -56.75 139.17 51.64 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.175 -1.046 . . . . 63.13 108.175 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.95 152.52 44.09 Favored Glycine 0 CA--C 1.476 -2.357 0 N-CA-C 106.602 -2.599 . . . . 61.23 106.602 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -105.29 -171.9 2.0 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 104.773 -2.306 . . . . 60.34 104.773 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 p -82.45 153.22 68.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 105.501 -2.037 . . . . 74.4 105.501 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.13 152.9 62.56 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 107.792 -1.657 . . . . 73.14 107.792 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 101.503 -3.517 . . . . 45.31 101.503 172.834 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.485 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.736 0 N-CA-C 108.564 -1.814 . . . . 52.55 108.564 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.38 155.35 67.45 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.812 2.341 . . . . 73.52 107.972 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 62.8 mttp -89.09 161.73 39.81 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 105.161 -2.163 . . . . 75.3 105.161 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 18.2 Cg_endo -59.58 132.92 48.48 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.686 1.591 . . . . 75.53 108.858 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.32 -19.44 42.76 Favored Glycine 0 CA--C 1.482 -2.007 0 N-CA-C 108.87 -1.692 . . . . 62.43 108.87 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.01 136.13 53.38 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.046 -1.094 . . . . 64.31 108.046 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.27 131.88 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 103.878 -2.638 . . . . 72.43 103.878 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.68 143.77 51.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.843 -1.91 . . . . 74.54 105.843 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.5 130.76 50.94 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.883 -1.895 . . . . 63.23 105.883 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.98 129.8 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.13 0 N-CA-C 105.024 -2.213 . . . . 73.23 105.024 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -103.44 110.75 22.88 Favored 'General case' 0 CA--C 1.471 -2.059 0 N-CA-C 105.745 -1.946 . . . . 72.04 105.745 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.683 -1.599 . . . . 64.12 106.683 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.36 147.84 25.85 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.964 -1.495 . . . . 74.55 106.964 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -93.43 31.05 1.58 Allowed 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.596 -2.002 . . . . 73.22 105.596 175.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -84.76 -51.08 7.05 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.496 -1.298 . . . . 72.14 107.496 -167.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.53 -56.37 22.85 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.738 -0.838 . . . . 75.12 108.738 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -154.14 164.85 37.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.642 -2.725 . . . . 70.42 103.642 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.1 m -46.23 150.79 0.57 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.726 0.81 . . . . 51.13 110.296 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.2 pt? -58.14 -57.33 13.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.505 -0.77 . . . . 64.34 111.78 -164.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.585 ' HA3' HG12 ' A' ' 42' ' ' ILE . . . 61.38 52.77 49.3 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.205 -0.758 . . . . 61.23 111.205 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.2 161.38 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 103.839 -2.652 . . . . 72.14 103.839 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.68 162.72 41.01 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.396 -2.816 . . . . 64.0 103.396 163.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.43 167.86 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 105.389 -2.078 . . . . 74.54 105.389 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -146.77 166.33 26.97 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.958 -2.608 . . . . 61.03 103.958 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 83.92 138.6 3.74 Favored Glycine 0 C--O 1.191 -2.543 0 N-CA-C 111.472 -0.651 . . . . 63.32 111.472 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.31 -89.08 0.07 OUTLIER Glycine 0 C--N 1.362 2.002 0 N-CA-C 109.228 -1.549 . . . . 54.32 109.228 167.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.21 20.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 117.279 2.326 . . . . 64.3 117.279 -165.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 88.32 65.08 0.01 OUTLIER 'General case' 0 CA--C 1.466 -2.27 0 N-CA-C 105.332 -2.099 . . . . 74.32 105.332 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.482 ' H ' HG22 ' A' ' 29' ' ' THR . 5.1 t -85.7 -166.66 1.59 Allowed 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 110.972 -2.831 . . . . 73.4 106.115 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 m -60.93 -31.0 70.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.473 1.109 . . . . 72.43 110.552 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 29' ' ' THR . 4.7 m -87.33 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 107.849 -1.167 . . . . 72.41 107.849 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -67.11 -37.31 83.67 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.398 0.679 . . . . 63.14 110.111 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -69.47 -9.02 51.91 Favored 'General case' 0 C--O 1.211 -0.938 0 O-C-N 121.393 -0.817 . . . . 64.32 109.742 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.82 13.77 57.17 Favored Glycine 0 C--N 1.37 2.438 0 N-CA-C 108.589 -1.804 . . . . 72.45 108.589 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 144.99 47.57 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 109.609 -1.396 . . . . 64.51 109.609 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 25' ' ' GLY . 1.7 mm -85.83 104.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 102.454 -3.165 . . . . 70.12 102.454 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -101.29 147.51 26.21 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 107.501 -1.296 . . . . 73.0 107.501 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.25 132.62 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 106.77 -1.567 . . . . 72.34 106.77 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -109.07 -48.11 3.32 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.501 -0.926 . . . . 53.31 108.501 -167.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.61 146.04 34.13 Favored 'General case' 0 CA--C 1.463 -2.388 0 N-CA-C 105.806 -1.924 . . . . 50.45 105.806 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.9 t -130.59 130.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 103.981 -2.6 . . . . 74.24 103.981 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.585 HG12 ' HA3' ' A' ' 20' ' ' GLY . 34.0 mm -67.59 141.13 95.05 Favored Pre-proline 0 C--N 1.353 0.718 0 N-CA-C 106.093 -1.817 . . . . 73.41 106.093 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.52 109.12 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.153 1.902 . . . . 64.34 107.896 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 70.15 30.28 3.53 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.446 1.091 . . . . 70.14 110.929 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.45 -179.0 33.83 Favored Glycine 0 C--N 1.369 2.385 0 N-CA-C 107.279 -2.328 . . . . 65.21 107.279 162.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.89 -35.34 80.33 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 122.102 -0.646 . . . . 52.23 109.48 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.85 82.32 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.273 -0.64 . . . . 64.54 109.273 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.58 -34.71 77.59 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.617 -0.512 . . . . 73.23 109.617 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -70.05 -42.32 73.03 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.74 -0.837 . . . . 62.12 108.74 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -67.71 -37.07 81.76 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.691 -1.226 . . . . 74.44 107.691 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.64 -14.28 47.95 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 111.32 -0.712 . . . . 63.14 111.32 170.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -80.88 -35.06 33.12 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.741 -0.858 . . . . 65.12 108.968 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.2 mt -95.24 133.04 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.136 -1.801 . . . . 70.21 106.136 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -135.41 175.27 9.74 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.275 -1.75 . . . . 52.42 106.275 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -65.85 132.58 49.02 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.407 -0.96 . . . . 75.44 108.407 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' GLN . . . 98.81 -12.07 62.6 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.078 -1.609 . . . . 52.53 109.078 170.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -65.87 150.92 47.81 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 106.767 -1.568 . . . . 64.33 106.767 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.481 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.9 tmm_? -109.32 127.48 54.34 Favored 'General case' 0 C--O 1.197 -1.672 0 N-CA-C 106.265 -1.754 . . . . 71.54 106.265 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.48 138.66 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 106.17 -1.789 . . . . 65.14 106.17 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -52.21 2.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.553 -1.277 . . . . 72.35 107.553 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.3 165.52 23.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-O 122.157 0.98 . . . . 64.23 110.354 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.28 108.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 104.228 -2.508 . . . . 73.24 104.228 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.7 t30 54.94 38.18 30.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.333 0.653 . . . . 74.54 109.851 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.63 79.3 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 109.528 -1.429 . . . . 63.21 109.528 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.87 119.82 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 104.776 -2.305 . . . . 75.21 104.776 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.2 m -71.91 113.23 8.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.167 -1.049 . . . . 61.52 108.167 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.03 -28.8 62.56 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 107.589 -1.263 . . . . 73.42 107.589 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -52.3 145.04 11.66 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 122.806 0.442 . . . . 73.43 110.53 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.49 -36.45 3.58 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 110.062 -1.215 . . . . 54.31 110.062 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.52 173.82 5.58 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.191 0.996 . . . . 74.02 110.006 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 p -81.01 160.56 24.54 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 107.966 -1.124 . . . . 71.13 107.966 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -64.29 -38.6 91.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.7 -0.852 . . . . 75.2 108.7 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -60.88 -41.86 96.79 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 120.449 -0.5 . . . . 63.43 109.661 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -63.64 -38.88 92.79 Favored 'General case' 0 C--N 1.369 1.421 0 N-CA-C 108.523 -0.917 . . . . 73.52 108.523 -172.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.91 70.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 109.958 -0.386 . . . . 74.34 109.958 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -74.17 -53.87 16.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.528 -1.286 . . . . 65.01 107.528 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.09 -28.31 38.36 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.263 -1.014 . . . . 52.43 108.263 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -67.7 -53.75 25.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.986 -1.116 . . . . 74.31 107.986 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -58.0 -56.83 16.95 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.158 -0.682 . . . . 52.12 109.158 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -51.63 -16.29 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.49 0.922 . . . . 73.44 113.49 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -99.53 -2.86 34.75 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.994 -1.066 . . . . 74.02 108.555 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -78.57 166.54 22.43 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.374 -0.829 . . . . 75.24 109.435 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.4 -140.9 6.08 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 109.364 -1.494 . . . . 51.01 109.364 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -84.03 -48.74 9.6 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.125 -1.065 . . . . 71.15 108.125 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.81 135.63 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.968 -2.605 . . . . 63.42 103.968 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -123.51 142.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 104.7 -2.333 . . . . 64.23 104.7 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -96.25 115.63 27.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.354 -2.462 . . . . 63.3 104.354 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.1 mt -117.4 143.35 46.08 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 106.073 -1.825 . . . . 75.34 106.073 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.51 131.29 56.74 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 103.982 -2.599 . . . . 74.31 103.982 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.99 155.32 48.2 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.987 -1.857 . . . . 72.24 105.987 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.481 ' CD ' HH21 ' A' ' 58' ' ' ARG . 39.0 tt0 -121.36 132.76 54.95 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 105.019 -2.215 . . . . 75.13 105.019 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 69.8 mmtt -69.86 152.35 44.63 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 122.63 1.205 . . . . 51.3 111.798 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.17 53.42 0.06 OUTLIER Glycine 0 CA--C 1.459 -3.412 0 N-CA-C 103.93 -3.668 . . . . 65.22 103.93 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 4.7 pt20 -82.97 145.28 29.44 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 107.385 -1.339 . . . . 72.13 107.385 -174.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 m -62.61 159.62 41.49 Favored Pre-proline 0 N--CA 1.436 -1.163 0 C-N-CA 123.211 0.604 . . . . 62.01 109.592 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.06 167.85 20.64 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.611 2.207 . . . . 71.23 107.738 171.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.41 -2.432 0 N-CA-C 103.173 -2.899 . . . . 74.2 103.173 177.14 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.134 0 N-CA-C 107.915 -2.074 . . . . 72.55 107.915 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.68 137.26 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.536 2.158 . . . . 71.1 108.277 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 56.1 mtmt -86.02 160.98 51.15 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 105.551 -2.018 . . . . 73.31 105.551 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 25.6 Cg_endo -62.43 138.17 69.38 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.866 1.71 . . . . 75.13 109.388 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.88 12.94 73.29 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.038 -1.625 . . . . 55.3 109.038 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -98.01 145.55 26.4 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.822 -2.288 . . . . 61.22 104.822 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.72 129.04 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.499 -2.408 . . . . 74.33 104.499 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -129.43 141.14 51.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.064 -1.828 . . . . 63.15 106.064 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -102.58 134.32 46.13 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 105.926 -1.879 . . . . 73.51 105.926 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -130.44 130.65 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.116 0 N-CA-C 105.461 -2.051 . . . . 74.51 105.461 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -106.25 125.92 51.59 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.666 -2.346 . . . . 72.24 104.666 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.32 122.73 47.98 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.544 -1.651 . . . . 62.53 106.544 -167.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.88 137.17 35.33 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.476 -1.305 . . . . 62.12 107.476 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.2 35.07 0.86 Allowed 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.652 -1.61 . . . . 72.14 106.652 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -60.35 -44.65 95.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.9 -1.519 . . . . 74.33 106.9 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -81.83 146.13 30.04 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 105.118 -2.179 . . . . 64.53 105.118 169.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.12 -35.69 59.16 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.934 -0.395 . . . . 65.44 109.934 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.2 m -72.38 121.0 18.77 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.204 -1.036 . . . . 71.3 108.204 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -72.86 -57.58 3.97 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 104.913 -2.254 . . . . 75.44 104.913 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.55 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 53.77 47.8 63.78 Favored Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 113.408 -1.723 . . . . 72.33 111.524 172.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.45 156.17 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.79 -3.041 . . . . 65.44 102.79 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.2 m -145.57 160.88 40.99 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 102.575 -3.12 . . . . 71.41 102.575 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.63 165.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 105.738 -1.949 . . . . 74.15 105.738 -167.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -144.41 166.16 25.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 103.045 -2.946 . . . . 75.31 103.045 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' H ' HG21 ' A' ' 29' ' ' THR . . . 130.08 -178.43 17.53 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 107.694 -2.162 . . . . 72.2 107.694 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.45 -133.19 7.4 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.172 -1.571 . . . . 70.23 109.172 172.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.21 19.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.87 2.068 . . . . 74.54 113.588 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 87.82 65.58 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.429 -1.323 . . . . 52.1 107.429 -169.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 25' ' ' GLY . 14.8 t -89.37 -165.81 1.44 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.304 -2.48 . . . . 62.2 104.304 170.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -46.14 -31.06 2.18 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.788 0.835 . . . . 71.34 112.89 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 m -84.96 133.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -56.65 -57.06 14.03 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 115.945 -0.57 . . . . 74.41 111.064 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -74.75 -0.39 18.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.491 -0.559 . . . . 73.32 109.491 -169.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.73 14.32 43.31 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 110.148 -1.181 . . . . 64.15 110.148 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.35 154.38 52.91 Favored Glycine 0 CA--C 1.473 -2.552 0 N-CA-C 107.581 -2.208 . . . . 52.11 107.581 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 86.68 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 105.672 -1.973 . . . . 75.22 105.672 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 70.6 m-85 -84.56 142.18 30.17 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 106.992 -1.484 . . . . 75.24 106.992 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.84 128.5 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.262 -1.755 . . . . 63.02 106.262 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -102.51 -42.21 6.03 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.91 -1.144 . . . . 73.55 107.91 -166.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.38 153.2 34.28 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 106.53 -1.656 . . . . 73.03 106.53 -173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.92 131.72 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 104.116 -2.55 . . . . 52.21 104.116 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.55 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.9 mm -75.43 143.04 75.45 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 104.288 -2.486 . . . . 71.24 104.288 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.75 115.01 2.24 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 107.714 -1.687 . . . . 55.4 107.714 166.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 77.16 18.28 1.47 Allowed 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 124.857 1.348 . . . . 73.31 111.01 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.11 172.68 40.41 Favored Glycine 0 C--N 1.367 2.282 0 N-CA-C 106.447 -2.661 . . . . 42.42 106.447 164.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.4 80.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.811 -0.817 . . . . 61.43 109.165 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.58 91.98 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.078 -0.712 . . . . 71.25 109.078 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -69.58 -36.32 76.16 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.76 -0.829 . . . . 71.0 108.76 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.6 m -70.27 -35.37 73.7 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.392 -0.966 . . . . 73.33 108.392 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.439 -1.319 . . . . 75.13 107.439 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.6 49.92 Favored Glycine 0 C--O 1.214 -1.151 0 N-CA-C 110.771 -0.932 . . . . 75.34 110.771 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -73.09 -39.1 66.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.419 -1.048 . . . . 65.12 109.144 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.45 131.76 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 107.225 -1.398 . . . . 61.23 107.225 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -141.49 -179.67 6.29 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.646 -1.983 . . . . 71.34 105.646 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -66.61 143.81 56.79 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.162 -1.792 . . . . 71.53 106.162 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.51 50.52 Favored Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 108.085 -2.006 . . . . 61.32 108.085 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.83 161.06 17.74 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.309 -2.108 . . . . 61.53 105.309 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.6 ptt-85 -132.34 146.68 52.15 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.8 -1.556 . . . . 71.12 106.8 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.1 145.3 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.579 -2.378 . . . . 72.14 104.579 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 -47.43 2.63 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.735 -1.58 . . . . 74.12 106.735 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.54 166.8 19.81 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.52 1.152 . . . . 52.3 109.779 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -137.71 103.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 103.743 -2.688 . . . . 75.03 103.743 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.5 t30 56.44 36.96 28.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.315 0.579 . . . . 64.52 110.314 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.21 10.43 84.78 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 109.389 -1.484 . . . . 54.22 109.389 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.82 119.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 N-CA-C 104.311 -2.478 . . . . 43.12 104.311 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -69.69 106.41 3.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.665 -1.235 . . . . 51.31 107.665 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -18.07 36.92 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.109 -1.071 . . . . 73.14 108.109 -175.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.64 146.13 46.59 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.811 -0.811 . . . . 72.14 108.811 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.16 -35.03 4.26 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.452 -1.459 . . . . 74.44 109.452 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.66 156.28 39.68 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.286 -1.005 . . . . 62.0 108.286 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.5 p -75.67 166.14 24.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.827 -0.805 . . . . 73.33 108.827 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -65.8 -40.14 91.6 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.237 -1.023 . . . . 75.32 108.237 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -54.38 -48.16 71.86 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 110.256 -0.275 . . . . 71.41 110.256 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -34.6 78.13 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 108.95 -0.759 . . . . 75.4 108.95 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.92 85.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.23 -0.655 . . . . 71.04 109.23 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.46 -54.79 16.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.641 -1.244 . . . . 70.03 107.641 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.4 m -56.2 -26.84 52.41 Favored 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 108.101 -1.074 . . . . 75.54 108.101 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -64.87 -54.63 27.97 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 107.018 -1.475 . . . . 73.14 107.018 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.4 -55.5 30.94 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.525 -0.917 . . . . 74.22 108.525 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.8 mtp85 -45.83 -47.14 15.87 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.041 0.386 . . . . 74.22 112.041 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -87.89 1.09 54.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.121 0.873 . . . . 74.54 111.19 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.0 p -79.93 174.32 11.71 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.941 1.246 . . . . 50.32 108.374 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.8 -156.83 30.84 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 109.739 -1.344 . . . . 71.3 109.739 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.65 -44.48 27.97 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.72 -1.215 . . . . 72.23 107.72 -172.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.8 127.69 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.75 0 N-CA-C 103.879 -2.637 . . . . 72.21 103.879 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.54 143.63 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.888 0 N-CA-C 104.942 -2.244 . . . . 74.02 104.942 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -99.44 117.99 35.07 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 105.138 -2.171 . . . . 63.55 105.138 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.9 mt -114.88 139.32 49.88 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 105.055 -2.202 . . . . 55.31 105.055 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.85 123.94 49.41 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 104.336 -2.468 . . . . 54.12 104.336 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.46 159.3 38.47 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.194 -1.41 . . . . 63.34 107.194 -171.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -123.34 134.83 53.99 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 104.042 -2.577 . . . . 74.03 104.042 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 142.62 51.25 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.446 -0.946 . . . . 55.31 108.446 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.25 178.34 34.28 Favored Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.851 -3.3 . . . . 61.21 104.851 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -67.49 146.89 53.52 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.895 -1.52 . . . . 72.41 106.895 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 m -55.53 140.72 65.38 Favored Pre-proline 0 C--N 1.347 0.461 0 CA-C-O 121.447 0.641 . . . . 63.15 109.929 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 128.21 19.05 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.89 2.394 . . . . 73.03 109.321 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.414 -2.241 0 N-CA-C 104.466 -2.42 . . . . 73.25 104.466 175.691 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.431 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.033 0 N-CA-C 107.424 -2.271 . . . . 50.35 107.424 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.29 110.91 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.929 2.419 . . . . 54.4 109.445 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.472 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 9.2 mtmp? -77.96 165.01 53.83 Favored Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 105.38 -2.081 . . . . 75.35 105.38 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 20.7 Cg_endo -60.52 116.82 3.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.009 1.806 . . . . 72.42 108.809 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.508 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 98.61 12.93 42.66 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 109.529 -1.428 . . . . 32.44 109.529 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.442 ' CG ' ' HZ2' ' A' ' 3' ' ' LYS . 74.6 m-20 -97.95 143.12 28.87 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.251 -1.759 . . . . 72.02 106.251 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 7' ' ' ILE . 3.2 mp -97.61 141.24 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 105.224 -2.139 . . . . 72.01 105.224 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.75 159.5 36.88 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.385 -2.079 . . . . 73.13 105.385 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -102.81 148.24 25.87 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.244 -2.132 . . . . 75.33 105.244 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.25 131.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 N-CA-C 104.321 -2.474 . . . . 71.25 104.321 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.03 133.43 54.2 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.382 -1.71 . . . . 75.12 106.382 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.66 128.89 51.2 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.657 -1.979 . . . . 73.43 105.657 -173.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -92.24 141.87 28.09 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.189 -1.041 . . . . 71.25 108.189 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -84.64 33.6 0.52 Allowed 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.022 -1.473 . . . . 75.03 107.022 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 13' ' ' ALA . 44.5 t30 -62.13 -41.43 98.24 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 106.95 -1.5 . . . . 70.54 106.95 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.86 160.65 30.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.427 -1.323 . . . . 73.14 107.427 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -74.33 -52.58 11.81 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.16 -1.422 . . . . 74.34 107.16 -172.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.8 m -85.71 136.23 33.43 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.303 -1.369 . . . . 75.31 107.303 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.45 -58.53 3.31 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.471 -2.418 . . . . 65.42 104.471 167.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 42' ' ' ILE . . . 60.55 48.94 83.71 Favored Glycine 0 CA--C 1.485 -1.82 0 CA-C-N 114.342 -1.299 . . . . 71.32 110.438 171.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mt -124.17 152.65 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 103.687 -2.709 . . . . 71.24 103.687 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.6 m -150.54 161.85 41.77 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 103.372 -2.825 . . . . 71.31 103.372 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.96 167.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 105.094 -2.188 . . . . 71.24 105.094 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -143.62 166.15 25.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 102.919 -2.993 . . . . 74.02 102.919 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.04 -173.37 16.18 Favored Glycine 0 CA--C 1.473 -2.562 0 N-CA-C 107.584 -2.206 . . . . 51.23 107.584 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 -123.69 5.53 Favored Glycine 0 CA--C 1.485 -1.789 0 N-CA-C 108.427 -1.869 . . . . 60.54 108.427 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.75 20.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 126.003 1.721 . . . . 72.2 113.659 -169.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 87.32 66.21 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.657 1.218 . . . . 61.25 107.876 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -84.27 -166.51 1.46 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.591 -2.744 . . . . 73.11 103.591 171.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -53.56 -22.04 7.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.762 0.652 . . . . 73.43 112.762 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.85 128.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 107.295 -1.372 . . . . 63.32 107.295 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -61.62 -46.16 91.0 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 122.952 0.501 . . . . 64.24 109.904 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -73.64 -5.33 39.76 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.766 -0.828 . . . . 73.03 108.766 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.02 10.25 19.04 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 110.998 -0.841 . . . . 73.32 110.998 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.9 151.74 51.14 Favored Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 108.477 -1.849 . . . . 43.23 108.477 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.69 89.66 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 N-CA-C 105.737 -1.949 . . . . 71.12 105.737 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -87.42 144.26 26.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.774 -1.565 . . . . 64.22 106.774 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.62 132.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.112 -1.81 . . . . 71.13 106.112 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.06 -45.08 4.62 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.382 -1.34 . . . . 73.43 107.382 -166.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 155.45 38.72 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 106.502 -1.666 . . . . 64.12 106.502 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.29 139.16 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 105.529 -2.026 . . . . 72.21 105.529 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HB ' ' HA3' ' A' ' 20' ' ' GLY . 6.0 mt -72.95 144.55 85.43 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.337 -1.357 . . . . 52.41 107.337 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.57 108.49 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.639 2.226 . . . . 55.33 108.879 168.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 75.15 27.63 1.1 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.745 1.218 . . . . 73.42 110.318 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.04 173.62 55.09 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 106.556 -2.618 . . . . 65.55 106.556 162.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.35 79.15 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.323 0.649 . . . . 62.02 110.298 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.17 -49.52 64.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.618 -0.512 . . . . 74.24 109.618 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.2 -42.0 99.25 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.615 -0.513 . . . . 55.42 109.615 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.5 m -59.96 -42.14 93.45 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-O 121.355 0.598 . . . . 72.21 109.624 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -77.71 -35.48 52.05 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.813 -1.18 . . . . 70.34 107.813 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.23 -4.63 70.85 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 111.306 -0.718 . . . . 73.14 111.306 173.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.17 -44.3 63.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.658 -0.907 . . . . 73.01 109.131 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 mt -109.98 136.54 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 105.826 -1.916 . . . . 72.13 105.826 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -122.96 170.03 10.55 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.98 -1.859 . . . . 75.43 105.98 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 146.49 53.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.338 -1.356 . . . . 75.3 107.338 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.72 -8.2 78.71 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 109.804 -1.318 . . . . 50.21 109.804 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -86.0 163.38 18.0 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.104 -1.813 . . . . 71.13 106.104 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -115.39 129.88 56.72 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.7 0.762 . . . . 65.32 109.148 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.94 148.82 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 104.942 -2.244 . . . . 73.34 104.942 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -44.43 2.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.742 -1.207 . . . . 70.12 107.742 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.23 164.35 24.73 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.017 -1.073 . . . . 73.25 109.905 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.5 t -140.76 107.51 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.917 -2.253 . . . . 75.15 104.917 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.8 t30 45.71 43.48 9.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.417 1.487 . . . . 72.23 111.073 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.97 76.87 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 109.614 -1.395 . . . . 72.43 109.614 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.87 117.53 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 103.815 -2.661 . . . . 75.54 103.815 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.0 m -69.62 110.44 4.84 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.501 -1.296 . . . . 70.34 107.501 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.61 -6.48 57.49 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.9 -1.148 . . . . 53.44 107.9 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.96 143.64 57.27 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.556 -1.276 . . . . 54.1 107.556 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.36 -39.12 3.13 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.116 -1.193 . . . . 34.44 110.116 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 163.98 24.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 108.951 -0.759 . . . . 50.32 108.951 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -84.58 168.65 15.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.799 0.809 . . . . 71.45 109.36 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -62.03 -40.46 95.79 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 115.404 -0.816 . . . . 71.1 109.27 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -60.78 -40.58 93.11 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.892 -0.505 . . . . 73.24 110.54 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.21 -39.2 93.95 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.5 1.045 . . . . 71.25 109.378 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.89 79.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.427 -0.583 . . . . 73.14 109.427 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -71.24 -54.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 107.423 -1.325 . . . . 74.11 107.423 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.7 t -53.35 -28.94 31.51 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.55 1.167 . . . . 73.01 108.521 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 m -70.59 -56.36 6.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.507 -1.294 . . . . 65.13 107.507 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -57.15 -54.72 43.61 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 107.937 -1.134 . . . . 52.45 107.937 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -44.49 -43.99 8.28 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.542 1.137 . . . . 73.22 111.9 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.15 9.02 43.91 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.713 1.142 . . . . 75.2 111.201 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.4 p -80.72 174.45 11.6 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.861 -1.149 . . . . 72.14 107.925 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.28 -148.53 16.38 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.599 -1.4 . . . . 63.43 109.599 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -80.6 -47.81 13.6 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 108.173 -1.047 . . . . 74.14 108.173 -169.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.12 132.69 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 N-CA-C 103.817 -2.66 . . . . 54.41 103.817 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.55 151.0 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 104.479 -2.415 . . . . 64.43 104.479 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -103.36 124.26 48.36 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 104.933 -2.247 . . . . 73.32 104.933 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.02 137.79 49.55 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.191 -2.522 . . . . 75.42 104.191 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -106.97 126.27 52.1 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 105.815 -1.92 . . . . 72.34 105.815 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 152.52 51.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.423 -2.065 . . . . 70.33 105.423 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -123.71 140.86 52.57 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 102.608 -3.108 . . . . 72.2 102.608 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.508 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 24.7 mmtp -61.73 139.63 58.3 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.809 0.814 . . . . 72.22 109.527 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.04 49.75 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 106.138 -2.785 . . . . 71.32 106.138 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -73.6 143.08 46.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 105.007 -2.22 . . . . 75.1 105.007 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -66.71 145.42 98.93 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 107.079 -1.452 . . . . 73.43 107.079 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.63 168.01 19.45 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.342 2.028 . . . . 72.55 107.025 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.415 -2.176 0 N-CA-C 105.862 -1.903 . . . . 73.32 105.862 -174.798 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.652 0 N-CA-C 108.019 -2.032 . . . . 71.32 108.019 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 113.73 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.977 2.451 . . . . 44.02 109.055 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -81.14 165.65 43.55 Favored Pre-proline 0 N--CA 1.441 -0.877 0 N-CA-C 106.21 -1.774 . . . . 70.03 106.21 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.36 124.62 16.58 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.152 1.902 . . . . 64.33 108.253 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 89.95 12.14 62.45 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.435 -1.066 . . . . 61.2 110.435 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.22 141.56 28.46 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.682 -2.34 . . . . 74.42 104.682 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.07 136.02 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 104.827 -2.286 . . . . 74.53 104.827 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.6 152.29 41.21 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.944 -1.873 . . . . 73.15 105.944 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 89' ' ' LEU . 46.9 mt-10 -105.31 143.53 33.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.669 -1.974 . . . . 72.44 105.669 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.95 130.74 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.0 0 N-CA-C 104.952 -2.24 . . . . 44.24 104.952 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.49 113.14 26.24 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 103.866 -2.642 . . . . 73.34 103.866 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 12' ' ' LEU . 1.1 tm? -103.58 122.21 44.5 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.885 -1.894 . . . . 75.22 105.885 -169.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.75 150.3 39.34 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.036 -1.839 . . . . 71.45 106.036 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 9.3 tptm -120.89 -72.71 0.68 Allowed 'General case' 0 CA--C 1.456 -2.659 0 N-CA-C 103.119 -2.919 . . . . 73.14 103.119 165.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' A' ' 14' ' ' LYS . 46.9 t30 170.73 -171.57 0.03 OUTLIER 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 97.719 -4.919 . . . . 55.14 97.719 177.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -79.55 99.93 7.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.287 -1.745 . . . . 55.41 106.287 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -167.31 -110.57 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.826 -2.286 . . . . 51.53 104.826 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.8 m -135.99 152.81 51.32 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 104.274 -2.491 . . . . 62.24 104.274 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 86' ' ' VAL . 63.9 mt -73.09 -43.63 61.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.62 -0.881 . . . . 75.31 108.62 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.0 41.62 8.01 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 107.49 -2.244 . . . . 34.22 107.49 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 47' ' ' ALA . 22.2 mt -138.54 156.93 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 102.744 -3.058 . . . . 70.01 102.744 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.5 m -153.11 168.64 25.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.527 -2.768 . . . . 73.42 103.527 169.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.437 HG21 ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -140.6 167.99 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 106.497 -1.668 . . . . 74.21 106.497 -167.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 t -143.58 167.0 23.27 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 103.68 -2.711 . . . . 64.03 103.68 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 88.31 134.45 4.73 Favored Glycine 0 C--O 1.201 -1.969 0 N-CA-C 108.83 -1.708 . . . . 63.14 108.83 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.3 -98.89 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 108.986 -1.646 . . . . 43.11 108.986 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.04 20.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 126.617 1.967 . . . . 64.33 115.833 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.9 t30 87.2 65.19 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.181 -1.414 . . . . 75.22 107.181 -172.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 t -92.29 -166.09 1.48 Allowed 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.705 -2.331 . . . . 75.35 104.705 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -52.29 -21.8 3.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.5 1.12 . . . . 73.15 112.391 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.52 130.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 107.61 -1.256 . . . . 65.22 107.61 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -68.73 -36.31 78.25 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 116.017 -0.538 . . . . 61.32 111.532 -168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -79.06 -4.36 49.81 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.966 -1.084 . . . . 75.54 108.909 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.68 62.98 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 108.355 -1.898 . . . . 74.02 108.355 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.41 134.78 39.05 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 109.095 -1.602 . . . . 65.42 109.095 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.3 mm -78.08 103.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 103.516 -2.772 . . . . 74.55 103.516 173.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.39 147.83 24.3 Favored 'General case' 0 CA--C 1.468 -2.205 0 N-CA-C 106.58 -1.637 . . . . 71.33 106.58 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.66 133.98 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 106.657 -1.608 . . . . 73.42 106.657 168.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.03 -49.34 2.98 Favored 'General case' 0 CA--C 1.472 -2.038 0 N-CA-C 107.195 -1.409 . . . . 62.43 107.195 -169.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.09 130.81 41.73 Favored 'General case' 0 CA--C 1.456 -2.637 0 N-CA-C 105.868 -1.901 . . . . 55.42 105.868 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 47' ' ' ALA . 95.3 t -120.37 117.43 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 103.576 -2.75 . . . . 61.43 103.576 172.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.59 136.23 96.68 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 106.712 -1.588 . . . . 72.04 106.712 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.67 111.4 1.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.495 2.13 . . . . 75.32 107.665 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 75.73 20.68 1.78 Allowed 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.259 0.974 . . . . 73.42 110.541 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.52 -176.88 45.74 Favored Glycine 0 C--N 1.358 1.796 0 N-CA-C 107.024 -2.43 . . . . 71.12 107.024 168.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . . . -71.72 -19.84 61.99 Favored 'General case' 0 C--O 1.219 -0.53 0 O-C-N 122.359 -0.495 . . . . 75.3 110.744 -171.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG13 ' A' ' 41' ' ' VAL . . . -81.09 -49.19 11.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.163 -1.421 . . . . 70.25 107.163 -174.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.99 -38.16 87.56 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.169 -0.678 . . . . 74.44 109.169 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -70.65 -39.38 73.65 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.569 -0.9 . . . . 71.12 108.569 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.4 -39.05 88.78 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.384 -1.339 . . . . 61.54 107.384 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.6 -19.36 37.18 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 110.322 -1.111 . . . . 64.41 110.322 171.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.18 -39.68 40.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.81 -1.182 . . . . 70.21 107.81 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.85 132.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.722 -1.584 . . . . 72.24 106.722 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -142.67 -176.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 104.715 -2.328 . . . . 71.34 104.715 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -66.58 141.71 57.74 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.295 -1.743 . . . . 72.53 106.295 172.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.84 -30.13 8.34 Favored Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 107.486 -2.246 . . . . 31.33 107.486 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -72.78 150.73 42.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.428 -0.953 . . . . 70.12 108.428 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -123.56 128.77 50.2 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.157 -1.794 . . . . 72.31 106.157 -173.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.84 144.27 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 106.249 -1.76 . . . . 71.11 106.249 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.28 -44.08 2.6 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.559 -1.274 . . . . 61.32 107.559 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.89 159.49 36.47 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.944 -1.102 . . . . 45.14 109.378 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.16 116.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 104.942 -2.244 . . . . 73.3 104.942 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.3 t30 55.09 30.98 15.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.595 0.758 . . . . 73.33 109.886 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 16.43 77.21 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 109.324 -1.51 . . . . 72.52 109.324 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -106.72 124.01 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.814 0 N-CA-C 104.682 -2.34 . . . . 65.22 104.682 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -68.81 112.69 5.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.415 -1.328 . . . . 71.11 107.415 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.22 -1.0 57.58 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.571 -1.27 . . . . 52.51 107.571 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.74 143.13 58.09 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.608 -1.256 . . . . 44.21 107.608 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.85 3.81 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.451 -1.06 . . . . 63.12 110.451 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.44 13.37 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.761 0.78 . . . . 40.44 109.323 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -81.39 162.99 23.15 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.515 -1.291 . . . . 62.54 107.515 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -65.23 -36.75 85.13 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.532 -1.285 . . . . 75.43 107.532 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.03 -51.64 56.1 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 109.983 -0.377 . . . . 73.43 109.983 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -66.92 -37.68 84.78 Favored 'General case' 0 C--N 1.369 1.455 0 N-CA-C 109.286 -0.635 . . . . 70.24 109.286 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -55.75 -43.97 77.17 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 118.033 0.379 . . . . 42.3 110.175 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.66 -50.77 36.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.267 -1.383 . . . . 73.43 107.267 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.5 t -53.92 -28.65 38.21 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-O 122.127 0.965 . . . . 50.44 108.671 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.87 -55.15 13.98 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 107.184 -1.413 . . . . 73.33 107.184 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.487 ' HB3' HD12 ' A' ' 19' ' ' LEU . 86.1 mt -56.65 -55.79 29.58 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.074 0.94 . . . . 73.53 108.613 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -46.6 -25.56 0.73 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.23 -0.896 . . . . 61.43 113.177 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -116.57 10.62 14.52 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.639 -1.288 . . . . 75.24 110.07 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.3 p -84.92 173.42 10.59 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.809 -1.182 . . . . 74.43 107.809 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.63 -155.19 22.55 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 109.767 -1.333 . . . . 62.12 109.767 -172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -80.77 -31.89 35.65 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 108.439 -0.949 . . . . 62.13 108.439 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.33 133.52 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 103.908 -2.626 . . . . 72.33 103.908 175.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.504 HG21 HD11 ' A' ' 19' ' ' LEU . 6.4 t -123.57 141.98 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 105.461 -2.051 . . . . 64.34 105.461 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -95.61 115.82 27.98 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.321 -2.474 . . . . 72.41 104.321 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.4 mt -116.57 140.37 49.46 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 106.36 -1.719 . . . . 62.2 106.36 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 9' ' ' GLU . 26.1 tp -114.52 126.08 54.53 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 105.107 -2.182 . . . . 74.34 105.107 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.81 156.15 46.53 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.267 -1.383 . . . . 70.03 107.267 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.39 136.36 52.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 103.676 -2.713 . . . . 61.22 103.676 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 69.9 mmtt -61.84 149.74 39.32 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.981 0.896 . . . . 71.34 109.643 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.96 -166.79 21.49 Favored Glycine 0 CA--C 1.472 -2.648 0 N-CA-C 104.086 -3.606 . . . . 71.25 104.086 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.84 117.68 7.29 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.582 -1.266 . . . . 75.01 107.582 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.4 m -115.82 147.94 40.16 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 103.637 -2.727 . . . . 61.23 103.637 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.0 -25.39 44.42 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.662 1.575 . . . . 54.54 109.0 173.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 C--O 1.257 1.487 0 N-CA-C 104.752 -2.314 . . . . 73.11 104.752 177.509 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.427 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.242 0 N-CA-C 108.899 -1.68 . . . . 50.1 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.28 146.57 76.06 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.324 2.016 . . . . 74.51 107.596 170.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 98.0 mttt -77.57 162.66 67.66 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.318 -1.734 . . . . 62.23 106.318 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 19.6 Cg_endo -60.82 120.43 8.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.221 1.947 . . . . 75.54 109.089 174.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.91 12.74 57.49 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 108.636 -1.785 . . . . 31.32 108.636 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -96.0 140.21 31.07 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 105.142 -2.17 . . . . 74.34 105.142 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.18 139.93 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.205 0 N-CA-C 103.86 -2.645 . . . . 70.2 103.86 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.99 160.24 42.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 105.594 -2.002 . . . . 74.41 105.594 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.7 146.22 28.54 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.138 -1.801 . . . . 65.4 106.138 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.7 t -127.81 127.34 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.226 0 N-CA-C 103.453 -2.795 . . . . 60.22 103.453 167.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.49 114.09 28.1 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.31 -2.478 . . . . 54.33 104.31 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 124.31 48.51 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.809 -1.923 . . . . 74.04 105.809 -169.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.69 147.22 25.07 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.102 -1.444 . . . . 73.0 107.102 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -95.12 31.59 1.87 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.276 -1.749 . . . . 73.44 106.276 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -77.48 -50.08 13.42 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.017 -1.475 . . . . 63.33 107.017 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.09 -64.18 1.04 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.834 -0.802 . . . . 70.31 108.834 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -148.77 167.48 25.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.215 -2.142 . . . . 74.4 105.215 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -53.17 173.18 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.131 0.972 . . . . 65.34 110.737 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -58.36 -58.75 7.14 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.106 -0.952 . . . . 61.35 109.816 -164.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 52.42 51.21 44.11 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 122.462 -0.149 . . . . 61.14 113.056 173.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -135.67 165.19 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 102.921 -2.992 . . . . 55.52 102.921 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.6 m -152.17 165.53 34.54 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 102.625 -3.102 . . . . 61.33 102.625 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.83 169.37 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 105.957 -1.868 . . . . 70.44 105.957 -167.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -148.88 167.32 26.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 103.002 -2.962 . . . . 73.25 103.002 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.6 -168.93 13.15 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 106.652 -2.579 . . . . 72.43 106.652 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 -116.04 3.2 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 107.879 -2.088 . . . . 51.12 107.879 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.18 19.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.89 1.276 . . . . 72.11 113.742 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.27 82.1 m-20 88.68 68.17 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 123.179 1.466 . . . . 75.31 108.442 -170.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.723 HG22 ' H ' ' A' ' 30' ' ' SER . 6.3 m -81.99 -166.99 1.37 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 103.423 -2.806 . . . . 73.21 103.423 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.723 ' H ' HG22 ' A' ' 29' ' ' THR . 11.8 m -53.74 -20.16 5.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 53.41 112.573 -174.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -89.97 128.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.625 -1.25 . . . . 70.32 107.625 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.29 -45.71 90.14 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 115.629 -0.714 . . . . 75.54 110.834 -170.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.04 1.79 14.55 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.731 -0.606 . . . . 72.13 109.747 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.17 22.26 68.85 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 109.984 -1.247 . . . . 50.54 109.984 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.57 150.82 50.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.137 -1.985 . . . . 71.51 108.137 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.5 mm -93.09 105.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.026 -2.583 . . . . 73.14 104.026 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -97.74 142.28 29.72 Favored 'General case' 0 CA--C 1.465 -2.296 0 N-CA-C 106.699 -1.593 . . . . 65.05 106.699 -174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.45 135.45 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 106.97 -1.492 . . . . 71.24 106.97 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -45.25 4.04 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.549 -1.649 . . . . 62.21 106.549 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.15 156.08 44.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.633 -1.988 . . . . 54.13 105.633 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.55 136.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 103.67 -2.715 . . . . 73.3 103.67 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.527 HG12 ' CA ' ' A' ' 20' ' ' GLY . 21.5 mm -69.1 143.92 94.76 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.179 -1.785 . . . . 71.1 106.179 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.33 114.93 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.295 1.997 . . . . 65.24 107.766 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 60.46 35.87 20.27 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.715 0.806 . . . . 71.32 111.122 -172.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 178.42 48.6 Favored Glycine 0 C--N 1.366 2.196 0 N-CA-C 106.614 -2.594 . . . . 74.14 106.614 163.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.21 93.88 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 109.383 -0.599 . . . . 71.04 109.383 -172.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.59 75.75 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.596 -0.52 . . . . 71.44 109.596 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.79 -39.86 87.93 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.303 -0.629 . . . . 75.53 109.303 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.0 m -64.97 -36.12 83.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.26 -0.644 . . . . 71.11 109.26 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.59 -32.52 68.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 108.246 -1.02 . . . . 71.15 108.246 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -20.01 29.48 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.546 -1.022 . . . . 61.3 110.546 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -72.64 -44.9 61.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.111 -1.07 . . . . 74.34 108.111 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mt -98.15 149.77 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.878 -1.897 . . . . 51.22 105.878 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -151.49 170.38 19.76 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.082 -2.192 . . . . 75.55 105.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -67.29 142.57 56.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.627 -1.62 . . . . 64.1 106.627 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.3 -3.36 84.02 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 119.84 -1.171 . . . . 74.4 110.181 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -80.16 150.34 30.21 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 106.939 -1.504 . . . . 61.53 106.939 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.88 118.48 36.93 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.073 -1.455 . . . . 63.43 107.073 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 t -103.61 148.52 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 105.457 -2.053 . . . . 74.51 105.457 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.38 -48.01 2.9 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.773 -1.195 . . . . 73.23 107.773 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.08 162.37 28.94 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.576 -0.85 . . . . 42.1 109.184 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.18 111.82 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.349 -2.093 . . . . 73.3 105.349 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 49.45 36.84 10.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.13 1.372 . . . . 75.13 111.363 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.48 4.87 76.19 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 109.671 -1.371 . . . . 71.32 109.671 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.93 120.53 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 104.572 -2.381 . . . . 74.0 104.572 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -72.72 108.57 5.78 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 106.861 -1.533 . . . . 74.54 106.861 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.98 -2.01 42.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.565 -0.743 . . . . 63.44 109.798 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.29 143.8 57.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.865 -1.161 . . . . 73.34 107.865 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.2 -31.32 4.12 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.74 -1.344 . . . . 41.24 109.74 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.46 162.16 29.84 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 118.495 1.148 . . . . 51.12 108.383 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.1 p -85.38 169.52 13.61 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.856 0.836 . . . . 60.13 109.06 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -64.26 -44.91 90.31 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.854 -1.165 . . . . 74.41 107.854 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.11 -41.35 96.54 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 119.265 -0.397 . . . . 64.03 110.095 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -37.45 87.08 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 119.281 0.946 . . . . 54.44 108.84 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -55.78 -38.23 69.62 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.539 0.609 . . . . 73.33 109.973 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.11 -55.06 14.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 107.641 -1.244 . . . . 70.21 107.641 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.36 -26.75 68.62 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.758 -0.83 . . . . 72.4 108.758 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.6 m -60.16 -54.0 51.09 Favored 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 107.088 -1.449 . . . . 73.21 107.088 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -56.11 -56.05 25.61 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 121.701 0.762 . . . . 71.32 109.123 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -48.72 -30.2 5.3 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 121.647 -0.658 . . . . 74.24 112.676 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -93.2 -7.34 45.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.349 -0.844 . . . . 75.43 109.939 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 p -79.41 170.28 16.83 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.856 -1.165 . . . . 52.43 107.856 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.16 -136.57 3.74 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 110.142 -1.183 . . . . 62.24 110.142 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.3 -45.88 8.76 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.82 -1.178 . . . . 63.23 107.82 -172.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.94 128.31 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 104.079 -2.563 . . . . 73.23 104.079 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -123.94 138.43 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.212 -2.514 . . . . 51.23 104.212 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.54 117.92 31.95 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 104.694 -2.336 . . . . 72.32 104.694 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.9 mt -116.74 137.84 51.91 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.864 -1.902 . . . . 75.41 105.864 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.74 130.31 56.11 Favored 'General case' 0 CA--C 1.463 -2.4 0 N-CA-C 104.589 -2.374 . . . . 73.11 104.589 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.68 153.84 49.58 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 105.848 -1.908 . . . . 72.34 105.848 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -117.3 133.33 56.11 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 103.786 -2.672 . . . . 61.32 103.786 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 135.81 56.6 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.704 -0.85 . . . . 74.45 108.704 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.49 51.74 0.02 OUTLIER Glycine 0 CA--C 1.47 -2.724 0 N-CA-C 105.334 -3.106 . . . . 54.15 105.334 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -85.93 151.63 23.6 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.916 -1.512 . . . . 74.21 106.916 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.3 p -84.9 168.51 20.43 Favored Pre-proline 0 N--CA 1.417 -2.084 0 N-CA-C 104.055 -2.572 . . . . 51.23 104.055 166.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 26.7 Cg_endo -62.43 161.3 28.05 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.769 1.646 . . . . 72.34 108.661 176.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 105.895 -1.891 . . . . 64.34 105.895 -177.688 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.432 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.682 0 N-CA-C 108.428 -1.869 . . . . 74.13 108.428 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.68 118.04 5.31 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.869 2.38 . . . . 72.42 108.267 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 52.3 mtmt -80.93 164.28 51.56 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 105.805 -1.924 . . . . 74.05 105.805 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 19.6 Cg_endo -58.18 118.09 4.91 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.156 1.904 . . . . 54.44 108.783 173.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 110.46 -24.44 17.79 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 109.32 -1.512 . . . . 74.2 109.32 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.57 143.66 57.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 117.669 0.735 . . . . 74.23 109.24 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.52 134.79 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.035 -2.58 . . . . 72.23 104.035 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -128.01 142.12 51.32 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 105.78 -1.933 . . . . 72.4 105.78 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -103.05 132.13 49.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 104.711 -2.329 . . . . 71.43 104.711 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.25 135.93 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 106.318 -1.734 . . . . 75.51 106.318 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.04 118.13 36.13 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.234 -2.506 . . . . 63.31 104.234 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -102.91 121.09 41.81 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 104.962 -2.236 . . . . 62.2 104.962 -175.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.1 133.36 37.66 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.253 -1.388 . . . . 63.11 107.253 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -87.72 34.33 0.71 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.648 1.179 . . . . 74.01 108.072 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.06 -25.89 68.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.219 -1.771 . . . . 73.15 106.219 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -93.86 140.66 29.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 104.049 -2.575 . . . . 53.53 104.049 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.6 -25.9 41.38 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.616 -0.513 . . . . 74.5 109.616 -166.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -87.94 122.05 31.09 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.308 -1.738 . . . . 70.33 106.308 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.79 -57.37 5.18 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 104.446 -2.428 . . . . 74.44 104.446 172.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 72.3 48.78 23.28 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 110.982 -0.847 . . . . 52.33 110.982 162.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.7 mt -131.68 148.43 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 101.042 -3.688 . . . . 74.22 101.042 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -146.68 164.02 34.04 Favored 'General case' 0 CA--C 1.46 -2.488 0 N-CA-C 102.568 -3.123 . . . . 74.13 102.568 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG21 ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -141.48 167.92 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 106.498 -1.667 . . . . 74.22 106.498 -161.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -144.72 165.89 26.78 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.233 -2.506 . . . . 75.2 104.233 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.457 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 79.39 140.5 2.06 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 110.871 -0.891 . . . . 60.41 110.871 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.62 -87.42 0.07 OUTLIER Glycine 0 C--N 1.351 1.41 0 N-CA-C 109.782 -1.327 . . . . 74.3 109.782 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.56 20.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 128.934 2.893 . . . . 55.45 117.057 -172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 86.91 66.13 0.01 OUTLIER 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 105.564 -2.013 . . . . 53.32 105.564 -170.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -84.39 -166.88 1.57 Allowed 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 111.807 -2.451 . . . . 72.33 105.785 -175.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -59.43 -26.57 65.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 123.803 0.841 . . . . 73.34 110.952 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' THR . 27.3 m -87.46 139.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.749 -1.574 . . . . 63.13 106.749 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -51.95 -58.16 7.32 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.882 0.873 . . . . 72.33 111.711 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.93 8.49 6.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.941 -0.474 . . . . 63.41 111.062 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.25 29.33 74.2 Favored Glycine 0 C--N 1.36 1.864 0 N-CA-C 108.537 -1.825 . . . . 71.11 108.537 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.14 127.53 27.29 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.037 -1.625 . . . . 72.31 109.037 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 25' ' ' GLY . 1.2 mm -79.03 104.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.361 -2.829 . . . . 71.53 103.361 172.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -98.43 146.5 25.67 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 107.69 -1.226 . . . . 74.2 107.69 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 130.72 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.983 -1.858 . . . . 54.11 105.983 171.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -104.92 -47.14 4.1 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.005 -1.48 . . . . 71.22 107.005 -168.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.06 147.89 39.32 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 105.841 -1.911 . . . . 74.22 105.841 -169.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.93 128.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 103.552 -2.758 . . . . 73.54 103.552 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.542 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.4 mm -64.61 144.87 98.76 Favored Pre-proline 0 N--CA 1.477 0.875 0 N-CA-C 105.959 -1.867 . . . . 74.41 105.959 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 111.99 1.05 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 N-CA-C 107.319 -1.839 . . . . 73.14 107.319 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 34.8 mt-30 70.55 29.58 3.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 124.58 1.175 . . . . 71.13 110.654 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.03 172.38 40.67 Favored Glycine 0 C--N 1.363 2.08 0 N-CA-C 107.946 -2.062 . . . . 74.23 107.946 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.73 76.2 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 108.689 -0.856 . . . . 41.21 108.689 -175.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.8 80.18 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 109.443 -0.577 . . . . 34.11 109.443 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 44' ' ' GLN . 36.7 tt0 -62.3 -40.66 97.02 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 109.017 -0.735 . . . . 75.11 109.017 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -66.08 -41.71 90.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.15 -1.056 . . . . 55.21 108.15 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.01 -40.59 91.24 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.616 -1.253 . . . . 74.4 107.616 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.81 -10.45 59.97 Favored Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 110.859 -0.896 . . . . 74.22 110.859 172.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -81.45 -40.13 23.8 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.158 -1.052 . . . . 73.44 108.158 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.1 mt -93.75 140.78 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.848 -1.538 . . . . 73.32 106.848 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.32 174.9 10.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.057 -1.831 . . . . 71.45 106.057 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.41 143.47 57.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 106.15 -1.796 . . . . 74.42 106.15 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.12 52.27 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.785 -2.126 . . . . 74.52 107.785 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.36 147.33 40.14 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.592 -1.633 . . . . 52.31 106.592 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.538 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.6 tmm_? -109.73 118.85 37.63 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.045 -2.206 . . . . 70.15 105.045 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.24 131.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.252 -2.129 . . . . 74.24 105.252 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 -50.77 3.24 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.868 -1.53 . . . . 73.32 106.868 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.59 166.44 20.64 Favored 'General case' 0 CA--C 1.47 -2.099 0 CA-C-O 122.313 1.054 . . . . 73.33 109.272 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.09 109.5 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 103.684 -2.709 . . . . 74.5 103.684 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.73 40.02 11.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.596 1.158 . . . . 75.43 111.556 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.28 6.81 70.63 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 110.426 -1.07 . . . . 43.3 110.426 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.55 117.75 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.816 0 N-CA-C 104.284 -2.487 . . . . 75.21 104.284 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -69.16 110.98 4.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.646 -1.242 . . . . 73.21 107.646 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.27 -7.96 58.75 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.807 -0.812 . . . . 62.42 108.807 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.97 144.31 56.95 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.288 -1.004 . . . . 55.33 108.288 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 -30.86 3.93 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.784 -0.926 . . . . 41.33 110.784 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.63 164.97 15.69 Favored 'General case' 0 C--N 1.365 1.244 0 CA-C-N 118.396 1.098 . . . . 65.42 109.16 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 p -83.38 164.39 20.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.745 -1.206 . . . . 73.42 107.745 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.58 -37.95 86.01 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.569 -0.9 . . . . 75.15 108.569 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -58.58 -42.02 87.1 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 119.661 -0.816 . . . . 61.54 110.211 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.93 -40.12 91.14 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 108.625 -0.88 . . . . 62.51 108.625 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 23' ' ' VAL . . . -56.26 -43.29 78.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.691 -0.485 . . . . 70.45 109.691 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.58 -50.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 107.281 -1.378 . . . . 62.23 107.281 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.2 t -53.41 -28.63 30.77 Favored 'General case' 0 N--CA 1.514 2.74 0 CA-C-O 122.446 1.117 . . . . 71.41 108.649 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.7 m -71.73 -46.71 57.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.64 -53.06 57.42 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.006 -1.109 . . . . 63.1 108.006 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -44.45 -46.35 9.57 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 74.42 111.607 174.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -95.0 61.12 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' HG22 ' A' ' 86' ' ' VAL . 12.0 p -111.16 156.53 21.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.95 -1.13 . . . . 54.15 107.95 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.12 -125.43 3.58 Favored Glycine 0 CA--C 1.492 -1.348 0 N-CA-C 108.573 -1.811 . . . . 35.11 108.573 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -89.32 -52.12 5.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.868 -1.16 . . . . 75.32 107.868 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.04 136.63 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 105.243 -2.132 . . . . 52.05 105.243 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 82' ' ' THR . 3.9 t -114.82 130.55 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 105.21 -2.144 . . . . 73.02 105.21 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -95.11 116.86 29.27 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.788 -2.301 . . . . 70.03 104.788 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 mt -122.1 144.56 48.85 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.552 -1.647 . . . . 62.13 106.552 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -116.73 131.53 56.93 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 103.777 -2.675 . . . . 72.22 103.777 172.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mp -133.32 155.71 48.94 Favored 'General case' 0 CA--C 1.469 -2.153 0 N-CA-C 106.493 -1.669 . . . . 73.1 106.493 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.538 ' CD ' HH21 ' A' ' 58' ' ' ARG . 31.8 tt0 -123.93 133.82 53.65 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.894 -2.261 . . . . 75.41 104.894 -175.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 7.0 mmpt? -69.08 150.7 47.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.081 0.943 . . . . 54.32 109.517 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 94' ' ' GLN . . . 163.25 23.69 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.363 0 N-CA-C 108.877 -1.689 . . . . 64.54 108.877 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.412 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 4.0 pm0 -77.88 -178.86 5.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.451 -1.315 . . . . 75.54 107.451 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -83.59 119.65 74.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 103.577 -2.749 . . . . 74.02 103.577 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.72 76.68 2.37 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.659 2.239 . . . . 72.14 109.783 -167.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.415 -2.204 0 N-CA-C 104.477 -2.416 . . . . 71.42 104.477 172.963 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.276 0 N-CA-C 108.466 -1.853 . . . . 72.23 108.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.18 158.66 14.34 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.605 2.87 . . . . 73.4 109.687 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -82.46 161.6 58.79 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 106.332 -1.729 . . . . 71.21 106.332 -173.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.62 120.29 8.11 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.33 2.02 . . . . 74.15 109.881 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.563 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 105.32 -21.06 36.16 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 108.624 -1.79 . . . . 62.54 108.624 177.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.92 140.58 58.3 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.907 -0.775 . . . . 64.23 108.907 -176.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.83 134.92 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 103.643 -2.725 . . . . 75.23 103.643 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.16 150.76 44.62 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.327 -1.731 . . . . 74.43 106.327 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -102.71 140.95 36.32 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.497 -2.038 . . . . 72.52 105.497 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.1 t -124.9 125.99 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 103.878 -2.638 . . . . 72.24 103.878 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -102.76 125.06 49.36 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.414 -2.069 . . . . 50.34 105.414 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 121.66 42.66 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.638 -1.616 . . . . 74.05 106.638 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.55 139.49 34.19 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.274 -1.75 . . . . 51.13 106.274 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.08 33.44 3.81 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.304 -1.739 . . . . 61.52 106.304 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -81.77 55.46 2.72 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.445 -1.687 . . . . 63.12 106.445 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 22.8 t70 -139.13 -133.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 102.073 -3.306 . . . . 74.43 102.073 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 72.1 m-20 -135.18 -55.68 0.81 Allowed 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 103.981 -2.6 . . . . 75.23 103.981 171.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -73.24 110.75 7.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.086 -1.079 . . . . 73.21 108.086 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -72.7 -56.87 4.64 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.597 -2.742 . . . . 65.25 103.597 171.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.47 49.3 80.0 Favored Glycine 0 CA--C 1.48 -2.14 0 CA-C-N 112.425 -2.17 . . . . 74.24 112.753 165.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.21 150.52 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 104.056 -2.572 . . . . 43.54 104.056 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.2 m -151.88 167.21 29.04 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 102.673 -3.084 . . . . 63.32 102.673 167.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.08 168.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 106.111 -1.811 . . . . 51.02 106.111 -167.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -139.54 166.12 25.42 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 102.711 -3.07 . . . . 54.53 102.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 87.66 131.19 3.41 Favored Glycine 0 C--O 1.199 -2.054 0 N-CA-C 109.637 -1.385 . . . . 73.01 109.637 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.27 -92.18 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 107.874 -2.09 . . . . 52.31 107.874 165.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.36 19.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.376 1.471 . . . . 61.44 114.169 -171.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m120 88.5 65.79 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.942 -1.503 . . . . 70.11 106.942 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 30' ' ' SER . 2.4 m -88.09 -166.45 1.59 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.877 -2.638 . . . . 74.11 103.877 172.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.68 ' H ' HG22 ' A' ' 29' ' ' THR . 5.0 m -44.86 -33.22 1.86 Allowed 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.661 1.184 . . . . 53.43 112.063 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 31' ' ' VAL . 14.4 m -85.36 129.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.055 -1.091 . . . . 74.43 108.055 -176.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -66.45 -34.16 77.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.041 -0.981 . . . . 74.31 112.789 -166.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -75.57 -2.25 28.27 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.962 -1.086 . . . . 73.1 109.338 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.97 20.2 59.83 Favored Glycine 0 C--N 1.36 1.906 0 N-CA-C 108.281 -1.927 . . . . 54.1 108.281 -167.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.38 153.06 48.92 Favored Glycine 0 CA--C 1.476 -2.358 0 N-CA-C 107.964 -2.054 . . . . 41.04 107.964 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.8 mm -90.72 119.87 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 103.89 -2.633 . . . . 73.54 103.89 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.69 145.88 43.15 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 106.667 -1.605 . . . . 71.41 106.667 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.67 131.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.175 -1.416 . . . . 71.34 107.175 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.0 -47.02 3.79 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 106.665 -1.605 . . . . 71.14 106.665 -168.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.84 138.51 42.59 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 105.594 -2.002 . . . . 71.13 105.594 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.02 126.31 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 105.081 -2.192 . . . . 70.24 105.081 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -69.9 137.24 87.51 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.685 -1.598 . . . . 62.21 106.685 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.87 117.67 4.46 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.367 2.045 . . . . 62.3 108.31 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 62.03 25.37 15.21 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.863 0.865 . . . . 63.13 111.879 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.77 54.86 Favored Glycine 0 C--N 1.364 2.092 0 N-CA-C 105.689 -2.964 . . . . 63.12 105.689 165.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.13 48.79 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 117.325 0.562 . . . . 54.15 111.782 -171.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.95 67.03 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.199 -0.667 . . . . 62.22 109.199 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.04 -34.4 77.62 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.875 -0.417 . . . . 74.33 109.875 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.5 m -64.1 -31.96 73.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.743 -0.836 . . . . 72.24 108.743 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.85 -42.31 73.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.646 -1.242 . . . . 73.34 107.646 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.03 -20.6 35.43 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.122 -1.191 . . . . 63.22 110.122 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -78.27 -41.2 34.76 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.031 -1.099 . . . . 61.34 108.031 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.9 mt -95.94 134.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.578 -1.638 . . . . 64.13 106.578 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.18 179.91 7.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.952 -1.87 . . . . 74.23 105.952 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -66.82 138.56 57.43 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 106.781 -1.562 . . . . 60.2 106.781 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.6 -14.18 50.3 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 108.528 -1.829 . . . . 71.4 108.528 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HA ' ' HG3' ' A' ' 94' ' ' GLN . 1.6 m-20 -71.64 151.02 44.06 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.737 -0.838 . . . . 73.35 108.737 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -113.18 126.9 55.94 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.287 -2.116 . . . . 75.13 105.287 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 t -104.77 142.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 104.554 -2.388 . . . . 72.3 104.554 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.81 -48.22 2.76 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.342 -1.355 . . . . 75.33 107.342 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.95 164.14 24.89 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 122.327 1.06 . . . . 72.44 109.785 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.14 109.1 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 N-CA-C 104.302 -2.481 . . . . 72.35 104.302 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 48.0 42.16 16.18 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.829 0.852 . . . . 63.22 110.598 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.4 10.08 82.59 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.691 -0.964 . . . . 70.31 110.691 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.31 118.02 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 104.712 -2.329 . . . . 73.14 104.712 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -71.42 113.07 8.08 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.307 -1.368 . . . . 72.21 107.307 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.2 mt -70.68 -23.15 62.43 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.222 -0.899 . . . . 74.42 109.608 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -55.49 144.94 24.24 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.532 0.682 . . . . 74.4 110.664 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.85 -33.31 5.28 Favored Glycine 0 CA--C 1.496 -1.15 0 N-CA-C 109.369 -1.492 . . . . 70.43 109.369 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.59 162.55 28.69 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.033 -0.729 . . . . 55.44 109.033 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -80.48 167.32 20.29 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.832 -1.174 . . . . 61.44 107.832 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -64.69 -39.05 93.0 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 106.543 -1.651 . . . . 71.1 106.543 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -51.9 -51.03 59.69 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 123.618 0.767 . . . . 73.43 110.047 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -66.65 -39.73 88.37 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 109.165 -0.679 . . . . 53.15 109.165 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -54.94 -41.06 70.59 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.42 0.555 . . . . 64.52 109.778 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.03 -54.64 17.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 N-CA-C 106.873 -1.528 . . . . 71.5 106.873 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 11.1 t -54.77 -28.65 50.31 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 122.268 1.032 . . . . 74.01 108.763 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.4 m -66.57 -53.76 31.05 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.331 -1.359 . . . . 54.01 107.331 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.35 -55.51 27.83 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 108.589 -0.893 . . . . 74.31 108.589 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -46.67 -32.82 3.78 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.882 0.697 . . . . 72.53 112.882 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.64 2.17 51.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.49 -0.756 . . . . 72.41 110.252 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.5 p -73.98 168.47 19.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 119.5 1.045 . . . . 75.34 109.44 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.1 -166.39 28.5 Favored Glycine 0 C--N 1.371 2.499 0 N-CA-C 108.783 -1.727 . . . . 52.14 108.783 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.29 -32.18 26.51 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.792 -0.818 . . . . 52.33 108.792 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.3 t -112.37 130.46 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 103.573 -2.751 . . . . 64.33 103.573 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.88 150.19 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.116 -2.179 . . . . 75.14 105.116 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -110.3 121.62 45.72 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 104.968 -2.234 . . . . 65.25 104.968 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.8 mt -116.4 141.33 48.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 N-CA-C 104.711 -2.329 . . . . 71.32 104.711 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 tp -114.73 127.84 55.97 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 105.672 -1.973 . . . . 64.35 105.672 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.11 155.8 50.11 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.337 -1.727 . . . . 73.0 106.337 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -124.45 136.53 54.11 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 105.085 -2.191 . . . . 62.54 105.085 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 74.2 mmtt -69.1 144.69 53.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 122.236 1.017 . . . . 71.52 109.579 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.94 49.94 0.08 OUTLIER Glycine 0 CA--C 1.469 -2.823 0 N-CA-C 103.975 -3.65 . . . . 65.5 103.975 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.504 HE22 ' HA ' ' A' ' 92' ' ' LYS . 11.7 mp0 -76.0 136.13 39.98 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 105.488 -2.041 . . . . 72.02 105.488 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 45.2 m -81.12 161.09 64.08 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 105.979 -1.86 . . . . 75.03 105.979 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 38.4 Cg_endo -65.4 162.2 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.234 1.956 . . . . 45.44 108.957 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 106.225 -1.768 . . . . 71.5 106.225 -179.726 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.416 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.624 0 N-CA-C 107.842 -2.103 . . . . 75.35 107.842 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.5 146.84 81.14 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.65 2.233 . . . . 62.11 108.606 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 98.6 mttt -106.88 159.99 27.93 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 105.037 -2.209 . . . . 74.01 105.037 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 28.7 Cg_endo -62.21 138.14 70.28 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.217 1.944 . . . . 64.23 108.806 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.71 -21.35 16.56 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 108.322 -1.911 . . . . 33.44 108.322 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.36 132.99 43.67 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.6 -0.889 . . . . 74.34 108.6 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.03 137.8 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 N-CA-C 105.003 -2.221 . . . . 73.45 105.003 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -137.6 153.6 49.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.572 -2.01 . . . . 51.42 105.572 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.76 141.46 35.52 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.758 -1.571 . . . . 74.45 106.758 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.5 126.06 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 103.894 -2.632 . . . . 75.21 103.894 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -96.76 125.53 41.28 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.553 -2.388 . . . . 73.33 104.553 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 121.04 44.34 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.611 -1.626 . . . . 75.14 106.611 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.71 102.78 13.26 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 104.268 -2.493 . . . . 75.12 104.268 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -119.61 36.49 4.48 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.456 -1.247 . . . . 75.14 107.89 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -56.74 162.93 2.08 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 109.087 -0.709 . . . . 74.24 109.087 -170.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.5 124.98 22.37 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.238 -1.023 . . . . 70.2 108.238 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -176.56 -148.64 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 99.379 -4.304 . . . . 71.11 99.379 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.0 m -80.28 112.65 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.594 -2.373 . . . . 51.51 104.594 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.66 -57.91 3.95 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 105.137 -2.172 . . . . 71.42 105.137 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 41.55 40.61 Favored Glycine 0 CA--C 1.474 -2.471 0 N-CA-C 109.702 -1.359 . . . . 53.53 109.702 161.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.8 mt -131.32 144.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 103.02 -2.956 . . . . 73.42 103.02 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.1 m -147.81 163.69 35.95 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 103.484 -2.784 . . . . 64.1 103.484 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.03 169.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 105.727 -1.953 . . . . 74.45 105.727 -160.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -145.53 167.23 23.51 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.65 -2.722 . . . . 51.41 103.65 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.86 -172.98 14.67 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.061 -2.415 . . . . 51.24 107.061 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.06 -123.17 5.24 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 109.185 -1.566 . . . . 71.01 109.185 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 m -72.47 19.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 126.114 1.765 . . . . 72.5 112.908 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 87.58 64.47 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.12 -1.807 . . . . 61.42 106.12 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 30' ' ' SER . 3.3 m -84.8 -165.7 1.27 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 103.827 -2.657 . . . . 63.13 103.827 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.695 ' H ' HG22 ' A' ' 29' ' ' THR . 3.6 m -37.45 -40.37 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.616 1.566 . . . . 74.14 112.911 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.57 135.34 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.159 -1.052 . . . . 71.54 108.159 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.7 mtm105 -72.47 -35.33 68.21 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.57 -0.9 . . . . 72.21 108.57 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.88 -17.25 63.0 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 109.118 -0.697 . . . . 52.22 109.118 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 -3.19 3.78 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.189 -0.364 . . . . 73.45 112.189 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.32 170.61 47.72 Favored Glycine 0 CA--C 1.483 -1.956 0 N-CA-C 107.229 -2.348 . . . . 71.01 107.229 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.39 132.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.436 -2.061 . . . . 63.31 105.436 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -124.97 140.71 52.67 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 104.989 -2.226 . . . . 73.32 104.989 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -68.51 132.67 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.953 -1.499 . . . . 71.33 106.953 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -106.21 -46.23 4.11 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.295 -1.372 . . . . 50.14 107.295 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.26 144.17 38.28 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 105.608 -1.997 . . . . 43.34 105.608 -173.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.9 129.55 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 104.581 -2.378 . . . . 74.33 104.581 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 mt -74.36 138.91 74.84 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.125 -1.805 . . . . 72.4 106.125 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.8 110.76 0.88 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.614 2.21 . . . . 25.54 108.166 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 70.67 25.5 4.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.378 1.049 . . . . 71.42 111.318 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.44 -173.67 33.94 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 106.34 -2.704 . . . . 54.52 106.34 162.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.27 78.46 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 121.942 -0.74 . . . . 52.45 110.091 -171.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.4 80.53 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 110.155 -0.313 . . . . 75.24 110.155 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.13 -34.42 73.05 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.345 -0.613 . . . . 60.4 109.345 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -67.98 -39.69 83.26 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.481 -1.303 . . . . 72.22 107.481 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.76 -32.76 73.57 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 107.931 -1.137 . . . . 55.12 107.931 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.48 -25.99 4.78 Favored Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 110.951 -0.86 . . . . 72.33 110.951 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -69.63 -40.1 76.74 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.536 -0.912 . . . . 74.51 108.536 -173.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 mt -98.38 138.46 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 105.924 -1.88 . . . . 73.34 105.924 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -134.76 174.43 10.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.143 -1.428 . . . . 61.11 107.143 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -66.53 138.98 57.89 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.695 -1.965 . . . . 73.23 105.695 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.7 -4.8 61.72 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 109.191 -1.563 . . . . 40.52 109.191 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.43 152.96 37.9 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.383 -1.34 . . . . 73.42 107.383 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -112.79 123.83 51.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.15 -2.167 . . . . 71.21 105.15 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.73 139.97 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 104.741 -2.318 . . . . 70.14 104.741 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.08 -55.35 2.34 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.019 -1.474 . . . . 75.2 107.019 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.57 165.18 23.3 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 122.153 0.977 . . . . 72.2 109.531 -168.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.62 109.84 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 105.085 -2.191 . . . . 70.21 105.085 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 51.72 41.37 29.0 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.615 1.166 . . . . 62.23 111.812 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.44 7.01 73.07 Favored Glycine 0 CA--C 1.498 -1.006 0 N-CA-C 109.396 -1.482 . . . . 33.22 109.396 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 67' ' ' LEU . 26.8 t -112.12 117.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 105.134 -2.172 . . . . 73.05 105.134 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -80.8 15.39 1.78 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.332 -0.395 . . . . 74.21 110.424 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.496 ' H ' HG12 ' A' ' 65' ' ' VAL . 87.5 mt 38.79 45.11 0.89 Allowed 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.236 1.414 . . . . 72.21 110.937 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.2 125.14 28.62 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.514 -0.921 . . . . 45.14 108.514 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.96 -4.52 81.61 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.822 -1.711 . . . . 74.1 108.822 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.71 137.4 56.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 108.299 -1.0 . . . . 54.34 108.299 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.7 p -76.13 174.04 10.56 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.752 -1.573 . . . . 75.55 106.752 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -61.18 -39.83 91.62 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 107.816 -1.179 . . . . 71.32 107.816 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.01 -50.68 66.08 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.878 0.471 . . . . 65.45 110.713 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -66.62 -29.25 69.25 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.241 0.928 . . . . 63.3 109.437 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.53 -38.5 84.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.562 -0.903 . . . . 62.24 108.562 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.5 t -72.82 -49.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.009 -1.478 . . . . 73.45 107.009 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.1 m -52.49 -29.28 24.15 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 108.488 -0.93 . . . . 72.34 108.488 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -65.81 -55.87 14.88 Favored 'General case' 0 C--O 1.199 -1.597 0 N-CA-C 107.486 -1.301 . . . . 65.43 107.486 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.03 -56.14 24.34 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.943 -0.762 . . . . 72.33 108.943 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -49.85 -28.01 5.9 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.482 0.549 . . . . 54.42 112.482 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -92.87 -13.15 29.39 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.774 -0.579 . . . . 54.23 109.708 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.3 p -80.56 173.71 12.33 Favored 'General case' 0 C--O 1.245 0.839 0 O-C-N 120.795 -1.191 . . . . 74.15 108.909 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.79 -155.33 11.8 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.645 -1.382 . . . . 55.13 109.645 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -80.11 -43.77 21.14 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 107.443 -1.318 . . . . 72.31 107.443 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.75 131.27 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.892 0 N-CA-C 103.502 -2.777 . . . . 71.54 103.502 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.54 140.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 105.379 -2.082 . . . . 70.15 105.379 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -97.18 118.11 32.88 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 104.834 -2.284 . . . . 74.43 104.834 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 34.5 mt -121.19 142.39 49.94 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 105.661 -1.978 . . . . 72.54 105.661 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.06 133.25 56.23 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 104.723 -2.325 . . . . 74.21 104.723 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.43 152.74 51.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.314 -1.736 . . . . 53.43 106.314 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -115.2 129.52 56.67 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.627 -1.99 . . . . 71.02 105.627 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 4' ' ' PRO . 7.9 tmtt? -62.4 138.05 58.38 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.32 -0.622 . . . . 73.51 109.32 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.13 51.39 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.188 0 N-CA-C 104.139 -3.585 . . . . 75.11 104.139 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -90.11 155.05 19.32 Favored 'General case' 0 CA--C 1.478 -1.823 0 N-CA-C 107.036 -1.468 . . . . 62.44 107.036 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 47.1 m -83.88 166.1 35.73 Favored Pre-proline 0 N--CA 1.428 -1.533 0 N-CA-C 105.124 -2.176 . . . . 51.01 105.124 169.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 28.9 Cg_endo -62.7 167.91 11.0 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.276 1.984 . . . . 73.11 110.062 172.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 105.43 -2.063 . . . . 74.41 105.43 -174.515 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.484 ' H5 ' ' C1 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.367 0 N-CA-C 108.291 -1.924 . . . . 71.12 108.291 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.17 143.92 73.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.033 2.489 . . . . 74.4 109.217 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.19 163.19 46.42 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 106.707 -1.59 . . . . 74.33 106.707 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.81 137.93 60.88 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.067 1.845 . . . . 71.42 107.712 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.55 61.08 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 108.97 -1.652 . . . . 70.23 108.97 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.01 126.57 28.99 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.804 -1.184 . . . . 64.43 107.804 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.59 134.96 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.847 -2.649 . . . . 74.12 103.847 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -138.85 153.13 48.3 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 106.75 -1.574 . . . . 72.52 106.75 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -103.06 136.95 41.92 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 105.515 -2.032 . . . . 74.41 105.515 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.36 130.71 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.123 0 N-CA-C 104.217 -2.512 . . . . 71.15 104.217 173.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -107.22 114.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.048 -2.575 . . . . 73.35 104.048 170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.31 122.66 44.68 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 105.051 -2.203 . . . . 64.4 105.051 -168.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 146.67 25.97 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.025 -1.842 . . . . 42.25 106.025 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.32 33.57 3.07 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.714 -1.588 . . . . 75.1 106.714 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -69.23 -46.48 67.26 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.524 -1.658 . . . . 73.31 106.524 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.36 -71.85 0.11 Allowed 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.913 -0.773 . . . . 73.15 108.913 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -148.82 -177.79 5.99 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.6 -1.259 . . . . 55.12 107.6 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 m -45.44 176.34 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.979 1.712 . . . . 75.5 113.947 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 mt -59.37 -57.88 11.07 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-N 114.819 -1.082 . . . . 61.3 110.751 -166.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 43.39 48.92 6.94 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.835 1.684 . . . . 63.31 114.171 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -136.72 154.39 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 104.095 -2.557 . . . . 72.51 104.095 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -149.76 165.81 31.33 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 103.249 -2.871 . . . . 53.23 103.249 168.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.51 168.39 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 106.735 -1.58 . . . . 72.21 106.735 -164.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -148.3 167.21 25.76 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 102.625 -3.102 . . . . 73.31 102.625 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.34 -171.77 14.42 Favored Glycine 0 CA--C 1.474 -2.499 0 N-CA-C 107.568 -2.213 . . . . 33.35 107.568 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.89 -120.87 4.41 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 110.098 -1.201 . . . . 71.23 110.098 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.99 19.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 126.204 1.801 . . . . 74.3 113.96 -165.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 88.05 66.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 123.251 1.501 . . . . 74.32 107.915 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -86.78 -165.4 1.27 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 103.107 -2.923 . . . . 73.45 103.107 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -44.73 -28.91 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.902 0.881 . . . . 61.23 112.626 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -88.18 124.07 41.05 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 107.476 -1.305 . . . . 75.44 107.476 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -72.66 -23.61 60.92 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 116.088 -0.505 . . . . 55.21 109.883 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.68 -17.02 64.0 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.197 -1.038 . . . . 71.11 108.197 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.08 7.86 26.42 Favored Glycine 0 C--N 1.356 1.673 0 N-CA-C 110.479 -1.048 . . . . 74.22 110.479 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 162.03 49.56 Favored Glycine 0 CA--C 1.48 -2.155 0 N-CA-C 108.238 -1.945 . . . . 53.22 108.238 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.2 mm -90.45 133.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 104.221 -2.511 . . . . 72.42 104.221 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.79 145.29 49.82 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.154 -2.165 . . . . 73.1 105.154 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.12 134.33 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.675 -1.232 . . . . 74.32 107.675 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -106.38 -49.39 3.35 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.465 -1.68 . . . . 71.51 106.465 -169.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.08 140.85 34.26 Favored 'General case' 0 CA--C 1.463 -2.393 0 N-CA-C 105.948 -1.871 . . . . 34.11 105.948 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.51 131.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 103.593 -2.743 . . . . 73.22 103.593 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.492 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.1 mm -64.66 142.16 98.44 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 105.568 -2.012 . . . . 73.0 105.568 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.11 111.33 0.96 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.121 -1.915 . . . . 54.34 107.121 165.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 75.32 26.0 1.22 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.826 1.329 . . . . 73.22 110.957 -174.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.62 172.62 48.24 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 107.397 -2.281 . . . . 71.14 107.397 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.88 71.01 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 122.091 -0.653 . . . . 72.54 109.36 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.01 74.97 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.513 -0.921 . . . . 74.0 108.513 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.53 -36.41 82.62 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 109.129 -0.693 . . . . 71.3 109.129 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -65.67 -39.69 91.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.715 -0.846 . . . . 73.43 108.715 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.64 -40.72 72.92 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.17 -1.048 . . . . 75.14 108.17 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.5 -13.75 66.07 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.42 -1.072 . . . . 72.23 110.42 172.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -84.99 -41.35 15.92 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.618 -0.931 . . . . 70.31 109.808 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 mt -97.09 127.95 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 106.275 -1.75 . . . . 72.3 106.275 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -122.69 174.59 7.01 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.46 -1.682 . . . . 72.12 106.46 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -66.7 137.83 56.97 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.357 -1.72 . . . . 74.12 106.357 166.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 -17.25 57.34 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 108.923 -1.671 . . . . 63.41 108.923 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 94' ' ' GLN . 1.0 OUTLIER -65.22 147.21 53.86 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 109.044 -0.724 . . . . 75.12 109.044 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -105.66 125.88 51.5 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 106.286 -1.746 . . . . 72.5 106.286 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.99 144.07 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 104.811 -2.292 . . . . 61.0 104.811 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -45.13 2.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.314 -1.365 . . . . 54.02 107.314 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.85 160.46 33.45 Favored 'General case' 0 CA--C 1.48 -1.733 0 C-N-CA 118.838 -1.145 . . . . 72.4 109.268 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.6 109.39 6.39 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 N-CA-C 105.315 -2.106 . . . . 33.13 105.315 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 47.79 40.51 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.922 1.689 . . . . 73.41 111.911 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.24 4.58 83.74 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 109.483 -1.447 . . . . 75.25 109.483 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.04 122.76 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 104.826 -2.287 . . . . 62.23 104.826 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.9 m -70.63 111.18 5.92 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.23 -1.026 . . . . 74.35 108.23 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.72 9.39 37.24 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 106.842 -1.54 . . . . 64.24 106.842 171.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -65.69 133.67 51.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.983 -1.488 . . . . 74.23 106.983 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.26 -18.65 5.18 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-O 119.629 -0.54 . . . . 72.21 111.78 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 171.71 1.87 Allowed 'General case' 0 C--N 1.37 1.459 0 CA-C-N 118.397 1.099 . . . . 74.33 110.228 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -83.85 159.86 21.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.485 -1.302 . . . . 73.31 107.485 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.33 -42.51 98.97 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.43 -0.952 . . . . 75.21 108.43 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.7 -43.13 94.22 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 110.024 -0.361 . . . . 71.31 110.024 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -61.71 -36.28 80.49 Favored 'General case' 0 C--N 1.383 2.035 0 O-C-N 121.368 -0.833 . . . . 54.2 109.164 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.97 79.53 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.958 -0.756 . . . . 52.24 108.958 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.9 t -73.89 -50.56 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.219 -1.4 . . . . 75.35 107.219 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.0 m -53.01 -29.94 32.41 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-O 122.07 0.938 . . . . 74.43 108.617 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -67.32 -53.82 26.16 Favored 'General case' 0 C--O 1.209 -1.074 0 O-C-N 120.933 -1.104 . . . . 53.12 108.033 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.84 -55.48 31.94 Favored 'General case' 0 C--O 1.211 -0.97 0 N-CA-C 109.149 -0.686 . . . . 63.15 109.149 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -48.28 -28.22 2.96 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.57 0.582 . . . . 70.22 112.57 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.77 -14.66 27.58 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.638 -0.664 . . . . 62.25 110.078 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 p -81.86 171.13 14.85 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.725 -1.234 . . . . 60.14 109.659 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.95 -154.2 12.91 Favored Glycine 0 C--N 1.36 1.881 0 N-CA-C 110.037 -1.225 . . . . 72.25 110.037 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -80.48 -35.8 34.3 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 107.857 -1.164 . . . . 55.12 107.857 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.84 126.87 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 104.554 -2.387 . . . . 52.34 104.554 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 139.36 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 N-CA-C 103.486 -2.783 . . . . 61.24 103.486 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -96.7 118.98 34.33 Favored 'General case' 0 CA--C 1.474 -1.96 0 N-CA-C 104.649 -2.352 . . . . 74.23 104.649 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -115.97 136.82 52.68 Favored 'General case' 0 CA--C 1.468 -2.173 0 N-CA-C 105.18 -2.156 . . . . 64.24 105.18 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.21 125.51 54.41 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.051 -2.203 . . . . 72.43 105.051 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.12 161.33 36.03 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 105.634 -1.988 . . . . 63.13 105.634 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -138.48 158.41 44.32 Favored 'General case' 0 CA--C 1.468 -2.191 0 N-CA-C 108.0 -1.111 . . . . 65.22 108.0 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -70.55 144.58 51.23 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.258 -1.337 . . . . 61.02 110.931 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.27 34.85 0.52 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 105.03 -3.228 . . . . 42.32 105.03 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -91.03 151.77 20.92 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 106.855 -1.535 . . . . 63.12 106.855 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.502 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 14.5 m -83.29 168.03 25.15 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 106.513 -1.662 . . . . 75.11 106.513 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 35.8 Cg_endo -65.29 169.34 12.51 Favored 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 122.34 2.027 . . . . 61.22 108.965 174.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 C--O 1.258 1.537 0 N-CA-C 108.438 -0.949 . . . . 73.32 108.438 -177.058 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.401 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.489 -1.397 0 N-CA-C 103.462 -2.792 . . . . 42.109999999999999 103.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.59 153.61 44.91 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.715 -1.587 . . . . 74.409999999999997 106.715 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -108.76 141.59 40.54 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.175 -1.787 . . . . 73.150000000000006 106.175 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.4 t -128.53 130.61 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 N-CA-C 104.819 -2.289 . . . . 61.520000000000003 104.819 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -105.71 113.21 26.64 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 104.931 -2.248 . . . . 72.129999999999995 104.931 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 120.98 41.54 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.231 -1.766 . . . . 64.219999999999999 106.231 -169.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.72 142.59 28.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.232 -1.766 . . . . 61.109999999999999 106.232 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm . . . . . 0 CA--C 1.499 -1.015 0 N-CA-C 107.026 -1.472 . . . . 65.430000000000007 107.026 -178.503 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 N-CA-C 110.27 -1.132 . . . . 40.219999999999999 110.27 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mt -129.24 158.86 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.433 -2.432 . . . . 53.520000000000003 104.433 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -149.99 165.42 32.72 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.147 -3.279 . . . . 43.43 102.147 168.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.71 168.19 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 105.936 -1.875 . . . . 74.010000000000005 105.936 -170.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -146.45 166.59 25.95 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 103.029 -2.952 . . . . 73.430000000000007 103.029 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.5 -173.3 14.66 Favored Glycine 0 CA--C 1.472 -2.624 0 N-CA-C 107.548 -2.221 . . . . 73.420000000000002 107.548 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.78 -127.81 6.08 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 108.838 -1.705 . . . . 31.420000000000002 108.838 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -73.18 19.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 126.222 1.809 . . . . 71.219999999999999 112.419 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.262 9.5 m120 87.31 65.52 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.672 0 N-CA-C 106.34 -1.726 . . . . 62.43 106.34 -168.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 30' ' ' SER . 3.4 m -80.96 -165.78 0.98 Allowed 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 104.003 -2.592 . . . . 73.200000000000003 104.003 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.661 ' H ' HG22 ' A' ' 29' ' ' THR . 3.4 p -42.96 -40.73 3.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 53.039999999999999 112.032 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.51 138.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.583 -0.895 . . . . 74.439999999999998 108.583 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.24 -42.39 68.92 Favored 'General case' 0 C--N 1.364 1.206 0 N-CA-C 109.787 -0.449 . . . . 63.5 109.787 -171.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -73.9 -5.64 42.34 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.843 -0.799 . . . . 71.230000000000004 108.843 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.22 3.25 11.5 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.304 -0.718 . . . . 74.409999999999997 111.304 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.53 150.19 42.09 Favored Glycine 0 CA--C 1.475 -2.448 0 N-CA-C 109.625 -1.39 . . . . 40.409999999999997 109.625 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.81 87.96 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 105.49 -2.041 . . . . 74.319999999999993 105.49 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -88.75 144.19 26.41 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.585 -1.635 . . . . 73.510000000000005 106.585 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.21 133.82 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.535 -1.654 . . . . 70.209999999999994 106.535 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -104.1 -43.66 5.2 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 106.712 -1.588 . . . . 64.530000000000001 106.712 -167.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.18 150.8 36.55 Favored 'General case' 0 CA--C 1.458 -2.569 0 N-CA-C 105.441 -2.059 . . . . 54.409999999999997 105.441 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -137.26 132.14 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.622 -2.362 . . . . 72.549999999999997 104.622 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.419 HG23 ' HD2' ' A' ' 43' ' ' PRO . 27.3 mt -70.6 137.88 85.91 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 105.546 -2.02 . . . . 74.329999999999998 105.546 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 42' ' ' ILE . 19.6 Cg_endo -57.56 123.53 13.96 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.165 1.91 . . . . 71.430000000000007 108.744 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 55.74 32.6 19.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.497 1.119 . . . . 71.540000000000006 112.053 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.92 -177.95 46.08 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 105.36 -3.096 . . . . 64.409999999999997 105.36 168.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.51 98.75 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.279 1.04 . . . . 63.200000000000003 109.6 -168.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.05 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 109.233 -0.654 . . . . 64.120000000000005 109.233 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -69.24 -38.74 78.62 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 109.648 -0.501 . . . . 73.439999999999998 109.648 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -65.38 -37.49 87.16 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.958 -1.126 . . . . 74.409999999999997 107.958 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.42 -32.56 66.43 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.532 -1.285 . . . . 72.340000000000003 107.532 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.79 64.99 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.726 -0.95 . . . . 61.340000000000003 110.726 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -83.33 -41.03 18.71 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.459 -0.941 . . . . 73.239999999999995 108.459 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.8 mt -104.78 136.69 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.902 -1.888 . . . . 62.130000000000003 105.902 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -138.33 -178.52 5.32 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 104.843 -2.28 . . . . 74.310000000000002 104.843 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.42 146.9 54.04 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.678 -0.86 . . . . 70.430000000000007 108.678 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.21 -3.73 86.57 Favored Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 109.704 -1.359 . . . . 52.229999999999997 109.704 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -80.51 155.45 27.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.461 -2.052 . . . . 75.319999999999993 105.461 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -119.68 127.35 52.8 Favored 'General case' 0 CA--C 1.478 -1.807 0 C-N-CA 119.411 -0.916 . . . . 62.329999999999998 109.099 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.07 148.13 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.09 -2.189 . . . . 64.120000000000005 105.09 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.65 -45.05 2.52 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 106.929 -1.508 . . . . 72.140000000000001 106.929 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.81 34.86 Favored 'General case' 0 CA--C 1.482 -1.667 0 C-N-CA 119.226 -0.99 . . . . 75.329999999999998 109.288 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.11 110.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 104.097 -2.557 . . . . 70.530000000000001 104.097 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.303 0.8 OUTLIER 46.48 38.3 5.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.541 1.137 . . . . 62.340000000000003 112.292 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.28 65.87 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.799 -1.32 . . . . 73.530000000000001 109.799 171.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.08 119.91 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.693 0 N-CA-C 104.971 -2.233 . . . . 70.519999999999996 104.971 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m -67.59 111.0 3.93 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.358 -1.349 . . . . 70.200000000000003 107.358 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.31 -14.91 51.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.926 -0.768 . . . . 72.030000000000001 108.926 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.98 146.58 46.46 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 109.332 -0.618 . . . . 65.549999999999997 109.332 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 -39.23 3.01 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 109.555 -1.418 . . . . 74.430000000000007 109.555 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 166.13 22.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.354 -0.98 . . . . 73.549999999999997 108.354 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.8 p -89.73 174.55 7.66 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.009 -1.108 . . . . 53.130000000000003 108.009 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -64.98 -38.73 91.93 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.987 -0.745 . . . . 64.099999999999994 108.987 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -59.59 -45.13 92.79 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 120.016 -0.674 . . . . 64.010000000000005 111.008 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -62.65 -39.99 95.63 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 119.746 1.157 . . . . 72.319999999999993 108.302 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.1 -42.97 86.8 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.8 -0.445 . . . . 74.140000000000001 109.8 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -69.25 -54.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 107.2 -1.407 . . . . 72.219999999999999 107.2 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -57.39 -26.46 61.11 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.222 -0.659 . . . . 71.310000000000002 109.222 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -65.81 -56.13 13.53 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 106.886 -1.524 . . . . 72.420000000000002 106.886 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.52 -55.1 35.8 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.153 -1.054 . . . . 74.5 108.153 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -45.63 -34.89 3.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.251 1.02 . . . . 70.209999999999994 111.975 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -96.6 -3.05 43.61 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.435 -0.79 . . . . 72.329999999999998 109.69 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -84.35 170.17 13.89 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.736 -1.227 . . . . 73.430000000000007 108.627 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.74 -149.32 24.59 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 122.508 1.06 . . . . 41.210000000000001 110.616 -171.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -77.82 -53.15 7.82 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.831 -1.174 . . . . 73.540000000000006 107.831 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.12 127.89 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.798 0 N-CA-C 103.576 -2.75 . . . . 71.430000000000007 103.576 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -133.16 143.13 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 103.796 -2.668 . . . . 74.340000000000003 103.796 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -97.28 116.0 28.67 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.542 -2.392 . . . . 73.040000000000006 104.542 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -114.52 138.0 51.16 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 105.7 -1.963 . . . . 62.299999999999997 105.7 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -113.82 127.85 56.17 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.548 -2.019 . . . . 44.240000000000002 105.548 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.81 155.97 49.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.26 -1.756 . . . . 74.519999999999996 106.26 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 CA--C 1.488 -1.419 0 N-CA-C 105.596 -2.002 . . . . 72.109999999999999 105.596 -178.714 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 104.719 -2.326 . . . . 71.510000000000005 104.719 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -145.88 157.11 43.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 105.893 -1.891 . . . . 72.099999999999994 105.893 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.25 143.62 32.41 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.848 -1.908 . . . . 73.319999999999993 105.848 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.06 128.12 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 104.167 -2.531 . . . . 73.010000000000005 104.167 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.26 114.62 26.39 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 105.552 -2.018 . . . . 73.430000000000007 105.552 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -103.61 120.84 41.69 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 105.994 -1.854 . . . . 72.430000000000007 105.994 -174.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.85 134.71 37.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.163 -1.421 . . . . 71.010000000000005 107.163 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 106.356 -1.72 . . . . 75.0 106.356 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.571 ' HA3' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.496 -1.095 0 CA-C-O 119.749 -0.473 . . . . 64.340000000000003 112.459 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.2 mt -123.05 153.02 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.394 -2.447 . . . . 75.540000000000006 104.394 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.5 m -151.81 163.37 39.33 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 102.769 -3.048 . . . . 71.530000000000001 102.769 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.74 168.32 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.401 -2.444 . . . . 73.140000000000001 104.401 -166.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -149.65 167.4 26.51 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 103.962 -2.607 . . . . 62.409999999999997 103.962 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.65 -171.89 13.99 Favored Glycine 0 CA--C 1.473 -2.56 0 N-CA-C 107.0 -2.44 . . . . 65.019999999999996 107.0 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.48 -124.23 5.83 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 108.687 -1.765 . . . . 74.129999999999995 108.687 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 m -73.27 20.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.694 0 C-N-CA 125.883 1.673 . . . . 50.240000000000002 113.142 -167.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.1 t30 89.93 66.04 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 123.146 1.45 . . . . 72.329999999999998 107.39 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 30' ' ' SER . 2.0 m -82.71 -167.2 1.54 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.465 -2.42 . . . . 73.099999999999994 104.465 170.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.582 ' H ' HG22 ' A' ' 29' ' ' THR . 16.3 m -58.17 -25.21 61.23 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 121.5 -0.75 . . . . 64.329999999999998 111.535 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 m -78.79 131.45 34.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 107.505 -1.295 . . . . 72.519999999999996 107.505 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -60.11 -53.69 54.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.921 0.488 . . . . 72.25 110.675 -171.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -76.87 4.77 9.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.829 -0.544 . . . . 74.099999999999994 109.88 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.62 13.46 24.17 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.249 -0.74 . . . . 75.519999999999996 111.249 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.31 148.02 50.46 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 108.385 -1.886 . . . . 50.100000000000001 108.385 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.13 97.11 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.542 -1.651 . . . . 75.409999999999997 106.542 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -95.76 143.93 26.58 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 107.043 -1.465 . . . . 74.25 107.043 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.6 t -72.02 130.61 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 N-CA-C 105.064 -2.198 . . . . 45.409999999999997 105.064 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -103.09 -39.97 6.66 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 107.316 -1.365 . . . . 50.530000000000001 107.316 -166.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.38 158.48 40.12 Favored 'General case' 0 CA--C 1.465 -2.29 0 N-CA-C 106.011 -1.848 . . . . 73.319999999999993 106.011 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.46 140.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 104.221 -2.511 . . . . 75.019999999999996 104.221 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.571 HG12 ' HA3' ' A' ' 20' ' ' GLY . 24.3 mm -70.67 143.99 90.51 Favored Pre-proline 0 C--N 1.355 0.805 0 N-CA-C 105.741 -1.948 . . . . 74.25 105.741 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.2 112.18 0.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.429 2.086 . . . . 70.340000000000003 108.948 165.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 74.91 22.04 1.93 Allowed 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.354 1.034 . . . . 60.240000000000002 110.483 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.74 175.68 30.17 Favored Glycine 0 C--N 1.375 2.732 0 N-CA-C 108.275 -1.93 . . . . 74.299999999999997 108.275 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.69 98.74 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.036 -0.727 . . . . 60.450000000000003 109.036 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.27 76.61 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.582 -0.525 . . . . 74.010000000000005 109.582 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.66 -35.13 79.43 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.134 -0.691 . . . . 63.039999999999999 109.134 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 m -66.02 -37.43 85.88 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.135 -1.061 . . . . 72.319999999999993 108.135 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.48 -41.24 89.27 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.397 -0.964 . . . . 71.230000000000004 108.397 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 90.71 -22.83 26.04 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.104 -1.198 . . . . 74.239999999999995 110.104 173.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -78.48 -38.72 40.27 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.693 -1.225 . . . . 72.319999999999993 107.693 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mt -104.84 129.37 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.258 -1.386 . . . . 72.530000000000001 107.258 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.46 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 76.8 m80 -140.19 -175.71 4.34 Favored 'General case' 0 CA--C 1.467 -2.25 0 N-CA-C 104.039 -2.578 . . . . 72.140000000000001 104.039 172.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 146.38 53.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.339 -1.356 . . . . 73.329999999999998 107.339 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.69 -25.23 28.22 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 107.827 -2.109 . . . . 52.539999999999999 107.827 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.27 154.68 32.71 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.223 -1.769 . . . . 72.439999999999998 106.223 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -134.39 141.0 46.7 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 107.487 -1.301 . . . . 64.25 107.487 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.33 150.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.401 -1.704 . . . . 74.209999999999994 106.401 -172.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.59 -46.41 2.86 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 106.953 -1.499 . . . . 73.340000000000003 106.953 169.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.16 161.89 30.1 Favored 'General case' 0 CA--C 1.484 -1.577 0 C-N-CA 118.915 -1.114 . . . . 64.549999999999997 110.19 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.37 107.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 104.206 -2.516 . . . . 74.109999999999999 104.206 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 t30 48.83 37.98 11.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.496 1.119 . . . . 73.329999999999998 111.021 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.64 10.17 70.64 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.345 -1.102 . . . . 63.439999999999998 110.345 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.59 117.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.948 0 N-CA-C 103.933 -2.617 . . . . 73.120000000000005 103.933 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 m -71.66 111.48 6.99 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.561 -1.274 . . . . 73.129999999999995 107.561 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.26 -3.26 58.89 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.674 -0.861 . . . . 65.219999999999999 108.674 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -63.94 144.03 57.39 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 106.963 -1.495 . . . . 72.310000000000002 106.963 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -34.83 3.09 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.022 -0.831 . . . . 62.329999999999998 111.022 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.68 162.11 24.41 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 118.356 1.078 . . . . 64.219999999999999 108.281 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -82.94 170.21 15.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.94 -0.763 . . . . 54.350000000000001 108.94 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -62.81 -44.1 97.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.702 -0.851 . . . . 73.239999999999995 108.702 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -62.35 -43.31 99.13 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 118.574 -0.727 . . . . 63.140000000000001 111.129 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -35.31 80.16 Favored 'General case' 0 C--N 1.383 2.028 0 CA-C-N 120.166 1.348 . . . . 70.329999999999998 109.005 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.89 74.23 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.913 -0.773 . . . . 61.049999999999997 108.913 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -73.88 -54.65 14.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 107.527 -1.286 . . . . 75.120000000000005 107.527 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 14.4 m -55.33 -29.27 57.97 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 122.705 1.24 . . . . 51.0 108.365 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -68.51 -54.36 17.31 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.504 -1.372 . . . . 72.0 107.647 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.6 mt -54.7 -56.18 21.9 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.707 -0.849 . . . . 71.239999999999995 108.707 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -46.15 -47.09 17.62 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.185 0.439 . . . . 73.120000000000005 112.185 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -82.93 3.35 30.31 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.357 -0.84 . . . . 60.310000000000002 111.077 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.2 p -82.17 173.71 11.87 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.583 1.083 . . . . 73.409999999999997 108.375 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.93 -163.12 26.91 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 109.6 -1.4 . . . . 74.400000000000006 109.6 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.75 -32.98 27.56 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.101 -1.074 . . . . 62.329999999999998 108.101 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.2 t -115.95 127.19 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.605 -2.739 . . . . 61.310000000000002 103.605 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.46 151.32 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 104.609 -2.367 . . . . 75.510000000000005 104.609 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -102.08 123.68 46.37 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 104.271 -2.492 . . . . 61.100000000000001 104.271 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 12' ' ' LEU . 62.1 mt -114.99 138.69 50.55 Favored 'General case' 0 CA--C 1.467 -2.242 0 N-CA-C 104.301 -2.481 . . . . 72.510000000000005 104.301 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -112.63 125.37 54.21 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.647 -1.983 . . . . 74.200000000000003 105.647 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.75 153.68 49.83 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.164 -1.791 . . . . 65.129999999999995 106.164 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.475 -1.932 0 N-CA-C 105.024 -2.214 . . . . 73.409999999999997 105.024 -178.421 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 103.692 -2.707 . . . . 53.520000000000003 103.692 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -138.58 146.51 41.91 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.233 -1.766 . . . . 71.25 106.233 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.18 138.84 40.07 Favored 'General case' 0 N--CA 1.396 -3.128 0 N-CA-C 104.483 -2.414 . . . . 62.420000000000002 104.483 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.02 130.99 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.772 0 N-CA-C 105.498 -2.038 . . . . 72.5 105.498 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -100.78 119.86 39.26 Favored 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 104.707 -2.331 . . . . 72.219999999999999 104.707 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 121.08 44.04 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 105.979 -1.86 . . . . 74.450000000000003 105.979 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.32 134.29 41.54 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.653 -1.24 . . . . 23.440000000000001 107.653 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.502 -0.903 0 N-CA-C 107.018 -1.475 . . . . 63.229999999999997 107.018 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.418 -2.51 0 N-CA-C 108.636 -1.786 . . . . 73.010000000000005 108.636 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.84 158.65 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 106.184 -1.784 . . . . 70.200000000000003 106.184 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.2 m -153.31 163.62 39.59 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 102.517 -3.142 . . . . 74.420000000000002 102.517 164.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.39 167.33 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 107.036 -1.468 . . . . 62.119999999999997 107.036 -161.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -143.71 165.99 26.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 104.562 -2.384 . . . . 71.200000000000003 104.562 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.22 -163.06 12.21 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 107.939 -2.065 . . . . 53.210000000000001 107.939 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.32 -127.5 6.08 Favored Glycine 0 C--N 1.36 1.877 0 N-CA-C 110.379 -1.088 . . . . 24.23 110.379 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 m -59.85 18.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.195 0 C-N-CA 128.282 2.633 . . . . 63.310000000000002 115.29 -167.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 86.44 64.34 0.01 OUTLIER 'General case' 0 CA--C 1.468 -2.196 0 N-CA-C 105.754 -1.943 . . . . 72.329999999999998 105.754 -165.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 30' ' ' SER . 2.3 m -88.43 -166.29 1.55 Allowed 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 111.686 -2.506 . . . . 64.400000000000006 104.546 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.668 ' H ' HG22 ' A' ' 29' ' ' THR . 11.8 m -58.35 -20.49 43.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.39 0.676 . . . . 21.23 111.226 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.629 -1.248 . . . . 51.409999999999997 107.629 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -70.32 -34.24 72.46 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-O 121.508 0.67 . . . . 72.340000000000003 109.756 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.44 -15.65 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.202 -1.036 . . . . 72.299999999999997 108.202 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.24 8.72 25.89 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 110.391 -1.083 . . . . 75.409999999999997 110.391 -176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.97 159.46 53.9 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 107.976 -2.05 . . . . 52.420000000000002 107.976 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.0 mm -90.64 95.16 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.464 -2.05 . . . . 33.509999999999998 105.464 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.05 146.74 26.5 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.507 -1.294 . . . . 74.319999999999993 107.507 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.39 129.0 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.426 -1.694 . . . . 70.230000000000004 106.426 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -106.41 -43.79 4.68 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 107.88 -1.155 . . . . 73.5 107.88 -171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.8 144.59 39.42 Favored 'General case' 0 CA--C 1.46 -2.502 0 N-CA-C 105.732 -1.951 . . . . 74.299999999999997 105.732 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.7 120.01 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 104.17 -2.53 . . . . 74.030000000000001 104.17 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.498 HD12 ' HA2' ' A' ' 20' ' ' GLY . 18.3 mt -72.88 135.06 80.79 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.122 -1.807 . . . . 64.219999999999999 106.122 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 42' ' ' ILE . 19.0 Cg_endo -58.2 121.6 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.803 2.335 . . . . 74.010000000000005 109.647 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 65.65 23.2 11.66 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.482 1.114 . . . . 74.310000000000002 110.461 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 175.34 49.18 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 106.698 -2.561 . . . . 50.039999999999999 106.698 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.1 82.92 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.613 -0.884 . . . . 74.409999999999997 108.613 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.48 76.85 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.222 -0.659 . . . . 71.549999999999997 109.222 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.32 -35.07 73.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.816 0.341 . . . . 74.040000000000006 110.112 -173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -68.33 -37.13 80.24 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.176 -1.046 . . . . 72.209999999999994 108.176 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.12 -47.0 72.45 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 107.124 -1.436 . . . . 65.430000000000007 107.124 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.09 -21.6 19.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 111.386 -0.686 . . . . 53.439999999999998 111.386 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -72.82 -35.13 67.24 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.559 1.18 . . . . 71.430000000000007 107.984 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.2 mt -94.55 135.98 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 105.964 -1.865 . . . . 45.539999999999999 105.964 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -144.31 176.06 9.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.262 -1.755 . . . . 54.130000000000003 106.262 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.95 137.1 56.28 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.799 -1.556 . . . . 72.120000000000005 106.799 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.99 -18.2 26.49 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 107.336 -2.306 . . . . 54.420000000000002 107.336 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.28 155.45 27.29 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 108.109 -1.071 . . . . 70.030000000000001 108.109 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -120.15 135.33 55.0 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 104.785 -2.302 . . . . 73.549999999999997 104.785 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.0 143.95 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 104.555 -2.387 . . . . 70.319999999999993 104.555 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -46.9 2.53 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.14 -1.43 . . . . 71.530000000000001 107.14 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.37 165.34 22.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 CA-C-O 122.394 1.093 . . . . 63.399999999999999 109.625 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -142.13 113.0 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 N-CA-C 103.486 -2.783 . . . . 72.430000000000007 103.486 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 53.52 31.27 12.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.072 0.549 . . . . 73.109999999999999 110.473 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.49 79.61 Favored Glycine 0 C--N 1.357 1.728 0 N-CA-C 110.209 -1.156 . . . . 62.210000000000001 110.209 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.98 124.92 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 104.707 -2.331 . . . . 72.319999999999993 104.707 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.0 m -64.35 104.33 0.75 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.436 -1.32 . . . . 62.439999999999998 107.436 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -21.3 21.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.486 -1.302 . . . . 74.329999999999998 107.486 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.41 146.26 48.93 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.005 . . . . 73.450000000000003 108.288 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.27 -35.39 3.58 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 109.872 -1.291 . . . . 51.310000000000002 109.872 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.78 161.65 28.0 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.102 -1.073 . . . . 73.519999999999996 108.102 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.0 p -77.83 168.46 19.89 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.685 0.755 . . . . 62.43 109.301 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -63.16 -42.27 99.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.986 -1.116 . . . . 63.049999999999997 107.986 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -56.02 -50.63 70.35 Favored 'General case' 0 C--N 1.367 1.338 0 N-CA-C 109.919 -0.4 . . . . 74.329999999999998 109.919 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -64.53 -37.12 86.45 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.307 -0.627 . . . . 64.400000000000006 109.307 -171.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.62 77.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.099 -0.704 . . . . 73.340000000000003 109.099 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.3 t -73.69 -52.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.529 -1.285 . . . . 73.319999999999993 107.529 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 46.6 m -53.04 -28.14 23.03 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-O 121.901 0.858 . . . . 70.209999999999994 109.009 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.25 -56.37 10.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.21 -1.404 . . . . 75.129999999999995 107.21 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.6 mt -56.75 -56.61 19.32 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.712 -0.847 . . . . 65.319999999999993 108.712 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -47.62 -27.14 1.73 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.048 1.129 . . . . 64.140000000000001 114.048 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.85 4.79 43.08 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 119.666 1.121 . . . . 74.430000000000007 109.047 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.2 p -84.86 170.28 13.29 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 121.055 -1.028 . . . . 73.120000000000005 108.4 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.6 -151.14 26.56 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.711 -1.755 . . . . 65.140000000000001 108.711 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -80.79 -43.17 20.52 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 107.994 -1.113 . . . . 64.319999999999993 107.994 -171.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.58 123.62 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 104.741 -2.318 . . . . 71.049999999999997 104.741 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -127.99 147.53 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.758 0 N-CA-C 105.373 -2.084 . . . . 53.350000000000001 105.373 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -99.88 115.66 30.13 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.152 -2.166 . . . . 62.210000000000001 105.152 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.82 134.27 52.66 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 104.62 -2.363 . . . . 60.32 104.62 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.57 124.37 52.2 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 105.129 -2.174 . . . . 75.120000000000005 105.129 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -133.18 159.34 40.46 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 106.843 -1.54 . . . . 75.209999999999994 106.843 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.478 -1.81 0 N-CA-C 103.112 -2.922 . . . . 74.340000000000003 103.112 172.751 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 103.91 -2.626 . . . . 72.239999999999995 103.91 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.13 150.51 45.74 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.656 -1.239 . . . . 74.200000000000003 107.656 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -102.69 136.7 42.04 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 104.875 -2.269 . . . . 71.129999999999995 104.875 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -125.56 134.26 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 105.63 -1.989 . . . . 74.010000000000005 105.63 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -106.68 109.88 21.92 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.575 -2.009 . . . . 75.450000000000003 105.575 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -102.99 121.6 42.88 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.841 -1.911 . . . . 74.319999999999993 105.841 -171.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.34 130.0 35.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.068 -1.456 . . . . 71.099999999999994 107.068 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 106.99 -1.485 . . . . 72.510000000000005 106.99 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.64 ' HA3' ' H ' ' A' ' 47' ' ' ALA . . . . . . . . 0 C--O 1.203 -1.789 0 N-CA-C 111.437 -0.665 . . . . 65.129999999999995 111.437 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mm -110.13 157.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 106.404 -1.702 . . . . 74.209999999999994 106.404 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.8 m -146.49 155.93 42.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 101.571 -3.492 . . . . 74.329999999999998 101.571 163.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.31 160.57 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 C-N-CA 119.309 -0.956 . . . . 74.319999999999993 109.833 -166.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 t -145.22 166.29 25.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 103.032 -2.951 . . . . 54.350000000000001 103.032 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.74 123.72 4.0 Favored Glycine 0 C--O 1.193 -2.408 0 N-CA-C 108.407 -1.877 . . . . 51.450000000000003 108.407 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.18 -115.37 0.44 Allowed Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.096 -1.602 . . . . 75.510000000000005 109.096 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.79 20.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 126.17 1.788 . . . . 51.240000000000002 115.031 -163.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.3 t30 88.3 64.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 123.702 1.715 . . . . 52.439999999999998 106.476 -164.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -90.0 -165.28 1.31 Allowed 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 102.587 -3.116 . . . . 73.329999999999998 102.587 165.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -40.49 -33.35 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.412 1.085 . . . . 72.219999999999999 112.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.68 132.99 36.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 O-C-N 121.15 -0.969 . . . . 75.209999999999994 108.579 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -64.12 -58.03 7.83 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.565 -1.198 . . . . 61.140000000000001 111.899 -168.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -79.94 5.06 14.92 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.49 -0.756 . . . . 75.109999999999999 109.071 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.85 33.26 83.54 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 108.504 -1.839 . . . . 75.299999999999997 108.504 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.4 124.77 34.17 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 107.525 -2.23 . . . . 63.149999999999999 107.525 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mm -81.39 90.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.675 -2.342 . . . . 73.030000000000001 104.675 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -85.57 146.16 27.02 Favored 'General case' 0 CA--C 1.467 -2.212 0 N-CA-C 107.887 -1.153 . . . . 65.109999999999999 107.887 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.12 125.98 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.749 -1.945 . . . . 71.230000000000004 105.749 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -91.55 -38.38 12.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 106.672 -1.603 . . . . 65.540000000000006 106.672 -168.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.59 155.5 38.56 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 105.825 -1.917 . . . . 75.019999999999996 105.825 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.97 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 102.06 -3.311 . . . . 74.510000000000005 102.06 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.95 130.35 93.93 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 106.554 -1.647 . . . . 65.430000000000007 106.554 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.26 123.93 14.49 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.809 2.339 . . . . 64.420000000000002 109.477 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 68.67 10.09 7.69 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 124.781 1.3 . . . . 72.25 110.756 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.57 -175.18 37.17 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.973 -1.651 . . . . 54.409999999999997 108.973 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.85 74.34 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.054 -0.721 . . . . 63.240000000000002 109.054 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.64 ' H ' ' HA3' ' A' ' 20' ' ' GLY . . . -68.99 -46.03 69.08 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 108.908 -0.775 . . . . 72.140000000000001 108.908 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.22 -36.0 80.62 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 108.741 -0.837 . . . . 73.109999999999999 108.741 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.7 t -64.18 -40.13 95.45 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 108.203 -1.036 . . . . 54.420000000000002 108.203 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -73.86 -48.25 32.44 Favored 'General case' 0 C--N 1.351 0.63 0 N-CA-C 107.577 -1.268 . . . . 75.530000000000001 107.577 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.34 -17.44 13.47 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.771 -0.532 . . . . 63.219999999999999 111.771 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . 33.9 ttm105 -72.98 -33.76 66.02 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.852 -1.166 . . . . 72.230000000000004 107.852 -173.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.16 135.61 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.069 -1.826 . . . . 72.319999999999993 106.069 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 52' ' ' ARG . 25.6 m80 -118.59 162.87 17.68 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 106.995 -1.483 . . . . 73.549999999999997 106.995 -175.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -65.78 136.42 56.19 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 106.981 -1.488 . . . . 71.409999999999997 106.981 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.75 -10.0 72.88 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.78 -1.728 . . . . 70.129999999999995 108.78 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -66.51 143.41 57.09 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 105.884 -1.895 . . . . 70.150000000000006 105.884 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.7 tmm_? -103.15 119.82 39.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.376 -1.342 . . . . 75.510000000000005 107.376 -169.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 t -89.18 141.62 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 105.766 -1.939 . . . . 73.219999999999999 105.766 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -47.0 2.51 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 70.310000000000002 107.32 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.32 167.63 18.92 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.373 1.082 . . . . 64.310000000000002 109.493 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -141.07 108.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 103.533 -2.766 . . . . 70.5 103.533 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 49.91 39.64 18.99 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.089 0.956 . . . . 73.099999999999994 110.598 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.55 20.1 78.74 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 109.936 -1.266 . . . . 62.340000000000003 109.936 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.63 119.35 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 N-CA-C 104.124 -2.547 . . . . 64.329999999999998 104.124 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -70.24 105.9 3.13 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.234 -0.654 . . . . 54.009999999999998 109.234 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.88 -7.07 53.23 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.027 -1.471 . . . . 72.25 107.027 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.97 143.67 57.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.109 -1.441 . . . . 72.409999999999997 107.109 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.83 2.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.983 -0.847 . . . . 23.010000000000002 110.983 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.89 172.66 4.19 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 118.218 1.009 . . . . 60.299999999999997 109.766 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -82.65 156.47 23.84 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.603 -1.258 . . . . 75.530000000000001 107.603 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -66.28 -37.65 85.94 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.89 -1.152 . . . . 72.340000000000003 107.89 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -39.45 87.16 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 120.639 -0.424 . . . . 72.209999999999994 110.188 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.71 -36.45 83.9 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-N 119.389 0.995 . . . . 73.230000000000004 109.018 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.14 75.83 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.078 -0.712 . . . . 72.109999999999999 109.078 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 -53.45 25.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 N-CA-C 107.278 -1.379 . . . . 71.400000000000006 107.278 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.0 m -52.49 -29.19 23.7 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 108.294 -1.002 . . . . 74.219999999999999 108.294 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.1 m -69.19 -56.23 8.25 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 108.015 -1.105 . . . . 70.510000000000005 108.015 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -53.52 -56.17 19.31 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.844 -0.799 . . . . 54.450000000000003 108.844 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -46.58 -43.3 17.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.551 -0.749 . . . . 74.5 111.475 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -77.37 -14.55 59.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.509 0.323 . . . . 62.219999999999999 110.711 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -76.13 163.26 27.27 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 120.668 -1.27 . . . . 74.420000000000002 108.927 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.84 -146.68 6.46 Favored Glycine 0 CA--C 1.491 -1.447 0 N-CA-C 109.245 -1.542 . . . . 72.239999999999995 109.245 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -85.39 -42.64 14.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 107.793 -1.188 . . . . 75.319999999999993 107.793 -172.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.6 t -108.08 128.31 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 104.277 -2.49 . . . . 55.5 104.277 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.07 139.15 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 105.825 -1.917 . . . . 74.230000000000004 105.825 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -97.24 115.87 28.41 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 104.699 -2.334 . . . . 73.120000000000005 104.699 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 12' ' ' LEU . 18.1 mt -112.84 137.22 51.51 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 104.84 -2.281 . . . . 75.310000000000002 104.84 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 tp -114.62 124.17 51.17 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.943 -2.243 . . . . 62.530000000000001 104.943 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.5 158.18 41.58 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 107.436 -1.32 . . . . 73.329999999999998 107.436 -173.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 58' ' ' ARG . 42.2 tt0 . . . . . 0 N--CA 1.408 -2.531 0 N-CA-C 103.876 -2.639 . . . . 71.129999999999995 103.876 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 104.139 -2.541 . . . . 75.319999999999993 104.139 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -152.34 159.77 43.41 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.346 -2.094 . . . . 72.329999999999998 105.346 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.12 145.79 28.85 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 105.256 -2.128 . . . . 73.099999999999994 105.256 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.72 122.74 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 103.448 -2.797 . . . . 44.219999999999999 103.448 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -99.6 109.48 21.98 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.283 -2.488 . . . . 63.219999999999999 104.283 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 105.44 -2.059 . . . . 74.099999999999994 105.44 -171.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.18 134.18 34.13 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.064 -1.828 . . . . 60.450000000000003 106.064 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 108.313 -0.995 . . . . 73.319999999999993 108.313 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.482 -2.025 0 N-CA-C 106.981 -2.447 . . . . 52.329999999999998 106.981 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 mt -131.05 160.04 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 104.959 -2.237 . . . . 71.439999999999998 104.959 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.14 162.86 37.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.562 -3.125 . . . . 71.120000000000005 102.562 163.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.97 167.85 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 N-CA-C 105.801 -1.925 . . . . 71.120000000000005 105.801 -165.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -147.41 166.5 26.99 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 102.721 -3.066 . . . . 63.329999999999998 102.721 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.496 ' H ' HG21 ' A' ' 29' ' ' THR . . . 127.92 178.57 15.4 Favored Glycine 0 CA--C 1.459 -3.46 0 N-CA-C 105.715 -2.954 . . . . 51.329999999999998 105.715 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.75 -130.52 6.99 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 108.823 -1.711 . . . . 54.130000000000003 108.823 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.39 19.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 126.721 2.008 . . . . 64.049999999999997 114.212 -165.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.5 t30 88.37 65.6 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.051 -1.463 . . . . 54.240000000000002 107.051 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.496 HG21 ' H ' ' A' ' 25' ' ' GLY . 15.3 t -94.71 -166.24 1.44 Allowed 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 104.094 -2.558 . . . . 73.239999999999995 104.094 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 m -47.41 -40.7 18.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.732 1.213 . . . . 60.229999999999997 112.59 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 m -76.16 133.78 30.4 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 N-CA-C 108.871 -0.788 . . . . 64.120000000000005 108.871 -173.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -57.77 -55.15 38.54 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.19 0.996 . . . . 75.129999999999995 112.492 -169.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -76.22 6.61 5.21 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.297 -0.877 . . . . 60.140000000000001 110.111 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 57.53 6.44 2.38 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 121.516 -0.74 . . . . 55.439999999999998 111.967 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.68 160.65 53.81 Favored Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 107.364 -2.294 . . . . 74.439999999999998 107.364 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mm -83.92 108.62 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 106.14 -1.8 . . . . 75.510000000000005 106.14 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 42.9 m-85 -103.75 144.08 31.94 Favored 'General case' 0 CA--C 1.48 -1.74 0 N-CA-C 106.84 -1.541 . . . . 74.109999999999999 106.84 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.94 132.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.031 -1.841 . . . . 54.439999999999998 106.031 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -114.72 -37.48 4.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.228 -1.027 . . . . 74.239999999999995 108.228 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.57 146.43 34.59 Favored 'General case' 0 CA--C 1.463 -2.366 0 N-CA-C 106.716 -1.587 . . . . 60.200000000000003 106.716 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.03 119.35 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 104.979 -2.23 . . . . 73.540000000000006 104.979 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 20' ' ' GLY . 23.3 mt -72.46 140.09 81.75 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 106.575 -1.639 . . . . 71.239999999999995 106.575 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 42' ' ' ILE . 18.7 Cg_endo -57.6 119.9 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.731 2.287 . . . . 63.420000000000002 109.785 177.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 68.75 25.29 6.38 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 125.12 1.512 . . . . 74.340000000000003 110.372 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.02 173.44 52.62 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 107.653 -2.179 . . . . 72.219999999999999 107.653 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.38 99.29 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.796 -0.816 . . . . 74.239999999999995 108.796 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.19 77.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.311 -0.626 . . . . 62.140000000000001 109.311 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.5 -42.17 95.81 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.027 -0.731 . . . . 61.539999999999999 109.027 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -67.82 -36.69 80.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.614 -0.513 . . . . 61.539999999999999 109.614 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.86 -36.91 75.89 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.637 -1.246 . . . . 35.310000000000002 107.637 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -18.95 23.94 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.039 -0.824 . . . . 62.240000000000002 111.039 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -74.62 -39.75 61.94 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.426 -0.953 . . . . 74.439999999999998 108.426 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -95.74 120.62 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 105.829 -1.915 . . . . 63.530000000000001 105.829 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.21 169.85 10.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.657 -1.979 . . . . 72.150000000000006 105.657 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -66.52 137.86 57.09 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.501 -1.666 . . . . 75.319999999999993 106.501 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.05 -26.16 23.99 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 108.328 -1.909 . . . . 75.129999999999995 108.328 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.55 166.5 21.68 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.69 -1.226 . . . . 71.030000000000001 107.69 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -130.29 139.39 50.74 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 107.489 -1.3 . . . . 71.120000000000005 107.489 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.48 143.97 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 104.086 -2.561 . . . . 54.5 104.086 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.37 -46.92 3.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.563 -1.273 . . . . 74.329999999999998 107.563 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.91 166.09 21.69 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.377 1.085 . . . . 70.340000000000003 109.827 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.46 104.35 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 103.783 -2.673 . . . . 61.25 103.783 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 46.91 43.28 13.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.091 0.956 . . . . 52.25 110.849 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.81 76.6 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.217 -1.153 . . . . 64.150000000000006 110.217 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.34 117.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 104.467 -2.42 . . . . 72.219999999999999 104.467 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -75.33 107.48 7.47 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.786 -1.191 . . . . 64.120000000000005 107.786 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.35 -6.29 56.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.513 -0.767 . . . . 71.200000000000003 110.034 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -61.47 142.75 56.81 Favored 'General case' 0 C--N 1.361 1.073 0 O-C-N 120.875 -1.141 . . . . 74.540000000000006 108.834 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.94 -25.06 6.19 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.385 -1.086 . . . . 54.25 110.385 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 164.0 26.5 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.203 1.001 . . . . 62.420000000000002 108.892 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 p -81.54 163.62 22.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.625 -0.88 . . . . 72.109999999999999 108.625 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -61.49 -44.94 96.19 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.445 -0.798 . . . . 72.049999999999997 108.936 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -30.73 70.66 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 120.302 -0.559 . . . . 72.340000000000003 109.918 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -65.55 -36.2 83.09 Favored 'General case' 0 C--N 1.373 1.622 0 N-CA-C 108.521 -0.918 . . . . 73.230000000000004 108.521 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.39 -34.19 73.56 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.553 -0.906 . . . . 50.130000000000003 108.553 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.67 -53.63 19.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.156 -1.424 . . . . 75.340000000000003 107.156 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.3 m -53.26 -29.05 30.71 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.199 -1.038 . . . . 54.109999999999999 108.199 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.5 m -69.91 -55.83 8.65 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.531 -1.285 . . . . 72.450000000000003 107.531 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -55.78 -55.49 31.74 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.062 -0.718 . . . . 73.140000000000001 109.062 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -45.97 -37.91 7.07 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.653 0.612 . . . . 73.25 112.653 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -90.23 8.28 33.95 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.29 0.95 . . . . 65.439999999999998 110.283 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -74.32 163.54 27.68 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-N 119.587 1.085 . . . . 63.140000000000001 109.51 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.74 -158.79 19.87 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 109.067 -1.613 . . . . 52.32 109.067 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.449 ' H ' ' CD ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -81.99 -38.45 25.08 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.886 -0.783 . . . . 62.32 108.886 -169.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.8 t -113.34 130.06 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 103.553 -2.758 . . . . 70.430000000000007 103.553 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -122.27 142.12 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 104.827 -2.286 . . . . 73.120000000000005 104.827 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -100.71 119.22 38.28 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 104.333 -2.469 . . . . 73.310000000000002 104.333 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.46 134.62 54.56 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 103.726 -2.694 . . . . 72.420000000000002 103.726 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.57 126.94 53.49 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 105.764 -1.939 . . . . 71.040000000000006 105.764 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -134.37 155.33 50.46 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.211 -1.774 . . . . 70.310000000000002 106.211 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 . . . . . 0 CA--C 1.477 -1.863 0 N-CA-C 102.685 -3.079 . . . . 53.25 102.685 176.053 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.499 -1.002 0 N-CA-C 104.704 -2.332 . . . . 75.030000000000001 104.704 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -138.53 149.04 44.94 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.599 -1.63 . . . . 74.219999999999999 106.599 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HG2' HD13 ' A' ' 89' ' ' LEU . 89.4 mt-10 -103.22 139.72 38.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.574 -1.639 . . . . 65.439999999999998 106.574 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.04 135.28 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 106.939 -1.504 . . . . 71.409999999999997 106.939 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -105.9 112.8 26.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 104.533 -2.395 . . . . 65.239999999999995 104.533 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.18 125.12 50.69 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.586 -1.635 . . . . 74.319999999999993 106.586 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.22 133.84 37.32 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.931 -1.507 . . . . 73.340000000000003 106.931 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mptt . . . . . 0 CA--C 1.483 -1.599 0 N-CA-C 105.993 -1.854 . . . . 60.43 105.993 -177.278 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.528 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.478 -2.247 0 N-CA-C 109.498 -1.441 . . . . 52.409999999999997 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.51 145.7 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 103.537 -2.764 . . . . 75.019999999999996 103.537 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.48 162.99 34.38 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 103.07 -2.937 . . . . 63.350000000000001 103.07 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.09 168.0 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 N-CA-C 104.829 -2.286 . . . . 71.409999999999997 104.829 -167.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.6 t -145.79 166.03 27.11 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.319 -2.474 . . . . 71.120000000000005 104.319 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.83 131.74 3.64 Favored Glycine 0 C--O 1.2 -2.01 0 N-CA-C 108.594 -1.802 . . . . 42.130000000000003 108.594 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.2 -99.07 0.14 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 107.526 -2.229 . . . . 64.510000000000005 107.526 167.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.31 20.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.386 1.874 . . . . 63.420000000000002 114.94 -170.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 88.71 66.41 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.926 0 CA-C-O 123.337 1.542 . . . . 75.109999999999999 106.991 -168.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.78 HG22 ' H ' ' A' ' 30' ' ' SER . 4.3 m -84.38 -166.57 1.48 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.478 -2.416 . . . . 71.519999999999996 104.478 173.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.78 ' H ' HG22 ' A' ' 29' ' ' THR . 10.5 m -53.16 -28.11 24.57 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.339 0.656 . . . . 60.109999999999999 110.9 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 m -82.57 122.25 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.787 -1.56 . . . . 63.130000000000003 106.787 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -83.59 -16.76 44.1 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.683 -0.858 . . . . 63.049999999999997 108.683 -170.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 35' ' ' GLY . 43.3 t60 -70.77 -12.19 61.4 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.739 -1.208 . . . . 70.200000000000003 107.739 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.37 -5.36 1.54 Allowed Glycine 0 C--N 1.365 2.147 0 C-N-CA 124.155 0.883 . . . . 71.129999999999995 111.505 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 33' ' ' HIS . . . -70.28 151.19 49.59 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 107.931 -2.067 . . . . 71.150000000000006 107.931 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.408 HG21 ' HB1' ' A' ' 75' ' ' ALA . 10.7 mm -82.17 126.08 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.449 -2.426 . . . . 74.120000000000005 104.449 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -111.91 145.6 39.26 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 106.89 -1.522 . . . . 71.519999999999996 106.89 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -74.52 129.36 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.386 -2.079 . . . . 71.040000000000006 105.386 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -116.45 -35.28 4.32 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.741 -1.207 . . . . 70.319999999999993 107.741 -170.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.04 136.28 45.87 Favored 'General case' 0 CA--C 1.452 -2.798 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 -167.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -139.39 129.76 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 103.765 -2.68 . . . . 73.109999999999999 103.765 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.528 HG12 ' CA ' ' A' ' 20' ' ' GLY . 6.5 mm -70.94 147.46 94.0 Favored Pre-proline 0 CA--C 1.505 -0.751 0 N-CA-C 105.082 -2.192 . . . . 75.409999999999997 105.082 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 114.35 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.876 1.717 . . . . 63.100000000000001 107.801 164.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 68.95 26.49 5.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 124.542 1.151 . . . . 60.340000000000003 111.044 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.15 177.12 43.14 Favored Glycine 0 C--N 1.368 2.34 0 N-CA-C 106.474 -2.65 . . . . 51.030000000000001 106.474 167.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.04 95.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 122.124 -0.633 . . . . 72.420000000000002 109.342 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.25 -49.2 78.07 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.413 -0.588 . . . . 73.239999999999995 109.413 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.46 -36.8 81.88 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.864 -0.791 . . . . 74.140000000000001 108.864 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -65.18 -44.02 89.79 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.458 -0.942 . . . . 61.43 108.458 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -70.36 -33.0 70.92 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.235 -1.395 . . . . 74.310000000000002 107.235 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.27 -16.12 45.76 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 110.481 -1.048 . . . . 55.210000000000001 110.481 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -79.42 -34.68 41.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.695 -0.854 . . . . 74.040000000000006 108.695 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.4 mt -105.25 141.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.852 -1.907 . . . . 71.030000000000001 105.852 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -143.56 178.33 7.86 Favored 'General case' 0 CA--C 1.466 -2.252 0 N-CA-C 104.526 -2.398 . . . . 74.400000000000006 104.526 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.91 146.96 53.85 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.007 -1.479 . . . . 73.109999999999999 107.007 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.14 -16.49 53.62 Favored Glycine 0 CA--C 1.498 -0.997 0 N-CA-C 107.335 -2.306 . . . . 65.510000000000005 107.335 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.29 146.57 31.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.998 -1.852 . . . . 70.319999999999993 105.998 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.8 tmm_? -108.83 123.82 49.65 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 105.377 -2.083 . . . . 74.239999999999995 105.377 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.29 141.2 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 105.545 -2.021 . . . . 63.32 105.545 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -49.01 2.31 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.89 -1.152 . . . . 71.219999999999999 107.89 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.98 166.83 19.27 Favored 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 118.873 -1.131 . . . . 74.5 109.92 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.71 100.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 103.395 -2.817 . . . . 73.319999999999993 103.395 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 t30 48.16 41.99 16.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.731 1.212 . . . . 51.509999999999998 110.954 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 13.04 77.02 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.053 -1.219 . . . . 75.230000000000004 110.053 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.14 116.85 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.759 0 N-CA-C 103.647 -2.723 . . . . 74.239999999999995 103.647 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 m -72.45 112.22 8.32 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.137 -1.06 . . . . 53.350000000000001 108.137 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.79 9.63 26.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.905 -1.517 . . . . 70.150000000000006 106.905 172.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.79 140.01 49.25 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.436 -1.69 . . . . 72.230000000000004 106.436 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 -23.23 4.58 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.291 -1.124 . . . . 62.210000000000001 110.291 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.93 164.72 16.93 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.895 0.855 . . . . 53.340000000000003 109.53 -175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 p -82.36 155.16 24.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.958 -1.497 . . . . 55.329999999999998 106.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -62.72 -37.63 87.28 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.881 -0.785 . . . . 71.340000000000003 108.881 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -55.84 -43.05 76.66 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 110.097 -0.334 . . . . 65.400000000000006 110.097 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -66.23 -39.97 89.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.277 -1.009 . . . . 60.409999999999997 108.277 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB1' HG21 ' A' ' 36' ' ' ILE . . . -55.97 -39.73 72.22 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 110.056 -0.35 . . . . 42.409999999999997 110.056 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.04 -56.25 9.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 107.754 -1.202 . . . . 52.219999999999999 107.754 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 72.0 m -63.59 -25.97 68.48 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.788 -0.819 . . . . 74.120000000000005 108.788 -166.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.7 m -60.7 -52.81 63.55 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 107.669 -1.234 . . . . 71.439999999999998 107.669 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.1 mt -55.27 -55.23 33.82 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.657 0.742 . . . . 62.439999999999998 109.519 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -48.16 -36.41 13.48 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.035 -0.415 . . . . 74.319999999999993 112.082 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -89.93 -9.75 47.67 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.67 -0.644 . . . . 72.519999999999996 110.095 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -81.31 179.54 7.81 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.754 -1.202 . . . . 71.200000000000003 107.754 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.88 -166.73 31.43 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.843 -1.303 . . . . 71.200000000000003 109.843 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.63 -35.95 38.62 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.808 -1.553 . . . . 74.109999999999999 106.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -116.29 127.74 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 N-CA-C 103.036 -2.95 . . . . 75.140000000000001 103.036 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.76 151.58 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.87 0 N-CA-C 104.606 -2.368 . . . . 62.350000000000001 104.606 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.85 123.88 40.68 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 104.305 -2.48 . . . . 71.030000000000001 104.305 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.4 mt -118.84 140.77 49.42 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 105.428 -2.064 . . . . 54.039999999999999 105.428 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.406 HD13 ' HG2' ' A' ' 9' ' ' GLU . 17.8 tp -114.22 124.14 51.3 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 105.053 -2.203 . . . . 75.019999999999996 105.053 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.11 157.19 44.85 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.691 -1.226 . . . . 74.030000000000001 107.691 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 58' ' ' ARG . 36.2 tt0 . . . . . 0 N--CA 1.4 -2.972 0 N-CA-C 103.154 -2.906 . . . . 62.450000000000003 103.154 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 103.82 -2.659 . . . . 61.039999999999999 103.82 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.21 146.57 52.11 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 105.209 -2.145 . . . . 73.109999999999999 105.209 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -102.44 135.4 44.12 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.024 -2.213 . . . . 63.149999999999999 105.024 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.27 129.94 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 105.851 -1.907 . . . . 71.310000000000002 105.851 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -101.05 112.5 24.97 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 103.72 -2.696 . . . . 54.399999999999999 103.72 168.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HB2' HD12 ' A' ' 88' ' ' LEU . 1.3 tm? -102.87 124.71 48.89 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.486 -2.042 . . . . 61.409999999999997 105.486 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.8 120.31 29.0 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.504 -1.665 . . . . 52.109999999999999 106.504 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? . . . . . 0 CA--C 1.492 -1.274 0 N-CA-C 107.034 -1.469 . . . . 73.129999999999995 107.034 176.177 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.976 0 N-CA-C 110.691 -0.964 . . . . 75.129999999999995 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.63 154.28 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.026 -2.583 . . . . 64.340000000000003 104.026 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.5 t -154.14 165.87 34.86 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.461 -2.422 . . . . 74.340000000000003 104.461 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.21 167.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 105.688 -1.967 . . . . 72.409999999999997 105.688 -168.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -146.11 166.53 25.87 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 104.584 -2.376 . . . . 74.329999999999998 104.584 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.93 134.37 3.02 Favored Glycine 0 C--O 1.196 -2.241 0 N-CA-C 108.853 -1.699 . . . . 43.140000000000001 108.853 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.97 -97.41 0.12 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 108.717 -1.753 . . . . 40.340000000000003 108.717 167.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.98 21.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 127.183 2.193 . . . . 74.409999999999997 116.017 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 87.37 66.29 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.733 -1.58 . . . . 64.310000000000002 106.733 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 30' ' ' SER . 4.1 m -88.38 -166.97 1.73 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.184 -2.524 . . . . 74.239999999999995 104.184 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.715 ' H ' HG22 ' A' ' 29' ' ' THR . 15.6 m -58.43 -21.01 49.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.553 -0.717 . . . . 54.210000000000001 110.625 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.58 126.27 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.765 -1.568 . . . . 64.129999999999995 106.765 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.7 mtm-85 -51.92 -57.6 8.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 115.204 -0.907 . . . . 72.400000000000006 112.363 -168.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -82.87 7.15 16.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.938 -0.764 . . . . 71.519999999999996 108.938 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.13 25.1 69.32 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 108.592 -1.803 . . . . 33.310000000000002 108.592 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.43 139.84 38.14 Favored Glycine 0 CA--C 1.479 -2.201 0 N-CA-C 107.394 -2.282 . . . . 52.399999999999999 107.394 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.29 120.35 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 104.645 -2.354 . . . . 74.200000000000003 104.645 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.55 146.65 41.54 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 106.306 -1.739 . . . . 74.400000000000006 106.306 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.26 135.02 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 73.109999999999999 107.084 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -49.12 3.22 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.518 -1.29 . . . . 72.430000000000007 107.518 -167.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 144.42 34.0 Favored 'General case' 0 CA--C 1.461 -2.469 0 N-CA-C 104.859 -2.274 . . . . 73.540000000000006 104.859 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.83 132.57 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 104.265 -2.494 . . . . 72.319999999999993 104.265 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.53 133.46 80.19 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 106.037 -1.838 . . . . 71.010000000000005 106.037 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.48 113.66 1.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.52 2.146 . . . . 64.219999999999999 108.141 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.36 21.9 5.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 124.621 1.201 . . . . 72.209999999999994 111.327 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.67 -166.74 27.96 Favored Glycine 0 C--N 1.367 2.271 0 N-CA-C 106.206 -2.758 . . . . 71.540000000000006 106.206 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 117.999 0.899 . . . . 72.439999999999998 110.427 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.58 -45.75 74.65 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 109.916 -0.402 . . . . 75.140000000000001 109.916 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -71.88 -39.06 69.88 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.481 -0.563 . . . . 72.349999999999994 109.481 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 t -65.9 -46.12 79.48 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.777 -1.194 . . . . 71.150000000000006 107.777 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.52 -32.33 71.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 106.92 -1.511 . . . . 60.219999999999999 106.92 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.73 -10.4 51.65 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.524 -0.762 . . . . 71.430000000000007 111.281 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -69.78 -38.25 76.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.945 -0.738 . . . . 61.409999999999997 110.025 -172.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.69 140.31 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 105.945 -1.872 . . . . 72.530000000000001 105.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -131.36 176.19 8.5 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.99 -1.485 . . . . 75.099999999999994 106.99 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.84 144.04 56.52 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.334 -0.987 . . . . 64.25 108.334 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.86 -4.17 74.93 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 109.678 -1.369 . . . . 72.120000000000005 109.678 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -86.25 156.35 20.32 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.823 -1.177 . . . . 71.540000000000006 107.823 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 118.56 37.04 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.992 -1.484 . . . . 73.25 106.992 -170.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.6 t -103.43 141.71 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 104.998 -2.223 . . . . 64.109999999999999 104.998 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.38 -45.66 2.62 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.589 -1.263 . . . . 71.040000000000006 107.589 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.34 158.21 39.76 Favored 'General case' 0 CA--C 1.477 -1.834 0 C-N-CA 118.695 -1.202 . . . . 75.439999999999998 109.345 -175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.79 106.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 104.775 -2.305 . . . . 74.439999999999998 104.775 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 45.19 43.9 8.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.255 1.422 . . . . 54.520000000000003 111.262 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.56 84.92 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.068 -1.213 . . . . 64.200000000000003 110.068 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.37 117.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.396 0 N-CA-C 103.151 -2.907 . . . . 75.109999999999999 103.151 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.7 m -75.69 114.33 14.15 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.775 -1.565 . . . . 74.299999999999997 106.775 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.29 28.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.594 -1.262 . . . . 74.519999999999996 107.594 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -75.55 122.5 23.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.12 -1.437 . . . . 50.520000000000003 107.12 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -9.68 52.81 Favored Glycine 0 C--N 1.328 0.1 0 N-CA-C 110.918 -0.873 . . . . 43.43 110.918 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 161.29 29.69 Favored 'General case' 0 C--N 1.364 1.232 0 CA-C-N 118.806 1.303 . . . . 73.430000000000007 107.598 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.6 p -82.31 167.14 18.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.406 -0.961 . . . . 72.450000000000003 108.406 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -66.52 -41.87 88.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.147 -0.686 . . . . 64.340000000000003 109.147 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -38.06 89.68 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.697 -0.668 . . . . 73.310000000000002 110.3 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -65.58 -35.8 81.9 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.143 1.338 . . . . 75.239999999999995 109.182 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.1 69.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.408 -0.59 . . . . 75.140000000000001 109.408 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.9 -53.75 19.13 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.265 -1.383 . . . . 70.450000000000003 107.265 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 63.8 m -54.7 -29.26 52.61 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 122.38 1.086 . . . . 75.319999999999993 108.374 -173.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.8 m -64.98 -53.32 47.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.149 -1.426 . . . . 73.230000000000004 107.149 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.42 -55.12 35.41 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.041 -0.725 . . . . 60.32 109.041 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -46.48 -41.07 13.45 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 116.629 -0.26 . . . . 61.409999999999997 111.273 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.52 -3.76 58.2 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.697 -0.627 . . . . 63.43 110.947 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 p -81.61 169.76 16.66 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 120.254 1.388 . . . . 73.530000000000001 108.598 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.02 -168.75 30.06 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.682 -1.367 . . . . 72.25 109.682 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -79.01 -25.07 43.3 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.485 -0.932 . . . . 63.530000000000001 108.485 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.13 130.35 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 103.625 -2.731 . . . . 64.209999999999994 103.625 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.94 139.59 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.791 -1.929 . . . . 70.239999999999995 105.791 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -95.67 116.57 29.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 104.402 -2.444 . . . . 73.120000000000005 104.402 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 12' ' ' LEU . 41.7 mt -118.79 139.82 50.96 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 106.138 -1.801 . . . . 73.239999999999995 106.138 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 127.87 55.72 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.461 -2.051 . . . . 72.319999999999993 105.461 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.86 156.72 47.57 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.689 -1.226 . . . . 73.430000000000007 107.689 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 . . . . . 0 CA--C 1.438 -3.336 0 N-CA-C 104.995 -2.224 . . . . 71.209999999999994 104.995 175.056 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.498 -1.029 0 N-CA-C 104.291 -2.485 . . . . 72.519999999999996 104.291 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -144.81 152.07 39.76 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.044 -2.206 . . . . 72.430000000000007 105.044 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.04 148.13 28.1 Favored 'General case' 0 N--CA 1.402 -2.829 0 N-CA-C 104.758 -2.312 . . . . 60.200000000000003 104.758 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.82 131.15 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 N-CA-C 103.712 -2.699 . . . . 64.310000000000002 103.712 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -103.85 111.91 24.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 104.327 -2.472 . . . . 75.109999999999999 104.327 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.425 ' CD1' ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -103.68 125.24 50.05 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.908 -1.516 . . . . 74.540000000000006 106.908 -164.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.1 124.8 37.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 105.694 -1.965 . . . . 54.240000000000002 105.694 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 107.639 -1.245 . . . . 64.540000000000006 107.639 -176.138 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.492 -1.375 0 N-CA-C 110.543 -1.023 . . . . 62.130000000000003 110.543 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.5 mt -128.43 163.12 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 102.263 -3.236 . . . . 64.329999999999998 102.263 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.2 t -153.15 159.09 42.67 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 102.821 -3.029 . . . . 74.310000000000002 102.821 174.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.86 167.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.941 -1.874 . . . . 73.420000000000002 105.941 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -153.78 167.71 28.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 103.499 -2.778 . . . . 72.239999999999995 103.499 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.16 -172.32 15.57 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 106.071 -2.812 . . . . 75.310000000000002 106.071 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.22 -124.63 5.38 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.962 -1.655 . . . . 64.430000000000007 108.962 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.08 18.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 126.292 1.837 . . . . 62.43 114.368 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 86.92 65.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.971 1.367 . . . . 71.310000000000002 107.342 -172.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.3 t -89.1 -165.12 1.26 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.076 -2.194 . . . . 71.109999999999999 105.076 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 m -49.63 -26.68 3.82 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.169 0.988 . . . . 61.100000000000001 112.208 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -86.71 118.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 N-CA-C 105.361 -2.088 . . . . 71.310000000000002 105.361 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.22 -14.35 60.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.787 -0.642 . . . . 74.329999999999998 111.053 -165.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -85.87 -5.99 59.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.346 -0.983 . . . . 75.340000000000003 108.346 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 10.59 27.49 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.894 -0.883 . . . . 32.109999999999999 110.894 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.56 158.29 53.5 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 107.986 -2.046 . . . . 61.340000000000003 107.986 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.47 129.0 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.602 -1.999 . . . . 72.439999999999998 105.602 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -125.38 144.97 50.26 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.281 -2.118 . . . . 75.409999999999997 105.281 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.72 134.16 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.09 -1.448 . . . . 74.200000000000003 107.09 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -103.93 -44.4 5.04 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.032 -1.099 . . . . 75.400000000000006 108.032 -171.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.68 153.97 40.0 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 105.964 -1.865 . . . . 62.439999999999998 105.964 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.42 130.0 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.309 -2.108 . . . . 70.120000000000005 105.309 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.474 HD12 ' HA2' ' A' ' 20' ' ' GLY . 17.1 mt -74.45 137.19 74.61 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.144 -1.799 . . . . 50.439999999999998 106.144 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.55 125.6 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.494 2.129 . . . . 75.219999999999999 108.685 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.467 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 33.9 mt-30 68.4 18.24 9.07 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 124.063 0.852 . . . . 74.200000000000003 109.817 -175.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.37 -177.68 52.01 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 106.153 -2.779 . . . . 60.310000000000002 106.153 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 12' ' ' LEU . . . -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.563 -0.375 . . . . 73.329999999999998 110.82 -168.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.89 94.8 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.065 -0.716 . . . . 75.420000000000002 109.065 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 44' ' ' GLN . 50.8 tp10 -59.49 -46.47 88.71 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.26 -0.644 . . . . 73.239999999999995 109.26 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 m -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.34 -0.615 . . . . 51.109999999999999 109.34 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.96 -45.49 74.05 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.204 -1.036 . . . . 74.340000000000003 108.204 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -32.8 5.52 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.312 -1.115 . . . . 72.310000000000002 110.312 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -75.17 -36.98 61.45 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 117.614 0.707 . . . . 72.329999999999998 109.132 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.04 138.24 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 104.761 -2.311 . . . . 73.329999999999998 104.761 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -136.6 179.11 6.56 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.124 -1.806 . . . . 75.150000000000006 106.124 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.08 139.85 58.76 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.7 -0.852 . . . . 74.409999999999997 108.7 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -3.34 87.22 Favored Glycine 0 CA--C 1.497 -1.082 0 N-CA-C 110.459 -1.056 . . . . 52.409999999999997 110.459 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.44 154.42 39.98 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-N 119.342 1.571 . . . . 63.219999999999999 107.219 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.71 118.29 36.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.555 -1.276 . . . . 75.439999999999998 107.555 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.57 145.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.843 -2.281 . . . . 75.209999999999994 104.843 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 -48.33 2.43 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.441 -1.318 . . . . 74.549999999999997 107.441 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.15 167.19 18.76 Favored 'General case' 0 CA--C 1.469 -2.148 0 C-N-CA 118.914 -1.114 . . . . 75.209999999999994 109.718 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.52 102.54 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 103.702 -2.703 . . . . 74.040000000000006 103.702 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.97 41.19 28.1 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.783 0.833 . . . . 63.200000000000003 111.03 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.04 15.06 73.38 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 109.935 -1.266 . . . . 70.239999999999995 109.935 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.44 116.31 52.23 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 104.353 -2.462 . . . . 74.450000000000003 104.353 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -76.4 7.39 4.43 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.546 0.738 . . . . 60.340000000000003 111.796 -171.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt 34.25 38.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.967 1.307 . . . . 51.130000000000003 111.775 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.9 129.72 36.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 O-C-N 121.148 -0.97 . . . . 65.209999999999994 109.534 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 0.98 83.03 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 109.102 -1.599 . . . . 64.239999999999995 109.102 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 152.26 45.99 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.951 -1.129 . . . . 74.409999999999997 107.951 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 159.74 26.89 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.673 -1.232 . . . . 63.409999999999997 107.673 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -62.29 -41.59 98.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.16 -1.052 . . . . 70.140000000000001 108.16 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -58.15 -41.76 84.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.793 -0.64 . . . . 73.239999999999995 109.865 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -66.25 -34.52 78.2 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 108.673 -0.862 . . . . 63.100000000000001 108.673 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.79 74.49 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.826 -0.805 . . . . 52.140000000000001 108.826 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.69 -52.6 22.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 107.26 -1.385 . . . . 64.239999999999995 107.26 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.6 m -52.96 -28.37 23.38 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.105 0.955 . . . . 62.130000000000003 108.45 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -65.75 -55.91 14.76 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.269 -1.382 . . . . 74.239999999999995 107.269 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.6 mt -53.78 -55.03 30.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 108.934 -0.765 . . . . 73.540000000000006 108.934 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -46.25 -42.13 13.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.231 -0.44 . . . . 75.439999999999998 111.615 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -86.68 -5.59 59.09 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 121.72 -0.612 . . . . 72.299999999999997 110.87 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -85.06 170.51 12.89 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.755 -1.216 . . . . 74.530000000000001 108.404 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 -161.56 22.04 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.394 -1.482 . . . . 75.109999999999999 109.394 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.99 -28.89 49.39 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.122 -1.066 . . . . 75.129999999999995 108.122 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.87 134.47 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.105 -2.554 . . . . 52.109999999999999 104.105 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.66 143.29 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.678 -2.341 . . . . 71.430000000000007 104.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -96.89 117.13 30.44 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.975 -2.232 . . . . 52.520000000000003 104.975 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.03 137.82 51.99 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 105.215 -2.143 . . . . 73.340000000000003 105.215 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.79 127.66 56.1 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 105.313 -2.106 . . . . 72.340000000000003 105.313 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.57 154.35 48.92 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.761 -1.57 . . . . 62.229999999999997 106.761 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 . . . . . 0 CA--C 1.476 -1.87 0 N-CA-C 105.089 -2.189 . . . . 60.009999999999998 105.089 179.173 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 105.963 -1.866 . . . . 72.129999999999995 105.963 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -133.78 149.84 51.44 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.19 -1.782 . . . . 73.230000000000004 106.19 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -102.26 138.1 39.65 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.99 -1.855 . . . . 72.129999999999995 105.99 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.9 t -129.11 127.58 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 104.939 -2.245 . . . . 62.140000000000001 104.939 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -103.34 109.45 21.07 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.676 -1.972 . . . . 73.25 105.676 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.99 122.95 45.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 N-CA-C 106.459 -1.682 . . . . 70.109999999999999 106.459 -164.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.37 138.18 32.64 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.343 -1.355 . . . . 74.409999999999997 107.343 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 106.359 -1.719 . . . . 74.329999999999998 106.359 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.609 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.434 -1.482 0 N-CA-C 110.944 -0.862 . . . . 71.450000000000003 110.944 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mm -111.7 160.94 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.214 -2.513 . . . . 74.040000000000006 104.214 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -154.01 159.23 41.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 102.624 -3.102 . . . . 73.099999999999994 102.624 165.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.59 166.83 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 105.918 -1.882 . . . . 54.119999999999997 105.918 -168.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -147.87 165.86 29.35 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.199 -2.889 . . . . 74.239999999999995 103.199 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.72 -171.79 15.23 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 107.378 -2.289 . . . . 74.349999999999994 107.378 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.87 -128.81 6.81 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.205 -1.558 . . . . 54.32 109.205 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.48 19.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 127.24 2.216 . . . . 34.420000000000002 114.396 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 85.52 64.03 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.919 -1.512 . . . . 73.329999999999998 106.919 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -93.28 -166.15 1.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 104.357 -2.46 . . . . 61.229999999999997 104.357 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -38.42 -38.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.628 1.571 . . . . 71.340000000000003 113.305 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.69 131.97 33.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.235 0 N-CA-C 107.683 -1.229 . . . . 74.530000000000001 107.683 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -59.93 -50.7 72.74 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.636 -0.711 . . . . 75.140000000000001 111.446 -168.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.36 -3.64 31.55 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.8 -0.562 . . . . 75.120000000000005 109.692 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.54 14.25 41.59 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 110.345 -1.102 . . . . 74.209999999999994 110.345 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.42 154.5 50.47 Favored Glycine 0 CA--C 1.478 -2.231 0 N-CA-C 107.643 -2.183 . . . . 73.439999999999998 107.643 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.86 108.62 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.639 -1.615 . . . . 74.340000000000003 106.639 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 58' ' ' ARG . 36.1 m-85 -98.28 143.19 29.04 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 106.225 -1.769 . . . . 71.420000000000002 106.225 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.28 126.99 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 105.717 -1.957 . . . . 74.340000000000003 105.717 169.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -99.69 -49.54 4.35 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 107.363 -1.347 . . . . 75.510000000000005 107.363 -168.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.87 149.13 38.12 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 106.042 -1.836 . . . . 54.240000000000002 106.042 -171.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.76 121.95 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 104.221 -2.511 . . . . 71.150000000000006 104.221 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.609 HD12 ' HA2' ' A' ' 20' ' ' GLY . 25.2 mt -75.58 138.27 70.63 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 105.215 -2.142 . . . . 73.299999999999997 105.215 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 42' ' ' ILE . 17.7 Cg_endo -56.47 129.48 34.94 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.133 1.889 . . . . 73.049999999999997 109.347 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 64.18 22.2 12.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 124.975 1.422 . . . . 63.399999999999999 111.329 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.69 175.95 43.38 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 107.202 -2.359 . . . . 74.439999999999998 107.202 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.54 73.48 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.255 -0.646 . . . . 61.409999999999997 109.255 -172.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.09 -49.71 59.53 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.231 -0.655 . . . . 54.539999999999999 109.231 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.24 -37.03 82.86 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 109.503 -0.554 . . . . 64.109999999999999 109.503 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.3 m -65.49 -37.97 88.39 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.47 -0.937 . . . . 73.519999999999996 108.47 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.74 -37.12 79.2 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.248 -1.019 . . . . 55.039999999999999 108.248 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.58 -21.71 8.64 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.898 -0.881 . . . . 31.329999999999998 110.898 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.9 mtt85 -75.44 -41.09 56.71 Favored 'General case' 0 CA--C 1.495 -1.165 0 O-C-N 121.524 -0.986 . . . . 72.549999999999997 108.61 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.36 128.02 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 106.15 -1.796 . . . . 63.329999999999998 106.15 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -131.34 177.4 7.51 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.645 -1.983 . . . . 72.219999999999999 105.645 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -67.06 145.27 55.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.615 -1.995 . . . . 73.219999999999999 105.615 171.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.05 58.04 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 107.377 -2.289 . . . . 45.009999999999998 107.377 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -84.8 158.47 20.67 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 105.301 -2.111 . . . . 54.420000000000002 105.301 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.46 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -137.23 150.64 48.0 Favored 'General case' 0 CA--C 1.47 -2.115 0 N-CA-C 107.054 -1.461 . . . . 74.439999999999998 107.054 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 t -104.86 145.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 104.786 -2.301 . . . . 53.240000000000002 104.786 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -48.23 3.02 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.329 -1.73 . . . . 71.219999999999999 106.329 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.18 161.49 31.0 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.429 1.109 . . . . 61.25 110.151 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -142.75 111.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 104.217 -2.512 . . . . 74.519999999999996 104.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 50.53 39.8 21.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.755 0.822 . . . . 72.510000000000005 110.466 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.37 7.18 79.96 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 109.978 -1.249 . . . . 53.520000000000003 109.978 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 67' ' ' LEU . 43.5 t -108.32 116.56 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.686 -2.338 . . . . 73.030000000000001 104.686 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -79.92 14.82 1.64 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.417 0.287 . . . . 63.420000000000002 111.348 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.502 ' H ' HG12 ' A' ' 65' ' ' VAL . 4.5 mm? 38.09 38.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.06 1.344 . . . . 74.150000000000006 111.329 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -76.09 125.25 28.79 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.762 -1.212 . . . . 64.109999999999999 108.499 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.72 -7.49 65.5 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 109.706 -1.358 . . . . 71.540000000000006 109.706 172.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.41 41.81 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.874 -1.158 . . . . 64.230000000000004 107.874 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -83.85 165.94 18.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.153 -1.054 . . . . 34.020000000000003 108.153 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.9 -36.6 84.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.302 -0.863 . . . . 71.510000000000005 109.118 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.2 -48.37 73.95 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 109.652 -0.499 . . . . 64.439999999999998 109.652 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -68.83 -30.21 68.71 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.598 -0.689 . . . . 70.150000000000006 109.334 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.11 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.336 -0.987 . . . . 70.200000000000003 108.336 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.16 -51.05 42.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 107.285 -1.376 . . . . 73.450000000000003 107.285 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.2 m -52.66 -28.36 21.22 Favored 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 108.554 -0.906 . . . . 73.239999999999995 108.554 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.2 m -72.67 -57.27 4.25 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.711 -1.218 . . . . 55.340000000000003 107.711 -171.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.81 -56.9 16.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.708 -0.849 . . . . 75.209999999999994 108.708 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -47.26 -38.75 12.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.89 0.7 . . . . 63.140000000000001 112.89 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -88.54 -2.01 58.36 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.324 -0.86 . . . . 63.5 110.241 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -77.73 176.67 8.8 Favored 'General case' 0 C--O 1.243 0.723 0 O-C-N 120.61 -1.306 . . . . 74.319999999999993 108.181 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.18 -163.62 26.03 Favored Glycine 0 CA--C 1.491 -1.425 0 N-CA-C 108.741 -1.744 . . . . 24.43 108.741 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.44 -33.93 42.07 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.945 -1.502 . . . . 62.130000000000003 106.945 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 t -113.57 130.54 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.096 0 N-CA-C 104.037 -2.579 . . . . 70.239999999999995 104.037 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 t -129.35 149.58 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 105.944 -1.873 . . . . 60.009999999999998 105.944 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -97.42 111.77 23.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.163 -2.162 . . . . 74.0 105.163 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -112.34 137.74 50.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.321 -2.103 . . . . 75.420000000000002 105.321 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 tp -115.92 124.18 49.95 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.807 -2.294 . . . . 62.509999999999998 104.807 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.8 155.41 46.01 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 106.934 -1.506 . . . . 61.420000000000002 106.934 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.416 -2.131 0 N-CA-C 103.248 -2.871 . . . . 72.409999999999997 103.248 179.49 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 105.384 -2.08 . . . . 75.0 105.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -142.95 149.69 38.72 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.255 -1.757 . . . . 73.430000000000007 106.255 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.15 140.86 36.78 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.553 -2.017 . . . . 72.040000000000006 105.553 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 52' ' ' ARG . 91.3 t -126.38 133.12 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 105.914 -1.884 . . . . 63.450000000000003 105.914 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.67 116.97 33.91 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.475 -2.046 . . . . 61.399999999999999 105.475 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -103.17 121.21 42.19 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.874 -1.898 . . . . 53.549999999999997 105.874 -173.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 134.42 38.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.827 -1.175 . . . . 65.040000000000006 107.827 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp . . . . . 0 C--O 1.21 -1.01 0 N-CA-C 107.268 -1.382 . . . . 73.239999999999995 107.268 175.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.493 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.496 -1.128 0 CA-C-O 120.021 -0.322 . . . . 72.239999999999995 112.988 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.9 mt -132.06 152.49 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.463 -2.791 . . . . 72.0 103.463 170.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.1 m -148.51 164.25 34.77 Favored 'General case' 0 CA--C 1.469 -2.164 0 N-CA-C 103.636 -2.727 . . . . 75.439999999999998 103.636 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -145.12 168.69 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 105.196 -2.15 . . . . 42.210000000000001 105.196 -168.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -142.79 166.0 25.84 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 102.108 -3.293 . . . . 64.209999999999994 102.108 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.71 -174.36 16.0 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 107.09 -2.404 . . . . 63.130000000000003 107.09 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.38 -128.27 5.91 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.115 -1.594 . . . . 64.519999999999996 109.115 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 m -66.92 19.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.638 1.975 . . . . 74.25 113.962 -168.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.256 85.5 m-20 87.04 66.35 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.956 0 CA-C-O 123.198 1.475 . . . . 62.240000000000002 107.479 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -80.82 -166.62 1.15 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.088 -2.56 . . . . 71.219999999999999 104.088 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -57.57 -19.42 25.44 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 121.536 -0.727 . . . . 64.310000000000002 112.178 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.471 ' H ' HG23 ' A' ' 29' ' ' THR . 27.6 m -85.84 135.23 25.42 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 N-CA-C 107.569 -1.271 . . . . 72.319999999999993 107.569 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -57.36 -55.47 34.42 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.624 0.77 . . . . 75.319999999999993 112.048 -166.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -85.63 12.07 9.52 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 121.166 -0.959 . . . . 63.200000000000003 109.308 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.44 22.94 59.68 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 110.217 -1.153 . . . . 64.129999999999995 110.217 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.8 145.88 50.03 Favored Glycine 0 C--N 1.36 1.902 0 N-CA-C 108.931 -1.668 . . . . 53.350000000000001 108.931 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mm -83.97 94.77 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.982 -1.858 . . . . 64.549999999999997 105.982 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -91.48 143.73 26.3 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 106.998 -1.482 . . . . 64.409999999999997 106.998 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.8 131.47 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.351 -1.722 . . . . 62.32 106.351 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -102.61 -47.52 4.41 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.785 -1.561 . . . . 63.32 106.785 -166.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.45 151.22 36.06 Favored 'General case' 0 CA--C 1.465 -2.322 0 N-CA-C 105.473 -2.047 . . . . 52.100000000000001 105.473 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.26 130.21 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 104.065 -2.569 . . . . 74.310000000000002 104.065 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.493 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.8 mm -69.46 146.21 96.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 105.141 -2.17 . . . . 74.519999999999996 105.141 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 42' ' ' ILE . 13.0 Cg_endo -55.05 118.36 5.07 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.087 1.858 . . . . 42.43 108.217 167.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.54 29.49 19.06 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.16 0.913 . . . . 73.329999999999998 111.654 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.64 -174.31 35.76 Favored Glycine 0 C--N 1.379 2.956 0 N-CA-C 106.724 -2.551 . . . . 62.530000000000001 106.724 167.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.19 74.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 122.004 -0.703 . . . . 75.239999999999995 110.378 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.5 91.24 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.819 -0.438 . . . . 53.200000000000003 109.819 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.2 -38.87 91.84 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.104 -0.702 . . . . 73.430000000000007 109.104 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 t -65.14 -42.47 93.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.438 -0.949 . . . . 53.43 108.438 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.93 -39.87 94.18 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 107.499 -1.297 . . . . 70.109999999999999 107.499 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 82.49 -14.94 32.48 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 110.631 -0.988 . . . . 44.039999999999999 110.631 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.467 ' HD2' HG13 ' A' ' 10' ' ' VAL . 39.7 ttm105 -81.5 -38.8 25.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.55 -0.971 . . . . 64.510000000000005 108.554 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.6 mt -101.98 133.08 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.016 -1.846 . . . . 63.409999999999997 106.016 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 93.3 m-70 -126.54 179.19 5.45 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.573 -1.64 . . . . 75.230000000000004 106.573 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.02 144.25 55.21 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 105.455 -2.054 . . . . 70.239999999999995 105.455 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.24 -23.86 32.99 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.207 -1.957 . . . . 70.209999999999994 108.207 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.19 152.18 46.2 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 107.52 -1.289 . . . . 74.209999999999994 107.52 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.71 131.92 47.97 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 106.938 -1.505 . . . . 34.530000000000001 106.938 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.06 150.54 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 105.246 -2.131 . . . . 73.230000000000004 105.246 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.49 -46.63 2.86 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.54 -1.281 . . . . 72.109999999999999 107.54 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.47 159.58 35.84 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 118.974 -1.091 . . . . 61.219999999999999 109.235 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.99 107.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.748 -2.315 . . . . 71.219999999999999 104.748 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.2 t30 51.2 36.91 17.02 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.365 1.066 . . . . 71.420000000000002 111.417 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.52 68.65 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.648 -1.381 . . . . 73.140000000000001 109.648 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.12 120.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 105.024 -2.213 . . . . 61.32 105.024 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -68.24 106.75 2.55 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.516 -1.661 . . . . 71.439999999999998 106.516 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -21.38 56.76 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.168 -0.679 . . . . 72.329999999999998 109.168 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -57.85 145.0 36.76 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.073 -0.714 . . . . 64.120000000000005 109.073 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.57 -38.5 3.11 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 108.976 -1.65 . . . . 52.0 108.976 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.44 158.37 29.63 Favored 'General case' 0 C--N 1.363 1.162 0 CA-C-N 117.783 0.791 . . . . 74.530000000000001 109.596 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -84.73 166.11 17.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.394 -1.336 . . . . 73.319999999999993 107.394 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -65.04 -41.04 95.59 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.05 -0.722 . . . . 75.5 109.05 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -54.88 -46.18 74.71 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 109.932 -0.395 . . . . 64.219999999999999 109.932 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -69.7 -35.81 75.4 Favored 'General case' 0 C--N 1.366 1.302 0 N-CA-C 108.864 -0.791 . . . . 75.109999999999999 108.864 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.41 -41.94 77.18 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.383 -0.599 . . . . 53.340000000000003 109.383 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 23' ' ' VAL . 48.0 t -68.89 -54.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 N-CA-C 107.861 -1.162 . . . . 73.319999999999993 107.861 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.92 -27.57 44.22 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 108.587 -0.894 . . . . 61.130000000000003 108.587 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -66.48 -53.46 34.99 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.325 -1.361 . . . . 61.32 107.325 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.93 -56.92 15.47 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.677 -0.86 . . . . 72.200000000000003 108.677 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -48.27 -26.13 1.85 Allowed 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 113.382 0.882 . . . . 54.039999999999999 113.382 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -92.36 -10.63 37.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.09 0.859 . . . . 75.349999999999994 109.379 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -78.55 175.5 10.29 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 120.97 -1.081 . . . . 72.129999999999995 108.795 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.72 -163.38 26.91 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.406 -1.478 . . . . 63.520000000000003 109.406 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -78.5 -35.82 45.88 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.968 -1.493 . . . . 74.239999999999995 106.968 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.07 128.54 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.825 0 N-CA-C 102.692 -3.077 . . . . 72.340000000000003 102.692 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.73 140.1 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.905 0 N-CA-C 105.101 -2.185 . . . . 74.129999999999995 105.101 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -92.42 111.24 22.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 104.783 -2.302 . . . . 42.130000000000003 104.783 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 12' ' ' LEU . 80.2 mt -114.77 140.33 48.99 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 106.163 -1.792 . . . . 75.010000000000005 106.163 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 tp -111.86 127.14 55.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.888 -1.893 . . . . 75.340000000000003 105.888 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mp -133.48 155.56 49.33 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.472 -1.677 . . . . 65.319999999999993 106.472 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 104.872 -2.27 . . . . 74.120000000000005 104.872 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 104.925 -2.25 . . . . 70.109999999999999 104.925 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.01 160.32 43.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.464 -1.68 . . . . 55.130000000000003 106.464 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -102.48 139.36 38.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.824 -1.917 . . . . 71.439999999999998 105.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.37 134.16 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 N-CA-C 105.841 -1.911 . . . . 62.399999999999999 105.841 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.68 124.01 48.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.008 -2.219 . . . . 72.450000000000003 105.008 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.84 120.94 43.02 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 104.894 -2.262 . . . . 65.239999999999995 104.894 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.32 29.72 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 107.923 -1.14 . . . . 74.329999999999998 107.923 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp . . . . . 0 N--CA 1.433 -1.281 0 N-CA-C 106.88 -1.526 . . . . 75.25 106.88 175.01 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.104 0 N-CA-C 108.458 -1.857 . . . . 63.219999999999999 108.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 mt -127.99 153.43 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 104.131 -2.544 . . . . 64.120000000000005 104.131 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.4 m -144.97 160.38 41.43 Favored 'General case' 0 CA--C 1.479 -1.75 0 N-CA-C 102.918 -2.993 . . . . 55.439999999999998 102.918 169.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.56 167.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 106.736 -1.579 . . . . 72.209999999999994 106.736 -162.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -149.57 166.62 28.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 103.619 -2.734 . . . . 71.299999999999997 103.619 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.83 -177.39 17.1 Favored Glycine 0 CA--C 1.486 -1.733 0 N-CA-C 107.417 -2.273 . . . . 60.32 107.417 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.53 -133.65 6.94 Favored Glycine 0 C--N 1.364 2.086 0 N-CA-C 110.014 -1.234 . . . . 54.43 110.014 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.04 19.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.823 2.449 . . . . 64.409999999999997 114.812 -167.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.0 t30 86.23 65.24 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.667 -1.605 . . . . 73.239999999999995 106.667 -169.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.1 t -96.34 -164.82 1.19 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.571 -2.751 . . . . 64.040000000000006 103.571 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -27.88 -49.46 0.06 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.027 1.731 . . . . 52.200000000000003 113.12 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.3 129.95 38.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.132 -1.062 . . . . 75.530000000000001 108.132 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.18 -27.11 59.52 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 107.655 -1.239 . . . . 74.030000000000001 107.655 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -63.34 -17.75 62.91 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 108.466 -0.939 . . . . 73.310000000000002 108.466 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.15 -5.65 2.64 Favored Glycine 0 C--N 1.372 2.539 0 N-CA-C 111.34 -0.704 . . . . 60.450000000000003 111.34 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.46 153.51 52.94 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 108.978 -1.649 . . . . 42.340000000000003 108.978 -172.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -83.13 97.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 105.918 -1.882 . . . . 63.030000000000001 105.918 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.32 146.09 25.48 Favored 'General case' 0 CA--C 1.477 -1.865 0 N-CA-C 107.46 -1.311 . . . . 73.019999999999996 107.46 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.52 130.83 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.851 -1.907 . . . . 65.549999999999997 105.851 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -108.09 -36.82 6.22 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.146 -1.427 . . . . 70.349999999999994 107.146 -167.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.23 151.48 33.08 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 106.897 -1.519 . . . . 73.109999999999999 106.897 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.46 128.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 104.743 -2.317 . . . . 71.239999999999995 104.743 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 mt -69.27 136.01 88.97 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 107.471 -1.307 . . . . 54.530000000000001 107.471 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.12 111.16 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.757 2.305 . . . . 71.150000000000006 108.725 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 74.7 21.3 2.19 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 124.552 1.157 . . . . 74.349999999999994 110.602 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.61 179.26 40.94 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 107.049 -2.42 . . . . 61.409999999999997 107.049 165.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.8 98.84 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.871 -0.788 . . . . 74.040000000000006 108.871 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -47.64 73.61 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.174 -0.466 . . . . 64.140000000000001 110.195 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.56 -37.95 89.27 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 109.232 -0.655 . . . . 64.510000000000005 109.232 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -64.28 -37.43 87.46 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 107.999 -1.111 . . . . 70.010000000000005 107.999 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.26 -46.38 70.59 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 107.648 -1.241 . . . . 72.109999999999999 107.648 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.5 -13.27 47.63 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.394 -0.682 . . . . 63.109999999999999 111.394 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -73.91 -41.71 61.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.636 1.218 . . . . 72.329999999999998 108.39 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.78 135.48 33.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 106.982 -1.488 . . . . 75.510000000000005 106.982 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.52 -178.56 5.17 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 105.582 -2.007 . . . . 64.019999999999996 105.582 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 141.24 57.74 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.873 -1.899 . . . . 73.140000000000001 105.873 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.26 -13.29 48.27 Favored Glycine 0 CA--C 1.477 -2.296 0 N-CA-C 107.91 -2.076 . . . . 71.25 107.91 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -82.87 150.25 26.64 Favored 'General case' 0 CA--C 1.485 -1.538 0 N-CA-C 106.184 -1.784 . . . . 74.230000000000004 106.184 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.545 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.7 tmm_? -115.91 123.08 47.2 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 106.265 -1.754 . . . . 72.030000000000001 106.265 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -94.12 140.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.248 -2.13 . . . . 72.150000000000006 105.248 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 -43.95 3.06 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 106.96 -1.496 . . . . 72.230000000000004 106.96 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.51 165.37 22.83 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 122.536 1.16 . . . . 74.019999999999996 110.029 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.56 102.37 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 103.376 -2.824 . . . . 64.540000000000006 103.376 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 t30 51.89 42.28 30.03 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.373 1.069 . . . . 71.5 110.275 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.98 14.31 79.66 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.27 -1.132 . . . . 74.099999999999994 110.27 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.16 117.25 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 103.835 -2.654 . . . . 72.0 103.835 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -70.4 115.93 10.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.189 -1.041 . . . . 53.340000000000003 108.189 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.6 13.97 7.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.827 -1.175 . . . . 73.349999999999994 107.827 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.72 137.7 54.31 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.704 -1.221 . . . . 61.399999999999999 107.704 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.26 -16.93 14.6 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.012 -1.235 . . . . 55.020000000000003 110.012 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.54 154.44 41.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.095 -1.076 . . . . 74.409999999999997 108.095 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.75 163.13 19.33 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.589 -1.263 . . . . 74.430000000000007 107.589 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -63.07 -38.87 92.92 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 116.167 -0.47 . . . . 72.510000000000005 110.951 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.32 -35.21 79.62 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 120.384 -0.526 . . . . 51.109999999999999 109.929 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.15 -31.07 69.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 121.145 -0.972 . . . . 61.399999999999999 108.99 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.19 79.88 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.975 -1.12 . . . . 75.409999999999997 107.975 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.22 -55.02 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.625 -1.25 . . . . 64.219999999999999 107.625 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.3 m -56.2 -27.73 55.74 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 108.829 -0.804 . . . . 62.409999999999997 108.829 -171.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -61.79 -55.86 25.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 106.975 -1.491 . . . . 61.109999999999999 106.975 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.57 -55.68 30.79 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 109.027 -0.731 . . . . 74.140000000000001 109.027 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -46.77 -34.02 4.88 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.625 -0.672 . . . . 71.239999999999995 112.52 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -98.56 4.2 48.11 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.255 -0.903 . . . . 74.109999999999999 110.413 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 p -80.76 173.63 12.42 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.645 -1.284 . . . . 72.129999999999995 108.685 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.2 -136.08 7.22 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.297 -0.721 . . . . 64.109999999999999 111.297 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -82.99 -49.09 9.94 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.32 -0.993 . . . . 72.439999999999998 108.32 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.0 132.98 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 N-CA-C 104.11 -2.552 . . . . 72.140000000000001 104.11 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -116.83 134.23 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 105.056 -2.202 . . . . 61.450000000000003 105.056 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.92 120.2 35.78 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.546 -2.02 . . . . 72.319999999999993 105.546 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.67 137.23 52.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.074 -1.825 . . . . 73.140000000000001 106.074 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.88 125.69 53.9 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.454 -2.424 . . . . 65.310000000000002 104.454 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.25 155.44 46.28 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 108.449 -0.945 . . . . 74.200000000000003 108.449 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.545 ' CD ' HH21 ' A' ' 58' ' ' ARG . 35.6 tt0 . . . . . 0 N--CA 1.414 -2.262 0 N-CA-C 102.404 -3.184 . . . . 44.43 102.404 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.486 -1.517 0 N-CA-C 103.878 -2.638 . . . . 72.430000000000007 103.878 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.68 143.77 51.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.843 -1.91 . . . . 74.540000000000006 105.843 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.5 130.76 50.94 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.883 -1.895 . . . . 63.229999999999997 105.883 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.98 129.8 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.13 0 N-CA-C 105.024 -2.213 . . . . 73.230000000000004 105.024 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -103.44 110.75 22.88 Favored 'General case' 0 CA--C 1.471 -2.059 0 N-CA-C 105.745 -1.946 . . . . 72.040000000000006 105.745 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.683 -1.599 . . . . 64.120000000000005 106.683 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.36 147.84 25.85 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.964 -1.495 . . . . 74.549999999999997 106.964 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 105.596 -2.002 . . . . 73.219999999999999 105.596 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.585 ' HA3' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.438 -1.199 0 N-CA-C 111.205 -0.758 . . . . 61.229999999999997 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.2 161.38 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 103.839 -2.652 . . . . 72.140000000000001 103.839 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.68 162.72 41.01 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.396 -2.816 . . . . 64.0 103.396 163.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.43 167.86 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 105.389 -2.078 . . . . 74.540000000000006 105.389 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -146.77 166.33 26.97 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.958 -2.608 . . . . 61.030000000000001 103.958 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 83.92 138.6 3.74 Favored Glycine 0 C--O 1.191 -2.543 0 N-CA-C 111.472 -0.651 . . . . 63.32 111.472 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.31 -89.08 0.07 OUTLIER Glycine 0 C--N 1.362 2.002 0 N-CA-C 109.228 -1.549 . . . . 54.32 109.228 167.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.21 20.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 117.279 2.326 . . . . 64.299999999999997 117.279 -165.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 88.32 65.08 0.01 OUTLIER 'General case' 0 CA--C 1.466 -2.27 0 N-CA-C 105.332 -2.099 . . . . 74.319999999999993 105.332 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.482 ' H ' HG22 ' A' ' 29' ' ' THR . 5.1 t -85.7 -166.66 1.59 Allowed 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 110.972 -2.831 . . . . 73.400000000000006 106.115 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 m -60.93 -31.0 70.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.473 1.109 . . . . 72.430000000000007 110.552 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 29' ' ' THR . 4.7 m -87.33 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 107.849 -1.167 . . . . 72.409999999999997 107.849 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -67.11 -37.31 83.67 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.398 0.679 . . . . 63.140000000000001 110.111 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -69.47 -9.02 51.91 Favored 'General case' 0 C--O 1.211 -0.938 0 O-C-N 121.393 -0.817 . . . . 64.319999999999993 109.742 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.82 13.77 57.17 Favored Glycine 0 C--N 1.37 2.438 0 N-CA-C 108.589 -1.804 . . . . 72.450000000000003 108.589 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 144.99 47.57 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 109.609 -1.396 . . . . 64.510000000000005 109.609 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 25' ' ' GLY . 1.7 mm -85.83 104.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 102.454 -3.165 . . . . 70.120000000000005 102.454 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -101.29 147.51 26.21 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 107.501 -1.296 . . . . 73.0 107.501 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.25 132.62 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 106.77 -1.567 . . . . 72.340000000000003 106.77 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -109.07 -48.11 3.32 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.501 -0.926 . . . . 53.310000000000002 108.501 -167.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.61 146.04 34.13 Favored 'General case' 0 CA--C 1.463 -2.388 0 N-CA-C 105.806 -1.924 . . . . 50.450000000000003 105.806 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.9 t -130.59 130.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 103.981 -2.6 . . . . 74.239999999999995 103.981 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.585 HG12 ' HA3' ' A' ' 20' ' ' GLY . 34.0 mm -67.59 141.13 95.05 Favored Pre-proline 0 C--N 1.353 0.718 0 N-CA-C 106.093 -1.817 . . . . 73.409999999999997 106.093 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.52 109.12 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.153 1.902 . . . . 64.340000000000003 107.896 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 70.15 30.28 3.53 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.446 1.091 . . . . 70.140000000000001 110.929 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.45 -179.0 33.83 Favored Glycine 0 C--N 1.369 2.385 0 N-CA-C 107.279 -2.328 . . . . 65.209999999999994 107.279 162.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.89 -35.34 80.33 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 122.102 -0.646 . . . . 52.229999999999997 109.48 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.85 82.32 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.273 -0.64 . . . . 64.540000000000006 109.273 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.58 -34.71 77.59 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.617 -0.512 . . . . 73.230000000000004 109.617 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -70.05 -42.32 73.03 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.74 -0.837 . . . . 62.119999999999997 108.74 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -67.71 -37.07 81.76 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.691 -1.226 . . . . 74.439999999999998 107.691 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.64 -14.28 47.95 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 111.32 -0.712 . . . . 63.140000000000001 111.32 170.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -80.88 -35.06 33.12 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.741 -0.858 . . . . 65.120000000000005 108.968 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.2 mt -95.24 133.04 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.136 -1.801 . . . . 70.209999999999994 106.136 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -135.41 175.27 9.74 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.275 -1.75 . . . . 52.420000000000002 106.275 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -65.85 132.58 49.02 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.407 -0.96 . . . . 75.439999999999998 108.407 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.81 -12.07 62.6 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.078 -1.609 . . . . 52.530000000000001 109.078 170.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -65.87 150.92 47.81 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 106.767 -1.568 . . . . 64.329999999999998 106.767 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.481 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.9 tmm_? -109.32 127.48 54.34 Favored 'General case' 0 C--O 1.197 -1.672 0 N-CA-C 106.265 -1.754 . . . . 71.540000000000006 106.265 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.48 138.66 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 106.17 -1.789 . . . . 65.140000000000001 106.17 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -52.21 2.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.553 -1.277 . . . . 72.349999999999994 107.553 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.3 165.52 23.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-O 122.157 0.98 . . . . 64.230000000000004 110.354 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.28 108.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 104.228 -2.508 . . . . 73.239999999999995 104.228 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.7 t30 54.94 38.18 30.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.333 0.653 . . . . 74.540000000000006 109.851 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.63 79.3 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 109.528 -1.429 . . . . 63.210000000000001 109.528 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.87 119.82 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 104.776 -2.305 . . . . 75.209999999999994 104.776 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.2 m -71.91 113.23 8.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.167 -1.049 . . . . 61.520000000000003 108.167 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.03 -28.8 62.56 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 107.589 -1.263 . . . . 73.420000000000002 107.589 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -52.3 145.04 11.66 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 122.806 0.442 . . . . 73.430000000000007 110.53 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.49 -36.45 3.58 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 110.062 -1.215 . . . . 54.310000000000002 110.062 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.52 173.82 5.58 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.191 0.996 . . . . 74.019999999999996 110.006 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 p -81.01 160.56 24.54 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 107.966 -1.124 . . . . 71.129999999999995 107.966 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -64.29 -38.6 91.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.7 -0.852 . . . . 75.200000000000003 108.7 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -60.88 -41.86 96.79 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 120.449 -0.5 . . . . 63.43 109.661 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -63.64 -38.88 92.79 Favored 'General case' 0 C--N 1.369 1.421 0 N-CA-C 108.523 -0.917 . . . . 73.519999999999996 108.523 -172.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.91 70.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 109.958 -0.386 . . . . 74.340000000000003 109.958 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -74.17 -53.87 16.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.528 -1.286 . . . . 65.010000000000005 107.528 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.09 -28.31 38.36 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.263 -1.014 . . . . 52.43 108.263 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -67.7 -53.75 25.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.986 -1.116 . . . . 74.310000000000002 107.986 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -58.0 -56.83 16.95 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.158 -0.682 . . . . 52.119999999999997 109.158 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -51.63 -16.29 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.49 0.922 . . . . 73.439999999999998 113.49 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -99.53 -2.86 34.75 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.994 -1.066 . . . . 74.019999999999996 108.555 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -78.57 166.54 22.43 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.374 -0.829 . . . . 75.239999999999995 109.435 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.4 -140.9 6.08 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 109.364 -1.494 . . . . 51.009999999999998 109.364 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -84.03 -48.74 9.6 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.125 -1.065 . . . . 71.150000000000006 108.125 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.81 135.63 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.968 -2.605 . . . . 63.420000000000002 103.968 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -123.51 142.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 104.7 -2.333 . . . . 64.230000000000004 104.7 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -96.25 115.63 27.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.354 -2.462 . . . . 63.299999999999997 104.354 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.1 mt -117.4 143.35 46.08 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 106.073 -1.825 . . . . 75.340000000000003 106.073 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.51 131.29 56.74 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 103.982 -2.599 . . . . 74.310000000000002 103.982 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.99 155.32 48.2 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.987 -1.857 . . . . 72.239999999999995 105.987 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.481 ' CD ' HH21 ' A' ' 58' ' ' ARG . 39.0 tt0 . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 105.019 -2.215 . . . . 75.129999999999995 105.019 -176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.494 -1.194 0 N-CA-C 104.499 -2.408 . . . . 74.329999999999998 104.499 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -129.43 141.14 51.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.064 -1.828 . . . . 63.149999999999999 106.064 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -102.58 134.32 46.13 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 105.926 -1.879 . . . . 73.510000000000005 105.926 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -130.44 130.65 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.116 0 N-CA-C 105.461 -2.051 . . . . 74.510000000000005 105.461 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.42 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 9.0 pt-20 -106.25 125.92 51.59 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.666 -2.346 . . . . 72.239999999999995 104.666 169.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.32 122.73 47.98 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.544 -1.651 . . . . 62.530000000000001 106.544 -167.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.88 137.17 35.33 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.476 -1.305 . . . . 62.119999999999997 107.476 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 106.652 -1.61 . . . . 72.140000000000001 106.652 173.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.55 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.492 -1.378 0 N-CA-C 111.524 -0.631 . . . . 72.329999999999998 111.524 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.45 156.17 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.79 -3.041 . . . . 65.439999999999998 102.79 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.2 m -145.57 160.88 40.99 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 102.575 -3.12 . . . . 71.409999999999997 102.575 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.63 165.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 105.738 -1.949 . . . . 74.150000000000006 105.738 -167.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -144.41 166.16 25.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 103.045 -2.946 . . . . 75.310000000000002 103.045 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.426 ' H ' HG21 ' A' ' 29' ' ' THR . . . 130.08 -178.43 17.53 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 107.694 -2.162 . . . . 72.200000000000003 107.694 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.45 -133.19 7.4 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.172 -1.571 . . . . 70.230000000000004 109.172 172.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.21 19.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.87 2.068 . . . . 74.540000000000006 113.588 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 87.82 65.58 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.429 -1.323 . . . . 52.100000000000001 107.429 -169.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 25' ' ' GLY . 14.8 t -89.37 -165.81 1.44 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.304 -2.48 . . . . 62.200000000000003 104.304 170.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -46.14 -31.06 2.18 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.788 0.835 . . . . 71.340000000000003 112.89 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 m -84.96 133.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 108.163 -1.051 . . . . 74.430000000000007 108.163 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -56.65 -57.06 14.03 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 115.945 -0.57 . . . . 74.409999999999997 111.064 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -74.75 -0.39 18.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.491 -0.559 . . . . 73.319999999999993 109.491 -169.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.73 14.32 43.31 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 110.148 -1.181 . . . . 64.150000000000006 110.148 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.35 154.38 52.91 Favored Glycine 0 CA--C 1.473 -2.552 0 N-CA-C 107.581 -2.208 . . . . 52.109999999999999 107.581 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 86.68 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 105.672 -1.973 . . . . 75.219999999999999 105.672 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 70.6 m-85 -84.56 142.18 30.17 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 106.992 -1.484 . . . . 75.239999999999995 106.992 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.84 128.5 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.262 -1.755 . . . . 63.020000000000003 106.262 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -102.51 -42.21 6.03 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.91 -1.144 . . . . 73.549999999999997 107.91 -166.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.38 153.2 34.28 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 106.53 -1.656 . . . . 73.030000000000001 106.53 -173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.92 131.72 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 104.116 -2.55 . . . . 52.210000000000001 104.116 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.55 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.9 mm -75.43 143.04 75.45 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 104.288 -2.486 . . . . 71.239999999999995 104.288 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.75 115.01 2.24 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 107.714 -1.687 . . . . 55.399999999999999 107.714 166.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 77.16 18.28 1.47 Allowed 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 124.857 1.348 . . . . 73.310000000000002 111.01 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.11 172.68 40.41 Favored Glycine 0 C--N 1.367 2.282 0 N-CA-C 106.447 -2.661 . . . . 42.420000000000002 106.447 164.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.4 80.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.811 -0.817 . . . . 61.43 109.165 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.58 91.98 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.078 -0.712 . . . . 71.25 109.078 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -69.58 -36.32 76.16 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.76 -0.829 . . . . 71.0 108.76 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.6 m -70.27 -35.37 73.7 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.392 -0.966 . . . . 73.329999999999998 108.392 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.439 -1.319 . . . . 75.129999999999995 107.439 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.6 49.92 Favored Glycine 0 C--O 1.214 -1.151 0 N-CA-C 110.771 -0.932 . . . . 75.340000000000003 110.771 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -73.09 -39.1 66.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.419 -1.048 . . . . 65.120000000000005 109.144 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.45 131.76 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 107.225 -1.398 . . . . 61.229999999999997 107.225 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -141.49 -179.67 6.29 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.646 -1.983 . . . . 71.340000000000003 105.646 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -66.61 143.81 56.79 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.162 -1.792 . . . . 71.530000000000001 106.162 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.51 50.52 Favored Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 108.085 -2.006 . . . . 61.32 108.085 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.83 161.06 17.74 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.309 -2.108 . . . . 61.530000000000001 105.309 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.6 ptt-85 -132.34 146.68 52.15 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.8 -1.556 . . . . 71.120000000000005 106.8 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.1 145.3 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.579 -2.378 . . . . 72.140000000000001 104.579 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 -47.43 2.63 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.735 -1.58 . . . . 74.120000000000005 106.735 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.54 166.8 19.81 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.52 1.152 . . . . 52.299999999999997 109.779 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -137.71 103.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 103.743 -2.688 . . . . 75.030000000000001 103.743 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.5 t30 56.44 36.96 28.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.315 0.579 . . . . 64.519999999999996 110.314 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.21 10.43 84.78 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 109.389 -1.484 . . . . 54.219999999999999 109.389 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.82 119.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 N-CA-C 104.311 -2.478 . . . . 43.119999999999997 104.311 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -69.69 106.41 3.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.665 -1.235 . . . . 51.310000000000002 107.665 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -18.07 36.92 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.109 -1.071 . . . . 73.140000000000001 108.109 -175.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.64 146.13 46.59 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.811 -0.811 . . . . 72.140000000000001 108.811 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.16 -35.03 4.26 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.452 -1.459 . . . . 74.439999999999998 109.452 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.66 156.28 39.68 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.286 -1.005 . . . . 62.0 108.286 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.5 p -75.67 166.14 24.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.827 -0.805 . . . . 73.329999999999998 108.827 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -65.8 -40.14 91.6 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.237 -1.023 . . . . 75.319999999999993 108.237 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -54.38 -48.16 71.86 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 110.256 -0.275 . . . . 71.409999999999997 110.256 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -34.6 78.13 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 108.95 -0.759 . . . . 75.400000000000006 108.95 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.92 85.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.23 -0.655 . . . . 71.040000000000006 109.23 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.46 -54.79 16.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.641 -1.244 . . . . 70.030000000000001 107.641 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.4 m -56.2 -26.84 52.41 Favored 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 108.101 -1.074 . . . . 75.540000000000006 108.101 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -64.87 -54.63 27.97 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 107.018 -1.475 . . . . 73.140000000000001 107.018 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.4 -55.5 30.94 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.525 -0.917 . . . . 74.219999999999999 108.525 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.8 mtp85 -45.83 -47.14 15.87 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.041 0.386 . . . . 74.219999999999999 112.041 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -87.89 1.09 54.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.121 0.873 . . . . 74.540000000000006 111.19 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.0 p -79.93 174.32 11.71 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.941 1.246 . . . . 50.32 108.374 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.8 -156.83 30.84 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 109.739 -1.344 . . . . 71.299999999999997 109.739 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.65 -44.48 27.97 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.72 -1.215 . . . . 72.230000000000004 107.72 -172.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.8 127.69 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.75 0 N-CA-C 103.879 -2.637 . . . . 72.209999999999994 103.879 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.54 143.63 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.888 0 N-CA-C 104.942 -2.244 . . . . 74.019999999999996 104.942 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.42 ' HE1' ' OE1' ' A' ' 11' ' ' GLU . 68.6 m-70 -99.44 117.99 35.07 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 105.138 -2.171 . . . . 63.549999999999997 105.138 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.9 mt -114.88 139.32 49.88 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 105.055 -2.202 . . . . 55.310000000000002 105.055 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.85 123.94 49.41 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 104.336 -2.468 . . . . 54.119999999999997 104.336 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.46 159.3 38.47 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.194 -1.41 . . . . 63.340000000000003 107.194 -171.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.412 -2.344 0 N-CA-C 104.042 -2.577 . . . . 74.030000000000001 104.042 175.819 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 7' ' ' ILE . 3.2 mp . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 105.224 -2.139 . . . . 72.010000000000005 105.224 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.75 159.5 36.88 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.385 -2.079 . . . . 73.129999999999995 105.385 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -102.81 148.24 25.87 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.244 -2.132 . . . . 75.329999999999998 105.244 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.25 131.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 N-CA-C 104.321 -2.474 . . . . 71.25 104.321 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.03 133.43 54.2 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.382 -1.71 . . . . 75.120000000000005 106.382 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.66 128.89 51.2 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.657 -1.979 . . . . 73.430000000000007 105.657 -173.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.24 141.87 28.09 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.189 -1.041 . . . . 71.25 108.189 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 107.022 -1.473 . . . . 75.030000000000001 107.022 171.825 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.485 -1.82 0 N-CA-C 110.438 -1.065 . . . . 71.319999999999993 110.438 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mt -124.17 152.65 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 103.687 -2.709 . . . . 71.239999999999995 103.687 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.6 m -150.54 161.85 41.77 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 103.372 -2.825 . . . . 71.310000000000002 103.372 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.96 167.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 105.094 -2.188 . . . . 71.239999999999995 105.094 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -143.62 166.15 25.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 102.919 -2.993 . . . . 74.019999999999996 102.919 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.04 -173.37 16.18 Favored Glycine 0 CA--C 1.473 -2.562 0 N-CA-C 107.584 -2.206 . . . . 51.229999999999997 107.584 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 -123.69 5.53 Favored Glycine 0 CA--C 1.485 -1.789 0 N-CA-C 108.427 -1.869 . . . . 60.539999999999999 108.427 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.75 20.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 126.003 1.721 . . . . 72.200000000000003 113.659 -169.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 87.32 66.21 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.657 1.218 . . . . 61.25 107.876 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -84.27 -166.51 1.46 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.591 -2.744 . . . . 73.109999999999999 103.591 171.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -53.56 -22.04 7.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.762 0.652 . . . . 73.430000000000007 112.762 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.85 128.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 107.295 -1.372 . . . . 63.32 107.295 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -61.62 -46.16 91.0 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 122.952 0.501 . . . . 64.239999999999995 109.904 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -73.64 -5.33 39.76 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.766 -0.828 . . . . 73.030000000000001 108.766 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.02 10.25 19.04 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 110.998 -0.841 . . . . 73.319999999999993 110.998 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.9 151.74 51.14 Favored Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 108.477 -1.849 . . . . 43.229999999999997 108.477 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.69 89.66 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 N-CA-C 105.737 -1.949 . . . . 71.120000000000005 105.737 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -87.42 144.26 26.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.774 -1.565 . . . . 64.219999999999999 106.774 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.62 132.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.112 -1.81 . . . . 71.129999999999995 106.112 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.06 -45.08 4.62 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.382 -1.34 . . . . 73.430000000000007 107.382 -166.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 155.45 38.72 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 106.502 -1.666 . . . . 64.120000000000005 106.502 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.29 139.16 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 105.529 -2.026 . . . . 72.209999999999994 105.529 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HB ' ' HA3' ' A' ' 20' ' ' GLY . 6.0 mt -72.95 144.55 85.43 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.337 -1.357 . . . . 52.409999999999997 107.337 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.57 108.49 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.639 2.226 . . . . 55.329999999999998 108.879 168.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 75.15 27.63 1.1 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.745 1.218 . . . . 73.420000000000002 110.318 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.04 173.62 55.09 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 106.556 -2.618 . . . . 65.549999999999997 106.556 162.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.35 79.15 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.323 0.649 . . . . 62.020000000000003 110.298 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.17 -49.52 64.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.618 -0.512 . . . . 74.239999999999995 109.618 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.2 -42.0 99.25 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.615 -0.513 . . . . 55.420000000000002 109.615 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.5 m -59.96 -42.14 93.45 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-O 121.355 0.598 . . . . 72.209999999999994 109.624 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -77.71 -35.48 52.05 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.813 -1.18 . . . . 70.340000000000003 107.813 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 81.23 -4.63 70.85 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 111.306 -0.718 . . . . 73.140000000000001 111.306 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.17 -44.3 63.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.658 -0.907 . . . . 73.010000000000005 109.131 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 mt -109.98 136.54 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 105.826 -1.916 . . . . 72.129999999999995 105.826 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.418 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 53.5 m80 -122.96 170.03 10.55 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.98 -1.859 . . . . 75.430000000000007 105.98 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 146.49 53.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.338 -1.356 . . . . 75.299999999999997 107.338 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.72 -8.2 78.71 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 109.804 -1.318 . . . . 50.210000000000001 109.804 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -86.0 163.38 18.0 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.104 -1.813 . . . . 71.129999999999995 106.104 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -115.39 129.88 56.72 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.7 0.762 . . . . 65.319999999999993 109.148 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.94 148.82 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 104.942 -2.244 . . . . 73.340000000000003 104.942 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -44.43 2.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.742 -1.207 . . . . 70.120000000000005 107.742 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.23 164.35 24.73 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.017 -1.073 . . . . 73.25 109.905 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.5 t -140.76 107.51 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.917 -2.253 . . . . 75.150000000000006 104.917 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.8 t30 45.71 43.48 9.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.417 1.487 . . . . 72.230000000000004 111.073 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.97 76.87 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 109.614 -1.395 . . . . 72.430000000000007 109.614 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.87 117.53 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 103.815 -2.661 . . . . 75.540000000000006 103.815 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.0 m -69.62 110.44 4.84 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.501 -1.296 . . . . 70.340000000000003 107.501 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.61 -6.48 57.49 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.9 -1.148 . . . . 53.439999999999998 107.9 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.96 143.64 57.27 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.556 -1.276 . . . . 54.100000000000001 107.556 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.36 -39.12 3.13 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.116 -1.193 . . . . 34.439999999999998 110.116 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 163.98 24.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 108.951 -0.759 . . . . 50.32 108.951 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -84.58 168.65 15.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.799 0.809 . . . . 71.450000000000003 109.36 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -62.03 -40.46 95.79 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 115.404 -0.816 . . . . 71.099999999999994 109.27 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -60.78 -40.58 93.11 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.892 -0.505 . . . . 73.239999999999995 110.54 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.21 -39.2 93.95 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.5 1.045 . . . . 71.25 109.378 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.89 79.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.427 -0.583 . . . . 73.140000000000001 109.427 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -71.24 -54.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 107.423 -1.325 . . . . 74.109999999999999 107.423 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.7 t -53.35 -28.94 31.51 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.55 1.167 . . . . 73.010000000000005 108.521 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 m -70.59 -56.36 6.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.507 -1.294 . . . . 65.129999999999995 107.507 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -57.15 -54.72 43.61 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 107.937 -1.134 . . . . 52.450000000000003 107.937 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -44.49 -43.99 8.28 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.542 1.137 . . . . 73.219999999999999 111.9 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.15 9.02 43.91 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.713 1.142 . . . . 75.200000000000003 111.201 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.4 p -80.72 174.45 11.6 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.861 -1.149 . . . . 72.140000000000001 107.925 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.28 -148.53 16.38 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.599 -1.4 . . . . 63.43 109.599 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -80.6 -47.81 13.6 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 108.173 -1.047 . . . . 74.140000000000001 108.173 -169.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.12 132.69 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 N-CA-C 103.817 -2.66 . . . . 54.409999999999997 103.817 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.55 151.0 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 104.479 -2.415 . . . . 64.430000000000007 104.479 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -103.36 124.26 48.36 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 104.933 -2.247 . . . . 73.319999999999993 104.933 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.02 137.79 49.55 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.191 -2.522 . . . . 75.420000000000002 104.191 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -106.97 126.27 52.1 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 105.815 -1.92 . . . . 72.340000000000003 105.815 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 152.52 51.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.423 -2.065 . . . . 70.329999999999998 105.423 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.462 -2.429 0 N-CA-C 102.608 -3.108 . . . . 72.200000000000003 102.608 176.218 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 104.827 -2.286 . . . . 74.530000000000001 104.827 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.6 152.29 41.21 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.944 -1.873 . . . . 73.150000000000006 105.944 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 89' ' ' LEU . 46.9 mt-10 -105.31 143.53 33.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.669 -1.974 . . . . 72.439999999999998 105.669 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.95 130.74 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.0 0 N-CA-C 104.952 -2.24 . . . . 44.240000000000002 104.952 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.49 113.14 26.24 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 103.866 -2.642 . . . . 73.340000000000003 103.866 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 12' ' ' LEU . 1.1 tm? -103.58 122.21 44.5 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.885 -1.894 . . . . 75.219999999999999 105.885 -169.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.75 150.3 39.34 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.036 -1.839 . . . . 71.450000000000003 106.036 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 9.3 tptm . . . . . 0 CA--C 1.456 -2.659 0 N-CA-C 103.119 -2.919 . . . . 73.140000000000001 103.119 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.322 0 N-CA-C 107.49 -2.244 . . . . 34.219999999999999 107.49 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 47' ' ' ALA . 22.2 mt -138.54 156.93 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 102.744 -3.058 . . . . 70.010000000000005 102.744 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.5 m -153.11 168.64 25.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.527 -2.768 . . . . 73.420000000000002 103.527 169.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.437 HG21 ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -140.6 167.99 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 106.497 -1.668 . . . . 74.209999999999994 106.497 -167.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 t -143.58 167.0 23.27 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 103.68 -2.711 . . . . 64.030000000000001 103.68 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 88.31 134.45 4.73 Favored Glycine 0 C--O 1.201 -1.969 0 N-CA-C 108.83 -1.708 . . . . 63.140000000000001 108.83 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.3 -98.89 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 108.986 -1.646 . . . . 43.109999999999999 108.986 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.04 20.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 126.617 1.967 . . . . 64.329999999999998 115.833 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.9 t30 87.2 65.19 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.181 -1.414 . . . . 75.219999999999999 107.181 -172.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 t -92.29 -166.09 1.48 Allowed 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.705 -2.331 . . . . 75.349999999999994 104.705 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -52.29 -21.8 3.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.5 1.12 . . . . 73.150000000000006 112.391 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.52 130.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 107.61 -1.256 . . . . 65.219999999999999 107.61 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -68.73 -36.31 78.25 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 116.017 -0.538 . . . . 61.32 111.532 -168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -79.06 -4.36 49.81 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.966 -1.084 . . . . 75.540000000000006 108.909 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.68 62.98 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 108.355 -1.898 . . . . 74.019999999999996 108.355 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.41 134.78 39.05 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 109.095 -1.602 . . . . 65.420000000000002 109.095 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.3 mm -78.08 103.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 103.516 -2.772 . . . . 74.549999999999997 103.516 173.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.39 147.83 24.3 Favored 'General case' 0 CA--C 1.468 -2.205 0 N-CA-C 106.58 -1.637 . . . . 71.329999999999998 106.58 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.66 133.98 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 106.657 -1.608 . . . . 73.420000000000002 106.657 168.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.03 -49.34 2.98 Favored 'General case' 0 CA--C 1.472 -2.038 0 N-CA-C 107.195 -1.409 . . . . 62.43 107.195 -169.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.09 130.81 41.73 Favored 'General case' 0 CA--C 1.456 -2.637 0 N-CA-C 105.868 -1.901 . . . . 55.420000000000002 105.868 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 47' ' ' ALA . 95.3 t -120.37 117.43 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 103.576 -2.75 . . . . 61.43 103.576 172.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.59 136.23 96.68 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 106.712 -1.588 . . . . 72.040000000000006 106.712 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.67 111.4 1.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.495 2.13 . . . . 75.319999999999993 107.665 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 75.73 20.68 1.78 Allowed 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.259 0.974 . . . . 73.420000000000002 110.541 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.52 -176.88 45.74 Favored Glycine 0 C--N 1.358 1.796 0 N-CA-C 107.024 -2.43 . . . . 71.120000000000005 107.024 168.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . . . -71.72 -19.84 61.99 Favored 'General case' 0 C--O 1.219 -0.53 0 O-C-N 122.359 -0.495 . . . . 75.299999999999997 110.744 -171.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG13 ' A' ' 41' ' ' VAL . . . -81.09 -49.19 11.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.163 -1.421 . . . . 70.25 107.163 -174.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.99 -38.16 87.56 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.169 -0.678 . . . . 74.439999999999998 109.169 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -70.65 -39.38 73.65 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.569 -0.9 . . . . 71.120000000000005 108.569 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.4 -39.05 88.78 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.384 -1.339 . . . . 61.539999999999999 107.384 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.6 -19.36 37.18 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 110.322 -1.111 . . . . 64.409999999999997 110.322 171.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.18 -39.68 40.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.81 -1.182 . . . . 70.209999999999994 107.81 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.85 132.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.722 -1.584 . . . . 72.239999999999995 106.722 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -142.67 -176.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 104.715 -2.328 . . . . 71.340000000000003 104.715 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -66.58 141.71 57.74 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.295 -1.743 . . . . 72.530000000000001 106.295 172.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.84 -30.13 8.34 Favored Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 107.486 -2.246 . . . . 31.329999999999998 107.486 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -72.78 150.73 42.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.428 -0.953 . . . . 70.120000000000005 108.428 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -123.56 128.77 50.2 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.157 -1.794 . . . . 72.310000000000002 106.157 -173.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.84 144.27 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 106.249 -1.76 . . . . 71.109999999999999 106.249 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.28 -44.08 2.6 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.559 -1.274 . . . . 61.32 107.559 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.89 159.49 36.47 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.944 -1.102 . . . . 45.140000000000001 109.378 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.16 116.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 104.942 -2.244 . . . . 73.299999999999997 104.942 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.3 t30 55.09 30.98 15.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.595 0.758 . . . . 73.329999999999998 109.886 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 16.43 77.21 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 109.324 -1.51 . . . . 72.519999999999996 109.324 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -106.72 124.01 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.814 0 N-CA-C 104.682 -2.34 . . . . 65.219999999999999 104.682 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -68.81 112.69 5.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.415 -1.328 . . . . 71.109999999999999 107.415 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.22 -1.0 57.58 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.571 -1.27 . . . . 52.509999999999998 107.571 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.74 143.13 58.09 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.608 -1.256 . . . . 44.210000000000001 107.608 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.85 3.81 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.451 -1.06 . . . . 63.119999999999997 110.451 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.44 13.37 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.761 0.78 . . . . 40.439999999999998 109.323 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -81.39 162.99 23.15 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.515 -1.291 . . . . 62.539999999999999 107.515 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -65.23 -36.75 85.13 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.532 -1.285 . . . . 75.430000000000007 107.532 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.03 -51.64 56.1 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 109.983 -0.377 . . . . 73.430000000000007 109.983 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -66.92 -37.68 84.78 Favored 'General case' 0 C--N 1.369 1.455 0 N-CA-C 109.286 -0.635 . . . . 70.239999999999995 109.286 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -55.75 -43.97 77.17 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 118.033 0.379 . . . . 42.299999999999997 110.175 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.66 -50.77 36.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.267 -1.383 . . . . 73.430000000000007 107.267 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.5 t -53.92 -28.65 38.21 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-O 122.127 0.965 . . . . 50.439999999999998 108.671 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.87 -55.15 13.98 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 107.184 -1.413 . . . . 73.329999999999998 107.184 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.65 -55.79 29.58 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.074 0.94 . . . . 73.530000000000001 108.613 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -46.6 -25.56 0.73 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.23 -0.896 . . . . 61.43 113.177 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -116.57 10.62 14.52 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.639 -1.288 . . . . 75.239999999999995 110.07 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.3 p -84.92 173.42 10.59 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.809 -1.182 . . . . 74.430000000000007 107.809 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.63 -155.19 22.55 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 109.767 -1.333 . . . . 62.119999999999997 109.767 -172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -80.77 -31.89 35.65 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 108.439 -0.949 . . . . 62.130000000000003 108.439 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.33 133.52 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 103.908 -2.626 . . . . 72.329999999999998 103.908 175.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.57 141.98 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 105.461 -2.051 . . . . 64.340000000000003 105.461 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -95.61 115.82 27.98 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.321 -2.474 . . . . 72.409999999999997 104.321 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.4 mt -116.57 140.37 49.46 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 106.36 -1.719 . . . . 62.200000000000003 106.36 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 9' ' ' GLU . 26.1 tp -114.52 126.08 54.53 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 105.107 -2.182 . . . . 74.340000000000003 105.107 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.81 156.15 46.53 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.267 -1.383 . . . . 70.030000000000001 107.267 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.418 -2.057 0 N-CA-C 103.676 -2.713 . . . . 61.219999999999999 103.676 175.381 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 103.86 -2.645 . . . . 70.200000000000003 103.86 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.99 160.24 42.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 105.594 -2.002 . . . . 74.409999999999997 105.594 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.7 146.22 28.54 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.138 -1.801 . . . . 65.400000000000006 106.138 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.7 t -127.81 127.34 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.226 0 N-CA-C 103.453 -2.795 . . . . 60.219999999999999 103.453 167.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.49 114.09 28.1 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.31 -2.478 . . . . 54.329999999999998 104.31 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 124.31 48.51 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.809 -1.923 . . . . 74.040000000000006 105.809 -169.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.69 147.22 25.07 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.102 -1.444 . . . . 73.0 107.102 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 106.276 -1.749 . . . . 73.439999999999998 106.276 176.245 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.475 1.261 0 CA-C-O 120.392 -0.115 . . . . 61.140000000000001 113.056 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -135.67 165.19 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 102.921 -2.992 . . . . 55.520000000000003 102.921 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.6 m -152.17 165.53 34.54 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 102.625 -3.102 . . . . 61.329999999999998 102.625 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.83 169.37 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 105.957 -1.868 . . . . 70.439999999999998 105.957 -167.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -148.88 167.32 26.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 103.002 -2.962 . . . . 73.25 103.002 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.6 -168.93 13.15 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 106.652 -2.579 . . . . 72.430000000000007 106.652 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 -116.04 3.2 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 107.879 -2.088 . . . . 51.119999999999997 107.879 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.18 19.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.89 1.276 . . . . 72.109999999999999 113.742 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.27 82.1 m-20 88.68 68.17 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 123.179 1.466 . . . . 75.310000000000002 108.442 -170.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.723 HG22 ' H ' ' A' ' 30' ' ' SER . 6.3 m -81.99 -166.99 1.37 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 103.423 -2.806 . . . . 73.209999999999994 103.423 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.723 ' H ' HG22 ' A' ' 29' ' ' THR . 11.8 m -53.74 -20.16 5.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 53.409999999999997 112.573 -174.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -89.97 128.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.625 -1.25 . . . . 70.319999999999993 107.625 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.29 -45.71 90.14 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 115.629 -0.714 . . . . 75.540000000000006 110.834 -170.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.04 1.79 14.55 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.731 -0.606 . . . . 72.129999999999995 109.747 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.17 22.26 68.85 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 109.984 -1.247 . . . . 50.539999999999999 109.984 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.57 150.82 50.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.137 -1.985 . . . . 71.510000000000005 108.137 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.5 mm -93.09 105.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.026 -2.583 . . . . 73.140000000000001 104.026 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -97.74 142.28 29.72 Favored 'General case' 0 CA--C 1.465 -2.296 0 N-CA-C 106.699 -1.593 . . . . 65.049999999999997 106.699 -174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.45 135.45 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 106.97 -1.492 . . . . 71.239999999999995 106.97 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -45.25 4.04 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.549 -1.649 . . . . 62.210000000000001 106.549 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.15 156.08 44.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.633 -1.988 . . . . 54.130000000000003 105.633 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.55 136.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 103.67 -2.715 . . . . 73.299999999999997 103.67 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.527 HG12 ' CA ' ' A' ' 20' ' ' GLY . 21.5 mm -69.1 143.92 94.76 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.179 -1.785 . . . . 71.099999999999994 106.179 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.33 114.93 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.295 1.997 . . . . 65.239999999999995 107.766 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 60.46 35.87 20.27 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.715 0.806 . . . . 71.319999999999993 111.122 -172.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 178.42 48.6 Favored Glycine 0 C--N 1.366 2.196 0 N-CA-C 106.614 -2.594 . . . . 74.140000000000001 106.614 163.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.21 93.88 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 109.383 -0.599 . . . . 71.040000000000006 109.383 -172.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.59 75.75 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.596 -0.52 . . . . 71.439999999999998 109.596 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.79 -39.86 87.93 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.303 -0.629 . . . . 75.530000000000001 109.303 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.0 m -64.97 -36.12 83.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.26 -0.644 . . . . 71.109999999999999 109.26 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.59 -32.52 68.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 108.246 -1.02 . . . . 71.150000000000006 108.246 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -20.01 29.48 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.546 -1.022 . . . . 61.299999999999997 110.546 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -72.64 -44.9 61.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.111 -1.07 . . . . 74.340000000000003 108.111 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mt -98.15 149.77 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.878 -1.897 . . . . 51.219999999999999 105.878 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -151.49 170.38 19.76 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.082 -2.192 . . . . 75.549999999999997 105.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -67.29 142.57 56.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.627 -1.62 . . . . 64.099999999999994 106.627 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.3 -3.36 84.02 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 119.84 -1.171 . . . . 74.400000000000006 110.181 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -80.16 150.34 30.21 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 106.939 -1.504 . . . . 61.530000000000001 106.939 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.88 118.48 36.93 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.073 -1.455 . . . . 63.43 107.073 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 t -103.61 148.52 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 105.457 -2.053 . . . . 74.510000000000005 105.457 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.38 -48.01 2.9 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.773 -1.195 . . . . 73.230000000000004 107.773 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.08 162.37 28.94 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.576 -0.85 . . . . 42.100000000000001 109.184 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.18 111.82 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.349 -2.093 . . . . 73.299999999999997 105.349 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 49.45 36.84 10.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.13 1.372 . . . . 75.129999999999995 111.363 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.48 4.87 76.19 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 109.671 -1.371 . . . . 71.319999999999993 109.671 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.93 120.53 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 104.572 -2.381 . . . . 74.0 104.572 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -72.72 108.57 5.78 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 106.861 -1.533 . . . . 74.540000000000006 106.861 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.98 -2.01 42.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.565 -0.743 . . . . 63.439999999999998 109.798 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.29 143.8 57.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.865 -1.161 . . . . 73.340000000000003 107.865 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.2 -31.32 4.12 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.74 -1.344 . . . . 41.240000000000002 109.74 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.46 162.16 29.84 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 118.495 1.148 . . . . 51.119999999999997 108.383 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.1 p -85.38 169.52 13.61 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.856 0.836 . . . . 60.130000000000003 109.06 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -64.26 -44.91 90.31 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.854 -1.165 . . . . 74.409999999999997 107.854 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.11 -41.35 96.54 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 119.265 -0.397 . . . . 64.030000000000001 110.095 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -37.45 87.08 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 119.281 0.946 . . . . 54.439999999999998 108.84 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -55.78 -38.23 69.62 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.539 0.609 . . . . 73.329999999999998 109.973 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.11 -55.06 14.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 107.641 -1.244 . . . . 70.209999999999994 107.641 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.36 -26.75 68.62 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.758 -0.83 . . . . 72.400000000000006 108.758 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.6 m -60.16 -54.0 51.09 Favored 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 107.088 -1.449 . . . . 73.209999999999994 107.088 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -56.11 -56.05 25.61 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 121.701 0.762 . . . . 71.319999999999993 109.123 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -48.72 -30.2 5.3 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 121.647 -0.658 . . . . 74.239999999999995 112.676 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -93.2 -7.34 45.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.349 -0.844 . . . . 75.430000000000007 109.939 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 p -79.41 170.28 16.83 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.856 -1.165 . . . . 52.43 107.856 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.16 -136.57 3.74 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 110.142 -1.183 . . . . 62.240000000000002 110.142 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.3 -45.88 8.76 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.82 -1.178 . . . . 63.229999999999997 107.82 -172.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.94 128.31 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 104.079 -2.563 . . . . 73.230000000000004 104.079 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -123.94 138.43 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.212 -2.514 . . . . 51.229999999999997 104.212 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.54 117.92 31.95 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 104.694 -2.336 . . . . 72.319999999999993 104.694 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.9 mt -116.74 137.84 51.91 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.864 -1.902 . . . . 75.409999999999997 105.864 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.74 130.31 56.11 Favored 'General case' 0 CA--C 1.463 -2.4 0 N-CA-C 104.589 -2.374 . . . . 73.109999999999999 104.589 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.68 153.84 49.58 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 105.848 -1.908 . . . . 72.340000000000003 105.848 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 . . . . . 0 CA--C 1.476 -1.865 0 N-CA-C 103.786 -2.672 . . . . 61.32 103.786 179.146 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 104.035 -2.58 . . . . 72.230000000000004 104.035 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -128.01 142.12 51.32 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 105.78 -1.933 . . . . 72.400000000000006 105.78 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -103.05 132.13 49.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 104.711 -2.329 . . . . 71.430000000000007 104.711 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.25 135.93 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 106.318 -1.734 . . . . 75.510000000000005 106.318 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.04 118.13 36.13 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.234 -2.506 . . . . 63.310000000000002 104.234 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -102.91 121.09 41.81 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 104.962 -2.236 . . . . 62.200000000000003 104.962 -175.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.1 133.36 37.66 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.253 -1.388 . . . . 63.109999999999999 107.253 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm . . . . . 0 CA--C 1.495 -1.138 0 C-N-CA 124.648 1.179 . . . . 74.010000000000005 108.072 179.349 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 CA--C 1.478 -2.259 0 N-CA-C 110.982 -0.847 . . . . 52.329999999999998 110.982 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.7 mt -131.68 148.43 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 101.042 -3.688 . . . . 74.219999999999999 101.042 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -146.68 164.02 34.04 Favored 'General case' 0 CA--C 1.46 -2.488 0 N-CA-C 102.568 -3.123 . . . . 74.129999999999995 102.568 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG21 ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -141.48 167.92 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 106.498 -1.667 . . . . 74.219999999999999 106.498 -161.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -144.72 165.89 26.78 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.233 -2.506 . . . . 75.200000000000003 104.233 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.457 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 79.39 140.5 2.06 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 110.871 -0.891 . . . . 60.409999999999997 110.871 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.62 -87.42 0.07 OUTLIER Glycine 0 C--N 1.351 1.41 0 N-CA-C 109.782 -1.327 . . . . 74.299999999999997 109.782 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.56 20.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 128.934 2.893 . . . . 55.450000000000003 117.057 -172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 86.91 66.13 0.01 OUTLIER 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 105.564 -2.013 . . . . 53.32 105.564 -170.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -84.39 -166.88 1.57 Allowed 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 111.807 -2.451 . . . . 72.329999999999998 105.785 -175.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -59.43 -26.57 65.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 123.803 0.841 . . . . 73.340000000000003 110.952 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' THR . 27.3 m -87.46 139.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.749 -1.574 . . . . 63.130000000000003 106.749 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -51.95 -58.16 7.32 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.882 0.873 . . . . 72.329999999999998 111.711 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.93 8.49 6.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.941 -0.474 . . . . 63.409999999999997 111.062 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.25 29.33 74.2 Favored Glycine 0 C--N 1.36 1.864 0 N-CA-C 108.537 -1.825 . . . . 71.109999999999999 108.537 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.14 127.53 27.29 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.037 -1.625 . . . . 72.310000000000002 109.037 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 25' ' ' GLY . 1.2 mm -79.03 104.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.361 -2.829 . . . . 71.530000000000001 103.361 172.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -98.43 146.5 25.67 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 107.69 -1.226 . . . . 74.200000000000003 107.69 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 130.72 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.983 -1.858 . . . . 54.109999999999999 105.983 171.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -104.92 -47.14 4.1 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.005 -1.48 . . . . 71.219999999999999 107.005 -168.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.06 147.89 39.32 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 105.841 -1.911 . . . . 74.219999999999999 105.841 -169.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.93 128.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 103.552 -2.758 . . . . 73.540000000000006 103.552 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.542 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.4 mm -64.61 144.87 98.76 Favored Pre-proline 0 N--CA 1.477 0.875 0 N-CA-C 105.959 -1.867 . . . . 74.409999999999997 105.959 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 111.99 1.05 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 N-CA-C 107.319 -1.839 . . . . 73.140000000000001 107.319 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 34.8 mt-30 70.55 29.58 3.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 124.58 1.175 . . . . 71.129999999999995 110.654 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.03 172.38 40.67 Favored Glycine 0 C--N 1.363 2.08 0 N-CA-C 107.946 -2.062 . . . . 74.230000000000004 107.946 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.73 76.2 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 108.689 -0.856 . . . . 41.210000000000001 108.689 -175.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.8 80.18 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 109.443 -0.577 . . . . 34.109999999999999 109.443 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 44' ' ' GLN . 36.7 tt0 -62.3 -40.66 97.02 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 109.017 -0.735 . . . . 75.109999999999999 109.017 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -66.08 -41.71 90.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.15 -1.056 . . . . 55.210000000000001 108.15 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.01 -40.59 91.24 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.616 -1.253 . . . . 74.400000000000006 107.616 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.81 -10.45 59.97 Favored Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 110.859 -0.896 . . . . 74.219999999999999 110.859 172.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -81.45 -40.13 23.8 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.158 -1.052 . . . . 73.439999999999998 108.158 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.1 mt -93.75 140.78 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.848 -1.538 . . . . 73.319999999999993 106.848 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.32 174.9 10.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.057 -1.831 . . . . 71.450000000000003 106.057 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.41 143.47 57.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 106.15 -1.796 . . . . 74.420000000000002 106.15 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.12 52.27 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.785 -2.126 . . . . 74.519999999999996 107.785 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.36 147.33 40.14 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.592 -1.633 . . . . 52.310000000000002 106.592 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.538 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.6 tmm_? -109.73 118.85 37.63 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.045 -2.206 . . . . 70.150000000000006 105.045 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.24 131.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.252 -2.129 . . . . 74.239999999999995 105.252 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 -50.77 3.24 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.868 -1.53 . . . . 73.319999999999993 106.868 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.59 166.44 20.64 Favored 'General case' 0 CA--C 1.47 -2.099 0 CA-C-O 122.313 1.054 . . . . 73.329999999999998 109.272 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.09 109.5 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 103.684 -2.709 . . . . 74.5 103.684 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.73 40.02 11.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.596 1.158 . . . . 75.430000000000007 111.556 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.28 6.81 70.63 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 110.426 -1.07 . . . . 43.299999999999997 110.426 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.55 117.75 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.816 0 N-CA-C 104.284 -2.487 . . . . 75.209999999999994 104.284 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -69.16 110.98 4.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.646 -1.242 . . . . 73.209999999999994 107.646 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.27 -7.96 58.75 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.807 -0.812 . . . . 62.420000000000002 108.807 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.97 144.31 56.95 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.288 -1.004 . . . . 55.329999999999998 108.288 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 -30.86 3.93 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.784 -0.926 . . . . 41.329999999999998 110.784 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.63 164.97 15.69 Favored 'General case' 0 C--N 1.365 1.244 0 CA-C-N 118.396 1.098 . . . . 65.420000000000002 109.16 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 p -83.38 164.39 20.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.745 -1.206 . . . . 73.420000000000002 107.745 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.58 -37.95 86.01 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.569 -0.9 . . . . 75.150000000000006 108.569 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -58.58 -42.02 87.1 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 119.661 -0.816 . . . . 61.539999999999999 110.211 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.93 -40.12 91.14 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 108.625 -0.88 . . . . 62.509999999999998 108.625 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 23' ' ' VAL . . . -56.26 -43.29 78.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.691 -0.485 . . . . 70.450000000000003 109.691 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.58 -50.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 107.281 -1.378 . . . . 62.229999999999997 107.281 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.2 t -53.41 -28.63 30.77 Favored 'General case' 0 N--CA 1.514 2.74 0 CA-C-O 122.446 1.117 . . . . 71.409999999999997 108.649 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.7 m -71.73 -46.71 57.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.566 -1.272 . . . . 74.319999999999993 107.566 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.64 -53.06 57.42 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.006 -1.109 . . . . 63.100000000000001 108.006 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -44.45 -46.35 9.57 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 74.420000000000002 111.607 174.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -95.0 61.12 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.326 -0.99 . . . . 72.340000000000003 108.326 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' HG22 ' A' ' 86' ' ' VAL . 12.0 p -111.16 156.53 21.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.95 -1.13 . . . . 54.149999999999999 107.95 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.12 -125.43 3.58 Favored Glycine 0 CA--C 1.492 -1.348 0 N-CA-C 108.573 -1.811 . . . . 35.109999999999999 108.573 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -89.32 -52.12 5.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.868 -1.16 . . . . 75.319999999999993 107.868 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.04 136.63 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 105.243 -2.132 . . . . 52.049999999999997 105.243 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 82' ' ' THR . 3.9 t -114.82 130.55 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 105.21 -2.144 . . . . 73.019999999999996 105.21 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -95.11 116.86 29.27 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.788 -2.301 . . . . 70.030000000000001 104.788 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 mt -122.1 144.56 48.85 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.552 -1.647 . . . . 62.130000000000003 106.552 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -116.73 131.53 56.93 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 103.777 -2.675 . . . . 72.219999999999999 103.777 172.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mp -133.32 155.71 48.94 Favored 'General case' 0 CA--C 1.469 -2.153 0 N-CA-C 106.493 -1.669 . . . . 73.099999999999994 106.493 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.538 ' CD ' HH21 ' A' ' 58' ' ' ARG . 31.8 tt0 . . . . . 0 N--CA 1.416 -2.168 0 N-CA-C 104.894 -2.261 . . . . 75.409999999999997 104.894 -175.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.434 -1.254 0 N-CA-C 103.643 -2.725 . . . . 75.230000000000004 103.643 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.16 150.76 44.62 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.327 -1.731 . . . . 74.430000000000007 106.327 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -102.71 140.95 36.32 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.497 -2.038 . . . . 72.519999999999996 105.497 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.1 t -124.9 125.99 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 103.878 -2.638 . . . . 72.239999999999995 103.878 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -102.76 125.06 49.36 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.414 -2.069 . . . . 50.340000000000003 105.414 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 121.66 42.66 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.638 -1.616 . . . . 74.049999999999997 106.638 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.55 139.49 34.19 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.274 -1.75 . . . . 51.130000000000003 106.274 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.816 0 N-CA-C 106.304 -1.739 . . . . 61.520000000000003 106.304 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.14 0 CA-C-O 119.734 -0.481 . . . . 74.239999999999995 112.753 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.21 150.52 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 104.056 -2.572 . . . . 43.539999999999999 104.056 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.2 m -151.88 167.21 29.04 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 102.673 -3.084 . . . . 63.32 102.673 167.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.08 168.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 106.111 -1.811 . . . . 51.020000000000003 106.111 -167.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -139.54 166.12 25.42 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 102.711 -3.07 . . . . 54.530000000000001 102.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 87.66 131.19 3.41 Favored Glycine 0 C--O 1.199 -2.054 0 N-CA-C 109.637 -1.385 . . . . 73.010000000000005 109.637 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.27 -92.18 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 107.874 -2.09 . . . . 52.310000000000002 107.874 165.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.36 19.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.376 1.471 . . . . 61.439999999999998 114.169 -171.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 88.5 65.79 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.942 -1.503 . . . . 70.109999999999999 106.942 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 30' ' ' SER . 2.4 m -88.09 -166.45 1.59 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.877 -2.638 . . . . 74.109999999999999 103.877 172.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.68 ' H ' HG22 ' A' ' 29' ' ' THR . 5.0 m -44.86 -33.22 1.86 Allowed 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.661 1.184 . . . . 53.43 112.063 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 31' ' ' VAL . 14.4 m -85.36 129.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.055 -1.091 . . . . 74.430000000000007 108.055 -176.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -66.45 -34.16 77.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.041 -0.981 . . . . 74.310000000000002 112.789 -166.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -75.57 -2.25 28.27 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.962 -1.086 . . . . 73.099999999999994 109.338 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.97 20.2 59.83 Favored Glycine 0 C--N 1.36 1.906 0 N-CA-C 108.281 -1.927 . . . . 54.100000000000001 108.281 -167.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.38 153.06 48.92 Favored Glycine 0 CA--C 1.476 -2.358 0 N-CA-C 107.964 -2.054 . . . . 41.039999999999999 107.964 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.8 mm -90.72 119.87 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 103.89 -2.633 . . . . 73.540000000000006 103.89 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.69 145.88 43.15 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 106.667 -1.605 . . . . 71.409999999999997 106.667 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.67 131.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.175 -1.416 . . . . 71.340000000000003 107.175 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.0 -47.02 3.79 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 106.665 -1.605 . . . . 71.140000000000001 106.665 -168.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.84 138.51 42.59 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 105.594 -2.002 . . . . 71.129999999999995 105.594 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.02 126.31 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 105.081 -2.192 . . . . 70.239999999999995 105.081 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -69.9 137.24 87.51 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.685 -1.598 . . . . 62.210000000000001 106.685 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.87 117.67 4.46 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.367 2.045 . . . . 62.299999999999997 108.31 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 62.03 25.37 15.21 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.863 0.865 . . . . 63.130000000000003 111.879 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.77 54.86 Favored Glycine 0 C--N 1.364 2.092 0 N-CA-C 105.689 -2.964 . . . . 63.119999999999997 105.689 165.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.13 48.79 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 117.325 0.562 . . . . 54.149999999999999 111.782 -171.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.95 67.03 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.199 -0.667 . . . . 62.219999999999999 109.199 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.04 -34.4 77.62 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.875 -0.417 . . . . 74.329999999999998 109.875 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.5 m -64.1 -31.96 73.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.743 -0.836 . . . . 72.239999999999995 108.743 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.85 -42.31 73.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.646 -1.242 . . . . 73.340000000000003 107.646 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.03 -20.6 35.43 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.122 -1.191 . . . . 63.219999999999999 110.122 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -78.27 -41.2 34.76 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.031 -1.099 . . . . 61.340000000000003 108.031 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.9 mt -95.94 134.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.578 -1.638 . . . . 64.129999999999995 106.578 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.18 179.91 7.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.952 -1.87 . . . . 74.230000000000004 105.952 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -66.82 138.56 57.43 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 106.781 -1.562 . . . . 60.200000000000003 106.781 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.6 -14.18 50.3 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 108.528 -1.829 . . . . 71.400000000000006 108.528 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.64 151.02 44.06 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.737 -0.838 . . . . 73.349999999999994 108.737 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -113.18 126.9 55.94 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.287 -2.116 . . . . 75.129999999999995 105.287 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 t -104.77 142.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 104.554 -2.388 . . . . 72.299999999999997 104.554 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.81 -48.22 2.76 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.342 -1.355 . . . . 75.329999999999998 107.342 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.95 164.14 24.89 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 122.327 1.06 . . . . 72.439999999999998 109.785 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.14 109.1 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 N-CA-C 104.302 -2.481 . . . . 72.349999999999994 104.302 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 48.0 42.16 16.18 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.829 0.852 . . . . 63.219999999999999 110.598 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.4 10.08 82.59 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.691 -0.964 . . . . 70.310000000000002 110.691 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.31 118.02 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 104.712 -2.329 . . . . 73.140000000000001 104.712 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -71.42 113.07 8.08 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.307 -1.368 . . . . 72.209999999999994 107.307 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.2 mt -70.68 -23.15 62.43 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.222 -0.899 . . . . 74.420000000000002 109.608 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -55.49 144.94 24.24 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.532 0.682 . . . . 74.400000000000006 110.664 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.85 -33.31 5.28 Favored Glycine 0 CA--C 1.496 -1.15 0 N-CA-C 109.369 -1.492 . . . . 70.430000000000007 109.369 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.59 162.55 28.69 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.033 -0.729 . . . . 55.439999999999998 109.033 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -80.48 167.32 20.29 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.832 -1.174 . . . . 61.439999999999998 107.832 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -64.69 -39.05 93.0 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 106.543 -1.651 . . . . 71.099999999999994 106.543 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -51.9 -51.03 59.69 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 123.618 0.767 . . . . 73.430000000000007 110.047 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -66.65 -39.73 88.37 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 109.165 -0.679 . . . . 53.149999999999999 109.165 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -54.94 -41.06 70.59 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.42 0.555 . . . . 64.519999999999996 109.778 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.03 -54.64 17.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 N-CA-C 106.873 -1.528 . . . . 71.5 106.873 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 11.1 t -54.77 -28.65 50.31 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 122.268 1.032 . . . . 74.010000000000005 108.763 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.4 m -66.57 -53.76 31.05 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.331 -1.359 . . . . 54.009999999999998 107.331 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.35 -55.51 27.83 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 108.589 -0.893 . . . . 74.310000000000002 108.589 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -46.67 -32.82 3.78 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.882 0.697 . . . . 72.530000000000001 112.882 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.64 2.17 51.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.49 -0.756 . . . . 72.409999999999997 110.252 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.5 p -73.98 168.47 19.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 119.5 1.045 . . . . 75.340000000000003 109.44 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.1 -166.39 28.5 Favored Glycine 0 C--N 1.371 2.499 0 N-CA-C 108.783 -1.727 . . . . 52.140000000000001 108.783 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.29 -32.18 26.51 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.792 -0.818 . . . . 52.329999999999998 108.792 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.3 t -112.37 130.46 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 103.573 -2.751 . . . . 64.329999999999998 103.573 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.88 150.19 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.116 -2.179 . . . . 75.140000000000001 105.116 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -110.3 121.62 45.72 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 104.968 -2.234 . . . . 65.25 104.968 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.8 mt -116.4 141.33 48.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 N-CA-C 104.711 -2.329 . . . . 71.319999999999993 104.711 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 tp -114.73 127.84 55.97 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 105.672 -1.973 . . . . 64.349999999999994 105.672 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.11 155.8 50.11 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.337 -1.727 . . . . 73.0 106.337 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 CA--C 1.483 -1.599 0 N-CA-C 105.085 -2.191 . . . . 62.539999999999999 105.085 -178.07 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.494 -1.18 0 N-CA-C 105.003 -2.221 . . . . 73.450000000000003 105.003 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -137.6 153.6 49.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.572 -2.01 . . . . 51.420000000000002 105.572 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.76 141.46 35.52 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.758 -1.571 . . . . 74.450000000000003 106.758 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.5 126.06 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 103.894 -2.632 . . . . 75.209999999999994 103.894 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -96.76 125.53 41.28 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.553 -2.388 . . . . 73.329999999999998 104.553 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 121.04 44.34 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.611 -1.626 . . . . 75.140000000000001 106.611 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.71 102.78 13.26 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 104.268 -2.493 . . . . 75.120000000000005 104.268 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp . . . . . 0 N--CA 1.424 -1.765 0 CA-C-N 114.456 -1.247 . . . . 75.140000000000001 107.89 -164.027 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.471 0 N-CA-C 109.702 -1.359 . . . . 53.530000000000001 109.702 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.8 mt -131.32 144.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 103.02 -2.956 . . . . 73.420000000000002 103.02 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.1 m -147.81 163.69 35.95 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 103.484 -2.784 . . . . 64.099999999999994 103.484 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.03 169.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 105.727 -1.953 . . . . 74.450000000000003 105.727 -160.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -145.53 167.23 23.51 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.65 -2.722 . . . . 51.409999999999997 103.65 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.86 -172.98 14.67 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.061 -2.415 . . . . 51.240000000000002 107.061 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.06 -123.17 5.24 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 109.185 -1.566 . . . . 71.010000000000005 109.185 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 m -72.47 19.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 126.114 1.765 . . . . 72.5 112.908 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 87.58 64.47 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.12 -1.807 . . . . 61.420000000000002 106.12 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 30' ' ' SER . 3.3 m -84.8 -165.7 1.27 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 103.827 -2.657 . . . . 63.130000000000003 103.827 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.695 ' H ' HG22 ' A' ' 29' ' ' THR . 3.6 m -37.45 -40.37 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.616 1.566 . . . . 74.140000000000001 112.911 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.57 135.34 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.159 -1.052 . . . . 71.540000000000006 108.159 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.7 mtm105 -72.47 -35.33 68.21 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.57 -0.9 . . . . 72.209999999999994 108.57 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.88 -17.25 63.0 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 109.118 -0.697 . . . . 52.219999999999999 109.118 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 -3.19 3.78 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.189 -0.364 . . . . 73.450000000000003 112.189 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.32 170.61 47.72 Favored Glycine 0 CA--C 1.483 -1.956 0 N-CA-C 107.229 -2.348 . . . . 71.010000000000005 107.229 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.39 132.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.436 -2.061 . . . . 63.310000000000002 105.436 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -124.97 140.71 52.67 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 104.989 -2.226 . . . . 73.319999999999993 104.989 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -68.51 132.67 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.953 -1.499 . . . . 71.329999999999998 106.953 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -106.21 -46.23 4.11 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.295 -1.372 . . . . 50.140000000000001 107.295 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.26 144.17 38.28 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 105.608 -1.997 . . . . 43.340000000000003 105.608 -173.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.9 129.55 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 104.581 -2.378 . . . . 74.329999999999998 104.581 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 mt -74.36 138.91 74.84 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.125 -1.805 . . . . 72.400000000000006 106.125 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.8 110.76 0.88 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.614 2.21 . . . . 25.539999999999999 108.166 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 70.67 25.5 4.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.378 1.049 . . . . 71.420000000000002 111.318 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.44 -173.67 33.94 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 106.34 -2.704 . . . . 54.520000000000003 106.34 162.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.27 78.46 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 121.942 -0.74 . . . . 52.450000000000003 110.091 -171.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.4 80.53 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 110.155 -0.313 . . . . 75.239999999999995 110.155 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.13 -34.42 73.05 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.345 -0.613 . . . . 60.399999999999999 109.345 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -67.98 -39.69 83.26 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.481 -1.303 . . . . 72.219999999999999 107.481 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.76 -32.76 73.57 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 107.931 -1.137 . . . . 55.119999999999997 107.931 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.48 -25.99 4.78 Favored Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 110.951 -0.86 . . . . 72.329999999999998 110.951 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -69.63 -40.1 76.74 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.536 -0.912 . . . . 74.510000000000005 108.536 -173.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 mt -98.38 138.46 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 105.924 -1.88 . . . . 73.340000000000003 105.924 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -134.76 174.43 10.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.143 -1.428 . . . . 61.109999999999999 107.143 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -66.53 138.98 57.89 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.695 -1.965 . . . . 73.230000000000004 105.695 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.7 -4.8 61.72 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 109.191 -1.563 . . . . 40.520000000000003 109.191 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.43 152.96 37.9 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.383 -1.34 . . . . 73.420000000000002 107.383 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -112.79 123.83 51.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.15 -2.167 . . . . 71.209999999999994 105.15 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.73 139.97 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 104.741 -2.318 . . . . 70.140000000000001 104.741 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.08 -55.35 2.34 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.019 -1.474 . . . . 75.200000000000003 107.019 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.57 165.18 23.3 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 122.153 0.977 . . . . 72.200000000000003 109.531 -168.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.62 109.84 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 105.085 -2.191 . . . . 70.209999999999994 105.085 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 51.72 41.37 29.0 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.615 1.166 . . . . 62.229999999999997 111.812 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.44 7.01 73.07 Favored Glycine 0 CA--C 1.498 -1.006 0 N-CA-C 109.396 -1.482 . . . . 33.219999999999999 109.396 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 67' ' ' LEU . 26.8 t -112.12 117.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 105.134 -2.172 . . . . 73.049999999999997 105.134 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -80.8 15.39 1.78 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.332 -0.395 . . . . 74.209999999999994 110.424 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.496 ' H ' HG12 ' A' ' 65' ' ' VAL . 87.5 mt 38.79 45.11 0.89 Allowed 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.236 1.414 . . . . 72.209999999999994 110.937 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.2 125.14 28.62 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.514 -0.921 . . . . 45.140000000000001 108.514 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.96 -4.52 81.61 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.822 -1.711 . . . . 74.099999999999994 108.822 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.71 137.4 56.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 108.299 -1.0 . . . . 54.340000000000003 108.299 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.7 p -76.13 174.04 10.56 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.752 -1.573 . . . . 75.549999999999997 106.752 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -61.18 -39.83 91.62 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 107.816 -1.179 . . . . 71.319999999999993 107.816 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.01 -50.68 66.08 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.878 0.471 . . . . 65.450000000000003 110.713 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -66.62 -29.25 69.25 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.241 0.928 . . . . 63.299999999999997 109.437 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.53 -38.5 84.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.562 -0.903 . . . . 62.240000000000002 108.562 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.5 t -72.82 -49.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.009 -1.478 . . . . 73.450000000000003 107.009 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.1 m -52.49 -29.28 24.15 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 108.488 -0.93 . . . . 72.340000000000003 108.488 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -65.81 -55.87 14.88 Favored 'General case' 0 C--O 1.199 -1.597 0 N-CA-C 107.486 -1.301 . . . . 65.430000000000007 107.486 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.03 -56.14 24.34 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.943 -0.762 . . . . 72.329999999999998 108.943 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -49.85 -28.01 5.9 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.482 0.549 . . . . 54.420000000000002 112.482 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -92.87 -13.15 29.39 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.774 -0.579 . . . . 54.229999999999997 109.708 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.3 p -80.56 173.71 12.33 Favored 'General case' 0 C--O 1.245 0.839 0 O-C-N 120.795 -1.191 . . . . 74.150000000000006 108.909 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.79 -155.33 11.8 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.645 -1.382 . . . . 55.130000000000003 109.645 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -80.11 -43.77 21.14 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 107.443 -1.318 . . . . 72.310000000000002 107.443 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.75 131.27 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.892 0 N-CA-C 103.502 -2.777 . . . . 71.540000000000006 103.502 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.54 140.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 105.379 -2.082 . . . . 70.150000000000006 105.379 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -97.18 118.11 32.88 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 104.834 -2.284 . . . . 74.430000000000007 104.834 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 34.5 mt -121.19 142.39 49.94 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 105.661 -1.978 . . . . 72.540000000000006 105.661 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.06 133.25 56.23 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 104.723 -2.325 . . . . 74.209999999999994 104.723 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.43 152.74 51.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.314 -1.736 . . . . 53.43 106.314 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 . . . . . 0 CA--C 1.48 -1.741 0 N-CA-C 105.627 -1.99 . . . . 71.019999999999996 105.627 -173.912 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 103.847 -2.649 . . . . 74.120000000000005 103.847 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -138.85 153.13 48.3 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 106.75 -1.574 . . . . 72.519999999999996 106.75 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -103.06 136.95 41.92 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 105.515 -2.032 . . . . 74.409999999999997 105.515 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.36 130.71 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.123 0 N-CA-C 104.217 -2.512 . . . . 71.150000000000006 104.217 173.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -107.22 114.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.048 -2.575 . . . . 73.349999999999994 104.048 170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.31 122.66 44.68 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 105.051 -2.203 . . . . 64.400000000000006 105.051 -168.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 146.67 25.97 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.025 -1.842 . . . . 42.25 106.025 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.5 -0.963 0 N-CA-C 106.714 -1.588 . . . . 75.099999999999994 106.714 177.822 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.492 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.464 0.553 0 CA-C-O 119.535 -0.592 . . . . 63.310000000000002 114.171 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -136.72 154.39 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 104.095 -2.557 . . . . 72.510000000000005 104.095 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -149.76 165.81 31.33 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 103.249 -2.871 . . . . 53.229999999999997 103.249 168.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.51 168.39 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 106.735 -1.58 . . . . 72.209999999999994 106.735 -164.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -148.3 167.21 25.76 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 102.625 -3.102 . . . . 73.310000000000002 102.625 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.34 -171.77 14.42 Favored Glycine 0 CA--C 1.474 -2.499 0 N-CA-C 107.568 -2.213 . . . . 33.350000000000001 107.568 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.89 -120.87 4.41 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 110.098 -1.201 . . . . 71.230000000000004 110.098 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.99 19.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 126.204 1.801 . . . . 74.299999999999997 113.96 -165.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 88.05 66.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 123.251 1.501 . . . . 74.319999999999993 107.915 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -86.78 -165.4 1.27 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 103.107 -2.923 . . . . 73.450000000000003 103.107 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -44.73 -28.91 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.902 0.881 . . . . 61.229999999999997 112.626 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -88.18 124.07 41.05 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 107.476 -1.305 . . . . 75.439999999999998 107.476 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -72.66 -23.61 60.92 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 116.088 -0.505 . . . . 55.210000000000001 109.883 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.68 -17.02 64.0 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.197 -1.038 . . . . 71.109999999999999 108.197 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.08 7.86 26.42 Favored Glycine 0 C--N 1.356 1.673 0 N-CA-C 110.479 -1.048 . . . . 74.219999999999999 110.479 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 162.03 49.56 Favored Glycine 0 CA--C 1.48 -2.155 0 N-CA-C 108.238 -1.945 . . . . 53.219999999999999 108.238 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.2 mm -90.45 133.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 104.221 -2.511 . . . . 72.420000000000002 104.221 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.79 145.29 49.82 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.154 -2.165 . . . . 73.099999999999994 105.154 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.12 134.33 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.675 -1.232 . . . . 74.319999999999993 107.675 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -106.38 -49.39 3.35 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.465 -1.68 . . . . 71.510000000000005 106.465 -169.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.08 140.85 34.26 Favored 'General case' 0 CA--C 1.463 -2.393 0 N-CA-C 105.948 -1.871 . . . . 34.109999999999999 105.948 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.51 131.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 103.593 -2.743 . . . . 73.219999999999999 103.593 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.492 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.1 mm -64.66 142.16 98.44 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 105.568 -2.012 . . . . 73.0 105.568 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.11 111.33 0.96 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.121 -1.915 . . . . 54.340000000000003 107.121 165.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 75.32 26.0 1.22 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.826 1.329 . . . . 73.219999999999999 110.957 -174.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.62 172.62 48.24 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 107.397 -2.281 . . . . 71.140000000000001 107.397 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.88 71.01 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 122.091 -0.653 . . . . 72.540000000000006 109.36 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.01 74.97 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.513 -0.921 . . . . 74.0 108.513 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.53 -36.41 82.62 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 109.129 -0.693 . . . . 71.299999999999997 109.129 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -65.67 -39.69 91.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.715 -0.846 . . . . 73.430000000000007 108.715 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.64 -40.72 72.92 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.17 -1.048 . . . . 75.140000000000001 108.17 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.459 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 95.5 -13.75 66.07 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.42 -1.072 . . . . 72.230000000000004 110.42 172.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -84.99 -41.35 15.92 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.618 -0.931 . . . . 70.310000000000002 109.808 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 mt -97.09 127.95 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 106.275 -1.75 . . . . 72.299999999999997 106.275 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 44.5 m-70 -122.69 174.59 7.01 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.46 -1.682 . . . . 72.120000000000005 106.46 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -66.7 137.83 56.97 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.357 -1.72 . . . . 74.120000000000005 106.357 166.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 -17.25 57.34 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 108.923 -1.671 . . . . 63.409999999999997 108.923 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.22 147.21 53.86 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 109.044 -0.724 . . . . 75.120000000000005 109.044 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -105.66 125.88 51.5 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 106.286 -1.746 . . . . 72.5 106.286 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.99 144.07 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 104.811 -2.292 . . . . 61.0 104.811 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -45.13 2.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.314 -1.365 . . . . 54.020000000000003 107.314 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.85 160.46 33.45 Favored 'General case' 0 CA--C 1.48 -1.733 0 C-N-CA 118.838 -1.145 . . . . 72.400000000000006 109.268 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.6 109.39 6.39 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 N-CA-C 105.315 -2.106 . . . . 33.130000000000003 105.315 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 47.79 40.51 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.922 1.689 . . . . 73.409999999999997 111.911 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.24 4.58 83.74 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 109.483 -1.447 . . . . 75.25 109.483 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.04 122.76 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 104.826 -2.287 . . . . 62.229999999999997 104.826 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.9 m -70.63 111.18 5.92 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.23 -1.026 . . . . 74.349999999999994 108.23 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.72 9.39 37.24 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 106.842 -1.54 . . . . 64.239999999999995 106.842 171.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -65.69 133.67 51.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.983 -1.488 . . . . 74.230000000000004 106.983 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.26 -18.65 5.18 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-O 119.629 -0.54 . . . . 72.209999999999994 111.78 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 171.71 1.87 Allowed 'General case' 0 C--N 1.37 1.459 0 CA-C-N 118.397 1.099 . . . . 74.329999999999998 110.228 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -83.85 159.86 21.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.485 -1.302 . . . . 73.310000000000002 107.485 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.33 -42.51 98.97 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.43 -0.952 . . . . 75.209999999999994 108.43 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.7 -43.13 94.22 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 110.024 -0.361 . . . . 71.310000000000002 110.024 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -61.71 -36.28 80.49 Favored 'General case' 0 C--N 1.383 2.035 0 O-C-N 121.368 -0.833 . . . . 54.200000000000003 109.164 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.97 79.53 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.958 -0.756 . . . . 52.240000000000002 108.958 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.9 t -73.89 -50.56 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.219 -1.4 . . . . 75.349999999999994 107.219 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.0 m -53.01 -29.94 32.41 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-O 122.07 0.938 . . . . 74.430000000000007 108.617 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -67.32 -53.82 26.16 Favored 'General case' 0 C--O 1.209 -1.074 0 O-C-N 120.933 -1.104 . . . . 53.119999999999997 108.033 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.84 -55.48 31.94 Favored 'General case' 0 C--O 1.211 -0.97 0 N-CA-C 109.149 -0.686 . . . . 63.149999999999999 109.149 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -48.28 -28.22 2.96 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.57 0.582 . . . . 70.219999999999999 112.57 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.77 -14.66 27.58 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.638 -0.664 . . . . 62.25 110.078 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 p -81.86 171.13 14.85 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.725 -1.234 . . . . 60.140000000000001 109.659 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.95 -154.2 12.91 Favored Glycine 0 C--N 1.36 1.881 0 N-CA-C 110.037 -1.225 . . . . 72.25 110.037 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -80.48 -35.8 34.3 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 107.857 -1.164 . . . . 55.119999999999997 107.857 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.84 126.87 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 104.554 -2.387 . . . . 52.340000000000003 104.554 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 139.36 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 N-CA-C 103.486 -2.783 . . . . 61.240000000000002 103.486 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -96.7 118.98 34.33 Favored 'General case' 0 CA--C 1.474 -1.96 0 N-CA-C 104.649 -2.352 . . . . 74.230000000000004 104.649 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -115.97 136.82 52.68 Favored 'General case' 0 CA--C 1.468 -2.173 0 N-CA-C 105.18 -2.156 . . . . 64.239999999999995 105.18 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.21 125.51 54.41 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.051 -2.203 . . . . 72.430000000000007 105.051 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.12 161.33 36.03 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 105.634 -1.988 . . . . 63.130000000000003 105.634 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 . . . . . 0 CA--C 1.468 -2.191 0 N-CA-C 108.0 -1.111 . . . . 65.219999999999999 108.0 174.319 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -2.028 0 N-CA-C 107.519 -2.233 . . . . 51.140000000000001 107.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.403 ' HG2' ' HE3' ' A' ' 92' ' ' LYS . 36.5 Cg_endo -66.71 151.9 81.66 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.071 1.847 . . . . 65.439999999999998 108.461 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -79.39 159.76 71.7 Favored Pre-proline 0 C--N 1.351 0.637 0 N-CA-C 108.303 -0.999 . . . . 74.439999999999998 108.303 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.66 128.7 18.48 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.063 1.842 . . . . 74.439999999999998 108.181 172.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 93.99 13.97 53.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 107.927 -2.069 . . . . 75.099999999999994 107.927 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 92' ' ' LYS . 18.5 t0 -89.77 134.57 34.11 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 105.594 -2.002 . . . . 73.109999999999999 105.594 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.84 130.91 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.397 0 N-CA-C 103.462 -2.792 . . . . 42.109999999999999 103.462 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.59 153.61 44.91 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.715 -1.587 . . . . 74.409999999999997 106.715 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -108.76 141.59 40.54 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 106.175 -1.787 . . . . 73.150000000000006 106.175 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.4 t -128.53 130.61 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 N-CA-C 104.819 -2.289 . . . . 61.520000000000003 104.819 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -105.71 113.21 26.64 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 104.931 -2.248 . . . . 72.129999999999995 104.931 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 120.98 41.54 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 106.231 -1.766 . . . . 64.219999999999999 106.231 -169.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.72 142.59 28.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.232 -1.766 . . . . 61.109999999999999 106.232 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HE2' HD22 ' A' ' 19' ' ' LEU . 33.4 mmtm -101.94 33.77 2.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.026 -1.472 . . . . 65.430000000000007 107.026 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.29 -51.45 15.2 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.262 -1.385 . . . . 73.129999999999995 107.262 -172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.7 -58.17 9.59 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 109.456 -0.572 . . . . 73.109999999999999 109.456 -173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -154.54 175.4 13.67 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.262 -1.755 . . . . 63.049999999999997 106.262 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.2 t -44.88 156.65 0.08 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.011 1.724 . . . . 72.25 110.39 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.406 HD22 ' HE2' ' A' ' 14' ' ' LYS . 5.5 mt -54.88 -57.81 10.13 Favored 'General case' 0 C--N 1.374 1.674 0 N-CA-C 108.6 -0.889 . . . . 54.219999999999999 108.6 -170.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.45 48.53 85.54 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 110.27 -1.132 . . . . 40.219999999999999 110.27 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.0 mt -129.24 158.86 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 104.433 -2.432 . . . . 53.520000000000003 104.433 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -149.99 165.42 32.72 Favored 'General case' 0 CA--C 1.476 -1.877 0 N-CA-C 102.147 -3.279 . . . . 43.43 102.147 168.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.71 168.19 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 105.936 -1.875 . . . . 74.010000000000005 105.936 -170.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -146.45 166.59 25.95 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 103.029 -2.952 . . . . 73.430000000000007 103.029 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.5 -173.3 14.66 Favored Glycine 0 CA--C 1.472 -2.624 0 N-CA-C 107.548 -2.221 . . . . 73.420000000000002 107.548 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.78 -127.81 6.08 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 108.838 -1.705 . . . . 31.420000000000002 108.838 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -73.18 19.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 126.222 1.809 . . . . 71.219999999999999 112.419 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.262 9.5 m120 87.31 65.52 0.01 OUTLIER 'General case' 0 CA--C 1.456 -2.672 0 N-CA-C 106.34 -1.726 . . . . 62.43 106.34 -168.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.661 HG22 ' H ' ' A' ' 30' ' ' SER . 3.4 m -80.96 -165.78 0.98 Allowed 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 104.003 -2.592 . . . . 73.200000000000003 104.003 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.661 ' H ' HG22 ' A' ' 29' ' ' THR . 3.4 p -42.96 -40.73 3.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 53.039999999999999 112.032 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.51 138.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 108.583 -0.895 . . . . 74.439999999999998 108.583 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.24 -42.39 68.92 Favored 'General case' 0 C--N 1.364 1.206 0 N-CA-C 109.787 -0.449 . . . . 63.5 109.787 -171.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -73.9 -5.64 42.34 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.843 -0.799 . . . . 71.230000000000004 108.843 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.22 3.25 11.5 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.304 -0.718 . . . . 74.409999999999997 111.304 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.53 150.19 42.09 Favored Glycine 0 CA--C 1.475 -2.448 0 N-CA-C 109.625 -1.39 . . . . 40.409999999999997 109.625 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.81 87.96 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 105.49 -2.041 . . . . 74.319999999999993 105.49 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -88.75 144.19 26.41 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.585 -1.635 . . . . 73.510000000000005 106.585 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.21 133.82 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 106.535 -1.654 . . . . 70.209999999999994 106.535 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -104.1 -43.66 5.2 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 106.712 -1.588 . . . . 64.530000000000001 106.712 -167.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.18 150.8 36.55 Favored 'General case' 0 CA--C 1.458 -2.569 0 N-CA-C 105.441 -2.059 . . . . 54.409999999999997 105.441 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -137.26 132.14 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.622 -2.362 . . . . 72.549999999999997 104.622 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.419 HG23 ' HD2' ' A' ' 43' ' ' PRO . 27.3 mt -70.6 137.88 85.91 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 105.546 -2.02 . . . . 74.329999999999998 105.546 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 42' ' ' ILE . 19.6 Cg_endo -57.56 123.53 13.96 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.165 1.91 . . . . 71.430000000000007 108.744 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 55.74 32.6 19.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.497 1.119 . . . . 71.540000000000006 112.053 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.92 -177.95 46.08 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 105.36 -3.096 . . . . 64.409999999999997 105.36 168.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.51 98.75 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.279 1.04 . . . . 63.200000000000003 109.6 -168.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.43 71.05 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 109.233 -0.654 . . . . 64.120000000000005 109.233 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -69.24 -38.74 78.62 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 109.648 -0.501 . . . . 73.439999999999998 109.648 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -65.38 -37.49 87.16 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.958 -1.126 . . . . 74.409999999999997 107.958 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.42 -32.56 66.43 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.532 -1.285 . . . . 72.340000000000003 107.532 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.22 -10.79 64.99 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 110.726 -0.95 . . . . 61.340000000000003 110.726 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -83.33 -41.03 18.71 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.459 -0.941 . . . . 73.239999999999995 108.459 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.8 mt -104.78 136.69 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.902 -1.888 . . . . 62.130000000000003 105.902 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -138.33 -178.52 5.32 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 104.843 -2.28 . . . . 74.310000000000002 104.843 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.42 146.9 54.04 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 108.678 -0.86 . . . . 70.430000000000007 108.678 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.21 -3.73 86.57 Favored Glycine 0 CA--C 1.493 -1.34 0 N-CA-C 109.704 -1.359 . . . . 52.229999999999997 109.704 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -80.51 155.45 27.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.461 -2.052 . . . . 75.319999999999993 105.461 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.5 ptt85 -119.68 127.35 52.8 Favored 'General case' 0 CA--C 1.478 -1.807 0 C-N-CA 119.411 -0.916 . . . . 62.329999999999998 109.099 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.07 148.13 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.09 -2.189 . . . . 64.120000000000005 105.09 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.65 -45.05 2.52 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 106.929 -1.508 . . . . 72.140000000000001 106.929 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.16 159.81 34.86 Favored 'General case' 0 CA--C 1.482 -1.667 0 C-N-CA 119.226 -0.99 . . . . 75.329999999999998 109.288 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.11 110.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 104.097 -2.557 . . . . 70.530000000000001 104.097 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.303 0.8 OUTLIER 46.48 38.3 5.28 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.541 1.137 . . . . 62.340000000000003 112.292 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.28 65.87 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.799 -1.32 . . . . 73.530000000000001 109.799 171.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.08 119.91 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.693 0 N-CA-C 104.971 -2.233 . . . . 70.519999999999996 104.971 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m -67.59 111.0 3.93 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.358 -1.349 . . . . 70.200000000000003 107.358 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.31 -14.91 51.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.926 -0.768 . . . . 72.030000000000001 108.926 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.98 146.58 46.46 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 109.332 -0.618 . . . . 65.549999999999997 109.332 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 -39.23 3.01 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 109.555 -1.418 . . . . 74.430000000000007 109.555 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 166.13 22.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.354 -0.98 . . . . 73.549999999999997 108.354 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.8 p -89.73 174.55 7.66 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.009 -1.108 . . . . 53.130000000000003 108.009 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -64.98 -38.73 91.93 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.987 -0.745 . . . . 64.099999999999994 108.987 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -59.59 -45.13 92.79 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 120.016 -0.674 . . . . 64.010000000000005 111.008 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -62.65 -39.99 95.63 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 119.746 1.157 . . . . 72.319999999999993 108.302 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.1 -42.97 86.8 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.8 -0.445 . . . . 74.140000000000001 109.8 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -69.25 -54.52 19.52 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 107.2 -1.407 . . . . 72.219999999999999 107.2 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -57.39 -26.46 61.11 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 109.222 -0.659 . . . . 71.310000000000002 109.222 -174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -65.81 -56.13 13.53 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 106.886 -1.524 . . . . 72.420000000000002 106.886 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.52 -55.1 35.8 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.153 -1.054 . . . . 74.5 108.153 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -45.63 -34.89 3.71 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.251 1.02 . . . . 70.209999999999994 111.975 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -96.6 -3.05 43.61 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.435 -0.79 . . . . 72.329999999999998 109.69 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -84.35 170.17 13.89 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 120.736 -1.227 . . . . 73.430000000000007 108.627 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.74 -149.32 24.59 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 122.508 1.06 . . . . 41.210000000000001 110.616 -171.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -77.82 -53.15 7.82 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.831 -1.174 . . . . 73.540000000000006 107.831 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.12 127.89 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.798 0 N-CA-C 103.576 -2.75 . . . . 71.430000000000007 103.576 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -133.16 143.13 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 103.796 -2.668 . . . . 74.340000000000003 103.796 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -97.28 116.0 28.67 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 104.542 -2.392 . . . . 73.040000000000006 104.542 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.0 mt -114.52 138.0 51.16 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 105.7 -1.963 . . . . 62.299999999999997 105.7 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.3 tp -113.82 127.85 56.17 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.548 -2.019 . . . . 44.240000000000002 105.548 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.81 155.97 49.7 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.26 -1.756 . . . . 74.519999999999996 106.26 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -129.28 137.64 51.16 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 105.596 -2.002 . . . . 72.109999999999999 105.596 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.57 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 72.3 mmtt -66.45 150.33 49.09 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.372 1.082 . . . . 53.229999999999997 110.844 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.72 45.35 0.39 Allowed Glycine 0 CA--C 1.48 -2.116 0 N-CA-C 104.893 -3.283 . . . . 71.400000000000006 104.893 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -103.75 168.8 8.9 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 107.147 -1.427 . . . . 73.299999999999997 107.147 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 5.3 m -68.88 162.87 61.08 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.711 -1.218 . . . . 40.020000000000003 107.711 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 34.9 Cg_endo -64.36 171.7 7.58 Favored 'Trans proline' 0 C--O 1.257 1.435 0 C-N-CA 122.492 2.128 . . . . 53.039999999999999 109.276 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.414 -2.254 0 N-CA-C 105.035 -2.209 . . . . 75.409999999999997 105.035 -173.392 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.414 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.722 0 N-CA-C 108.426 -1.87 . . . . 74.329999999999998 108.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.46 116.11 3.89 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.855 2.37 . . . . 74.329999999999998 109.116 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 99.3 mttt -88.65 165.92 25.34 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 105.324 -2.102 . . . . 75.099999999999994 105.324 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 16.8 Cg_endo -57.46 116.33 3.14 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.547 2.165 . . . . 73.219999999999999 110.705 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 12.28 51.64 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 108.237 -1.945 . . . . 64.409999999999997 108.237 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.44 136.76 36.51 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 105.691 -1.966 . . . . 74.430000000000007 105.691 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.22 137.07 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 104.719 -2.326 . . . . 71.510000000000005 104.719 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -145.88 157.11 43.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 105.893 -1.891 . . . . 72.099999999999994 105.893 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.25 143.62 32.41 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.848 -1.908 . . . . 73.319999999999993 105.848 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.4 t -122.06 128.12 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 104.167 -2.531 . . . . 73.010000000000005 104.167 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.26 114.62 26.39 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 105.552 -2.018 . . . . 73.430000000000007 105.552 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -103.61 120.84 41.69 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 105.994 -1.854 . . . . 72.430000000000007 105.994 -174.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.85 134.71 37.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.163 -1.421 . . . . 71.010000000000005 107.163 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.99 35.36 0.85 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.356 -1.72 . . . . 75.0 106.356 174.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -58.24 -38.38 76.75 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 108.557 -0.905 . . . . 71.219999999999999 108.557 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.28 175.08 7.94 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 107.482 -1.303 . . . . 73.140000000000001 107.482 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -80.6 -48.06 13.24 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 106.834 -1.543 . . . . 73.219999999999999 106.834 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.9 p -77.01 117.73 18.89 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.045 -0.724 . . . . 42.299999999999997 109.045 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.0 mt -72.88 -57.99 3.66 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 104.654 -2.35 . . . . 74.530000000000001 104.654 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.571 ' HA3' HG12 ' A' ' 42' ' ' ILE . . . 52.5 50.65 47.18 Favored Glycine 0 C--N 1.353 1.521 0 CA-C-N 113.373 -1.74 . . . . 64.340000000000003 112.459 169.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.2 mt -123.05 153.02 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 104.394 -2.447 . . . . 75.540000000000006 104.394 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.5 m -151.81 163.37 39.33 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 102.769 -3.048 . . . . 71.530000000000001 102.769 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.74 168.32 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 N-CA-C 104.401 -2.444 . . . . 73.140000000000001 104.401 -166.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.0 t -149.65 167.4 26.51 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 103.962 -2.607 . . . . 62.409999999999997 103.962 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.65 -171.89 13.99 Favored Glycine 0 CA--C 1.473 -2.56 0 N-CA-C 107.0 -2.44 . . . . 65.019999999999996 107.0 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.48 -124.23 5.83 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 108.687 -1.765 . . . . 74.129999999999995 108.687 177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 m -73.27 20.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.694 0 C-N-CA 125.883 1.673 . . . . 50.240000000000002 113.142 -167.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.1 t30 89.93 66.04 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 123.146 1.45 . . . . 72.329999999999998 107.39 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 30' ' ' SER . 2.0 m -82.71 -167.2 1.54 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.465 -2.42 . . . . 73.099999999999994 104.465 170.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.582 ' H ' HG22 ' A' ' 29' ' ' THR . 16.3 m -58.17 -25.21 61.23 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 121.5 -0.75 . . . . 64.329999999999998 111.535 -173.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 m -78.79 131.45 34.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.879 0 N-CA-C 107.505 -1.295 . . . . 72.519999999999996 107.505 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -60.11 -53.69 54.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.921 0.488 . . . . 72.25 110.675 -171.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -76.87 4.77 9.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.829 -0.544 . . . . 74.099999999999994 109.88 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.62 13.46 24.17 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.249 -0.74 . . . . 75.519999999999996 111.249 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.31 148.02 50.46 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 108.385 -1.886 . . . . 50.100000000000001 108.385 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.13 97.11 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.542 -1.651 . . . . 75.409999999999997 106.542 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -95.76 143.93 26.58 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 107.043 -1.465 . . . . 74.25 107.043 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.6 t -72.02 130.61 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 N-CA-C 105.064 -2.198 . . . . 45.409999999999997 105.064 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -103.09 -39.97 6.66 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 107.316 -1.365 . . . . 50.530000000000001 107.316 -166.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.38 158.48 40.12 Favored 'General case' 0 CA--C 1.465 -2.29 0 N-CA-C 106.011 -1.848 . . . . 73.319999999999993 106.011 -171.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.46 140.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 104.221 -2.511 . . . . 75.019999999999996 104.221 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.571 HG12 ' HA3' ' A' ' 20' ' ' GLY . 24.3 mm -70.67 143.99 90.51 Favored Pre-proline 0 C--N 1.355 0.805 0 N-CA-C 105.741 -1.948 . . . . 74.25 105.741 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.2 112.18 0.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.429 2.086 . . . . 70.340000000000003 108.948 165.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 74.91 22.04 1.93 Allowed 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.354 1.034 . . . . 60.240000000000002 110.483 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.74 175.68 30.17 Favored Glycine 0 C--N 1.375 2.732 0 N-CA-C 108.275 -1.93 . . . . 74.299999999999997 108.275 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.31 -41.69 98.74 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.036 -0.727 . . . . 60.450000000000003 109.036 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.1 -49.27 76.61 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.582 -0.525 . . . . 74.010000000000005 109.582 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -66.66 -35.13 79.43 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.134 -0.691 . . . . 63.039999999999999 109.134 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 m -66.02 -37.43 85.88 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.135 -1.061 . . . . 72.319999999999993 108.135 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.48 -41.24 89.27 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.397 -0.964 . . . . 71.230000000000004 108.397 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 90.71 -22.83 26.04 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.104 -1.198 . . . . 74.239999999999995 110.104 173.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -78.48 -38.72 40.27 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.693 -1.225 . . . . 72.319999999999993 107.693 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mt -104.84 129.37 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.258 -1.386 . . . . 72.530000000000001 107.258 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.46 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 76.8 m80 -140.19 -175.71 4.34 Favored 'General case' 0 CA--C 1.467 -2.25 0 N-CA-C 104.039 -2.578 . . . . 72.140000000000001 104.039 172.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 146.38 53.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.339 -1.356 . . . . 73.329999999999998 107.339 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.69 -25.23 28.22 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 107.827 -2.109 . . . . 52.539999999999999 107.827 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' HA ' ' HG3' ' A' ' 94' ' ' GLN . 6.7 m-20 -77.27 154.68 32.71 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 106.223 -1.769 . . . . 72.439999999999998 106.223 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -134.39 141.0 46.7 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 107.487 -1.301 . . . . 64.25 107.487 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.33 150.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.401 -1.704 . . . . 74.209999999999994 106.401 -172.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.59 -46.41 2.86 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 106.953 -1.499 . . . . 73.340000000000003 106.953 169.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.16 161.89 30.1 Favored 'General case' 0 CA--C 1.484 -1.577 0 C-N-CA 118.915 -1.114 . . . . 64.549999999999997 110.19 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -138.37 107.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 104.206 -2.516 . . . . 74.109999999999999 104.206 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 t30 48.83 37.98 11.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.496 1.119 . . . . 73.329999999999998 111.021 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.64 10.17 70.64 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.345 -1.102 . . . . 63.439999999999998 110.345 174.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.59 117.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.948 0 N-CA-C 103.933 -2.617 . . . . 73.120000000000005 103.933 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 m -71.66 111.48 6.99 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 107.561 -1.274 . . . . 73.129999999999995 107.561 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.26 -3.26 58.89 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.674 -0.861 . . . . 65.219999999999999 108.674 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -63.94 144.03 57.39 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 106.963 -1.495 . . . . 72.310000000000002 106.963 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -34.83 3.09 Favored Glycine 0 C--O 1.24 0.493 0 N-CA-C 111.022 -0.831 . . . . 62.329999999999998 111.022 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.68 162.11 24.41 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 118.356 1.078 . . . . 64.219999999999999 108.281 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -82.94 170.21 15.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.94 -0.763 . . . . 54.350000000000001 108.94 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -62.81 -44.1 97.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.702 -0.851 . . . . 73.239999999999995 108.702 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -62.35 -43.31 99.13 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-O 118.574 -0.727 . . . . 63.140000000000001 111.129 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -35.31 80.16 Favored 'General case' 0 C--N 1.383 2.028 0 CA-C-N 120.166 1.348 . . . . 70.329999999999998 109.005 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.89 74.23 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.913 -0.773 . . . . 61.049999999999997 108.913 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -73.88 -54.65 14.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 107.527 -1.286 . . . . 75.120000000000005 107.527 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 14.4 m -55.33 -29.27 57.97 Favored 'General case' 0 N--CA 1.523 3.207 0 CA-C-O 122.705 1.24 . . . . 51.0 108.365 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -68.51 -54.36 17.31 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.504 -1.372 . . . . 72.0 107.647 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.6 mt -54.7 -56.18 21.9 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.707 -0.849 . . . . 71.239999999999995 108.707 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -46.15 -47.09 17.62 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.185 0.439 . . . . 73.120000000000005 112.185 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -82.93 3.35 30.31 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.357 -0.84 . . . . 60.310000000000002 111.077 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.2 p -82.17 173.71 11.87 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.583 1.083 . . . . 73.409999999999997 108.375 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.93 -163.12 26.91 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 109.6 -1.4 . . . . 74.400000000000006 109.6 -176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.75 -32.98 27.56 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.101 -1.074 . . . . 62.329999999999998 108.101 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.2 t -115.95 127.19 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.605 -2.739 . . . . 61.310000000000002 103.605 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.46 151.32 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 104.609 -2.367 . . . . 75.510000000000005 104.609 -174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -102.08 123.68 46.37 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 104.271 -2.492 . . . . 61.100000000000001 104.271 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 12' ' ' LEU . 62.1 mt -114.99 138.69 50.55 Favored 'General case' 0 CA--C 1.467 -2.242 0 N-CA-C 104.301 -2.481 . . . . 72.510000000000005 104.301 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -112.63 125.37 54.21 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 105.647 -1.983 . . . . 74.200000000000003 105.647 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.75 153.68 49.83 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 106.164 -1.791 . . . . 65.129999999999995 106.164 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -123.76 133.29 53.87 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 105.024 -2.214 . . . . 73.409999999999997 105.024 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -67.19 142.65 56.92 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.575 0.702 . . . . 72.430000000000007 109.463 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.12 56.56 0.04 OUTLIER Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 104.295 -3.522 . . . . 73.400000000000006 104.295 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 57' ' ' ASP . 29.2 mp0 -91.37 134.66 34.42 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 106.157 -1.794 . . . . 73.319999999999993 106.157 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.0 m -99.65 148.06 34.22 Favored Pre-proline 0 N--CA 1.437 -1.124 0 N-CA-C 104.231 -2.507 . . . . 73.409999999999997 104.231 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.79 90.59 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.184 1.923 . . . . 74.230000000000004 107.584 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.415 -2.198 0 N-CA-C 105.929 -1.878 . . . . 74.329999999999998 105.929 -177.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.432 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.861 0 N-CA-C 108.377 -1.889 . . . . 72.439999999999998 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.07 101.81 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.861 2.374 . . . . 52.200000000000003 108.402 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 94.9 mttt -80.68 161.04 65.45 Favored Pre-proline 0 C--O 1.22 -0.478 0 N-CA-C 105.891 -1.892 . . . . 71.120000000000005 105.891 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 26.3 Cg_endo -61.85 115.61 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 74.230000000000004 109.837 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.91 12.95 58.52 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 108.369 -1.893 . . . . 62.350000000000001 108.369 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -94.61 141.69 28.31 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 105.179 -2.156 . . . . 61.210000000000001 105.179 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.54 129.39 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 103.692 -2.707 . . . . 53.520000000000003 103.692 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -138.58 146.51 41.91 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.233 -1.766 . . . . 71.25 106.233 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.18 138.84 40.07 Favored 'General case' 0 N--CA 1.396 -3.128 0 N-CA-C 104.483 -2.414 . . . . 62.420000000000002 104.483 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.02 130.99 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.772 0 N-CA-C 105.498 -2.038 . . . . 72.5 105.498 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -100.78 119.86 39.26 Favored 'General case' 0 N--CA 1.401 -2.893 0 N-CA-C 104.707 -2.331 . . . . 72.219999999999999 104.707 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 121.08 44.04 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 105.979 -1.86 . . . . 74.450000000000003 105.979 -171.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.32 134.29 41.54 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.653 -1.24 . . . . 23.440000000000001 107.653 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.37 34.64 1.41 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 107.018 -1.475 . . . . 63.229999999999997 107.018 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -58.94 -25.43 63.49 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.404 -0.591 . . . . 70.219999999999999 109.404 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -86.98 -131.26 0.06 Allowed 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.492 -1.67 . . . . 74.129999999999995 106.492 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -126.98 -51.23 1.44 Allowed 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.631 -0.877 . . . . 73.120000000000005 108.631 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.5 p -84.56 139.87 31.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.612 -1.255 . . . . 74.409999999999997 107.612 -170.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 80' ' ' ARG . 16.1 mt -73.03 -58.96 2.94 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 104.863 -2.273 . . . . 55.340000000000003 104.863 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . 94.64 24.13 19.06 Favored Glycine 0 N--CA 1.418 -2.51 0 N-CA-C 108.636 -1.786 . . . . 73.010000000000005 108.636 164.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.84 158.65 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 106.184 -1.784 . . . . 70.200000000000003 106.184 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.2 m -153.31 163.62 39.59 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 102.517 -3.142 . . . . 74.420000000000002 102.517 164.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.39 167.33 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 107.036 -1.468 . . . . 62.119999999999997 107.036 -161.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -143.71 165.99 26.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 104.562 -2.384 . . . . 71.200000000000003 104.562 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.22 -163.06 12.21 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 107.939 -2.065 . . . . 53.210000000000001 107.939 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.32 -127.5 6.08 Favored Glycine 0 C--N 1.36 1.877 0 N-CA-C 110.379 -1.088 . . . . 24.23 110.379 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 m -59.85 18.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.195 0 C-N-CA 128.282 2.633 . . . . 63.310000000000002 115.29 -167.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 86.44 64.34 0.01 OUTLIER 'General case' 0 CA--C 1.468 -2.196 0 N-CA-C 105.754 -1.943 . . . . 72.329999999999998 105.754 -165.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 30' ' ' SER . 2.3 m -88.43 -166.29 1.55 Allowed 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 111.686 -2.506 . . . . 64.400000000000006 104.546 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.668 ' H ' HG22 ' A' ' 29' ' ' THR . 11.8 m -58.35 -20.49 43.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.39 0.676 . . . . 21.23 111.226 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.18 130.64 36.71 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.629 -1.248 . . . . 51.409999999999997 107.629 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -70.32 -34.24 72.46 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-O 121.508 0.67 . . . . 72.340000000000003 109.756 -171.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.44 -15.65 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.202 -1.036 . . . . 72.299999999999997 108.202 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.24 8.72 25.89 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 110.391 -1.083 . . . . 75.409999999999997 110.391 -176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.97 159.46 53.9 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 107.976 -2.05 . . . . 52.420000000000002 107.976 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.0 mm -90.64 95.16 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.464 -2.05 . . . . 33.509999999999998 105.464 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.05 146.74 26.5 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 107.507 -1.294 . . . . 74.319999999999993 107.507 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.39 129.0 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 106.426 -1.694 . . . . 70.230000000000004 106.426 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -106.41 -43.79 4.68 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 107.88 -1.155 . . . . 73.5 107.88 -171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.8 144.59 39.42 Favored 'General case' 0 CA--C 1.46 -2.502 0 N-CA-C 105.732 -1.951 . . . . 74.299999999999997 105.732 -172.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.7 120.01 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 104.17 -2.53 . . . . 74.030000000000001 104.17 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.498 HD12 ' HA2' ' A' ' 20' ' ' GLY . 18.3 mt -72.88 135.06 80.79 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.122 -1.807 . . . . 64.219999999999999 106.122 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 42' ' ' ILE . 19.0 Cg_endo -58.2 121.6 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.803 2.335 . . . . 74.010000000000005 109.647 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 65.65 23.2 11.66 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 124.482 1.114 . . . . 74.310000000000002 110.461 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 175.34 49.18 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 106.698 -2.561 . . . . 50.039999999999999 106.698 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.1 82.92 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.613 -0.884 . . . . 74.409999999999997 108.613 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -49.48 76.85 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 109.222 -0.659 . . . . 71.549999999999997 109.222 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -70.32 -35.07 73.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.816 0.341 . . . . 74.040000000000006 110.112 -173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.0 m -68.33 -37.13 80.24 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.176 -1.046 . . . . 72.209999999999994 108.176 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.12 -47.0 72.45 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 107.124 -1.436 . . . . 65.430000000000007 107.124 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.09 -21.6 19.42 Favored Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 111.386 -0.686 . . . . 53.439999999999998 111.386 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -72.82 -35.13 67.24 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.559 1.18 . . . . 71.430000000000007 107.984 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.2 mt -94.55 135.98 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 105.964 -1.865 . . . . 45.539999999999999 105.964 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -144.31 176.06 9.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.262 -1.755 . . . . 54.130000000000003 106.262 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -66.95 137.1 56.28 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 106.799 -1.556 . . . . 72.120000000000005 106.799 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.99 -18.2 26.49 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 107.336 -2.306 . . . . 54.420000000000002 107.336 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.28 155.45 27.29 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 108.109 -1.071 . . . . 70.030000000000001 108.109 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -120.15 135.33 55.0 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 104.785 -2.302 . . . . 73.549999999999997 104.785 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 t -100.0 143.95 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 104.555 -2.387 . . . . 70.319999999999993 104.555 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.8 -46.9 2.53 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.14 -1.43 . . . . 71.530000000000001 107.14 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.37 165.34 22.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 CA-C-O 122.394 1.093 . . . . 63.399999999999999 109.625 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.2 t -142.13 113.0 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 N-CA-C 103.486 -2.783 . . . . 72.430000000000007 103.486 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 53.52 31.27 12.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.072 0.549 . . . . 73.109999999999999 110.473 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.49 79.61 Favored Glycine 0 C--N 1.357 1.728 0 N-CA-C 110.209 -1.156 . . . . 62.210000000000001 110.209 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.8 t -96.98 124.92 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 104.707 -2.331 . . . . 72.319999999999993 104.707 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.0 m -64.35 104.33 0.75 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.436 -1.32 . . . . 62.439999999999998 107.436 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -21.3 21.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 107.486 -1.302 . . . . 74.329999999999998 107.486 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -61.41 146.26 48.93 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.005 . . . . 73.450000000000003 108.288 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.27 -35.39 3.58 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 109.872 -1.291 . . . . 51.310000000000002 109.872 -172.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.78 161.65 28.0 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 108.102 -1.073 . . . . 73.519999999999996 108.102 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.0 p -77.83 168.46 19.89 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.685 0.755 . . . . 62.43 109.301 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -63.16 -42.27 99.4 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.986 -1.116 . . . . 63.049999999999997 107.986 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -56.02 -50.63 70.35 Favored 'General case' 0 C--N 1.367 1.338 0 N-CA-C 109.919 -0.4 . . . . 74.329999999999998 109.919 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -64.53 -37.12 86.45 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.307 -0.627 . . . . 64.400000000000006 109.307 -171.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.62 77.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.099 -0.704 . . . . 73.340000000000003 109.099 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.3 t -73.69 -52.77 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.529 -1.285 . . . . 73.319999999999993 107.529 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 46.6 m -53.04 -28.14 23.03 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-O 121.901 0.858 . . . . 70.209999999999994 109.009 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.25 -56.37 10.12 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 107.21 -1.404 . . . . 75.129999999999995 107.21 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.6 mt -56.75 -56.61 19.32 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.712 -0.847 . . . . 65.319999999999993 108.712 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.409 ' HA ' HD11 ' A' ' 19' ' ' LEU . 98.6 mtt180 -47.62 -27.14 1.73 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.048 1.129 . . . . 64.140000000000001 114.048 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -100.85 4.79 43.08 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 119.666 1.121 . . . . 74.430000000000007 109.047 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.2 p -84.86 170.28 13.29 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 121.055 -1.028 . . . . 73.120000000000005 108.4 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.6 -151.14 26.56 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 108.711 -1.755 . . . . 65.140000000000001 108.711 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -80.79 -43.17 20.52 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 107.994 -1.113 . . . . 64.319999999999993 107.994 -171.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.58 123.62 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 104.741 -2.318 . . . . 71.049999999999997 104.741 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 t -127.99 147.53 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.758 0 N-CA-C 105.373 -2.084 . . . . 53.350000000000001 105.373 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -99.88 115.66 30.13 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.152 -2.166 . . . . 62.210000000000001 105.152 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.82 134.27 52.66 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 104.62 -2.363 . . . . 60.32 104.62 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.57 124.37 52.2 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 105.129 -2.174 . . . . 75.120000000000005 105.129 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -133.18 159.34 40.46 Favored 'General case' 0 CA--C 1.473 -1.997 0 N-CA-C 106.843 -1.54 . . . . 75.209999999999994 106.843 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -123.8 135.09 53.58 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 103.112 -2.922 . . . . 74.340000000000003 103.112 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -66.4 150.97 48.1 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.986 0.898 . . . . 64.140000000000001 109.569 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -114.18 -168.29 16.26 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 105.26 -3.136 . . . . 65.519999999999996 105.26 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -74.2 155.99 37.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.128 -1.064 . . . . 70.209999999999994 108.128 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.489 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 52.1 m -79.87 165.12 49.42 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 104.888 -2.264 . . . . 72.519999999999996 104.888 169.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 16.2 Cg_endo -56.95 106.93 0.24 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.405 2.07 . . . . 74.209999999999994 109.135 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.416 -2.147 0 N-CA-C 104.705 -2.331 . . . . 62.25 104.705 -175.689 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.417 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.959 0 N-CA-C 108.794 -1.722 . . . . 64.329999999999998 108.794 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.94 124.93 12.41 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.753 2.302 . . . . 72.200000000000003 108.158 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -81.05 156.71 71.9 Favored Pre-proline 0 CA--C 1.506 -0.715 0 N-CA-C 106.177 -1.786 . . . . 64.420000000000002 106.177 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.82 141.49 59.4 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 N-CA-C 107.671 -1.703 . . . . 62.340000000000003 107.671 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.28 75.79 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 108.262 -1.935 . . . . 45.140000000000001 108.262 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' H ' ' HB2' ' A' ' 92' ' ' LYS . 22.4 t0 -89.58 136.48 33.01 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 104.545 -2.391 . . . . 74.5 104.545 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp -94.55 131.14 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 103.91 -2.626 . . . . 72.239999999999995 103.91 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.13 150.51 45.74 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.656 -1.239 . . . . 74.200000000000003 107.656 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.6 mp0 -102.69 136.7 42.04 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 104.875 -2.269 . . . . 71.129999999999995 104.875 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 t -125.56 134.26 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.743 0 N-CA-C 105.63 -1.989 . . . . 74.010000000000005 105.63 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -106.68 109.88 21.92 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.575 -2.009 . . . . 75.450000000000003 105.575 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -102.99 121.6 42.88 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.841 -1.911 . . . . 74.319999999999993 105.841 -171.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.34 130.0 35.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.068 -1.456 . . . . 71.099999999999994 107.068 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 32.51 0.64 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.99 -1.485 . . . . 72.510000000000005 106.99 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -71.5 -14.68 62.19 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 108.758 -0.83 . . . . 75.109999999999999 108.758 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 29.5 t70 -81.28 -154.43 0.11 Allowed 'General case' 0 C--N 1.351 0.671 0 N-CA-C 105.526 -2.027 . . . . 62.340000000000003 105.526 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.529 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 35.7 m120 -118.0 -39.97 3.03 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 104.576 -2.379 . . . . 74.140000000000001 104.576 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.0 m -76.19 150.07 37.17 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.455 -1.313 . . . . 55.130000000000003 107.455 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -71.85 -19.04 62.02 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.089 -1.078 . . . . 64.310000000000002 108.089 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.64 ' HA3' ' H ' ' A' ' 47' ' ' ALA . . . 77.49 -34.5 1.57 Allowed Glycine 0 C--O 1.203 -1.789 0 CA-C-N 115.363 -0.835 . . . . 65.129999999999995 111.437 -176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mm -110.13 157.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 106.404 -1.702 . . . . 74.209999999999994 106.404 -170.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.8 m -146.49 155.93 42.89 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 101.571 -3.492 . . . . 74.329999999999998 101.571 163.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.31 160.57 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 C-N-CA 119.309 -0.956 . . . . 74.319999999999993 109.833 -166.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 t -145.22 166.29 25.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 103.032 -2.951 . . . . 54.350000000000001 103.032 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.74 123.72 4.0 Favored Glycine 0 C--O 1.193 -2.408 0 N-CA-C 108.407 -1.877 . . . . 51.450000000000003 108.407 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.18 -115.37 0.44 Allowed Glycine 0 C--N 1.354 1.543 0 N-CA-C 109.096 -1.602 . . . . 75.510000000000005 109.096 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.79 20.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 126.17 1.788 . . . . 51.240000000000002 115.031 -163.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.3 t30 88.3 64.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 123.702 1.715 . . . . 52.439999999999998 106.476 -164.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -90.0 -165.28 1.31 Allowed 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 102.587 -3.116 . . . . 73.329999999999998 102.587 165.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -40.49 -33.35 0.26 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.412 1.085 . . . . 72.219999999999999 112.91 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 m -93.68 132.99 36.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 O-C-N 121.15 -0.969 . . . . 75.209999999999994 108.579 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -64.12 -58.03 7.83 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.565 -1.198 . . . . 61.140000000000001 111.899 -168.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -79.94 5.06 14.92 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.49 -0.756 . . . . 75.109999999999999 109.071 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.85 33.26 83.54 Favored Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 108.504 -1.839 . . . . 75.299999999999997 108.504 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.4 124.77 34.17 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 107.525 -2.23 . . . . 63.149999999999999 107.525 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mm -81.39 90.15 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.675 -2.342 . . . . 73.030000000000001 104.675 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -85.57 146.16 27.02 Favored 'General case' 0 CA--C 1.467 -2.212 0 N-CA-C 107.887 -1.153 . . . . 65.109999999999999 107.887 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.12 125.98 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.749 -1.945 . . . . 71.230000000000004 105.749 167.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -91.55 -38.38 12.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 106.672 -1.603 . . . . 65.540000000000006 106.672 -168.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.59 155.5 38.56 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 105.825 -1.917 . . . . 75.019999999999996 105.825 -172.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -110.97 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 102.06 -3.311 . . . . 74.510000000000005 102.06 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.5 mt -66.95 130.35 93.93 Favored Pre-proline 0 N--CA 1.444 -0.753 0 N-CA-C 106.554 -1.647 . . . . 65.430000000000007 106.554 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.26 123.93 14.49 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 122.809 2.339 . . . . 64.420000000000002 109.477 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 68.67 10.09 7.69 Favored 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 124.781 1.3 . . . . 72.25 110.756 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.57 -175.18 37.17 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.973 -1.651 . . . . 54.409999999999997 108.973 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.85 74.34 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.054 -0.721 . . . . 63.240000000000002 109.054 -175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.64 ' H ' ' HA3' ' A' ' 20' ' ' GLY . . . -68.99 -46.03 69.08 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 108.908 -0.775 . . . . 72.140000000000001 108.908 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.22 -36.0 80.62 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 108.741 -0.837 . . . . 73.109999999999999 108.741 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.7 t -64.18 -40.13 95.45 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 108.203 -1.036 . . . . 54.420000000000002 108.203 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -73.86 -48.25 32.44 Favored 'General case' 0 C--N 1.351 0.63 0 N-CA-C 107.577 -1.268 . . . . 75.530000000000001 107.577 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.34 -17.44 13.47 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.771 -0.532 . . . . 63.219999999999999 111.771 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . 33.9 ttm105 -72.98 -33.76 66.02 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.852 -1.166 . . . . 72.230000000000004 107.852 -173.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.16 135.61 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.069 -1.826 . . . . 72.319999999999993 106.069 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 52' ' ' ARG . 25.6 m80 -118.59 162.87 17.68 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 106.995 -1.483 . . . . 73.549999999999997 106.995 -175.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -65.78 136.42 56.19 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 106.981 -1.488 . . . . 71.409999999999997 106.981 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.75 -10.0 72.88 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.78 -1.728 . . . . 70.129999999999995 108.78 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -66.51 143.41 57.09 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 105.884 -1.895 . . . . 70.150000000000006 105.884 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.7 tmm_? -103.15 119.82 39.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 107.376 -1.342 . . . . 75.510000000000005 107.376 -169.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 t -89.18 141.62 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 105.766 -1.939 . . . . 73.219999999999999 105.766 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 -47.0 2.51 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 107.32 -1.363 . . . . 70.310000000000002 107.32 176.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.32 167.63 18.92 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-O 122.373 1.082 . . . . 64.310000000000002 109.493 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -141.07 108.31 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 103.533 -2.766 . . . . 70.5 103.533 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 64.8 t30 49.91 39.64 18.99 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.089 0.956 . . . . 73.099999999999994 110.598 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.55 20.1 78.74 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 109.936 -1.266 . . . . 62.340000000000003 109.936 175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.3 t -99.63 119.35 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.404 0 N-CA-C 104.124 -2.547 . . . . 64.329999999999998 104.124 171.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -70.24 105.9 3.13 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.234 -0.654 . . . . 54.009999999999998 109.234 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.88 -7.07 53.23 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.027 -1.471 . . . . 72.25 107.027 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.97 143.67 57.8 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.109 -1.441 . . . . 72.409999999999997 107.109 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.83 2.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 110.983 -0.847 . . . . 23.010000000000002 110.983 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.89 172.66 4.19 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 118.218 1.009 . . . . 60.299999999999997 109.766 -174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -82.65 156.47 23.84 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.603 -1.258 . . . . 75.530000000000001 107.603 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -66.28 -37.65 85.94 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 107.89 -1.152 . . . . 72.340000000000003 107.89 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -39.45 87.16 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 120.639 -0.424 . . . . 72.209999999999994 110.188 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.71 -36.45 83.9 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-N 119.389 0.995 . . . . 73.230000000000004 109.018 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.14 75.83 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 109.078 -0.712 . . . . 72.109999999999999 109.078 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 -53.45 25.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 N-CA-C 107.278 -1.379 . . . . 71.400000000000006 107.278 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.0 m -52.49 -29.19 23.7 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 108.294 -1.002 . . . . 74.219999999999999 108.294 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.1 m -69.19 -56.23 8.25 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 108.015 -1.105 . . . . 70.510000000000005 108.015 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -53.52 -56.17 19.31 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.844 -0.799 . . . . 54.450000000000003 108.844 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -46.58 -43.3 17.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.551 -0.749 . . . . 74.5 111.475 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -77.37 -14.55 59.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.509 0.323 . . . . 62.219999999999999 110.711 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -76.13 163.26 27.27 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 120.668 -1.27 . . . . 74.420000000000002 108.927 -171.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.84 -146.68 6.46 Favored Glycine 0 CA--C 1.491 -1.447 0 N-CA-C 109.245 -1.542 . . . . 72.239999999999995 109.245 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -85.39 -42.64 14.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 107.793 -1.188 . . . . 75.319999999999993 107.793 -172.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.6 t -108.08 128.31 63.58 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.552 0 N-CA-C 104.277 -2.49 . . . . 55.5 104.277 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.07 139.15 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 105.825 -1.917 . . . . 74.230000000000004 105.825 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -97.24 115.87 28.41 Favored 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 104.699 -2.334 . . . . 73.120000000000005 104.699 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 12' ' ' LEU . 18.1 mt -112.84 137.22 51.51 Favored 'General case' 0 CA--C 1.477 -1.843 0 N-CA-C 104.84 -2.281 . . . . 75.310000000000002 104.84 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 tp -114.62 124.17 51.17 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.943 -2.243 . . . . 62.530000000000001 104.943 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.5 158.18 41.58 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 107.436 -1.32 . . . . 73.329999999999998 107.436 -173.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 58' ' ' ARG . 42.2 tt0 -120.28 128.1 53.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 103.876 -2.639 . . . . 71.129999999999995 103.876 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 6' ' ' ASP . 25.5 mmtp -62.84 153.07 34.3 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-O 122.244 1.021 . . . . 72.099999999999994 110.498 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.06 58.57 0.03 OUTLIER Glycine 0 CA--C 1.451 -3.933 0 N-CA-C 104.075 -3.61 . . . . 74.239999999999995 104.075 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -79.25 130.42 35.45 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 105.401 -2.074 . . . . 72.420000000000002 105.401 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.9 p -104.14 149.94 37.8 Favored Pre-proline 0 N--CA 1.416 -2.162 0 N-CA-C 106.392 -1.707 . . . . 74.150000000000006 106.392 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.4 76.2 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.548 2.166 . . . . 74.439999999999998 107.796 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.25 1.096 0 N-CA-C 106.071 -1.826 . . . . 71.209999999999994 106.071 -178.825 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.609 0 N-CA-C 108.689 -1.764 . . . . 74.310000000000002 108.689 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.84 137.99 66.14 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.982 2.454 . . . . 65.239999999999995 108.935 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 6.1 mtpm? -81.61 165.5 43.6 Favored Pre-proline 0 N--CA 1.44 -0.939 0 N-CA-C 106.245 -1.761 . . . . 74.219999999999999 106.245 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 18.5 Cg_endo -58.76 112.05 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.742 2.295 . . . . 75.150000000000006 108.78 172.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.66 12.9 29.27 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.685 -1.366 . . . . 70.209999999999994 109.685 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.46 137.92 32.27 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 105.618 -1.993 . . . . 71.530000000000001 105.618 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.3 140.01 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 104.139 -2.541 . . . . 75.319999999999993 104.139 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -152.34 159.77 43.41 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 105.346 -2.094 . . . . 72.329999999999998 105.346 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -102.12 145.79 28.85 Favored 'General case' 0 CA--C 1.475 -1.918 0 N-CA-C 105.256 -2.128 . . . . 73.099999999999994 105.256 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.72 122.74 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 N-CA-C 103.448 -2.797 . . . . 44.219999999999999 103.448 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -99.6 109.48 21.98 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.283 -2.488 . . . . 63.219999999999999 104.283 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 105.44 -2.059 . . . . 74.099999999999994 105.44 -171.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.18 134.18 34.13 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.064 -1.828 . . . . 60.450000000000003 106.064 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.67 33.71 0.32 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.313 -0.995 . . . . 73.319999999999993 108.313 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -53.77 -33.4 55.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 123.45 0.7 . . . . 62.210000000000001 109.247 -171.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -65.6 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.676 0 N-CA-C 107.15 -1.426 . . . . 53.439999999999998 107.15 171.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.4 t30 165.49 -32.71 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 103.935 -2.617 . . . . 64.540000000000006 103.935 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 m -94.61 149.21 21.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 105.372 -2.084 . . . . 75.409999999999997 105.372 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -73.07 -57.28 4.14 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 104.301 -2.481 . . . . 71.400000000000006 104.301 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . 88.14 34.42 9.76 Favored Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.981 -2.447 . . . . 52.329999999999998 106.981 175.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 mt -131.05 160.04 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 104.959 -2.237 . . . . 71.439999999999998 104.959 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.14 162.86 37.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 102.562 -3.125 . . . . 71.120000000000005 102.562 163.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.97 167.85 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 N-CA-C 105.801 -1.925 . . . . 71.120000000000005 105.801 -165.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -147.41 166.5 26.99 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 102.721 -3.066 . . . . 63.329999999999998 102.721 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' H ' HG21 ' A' ' 29' ' ' THR . . . 127.92 178.57 15.4 Favored Glycine 0 CA--C 1.459 -3.46 0 N-CA-C 105.715 -2.954 . . . . 51.329999999999998 105.715 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.75 -130.52 6.99 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 108.823 -1.711 . . . . 54.130000000000003 108.823 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.39 19.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 126.721 2.008 . . . . 64.049999999999997 114.212 -165.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.5 t30 88.37 65.6 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.051 -1.463 . . . . 54.240000000000002 107.051 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.496 HG21 ' H ' ' A' ' 25' ' ' GLY . 15.3 t -94.71 -166.24 1.44 Allowed 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 104.094 -2.558 . . . . 73.239999999999995 104.094 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 m -47.41 -40.7 18.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.732 1.213 . . . . 60.229999999999997 112.59 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 m -76.16 133.78 30.4 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 N-CA-C 108.871 -0.788 . . . . 64.120000000000005 108.871 -173.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -57.77 -55.15 38.54 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 124.19 0.996 . . . . 75.129999999999995 112.492 -169.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -76.22 6.61 5.21 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.297 -0.877 . . . . 60.140000000000001 110.111 -173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 57.53 6.44 2.38 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 121.516 -0.74 . . . . 55.439999999999998 111.967 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.68 160.65 53.81 Favored Glycine 0 CA--C 1.473 -2.551 0 N-CA-C 107.364 -2.294 . . . . 74.439999999999998 107.364 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mm -83.92 108.62 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 106.14 -1.8 . . . . 75.510000000000005 106.14 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 42.9 m-85 -103.75 144.08 31.94 Favored 'General case' 0 CA--C 1.48 -1.74 0 N-CA-C 106.84 -1.541 . . . . 74.109999999999999 106.84 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.94 132.12 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.031 -1.841 . . . . 54.439999999999998 106.031 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -114.72 -37.48 4.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.228 -1.027 . . . . 74.239999999999995 108.228 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.57 146.43 34.59 Favored 'General case' 0 CA--C 1.463 -2.366 0 N-CA-C 106.716 -1.587 . . . . 60.200000000000003 106.716 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.03 119.35 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 104.979 -2.23 . . . . 73.540000000000006 104.979 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 20' ' ' GLY . 23.3 mt -72.46 140.09 81.75 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 106.575 -1.639 . . . . 71.239999999999995 106.575 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 42' ' ' ILE . 18.7 Cg_endo -57.6 119.9 7.45 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.731 2.287 . . . . 63.420000000000002 109.785 177.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 68.75 25.29 6.38 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 125.12 1.512 . . . . 74.340000000000003 110.372 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.02 173.44 52.62 Favored Glycine 0 C--N 1.357 1.716 0 N-CA-C 107.653 -2.179 . . . . 72.219999999999999 107.653 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.38 99.29 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.796 -0.816 . . . . 74.239999999999995 108.796 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.86 -49.19 77.24 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.311 -0.626 . . . . 62.140000000000001 109.311 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.5 -42.17 95.81 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.027 -0.731 . . . . 61.539999999999999 109.027 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -67.82 -36.69 80.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.614 -0.513 . . . . 61.539999999999999 109.614 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.86 -36.91 75.89 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.637 -1.246 . . . . 35.310000000000002 107.637 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -18.95 23.94 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.039 -0.824 . . . . 62.240000000000002 111.039 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -74.62 -39.75 61.94 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.426 -0.953 . . . . 74.439999999999998 108.426 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.9 mt -95.74 120.62 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 105.829 -1.915 . . . . 63.530000000000001 105.829 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -121.21 169.85 10.15 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 105.657 -1.979 . . . . 72.150000000000006 105.657 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -66.52 137.86 57.09 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.501 -1.666 . . . . 75.319999999999993 106.501 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.05 -26.16 23.99 Favored Glycine 0 CA--C 1.495 -1.159 0 N-CA-C 108.328 -1.909 . . . . 75.129999999999995 108.328 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.55 166.5 21.68 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 107.69 -1.226 . . . . 71.030000000000001 107.69 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -130.29 139.39 50.74 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 107.489 -1.3 . . . . 71.120000000000005 107.489 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.48 143.97 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 104.086 -2.561 . . . . 54.5 104.086 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.37 -46.92 3.13 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 107.563 -1.273 . . . . 74.329999999999998 107.563 176.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.91 166.09 21.69 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 122.377 1.085 . . . . 70.340000000000003 109.827 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.46 104.35 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 103.783 -2.673 . . . . 61.25 103.783 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 46.91 43.28 13.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.091 0.956 . . . . 52.25 110.849 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.81 76.6 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.217 -1.153 . . . . 64.150000000000006 110.217 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.34 117.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 104.467 -2.42 . . . . 72.219999999999999 104.467 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.1 m -75.33 107.48 7.47 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 107.786 -1.191 . . . . 64.120000000000005 107.786 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.35 -6.29 56.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.513 -0.767 . . . . 71.200000000000003 110.034 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 -61.47 142.75 56.81 Favored 'General case' 0 C--N 1.361 1.073 0 O-C-N 120.875 -1.141 . . . . 74.540000000000006 108.834 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.94 -25.06 6.19 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.385 -1.086 . . . . 54.25 110.385 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 164.0 26.5 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.203 1.001 . . . . 62.420000000000002 108.892 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.6 p -81.54 163.62 22.53 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.625 -0.88 . . . . 72.109999999999999 108.625 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -61.49 -44.94 96.19 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.445 -0.798 . . . . 72.049999999999997 108.936 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -30.73 70.66 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 120.302 -0.559 . . . . 72.340000000000003 109.918 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -65.55 -36.2 83.09 Favored 'General case' 0 C--N 1.373 1.622 0 N-CA-C 108.521 -0.918 . . . . 73.230000000000004 108.521 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.39 -34.19 73.56 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.553 -0.906 . . . . 50.130000000000003 108.553 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.67 -53.63 19.85 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.156 -1.424 . . . . 75.340000000000003 107.156 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.3 m -53.26 -29.05 30.71 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.199 -1.038 . . . . 54.109999999999999 108.199 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.5 m -69.91 -55.83 8.65 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.531 -1.285 . . . . 72.450000000000003 107.531 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -55.78 -55.49 31.74 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.062 -0.718 . . . . 73.140000000000001 109.062 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -45.97 -37.91 7.07 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.653 0.612 . . . . 73.25 112.653 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -90.23 8.28 33.95 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.29 0.95 . . . . 65.439999999999998 110.283 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -74.32 163.54 27.68 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-N 119.587 1.085 . . . . 63.140000000000001 109.51 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.74 -158.79 19.87 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 109.067 -1.613 . . . . 52.32 109.067 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.449 ' H ' ' CD ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -81.99 -38.45 25.08 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.886 -0.783 . . . . 62.32 108.886 -169.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.8 t -113.34 130.06 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 103.553 -2.758 . . . . 70.430000000000007 103.553 173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -122.27 142.12 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 N-CA-C 104.827 -2.286 . . . . 73.120000000000005 104.827 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -100.71 119.22 38.28 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 104.333 -2.469 . . . . 73.310000000000002 104.333 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.46 134.62 54.56 Favored 'General case' 0 CA--C 1.468 -2.19 0 N-CA-C 103.726 -2.694 . . . . 72.420000000000002 103.726 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.57 126.94 53.49 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 105.764 -1.939 . . . . 71.040000000000006 105.764 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -134.37 155.33 50.46 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 106.211 -1.774 . . . . 70.310000000000002 106.211 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -118.21 135.65 54.12 Favored 'General case' 0 CA--C 1.477 -1.863 0 N-CA-C 102.685 -3.079 . . . . 53.25 102.685 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.48 141.76 50.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.665 -0.865 . . . . 73.109999999999999 108.665 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.21 67.01 0.05 OUTLIER Glycine 0 CA--C 1.472 -2.628 0 N-CA-C 107.44 -2.264 . . . . 64.319999999999993 107.44 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -75.17 130.21 38.8 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 105.478 -2.045 . . . . 73.349999999999994 105.478 171.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m -87.23 151.9 52.0 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 105.688 -1.967 . . . . 62.229999999999997 105.688 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.42 65.6 7.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.658 2.239 . . . . 74.120000000000005 108.199 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.421 -1.899 0 N-CA-C 105.309 -2.108 . . . . 62.310000000000002 105.309 -178.382 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 108.406 -1.877 . . . . 72.340000000000003 108.406 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.59 169.57 17.05 Favored 'Trans proline' 0 CA--C 1.512 -0.593 0 C-N-CA 123.082 2.521 . . . . 64.540000000000006 108.283 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -97.57 152.64 38.28 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 105.841 -1.911 . . . . 65.120000000000005 105.841 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 132.63 31.82 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.606 2.204 . . . . 74.310000000000002 109.915 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.0 64.25 Favored Glycine 0 CA--C 1.497 -1.042 0 N-CA-C 109.518 -1.433 . . . . 64.329999999999998 109.518 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.52 139.6 30.55 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 105.765 -1.939 . . . . 74.340000000000003 105.765 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.41 130.69 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 N-CA-C 104.704 -2.332 . . . . 75.030000000000001 104.704 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -138.53 149.04 44.94 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.599 -1.63 . . . . 74.219999999999999 106.599 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HG2' HD13 ' A' ' 89' ' ' LEU . 89.4 mt-10 -103.22 139.72 38.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.574 -1.639 . . . . 65.439999999999998 106.574 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.04 135.28 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 106.939 -1.504 . . . . 71.409999999999997 106.939 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -105.9 112.8 26.0 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 104.533 -2.395 . . . . 65.239999999999995 104.533 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.18 125.12 50.69 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.586 -1.635 . . . . 74.319999999999993 106.586 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.22 133.84 37.32 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.931 -1.507 . . . . 73.340000000000003 106.931 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -103.91 34.89 2.84 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 105.993 -1.854 . . . . 60.43 105.993 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.97 83.97 3.5 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.86 -1.904 . . . . 72.340000000000003 105.86 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -175.19 -171.25 0.49 Allowed 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 100.527 -3.879 . . . . 73.319999999999993 100.527 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -91.2 -47.23 7.63 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 106.715 -1.587 . . . . 72.510000000000005 106.715 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.4 m -93.15 139.62 30.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.84 -1.541 . . . . 64.109999999999999 106.84 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.98 -57.66 3.88 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 104.022 -2.584 . . . . 71.299999999999997 104.022 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 81.07 39.22 13.31 Favored Glycine 0 CA--C 1.478 -2.247 0 CA-C-N 113.731 -1.577 . . . . 52.409999999999997 109.498 167.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.51 145.7 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 103.537 -2.764 . . . . 75.019999999999996 103.537 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.48 162.99 34.38 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 103.07 -2.937 . . . . 63.350000000000001 103.07 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.09 168.0 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 N-CA-C 104.829 -2.286 . . . . 71.409999999999997 104.829 -167.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.6 t -145.79 166.03 27.11 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.319 -2.474 . . . . 71.120000000000005 104.319 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.83 131.74 3.64 Favored Glycine 0 C--O 1.2 -2.01 0 N-CA-C 108.594 -1.802 . . . . 42.130000000000003 108.594 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.2 -99.07 0.14 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 107.526 -2.229 . . . . 64.510000000000005 107.526 167.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.31 20.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.386 1.874 . . . . 63.420000000000002 114.94 -170.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 88.71 66.41 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.926 0 CA-C-O 123.337 1.542 . . . . 75.109999999999999 106.991 -168.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.78 HG22 ' H ' ' A' ' 30' ' ' SER . 4.3 m -84.38 -166.57 1.48 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 104.478 -2.416 . . . . 71.519999999999996 104.478 173.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.78 ' H ' HG22 ' A' ' 29' ' ' THR . 10.5 m -53.16 -28.11 24.57 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.339 0.656 . . . . 60.109999999999999 110.9 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 m -82.57 122.25 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.787 -1.56 . . . . 63.130000000000003 106.787 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -83.59 -16.76 44.1 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.683 -0.858 . . . . 63.049999999999997 108.683 -170.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 35' ' ' GLY . 43.3 t60 -70.77 -12.19 61.4 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.739 -1.208 . . . . 70.200000000000003 107.739 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.37 -5.36 1.54 Allowed Glycine 0 C--N 1.365 2.147 0 C-N-CA 124.155 0.883 . . . . 71.129999999999995 111.505 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 33' ' ' HIS . . . -70.28 151.19 49.59 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 107.931 -2.067 . . . . 71.150000000000006 107.931 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.408 HG21 ' HB1' ' A' ' 75' ' ' ALA . 10.7 mm -82.17 126.08 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 N-CA-C 104.449 -2.426 . . . . 74.120000000000005 104.449 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -111.91 145.6 39.26 Favored 'General case' 0 CA--C 1.468 -2.198 0 N-CA-C 106.89 -1.522 . . . . 71.519999999999996 106.89 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -74.52 129.36 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.386 -2.079 . . . . 71.040000000000006 105.386 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -116.45 -35.28 4.32 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.741 -1.207 . . . . 70.319999999999993 107.741 -170.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.04 136.28 45.87 Favored 'General case' 0 CA--C 1.452 -2.798 0 N-CA-C 105.521 -2.029 . . . . 75.0 105.521 -167.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -139.39 129.76 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 103.765 -2.68 . . . . 73.109999999999999 103.765 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.528 HG12 ' CA ' ' A' ' 20' ' ' GLY . 6.5 mm -70.94 147.46 94.0 Favored Pre-proline 0 CA--C 1.505 -0.751 0 N-CA-C 105.082 -2.192 . . . . 75.409999999999997 105.082 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.59 114.35 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.876 1.717 . . . . 63.100000000000001 107.801 164.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 68.95 26.49 5.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 124.542 1.151 . . . . 60.340000000000003 111.044 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.15 177.12 43.14 Favored Glycine 0 C--N 1.368 2.34 0 N-CA-C 106.474 -2.65 . . . . 51.030000000000001 106.474 167.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.04 95.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 122.124 -0.633 . . . . 72.420000000000002 109.342 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.25 -49.2 78.07 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.413 -0.588 . . . . 73.239999999999995 109.413 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.46 -36.8 81.88 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.864 -0.791 . . . . 74.140000000000001 108.864 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -65.18 -44.02 89.79 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.458 -0.942 . . . . 61.43 108.458 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -70.36 -33.0 70.92 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.235 -1.395 . . . . 74.310000000000002 107.235 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.27 -16.12 45.76 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 110.481 -1.048 . . . . 55.210000000000001 110.481 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -79.42 -34.68 41.5 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.695 -0.854 . . . . 74.040000000000006 108.695 -171.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.4 mt -105.25 141.29 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 105.852 -1.907 . . . . 71.030000000000001 105.852 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -143.56 178.33 7.86 Favored 'General case' 0 CA--C 1.466 -2.252 0 N-CA-C 104.526 -2.398 . . . . 74.400000000000006 104.526 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.91 146.96 53.85 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 107.007 -1.479 . . . . 73.109999999999999 107.007 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.14 -16.49 53.62 Favored Glycine 0 CA--C 1.498 -0.997 0 N-CA-C 107.335 -2.306 . . . . 65.510000000000005 107.335 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.29 146.57 31.56 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.998 -1.852 . . . . 70.319999999999993 105.998 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.8 tmm_? -108.83 123.82 49.65 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 105.377 -2.083 . . . . 74.239999999999995 105.377 -175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.29 141.2 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.998 0 N-CA-C 105.545 -2.021 . . . . 63.32 105.545 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.09 -49.01 2.31 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.89 -1.152 . . . . 71.219999999999999 107.89 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.98 166.83 19.27 Favored 'General case' 0 CA--C 1.475 -1.923 0 C-N-CA 118.873 -1.131 . . . . 74.5 109.92 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.71 100.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 103.395 -2.817 . . . . 73.319999999999993 103.395 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.8 t30 48.16 41.99 16.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.731 1.212 . . . . 51.509999999999998 110.954 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 13.04 77.02 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 110.053 -1.219 . . . . 75.230000000000004 110.053 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.14 116.85 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.759 0 N-CA-C 103.647 -2.723 . . . . 74.239999999999995 103.647 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 m -72.45 112.22 8.32 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.137 -1.06 . . . . 53.350000000000001 108.137 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.79 9.63 26.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.905 -1.517 . . . . 70.150000000000006 106.905 172.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -71.79 140.01 49.25 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.436 -1.69 . . . . 72.230000000000004 106.436 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 -23.23 4.58 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.291 -1.124 . . . . 62.210000000000001 110.291 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.93 164.72 16.93 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.895 0.855 . . . . 53.340000000000003 109.53 -175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 p -82.36 155.16 24.88 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.958 -1.497 . . . . 55.329999999999998 106.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -62.72 -37.63 87.28 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 108.881 -0.785 . . . . 71.340000000000003 108.881 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -55.84 -43.05 76.66 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 110.097 -0.334 . . . . 65.400000000000006 110.097 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -66.23 -39.97 89.93 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.277 -1.009 . . . . 60.409999999999997 108.277 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB1' HG21 ' A' ' 36' ' ' ILE . . . -55.97 -39.73 72.22 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 110.056 -0.35 . . . . 42.409999999999997 110.056 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.04 -56.25 9.81 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 107.754 -1.202 . . . . 52.219999999999999 107.754 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 72.0 m -63.59 -25.97 68.48 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.788 -0.819 . . . . 74.120000000000005 108.788 -166.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.7 m -60.7 -52.81 63.55 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 107.669 -1.234 . . . . 71.439999999999998 107.669 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.1 mt -55.27 -55.23 33.82 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.657 0.742 . . . . 62.439999999999998 109.519 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -48.16 -36.41 13.48 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 122.035 -0.415 . . . . 74.319999999999993 112.082 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -89.93 -9.75 47.67 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.67 -0.644 . . . . 72.519999999999996 110.095 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -81.31 179.54 7.81 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 107.754 -1.202 . . . . 71.200000000000003 107.754 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.88 -166.73 31.43 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 109.843 -1.303 . . . . 71.200000000000003 109.843 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -79.63 -35.95 38.62 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 106.808 -1.553 . . . . 74.109999999999999 106.808 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.5 t -116.29 127.74 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.7 0 N-CA-C 103.036 -2.95 . . . . 75.140000000000001 103.036 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.76 151.58 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.87 0 N-CA-C 104.606 -2.368 . . . . 62.350000000000001 104.606 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -96.85 123.88 40.68 Favored 'General case' 0 CA--C 1.479 -1.766 0 N-CA-C 104.305 -2.48 . . . . 71.030000000000001 104.305 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.4 mt -118.84 140.77 49.42 Favored 'General case' 0 CA--C 1.48 -1.722 0 N-CA-C 105.428 -2.064 . . . . 54.039999999999999 105.428 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.406 HD13 ' HG2' ' A' ' 9' ' ' GLU . 17.8 tp -114.22 124.14 51.3 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 105.053 -2.203 . . . . 75.019999999999996 105.053 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.11 157.19 44.85 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 107.691 -1.226 . . . . 74.030000000000001 107.691 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 58' ' ' ARG . 36.2 tt0 -123.95 131.58 53.59 Favored 'General case' 0 N--CA 1.4 -2.972 0 N-CA-C 103.154 -2.906 . . . . 62.450000000000003 103.154 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.653 ' HE3' ' H ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -61.3 150.18 35.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.792 -0.818 . . . . 73.439999999999998 108.792 179.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.653 ' H ' ' HE3' ' A' ' 92' ' ' LYS . . . -137.65 -149.64 5.58 Favored Glycine 0 CA--C 1.467 -2.929 0 N-CA-C 103.322 -3.911 . . . . 74.230000000000004 103.322 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -142.66 173.19 11.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 104.288 -2.486 . . . . 74.040000000000006 104.288 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.7 m -84.39 114.19 53.35 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 105.489 -2.041 . . . . 74.049999999999997 105.489 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.19 120.47 7.44 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 122.592 2.195 . . . . 55.310000000000002 109.0 -170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.401 -2.909 0 N-CA-C 102.137 -3.283 . . . . 70.409999999999997 102.137 175.629 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.466 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.772 0 N-CA-C 108.272 -1.931 . . . . 72.439999999999998 108.272 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.8 157.17 60.35 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.073 2.515 . . . . 72.510000000000005 109.172 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -78.79 159.88 72.99 Favored Pre-proline 0 N--CA 1.439 -1.013 0 N-CA-C 107.031 -1.47 . . . . 51.219999999999999 107.031 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.07 132.01 30.57 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 106.959 -1.977 . . . . 71.420000000000002 106.959 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.47 -18.57 56.79 Favored Glycine 0 CA--C 1.497 -1.056 0 N-CA-C 109.395 -1.482 . . . . 34.200000000000003 109.395 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.86 143.74 57.61 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 118.686 1.243 . . . . 35.43 108.414 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.93 131.4 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.82 -2.659 . . . . 61.039999999999999 103.82 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.21 146.57 52.11 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 105.209 -2.145 . . . . 73.109999999999999 105.209 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -102.44 135.4 44.12 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.024 -2.213 . . . . 63.149999999999999 105.024 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 95.6 t -125.27 129.94 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 105.851 -1.907 . . . . 71.310000000000002 105.851 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -101.05 112.5 24.97 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 103.72 -2.696 . . . . 54.399999999999999 103.72 168.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HB2' HD12 ' A' ' 88' ' ' LEU . 1.3 tm? -102.87 124.71 48.89 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.486 -2.042 . . . . 61.409999999999997 105.486 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -87.8 120.31 29.0 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.504 -1.665 . . . . 52.109999999999999 106.504 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -92.52 33.74 1.1 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.034 -1.469 . . . . 73.129999999999995 107.034 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 13' ' ' ALA . 73.9 m-80 6.05 -91.95 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 128.584 2.753 . . . . 74.329999999999998 112.134 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -158.74 -178.48 7.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.746 -2.316 . . . . 32.420000000000002 104.746 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 74.14 -120.24 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.281 1.032 . . . . 74.299999999999997 108.493 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.1 m -91.68 132.53 36.3 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.557 -1.275 . . . . 70.230000000000004 107.557 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 mt -73.46 -58.87 3.01 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 105.869 -1.901 . . . . 73.299999999999997 105.869 173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.73 41.98 55.12 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 110.691 -0.964 . . . . 75.129999999999995 110.691 165.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.9 mt -127.63 154.28 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.026 -2.583 . . . . 64.340000000000003 104.026 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.5 t -154.14 165.87 34.86 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.461 -2.422 . . . . 74.340000000000003 104.461 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.21 167.7 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 105.688 -1.967 . . . . 72.409999999999997 105.688 -168.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -146.11 166.53 25.87 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 104.584 -2.376 . . . . 74.329999999999998 104.584 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.93 134.37 3.02 Favored Glycine 0 C--O 1.196 -2.241 0 N-CA-C 108.853 -1.699 . . . . 43.140000000000001 108.853 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.97 -97.41 0.12 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 108.717 -1.753 . . . . 40.340000000000003 108.717 167.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.98 21.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 127.183 2.193 . . . . 74.409999999999997 116.017 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 87.37 66.29 0.01 OUTLIER 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.733 -1.58 . . . . 64.310000000000002 106.733 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 30' ' ' SER . 4.1 m -88.38 -166.97 1.73 Allowed 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.184 -2.524 . . . . 74.239999999999995 104.184 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.715 ' H ' HG22 ' A' ' 29' ' ' THR . 15.6 m -58.43 -21.01 49.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.553 -0.717 . . . . 54.210000000000001 110.625 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.58 126.27 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.765 -1.568 . . . . 64.129999999999995 106.765 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.7 mtm-85 -51.92 -57.6 8.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 115.204 -0.907 . . . . 72.400000000000006 112.363 -168.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -82.87 7.15 16.11 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.938 -0.764 . . . . 71.519999999999996 108.938 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.13 25.1 69.32 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 108.592 -1.803 . . . . 33.310000000000002 108.592 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.43 139.84 38.14 Favored Glycine 0 CA--C 1.479 -2.201 0 N-CA-C 107.394 -2.282 . . . . 52.399999999999999 107.394 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.29 120.35 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 104.645 -2.354 . . . . 74.200000000000003 104.645 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.55 146.65 41.54 Favored 'General case' 0 CA--C 1.474 -1.977 0 N-CA-C 106.306 -1.739 . . . . 74.400000000000006 106.306 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.26 135.02 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 73.109999999999999 107.084 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 -49.12 3.22 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 107.518 -1.29 . . . . 72.430000000000007 107.518 -167.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 144.42 34.0 Favored 'General case' 0 CA--C 1.461 -2.469 0 N-CA-C 104.859 -2.274 . . . . 73.540000000000006 104.859 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.83 132.57 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 104.265 -2.494 . . . . 72.319999999999993 104.265 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 mt -73.53 133.46 80.19 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 106.037 -1.838 . . . . 71.010000000000005 106.037 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.48 113.66 1.89 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.52 2.146 . . . . 64.219999999999999 108.141 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.36 21.9 5.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 124.621 1.201 . . . . 72.209999999999994 111.327 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.67 -166.74 27.96 Favored Glycine 0 C--N 1.367 2.271 0 N-CA-C 106.206 -2.758 . . . . 71.540000000000006 106.206 162.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.23 -51.89 67.87 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-N 117.999 0.899 . . . . 72.439999999999998 110.427 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.58 -45.75 74.65 Favored 'General case' 0 C--O 1.208 -1.101 0 N-CA-C 109.916 -0.402 . . . . 75.140000000000001 109.916 -171.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -71.88 -39.06 69.88 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.481 -0.563 . . . . 72.349999999999994 109.481 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 t -65.9 -46.12 79.48 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.777 -1.194 . . . . 71.150000000000006 107.777 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -69.52 -32.33 71.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 106.92 -1.511 . . . . 60.219999999999999 106.92 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.73 -10.4 51.65 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.524 -0.762 . . . . 71.430000000000007 111.281 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -69.78 -38.25 76.65 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.945 -0.738 . . . . 61.409999999999997 110.025 -172.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.69 140.31 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 N-CA-C 105.945 -1.872 . . . . 72.530000000000001 105.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -131.36 176.19 8.5 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.99 -1.485 . . . . 75.099999999999994 106.99 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -66.84 144.04 56.52 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.334 -0.987 . . . . 64.25 108.334 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.86 -4.17 74.93 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 109.678 -1.369 . . . . 72.120000000000005 109.678 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -86.25 156.35 20.32 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.823 -1.177 . . . . 71.540000000000006 107.823 -174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 118.56 37.04 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.992 -1.484 . . . . 73.25 106.992 -170.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.6 t -103.43 141.71 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 104.998 -2.223 . . . . 64.109999999999999 104.998 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.38 -45.66 2.62 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 107.589 -1.263 . . . . 71.040000000000006 107.589 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.34 158.21 39.76 Favored 'General case' 0 CA--C 1.477 -1.834 0 C-N-CA 118.695 -1.202 . . . . 75.439999999999998 109.345 -175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.79 106.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 104.775 -2.305 . . . . 74.439999999999998 104.775 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.2 t30 45.19 43.9 8.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.255 1.422 . . . . 54.520000000000003 111.262 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.86 10.56 84.92 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.068 -1.213 . . . . 64.200000000000003 110.068 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.37 117.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.396 0 N-CA-C 103.151 -2.907 . . . . 75.109999999999999 103.151 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.7 m -75.69 114.33 14.15 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 106.775 -1.565 . . . . 74.299999999999997 106.775 177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.29 28.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.594 -1.262 . . . . 74.519999999999996 107.594 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -75.55 122.5 23.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.12 -1.437 . . . . 50.520000000000003 107.12 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -9.68 52.81 Favored Glycine 0 C--N 1.328 0.1 0 N-CA-C 110.918 -0.873 . . . . 43.43 110.918 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.38 161.29 29.69 Favored 'General case' 0 C--N 1.364 1.232 0 CA-C-N 118.806 1.303 . . . . 73.430000000000007 107.598 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.6 p -82.31 167.14 18.87 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.406 -0.961 . . . . 72.450000000000003 108.406 -175.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -66.52 -41.87 88.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.147 -0.686 . . . . 64.340000000000003 109.147 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -38.06 89.68 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.697 -0.668 . . . . 73.310000000000002 110.3 176.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -65.58 -35.8 81.9 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.143 1.338 . . . . 75.239999999999995 109.182 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.13 -35.1 69.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.408 -0.59 . . . . 75.140000000000001 109.408 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.9 -53.75 19.13 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 N-CA-C 107.265 -1.383 . . . . 70.450000000000003 107.265 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 63.8 m -54.7 -29.26 52.61 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 122.38 1.086 . . . . 75.319999999999993 108.374 -173.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.8 m -64.98 -53.32 47.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.149 -1.426 . . . . 73.230000000000004 107.149 -174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.42 -55.12 35.41 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.041 -0.725 . . . . 60.32 109.041 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -46.48 -41.07 13.45 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 116.629 -0.26 . . . . 61.409999999999997 111.273 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.52 -3.76 58.2 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 121.697 -0.627 . . . . 63.43 110.947 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 p -81.61 169.76 16.66 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 120.254 1.388 . . . . 73.530000000000001 108.598 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.02 -168.75 30.06 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.682 -1.367 . . . . 72.25 109.682 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -79.01 -25.07 43.3 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 108.485 -0.932 . . . . 63.530000000000001 108.485 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.13 130.35 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 103.625 -2.731 . . . . 64.209999999999994 103.625 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.94 139.59 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.791 -1.929 . . . . 70.239999999999995 105.791 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -95.67 116.57 29.06 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 104.402 -2.444 . . . . 73.120000000000005 104.402 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 12' ' ' LEU . 41.7 mt -118.79 139.82 50.96 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 106.138 -1.801 . . . . 73.239999999999995 106.138 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 127.87 55.72 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.461 -2.051 . . . . 72.319999999999993 105.461 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.86 156.72 47.57 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.689 -1.226 . . . . 73.430000000000007 107.689 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -117.3 133.51 55.9 Favored 'General case' 0 CA--C 1.438 -3.336 0 N-CA-C 104.995 -2.224 . . . . 71.209999999999994 104.995 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -62.71 150.61 40.69 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 65.329999999999998 110.289 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.54 50.44 0.21 Allowed Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 105.601 -2.999 . . . . 74.209999999999994 105.601 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.79 153.15 29.37 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.59 -1.263 . . . . 63.229999999999997 107.59 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 20.2 m -83.39 163.89 47.92 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 105.352 -2.092 . . . . 42.520000000000003 105.352 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 32.6 Cg_endo -64.35 163.72 25.59 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.272 1.982 . . . . 72.099999999999994 108.944 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.428 -1.525 0 N-CA-C 106.548 -1.649 . . . . 72.420000000000002 106.548 -176.504 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.415 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.655 0 N-CA-C 108.524 -1.831 . . . . 72.099999999999994 108.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.28 154.57 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.061 2.508 . . . . 61.25 108.889 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.713 ' HD3' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -94.22 161.96 27.89 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 105.063 -2.199 . . . . 74.340000000000003 105.063 -178.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 3' ' ' LYS . 18.9 Cg_endo -57.81 115.23 2.37 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.655 2.237 . . . . 74.420000000000002 110.761 -176.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.434 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 98.65 12.39 44.28 Favored Glycine 0 CA--C 1.497 -1.052 0 N-CA-C 109.07 -1.612 . . . . 64.120000000000005 109.07 175.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -92.46 136.12 33.48 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 104.881 -2.266 . . . . 71.219999999999999 104.881 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -95.99 132.08 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 104.291 -2.485 . . . . 72.519999999999996 104.291 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -144.81 152.07 39.76 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.044 -2.206 . . . . 72.430000000000007 105.044 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.04 148.13 28.1 Favored 'General case' 0 N--CA 1.402 -2.829 0 N-CA-C 104.758 -2.312 . . . . 60.200000000000003 104.758 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.82 131.15 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.21 0 N-CA-C 103.712 -2.699 . . . . 64.310000000000002 103.712 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -103.85 111.91 24.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 104.327 -2.472 . . . . 75.109999999999999 104.327 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.425 ' CD1' ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -103.68 125.24 50.05 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.908 -1.516 . . . . 74.540000000000006 106.908 -164.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.1 124.8 37.33 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 105.694 -1.965 . . . . 54.240000000000002 105.694 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' CE ' HD22 ' A' ' 19' ' ' LEU . 19.6 mtmm -91.98 31.96 1.19 Allowed 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.639 -1.245 . . . . 64.540000000000006 107.639 -176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 18.19 51.19 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 128.261 2.624 . . . . 74.239999999999995 111.196 -168.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.0 t0 11.31 58.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.056 2.142 . . . . 64.219999999999999 113.054 -164.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -145.69 -116.54 0.08 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 105.062 -2.199 . . . . 73.310000000000002 105.062 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.9 m -80.81 131.22 35.38 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.025 -1.472 . . . . 42.310000000000002 107.025 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.421 HD22 ' CE ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -73.26 -58.65 3.16 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 104.45 -2.426 . . . . 74.430000000000007 104.45 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . 65.25 39.78 96.25 Favored Glycine 0 CA--C 1.492 -1.375 0 CA-C-N 113.412 -1.722 . . . . 62.130000000000003 110.543 167.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.5 mt -128.43 163.12 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 102.263 -3.236 . . . . 64.329999999999998 102.263 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.2 t -153.15 159.09 42.67 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 102.821 -3.029 . . . . 74.310000000000002 102.821 174.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.86 167.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 N-CA-C 105.941 -1.874 . . . . 73.420000000000002 105.941 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -153.78 167.71 28.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 103.499 -2.778 . . . . 72.239999999999995 103.499 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.16 -172.32 15.57 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 106.071 -2.812 . . . . 75.310000000000002 106.071 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.22 -124.63 5.38 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.962 -1.655 . . . . 64.430000000000007 108.962 173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.08 18.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 126.292 1.837 . . . . 62.43 114.368 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 86.92 65.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.971 1.367 . . . . 71.310000000000002 107.342 -172.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.3 t -89.1 -165.12 1.26 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 105.076 -2.194 . . . . 71.109999999999999 105.076 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.9 m -49.63 -26.68 3.82 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.169 0.988 . . . . 61.100000000000001 112.208 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -86.71 118.74 33.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 N-CA-C 105.361 -2.088 . . . . 71.310000000000002 105.361 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.22 -14.35 60.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.787 -0.642 . . . . 74.329999999999998 111.053 -165.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -85.87 -5.99 59.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.346 -0.983 . . . . 75.340000000000003 108.346 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 10.59 27.49 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.894 -0.883 . . . . 32.109999999999999 110.894 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.56 158.29 53.5 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 107.986 -2.046 . . . . 61.340000000000003 107.986 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.47 129.0 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 105.602 -1.999 . . . . 72.439999999999998 105.602 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -125.38 144.97 50.26 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.281 -2.118 . . . . 75.409999999999997 105.281 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.72 134.16 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.09 -1.448 . . . . 74.200000000000003 107.09 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -103.93 -44.4 5.04 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.032 -1.099 . . . . 75.400000000000006 108.032 -171.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.68 153.97 40.0 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 105.964 -1.865 . . . . 62.439999999999998 105.964 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.42 130.0 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 105.309 -2.108 . . . . 70.120000000000005 105.309 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.474 HD12 ' HA2' ' A' ' 20' ' ' GLY . 17.1 mt -74.45 137.19 74.61 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.144 -1.799 . . . . 50.439999999999998 106.144 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.55 125.6 17.76 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.494 2.129 . . . . 75.219999999999999 108.685 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.467 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 33.9 mt-30 68.4 18.24 9.07 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 124.063 0.852 . . . . 74.200000000000003 109.817 -175.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.37 -177.68 52.01 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 106.153 -2.779 . . . . 60.310000000000002 106.153 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 12' ' ' LEU . . . -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.563 -0.375 . . . . 73.329999999999998 110.82 -168.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.89 94.8 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.065 -0.716 . . . . 75.420000000000002 109.065 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 44' ' ' GLN . 50.8 tp10 -59.49 -46.47 88.71 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.26 -0.644 . . . . 73.239999999999995 109.26 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.8 m -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.34 -0.615 . . . . 51.109999999999999 109.34 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.96 -45.49 74.05 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.204 -1.036 . . . . 74.340000000000003 108.204 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -32.8 5.52 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.312 -1.115 . . . . 72.310000000000002 110.312 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -75.17 -36.98 61.45 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 117.614 0.707 . . . . 72.329999999999998 109.132 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.04 138.24 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.134 0 N-CA-C 104.761 -2.311 . . . . 73.329999999999998 104.761 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.499 ' HE1' ' OE1' ' A' ' 94' ' ' GLN . 28.1 p80 -136.6 179.11 6.56 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.124 -1.806 . . . . 75.150000000000006 106.124 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.08 139.85 58.76 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.7 -0.852 . . . . 74.409999999999997 108.7 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -3.34 87.22 Favored Glycine 0 CA--C 1.497 -1.082 0 N-CA-C 110.459 -1.056 . . . . 52.409999999999997 110.459 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -73.44 154.42 39.98 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-N 119.342 1.571 . . . . 63.219999999999999 107.219 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.71 118.29 36.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 107.555 -1.276 . . . . 75.439999999999998 107.555 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.57 145.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.843 -2.281 . . . . 75.209999999999994 104.843 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 -48.33 2.43 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.441 -1.318 . . . . 74.549999999999997 107.441 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.15 167.19 18.76 Favored 'General case' 0 CA--C 1.469 -2.148 0 C-N-CA 118.914 -1.114 . . . . 75.209999999999994 109.718 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.52 102.54 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 N-CA-C 103.702 -2.703 . . . . 74.040000000000006 103.702 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.97 41.19 28.1 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.783 0.833 . . . . 63.200000000000003 111.03 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.04 15.06 73.38 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 109.935 -1.266 . . . . 70.239999999999995 109.935 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.44 116.31 52.23 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 N-CA-C 104.353 -2.462 . . . . 74.450000000000003 104.353 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -76.4 7.39 4.43 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.546 0.738 . . . . 60.340000000000003 111.796 -171.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt 34.25 38.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.967 1.307 . . . . 51.130000000000003 111.775 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.9 129.72 36.58 Favored 'General case' 0 CA--C 1.488 -1.42 0 O-C-N 121.148 -0.97 . . . . 65.209999999999994 109.534 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.79 0.98 83.03 Favored Glycine 0 CA--C 1.493 -1.306 0 N-CA-C 109.102 -1.599 . . . . 64.239999999999995 109.102 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.42 152.26 45.99 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 107.951 -1.129 . . . . 74.409999999999997 107.951 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 159.74 26.89 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.673 -1.232 . . . . 63.409999999999997 107.673 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -62.29 -41.59 98.63 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.16 -1.052 . . . . 70.140000000000001 108.16 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -58.15 -41.76 84.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.793 -0.64 . . . . 73.239999999999995 109.865 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -66.25 -34.52 78.2 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 108.673 -0.862 . . . . 63.100000000000001 108.673 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.79 74.49 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.826 -0.805 . . . . 52.140000000000001 108.826 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.69 -52.6 22.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 N-CA-C 107.26 -1.385 . . . . 64.239999999999995 107.26 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 60.6 m -52.96 -28.37 23.38 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-O 122.105 0.955 . . . . 62.130000000000003 108.45 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.4 m -65.75 -55.91 14.76 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.269 -1.382 . . . . 74.239999999999995 107.269 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.6 mt -53.78 -55.03 30.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 108.934 -0.765 . . . . 73.540000000000006 108.934 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -46.25 -42.13 13.97 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.231 -0.44 . . . . 75.439999999999998 111.615 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -86.68 -5.59 59.09 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 121.72 -0.612 . . . . 72.299999999999997 110.87 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -85.06 170.51 12.89 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.755 -1.216 . . . . 74.530000000000001 108.404 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.35 -161.56 22.04 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.394 -1.482 . . . . 75.109999999999999 109.394 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.99 -28.89 49.39 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 108.122 -1.066 . . . . 75.129999999999995 108.122 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.87 134.47 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.105 -2.554 . . . . 52.109999999999999 104.105 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.66 143.29 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.678 -2.341 . . . . 71.430000000000007 104.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -96.89 117.13 30.44 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 104.975 -2.232 . . . . 52.520000000000003 104.975 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.03 137.82 51.99 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 105.215 -2.143 . . . . 73.340000000000003 105.215 -177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.79 127.66 56.1 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 105.313 -2.106 . . . . 72.340000000000003 105.313 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.57 154.35 48.92 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.761 -1.57 . . . . 62.229999999999997 106.761 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.1 135.73 46.64 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 105.089 -2.189 . . . . 60.009999999999998 105.089 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.434 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 71.1 mmtt -75.76 153.29 37.09 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.454 1.121 . . . . 74.329999999999998 111.002 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.14 48.46 0.12 Allowed Glycine 0 CA--C 1.468 -2.88 0 N-CA-C 105.034 -3.226 . . . . 33.200000000000003 105.034 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' OE1' ' HE1' ' A' ' 54' ' ' HIS . 3.0 pp0? -110.21 166.85 10.63 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.084 -1.45 . . . . 73.319999999999993 107.084 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.9 m -113.84 142.01 27.09 Favored Pre-proline 0 N--CA 1.427 -1.593 0 N-CA-C 104.385 -2.45 . . . . 54.200000000000003 104.385 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.25 115.38 3.29 Favored 'Trans proline' 0 CA--C 1.504 -0.997 0 C-N-CA 122.45 2.1 . . . . 70.25 107.15 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.417 -2.084 0 N-CA-C 104.866 -2.272 . . . . 73.439999999999998 104.866 -173.75 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.445 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.155 0 N-CA-C 109.513 -1.435 . . . . 63.119999999999997 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.82 156.5 65.75 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 123.046 2.498 . . . . 61.350000000000001 109.292 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 68.6 mttt -68.79 169.26 11.55 Favored Pre-proline 0 C--N 1.353 0.722 0 N-CA-C 106.69 -1.596 . . . . 64.420000000000002 106.69 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 33.7 Cg_endo -64.68 128.01 20.09 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 107.489 -1.773 . . . . 72.430000000000007 107.489 163.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.22 70.57 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 110.005 -1.238 . . . . 61.409999999999997 110.005 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -104.88 147.77 27.39 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.997 -1.853 . . . . 72.400000000000006 105.997 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -99.2 132.08 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 105.963 -1.866 . . . . 72.129999999999995 105.963 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -133.78 149.84 51.44 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 106.19 -1.782 . . . . 73.230000000000004 106.19 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -102.26 138.1 39.65 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.99 -1.855 . . . . 72.129999999999995 105.99 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.9 t -129.11 127.58 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 104.939 -2.245 . . . . 62.140000000000001 104.939 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -103.34 109.45 21.07 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 105.676 -1.972 . . . . 73.25 105.676 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.99 122.95 45.05 Favored 'General case' 0 CA--C 1.473 -2.014 0 N-CA-C 106.459 -1.682 . . . . 70.109999999999999 106.459 -164.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.37 138.18 32.64 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 107.343 -1.355 . . . . 74.409999999999997 107.343 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.49 33.61 0.64 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 106.359 -1.719 . . . . 74.329999999999998 106.359 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.72 74.58 4.28 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.919 -1.882 . . . . 63.210000000000001 105.919 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -176.72 -130.62 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 100.853 -3.758 . . . . 75.540000000000006 100.853 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -150.45 -45.81 0.12 Allowed 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.448 -2.056 . . . . 65.120000000000005 105.448 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -74.87 122.51 23.5 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.021 -1.474 . . . . 64.409999999999997 107.021 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.4 mt -73.2 -57.08 4.27 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 104.476 -2.416 . . . . 74.409999999999997 104.476 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.609 ' HA2' HD12 ' A' ' 42' ' ' ILE . . . 61.88 37.28 94.09 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.063 -1.88 . . . . 71.450000000000003 110.944 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mm -111.7 160.94 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.214 -2.513 . . . . 74.040000000000006 104.214 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -154.01 159.23 41.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 102.624 -3.102 . . . . 73.099999999999994 102.624 165.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.59 166.83 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 105.918 -1.882 . . . . 54.119999999999997 105.918 -168.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -147.87 165.86 29.35 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.199 -2.889 . . . . 74.239999999999995 103.199 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.72 -171.79 15.23 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 107.378 -2.289 . . . . 74.349999999999994 107.378 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.87 -128.81 6.81 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.205 -1.558 . . . . 54.32 109.205 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.48 19.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 127.24 2.216 . . . . 34.420000000000002 114.396 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 85.52 64.03 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 106.919 -1.512 . . . . 73.329999999999998 106.919 -173.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -93.28 -166.15 1.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 104.357 -2.46 . . . . 61.229999999999997 104.357 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 m -38.42 -38.49 0.38 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.628 1.571 . . . . 71.340000000000003 113.305 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.69 131.97 33.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.235 0 N-CA-C 107.683 -1.229 . . . . 74.530000000000001 107.683 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -59.93 -50.7 72.74 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.636 -0.711 . . . . 75.140000000000001 111.446 -168.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -74.36 -3.64 31.55 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.8 -0.562 . . . . 75.120000000000005 109.692 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.54 14.25 41.59 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 110.345 -1.102 . . . . 74.209999999999994 110.345 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.42 154.5 50.47 Favored Glycine 0 CA--C 1.478 -2.231 0 N-CA-C 107.643 -2.183 . . . . 73.439999999999998 107.643 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 mm -81.86 108.62 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.639 -1.615 . . . . 74.340000000000003 106.639 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 58' ' ' ARG . 36.1 m-85 -98.28 143.19 29.04 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 106.225 -1.769 . . . . 71.420000000000002 106.225 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.28 126.99 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 N-CA-C 105.717 -1.957 . . . . 74.340000000000003 105.717 169.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -99.69 -49.54 4.35 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 107.363 -1.347 . . . . 75.510000000000005 107.363 -168.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.87 149.13 38.12 Favored 'General case' 0 CA--C 1.458 -2.565 0 N-CA-C 106.042 -1.836 . . . . 54.240000000000002 106.042 -171.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.2 t -128.76 121.95 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 N-CA-C 104.221 -2.511 . . . . 71.150000000000006 104.221 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.609 HD12 ' HA2' ' A' ' 20' ' ' GLY . 25.2 mt -75.58 138.27 70.63 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 105.215 -2.142 . . . . 73.299999999999997 105.215 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 42' ' ' ILE . 17.7 Cg_endo -56.47 129.48 34.94 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.133 1.889 . . . . 73.049999999999997 109.347 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 64.18 22.2 12.78 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 124.975 1.422 . . . . 63.399999999999999 111.329 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.69 175.95 43.38 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 107.202 -2.359 . . . . 74.439999999999998 107.202 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.54 73.48 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.255 -0.646 . . . . 61.409999999999997 109.255 -172.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.09 -49.71 59.53 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.231 -0.655 . . . . 54.539999999999999 109.231 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.24 -37.03 82.86 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 109.503 -0.554 . . . . 64.109999999999999 109.503 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.3 m -65.49 -37.97 88.39 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.47 -0.937 . . . . 73.519999999999996 108.47 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.74 -37.12 79.2 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.248 -1.019 . . . . 55.039999999999999 108.248 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.58 -21.71 8.64 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.898 -0.881 . . . . 31.329999999999998 110.898 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.9 mtt85 -75.44 -41.09 56.71 Favored 'General case' 0 CA--C 1.495 -1.165 0 O-C-N 121.524 -0.986 . . . . 72.549999999999997 108.61 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.5 mt -97.36 128.02 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 106.15 -1.796 . . . . 63.329999999999998 106.15 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -131.34 177.4 7.51 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 105.645 -1.983 . . . . 72.219999999999999 105.645 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -67.06 145.27 55.53 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.615 -1.995 . . . . 73.219999999999999 105.615 171.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.05 58.04 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 107.377 -2.289 . . . . 45.009999999999998 107.377 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -84.8 158.47 20.67 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 105.301 -2.111 . . . . 54.420000000000002 105.301 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.46 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -137.23 150.64 48.0 Favored 'General case' 0 CA--C 1.47 -2.115 0 N-CA-C 107.054 -1.461 . . . . 74.439999999999998 107.054 178.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 t -104.86 145.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 104.786 -2.301 . . . . 53.240000000000002 104.786 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -48.23 3.02 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.329 -1.73 . . . . 71.219999999999999 106.329 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.18 161.49 31.0 Favored 'General case' 0 CA--C 1.484 -1.563 0 CA-C-O 122.429 1.109 . . . . 61.25 110.151 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -142.75 111.75 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 104.217 -2.512 . . . . 74.519999999999996 104.217 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 50.53 39.8 21.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.755 0.822 . . . . 72.510000000000005 110.466 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.37 7.18 79.96 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 109.978 -1.249 . . . . 53.520000000000003 109.978 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 67' ' ' LEU . 43.5 t -108.32 116.56 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.686 -2.338 . . . . 73.030000000000001 104.686 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 m -79.92 14.82 1.64 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.417 0.287 . . . . 63.420000000000002 111.348 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.502 ' H ' HG12 ' A' ' 65' ' ' VAL . 4.5 mm? 38.09 38.45 0.2 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.06 1.344 . . . . 74.150000000000006 111.329 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -76.09 125.25 28.79 Favored 'General case' 0 CA--C 1.489 -1.4 0 O-C-N 120.762 -1.212 . . . . 64.109999999999999 108.499 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.72 -7.49 65.5 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 109.706 -1.358 . . . . 71.540000000000006 109.706 172.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 154.41 41.81 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.874 -1.158 . . . . 64.230000000000004 107.874 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -83.85 165.94 18.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.153 -1.054 . . . . 34.020000000000003 108.153 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.9 -36.6 84.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.302 -0.863 . . . . 71.510000000000005 109.118 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.2 -48.37 73.95 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 109.652 -0.499 . . . . 64.439999999999998 109.652 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -68.83 -30.21 68.71 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.598 -0.689 . . . . 70.150000000000006 109.334 -173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.11 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.336 -0.987 . . . . 70.200000000000003 108.336 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.16 -51.05 42.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 107.285 -1.376 . . . . 73.450000000000003 107.285 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.2 m -52.66 -28.36 21.22 Favored 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 108.554 -0.906 . . . . 73.239999999999995 108.554 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.2 m -72.67 -57.27 4.25 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.711 -1.218 . . . . 55.340000000000003 107.711 -171.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.81 -56.9 16.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.708 -0.849 . . . . 75.209999999999994 108.708 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -47.26 -38.75 12.94 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.89 0.7 . . . . 63.140000000000001 112.89 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -88.54 -2.01 58.36 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.324 -0.86 . . . . 63.5 110.241 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -77.73 176.67 8.8 Favored 'General case' 0 C--O 1.243 0.723 0 O-C-N 120.61 -1.306 . . . . 74.319999999999993 108.181 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.18 -163.62 26.03 Favored Glycine 0 CA--C 1.491 -1.425 0 N-CA-C 108.741 -1.744 . . . . 24.43 108.741 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.44 -33.93 42.07 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.945 -1.502 . . . . 62.130000000000003 106.945 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 t -113.57 130.54 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.096 0 N-CA-C 104.037 -2.579 . . . . 70.239999999999995 104.037 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 t -129.35 149.58 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.478 0 N-CA-C 105.944 -1.873 . . . . 60.009999999999998 105.944 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -97.42 111.77 23.89 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.163 -2.162 . . . . 74.0 105.163 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.8 mt -112.34 137.74 50.05 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.321 -2.103 . . . . 75.420000000000002 105.321 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 tp -115.92 124.18 49.95 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.807 -2.294 . . . . 62.509999999999998 104.807 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.8 155.41 46.01 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 106.934 -1.506 . . . . 61.420000000000002 106.934 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -129.79 137.95 50.78 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 103.248 -2.871 . . . . 72.409999999999997 103.248 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 68.5 mmtt -68.44 148.65 50.33 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.24 1.019 . . . . 74.109999999999999 109.743 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.93 174.01 38.62 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.696 -2.962 . . . . 73.230000000000004 105.696 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -86.03 166.38 15.91 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 105.295 -2.113 . . . . 61.219999999999999 105.295 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.0 m -77.65 137.42 62.93 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 106.396 -1.705 . . . . 64.120000000000005 106.396 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.35 155.43 64.02 Favored 'Trans proline' 0 CA--C 1.496 -1.387 0 C-N-CA 122.566 2.177 . . . . 75.019999999999996 108.156 -169.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 104.264 -2.495 . . . . 73.120000000000005 104.264 176.108 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.452 ' H13' ' C8 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 109.372 -1.491 . . . . 75.439999999999998 109.372 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.73 156.49 63.27 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.054 2.502 . . . . 71.120000000000005 109.285 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 48.2 mttp -76.86 162.22 71.01 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 107.99 -1.115 . . . . 53.210000000000001 107.99 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 29.8 Cg_endo -63.98 120.81 8.29 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.465 2.11 . . . . 63.119999999999997 109.183 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.87 13.24 59.5 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 108.873 -1.691 . . . . 32.149999999999999 108.873 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -101.38 146.06 28.1 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.216 -2.142 . . . . 50.310000000000002 105.216 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.66 139.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 105.384 -2.08 . . . . 75.0 105.384 -172.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -142.95 149.69 38.72 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.255 -1.757 . . . . 73.430000000000007 106.255 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -103.15 140.86 36.78 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.553 -2.017 . . . . 72.040000000000006 105.553 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 52' ' ' ARG . 91.3 t -126.38 133.12 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.745 0 N-CA-C 105.914 -1.884 . . . . 63.450000000000003 105.914 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.67 116.97 33.91 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.475 -2.046 . . . . 61.399999999999999 105.475 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -103.17 121.21 42.19 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 105.874 -1.898 . . . . 53.549999999999997 105.874 -173.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.76 134.42 38.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 107.827 -1.175 . . . . 65.040000000000006 107.827 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -86.96 33.76 0.67 Allowed 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.268 -1.382 . . . . 73.239999999999995 107.268 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -44.56 -36.86 3.21 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 124.797 1.239 . . . . 71.109999999999999 112.043 -169.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 30.0 t70 -73.15 -153.21 0.03 OUTLIER 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.335 -1.357 . . . . 75.329999999999998 107.335 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.56 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 59.8 t30 -112.64 -32.13 6.54 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 105.128 -2.175 . . . . 73.219999999999999 105.128 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.0 m -76.54 118.64 19.4 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.996 -1.483 . . . . 74.25 106.996 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.36 -56.96 4.61 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.657 -2.349 . . . . 72.209999999999994 104.657 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.493 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 50.88 58.31 9.59 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 113.902 -1.499 . . . . 72.239999999999995 112.988 167.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.9 mt -132.06 152.49 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.463 -2.791 . . . . 72.0 103.463 170.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.1 m -148.51 164.25 34.77 Favored 'General case' 0 CA--C 1.469 -2.164 0 N-CA-C 103.636 -2.727 . . . . 75.439999999999998 103.636 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.475 ' H ' HG22 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -145.12 168.69 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 105.196 -2.15 . . . . 42.210000000000001 105.196 -168.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -142.79 166.0 25.84 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 102.108 -3.293 . . . . 64.209999999999994 102.108 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.71 -174.36 16.0 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 107.09 -2.404 . . . . 63.130000000000003 107.09 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.38 -128.27 5.91 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 109.115 -1.594 . . . . 64.519999999999996 109.115 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 m -66.92 19.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.638 1.975 . . . . 74.25 113.962 -168.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.256 85.5 m-20 87.04 66.35 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.956 0 CA-C-O 123.198 1.475 . . . . 62.240000000000002 107.479 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -80.82 -166.62 1.15 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.088 -2.56 . . . . 71.219999999999999 104.088 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -57.57 -19.42 25.44 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 121.536 -0.727 . . . . 64.310000000000002 112.178 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.471 ' H ' HG23 ' A' ' 29' ' ' THR . 27.6 m -85.84 135.23 25.42 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 N-CA-C 107.569 -1.271 . . . . 72.319999999999993 107.569 177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -57.36 -55.47 34.42 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.624 0.77 . . . . 75.319999999999993 112.048 -166.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -85.63 12.07 9.52 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 121.166 -0.959 . . . . 63.200000000000003 109.308 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.44 22.94 59.68 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 110.217 -1.153 . . . . 64.129999999999995 110.217 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.8 145.88 50.03 Favored Glycine 0 C--N 1.36 1.902 0 N-CA-C 108.931 -1.668 . . . . 53.350000000000001 108.931 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mm -83.97 94.77 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.982 -1.858 . . . . 64.549999999999997 105.982 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -91.48 143.73 26.3 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 106.998 -1.482 . . . . 64.409999999999997 106.998 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.8 131.47 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.351 -1.722 . . . . 62.32 106.351 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -102.61 -47.52 4.41 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.785 -1.561 . . . . 63.32 106.785 -166.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.45 151.22 36.06 Favored 'General case' 0 CA--C 1.465 -2.322 0 N-CA-C 105.473 -2.047 . . . . 52.100000000000001 105.473 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.26 130.21 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 104.065 -2.569 . . . . 74.310000000000002 104.065 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.493 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.8 mm -69.46 146.21 96.09 Favored Pre-proline 0 C--N 1.353 0.744 0 N-CA-C 105.141 -2.17 . . . . 74.519999999999996 105.141 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 42' ' ' ILE . 13.0 Cg_endo -55.05 118.36 5.07 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.087 1.858 . . . . 42.43 108.217 167.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 59.54 29.49 19.06 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.16 0.913 . . . . 73.329999999999998 111.654 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.64 -174.31 35.76 Favored Glycine 0 C--N 1.379 2.956 0 N-CA-C 106.724 -2.551 . . . . 62.530000000000001 106.724 167.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.19 74.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 122.004 -0.703 . . . . 75.239999999999995 110.378 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.5 91.24 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.819 -0.438 . . . . 53.200000000000003 109.819 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.2 -38.87 91.84 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.104 -0.702 . . . . 73.430000000000007 109.104 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 t -65.14 -42.47 93.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.438 -0.949 . . . . 53.43 108.438 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.93 -39.87 94.18 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 107.499 -1.297 . . . . 70.109999999999999 107.499 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 82.49 -14.94 32.48 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 110.631 -0.988 . . . . 44.039999999999999 110.631 173.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.467 ' HD2' HG13 ' A' ' 10' ' ' VAL . 39.7 ttm105 -81.5 -38.8 25.72 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.55 -0.971 . . . . 64.510000000000005 108.554 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.6 mt -101.98 133.08 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.016 -1.846 . . . . 63.409999999999997 106.016 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 93.3 m-70 -126.54 179.19 5.45 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.573 -1.64 . . . . 75.230000000000004 106.573 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.02 144.25 55.21 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 105.455 -2.054 . . . . 70.239999999999995 105.455 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.24 -23.86 32.99 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.207 -1.957 . . . . 70.209999999999994 108.207 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.19 152.18 46.2 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 107.52 -1.289 . . . . 74.209999999999994 107.52 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.71 131.92 47.97 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 106.938 -1.505 . . . . 34.530000000000001 106.938 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.06 150.54 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 105.246 -2.131 . . . . 73.230000000000004 105.246 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.49 -46.63 2.86 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.54 -1.281 . . . . 72.109999999999999 107.54 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.47 159.58 35.84 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 118.974 -1.091 . . . . 61.219999999999999 109.235 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.3 t -138.99 107.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.748 -2.315 . . . . 71.219999999999999 104.748 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.2 t30 51.2 36.91 17.02 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.365 1.066 . . . . 71.420000000000002 111.417 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.75 7.52 68.65 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.648 -1.381 . . . . 73.140000000000001 109.648 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.12 120.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 105.024 -2.213 . . . . 61.32 105.024 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -68.24 106.75 2.55 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.516 -1.661 . . . . 71.439999999999998 106.516 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -21.38 56.76 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.168 -0.679 . . . . 72.329999999999998 109.168 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -57.85 145.0 36.76 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.073 -0.714 . . . . 64.120000000000005 109.073 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.57 -38.5 3.11 Favored Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 108.976 -1.65 . . . . 52.0 108.976 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.44 158.37 29.63 Favored 'General case' 0 C--N 1.363 1.162 0 CA-C-N 117.783 0.791 . . . . 74.530000000000001 109.596 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -84.73 166.11 17.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.394 -1.336 . . . . 73.319999999999993 107.394 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -65.04 -41.04 95.59 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.05 -0.722 . . . . 75.5 109.05 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -54.88 -46.18 74.71 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 109.932 -0.395 . . . . 64.219999999999999 109.932 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -69.7 -35.81 75.4 Favored 'General case' 0 C--N 1.366 1.302 0 N-CA-C 108.864 -0.791 . . . . 75.109999999999999 108.864 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.41 -41.94 77.18 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.383 -0.599 . . . . 53.340000000000003 109.383 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 23' ' ' VAL . 48.0 t -68.89 -54.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 N-CA-C 107.861 -1.162 . . . . 73.319999999999993 107.861 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.92 -27.57 44.22 Favored 'General case' 0 N--CA 1.518 2.935 0 N-CA-C 108.587 -0.894 . . . . 61.130000000000003 108.587 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -66.48 -53.46 34.99 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.325 -1.361 . . . . 61.32 107.325 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.93 -56.92 15.47 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 108.677 -0.86 . . . . 72.200000000000003 108.677 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -48.27 -26.13 1.85 Allowed 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 113.382 0.882 . . . . 54.039999999999999 113.382 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -92.36 -10.63 37.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.09 0.859 . . . . 75.349999999999994 109.379 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 p -78.55 175.5 10.29 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 120.97 -1.081 . . . . 72.129999999999995 108.795 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.72 -163.38 26.91 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.406 -1.478 . . . . 63.520000000000003 109.406 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -78.5 -35.82 45.88 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 106.968 -1.493 . . . . 74.239999999999995 106.968 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.07 128.54 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.825 0 N-CA-C 102.692 -3.077 . . . . 72.340000000000003 102.692 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -120.73 140.1 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.905 0 N-CA-C 105.101 -2.185 . . . . 74.129999999999995 105.101 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -92.42 111.24 22.74 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 104.783 -2.302 . . . . 42.130000000000003 104.783 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 12' ' ' LEU . 80.2 mt -114.77 140.33 48.99 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 106.163 -1.792 . . . . 75.010000000000005 106.163 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 tp -111.86 127.14 55.74 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 105.888 -1.893 . . . . 75.340000000000003 105.888 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mp -133.48 155.56 49.33 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.472 -1.677 . . . . 65.319999999999993 106.472 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -127.55 138.66 52.96 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 104.872 -2.27 . . . . 74.120000000000005 104.872 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -65.68 150.62 48.19 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.033 0.92 . . . . 74.439999999999998 109.61 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.3 42.88 0.57 Allowed Glycine 0 CA--C 1.48 -2.105 0 N-CA-C 104.908 -3.277 . . . . 54.210000000000001 104.908 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.85 167.73 10.34 Favored 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 106.678 -1.601 . . . . 72.310000000000002 106.678 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 m -74.69 159.85 82.29 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 108.072 -1.085 . . . . 64.530000000000001 108.072 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -177.12 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.196 2.598 . . . . 71.340000000000003 109.445 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.358 0.953 0 N-CA-C 103.961 -2.607 . . . . 63.109999999999999 103.961 -170.907 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.657 0 N-CA-C 108.294 -1.922 . . . . 74.219999999999999 108.294 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.42 150.86 87.5 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 123.18 2.587 . . . . 70.120000000000005 109.314 -173.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 52.2 mtmt -83.14 159.41 62.48 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 105.747 -1.946 . . . . 74.299999999999997 105.747 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 28.3 Cg_endo -62.49 124.17 13.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.103 1.868 . . . . 74.099999999999994 108.759 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.7 64.48 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.71 -1.356 . . . . 60.539999999999999 109.71 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.61 145.12 27.17 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 105.489 -2.041 . . . . 70.519999999999996 105.489 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.65 140.3 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 104.925 -2.25 . . . . 70.109999999999999 104.925 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.01 160.32 43.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.464 -1.68 . . . . 55.130000000000003 106.464 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -102.48 139.36 38.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 105.824 -1.917 . . . . 71.439999999999998 105.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.37 134.16 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 N-CA-C 105.841 -1.911 . . . . 62.399999999999999 105.841 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -106.68 124.01 48.98 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.008 -2.219 . . . . 72.450000000000003 105.008 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.84 120.94 43.02 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 104.894 -2.262 . . . . 65.239999999999995 104.894 -176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.45 145.32 29.72 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 107.923 -1.14 . . . . 74.329999999999998 107.923 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -92.06 31.49 1.26 Allowed 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.88 -1.526 . . . . 75.25 106.88 175.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.54 -26.45 62.65 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 106.017 -1.846 . . . . 73.430000000000007 106.017 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.47 -83.1 0.1 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.359 -1.349 . . . . 74.319999999999993 107.359 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -156.21 -168.65 2.8 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.765 -2.309 . . . . 73.239999999999995 104.765 -168.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -47.67 152.99 0.63 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.132 -0.692 . . . . 63.439999999999998 109.132 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.65 -56.69 18.3 Favored 'General case' 0 C--N 1.374 1.642 0 N-CA-C 108.381 -0.97 . . . . 74.310000000000002 108.381 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.67 47.63 7.16 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.458 -1.857 . . . . 63.219999999999999 108.458 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 mt -127.99 153.43 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 104.131 -2.544 . . . . 64.120000000000005 104.131 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.4 m -144.97 160.38 41.43 Favored 'General case' 0 CA--C 1.479 -1.75 0 N-CA-C 102.918 -2.993 . . . . 55.439999999999998 102.918 169.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.56 167.97 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 106.736 -1.579 . . . . 72.209999999999994 106.736 -162.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 t -149.57 166.62 28.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 103.619 -2.734 . . . . 71.299999999999997 103.619 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.83 -177.39 17.1 Favored Glycine 0 CA--C 1.486 -1.733 0 N-CA-C 107.417 -2.273 . . . . 60.32 107.417 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.53 -133.65 6.94 Favored Glycine 0 C--N 1.364 2.086 0 N-CA-C 110.014 -1.234 . . . . 54.43 110.014 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.04 19.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.823 2.449 . . . . 64.409999999999997 114.812 -167.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.0 t30 86.23 65.24 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.667 -1.605 . . . . 73.239999999999995 106.667 -169.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.1 t -96.34 -164.82 1.19 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.571 -2.751 . . . . 64.040000000000006 103.571 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -27.88 -49.46 0.06 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.027 1.731 . . . . 52.200000000000003 113.12 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 m -88.3 129.95 38.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 108.132 -1.062 . . . . 75.530000000000001 108.132 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.18 -27.11 59.52 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 107.655 -1.239 . . . . 74.030000000000001 107.655 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -63.34 -17.75 62.91 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 108.466 -0.939 . . . . 73.310000000000002 108.466 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.15 -5.65 2.64 Favored Glycine 0 C--N 1.372 2.539 0 N-CA-C 111.34 -0.704 . . . . 60.450000000000003 111.34 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.46 153.51 52.94 Favored Glycine 0 CA--C 1.478 -2.223 0 N-CA-C 108.978 -1.649 . . . . 42.340000000000003 108.978 -172.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -83.13 97.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 105.918 -1.882 . . . . 63.030000000000001 105.918 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.32 146.09 25.48 Favored 'General case' 0 CA--C 1.477 -1.865 0 N-CA-C 107.46 -1.311 . . . . 73.019999999999996 107.46 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.52 130.83 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.851 -1.907 . . . . 65.549999999999997 105.851 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -108.09 -36.82 6.22 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.146 -1.427 . . . . 70.349999999999994 107.146 -167.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.23 151.48 33.08 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 106.897 -1.519 . . . . 73.109999999999999 106.897 -174.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.46 128.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 104.743 -2.317 . . . . 71.239999999999995 104.743 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 mt -69.27 136.01 88.97 Favored Pre-proline 0 C--O 1.236 0.378 0 N-CA-C 107.471 -1.307 . . . . 54.530000000000001 107.471 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.12 111.16 1.17 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 122.757 2.305 . . . . 71.150000000000006 108.725 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 74.7 21.3 2.19 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 124.552 1.157 . . . . 74.349999999999994 110.602 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.61 179.26 40.94 Favored Glycine 0 C--N 1.353 1.522 0 N-CA-C 107.049 -2.42 . . . . 61.409999999999997 107.049 165.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.8 98.84 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.871 -0.788 . . . . 74.040000000000006 108.871 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.07 -47.64 73.61 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 116.174 -0.466 . . . . 64.140000000000001 110.195 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.56 -37.95 89.27 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 109.232 -0.655 . . . . 64.510000000000005 109.232 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -64.28 -37.43 87.46 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 107.999 -1.111 . . . . 70.010000000000005 107.999 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.26 -46.38 70.59 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 107.648 -1.241 . . . . 72.109999999999999 107.648 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.5 -13.27 47.63 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.394 -0.682 . . . . 63.109999999999999 111.394 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -73.91 -41.71 61.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.636 1.218 . . . . 72.329999999999998 108.39 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.78 135.48 33.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 106.982 -1.488 . . . . 75.510000000000005 106.982 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -135.52 -178.56 5.17 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 105.582 -2.007 . . . . 64.019999999999996 105.582 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 141.24 57.74 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.873 -1.899 . . . . 73.140000000000001 105.873 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.26 -13.29 48.27 Favored Glycine 0 CA--C 1.477 -2.296 0 N-CA-C 107.91 -2.076 . . . . 71.25 107.91 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -82.87 150.25 26.64 Favored 'General case' 0 CA--C 1.485 -1.538 0 N-CA-C 106.184 -1.784 . . . . 74.230000000000004 106.184 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.545 HH21 ' CD ' ' A' ' 91' ' ' GLU . 1.7 tmm_? -115.91 123.08 47.2 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 106.265 -1.754 . . . . 72.030000000000001 106.265 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -94.12 140.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.248 -2.13 . . . . 72.150000000000006 105.248 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 -43.95 3.06 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 106.96 -1.496 . . . . 72.230000000000004 106.96 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.51 165.37 22.83 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 122.536 1.16 . . . . 74.019999999999996 110.029 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -137.56 102.37 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 103.376 -2.824 . . . . 64.540000000000006 103.376 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.5 t30 51.89 42.28 30.03 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 124.373 1.069 . . . . 71.5 110.275 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.98 14.31 79.66 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.27 -1.132 . . . . 74.099999999999994 110.27 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.16 117.25 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 103.835 -2.654 . . . . 72.0 103.835 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -70.4 115.93 10.14 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.189 -1.041 . . . . 53.340000000000003 108.189 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.6 13.97 7.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.827 -1.175 . . . . 73.349999999999994 107.827 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.72 137.7 54.31 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.704 -1.221 . . . . 61.399999999999999 107.704 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.26 -16.93 14.6 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.012 -1.235 . . . . 55.020000000000003 110.012 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.54 154.44 41.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.095 -1.076 . . . . 74.409999999999997 108.095 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.75 163.13 19.33 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.589 -1.263 . . . . 74.430000000000007 107.589 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -63.07 -38.87 92.92 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 116.167 -0.47 . . . . 72.510000000000005 110.951 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.32 -35.21 79.62 Favored 'General case' 0 C--O 1.204 -1.325 0 C-N-CA 120.384 -0.526 . . . . 51.109999999999999 109.929 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.15 -31.07 69.48 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 121.145 -0.972 . . . . 61.399999999999999 108.99 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.19 79.88 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.975 -1.12 . . . . 75.409999999999997 107.975 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.0 t -74.22 -55.02 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.625 -1.25 . . . . 64.219999999999999 107.625 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.3 m -56.2 -27.73 55.74 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 108.829 -0.804 . . . . 62.409999999999997 108.829 -171.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -61.79 -55.86 25.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 106.975 -1.491 . . . . 61.109999999999999 106.975 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.57 -55.68 30.79 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 109.027 -0.731 . . . . 74.140000000000001 109.027 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -46.77 -34.02 4.88 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.625 -0.672 . . . . 71.239999999999995 112.52 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -98.56 4.2 48.11 Favored 'General case' 0 C--N 1.35 0.622 0 O-C-N 121.255 -0.903 . . . . 74.109999999999999 110.413 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 p -80.76 173.63 12.42 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.645 -1.284 . . . . 72.129999999999995 108.685 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.2 -136.08 7.22 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.297 -0.721 . . . . 64.109999999999999 111.297 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -82.99 -49.09 9.94 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.32 -0.993 . . . . 72.439999999999998 108.32 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.0 132.98 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 N-CA-C 104.11 -2.552 . . . . 72.140000000000001 104.11 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.7 t -116.83 134.23 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 105.056 -2.202 . . . . 61.450000000000003 105.056 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -95.92 120.2 35.78 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 105.546 -2.02 . . . . 72.319999999999993 105.546 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.67 137.23 52.8 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.074 -1.825 . . . . 73.140000000000001 106.074 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 tp -110.88 125.69 53.9 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.454 -2.424 . . . . 65.310000000000002 104.454 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.25 155.44 46.28 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 108.449 -0.945 . . . . 74.200000000000003 108.449 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.545 ' CD ' HH21 ' A' ' 58' ' ' ARG . 35.6 tt0 -115.35 126.95 55.06 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 102.404 -3.184 . . . . 44.43 102.404 174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -56.75 139.17 51.64 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 108.175 -1.046 . . . . 63.130000000000003 108.175 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.95 152.52 44.09 Favored Glycine 0 CA--C 1.476 -2.357 0 N-CA-C 106.602 -2.599 . . . . 61.229999999999997 106.602 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -105.29 -171.9 2.0 Allowed 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 104.773 -2.306 . . . . 60.340000000000003 104.773 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.6 p -82.45 153.22 68.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 105.501 -2.037 . . . . 74.400000000000006 105.501 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.13 152.9 62.56 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 107.792 -1.657 . . . . 73.140000000000001 107.792 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.3 m . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 101.503 -3.517 . . . . 45.310000000000002 101.503 172.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.485 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.736 0 N-CA-C 108.564 -1.814 . . . . 52.549999999999997 108.564 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.38 155.35 67.45 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.812 2.341 . . . . 73.519999999999996 107.972 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 62.8 mttp -89.09 161.73 39.81 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 105.161 -2.163 . . . . 75.299999999999997 105.161 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 18.2 Cg_endo -59.58 132.92 48.48 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.686 1.591 . . . . 75.530000000000001 108.858 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.32 -19.44 42.76 Favored Glycine 0 CA--C 1.482 -2.007 0 N-CA-C 108.87 -1.692 . . . . 62.43 108.87 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.01 136.13 53.38 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.046 -1.094 . . . . 64.310000000000002 108.046 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.27 131.88 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 103.878 -2.638 . . . . 72.430000000000007 103.878 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.68 143.77 51.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.843 -1.91 . . . . 74.540000000000006 105.843 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.5 130.76 50.94 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.883 -1.895 . . . . 63.229999999999997 105.883 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.98 129.8 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.13 0 N-CA-C 105.024 -2.213 . . . . 73.230000000000004 105.024 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -103.44 110.75 22.88 Favored 'General case' 0 CA--C 1.471 -2.059 0 N-CA-C 105.745 -1.946 . . . . 72.040000000000006 105.745 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.42 121.57 43.08 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.683 -1.599 . . . . 64.120000000000005 106.683 -168.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.36 147.84 25.85 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 106.964 -1.495 . . . . 74.549999999999997 106.964 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -93.43 31.05 1.58 Allowed 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.596 -2.002 . . . . 73.219999999999999 105.596 175.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.76 -51.08 7.05 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 107.496 -1.298 . . . . 72.140000000000001 107.496 -167.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.53 -56.37 22.85 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.738 -0.838 . . . . 75.120000000000005 108.738 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -154.14 164.85 37.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.642 -2.725 . . . . 70.420000000000002 103.642 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.1 m -46.23 150.79 0.57 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 123.726 0.81 . . . . 51.130000000000003 110.296 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.2 pt? -58.14 -57.33 13.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.505 -0.77 . . . . 64.340000000000003 111.78 -164.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.585 ' HA3' HG12 ' A' ' 42' ' ' ILE . . . 61.38 52.77 49.3 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.205 -0.758 . . . . 61.229999999999997 111.205 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.2 161.38 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 N-CA-C 103.839 -2.652 . . . . 72.140000000000001 103.839 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 t -154.68 162.72 41.01 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 103.396 -2.816 . . . . 64.0 103.396 163.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.43 167.86 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.633 0 N-CA-C 105.389 -2.078 . . . . 74.540000000000006 105.389 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -146.77 166.33 26.97 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.958 -2.608 . . . . 61.030000000000001 103.958 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 83.92 138.6 3.74 Favored Glycine 0 C--O 1.191 -2.543 0 N-CA-C 111.472 -0.651 . . . . 63.32 111.472 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -169.31 -89.08 0.07 OUTLIER Glycine 0 C--N 1.362 2.002 0 N-CA-C 109.228 -1.549 . . . . 54.32 109.228 167.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.21 20.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 117.279 2.326 . . . . 64.299999999999997 117.279 -165.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 88.32 65.08 0.01 OUTLIER 'General case' 0 CA--C 1.466 -2.27 0 N-CA-C 105.332 -2.099 . . . . 74.319999999999993 105.332 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.482 ' H ' HG22 ' A' ' 29' ' ' THR . 5.1 t -85.7 -166.66 1.59 Allowed 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 110.972 -2.831 . . . . 73.400000000000006 106.115 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 m -60.93 -31.0 70.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.473 1.109 . . . . 72.430000000000007 110.552 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 29' ' ' THR . 4.7 m -87.33 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 107.849 -1.167 . . . . 72.409999999999997 107.849 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -67.11 -37.31 83.67 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.398 0.679 . . . . 63.140000000000001 110.111 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -69.47 -9.02 51.91 Favored 'General case' 0 C--O 1.211 -0.938 0 O-C-N 121.393 -0.817 . . . . 64.319999999999993 109.742 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.82 13.77 57.17 Favored Glycine 0 C--N 1.37 2.438 0 N-CA-C 108.589 -1.804 . . . . 72.450000000000003 108.589 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.87 144.99 47.57 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 109.609 -1.396 . . . . 64.510000000000005 109.609 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 25' ' ' GLY . 1.7 mm -85.83 104.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 102.454 -3.165 . . . . 70.120000000000005 102.454 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -101.29 147.51 26.21 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 107.501 -1.296 . . . . 73.0 107.501 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -65.25 132.62 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 106.77 -1.567 . . . . 72.340000000000003 106.77 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -109.07 -48.11 3.32 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.501 -0.926 . . . . 53.310000000000002 108.501 -167.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.61 146.04 34.13 Favored 'General case' 0 CA--C 1.463 -2.388 0 N-CA-C 105.806 -1.924 . . . . 50.450000000000003 105.806 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.9 t -130.59 130.33 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 103.981 -2.6 . . . . 74.239999999999995 103.981 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.585 HG12 ' HA3' ' A' ' 20' ' ' GLY . 34.0 mm -67.59 141.13 95.05 Favored Pre-proline 0 C--N 1.353 0.718 0 N-CA-C 106.093 -1.817 . . . . 73.409999999999997 106.093 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.52 109.12 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 122.153 1.902 . . . . 64.340000000000003 107.896 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 70.15 30.28 3.53 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 124.446 1.091 . . . . 70.140000000000001 110.929 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.45 -179.0 33.83 Favored Glycine 0 C--N 1.369 2.385 0 N-CA-C 107.279 -2.328 . . . . 65.209999999999994 107.279 162.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.89 -35.34 80.33 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 122.102 -0.646 . . . . 52.229999999999997 109.48 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.85 82.32 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 109.273 -0.64 . . . . 64.540000000000006 109.273 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.58 -34.71 77.59 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.617 -0.512 . . . . 73.230000000000004 109.617 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -70.05 -42.32 73.03 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.74 -0.837 . . . . 62.119999999999997 108.74 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -67.71 -37.07 81.76 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.691 -1.226 . . . . 74.439999999999998 107.691 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.64 -14.28 47.95 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 111.32 -0.712 . . . . 63.140000000000001 111.32 170.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -80.88 -35.06 33.12 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.741 -0.858 . . . . 65.120000000000005 108.968 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.2 mt -95.24 133.04 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 106.136 -1.801 . . . . 70.209999999999994 106.136 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -135.41 175.27 9.74 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.275 -1.75 . . . . 52.420000000000002 106.275 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -65.85 132.58 49.02 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.407 -0.96 . . . . 75.439999999999998 108.407 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' GLN . . . 98.81 -12.07 62.6 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.078 -1.609 . . . . 52.530000000000001 109.078 170.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -65.87 150.92 47.81 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 106.767 -1.568 . . . . 64.329999999999998 106.767 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.481 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.9 tmm_? -109.32 127.48 54.34 Favored 'General case' 0 C--O 1.197 -1.672 0 N-CA-C 106.265 -1.754 . . . . 71.540000000000006 106.265 -172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.48 138.66 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 106.17 -1.789 . . . . 65.140000000000001 106.17 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 -52.21 2.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.553 -1.277 . . . . 72.349999999999994 107.553 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.3 165.52 23.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 CA-C-O 122.157 0.98 . . . . 64.230000000000004 110.354 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -141.28 108.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 104.228 -2.508 . . . . 73.239999999999995 104.228 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.7 t30 54.94 38.18 30.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.333 0.653 . . . . 74.540000000000006 109.851 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.29 16.63 79.3 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 109.528 -1.429 . . . . 63.210000000000001 109.528 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.4 t -107.87 119.82 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 104.776 -2.305 . . . . 75.209999999999994 104.776 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.2 m -71.91 113.23 8.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.167 -1.049 . . . . 61.520000000000003 108.167 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.03 -28.8 62.56 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 107.589 -1.263 . . . . 73.420000000000002 107.589 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -52.3 145.04 11.66 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 122.806 0.442 . . . . 73.430000000000007 110.53 -175.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.49 -36.45 3.58 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 110.062 -1.215 . . . . 54.310000000000002 110.062 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.52 173.82 5.58 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.191 0.996 . . . . 74.019999999999996 110.006 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 p -81.01 160.56 24.54 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 107.966 -1.124 . . . . 71.129999999999995 107.966 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -64.29 -38.6 91.63 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.7 -0.852 . . . . 75.200000000000003 108.7 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -60.88 -41.86 96.79 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 120.449 -0.5 . . . . 63.43 109.661 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -63.64 -38.88 92.79 Favored 'General case' 0 C--N 1.369 1.421 0 N-CA-C 108.523 -0.917 . . . . 73.519999999999996 108.523 -172.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.91 70.42 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 109.958 -0.386 . . . . 74.340000000000003 109.958 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.9 t -74.17 -53.87 16.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.528 -1.286 . . . . 65.010000000000005 107.528 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.09 -28.31 38.36 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.263 -1.014 . . . . 52.43 108.263 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -67.7 -53.75 25.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.986 -1.116 . . . . 74.310000000000002 107.986 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -58.0 -56.83 16.95 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.158 -0.682 . . . . 52.119999999999997 109.158 -176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -51.63 -16.29 0.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.49 0.922 . . . . 73.439999999999998 113.49 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -99.53 -2.86 34.75 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.994 -1.066 . . . . 74.019999999999996 108.555 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -78.57 166.54 22.43 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.374 -0.829 . . . . 75.239999999999995 109.435 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.4 -140.9 6.08 Favored Glycine 0 C--N 1.347 1.146 0 N-CA-C 109.364 -1.494 . . . . 51.009999999999998 109.364 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -84.03 -48.74 9.6 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.125 -1.065 . . . . 71.150000000000006 108.125 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.81 135.63 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.968 -2.605 . . . . 63.420000000000002 103.968 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -123.51 142.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 N-CA-C 104.7 -2.333 . . . . 64.230000000000004 104.7 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -96.25 115.63 27.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.354 -2.462 . . . . 63.299999999999997 104.354 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.1 mt -117.4 143.35 46.08 Favored 'General case' 0 CA--C 1.475 -1.917 0 N-CA-C 106.073 -1.825 . . . . 75.340000000000003 106.073 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.51 131.29 56.74 Favored 'General case' 0 CA--C 1.467 -2.219 0 N-CA-C 103.982 -2.599 . . . . 74.310000000000002 103.982 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.99 155.32 48.2 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.987 -1.857 . . . . 72.239999999999995 105.987 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.481 ' CD ' HH21 ' A' ' 58' ' ' ARG . 39.0 tt0 -121.36 132.76 54.95 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 105.019 -2.215 . . . . 75.129999999999995 105.019 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 69.8 mmtt -69.86 152.35 44.63 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 122.63 1.205 . . . . 51.299999999999997 111.798 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.17 53.42 0.06 OUTLIER Glycine 0 CA--C 1.459 -3.412 0 N-CA-C 103.93 -3.668 . . . . 65.219999999999999 103.93 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 4.7 pt20 -82.97 145.28 29.44 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 107.385 -1.339 . . . . 72.129999999999995 107.385 -174.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 m -62.61 159.62 41.49 Favored Pre-proline 0 N--CA 1.436 -1.163 0 C-N-CA 123.211 0.604 . . . . 62.009999999999998 109.592 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.06 167.85 20.64 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.611 2.207 . . . . 71.230000000000004 107.738 171.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.41 -2.432 0 N-CA-C 103.173 -2.899 . . . . 74.200000000000003 103.173 177.14 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.134 0 N-CA-C 107.915 -2.074 . . . . 72.549999999999997 107.915 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.68 137.26 49.23 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.536 2.158 . . . . 71.099999999999994 108.277 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 56.1 mtmt -86.02 160.98 51.15 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 105.551 -2.018 . . . . 73.310000000000002 105.551 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 25.6 Cg_endo -62.43 138.17 69.38 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.866 1.71 . . . . 75.129999999999995 109.388 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.88 12.94 73.29 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.038 -1.625 . . . . 55.299999999999997 109.038 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -98.01 145.55 26.4 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.822 -2.288 . . . . 61.219999999999999 104.822 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.72 129.04 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.499 -2.408 . . . . 74.329999999999998 104.499 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -129.43 141.14 51.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.064 -1.828 . . . . 63.149999999999999 106.064 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -102.58 134.32 46.13 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 105.926 -1.879 . . . . 73.510000000000005 105.926 -175.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -130.44 130.65 65.28 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.116 0 N-CA-C 105.461 -2.051 . . . . 74.510000000000005 105.461 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.42 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 9.0 pt-20 -106.25 125.92 51.59 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.666 -2.346 . . . . 72.239999999999995 104.666 169.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.32 122.73 47.98 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 106.544 -1.651 . . . . 62.530000000000001 106.544 -167.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.88 137.17 35.33 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.476 -1.305 . . . . 62.119999999999997 107.476 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -90.2 35.07 0.86 Allowed 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.652 -1.61 . . . . 72.140000000000001 106.652 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -60.35 -44.65 95.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.9 -1.519 . . . . 74.329999999999998 106.9 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -81.83 146.13 30.04 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 105.118 -2.179 . . . . 64.530000000000001 105.118 169.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.12 -35.69 59.16 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.934 -0.395 . . . . 65.439999999999998 109.934 -167.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.2 m -72.38 121.0 18.77 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.204 -1.036 . . . . 71.299999999999997 108.204 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -72.86 -57.58 3.97 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 104.913 -2.254 . . . . 75.439999999999998 104.913 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.55 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 53.77 47.8 63.78 Favored Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 113.408 -1.723 . . . . 72.329999999999998 111.524 172.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.4 mt -123.45 156.17 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 102.79 -3.041 . . . . 65.439999999999998 102.79 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.2 m -145.57 160.88 40.99 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 102.575 -3.12 . . . . 71.409999999999997 102.575 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.63 165.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 105.738 -1.949 . . . . 74.150000000000006 105.738 -167.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -144.41 166.16 25.89 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 103.045 -2.946 . . . . 75.310000000000002 103.045 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' H ' HG21 ' A' ' 29' ' ' THR . . . 130.08 -178.43 17.53 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 107.694 -2.162 . . . . 72.200000000000003 107.694 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.45 -133.19 7.4 Favored Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 109.172 -1.571 . . . . 70.230000000000004 109.172 172.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.21 19.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.87 2.068 . . . . 74.540000000000006 113.588 -168.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 87.82 65.58 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.429 -1.323 . . . . 52.100000000000001 107.429 -169.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 25' ' ' GLY . 14.8 t -89.37 -165.81 1.44 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.304 -2.48 . . . . 62.200000000000003 104.304 170.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -46.14 -31.06 2.18 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.788 0.835 . . . . 71.340000000000003 112.89 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.8 m -84.96 133.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 108.163 -1.051 . . . . 74.430000000000007 108.163 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -56.65 -57.06 14.03 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 115.945 -0.57 . . . . 74.409999999999997 111.064 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -74.75 -0.39 18.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.491 -0.559 . . . . 73.319999999999993 109.491 -169.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.73 14.32 43.31 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 110.148 -1.181 . . . . 64.150000000000006 110.148 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.35 154.38 52.91 Favored Glycine 0 CA--C 1.473 -2.552 0 N-CA-C 107.581 -2.208 . . . . 52.109999999999999 107.581 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 86.68 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 N-CA-C 105.672 -1.973 . . . . 75.219999999999999 105.672 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 70.6 m-85 -84.56 142.18 30.17 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 106.992 -1.484 . . . . 75.239999999999995 106.992 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.84 128.5 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.262 -1.755 . . . . 63.020000000000003 106.262 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -102.51 -42.21 6.03 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.91 -1.144 . . . . 73.549999999999997 107.91 -166.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.38 153.2 34.28 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 106.53 -1.656 . . . . 73.030000000000001 106.53 -173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.92 131.72 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 N-CA-C 104.116 -2.55 . . . . 52.210000000000001 104.116 175.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.55 HG12 ' CA ' ' A' ' 20' ' ' GLY . 18.9 mm -75.43 143.04 75.45 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 104.288 -2.486 . . . . 71.239999999999995 104.288 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.75 115.01 2.24 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 107.714 -1.687 . . . . 55.399999999999999 107.714 166.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 77.16 18.28 1.47 Allowed 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 124.857 1.348 . . . . 73.310000000000002 111.01 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.11 172.68 40.41 Favored Glycine 0 C--N 1.367 2.282 0 N-CA-C 106.447 -2.661 . . . . 42.420000000000002 106.447 164.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.4 80.25 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 121.811 -0.817 . . . . 61.43 109.165 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.58 91.98 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 109.078 -0.712 . . . . 71.25 109.078 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -69.58 -36.32 76.16 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.76 -0.829 . . . . 71.0 108.76 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.6 m -70.27 -35.37 73.7 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.392 -0.966 . . . . 73.329999999999998 108.392 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 107.439 -1.319 . . . . 75.129999999999995 107.439 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.6 49.92 Favored Glycine 0 C--O 1.214 -1.151 0 N-CA-C 110.771 -0.932 . . . . 75.340000000000003 110.771 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -73.09 -39.1 66.1 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.419 -1.048 . . . . 65.120000000000005 109.144 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.45 131.76 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 107.225 -1.398 . . . . 61.229999999999997 107.225 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -141.49 -179.67 6.29 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.646 -1.983 . . . . 71.340000000000003 105.646 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -66.61 143.81 56.79 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.162 -1.792 . . . . 71.530000000000001 106.162 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.51 50.52 Favored Glycine 0 CA--C 1.486 -1.745 0 N-CA-C 108.085 -2.006 . . . . 61.32 108.085 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.83 161.06 17.74 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.309 -2.108 . . . . 61.530000000000001 105.309 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 19.6 ptt-85 -132.34 146.68 52.15 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 106.8 -1.556 . . . . 71.120000000000005 106.8 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.1 145.3 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.579 -2.378 . . . . 72.140000000000001 104.579 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 -47.43 2.63 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 106.735 -1.58 . . . . 74.120000000000005 106.735 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.54 166.8 19.81 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-O 122.52 1.152 . . . . 52.299999999999997 109.779 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -137.71 103.21 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 103.743 -2.688 . . . . 75.030000000000001 103.743 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.5 t30 56.44 36.96 28.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.315 0.579 . . . . 64.519999999999996 110.314 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.21 10.43 84.78 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 109.389 -1.484 . . . . 54.219999999999999 109.389 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.82 119.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 N-CA-C 104.311 -2.478 . . . . 43.119999999999997 104.311 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -69.69 106.41 3.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.665 -1.235 . . . . 51.310000000000002 107.665 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -18.07 36.92 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.109 -1.071 . . . . 73.140000000000001 108.109 -175.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.64 146.13 46.59 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.811 -0.811 . . . . 72.140000000000001 108.811 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.16 -35.03 4.26 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.452 -1.459 . . . . 74.439999999999998 109.452 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.66 156.28 39.68 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.286 -1.005 . . . . 62.0 108.286 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.5 p -75.67 166.14 24.0 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.827 -0.805 . . . . 73.329999999999998 108.827 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -65.8 -40.14 91.6 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.237 -1.023 . . . . 75.319999999999993 108.237 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -54.38 -48.16 71.86 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 110.256 -0.275 . . . . 71.409999999999997 110.256 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 -34.6 78.13 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 108.95 -0.759 . . . . 75.400000000000006 108.95 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.92 85.19 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.23 -0.655 . . . . 71.040000000000006 109.23 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.46 -54.79 16.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.641 -1.244 . . . . 70.030000000000001 107.641 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.4 m -56.2 -26.84 52.41 Favored 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 108.101 -1.074 . . . . 75.540000000000006 108.101 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.5 m -64.87 -54.63 27.97 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 107.018 -1.475 . . . . 73.140000000000001 107.018 -176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.4 mt -55.4 -55.5 30.94 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.525 -0.917 . . . . 74.219999999999999 108.525 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.8 mtp85 -45.83 -47.14 15.87 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.041 0.386 . . . . 74.219999999999999 112.041 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -87.89 1.09 54.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.121 0.873 . . . . 74.540000000000006 111.19 -173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.0 p -79.93 174.32 11.71 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.941 1.246 . . . . 50.32 108.374 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.8 -156.83 30.84 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 109.739 -1.344 . . . . 71.299999999999997 109.739 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -77.65 -44.48 27.97 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.72 -1.215 . . . . 72.230000000000004 107.72 -172.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.8 127.69 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.75 0 N-CA-C 103.879 -2.637 . . . . 72.209999999999994 103.879 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.54 143.63 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.888 0 N-CA-C 104.942 -2.244 . . . . 74.019999999999996 104.942 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.42 ' HE1' ' OE1' ' A' ' 11' ' ' GLU . 68.6 m-70 -99.44 117.99 35.07 Favored 'General case' 0 CA--C 1.474 -1.963 0 N-CA-C 105.138 -2.171 . . . . 63.549999999999997 105.138 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.9 mt -114.88 139.32 49.88 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 105.055 -2.202 . . . . 55.310000000000002 105.055 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.85 123.94 49.41 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 104.336 -2.468 . . . . 54.119999999999997 104.336 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.1 mp -131.46 159.3 38.47 Favored 'General case' 0 CA--C 1.469 -2.167 0 N-CA-C 107.194 -1.41 . . . . 63.340000000000003 107.194 -171.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -123.34 134.83 53.99 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 104.042 -2.577 . . . . 74.030000000000001 104.042 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 142.62 51.25 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.446 -0.946 . . . . 55.310000000000002 108.446 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.25 178.34 34.28 Favored Glycine 0 CA--C 1.472 -2.631 0 N-CA-C 104.851 -3.3 . . . . 61.210000000000001 104.851 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -67.49 146.89 53.52 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.895 -1.52 . . . . 72.409999999999997 106.895 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 m -55.53 140.72 65.38 Favored Pre-proline 0 C--N 1.347 0.461 0 CA-C-O 121.447 0.641 . . . . 63.149999999999999 109.929 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.19 128.21 19.05 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.89 2.394 . . . . 73.030000000000001 109.321 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.414 -2.241 0 N-CA-C 104.466 -2.42 . . . . 73.25 104.466 175.691 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.431 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.033 0 N-CA-C 107.424 -2.271 . . . . 50.350000000000001 107.424 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.29 110.91 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.929 2.419 . . . . 54.399999999999999 109.445 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.472 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 9.2 mtmp? -77.96 165.01 53.83 Favored Pre-proline 0 N--CA 1.44 -0.927 0 N-CA-C 105.38 -2.081 . . . . 75.349999999999994 105.38 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 20.7 Cg_endo -60.52 116.82 3.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.009 1.806 . . . . 72.420000000000002 108.809 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.508 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 98.61 12.93 42.66 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 109.529 -1.428 . . . . 32.439999999999998 109.529 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.442 ' CG ' ' HZ2' ' A' ' 3' ' ' LYS . 74.6 m-20 -97.95 143.12 28.87 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.251 -1.759 . . . . 72.019999999999996 106.251 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 7' ' ' ILE . 3.2 mp -97.61 141.24 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 N-CA-C 105.224 -2.139 . . . . 72.010000000000005 105.224 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.75 159.5 36.88 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.385 -2.079 . . . . 73.129999999999995 105.385 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -102.81 148.24 25.87 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.244 -2.132 . . . . 75.329999999999998 105.244 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.25 131.93 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 N-CA-C 104.321 -2.474 . . . . 71.25 104.321 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.03 133.43 54.2 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.382 -1.71 . . . . 75.120000000000005 106.382 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.66 128.89 51.2 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.657 -1.979 . . . . 73.430000000000007 105.657 -173.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -92.24 141.87 28.09 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.189 -1.041 . . . . 71.25 108.189 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -84.64 33.6 0.52 Allowed 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.022 -1.473 . . . . 75.030000000000001 107.022 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 13' ' ' ALA . 44.5 t30 -62.13 -41.43 98.24 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 106.95 -1.5 . . . . 70.540000000000006 106.95 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.86 160.65 30.23 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.427 -1.323 . . . . 73.140000000000001 107.427 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -74.33 -52.58 11.81 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 107.16 -1.422 . . . . 74.340000000000003 107.16 -172.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.8 m -85.71 136.23 33.43 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.303 -1.369 . . . . 75.310000000000002 107.303 -175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.45 -58.53 3.31 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.471 -2.418 . . . . 65.420000000000002 104.471 167.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 42' ' ' ILE . . . 60.55 48.94 83.71 Favored Glycine 0 CA--C 1.485 -1.82 0 CA-C-N 114.342 -1.299 . . . . 71.319999999999993 110.438 171.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mt -124.17 152.65 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 103.687 -2.709 . . . . 71.239999999999995 103.687 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 51.6 m -150.54 161.85 41.77 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 103.372 -2.825 . . . . 71.310000000000002 103.372 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.96 167.47 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 105.094 -2.188 . . . . 71.239999999999995 105.094 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -143.62 166.15 25.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 102.919 -2.993 . . . . 74.019999999999996 102.919 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.04 -173.37 16.18 Favored Glycine 0 CA--C 1.473 -2.562 0 N-CA-C 107.584 -2.206 . . . . 51.229999999999997 107.584 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 -123.69 5.53 Favored Glycine 0 CA--C 1.485 -1.789 0 N-CA-C 108.427 -1.869 . . . . 60.539999999999999 108.427 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.75 20.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 126.003 1.721 . . . . 72.200000000000003 113.659 -169.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 87.32 66.21 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 122.657 1.218 . . . . 61.25 107.876 -175.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -84.27 -166.51 1.46 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.591 -2.744 . . . . 73.109999999999999 103.591 171.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -53.56 -22.04 7.63 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.762 0.652 . . . . 73.430000000000007 112.762 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.85 128.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 107.295 -1.372 . . . . 63.32 107.295 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -61.62 -46.16 91.0 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 122.952 0.501 . . . . 64.239999999999995 109.904 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -73.64 -5.33 39.76 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.766 -0.828 . . . . 73.030000000000001 108.766 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.02 10.25 19.04 Favored Glycine 0 C--N 1.358 1.795 0 N-CA-C 110.998 -0.841 . . . . 73.319999999999993 110.998 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.9 151.74 51.14 Favored Glycine 0 CA--C 1.471 -2.662 0 N-CA-C 108.477 -1.849 . . . . 43.229999999999997 108.477 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.69 89.66 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 N-CA-C 105.737 -1.949 . . . . 71.120000000000005 105.737 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -87.42 144.26 26.83 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 106.774 -1.565 . . . . 64.219999999999999 106.774 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.62 132.05 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.112 -1.81 . . . . 71.129999999999995 106.112 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.06 -45.08 4.62 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.382 -1.34 . . . . 73.430000000000007 107.382 -166.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 155.45 38.72 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 106.502 -1.666 . . . . 64.120000000000005 106.502 -172.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.29 139.16 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.943 0 N-CA-C 105.529 -2.026 . . . . 72.209999999999994 105.529 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.416 ' HB ' ' HA3' ' A' ' 20' ' ' GLY . 6.0 mt -72.95 144.55 85.43 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.337 -1.357 . . . . 52.409999999999997 107.337 175.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.57 108.49 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.639 2.226 . . . . 55.329999999999998 108.879 168.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 75.15 27.63 1.1 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.745 1.218 . . . . 73.420000000000002 110.318 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.04 173.62 55.09 Favored Glycine 0 C--N 1.357 1.733 0 N-CA-C 106.556 -2.618 . . . . 65.549999999999997 106.556 162.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.35 79.15 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.323 0.649 . . . . 62.020000000000003 110.298 -170.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.17 -49.52 64.42 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.618 -0.512 . . . . 74.239999999999995 109.618 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.2 -42.0 99.25 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.615 -0.513 . . . . 55.420000000000002 109.615 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 61.5 m -59.96 -42.14 93.45 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-O 121.355 0.598 . . . . 72.209999999999994 109.624 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -77.71 -35.48 52.05 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.813 -1.18 . . . . 70.340000000000003 107.813 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 81.23 -4.63 70.85 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 111.306 -0.718 . . . . 73.140000000000001 111.306 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.17 -44.3 63.24 Favored 'General case' 0 CA--C 1.503 -0.844 0 O-C-N 121.658 -0.907 . . . . 73.010000000000005 109.131 -175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 mt -109.98 136.54 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 105.826 -1.916 . . . . 72.129999999999995 105.826 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.418 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 53.5 m80 -122.96 170.03 10.55 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.98 -1.859 . . . . 75.430000000000007 105.98 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 146.49 53.85 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.338 -1.356 . . . . 75.299999999999997 107.338 174.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.72 -8.2 78.71 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 109.804 -1.318 . . . . 50.210000000000001 109.804 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -86.0 163.38 18.0 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.104 -1.813 . . . . 71.129999999999995 106.104 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -115.39 129.88 56.72 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.7 0.762 . . . . 65.319999999999993 109.148 -172.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.94 148.82 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 104.942 -2.244 . . . . 73.340000000000003 104.942 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 -44.43 2.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 107.742 -1.207 . . . . 70.120000000000005 107.742 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.23 164.35 24.73 Favored 'General case' 0 CA--C 1.485 -1.536 0 C-N-CA 119.017 -1.073 . . . . 73.25 109.905 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.5 t -140.76 107.51 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 104.917 -2.253 . . . . 75.150000000000006 104.917 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.8 t30 45.71 43.48 9.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.417 1.487 . . . . 72.230000000000004 111.073 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.66 13.97 76.87 Favored Glycine 0 CA--C 1.499 -0.931 0 N-CA-C 109.614 -1.395 . . . . 72.430000000000007 109.614 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.87 117.53 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 103.815 -2.661 . . . . 75.540000000000006 103.815 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.0 m -69.62 110.44 4.84 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.501 -1.296 . . . . 70.340000000000003 107.501 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.61 -6.48 57.49 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.9 -1.148 . . . . 53.439999999999998 107.9 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.96 143.64 57.27 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.556 -1.276 . . . . 54.100000000000001 107.556 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.36 -39.12 3.13 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.116 -1.193 . . . . 34.439999999999998 110.116 -175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 163.98 24.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 108.951 -0.759 . . . . 50.32 108.951 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -84.58 168.65 15.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.799 0.809 . . . . 71.450000000000003 109.36 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -62.03 -40.46 95.79 Favored 'General case' 0 C--N 1.36 1.031 0 CA-C-N 115.404 -0.816 . . . . 71.099999999999994 109.27 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -60.78 -40.58 93.11 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.892 -0.505 . . . . 73.239999999999995 110.54 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.21 -39.2 93.95 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.5 1.045 . . . . 71.25 109.378 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.89 79.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.427 -0.583 . . . . 73.140000000000001 109.427 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.1 t -71.24 -54.45 17.4 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 N-CA-C 107.423 -1.325 . . . . 74.109999999999999 107.423 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.7 t -53.35 -28.94 31.51 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.55 1.167 . . . . 73.010000000000005 108.521 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 m -70.59 -56.36 6.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.507 -1.294 . . . . 65.129999999999995 107.507 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -57.15 -54.72 43.61 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 107.937 -1.134 . . . . 52.450000000000003 107.937 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -44.49 -43.99 8.28 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.542 1.137 . . . . 73.219999999999999 111.9 176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -98.15 9.02 43.91 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 119.713 1.142 . . . . 75.200000000000003 111.201 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.4 p -80.72 174.45 11.6 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.861 -1.149 . . . . 72.140000000000001 107.925 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.28 -148.53 16.38 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.599 -1.4 . . . . 63.43 109.599 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -80.6 -47.81 13.6 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 108.173 -1.047 . . . . 74.140000000000001 108.173 -169.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.12 132.69 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.709 0 N-CA-C 103.817 -2.66 . . . . 54.409999999999997 103.817 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.55 151.0 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 N-CA-C 104.479 -2.415 . . . . 64.430000000000007 104.479 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -103.36 124.26 48.36 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 104.933 -2.247 . . . . 73.319999999999993 104.933 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.6 mt -112.02 137.79 49.55 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 104.191 -2.522 . . . . 75.420000000000002 104.191 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.8 tp -106.97 126.27 52.1 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 105.815 -1.92 . . . . 72.340000000000003 105.815 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 152.52 51.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.423 -2.065 . . . . 70.329999999999998 105.423 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -123.71 140.86 52.57 Favored 'General case' 0 CA--C 1.462 -2.429 0 N-CA-C 102.608 -3.108 . . . . 72.200000000000003 102.608 176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.508 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 24.7 mmtp -61.73 139.63 58.3 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.809 0.814 . . . . 72.219999999999999 109.527 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.04 49.75 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 106.138 -2.785 . . . . 71.319999999999993 106.138 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -73.6 143.08 46.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 105.007 -2.22 . . . . 75.099999999999994 105.007 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -66.71 145.42 98.93 Favored Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 107.079 -1.452 . . . . 73.430000000000007 107.079 -175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.63 168.01 19.45 Favored 'Trans proline' 0 C--O 1.253 1.258 0 C-N-CA 122.342 2.028 . . . . 72.549999999999997 107.025 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.415 -2.176 0 N-CA-C 105.862 -1.903 . . . . 73.319999999999993 105.862 -174.798 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.652 0 N-CA-C 108.019 -2.032 . . . . 71.319999999999993 108.019 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.98 113.73 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.977 2.451 . . . . 44.020000000000003 109.055 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -81.14 165.65 43.55 Favored Pre-proline 0 N--CA 1.441 -0.877 0 N-CA-C 106.21 -1.774 . . . . 70.030000000000001 106.21 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.36 124.62 16.58 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.152 1.902 . . . . 64.329999999999998 108.253 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 89.95 12.14 62.45 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 110.435 -1.066 . . . . 61.200000000000003 110.435 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.22 141.56 28.46 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.682 -2.34 . . . . 74.420000000000002 104.682 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.07 136.02 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 104.827 -2.286 . . . . 74.530000000000001 104.827 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.6 152.29 41.21 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.944 -1.873 . . . . 73.150000000000006 105.944 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HG2' HD13 ' A' ' 89' ' ' LEU . 46.9 mt-10 -105.31 143.53 33.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.669 -1.974 . . . . 72.439999999999998 105.669 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.95 130.74 66.37 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.0 0 N-CA-C 104.952 -2.24 . . . . 44.240000000000002 104.952 175.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.49 113.14 26.24 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 103.866 -2.642 . . . . 73.340000000000003 103.866 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 12' ' ' LEU . 1.1 tm? -103.58 122.21 44.5 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.885 -1.894 . . . . 75.219999999999999 105.885 -169.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.75 150.3 39.34 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.036 -1.839 . . . . 71.450000000000003 106.036 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 9.3 tptm -120.89 -72.71 0.68 Allowed 'General case' 0 CA--C 1.456 -2.659 0 N-CA-C 103.119 -2.919 . . . . 73.140000000000001 103.119 165.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' A' ' 14' ' ' LYS . 46.9 t30 170.73 -171.57 0.03 OUTLIER 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 97.719 -4.919 . . . . 55.140000000000001 97.719 177.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -79.55 99.93 7.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.287 -1.745 . . . . 55.409999999999997 106.287 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -167.31 -110.57 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.826 -2.286 . . . . 51.530000000000001 104.826 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.8 m -135.99 152.81 51.32 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 104.274 -2.491 . . . . 62.240000000000002 104.274 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 86' ' ' VAL . 63.9 mt -73.09 -43.63 61.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.62 -0.881 . . . . 75.310000000000002 108.62 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.0 41.62 8.01 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 107.49 -2.244 . . . . 34.219999999999999 107.49 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 47' ' ' ALA . 22.2 mt -138.54 156.93 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 102.744 -3.058 . . . . 70.010000000000005 102.744 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.5 m -153.11 168.64 25.22 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.527 -2.768 . . . . 73.420000000000002 103.527 169.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.437 HG21 ' HB1' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -140.6 167.99 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 106.497 -1.668 . . . . 74.209999999999994 106.497 -167.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 t -143.58 167.0 23.27 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 103.68 -2.711 . . . . 64.030000000000001 103.68 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 88.31 134.45 4.73 Favored Glycine 0 C--O 1.201 -1.969 0 N-CA-C 108.83 -1.708 . . . . 63.140000000000001 108.83 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.3 -98.89 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 108.986 -1.646 . . . . 43.109999999999999 108.986 167.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.04 20.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 126.617 1.967 . . . . 64.329999999999998 115.833 -166.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.9 t30 87.2 65.19 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.576 0 N-CA-C 107.181 -1.414 . . . . 75.219999999999999 107.181 -172.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 t -92.29 -166.09 1.48 Allowed 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 104.705 -2.331 . . . . 75.349999999999994 104.705 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -52.29 -21.8 3.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.5 1.12 . . . . 73.150000000000006 112.391 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.52 130.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 107.61 -1.256 . . . . 65.219999999999999 107.61 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -68.73 -36.31 78.25 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 116.017 -0.538 . . . . 61.32 111.532 -168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -79.06 -4.36 49.81 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.966 -1.084 . . . . 75.540000000000006 108.909 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.72 17.68 62.98 Favored Glycine 0 C--N 1.362 1.975 0 N-CA-C 108.355 -1.898 . . . . 74.019999999999996 108.355 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.41 134.78 39.05 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 109.095 -1.602 . . . . 65.420000000000002 109.095 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.3 mm -78.08 103.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 103.516 -2.772 . . . . 74.549999999999997 103.516 173.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.39 147.83 24.3 Favored 'General case' 0 CA--C 1.468 -2.205 0 N-CA-C 106.58 -1.637 . . . . 71.329999999999998 106.58 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -61.66 133.98 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 106.657 -1.608 . . . . 73.420000000000002 106.657 168.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -112.03 -49.34 2.98 Favored 'General case' 0 CA--C 1.472 -2.038 0 N-CA-C 107.195 -1.409 . . . . 62.43 107.195 -169.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.09 130.81 41.73 Favored 'General case' 0 CA--C 1.456 -2.637 0 N-CA-C 105.868 -1.901 . . . . 55.420000000000002 105.868 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG13 ' HB3' ' A' ' 47' ' ' ALA . 95.3 t -120.37 117.43 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.621 0 N-CA-C 103.576 -2.75 . . . . 61.43 103.576 172.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.59 136.23 96.68 Favored Pre-proline 0 N--CA 1.447 -0.62 0 N-CA-C 106.712 -1.588 . . . . 72.040000000000006 106.712 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.67 111.4 1.5 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.495 2.13 . . . . 75.319999999999993 107.665 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 75.73 20.68 1.78 Allowed 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.259 0.974 . . . . 73.420000000000002 110.541 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.52 -176.88 45.74 Favored Glycine 0 C--N 1.358 1.796 0 N-CA-C 107.024 -2.43 . . . . 71.120000000000005 107.024 168.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 14' ' ' LYS . . . -71.72 -19.84 61.99 Favored 'General case' 0 C--O 1.219 -0.53 0 O-C-N 122.359 -0.495 . . . . 75.299999999999997 110.744 -171.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HB3' HG13 ' A' ' 41' ' ' VAL . . . -81.09 -49.19 11.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.163 -1.421 . . . . 70.25 107.163 -174.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.99 -38.16 87.56 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.169 -0.678 . . . . 74.439999999999998 109.169 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -70.65 -39.38 73.65 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.569 -0.9 . . . . 71.120000000000005 108.569 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.4 -39.05 88.78 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 107.384 -1.339 . . . . 61.539999999999999 107.384 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.6 -19.36 37.18 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 110.322 -1.111 . . . . 64.409999999999997 110.322 171.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.18 -39.68 40.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 107.81 -1.182 . . . . 70.209999999999994 107.81 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mt -96.85 132.96 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.722 -1.584 . . . . 72.239999999999995 106.722 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -142.67 -176.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 104.715 -2.328 . . . . 71.340000000000003 104.715 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -66.58 141.71 57.74 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.295 -1.743 . . . . 72.530000000000001 106.295 172.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.84 -30.13 8.34 Favored Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 107.486 -2.246 . . . . 31.329999999999998 107.486 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -72.78 150.73 42.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.428 -0.953 . . . . 70.120000000000005 108.428 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -123.56 128.77 50.2 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 106.157 -1.794 . . . . 72.310000000000002 106.157 -173.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.84 144.27 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 106.249 -1.76 . . . . 71.109999999999999 106.249 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.28 -44.08 2.6 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 107.559 -1.274 . . . . 61.32 107.559 175.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.89 159.49 36.47 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 118.944 -1.102 . . . . 45.140000000000001 109.378 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.16 116.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 104.942 -2.244 . . . . 73.299999999999997 104.942 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.3 t30 55.09 30.98 15.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.595 0.758 . . . . 73.329999999999998 109.886 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 16.43 77.21 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 109.324 -1.51 . . . . 72.519999999999996 109.324 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -106.72 124.01 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.814 0 N-CA-C 104.682 -2.34 . . . . 65.219999999999999 104.682 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -68.81 112.69 5.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.415 -1.328 . . . . 71.109999999999999 107.415 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.22 -1.0 57.58 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 107.571 -1.27 . . . . 52.509999999999998 107.571 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.74 143.13 58.09 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.608 -1.256 . . . . 44.210000000000001 107.608 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.85 3.81 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.451 -1.06 . . . . 63.119999999999997 110.451 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.44 13.37 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.761 0.78 . . . . 40.439999999999998 109.323 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -81.39 162.99 23.15 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.515 -1.291 . . . . 62.539999999999999 107.515 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -65.23 -36.75 85.13 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.532 -1.285 . . . . 75.430000000000007 107.532 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -52.03 -51.64 56.1 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 109.983 -0.377 . . . . 73.430000000000007 109.983 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -66.92 -37.68 84.78 Favored 'General case' 0 C--N 1.369 1.455 0 N-CA-C 109.286 -0.635 . . . . 70.239999999999995 109.286 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -55.75 -43.97 77.17 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 118.033 0.379 . . . . 42.299999999999997 110.175 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.66 -50.77 36.96 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.267 -1.383 . . . . 73.430000000000007 107.267 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.5 t -53.92 -28.65 38.21 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-O 122.127 0.965 . . . . 50.439999999999998 108.671 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.7 m -67.87 -55.15 13.98 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 107.184 -1.413 . . . . 73.329999999999998 107.184 -174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.487 ' HB3' HD12 ' A' ' 19' ' ' LEU . 86.1 mt -56.65 -55.79 29.58 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.074 0.94 . . . . 73.530000000000001 108.613 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -46.6 -25.56 0.73 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.23 -0.896 . . . . 61.43 113.177 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -116.57 10.62 14.52 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.639 -1.288 . . . . 75.239999999999995 110.07 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.3 p -84.92 173.42 10.59 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.809 -1.182 . . . . 74.430000000000007 107.809 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.63 -155.19 22.55 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 109.767 -1.333 . . . . 62.119999999999997 109.767 -172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -80.77 -31.89 35.65 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 108.439 -0.949 . . . . 62.130000000000003 108.439 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -122.33 133.52 68.34 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 103.908 -2.626 . . . . 72.329999999999998 103.908 175.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.504 HG21 HD11 ' A' ' 19' ' ' LEU . 6.4 t -123.57 141.98 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 105.461 -2.051 . . . . 64.340000000000003 105.461 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -95.61 115.82 27.98 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.321 -2.474 . . . . 72.409999999999997 104.321 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.4 mt -116.57 140.37 49.46 Favored 'General case' 0 CA--C 1.477 -1.833 0 N-CA-C 106.36 -1.719 . . . . 62.200000000000003 106.36 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 9' ' ' GLU . 26.1 tp -114.52 126.08 54.53 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 105.107 -2.182 . . . . 74.340000000000003 105.107 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.81 156.15 46.53 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.267 -1.383 . . . . 70.030000000000001 107.267 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.39 136.36 52.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 103.676 -2.713 . . . . 61.219999999999999 103.676 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 69.9 mmtt -61.84 149.74 39.32 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.981 0.896 . . . . 71.340000000000003 109.643 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.96 -166.79 21.49 Favored Glycine 0 CA--C 1.472 -2.648 0 N-CA-C 104.086 -3.606 . . . . 71.25 104.086 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -63.84 117.68 7.29 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.582 -1.266 . . . . 75.010000000000005 107.582 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.4 m -115.82 147.94 40.16 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 103.637 -2.727 . . . . 61.229999999999997 103.637 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.0 -25.39 44.42 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.662 1.575 . . . . 54.539999999999999 109.0 173.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 C--O 1.257 1.487 0 N-CA-C 104.752 -2.314 . . . . 73.109999999999999 104.752 177.509 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.427 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.242 0 N-CA-C 108.899 -1.68 . . . . 50.100000000000001 108.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.28 146.57 76.06 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.324 2.016 . . . . 74.510000000000005 107.596 170.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 98.0 mttt -77.57 162.66 67.66 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 106.318 -1.734 . . . . 62.229999999999997 106.318 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 19.6 Cg_endo -60.82 120.43 8.15 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.221 1.947 . . . . 75.540000000000006 109.089 174.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.91 12.74 57.49 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 108.636 -1.785 . . . . 31.32 108.636 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -96.0 140.21 31.07 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 105.142 -2.17 . . . . 74.340000000000003 105.142 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.18 139.93 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.205 0 N-CA-C 103.86 -2.645 . . . . 70.200000000000003 103.86 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.99 160.24 42.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 105.594 -2.002 . . . . 74.409999999999997 105.594 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.7 146.22 28.54 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 106.138 -1.801 . . . . 65.400000000000006 106.138 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.7 t -127.81 127.34 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.226 0 N-CA-C 103.453 -2.795 . . . . 60.219999999999999 103.453 167.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.49 114.09 28.1 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 104.31 -2.478 . . . . 54.329999999999998 104.31 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.46 124.31 48.51 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 105.809 -1.923 . . . . 74.040000000000006 105.809 -169.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.69 147.22 25.07 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.102 -1.444 . . . . 73.0 107.102 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -95.12 31.59 1.87 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.276 -1.749 . . . . 73.439999999999998 106.276 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -77.48 -50.08 13.42 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.017 -1.475 . . . . 63.329999999999998 107.017 -173.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.09 -64.18 1.04 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.834 -0.802 . . . . 70.310000000000002 108.834 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -148.77 167.48 25.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.215 -2.142 . . . . 74.400000000000006 105.215 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 t -53.17 173.18 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.131 0.972 . . . . 65.340000000000003 110.737 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -58.36 -58.75 7.14 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.106 -0.952 . . . . 61.350000000000001 109.816 -164.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 52.42 51.21 44.11 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 122.462 -0.149 . . . . 61.140000000000001 113.056 173.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -135.67 165.19 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 102.921 -2.992 . . . . 55.520000000000003 102.921 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.6 m -152.17 165.53 34.54 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 102.625 -3.102 . . . . 61.329999999999998 102.625 168.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.83 169.37 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 N-CA-C 105.957 -1.868 . . . . 70.439999999999998 105.957 -167.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -148.88 167.32 26.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 103.002 -2.962 . . . . 73.25 103.002 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.6 -168.93 13.15 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 106.652 -2.579 . . . . 72.430000000000007 106.652 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.42 -116.04 3.2 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 107.879 -2.088 . . . . 51.119999999999997 107.879 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.18 19.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.89 1.276 . . . . 72.109999999999999 113.742 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.27 82.1 m-20 88.68 68.17 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 123.179 1.466 . . . . 75.310000000000002 108.442 -170.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.723 HG22 ' H ' ' A' ' 30' ' ' SER . 6.3 m -81.99 -166.99 1.37 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 103.423 -2.806 . . . . 73.209999999999994 103.423 169.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.723 ' H ' HG22 ' A' ' 29' ' ' THR . 11.8 m -53.74 -20.16 5.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.198 0.908 . . . . 53.409999999999997 112.573 -174.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 m -89.97 128.88 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.625 -1.25 . . . . 70.319999999999993 107.625 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -63.29 -45.71 90.14 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 115.629 -0.714 . . . . 75.540000000000006 110.834 -170.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -76.04 1.79 14.55 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.731 -0.606 . . . . 72.129999999999995 109.747 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.17 22.26 68.85 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 109.984 -1.247 . . . . 50.539999999999999 109.984 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.57 150.82 50.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.137 -1.985 . . . . 71.510000000000005 108.137 -179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.5 mm -93.09 105.14 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.026 -2.583 . . . . 73.140000000000001 104.026 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -97.74 142.28 29.72 Favored 'General case' 0 CA--C 1.465 -2.296 0 N-CA-C 106.699 -1.593 . . . . 65.049999999999997 106.699 -174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.45 135.45 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 106.97 -1.492 . . . . 71.239999999999995 106.97 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -45.25 4.04 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.549 -1.649 . . . . 62.210000000000001 106.549 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.15 156.08 44.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.633 -1.988 . . . . 54.130000000000003 105.633 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.55 136.53 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 103.67 -2.715 . . . . 73.299999999999997 103.67 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.527 HG12 ' CA ' ' A' ' 20' ' ' GLY . 21.5 mm -69.1 143.92 94.76 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.179 -1.785 . . . . 71.099999999999994 106.179 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.33 114.93 2.2 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.295 1.997 . . . . 65.239999999999995 107.766 167.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 60.46 35.87 20.27 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.715 0.806 . . . . 71.319999999999993 111.122 -172.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 178.42 48.6 Favored Glycine 0 C--N 1.366 2.196 0 N-CA-C 106.614 -2.594 . . . . 74.140000000000001 106.614 163.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.21 93.88 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 109.383 -0.599 . . . . 71.040000000000006 109.383 -172.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.59 75.75 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.596 -0.52 . . . . 71.439999999999998 109.596 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.79 -39.86 87.93 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 109.303 -0.629 . . . . 75.530000000000001 109.303 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 67.0 m -64.97 -36.12 83.36 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.26 -0.644 . . . . 71.109999999999999 109.26 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.59 -32.52 68.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 108.246 -1.02 . . . . 71.150000000000006 108.246 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -20.01 29.48 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.546 -1.022 . . . . 61.299999999999997 110.546 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -72.64 -44.9 61.29 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.111 -1.07 . . . . 74.340000000000003 108.111 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mt -98.15 149.77 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.878 -1.897 . . . . 51.219999999999999 105.878 -173.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -151.49 170.38 19.76 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.082 -2.192 . . . . 75.549999999999997 105.082 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -67.29 142.57 56.82 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.627 -1.62 . . . . 64.099999999999994 106.627 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.3 -3.36 84.02 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 119.84 -1.171 . . . . 74.400000000000006 110.181 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -80.16 150.34 30.21 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 106.939 -1.504 . . . . 61.530000000000001 106.939 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.88 118.48 36.93 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 107.073 -1.455 . . . . 63.43 107.073 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 t -103.61 148.52 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 105.457 -2.053 . . . . 74.510000000000005 105.457 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.38 -48.01 2.9 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.773 -1.195 . . . . 73.230000000000004 107.773 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.08 162.37 28.94 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.576 -0.85 . . . . 42.100000000000001 109.184 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.18 111.82 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.349 -2.093 . . . . 73.299999999999997 105.349 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.6 t30 49.45 36.84 10.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.13 1.372 . . . . 75.129999999999995 111.363 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.48 4.87 76.19 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 109.671 -1.371 . . . . 71.319999999999993 109.671 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.93 120.53 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 104.572 -2.381 . . . . 74.0 104.572 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -72.72 108.57 5.78 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 106.861 -1.533 . . . . 74.540000000000006 106.861 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.98 -2.01 42.13 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.565 -0.743 . . . . 63.439999999999998 109.798 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.29 143.8 57.62 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.865 -1.161 . . . . 73.340000000000003 107.865 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.2 -31.32 4.12 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.74 -1.344 . . . . 41.240000000000002 109.74 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.46 162.16 29.84 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 118.495 1.148 . . . . 51.119999999999997 108.383 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.1 p -85.38 169.52 13.61 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.856 0.836 . . . . 60.130000000000003 109.06 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -64.26 -44.91 90.31 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.854 -1.165 . . . . 74.409999999999997 107.854 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.11 -41.35 96.54 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 119.265 -0.397 . . . . 64.030000000000001 110.095 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.35 -37.45 87.08 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 119.281 0.946 . . . . 54.439999999999998 108.84 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -55.78 -38.23 69.62 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.539 0.609 . . . . 73.329999999999998 109.973 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.11 -55.06 14.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 107.641 -1.244 . . . . 70.209999999999994 107.641 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.36 -26.75 68.62 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 108.758 -0.83 . . . . 72.400000000000006 108.758 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.6 m -60.16 -54.0 51.09 Favored 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 107.088 -1.449 . . . . 73.209999999999994 107.088 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 mt -56.11 -56.05 25.61 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 121.701 0.762 . . . . 71.319999999999993 109.123 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -48.72 -30.2 5.3 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 121.647 -0.658 . . . . 74.239999999999995 112.676 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -93.2 -7.34 45.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.349 -0.844 . . . . 75.430000000000007 109.939 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 p -79.41 170.28 16.83 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.856 -1.165 . . . . 52.43 107.856 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.16 -136.57 3.74 Favored Glycine 0 CA--C 1.496 -1.117 0 N-CA-C 110.142 -1.183 . . . . 62.240000000000002 110.142 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.3 -45.88 8.76 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.82 -1.178 . . . . 63.229999999999997 107.82 -172.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.94 128.31 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.676 0 N-CA-C 104.079 -2.563 . . . . 73.230000000000004 104.079 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 t -123.94 138.43 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 104.212 -2.514 . . . . 51.229999999999997 104.212 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -96.54 117.92 31.95 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 104.694 -2.336 . . . . 72.319999999999993 104.694 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.9 mt -116.74 137.84 51.91 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.864 -1.902 . . . . 75.409999999999997 105.864 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.74 130.31 56.11 Favored 'General case' 0 CA--C 1.463 -2.4 0 N-CA-C 104.589 -2.374 . . . . 73.109999999999999 104.589 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.68 153.84 49.58 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 105.848 -1.908 . . . . 72.340000000000003 105.848 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -117.3 133.33 56.11 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 103.786 -2.672 . . . . 61.32 103.786 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 135.81 56.6 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.704 -0.85 . . . . 74.450000000000003 108.704 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.49 51.74 0.02 OUTLIER Glycine 0 CA--C 1.47 -2.724 0 N-CA-C 105.334 -3.106 . . . . 54.149999999999999 105.334 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.93 151.63 23.6 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.916 -1.512 . . . . 74.209999999999994 106.916 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.3 p -84.9 168.51 20.43 Favored Pre-proline 0 N--CA 1.417 -2.084 0 N-CA-C 104.055 -2.572 . . . . 51.229999999999997 104.055 166.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 26.7 Cg_endo -62.43 161.3 28.05 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.769 1.646 . . . . 72.340000000000003 108.661 176.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 105.895 -1.891 . . . . 64.340000000000003 105.895 -177.688 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.432 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.682 0 N-CA-C 108.428 -1.869 . . . . 74.129999999999995 108.428 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.68 118.04 5.31 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.869 2.38 . . . . 72.420000000000002 108.267 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 52.3 mtmt -80.93 164.28 51.56 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 105.805 -1.924 . . . . 74.049999999999997 105.805 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 19.6 Cg_endo -58.18 118.09 4.91 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.156 1.904 . . . . 54.439999999999998 108.783 173.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 110.46 -24.44 17.79 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 109.32 -1.512 . . . . 74.200000000000003 109.32 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.57 143.66 57.48 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 117.669 0.735 . . . . 74.230000000000004 109.24 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.52 134.79 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.035 -2.58 . . . . 72.230000000000004 104.035 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -128.01 142.12 51.32 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 105.78 -1.933 . . . . 72.400000000000006 105.78 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -103.05 132.13 49.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 104.711 -2.329 . . . . 71.430000000000007 104.711 -175.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.25 135.93 57.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 106.318 -1.734 . . . . 75.510000000000005 106.318 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -103.04 118.13 36.13 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 104.234 -2.506 . . . . 63.310000000000002 104.234 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -102.91 121.09 41.81 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 104.962 -2.236 . . . . 62.200000000000003 104.962 -175.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.1 133.36 37.66 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.253 -1.388 . . . . 63.109999999999999 107.253 -176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -87.72 34.33 0.71 Allowed 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.648 1.179 . . . . 74.010000000000005 108.072 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.06 -25.89 68.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.219 -1.771 . . . . 73.150000000000006 106.219 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -93.86 140.66 29.42 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 104.049 -2.575 . . . . 53.530000000000001 104.049 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.6 -25.9 41.38 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.616 -0.513 . . . . 74.5 109.616 -166.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -87.94 122.05 31.09 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.308 -1.738 . . . . 70.329999999999998 106.308 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.79 -57.37 5.18 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 104.446 -2.428 . . . . 74.439999999999998 104.446 172.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.542 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 72.3 48.78 23.28 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 110.982 -0.847 . . . . 52.329999999999998 110.982 162.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.7 mt -131.68 148.43 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 101.042 -3.688 . . . . 74.219999999999999 101.042 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -146.68 164.02 34.04 Favored 'General case' 0 CA--C 1.46 -2.488 0 N-CA-C 102.568 -3.123 . . . . 74.129999999999995 102.568 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG21 ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -141.48 167.92 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 106.498 -1.667 . . . . 74.219999999999999 106.498 -161.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -144.72 165.89 26.78 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 104.233 -2.506 . . . . 75.200000000000003 104.233 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.457 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 79.39 140.5 2.06 Favored Glycine 0 C--O 1.19 -2.632 0 N-CA-C 110.871 -0.891 . . . . 60.409999999999997 110.871 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.62 -87.42 0.07 OUTLIER Glycine 0 C--N 1.351 1.41 0 N-CA-C 109.782 -1.327 . . . . 74.299999999999997 109.782 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.56 20.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 128.934 2.893 . . . . 55.450000000000003 117.057 -172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 86.91 66.13 0.01 OUTLIER 'General case' 0 CA--C 1.463 -2.398 0 N-CA-C 105.564 -2.013 . . . . 53.32 105.564 -170.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 31' ' ' VAL . 8.9 t -84.39 -166.88 1.57 Allowed 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 111.807 -2.451 . . . . 72.329999999999998 105.785 -175.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -59.43 -26.57 65.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 C-N-CA 123.803 0.841 . . . . 73.340000000000003 110.952 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' THR . 27.3 m -87.46 139.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 106.749 -1.574 . . . . 63.130000000000003 106.749 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -51.95 -58.16 7.32 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.882 0.873 . . . . 72.329999999999998 111.711 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -79.93 8.49 6.84 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.941 -0.474 . . . . 63.409999999999997 111.062 -168.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.25 29.33 74.2 Favored Glycine 0 C--N 1.36 1.864 0 N-CA-C 108.537 -1.825 . . . . 71.109999999999999 108.537 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.14 127.53 27.29 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.037 -1.625 . . . . 72.310000000000002 109.037 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 25' ' ' GLY . 1.2 mm -79.03 104.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.361 -2.829 . . . . 71.530000000000001 103.361 172.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -98.43 146.5 25.67 Favored 'General case' 0 CA--C 1.474 -1.974 0 N-CA-C 107.69 -1.226 . . . . 74.200000000000003 107.69 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 130.72 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.983 -1.858 . . . . 54.109999999999999 105.983 171.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -104.92 -47.14 4.1 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 107.005 -1.48 . . . . 71.219999999999999 107.005 -168.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.06 147.89 39.32 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 105.841 -1.911 . . . . 74.219999999999999 105.841 -169.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.3 t -132.93 128.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 103.552 -2.758 . . . . 73.540000000000006 103.552 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.542 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.4 mm -64.61 144.87 98.76 Favored Pre-proline 0 N--CA 1.477 0.875 0 N-CA-C 105.959 -1.867 . . . . 74.409999999999997 105.959 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 111.99 1.05 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 N-CA-C 107.319 -1.839 . . . . 73.140000000000001 107.319 165.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 34.8 mt-30 70.55 29.58 3.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 124.58 1.175 . . . . 71.129999999999995 110.654 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.03 172.38 40.67 Favored Glycine 0 C--N 1.363 2.08 0 N-CA-C 107.946 -2.062 . . . . 74.230000000000004 107.946 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.73 76.2 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 108.689 -0.856 . . . . 41.210000000000001 108.689 -175.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.8 80.18 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 109.443 -0.577 . . . . 34.109999999999999 109.443 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 44' ' ' GLN . 36.7 tt0 -62.3 -40.66 97.02 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 109.017 -0.735 . . . . 75.109999999999999 109.017 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 m -66.08 -41.71 90.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.15 -1.056 . . . . 55.210000000000001 108.15 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.01 -40.59 91.24 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 107.616 -1.253 . . . . 74.400000000000006 107.616 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.81 -10.45 59.97 Favored Glycine 0 CA--C 1.491 -1.418 0 N-CA-C 110.859 -0.896 . . . . 74.219999999999999 110.859 172.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -81.45 -40.13 23.8 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.158 -1.052 . . . . 73.439999999999998 108.158 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.1 mt -93.75 140.78 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 106.848 -1.538 . . . . 73.319999999999993 106.848 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.32 174.9 10.06 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.057 -1.831 . . . . 71.450000000000003 106.057 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.41 143.47 57.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 106.15 -1.796 . . . . 74.420000000000002 106.15 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.92 -15.12 52.27 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.785 -2.126 . . . . 74.519999999999996 107.785 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -75.36 147.33 40.14 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 106.592 -1.633 . . . . 52.310000000000002 106.592 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.538 HH21 ' CD ' ' A' ' 91' ' ' GLU . 2.6 tmm_? -109.73 118.85 37.63 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 105.045 -2.206 . . . . 70.150000000000006 105.045 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.24 131.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 105.252 -2.129 . . . . 74.239999999999995 105.252 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 -50.77 3.24 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.868 -1.53 . . . . 73.319999999999993 106.868 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.59 166.44 20.64 Favored 'General case' 0 CA--C 1.47 -2.099 0 CA-C-O 122.313 1.054 . . . . 73.329999999999998 109.272 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.09 109.5 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 103.684 -2.709 . . . . 74.5 103.684 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.73 40.02 11.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.596 1.158 . . . . 75.430000000000007 111.556 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.28 6.81 70.63 Favored Glycine 0 CA--C 1.49 -1.528 0 N-CA-C 110.426 -1.07 . . . . 43.299999999999997 110.426 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.0 t -98.55 117.75 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.816 0 N-CA-C 104.284 -2.487 . . . . 75.209999999999994 104.284 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.1 m -69.16 110.98 4.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.646 -1.242 . . . . 73.209999999999994 107.646 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.27 -7.96 58.75 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.807 -0.812 . . . . 62.420000000000002 108.807 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.97 144.31 56.95 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 108.288 -1.004 . . . . 55.329999999999998 108.288 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.31 -30.86 3.93 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 110.784 -0.926 . . . . 41.329999999999998 110.784 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.63 164.97 15.69 Favored 'General case' 0 C--N 1.365 1.244 0 CA-C-N 118.396 1.098 . . . . 65.420000000000002 109.16 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 p -83.38 164.39 20.0 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.745 -1.206 . . . . 73.420000000000002 107.745 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.58 -37.95 86.01 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.569 -0.9 . . . . 75.150000000000006 108.569 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -58.58 -42.02 87.1 Favored 'General case' 0 C--N 1.376 1.756 0 C-N-CA 119.661 -0.816 . . . . 61.539999999999999 110.211 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -65.93 -40.12 91.14 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 108.625 -0.88 . . . . 62.509999999999998 108.625 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 23' ' ' VAL . . . -56.26 -43.29 78.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.691 -0.485 . . . . 70.450000000000003 109.691 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.58 -50.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 107.281 -1.378 . . . . 62.229999999999997 107.281 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.2 t -53.41 -28.63 30.77 Favored 'General case' 0 N--CA 1.514 2.74 0 CA-C-O 122.446 1.117 . . . . 71.409999999999997 108.649 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.7 m -71.73 -46.71 57.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.566 -1.272 . . . . 74.319999999999993 107.566 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.64 -53.06 57.42 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.006 -1.109 . . . . 63.100000000000001 108.006 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -44.45 -46.35 9.57 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 74.420000000000002 111.607 174.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -95.0 61.12 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.326 -0.99 . . . . 72.340000000000003 108.326 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.411 ' HB ' HG22 ' A' ' 86' ' ' VAL . 12.0 p -111.16 156.53 21.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.95 -1.13 . . . . 54.149999999999999 107.95 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.12 -125.43 3.58 Favored Glycine 0 CA--C 1.492 -1.348 0 N-CA-C 108.573 -1.811 . . . . 35.109999999999999 108.573 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -89.32 -52.12 5.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.868 -1.16 . . . . 75.319999999999993 107.868 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.04 136.63 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 N-CA-C 105.243 -2.132 . . . . 52.049999999999997 105.243 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 82' ' ' THR . 3.9 t -114.82 130.55 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 105.21 -2.144 . . . . 73.019999999999996 105.21 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -95.11 116.86 29.27 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.788 -2.301 . . . . 70.030000000000001 104.788 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 mt -122.1 144.56 48.85 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.552 -1.647 . . . . 62.130000000000003 106.552 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -116.73 131.53 56.93 Favored 'General case' 0 CA--C 1.459 -2.535 0 N-CA-C 103.777 -2.675 . . . . 72.219999999999999 103.777 172.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mp -133.32 155.71 48.94 Favored 'General case' 0 CA--C 1.469 -2.153 0 N-CA-C 106.493 -1.669 . . . . 73.099999999999994 106.493 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.538 ' CD ' HH21 ' A' ' 58' ' ' ARG . 31.8 tt0 -123.93 133.82 53.65 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.894 -2.261 . . . . 75.409999999999997 104.894 -175.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 7.0 mmpt? -69.08 150.7 47.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.081 0.943 . . . . 54.32 109.517 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 94' ' ' GLN . . . 163.25 23.69 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.363 0 N-CA-C 108.877 -1.689 . . . . 64.540000000000006 108.877 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.412 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 4.0 pm0 -77.88 -178.86 5.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.451 -1.315 . . . . 75.540000000000006 107.451 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -83.59 119.65 74.1 Favored Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 103.577 -2.749 . . . . 74.019999999999996 103.577 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.72 76.68 2.37 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.659 2.239 . . . . 72.140000000000001 109.783 -167.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.415 -2.204 0 N-CA-C 104.477 -2.416 . . . . 71.420000000000002 104.477 172.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.276 0 N-CA-C 108.466 -1.853 . . . . 72.230000000000004 108.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.18 158.66 14.34 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.605 2.87 . . . . 73.400000000000006 109.687 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -82.46 161.6 58.79 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 106.332 -1.729 . . . . 71.209999999999994 106.332 -173.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.62 120.29 8.11 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.33 2.02 . . . . 74.150000000000006 109.881 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.563 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 105.32 -21.06 36.16 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 108.624 -1.79 . . . . 62.539999999999999 108.624 177.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.92 140.58 58.3 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.907 -0.775 . . . . 64.230000000000004 108.907 -176.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.83 134.92 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 103.643 -2.725 . . . . 75.230000000000004 103.643 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.16 150.76 44.62 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.327 -1.731 . . . . 74.430000000000007 106.327 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -102.71 140.95 36.32 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 105.497 -2.038 . . . . 72.519999999999996 105.497 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.1 t -124.9 125.99 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 103.878 -2.638 . . . . 72.239999999999995 103.878 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -102.76 125.06 49.36 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 105.414 -2.069 . . . . 50.340000000000003 105.414 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.27 121.66 42.66 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.638 -1.616 . . . . 74.049999999999997 106.638 -168.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.55 139.49 34.19 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 106.274 -1.75 . . . . 51.130000000000003 106.274 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.08 33.44 3.81 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 106.304 -1.739 . . . . 61.520000000000003 106.304 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -81.77 55.46 2.72 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.445 -1.687 . . . . 63.119999999999997 106.445 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 17' ' ' ASN . 22.8 t70 -139.13 -133.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 102.073 -3.306 . . . . 74.430000000000007 102.073 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 72.1 m-20 -135.18 -55.68 0.81 Allowed 'General case' 0 CA--C 1.48 -1.739 0 N-CA-C 103.981 -2.6 . . . . 75.230000000000004 103.981 171.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 m -73.24 110.75 7.76 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.086 -1.079 . . . . 73.209999999999994 108.086 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -72.7 -56.87 4.64 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.597 -2.742 . . . . 65.25 103.597 171.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.47 49.3 80.0 Favored Glycine 0 CA--C 1.48 -2.14 0 CA-C-N 112.425 -2.17 . . . . 74.239999999999995 112.753 165.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.9 mt -127.21 150.52 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 104.056 -2.572 . . . . 43.539999999999999 104.056 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.2 m -151.88 167.21 29.04 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 102.673 -3.084 . . . . 63.32 102.673 167.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.08 168.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 106.111 -1.811 . . . . 51.020000000000003 106.111 -167.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -139.54 166.12 25.42 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 102.711 -3.07 . . . . 54.530000000000001 102.711 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' HD13 ' A' ' 36' ' ' ILE . . . 87.66 131.19 3.41 Favored Glycine 0 C--O 1.199 -2.054 0 N-CA-C 109.637 -1.385 . . . . 73.010000000000005 109.637 175.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.27 -92.18 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 107.874 -2.09 . . . . 52.310000000000002 107.874 165.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.36 19.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.376 1.471 . . . . 61.439999999999998 114.169 -171.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 88.5 65.79 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.942 -1.503 . . . . 70.109999999999999 106.942 -167.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 30' ' ' SER . 2.4 m -88.09 -166.45 1.59 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.877 -2.638 . . . . 74.109999999999999 103.877 172.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.68 ' H ' HG22 ' A' ' 29' ' ' THR . 5.0 m -44.86 -33.22 1.86 Allowed 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.661 1.184 . . . . 53.43 112.063 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 31' ' ' VAL . 14.4 m -85.36 129.15 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.055 -1.091 . . . . 74.430000000000007 108.055 -176.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -66.45 -34.16 77.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.041 -0.981 . . . . 74.310000000000002 112.789 -166.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -75.57 -2.25 28.27 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.962 -1.086 . . . . 73.099999999999994 109.338 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.97 20.2 59.83 Favored Glycine 0 C--N 1.36 1.906 0 N-CA-C 108.281 -1.927 . . . . 54.100000000000001 108.281 -167.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.38 153.06 48.92 Favored Glycine 0 CA--C 1.476 -2.358 0 N-CA-C 107.964 -2.054 . . . . 41.039999999999999 107.964 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 75' ' ' ALA . 2.8 mm -90.72 119.87 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 103.89 -2.633 . . . . 73.540000000000006 103.89 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -116.69 145.88 43.15 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 106.667 -1.605 . . . . 71.409999999999997 106.667 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.67 131.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.175 -1.416 . . . . 71.340000000000003 107.175 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.0 -47.02 3.79 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 106.665 -1.605 . . . . 71.140000000000001 106.665 -168.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.84 138.51 42.59 Favored 'General case' 0 CA--C 1.468 -2.208 0 N-CA-C 105.594 -2.002 . . . . 71.129999999999995 105.594 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.02 126.31 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 105.081 -2.192 . . . . 70.239999999999995 105.081 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -69.9 137.24 87.51 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 106.685 -1.598 . . . . 62.210000000000001 106.685 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.87 117.67 4.46 Favored 'Trans proline' 0 C--N 1.362 1.241 0 C-N-CA 122.367 2.045 . . . . 62.299999999999997 108.31 174.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 62.03 25.37 15.21 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.863 0.865 . . . . 63.130000000000003 111.879 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.77 54.86 Favored Glycine 0 C--N 1.364 2.092 0 N-CA-C 105.689 -2.964 . . . . 63.119999999999997 105.689 165.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.13 48.79 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 117.325 0.562 . . . . 54.149999999999999 111.782 -171.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.95 67.03 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.199 -0.667 . . . . 62.219999999999999 109.199 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.04 -34.4 77.62 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.875 -0.417 . . . . 74.329999999999998 109.875 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.5 m -64.1 -31.96 73.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.743 -0.836 . . . . 72.239999999999995 108.743 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.85 -42.31 73.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.646 -1.242 . . . . 73.340000000000003 107.646 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.03 -20.6 35.43 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.122 -1.191 . . . . 63.219999999999999 110.122 175.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -78.27 -41.2 34.76 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.031 -1.099 . . . . 61.340000000000003 108.031 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.9 mt -95.94 134.04 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.578 -1.638 . . . . 64.129999999999995 106.578 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -147.18 179.91 7.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.952 -1.87 . . . . 74.230000000000004 105.952 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -66.82 138.56 57.43 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 106.781 -1.562 . . . . 60.200000000000003 106.781 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.6 -14.18 50.3 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 108.528 -1.829 . . . . 71.400000000000006 108.528 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HA ' ' HG3' ' A' ' 94' ' ' GLN . 1.6 m-20 -71.64 151.02 44.06 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 108.737 -0.838 . . . . 73.349999999999994 108.737 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -113.18 126.9 55.94 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.287 -2.116 . . . . 75.129999999999995 105.287 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 t -104.77 142.15 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 104.554 -2.388 . . . . 72.299999999999997 104.554 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.81 -48.22 2.76 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.342 -1.355 . . . . 75.329999999999998 107.342 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.95 164.14 24.89 Favored 'General case' 0 CA--C 1.483 -1.598 0 CA-C-O 122.327 1.06 . . . . 72.439999999999998 109.785 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.14 109.1 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 N-CA-C 104.302 -2.481 . . . . 72.349999999999994 104.302 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 48.0 42.16 16.18 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.829 0.852 . . . . 63.219999999999999 110.598 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.4 10.08 82.59 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.691 -0.964 . . . . 70.310000000000002 110.691 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.31 118.02 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 104.712 -2.329 . . . . 73.140000000000001 104.712 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -71.42 113.07 8.08 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.307 -1.368 . . . . 72.209999999999994 107.307 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.2 mt -70.68 -23.15 62.43 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 115.222 -0.899 . . . . 74.420000000000002 109.608 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -55.49 144.94 24.24 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.532 0.682 . . . . 74.400000000000006 110.664 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.85 -33.31 5.28 Favored Glycine 0 CA--C 1.496 -1.15 0 N-CA-C 109.369 -1.492 . . . . 70.430000000000007 109.369 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.59 162.55 28.69 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.033 -0.729 . . . . 55.439999999999998 109.033 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -80.48 167.32 20.29 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.832 -1.174 . . . . 61.439999999999998 107.832 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -64.69 -39.05 93.0 Favored 'General case' 0 C--O 1.208 -1.085 0 N-CA-C 106.543 -1.651 . . . . 71.099999999999994 106.543 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -51.9 -51.03 59.69 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 123.618 0.767 . . . . 73.430000000000007 110.047 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -66.65 -39.73 88.37 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 109.165 -0.679 . . . . 53.149999999999999 109.165 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -54.94 -41.06 70.59 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.42 0.555 . . . . 64.519999999999996 109.778 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.03 -54.64 17.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 N-CA-C 106.873 -1.528 . . . . 71.5 106.873 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 11.1 t -54.77 -28.65 50.31 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-O 122.268 1.032 . . . . 74.010000000000005 108.763 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.4 m -66.57 -53.76 31.05 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.331 -1.359 . . . . 54.009999999999998 107.331 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.35 -55.51 27.83 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 108.589 -0.893 . . . . 74.310000000000002 108.589 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -46.67 -32.82 3.78 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.882 0.697 . . . . 72.530000000000001 112.882 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.64 2.17 51.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.49 -0.756 . . . . 72.409999999999997 110.252 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.5 p -73.98 168.47 19.43 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 119.5 1.045 . . . . 75.340000000000003 109.44 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.1 -166.39 28.5 Favored Glycine 0 C--N 1.371 2.499 0 N-CA-C 108.783 -1.727 . . . . 52.140000000000001 108.783 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -83.29 -32.18 26.51 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.792 -0.818 . . . . 52.329999999999998 108.792 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.3 t -112.37 130.46 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 103.573 -2.751 . . . . 64.329999999999998 103.573 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 t -132.88 150.19 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.116 -2.179 . . . . 75.140000000000001 105.116 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -110.3 121.62 45.72 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 104.968 -2.234 . . . . 65.25 104.968 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.8 mt -116.4 141.33 48.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 N-CA-C 104.711 -2.329 . . . . 71.319999999999993 104.711 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.2 tp -114.73 127.84 55.97 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 105.672 -1.973 . . . . 64.349999999999994 105.672 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.11 155.8 50.11 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 106.337 -1.727 . . . . 73.0 106.337 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -124.45 136.53 54.11 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 105.085 -2.191 . . . . 62.539999999999999 105.085 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 74.2 mmtt -69.1 144.69 53.84 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 122.236 1.017 . . . . 71.519999999999996 109.579 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.94 49.94 0.08 OUTLIER Glycine 0 CA--C 1.469 -2.823 0 N-CA-C 103.975 -3.65 . . . . 65.5 103.975 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.504 HE22 ' HA ' ' A' ' 92' ' ' LYS . 11.7 mp0 -76.0 136.13 39.98 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 105.488 -2.041 . . . . 72.019999999999996 105.488 -176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 45.2 m -81.12 161.09 64.08 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 105.979 -1.86 . . . . 75.030000000000001 105.979 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 38.4 Cg_endo -65.4 162.2 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.234 1.956 . . . . 45.439999999999998 108.957 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 106.225 -1.768 . . . . 71.5 106.225 -179.726 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.416 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.624 0 N-CA-C 107.842 -2.103 . . . . 75.349999999999994 107.842 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.5 146.84 81.14 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.65 2.233 . . . . 62.109999999999999 108.606 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 98.6 mttt -106.88 159.99 27.93 Favored Pre-proline 0 N--CA 1.433 -1.282 0 N-CA-C 105.037 -2.209 . . . . 74.010000000000005 105.037 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 3' ' ' LYS . 28.7 Cg_endo -62.21 138.14 70.28 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.217 1.944 . . . . 64.230000000000004 108.806 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.71 -21.35 16.56 Favored Glycine 0 CA--C 1.484 -1.856 0 N-CA-C 108.322 -1.911 . . . . 33.439999999999998 108.322 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.36 132.99 43.67 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.6 -0.889 . . . . 74.340000000000003 108.6 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.03 137.8 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 N-CA-C 105.003 -2.221 . . . . 73.450000000000003 105.003 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -137.6 153.6 49.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.572 -2.01 . . . . 51.420000000000002 105.572 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.76 141.46 35.52 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 106.758 -1.571 . . . . 74.450000000000003 106.758 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.5 126.06 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 103.894 -2.632 . . . . 75.209999999999994 103.894 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -96.76 125.53 41.28 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.553 -2.388 . . . . 73.329999999999998 104.553 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 121.04 44.34 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.611 -1.626 . . . . 75.140000000000001 106.611 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.71 102.78 13.26 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 104.268 -2.493 . . . . 75.120000000000005 104.268 170.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -119.61 36.49 4.48 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.456 -1.247 . . . . 75.140000000000001 107.89 -164.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -56.74 162.93 2.08 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 109.087 -0.709 . . . . 74.239999999999995 109.087 -170.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.5 124.98 22.37 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 108.238 -1.023 . . . . 70.200000000000003 108.238 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -176.56 -148.64 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 99.379 -4.304 . . . . 71.109999999999999 99.379 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.0 m -80.28 112.65 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.594 -2.373 . . . . 51.509999999999998 104.594 166.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.66 -57.91 3.95 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 105.137 -2.172 . . . . 71.420000000000002 105.137 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 41.55 40.61 Favored Glycine 0 CA--C 1.474 -2.471 0 N-CA-C 109.702 -1.359 . . . . 53.530000000000001 109.702 161.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.8 mt -131.32 144.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 103.02 -2.956 . . . . 73.420000000000002 103.02 172.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.1 m -147.81 163.69 35.95 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 103.484 -2.784 . . . . 64.099999999999994 103.484 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 m -146.03 169.1 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 105.727 -1.953 . . . . 74.450000000000003 105.727 -160.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -145.53 167.23 23.51 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 103.65 -2.722 . . . . 51.409999999999997 103.65 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.86 -172.98 14.67 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.061 -2.415 . . . . 51.240000000000002 107.061 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.06 -123.17 5.24 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 109.185 -1.566 . . . . 71.010000000000005 109.185 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 m -72.47 19.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 126.114 1.765 . . . . 72.5 112.908 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 87.58 64.47 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.12 -1.807 . . . . 61.420000000000002 106.12 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 30' ' ' SER . 3.3 m -84.8 -165.7 1.27 Allowed 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 103.827 -2.657 . . . . 63.130000000000003 103.827 170.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.695 ' H ' HG22 ' A' ' 29' ' ' THR . 3.6 m -37.45 -40.37 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.616 1.566 . . . . 74.140000000000001 112.911 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.57 135.34 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 108.159 -1.052 . . . . 71.540000000000006 108.159 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.7 mtm105 -72.47 -35.33 68.21 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.57 -0.9 . . . . 72.209999999999994 108.57 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.88 -17.25 63.0 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 109.118 -0.697 . . . . 52.219999999999999 109.118 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 -3.19 3.78 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.189 -0.364 . . . . 73.450000000000003 112.189 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.32 170.61 47.72 Favored Glycine 0 CA--C 1.483 -1.956 0 N-CA-C 107.229 -2.348 . . . . 71.010000000000005 107.229 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.39 132.13 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.436 -2.061 . . . . 63.310000000000002 105.436 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -124.97 140.71 52.67 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 104.989 -2.226 . . . . 73.319999999999993 104.989 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -68.51 132.67 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 106.953 -1.499 . . . . 71.329999999999998 106.953 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -106.21 -46.23 4.11 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 107.295 -1.372 . . . . 50.140000000000001 107.295 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.26 144.17 38.28 Favored 'General case' 0 CA--C 1.46 -2.499 0 N-CA-C 105.608 -1.997 . . . . 43.340000000000003 105.608 -173.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.9 129.55 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 104.581 -2.378 . . . . 74.329999999999998 104.581 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 mt -74.36 138.91 74.84 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 106.125 -1.805 . . . . 72.400000000000006 106.125 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.8 110.76 0.88 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.614 2.21 . . . . 25.539999999999999 108.166 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 70.67 25.5 4.09 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.378 1.049 . . . . 71.420000000000002 111.318 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.44 -173.67 33.94 Favored Glycine 0 C--N 1.357 1.717 0 N-CA-C 106.34 -2.704 . . . . 54.520000000000003 106.34 162.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.4 -49.27 78.46 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 121.942 -0.74 . . . . 52.450000000000003 110.091 -171.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.4 80.53 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 110.155 -0.313 . . . . 75.239999999999995 110.155 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.13 -34.42 73.05 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.345 -0.613 . . . . 60.399999999999999 109.345 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 t -67.98 -39.69 83.26 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.481 -1.303 . . . . 72.219999999999999 107.481 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -67.76 -32.76 73.57 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 107.931 -1.137 . . . . 55.119999999999997 107.931 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.48 -25.99 4.78 Favored Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 110.951 -0.86 . . . . 72.329999999999998 110.951 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -69.63 -40.1 76.74 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.536 -0.912 . . . . 74.510000000000005 108.536 -173.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 mt -98.38 138.46 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 105.924 -1.88 . . . . 73.340000000000003 105.924 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -134.76 174.43 10.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.143 -1.428 . . . . 61.109999999999999 107.143 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -66.53 138.98 57.89 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.695 -1.965 . . . . 73.230000000000004 105.695 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.7 -4.8 61.72 Favored Glycine 0 CA--C 1.495 -1.198 0 N-CA-C 109.191 -1.563 . . . . 40.520000000000003 109.191 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.43 152.96 37.9 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 107.383 -1.34 . . . . 73.420000000000002 107.383 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -112.79 123.83 51.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.15 -2.167 . . . . 71.209999999999994 105.15 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 t -104.73 139.97 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 104.741 -2.318 . . . . 70.140000000000001 104.741 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.08 -55.35 2.34 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.019 -1.474 . . . . 75.200000000000003 107.019 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.57 165.18 23.3 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 122.153 0.977 . . . . 72.200000000000003 109.531 -168.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.62 109.84 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 105.085 -2.191 . . . . 70.209999999999994 105.085 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 51.72 41.37 29.0 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.615 1.166 . . . . 62.229999999999997 111.812 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.44 7.01 73.07 Favored Glycine 0 CA--C 1.498 -1.006 0 N-CA-C 109.396 -1.482 . . . . 33.219999999999999 109.396 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 67' ' ' LEU . 26.8 t -112.12 117.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 105.134 -2.172 . . . . 73.049999999999997 105.134 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -80.8 15.39 1.78 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.332 -0.395 . . . . 74.209999999999994 110.424 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.496 ' H ' HG12 ' A' ' 65' ' ' VAL . 87.5 mt 38.79 45.11 0.89 Allowed 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.236 1.414 . . . . 72.209999999999994 110.937 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.2 125.14 28.62 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.514 -0.921 . . . . 45.140000000000001 108.514 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.96 -4.52 81.61 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.822 -1.711 . . . . 74.099999999999994 108.822 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.71 137.4 56.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 108.299 -1.0 . . . . 54.340000000000003 108.299 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.7 p -76.13 174.04 10.56 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.752 -1.573 . . . . 75.549999999999997 106.752 176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -61.18 -39.83 91.62 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 107.816 -1.179 . . . . 71.319999999999993 107.816 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.01 -50.68 66.08 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.878 0.471 . . . . 65.450000000000003 110.713 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -66.62 -29.25 69.25 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.241 0.928 . . . . 63.299999999999997 109.437 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.53 -38.5 84.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.562 -0.903 . . . . 62.240000000000002 108.562 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.5 t -72.82 -49.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.009 -1.478 . . . . 73.450000000000003 107.009 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.1 m -52.49 -29.28 24.15 Favored 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 108.488 -0.93 . . . . 72.340000000000003 108.488 -174.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.9 m -65.81 -55.87 14.88 Favored 'General case' 0 C--O 1.199 -1.597 0 N-CA-C 107.486 -1.301 . . . . 65.430000000000007 107.486 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.5 mt -56.03 -56.14 24.34 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 108.943 -0.762 . . . . 72.329999999999998 108.943 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -49.85 -28.01 5.9 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.482 0.549 . . . . 54.420000000000002 112.482 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -92.87 -13.15 29.39 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.774 -0.579 . . . . 54.229999999999997 109.708 -174.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.3 p -80.56 173.71 12.33 Favored 'General case' 0 C--O 1.245 0.839 0 O-C-N 120.795 -1.191 . . . . 74.150000000000006 108.909 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.79 -155.33 11.8 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.645 -1.382 . . . . 55.130000000000003 109.645 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -80.11 -43.77 21.14 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 107.443 -1.318 . . . . 72.310000000000002 107.443 -173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.75 131.27 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.892 0 N-CA-C 103.502 -2.777 . . . . 71.540000000000006 103.502 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.54 140.02 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 105.379 -2.082 . . . . 70.150000000000006 105.379 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -97.18 118.11 32.88 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 104.834 -2.284 . . . . 74.430000000000007 104.834 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 34.5 mt -121.19 142.39 49.94 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 105.661 -1.978 . . . . 72.540000000000006 105.661 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mp -116.06 133.25 56.23 Favored 'General case' 0 CA--C 1.461 -2.465 0 N-CA-C 104.723 -2.325 . . . . 74.209999999999994 104.723 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.43 152.74 51.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.314 -1.736 . . . . 53.43 106.314 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -115.2 129.52 56.67 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.627 -1.99 . . . . 71.019999999999996 105.627 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 4' ' ' PRO . 7.9 tmtt? -62.4 138.05 58.38 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.32 -0.622 . . . . 73.510000000000005 109.32 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.13 51.39 0.08 OUTLIER Glycine 0 CA--C 1.463 -3.188 0 N-CA-C 104.139 -3.585 . . . . 75.109999999999999 104.139 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -90.11 155.05 19.32 Favored 'General case' 0 CA--C 1.478 -1.823 0 N-CA-C 107.036 -1.468 . . . . 62.439999999999998 107.036 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 47.1 m -83.88 166.1 35.73 Favored Pre-proline 0 N--CA 1.428 -1.533 0 N-CA-C 105.124 -2.176 . . . . 51.009999999999998 105.124 169.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 28.9 Cg_endo -62.7 167.91 11.0 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 122.276 1.984 . . . . 73.109999999999999 110.062 172.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 105.43 -2.063 . . . . 74.409999999999997 105.43 -174.515 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.484 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.367 0 N-CA-C 108.291 -1.924 . . . . 71.120000000000005 108.291 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.17 143.92 73.16 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.033 2.489 . . . . 74.400000000000006 109.217 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -85.19 163.19 46.42 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 106.707 -1.59 . . . . 74.329999999999998 106.707 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.81 137.93 60.88 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.067 1.845 . . . . 71.420000000000002 107.712 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.55 61.08 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 108.97 -1.652 . . . . 70.230000000000004 108.97 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.01 126.57 28.99 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.804 -1.184 . . . . 64.430000000000007 107.804 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.59 134.96 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 103.847 -2.649 . . . . 74.120000000000005 103.847 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -138.85 153.13 48.3 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 106.75 -1.574 . . . . 72.519999999999996 106.75 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -103.06 136.95 41.92 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 105.515 -2.032 . . . . 74.409999999999997 105.515 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.36 130.71 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.123 0 N-CA-C 104.217 -2.512 . . . . 71.150000000000006 104.217 173.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -107.22 114.9 29.24 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 104.048 -2.575 . . . . 73.349999999999994 104.048 170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.31 122.66 44.68 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 105.051 -2.203 . . . . 64.400000000000006 105.051 -168.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.26 146.67 25.97 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.025 -1.842 . . . . 42.25 106.025 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.32 33.57 3.07 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.714 -1.588 . . . . 75.099999999999994 106.714 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -69.23 -46.48 67.26 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 106.524 -1.658 . . . . 73.310000000000002 106.524 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.36 -71.85 0.11 Allowed 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.913 -0.773 . . . . 73.150000000000006 108.913 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -148.82 -177.79 5.99 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.6 -1.259 . . . . 55.119999999999997 107.6 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 m -45.44 176.34 0.0 OUTLIER 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.979 1.712 . . . . 75.5 113.947 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 mt -59.37 -57.88 11.07 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-N 114.819 -1.082 . . . . 61.299999999999997 110.751 -166.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' CA ' HG12 ' A' ' 42' ' ' ILE . . . 43.39 48.92 6.94 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 125.835 1.684 . . . . 63.310000000000002 114.171 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.2 mt -136.72 154.39 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 104.095 -2.557 . . . . 72.510000000000005 104.095 170.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -149.76 165.81 31.33 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 103.249 -2.871 . . . . 53.229999999999997 103.249 168.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.51 168.39 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 106.735 -1.58 . . . . 72.209999999999994 106.735 -164.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.0 t -148.3 167.21 25.76 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 102.625 -3.102 . . . . 73.310000000000002 102.625 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.34 -171.77 14.42 Favored Glycine 0 CA--C 1.474 -2.499 0 N-CA-C 107.568 -2.213 . . . . 33.350000000000001 107.568 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.89 -120.87 4.41 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 110.098 -1.201 . . . . 71.230000000000004 110.098 171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.99 19.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.632 0 C-N-CA 126.204 1.801 . . . . 74.299999999999997 113.96 -165.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 88.05 66.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 123.251 1.501 . . . . 74.319999999999993 107.915 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -86.78 -165.4 1.27 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 103.107 -2.923 . . . . 73.450000000000003 103.107 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -44.73 -28.91 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.902 0.881 . . . . 61.229999999999997 112.626 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -88.18 124.07 41.05 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 N-CA-C 107.476 -1.305 . . . . 75.439999999999998 107.476 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -72.66 -23.61 60.92 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 116.088 -0.505 . . . . 55.210000000000001 109.883 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.68 -17.02 64.0 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.197 -1.038 . . . . 71.109999999999999 108.197 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.08 7.86 26.42 Favored Glycine 0 C--N 1.356 1.673 0 N-CA-C 110.479 -1.048 . . . . 74.219999999999999 110.479 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 162.03 49.56 Favored Glycine 0 CA--C 1.48 -2.155 0 N-CA-C 108.238 -1.945 . . . . 53.219999999999999 108.238 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.2 mm -90.45 133.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 104.221 -2.511 . . . . 72.420000000000002 104.221 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -124.79 145.29 49.82 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 105.154 -2.165 . . . . 73.099999999999994 105.154 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.12 134.33 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.675 -1.232 . . . . 74.319999999999993 107.675 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -106.38 -49.39 3.35 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.465 -1.68 . . . . 71.510000000000005 106.465 -169.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.08 140.85 34.26 Favored 'General case' 0 CA--C 1.463 -2.393 0 N-CA-C 105.948 -1.871 . . . . 34.109999999999999 105.948 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.51 131.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 103.593 -2.743 . . . . 73.219999999999999 103.593 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.492 HG12 ' CA ' ' A' ' 20' ' ' GLY . 14.1 mm -64.66 142.16 98.44 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 105.568 -2.012 . . . . 73.0 105.568 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.11 111.33 0.96 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 N-CA-C 107.121 -1.915 . . . . 54.340000000000003 107.121 165.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 75.32 26.0 1.22 Allowed 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.826 1.329 . . . . 73.219999999999999 110.957 -174.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.62 172.62 48.24 Favored Glycine 0 C--N 1.364 2.127 0 N-CA-C 107.397 -2.281 . . . . 71.140000000000001 107.397 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.88 71.01 Favored 'General case' 0 C--N 1.368 1.375 0 O-C-N 122.091 -0.653 . . . . 72.540000000000006 109.36 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.01 74.97 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.513 -0.921 . . . . 74.0 108.513 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.53 -36.41 82.62 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 109.129 -0.693 . . . . 71.299999999999997 109.129 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -65.67 -39.69 91.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.715 -0.846 . . . . 73.430000000000007 108.715 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.64 -40.72 72.92 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.17 -1.048 . . . . 75.140000000000001 108.17 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.459 ' O ' ' CE1' ' A' ' 54' ' ' HIS . . . 95.5 -13.75 66.07 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 110.42 -1.072 . . . . 72.230000000000004 110.42 172.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -84.99 -41.35 15.92 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.618 -0.931 . . . . 70.310000000000002 109.808 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 mt -97.09 127.95 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 N-CA-C 106.275 -1.75 . . . . 72.299999999999997 106.275 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 51' ' ' GLY . 44.5 m-70 -122.69 174.59 7.01 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.46 -1.682 . . . . 72.120000000000005 106.46 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -66.7 137.83 56.97 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.357 -1.72 . . . . 74.120000000000005 106.357 166.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 -17.25 57.34 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 108.923 -1.671 . . . . 63.409999999999997 108.923 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 94' ' ' GLN . 1.0 OUTLIER -65.22 147.21 53.86 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 109.044 -0.724 . . . . 75.120000000000005 109.044 -174.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -105.66 125.88 51.5 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 106.286 -1.746 . . . . 72.5 106.286 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.99 144.07 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 104.811 -2.292 . . . . 61.0 104.811 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -45.13 2.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.314 -1.365 . . . . 54.020000000000003 107.314 175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.85 160.46 33.45 Favored 'General case' 0 CA--C 1.48 -1.733 0 C-N-CA 118.838 -1.145 . . . . 72.400000000000006 109.268 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.6 109.39 6.39 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.682 0 N-CA-C 105.315 -2.106 . . . . 33.130000000000003 105.315 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 t30 47.79 40.51 12.55 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.922 1.689 . . . . 73.409999999999997 111.911 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.24 4.58 83.74 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 109.483 -1.447 . . . . 75.25 109.483 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.04 122.76 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 104.826 -2.287 . . . . 62.229999999999997 104.826 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.9 m -70.63 111.18 5.92 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.23 -1.026 . . . . 74.349999999999994 108.23 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.72 9.39 37.24 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 106.842 -1.54 . . . . 64.239999999999995 106.842 171.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -65.69 133.67 51.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.983 -1.488 . . . . 74.230000000000004 106.983 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.26 -18.65 5.18 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-O 119.629 -0.54 . . . . 72.209999999999994 111.78 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 171.71 1.87 Allowed 'General case' 0 C--N 1.37 1.459 0 CA-C-N 118.397 1.099 . . . . 74.329999999999998 110.228 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -83.85 159.86 21.28 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.485 -1.302 . . . . 73.310000000000002 107.485 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -63.33 -42.51 98.97 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.43 -0.952 . . . . 75.209999999999994 108.43 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -59.7 -43.13 94.22 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 110.024 -0.361 . . . . 71.310000000000002 110.024 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -61.71 -36.28 80.49 Favored 'General case' 0 C--N 1.383 2.035 0 O-C-N 121.368 -0.833 . . . . 54.200000000000003 109.164 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.97 79.53 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.958 -0.756 . . . . 52.240000000000002 108.958 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.9 t -73.89 -50.56 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.219 -1.4 . . . . 75.349999999999994 107.219 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 83.0 m -53.01 -29.94 32.41 Favored 'General case' 0 N--CA 1.524 3.259 0 CA-C-O 122.07 0.938 . . . . 74.430000000000007 108.617 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -67.32 -53.82 26.16 Favored 'General case' 0 C--O 1.209 -1.074 0 O-C-N 120.933 -1.104 . . . . 53.119999999999997 108.033 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.84 -55.48 31.94 Favored 'General case' 0 C--O 1.211 -0.97 0 N-CA-C 109.149 -0.686 . . . . 63.149999999999999 109.149 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -48.28 -28.22 2.96 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.57 0.582 . . . . 70.219999999999999 112.57 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -92.77 -14.66 27.58 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.638 -0.664 . . . . 62.25 110.078 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 p -81.86 171.13 14.85 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 120.725 -1.234 . . . . 60.140000000000001 109.659 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.95 -154.2 12.91 Favored Glycine 0 C--N 1.36 1.881 0 N-CA-C 110.037 -1.225 . . . . 72.25 110.037 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -80.48 -35.8 34.3 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 107.857 -1.164 . . . . 55.119999999999997 107.857 -173.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -112.84 126.87 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 104.554 -2.387 . . . . 52.340000000000003 104.554 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.7 139.36 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.308 0 N-CA-C 103.486 -2.783 . . . . 61.240000000000002 103.486 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -96.7 118.98 34.33 Favored 'General case' 0 CA--C 1.474 -1.96 0 N-CA-C 104.649 -2.352 . . . . 74.230000000000004 104.649 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.6 mt -115.97 136.82 52.68 Favored 'General case' 0 CA--C 1.468 -2.173 0 N-CA-C 105.18 -2.156 . . . . 64.239999999999995 105.18 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.21 125.51 54.41 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 105.051 -2.203 . . . . 72.430000000000007 105.051 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.12 161.33 36.03 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 105.634 -1.988 . . . . 63.130000000000003 105.634 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -138.48 158.41 44.32 Favored 'General case' 0 CA--C 1.468 -2.191 0 N-CA-C 108.0 -1.111 . . . . 65.219999999999999 108.0 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -70.55 144.58 51.23 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 114.258 -1.337 . . . . 61.020000000000003 110.931 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 128.27 34.85 0.52 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 105.03 -3.228 . . . . 42.32 105.03 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -91.03 151.77 20.92 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 106.855 -1.535 . . . . 63.119999999999997 106.855 -175.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.502 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 14.5 m -83.29 168.03 25.15 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 106.513 -1.662 . . . . 75.109999999999999 106.513 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 95' ' ' SER . 35.8 Cg_endo -65.29 169.34 12.51 Favored 'Trans proline' 0 C--O 1.25 1.11 0 C-N-CA 122.34 2.027 . . . . 61.219999999999999 108.965 174.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 C--O 1.258 1.537 0 N-CA-C 108.438 -0.949 . . . . 73.319999999999993 108.438 -177.058 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.401 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_